SASSI,Descr,ASTAI,CURAB,VARI,ASSSUBCEFRAC,ASI,TII,CHI,SRI,BFO,ASSCA,ASTTY,ASSTR,RELATT,CEI,ASSTIS,DI,ASSORG,Ti,ASSTY,ASCETY,CONFSCO
,Biodistribution in normal rat kidney in the presence of 0.005 M Gd/0.01 M lig at 2 hr,10116.0,Intermediate,,,7524,2113.0,CHEMBL618647,1,BAO_0000218,,In vivo,,N,,Kidney,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in normal rat kidney in the presence of 0.01 M Gd/0.05 M lig,10116.0,Intermediate,,,7525,2113.0,CHEMBL618648,1,BAO_0000218,,In vivo,,N,,Kidney,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in normal rat kidney in the presence of NAC Gd 0.01 M lig at 2 hr,10116.0,Intermediate,,,7526,2113.0,CHEMBL618649,1,BAO_0000218,,In vivo,,N,,Kidney,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in normal rat liver in the presence of 0.005 M Gd/0.01 M lig at 2 hr,10116.0,Intermediate,,,7527,2107.0,CHEMBL618650,1,BAO_0000218,,In vivo,,N,,Liver,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in normal rat liver in the presence of 0.01 M Gd/0.05 M lig,10116.0,Intermediate,,,7528,2107.0,CHEMBL618651,1,BAO_0000218,,In vivo,,N,,Liver,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in normal rat liver in the presence of NAC Gd 0.01 M lig at 2 hr,10116.0,Intermediate,,,7529,2107.0,CHEMBL876497,1,BAO_0000218,,In vivo,,N,,Liver,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in normal rat lung in the presence of 0.005 M Gd/0.01 M lig at 2 hr,10116.0,Intermediate,,,7530,2048.0,CHEMBL618652,1,BAO_0000218,,In vivo,,N,,Lung,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in normal rat lung in the presence of 0.01 M Gd/0.05 M lig,10116.0,Intermediate,,,7531,2048.0,CHEMBL618653,1,BAO_0000218,,In vivo,,N,,Lung,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in normal rat lung in the presence of NAC Gd 0.01 M lig at 2 hr,10116.0,Intermediate,,,7532,2048.0,CHEMBL618654,1,BAO_0000218,,In vivo,,N,,Lung,9866,Rattus norvegicus,50597,A,,1
,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats; Not tested,10116.0,Intermediate,,,7533,,CHEMBL618655,1,BAO_0000218,,,,N,,,6351,Rattus norvegicus,50597,A,,1
,Compound was tested for solubility in water,10116.0,Intermediate,,,7534,,CHEMBL618656,1,BAO_0000218,,,,N,,,1465,Rattus norvegicus,50597,A,,1
,Solubility in phosphate buffered saline (1% DMSO) at pH 6.5 (24 hr equilibration),,Intermediate,,,7535,,CHEMBL618657,1,BAO_0000100,,,,U,,,5182,,22229,P,,0
,Solubility was determined,10116.0,Intermediate,,,7536,,CHEMBL618658,1,BAO_0000218,,,,N,,,17847,Rattus norvegicus,50597,A,,1
,solubility in water (ug/mL) at 37 degree C.,10116.0,Intermediate,,,7537,,CHEMBL618659,1,BAO_0000218,,,,N,,,15339,Rattus norvegicus,50597,A,,1
,First pass metabolism and metabolic bioavailability using rat hepatic microsomes,10116.0,Intermediate,,,7538,,CHEMBL618660,1,BAO_0000218,,,,N,,,5202,Rattus norvegicus,50597,A,,1
,In vitro stability relative to (+)-AJ76 in rat hepatocyte assay,10116.0,Intermediate,,,7539,,CHEMBL618661,1,BAO_0000218,,,,N,,,1088,Rattus norvegicus,50597,A,,1
,Half life in rats,10116.0,Intermediate,,,7540,,CHEMBL873807,1,BAO_0000218,,,,N,,,3169,Rattus norvegicus,50597,A,,1
,Half life in Dawley rat,10116.0,Intermediate,,,7541,,CHEMBL618662,1,BAO_0000218,,,,N,,,5353,Rattus norvegicus,50597,A,,1
,Half life period after 3 mg/kg iv administration,10116.0,Intermediate,,,7542,,CHEMBL618663,1,BAO_0000218,,In vivo,,N,,,2864,Rattus norvegicus,50597,A,,1
,Half life period after 3 mg/kg iv administration in rat,10116.0,Intermediate,,,7543,,CHEMBL618664,1,BAO_0000218,,In vivo,,N,,,2864,Rattus norvegicus,50597,A,,1
,Half life period after 3 mg/kg iv administration in the rat,10116.0,Intermediate,,,7544,,CHEMBL618665,1,BAO_0000218,,In vivo,,N,,,2864,Rattus norvegicus,50597,A,,1
,Half life period in female Sprague-Dawley rats,10116.0,Intermediate,,,7545,,CHEMBL876498,1,BAO_0000218,,,,N,,,6362,Rattus norvegicus,50597,A,,1
,Half life period in rat,10116.0,Intermediate,,,7546,,CHEMBL618666,1,BAO_0000218,,,,N,,,6249,Rattus norvegicus,50597,A,,1
,Half-life in rats was determined,10116.0,Intermediate,,,7547,,CHEMBL620440,1,BAO_0000218,,,,N,,,3169,Rattus norvegicus,50597,A,,1
,Half-life in rats with metabolic oxidation,10116.0,Intermediate,,,7548,,CHEMBL620441,1,BAO_0000218,,,,N,,,3169,Rattus norvegicus,50597,A,,1
,Half-life in rats,10116.0,Intermediate,,,7549,,CHEMBL620442,1,BAO_0000218,,,,N,,,3169,Rattus norvegicus,50597,A,,1
,T 1/2 at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,10116.0,Intermediate,,,7550,,CHEMBL620443,1,BAO_0000218,,In vivo,,N,,,17260,Rattus norvegicus,50597,A,,1
,T 1/2 at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,10116.0,Intermediate,,,7551,,CHEMBL620444,1,BAO_0000218,,In vivo,,N,,,17260,Rattus norvegicus,50597,A,,1
,T max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,10116.0,Intermediate,,,7552,,CHEMBL620445,1,BAO_0000218,,In vivo,,N,,,17260,Rattus norvegicus,50597,A,,1
,T max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,10116.0,Intermediate,,,7553,,CHEMBL620446,1,BAO_0000218,,In vivo,,N,,,17260,Rattus norvegicus,50597,A,,1
,Biological half-life measured in plasma of rat,10116.0,Intermediate,,,7554,1969.0,CHEMBL620447,1,BAO_0000218,,,,N,,Plasma,2879,Rattus norvegicus,50597,A,,1
,Biological half-life measured in plasma of rat; 22-25,10116.0,Intermediate,,,7555,1969.0,CHEMBL621129,1,BAO_0000218,,,,N,,Plasma,2879,Rattus norvegicus,50597,A,,1
,Biological half-life measured in plasma of rat; 9-16,10116.0,Intermediate,,,7556,1969.0,CHEMBL621130,1,BAO_0000218,,,,N,,Plasma,2879,Rattus norvegicus,50597,A,,1
,Compound was evaluated for its half life when administered intravenously in rat,10116.0,Intermediate,,,7557,,CHEMBL873808,1,BAO_0000218,,In vivo,,N,,,3184,Rattus norvegicus,50597,A,,1
,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 8 h,10116.0,Intermediate,,,7558,,CHEMBL876598,1,BAO_0000218,,In vivo,,N,,,4891,Rattus norvegicus,50597,A,,1
,Evaluated for pharmacokinetic parameter half-life in rat at the dose 50 mg/kg,10116.0,Intermediate,,,7559,,CHEMBL621131,1,BAO_0000218,,In vivo,,N,,,429,Rattus norvegicus,50597,A,,1
,Half life (T1/2) after oral administration in rat,10116.0,Intermediate,,,7560,,CHEMBL621132,1,BAO_0000218,,In vivo,,N,,,5656,Rattus norvegicus,50597,A,,1
,Half life of compound after iv administration of 20 mg/kg dose in rat,10116.0,Intermediate,,,7561,,CHEMBL621133,1,BAO_0000218,,In vivo,,N,,,4413,Rattus norvegicus,50597,A,,1
,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,10116.0,Expert,,,7562,,CHEMBL621312,1,BAO_0000218,,In vivo,,N,,,3598,Rattus norvegicus,50597,A,,1
,Half life of compound was determined in rat,10116.0,Intermediate,,,7563,,CHEMBL621313,1,BAO_0000218,,,,N,,,17267,Rattus norvegicus,50597,A,,1
,Half life of compound was determined in rat blood,10116.0,Intermediate,,,7564,178.0,CHEMBL621314,1,BAO_0000218,,,,N,,Blood,4727,Rattus norvegicus,50597,A,,1
,Half life at 1 mg/kg was determined in rat,10116.0,Intermediate,,,7565,,CHEMBL621315,1,BAO_0000218,,In vivo,,N,,,17651,Rattus norvegicus,50597,A,,1
,Half life at 10 mg/kg was determined in rat,10116.0,Intermediate,,,7566,,CHEMBL621316,1,BAO_0000218,,In vivo,,N,,,17651,Rattus norvegicus,50597,A,,1
,Half life in rats,10116.0,Intermediate,,,7567,,CHEMBL621317,1,BAO_0000218,,,,N,,,401,Rattus norvegicus,50597,A,,1
,Half life in rats in hours,10116.0,Intermediate,,,7568,,CHEMBL621318,1,BAO_0000218,,,,N,,,4942,Rattus norvegicus,50597,A,,1
,Half life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,10116.0,Intermediate,,,7569,,CHEMBL621319,1,BAO_0000218,,In vivo,,N,,,17735,Rattus norvegicus,50597,A,,1
,Half life was calculated at a single intravenous administration of 20 mg/kg in rat,10116.0,Intermediate,,,7570,,CHEMBL621377,1,BAO_0000218,,In vivo,,N,,,6056,Rattus norvegicus,50597,A,,1
,Half life was determined,10116.0,Intermediate,,,7571,,CHEMBL621378,1,BAO_0000218,,,,N,,,5213,Rattus norvegicus,50597,A,,1
,Half life after i.v. administration,10116.0,Intermediate,,,7572,,CHEMBL876599,1,BAO_0000218,,In vivo,,N,,,6616,Rattus norvegicus,50597,A,,1
,Half life in rat after intravenous administration at a concentration 0.5 mg/kg,10116.0,Intermediate,,,7573,,CHEMBL621379,1,BAO_0000218,,In vivo,,N,,,5937,Rattus norvegicus,50597,A,,1
,Half life in rat plasma,10116.0,Intermediate,,,7574,1969.0,CHEMBL621380,1,BAO_0000218,,,,N,,Plasma,5819,Rattus norvegicus,50597,A,,1
,Half life in rat plasma; Not detected,10116.0,Intermediate,,,7575,1969.0,CHEMBL621381,1,BAO_0000218,,,,N,,Plasma,5819,Rattus norvegicus,50597,A,,1
,Half life in rats,10116.0,Intermediate,,,7576,,CHEMBL618515,1,BAO_0000218,,,,N,,,6803,Rattus norvegicus,50597,A,,1
,Half life period of compound was determined after peroral administration,10116.0,Intermediate,,,7577,,CHEMBL618516,1,BAO_0000218,,In vivo,,N,,,17804,Rattus norvegicus,50597,A,,1
,Half life period of compound was determined at a dose of 3 mg/kg by intravenous administration,10116.0,Intermediate,,,7578,,CHEMBL618517,1,BAO_0000218,,In vivo,,N,,,17804,Rattus norvegicus,50597,A,,1
,Half life period in rat,10116.0,Intermediate,,,7579,,CHEMBL618518,1,BAO_0000218,,,,N,,,5948,Rattus norvegicus,50597,A,,1
,Half life period was evaluated against Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,10116.0,Intermediate,,,7580,,CHEMBL618519,1,BAO_0000218,,In vivo,,N,,,1916,Rattus norvegicus,50597,A,,1
,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,10116.0,Intermediate,,,7581,,CHEMBL618698,1,BAO_0000218,,In vivo,,N,,,1916,Rattus norvegicus,50597,A,,1
,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration; Not available,10116.0,Intermediate,,,7582,,CHEMBL618862,1,BAO_0000218,,In vivo,,N,,,1916,Rattus norvegicus,50597,A,,1
,Half life period was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,10116.0,Intermediate,,,7583,,CHEMBL618863,1,BAO_0000218,,In vivo,,N,,,4890,Rattus norvegicus,50597,A,,1
,Half life period was determined for compound after intravenous administration in rats at 24 uM/kg,10116.0,Intermediate,,,7584,,CHEMBL618864,1,BAO_0000218,,In vivo,,N,,,17764,Rattus norvegicus,50597,A,,1
,Half life time in rat the dose of 2 mg/kg,10116.0,Intermediate,,,7585,,CHEMBL618865,1,BAO_0000218,,In vivo,,N,,,4727,Rattus norvegicus,50597,A,,1
,Half-life 24 hr after 10 mg/kg iv administration in rats,10116.0,Intermediate,,,7586,,CHEMBL618866,1,BAO_0000218,,In vivo,,N,,,17509,Rattus norvegicus,50597,A,,1
,Half-life 24 hr after 2 mg/kg iv administration in rats,10116.0,Intermediate,,,7587,,CHEMBL618867,1,BAO_0000218,,In vivo,,N,,,17509,Rattus norvegicus,50597,A,,1
,Half-life consistent with the observed metabolic steady state in rats,10116.0,Intermediate,,,7588,,CHEMBL875828,1,BAO_0000218,,,,N,,,6597,Rattus norvegicus,50597,A,,1
,Half-life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,10116.0,Intermediate,,,7589,,CHEMBL618868,1,BAO_0000218,,In vivo,,N,,,17735,Rattus norvegicus,50597,A,,1
,Half-life for oxidative metabolic stability was determined using male human,10116.0,Intermediate,,,7590,,CHEMBL618869,1,BAO_0000218,,,,N,,,6597,Rattus norvegicus,50597,A,,1
,"Half-life in fischer rats at 5 mg/kg dose, administered intravenously",10116.0,Intermediate,,,7591,,CHEMBL618870,1,BAO_0000218,,In vivo,,N,,,17670,Rattus norvegicus,50597,A,,1
,Half-life in rat plasma,10116.0,Intermediate,,,7592,1969.0,CHEMBL618871,1,BAO_0000218,,,,N,,Plasma,1696,Rattus norvegicus,50597,A,,1
,Half-life in rat plasma was determined,10116.0,Intermediate,,,7593,1969.0,CHEMBL618872,1,BAO_0000218,,,,N,,Plasma,1742,Rattus norvegicus,50597,A,,1
,Half-life in rats was determined,10116.0,Intermediate,,,7594,,CHEMBL873816,1,BAO_0000218,,,,N,,,17800,Rattus norvegicus,50597,A,,1
,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by gavage method in dog,,Autocuration,,,7595,,CHEMBL618873,1,BAO_0000218,,,,U,,,12923,,22224,A,,0
,Area under curve after oral dose of 0.1 mg//kg,,Autocuration,,,7596,,CHEMBL621602,1,BAO_0000019,,,,U,,,11954,,22224,A,,0
,Area under curve after oral dose of 0.3 mg/kg,,Autocuration,,,7597,,CHEMBL621603,1,BAO_0000218,,,,U,,,11954,,22224,A,,0
,Area under curve after oral dose of 1 mg/kg,,Autocuration,,,7598,,CHEMBL621604,1,BAO_0000218,,,,U,,,11954,,22224,A,,0
,Area under curve after oral dose of 10 mg/kg,,Autocuration,,,7599,,CHEMBL621605,1,BAO_0000218,,,,U,,,11954,,22224,A,,0
,Area under curve after oral dose of 23.4 mg/kg,,Autocuration,,,7600,,CHEMBL621606,1,BAO_0000218,,,,U,,,11954,,22224,A,,0
,Area under curve after oral dose of 3 mg/kg,,Autocuration,,,7601,,CHEMBL621607,1,BAO_0000218,,,,U,,,11954,,22224,A,,0
,Area under curve after oral dose of 3.87 mg/kg,,Autocuration,,,7602,,CHEMBL621608,1,BAO_0000218,,,,U,,,11954,,22224,A,,0
,Area under curve was determined,,Autocuration,,,7603,,CHEMBL621609,1,BAO_0000019,,,,U,,,5237,,22224,A,,0
,Area under curve at a dose of 10 mg/kg,,Autocuration,,,7604,,CHEMBL621610,1,BAO_0000218,,,,U,,,4026,,22224,A,,0
,Area under curve was determined; ND=No data,10116.0,Intermediate,,,7605,,CHEMBL621611,1,BAO_0000218,,,,N,,,5237,Rattus norvegicus,50597,A,,1
,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,10116.0,Intermediate,,,7606,,CHEMBL621612,1,BAO_0000218,,,,N,,,14793,Rattus norvegicus,50597,A,,1
,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,10116.0,Intermediate,,,7607,,CHEMBL622308,1,BAO_0000218,,,,N,,,14793,Rattus norvegicus,50597,A,,1
,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,10116.0,Intermediate,,,7608,,CHEMBL622309,1,BAO_0000218,,,,N,,,14793,Rattus norvegicus,50597,A,,1
,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for infinite hours,10116.0,Intermediate,,,7609,,CHEMBL622310,1,BAO_0000218,,,,N,,,14793,Rattus norvegicus,50597,A,,1
,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,10116.0,Intermediate,,,7610,,CHEMBL622311,1,BAO_0000218,,,,N,,,14793,Rattus norvegicus,50597,A,,1
,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for infinite hours; Not calculated,10116.0,Intermediate,,,7611,,CHEMBL622312,1,BAO_0000218,,,,N,,,14793,Rattus norvegicus,50597,A,,1
,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,10116.0,Intermediate,,,7612,,CHEMBL622931,1,BAO_0000218,,,,N,,,14793,Rattus norvegicus,50597,A,,1
,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for infinite hours; Not calculated,10116.0,Intermediate,,,7613,,CHEMBL622932,1,BAO_0000218,,,,N,,,14793,Rattus norvegicus,50597,A,,1
,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,10116.0,Intermediate,,,7614,1969.0,CHEMBL622736,1,BAO_0000218,,,,N,,Plasma,14793,Rattus norvegicus,50597,A,,1
,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,10116.0,Intermediate,,,7615,1969.0,CHEMBL622737,1,BAO_0000218,,,,N,,Plasma,14793,Rattus norvegicus,50597,A,,1
,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,10116.0,Intermediate,,,7616,1969.0,CHEMBL622738,1,BAO_0000218,,,,N,,Plasma,14793,Rattus norvegicus,50597,A,,1
,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for infinite hours,10116.0,Intermediate,,,7617,1969.0,CHEMBL622739,1,BAO_0000218,,,,N,,Plasma,14793,Rattus norvegicus,50597,A,,1
,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,10116.0,Intermediate,,,7618,1969.0,CHEMBL622740,1,BAO_0000218,,,,N,,Plasma,14793,Rattus norvegicus,50597,A,,1
,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for infinite hours,10116.0,Intermediate,,,7619,1969.0,CHEMBL622741,1,BAO_0000218,,,,N,,Plasma,14793,Rattus norvegicus,50597,A,,1
,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,10116.0,Intermediate,,,7620,1969.0,CHEMBL622742,1,BAO_0000218,,,,N,,Plasma,14793,Rattus norvegicus,50597,A,,1
,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for infinite hours,10116.0,Intermediate,,,7621,1969.0,CHEMBL622743,1,BAO_0000218,,,,N,,Plasma,14793,Rattus norvegicus,50597,A,,1
,AUC in mice,10090.0,Intermediate,,,7622,1969.0,CHEMBL622744,1,BAO_0000218,,,,N,,Plasma,11637,Mus musculus,50594,A,,1
,Area under curve was measured from the graph obtained from concentration Vs time,,Autocuration,,,7623,,CHEMBL624134,1,BAO_0000019,,,,U,,,11149,,22224,A,,0
,Area under curve value of compound per hour after oral administration,,Autocuration,,,7624,,CHEMBL624135,1,BAO_0000019,,,,U,,,10016,,22224,A,,0
,Area under curve was determined after oral administration in rats,10116.0,Intermediate,,,7625,,CHEMBL624136,1,BAO_0000218,,,,N,,,17796,Rattus norvegicus,50597,A,,1
,Area under curve was determined after oral administration in rats; No data,10116.0,Intermediate,,,7626,,CHEMBL624137,1,BAO_0000218,,,,N,,,17796,Rattus norvegicus,50597,A,,1
,Area under curve was determined after oral administration in rats;No data,10116.0,Intermediate,,,7627,,CHEMBL624320,1,BAO_0000218,,,,N,,,17796,Rattus norvegicus,50597,A,,1
,Area under curve was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,9615.0,Intermediate,,,7628,,CHEMBL624321,1,BAO_0000218,,,,N,,,12923,Canis lupus familiaris,50588,A,,1
,Area under curve was determined for the compound after iv dose of 4.74 mg/kg in rats,10116.0,Intermediate,,,7629,,CHEMBL624322,1,BAO_0000218,,,,N,,,15372,Rattus norvegicus,50597,A,,1
,Area under curve was determined for the compound after iv dose of 5.06 in rats,10116.0,Intermediate,,,7630,,CHEMBL624323,1,BAO_0000218,,,,N,,,15372,Rattus norvegicus,50597,A,,1
,Area under curve was determined for the compound after iv dose of 5.10 mg/kg in rats,10116.0,Intermediate,,,7631,,CHEMBL624324,1,BAO_0000218,,,,N,,,15372,Rattus norvegicus,50597,A,,1
,Area under curve was determined for the compound after po dose of 5.01 mg/kg in rats,10116.0,Intermediate,,,7632,,CHEMBL624325,1,BAO_0000218,,,,N,,,15372,Rattus norvegicus,50597,A,,1
,Area under curve was determined for the compound after po dose of 5.03 mg/kg in rats,10116.0,Intermediate,,,7633,,CHEMBL624326,1,BAO_0000218,,,,N,,,15372,Rattus norvegicus,50597,A,,1
,Area under curve was determined for the compound after po dose of 5.22 mg/kg in rats,10116.0,Intermediate,,,7634,,CHEMBL624327,1,BAO_0000218,,,,N,,,15372,Rattus norvegicus,50597,A,,1
,Area under curve was determined for the compound after po dose of 5.46 mg/kg in rats,10116.0,Intermediate,,,7635,,CHEMBL624328,1,BAO_0000218,,,,N,,,15372,Rattus norvegicus,50597,A,,1
,Area under curve was determined in Dogs after peroral administration,9615.0,Intermediate,,,7636,,CHEMBL627848,1,BAO_0000218,,,,N,,,14169,Canis lupus familiaris,50588,A,,1
,Area under curve was determined in Rats after peroral administration,10116.0,Intermediate,,,7637,,CHEMBL627849,1,BAO_0000218,,,,N,,,14169,Rattus norvegicus,50597,A,,1
,Area under curve was determined in carotid blood of rat when administered intradermally,10116.0,Intermediate,,,7638,,CHEMBL627850,1,BAO_0000218,,,,N,,,14258,Rattus norvegicus,50597,A,,1
,Area under curve was determined in portal blood of rat when administered intradermally,10116.0,Intermediate,,,7639,,CHEMBL627851,1,BAO_0000218,,,,N,,,14258,Rattus norvegicus,50597,A,,1
,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,10090.0,Intermediate,,,7640,,CHEMBL627852,1,BAO_0000218,,,,N,,,15011,Mus musculus,50594,A,,1
,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,10090.0,Intermediate,,,7641,,CHEMBL627853,1,BAO_0000218,,,,N,,,15011,Mus musculus,50594,A,,1
,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),10090.0,Intermediate,,,7642,,CHEMBL627854,1,BAO_0000218,,,,N,,,15011,Mus musculus,50594,A,,1
,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,10090.0,Intermediate,,,7643,,CHEMBL627855,1,BAO_0000218,,,,N,,,15011,Mus musculus,50594,A,,1
,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg (run time 7 hr),10090.0,Intermediate,,,7644,,CHEMBL627856,1,BAO_0000218,,,,N,,,15011,Mus musculus,50594,A,,1
,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,10090.0,Intermediate,,,7645,,CHEMBL875339,1,BAO_0000218,,,,N,,,15011,Mus musculus,50594,A,,1
,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (Run time = 7 hr),10090.0,Intermediate,,,7646,,CHEMBL627857,1,BAO_0000218,,,,N,,,15011,Mus musculus,50594,A,,1
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 65 mins after i.v. administration,10116.0,Intermediate,,,7647,2106.0,CHEMBL627858,1,BAO_0000218,,In vivo,,N,,Spleen,11195,Rattus norvegicus,50597,A,,1
,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in blood; Expressed as percent dose/organ,10116.0,Intermediate,,,7648,178.0,CHEMBL627859,1,BAO_0000218,,,,N,,Blood,10130,Rattus norvegicus,50597,A,,1
,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in brain; Expressed as percent dose/organ,10116.0,Intermediate,,,7649,955.0,CHEMBL627860,1,BAO_0000218,,,,N,,Brain,10130,Rattus norvegicus,50597,A,,1
,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in heart; Expressed as percent dose/organ,10116.0,Intermediate,,,7650,948.0,CHEMBL627019,1,BAO_0000218,,,,N,,Heart,10130,Rattus norvegicus,50597,A,,1
,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in liver; Expressed as percent dose/organ,10116.0,Intermediate,,,7651,2107.0,CHEMBL627020,1,BAO_0000218,,,,N,,Liver,10130,Rattus norvegicus,50597,A,,1
,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in lung; Expressed as percent dose/organ,10116.0,Intermediate,,,7652,2048.0,CHEMBL627021,1,BAO_0000218,,,,N,,Lung,10130,Rattus norvegicus,50597,A,,1
,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in muscle; Expressed as percent dose/organ,10116.0,Intermediate,,,7653,2385.0,CHEMBL627022,1,BAO_0000218,,,,N,,Muscle tissue,10130,Rattus norvegicus,50597,A,,1
,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in skin; Expressed as percent dose/organ,10116.0,Intermediate,,,7654,,CHEMBL627023,1,BAO_0000218,,,,N,,,10130,Rattus norvegicus,50597,A,,1
,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in spleen; Expressed as percent dose/organ,10116.0,Intermediate,,,7655,2106.0,CHEMBL627024,1,BAO_0000218,,,,N,,Spleen,10130,Rattus norvegicus,50597,A,,1
,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in thyroid; Expressed as percent dose/organ,10116.0,Intermediate,,,7656,2046.0,CHEMBL627025,1,BAO_0000218,,,,N,,Thyroid gland,10130,Rattus norvegicus,50597,A,,1
,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in kidney; Expressed as percent dose/organ,10116.0,Intermediate,,,7657,2113.0,CHEMBL627026,1,BAO_0000218,,,,N,,Kidney,10130,Rattus norvegicus,50597,A,,1
,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in blood; Expressed as percent dose/organ,10116.0,Intermediate,,,7658,178.0,CHEMBL627027,1,BAO_0000218,,,,N,,Blood,10130,Rattus norvegicus,50597,A,,1
,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in brain; Expressed as percent dose/organ,10116.0,Intermediate,,,7659,955.0,CHEMBL627028,1,BAO_0000218,,,,N,,Brain,10130,Rattus norvegicus,50597,A,,1
,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in heart; Expressed as percent dose/organ,10116.0,Intermediate,,,7660,948.0,CHEMBL627029,1,BAO_0000218,,,,N,,Heart,10130,Rattus norvegicus,50597,A,,1
,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in kidney; Expressed as percent dose/organ,10116.0,Intermediate,,,7661,2113.0,CHEMBL627030,1,BAO_0000218,,,,N,,Kidney,10130,Rattus norvegicus,50597,A,,1
,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in liver; Expressed as percent dose/organ,10116.0,Intermediate,,,7662,2107.0,CHEMBL627031,1,BAO_0000218,,,,N,,Liver,10130,Rattus norvegicus,50597,A,,1
,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in lung; Expressed as percent dose/organ,10116.0,Intermediate,,,7663,2048.0,CHEMBL627032,1,BAO_0000218,,,,N,,Lung,10130,Rattus norvegicus,50597,A,,1
,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in muscle; Expressed as percent dose/organ,10116.0,Intermediate,,,7664,2385.0,CHEMBL627033,1,BAO_0000218,,,,N,,Muscle tissue,10130,Rattus norvegicus,50597,A,,1
,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in skin; Expressed as percent dose/organ,10116.0,Intermediate,,,7665,,CHEMBL627034,1,BAO_0000218,,,,N,,,10130,Rattus norvegicus,50597,A,,1
,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in spleen; Expressed as percent dose/organ,10116.0,Intermediate,,,7666,2106.0,CHEMBL627035,1,BAO_0000218,,,,N,,Spleen,10130,Rattus norvegicus,50597,A,,1
,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in thyroid; Expressed as percent dose/organ,10116.0,Intermediate,,,7667,2046.0,CHEMBL627036,1,BAO_0000218,,,,N,,Thyroid gland,10130,Rattus norvegicus,50597,A,,1
,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in blood; Expressed as percent dose/organ,10116.0,Intermediate,,,7668,178.0,CHEMBL875340,1,BAO_0000218,,,,N,,Blood,10130,Rattus norvegicus,50597,A,,1
,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in heart; Expressed as percent dose/organ,10116.0,Intermediate,,,7669,948.0,CHEMBL627037,1,BAO_0000218,,,,N,,Heart,10130,Rattus norvegicus,50597,A,,1
,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in kidney; Expressed as percent dose/organ,10116.0,Intermediate,,,7670,2113.0,CHEMBL627038,1,BAO_0000218,,,,N,,Kidney,10130,Rattus norvegicus,50597,A,,1
,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in liver; Expressed as percent dose/organ,10116.0,Intermediate,,,7671,2107.0,CHEMBL627039,1,BAO_0000218,,,,N,,Liver,10130,Rattus norvegicus,50597,A,,1
,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in muscle; Expressed as percent dose/organ,10116.0,Intermediate,,,7672,2385.0,CHEMBL627040,1,BAO_0000218,,,,N,,Muscle tissue,10130,Rattus norvegicus,50597,A,,1
,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in spleen; Expressed as percent dose/organ,10116.0,Intermediate,,,7673,2106.0,CHEMBL624663,1,BAO_0000218,,,,N,,Spleen,10130,Rattus norvegicus,50597,A,,1
,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in thyroid; Expressed as percent dose/organ,10116.0,Intermediate,,,7674,2046.0,CHEMBL625963,1,BAO_0000218,,,,N,,Thyroid gland,10130,Rattus norvegicus,50597,A,,1
,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in brain; Expressed as percent dose/organ,10116.0,Intermediate,,,7675,955.0,CHEMBL876799,1,BAO_0000218,,,,N,,Brain,10130,Rattus norvegicus,50597,A,,1
,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in lung; Expressed as percent dose/organ,10116.0,Intermediate,,,7676,2048.0,CHEMBL626133,1,BAO_0000218,,,,N,,Lung,10130,Rattus norvegicus,50597,A,,1
,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in skin; Expressed as percent dose/organ,10116.0,Intermediate,,,7677,,CHEMBL626134,1,BAO_0000218,,,,N,,,10130,Rattus norvegicus,50597,A,,1
,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,10116.0,Intermediate,,,7678,,CHEMBL626135,1,BAO_0000218,,,,N,,,6295,Rattus norvegicus,50597,A,,1
,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,10116.0,Intermediate,,,7679,,CHEMBL626136,1,BAO_0000218,,,,N,,,6296,Rattus norvegicus,50597,A,,1
,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg; Below detection limit,10116.0,Intermediate,,,7680,,CHEMBL626137,1,BAO_0000218,,,,N,,,6296,Rattus norvegicus,50597,A,,1
,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,10116.0,Intermediate,,,7681,,CHEMBL626138,1,BAO_0000218,,,,N,,,6295,Rattus norvegicus,50597,A,,1
,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,10116.0,Intermediate,,,7682,,CHEMBL626139,1,BAO_0000218,,,,N,,,6296,Rattus norvegicus,50597,A,,1
,C max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,10116.0,Intermediate,,,7683,,CHEMBL626140,1,BAO_0000218,,In vivo,,N,,,17260,Rattus norvegicus,50597,A,,1
,C max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,10116.0,Intermediate,,,7684,,CHEMBL626141,1,BAO_0000218,,In vivo,,N,,,17260,Rattus norvegicus,50597,A,,1
,C24h in rat p.o. at 20 mg/kg concentration,10116.0,Intermediate,,,7685,,CHEMBL626142,1,BAO_0000218,,,,N,,,17686,Rattus norvegicus,50597,A,,1
,Biodistribution in normal rat muscle in the presence of 0.005 M Gd/0.01 M lig at 2 hr,10116.0,Intermediate,,,7686,2385.0,CHEMBL627930,1,BAO_0000218,,In vivo,,N,,Muscle tissue,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in normal rat muscle in the presence of 0.01 M Gd/0.05 M lig,10116.0,Intermediate,,,7687,2385.0,CHEMBL627931,1,BAO_0000218,,In vivo,,N,,Muscle tissue,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in normal rat muscle in the presence of NAC Gd 0.01 M lig at 2 hr,10116.0,Intermediate,,,7688,2385.0,CHEMBL627932,1,BAO_0000218,,In vivo,,N,,Muscle tissue,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in normal rat spleen in the presence of 0.005 M Gd/0.01 M lig at 2 hr,10116.0,Intermediate,,,7689,2106.0,CHEMBL627933,1,BAO_0000218,,In vivo,,N,,Spleen,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in normal rat spleen in the presence of 0.01 M Gd/0.05 M lig,10116.0,Intermediate,,,7690,2106.0,CHEMBL627934,1,BAO_0000218,,In vivo,,N,,Spleen,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in normal rat spleen in the presence of NAC Gd 0.01 M lig at 2 hr,10116.0,Intermediate,,,7691,2106.0,CHEMBL627935,1,BAO_0000218,,In vivo,,N,,Spleen,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat blood in the presence of 0.001 M/0.008 M GdDTPA-AEP,10116.0,Intermediate,,,7692,178.0,CHEMBL627936,1,BAO_0000218,,In vivo,,N,,Blood,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat blood in the presence of 0.01 M GdDTPA-BDP,10116.0,Intermediate,,,7693,178.0,CHEMBL627937,1,BAO_0000218,,In vivo,,N,,Blood,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat blood in the presence of 0.01 M/0.01 M GdDTPA-AEP,10116.0,Intermediate,,,7694,178.0,CHEMBL627938,1,BAO_0000218,,In vivo,,N,,Blood,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat blood in the presence of 0.05 M Gd/0.15 M lig,10116.0,Intermediate,,,7695,178.0,CHEMBL627939,1,BAO_0000218,,In vivo,,N,,Blood,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat blood in the presence of 0.05 M GdDTPA-BDP,10116.0,Intermediate,,,7696,178.0,CHEMBL627940,1,BAO_0000218,,In vivo,,N,,Blood,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat blood in the presence of 0.05 M/0.05 M GdDTPA-AEP,10116.0,Intermediate,,,7697,178.0,CHEMBL627941,1,BAO_0000218,,In vivo,,N,,Blood,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat blood in the presence of 0.05 M/0.08 M GdDTPA-HPDP,10116.0,Intermediate,,,7698,178.0,CHEMBL876800,1,BAO_0000218,,In vivo,,N,,Blood,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat blood in the presence of 0.10 M GdDTPA-BDP,10116.0,Intermediate,,,7699,178.0,CHEMBL627942,1,BAO_0000218,,In vivo,,N,,Blood,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat blood in the presence of 0.10 M/0.11 M GdDTPA-AEP,10116.0,Intermediate,,,7700,178.0,CHEMBL627943,1,BAO_0000218,,In vivo,,N,,Blood,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat blood in the presence of 50 Gd/kg at 15 min,10116.0,Intermediate,,,7701,178.0,CHEMBL627944,1,BAO_0000218,,In vivo,,N,,Blood,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat blood in the presence of 50 Gd/kg at 2 hr,10116.0,Intermediate,,,7702,178.0,CHEMBL627945,1,BAO_0000218,,In vivo,,N,,Blood,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat blood in the presence of 50 Gd/kg at 6 hr,10116.0,Intermediate,,,7703,178.0,CHEMBL628584,1,BAO_0000218,,In vivo,,N,,Blood,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat blood in the presence of GdDTPA at 15 min,10116.0,Intermediate,,,7704,178.0,CHEMBL628585,1,BAO_0000218,,In vivo,,N,,Blood,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat blood in the presence of GdDTPA at 1 hr,10116.0,Intermediate,,,7705,178.0,CHEMBL628586,1,BAO_0000218,,In vivo,,N,,Blood,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat blood in the presence of GdDTPA at 30 min,10116.0,Intermediate,,,7706,178.0,CHEMBL628587,1,BAO_0000218,,In vivo,,N,,Blood,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat blood in the presence of GdDTPA at 4 hr,10116.0,Intermediate,,,7707,178.0,CHEMBL628588,1,BAO_0000218,,In vivo,,N,,Blood,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat blood in the presence of GdDTPA-BDP at 15 min,10116.0,Intermediate,,,7708,178.0,CHEMBL628589,1,BAO_0000218,,In vivo,,N,,Blood,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat blood in the presence of GdDTPA-BDP at 30 min,10116.0,Intermediate,,,7709,178.0,CHEMBL625304,1,BAO_0000218,,In vivo,,N,,Blood,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat blood in the presence of GdDTPA-BDP at 4 hr,10116.0,Intermediate,,,7710,178.0,CHEMBL625305,1,BAO_0000218,,In vivo,,N,,Blood,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat blood in the presence of GdDTPA-BDPat 1 hr,10116.0,Intermediate,,,7711,178.0,CHEMBL625306,1,BAO_0000218,,In vivo,,N,,Blood,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 15 min,10116.0,Intermediate,,,7712,178.0,CHEMBL625307,1,BAO_0000218,,In vivo,,N,,Blood,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 30 min,10116.0,Intermediate,,,7713,178.0,CHEMBL625308,1,BAO_0000218,,In vivo,,N,,Blood,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 4 hr,10116.0,Intermediate,,,7714,178.0,CHEMBL627740,1,BAO_0000218,,In vivo,,N,,Blood,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat blood in the presence of GdDTPA-HPDPat 1 hr,10116.0,Intermediate,,,7715,178.0,CHEMBL627741,1,BAO_0000218,,In vivo,,N,,Blood,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat blood in the presence of NAC Gd/0.01 M GdDTPA-HPDP,10116.0,Intermediate,,,7716,178.0,CHEMBL627742,1,BAO_0000218,,In vivo,,N,,Blood,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat blood in the presence of NCA Gd/0.01 M lip,10116.0,Intermediate,,,7717,178.0,CHEMBL627743,1,BAO_0000218,,In vivo,,N,,Blood,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat blood in the presence of NCAGd/0.01 M lig,10116.0,Intermediate,,,7718,178.0,CHEMBL627744,1,BAO_0000218,,In vivo,,N,,Blood,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat bone in the presence of 0.01 M GdDTPA-BDP,10116.0,Intermediate,,,7719,10000001.0,CHEMBL627745,1,BAO_0000218,,In vivo,,N,,Bone,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat bone in the presence of 0.01 M/0.01 M GdDTPA-AEP,10116.0,Intermediate,,,7720,10000001.0,CHEMBL627746,1,BAO_0000218,,In vivo,,N,,Bone,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat bone in the presence of 0.01 M/0.08 M GdDTPA-AEP,10116.0,Intermediate,,,7721,10000001.0,CHEMBL627747,1,BAO_0000218,,In vivo,,N,,Bone,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat bone in the presence of 0.05 M Gd/0.15 M lig,10116.0,Intermediate,,,7722,10000001.0,CHEMBL876810,1,BAO_0000218,,In vivo,,N,,Bone,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat bone in the presence of 0.05 M GdDTPA-BDP,10116.0,Intermediate,,,7723,10000001.0,CHEMBL627748,1,BAO_0000218,,In vivo,,N,,Bone,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat bone in the presence of 0.05 M/0.05 M GdDTPA-AEP,10116.0,Intermediate,,,7724,10000001.0,CHEMBL627749,1,BAO_0000218,,In vivo,,N,,Bone,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat bone in the presence of 0.05 M/0.08 M GdDTPA-HPDP,10116.0,Intermediate,,,7725,10000001.0,CHEMBL627750,1,BAO_0000218,,In vivo,,N,,Bone,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat bone in the presence of 0.10 M GdDTPA-BDP,10116.0,Intermediate,,,7726,10000001.0,CHEMBL618728,1,BAO_0000218,,In vivo,,N,,Bone,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat bone in the presence of 0.10 M/0.11 M GdDTPA-AEP,10116.0,Intermediate,,,7727,10000001.0,CHEMBL618729,1,BAO_0000218,,In vivo,,N,,Bone,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat bone in the presence of GdDTPA at 15 min,10116.0,Intermediate,,,7728,10000001.0,CHEMBL618730,1,BAO_0000218,,In vivo,,N,,Bone,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat bone in the presence of GdDTPA at 1 hr,10116.0,Intermediate,,,7729,10000001.0,CHEMBL618731,1,BAO_0000218,,In vivo,,N,,Bone,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat bone in the presence of GdDTPA at 30 min,10116.0,Intermediate,,,7730,10000001.0,CHEMBL618732,1,BAO_0000218,,In vivo,,N,,Bone,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat bone in the presence of GdDTPA at 4 hr,10116.0,Intermediate,,,7731,10000001.0,CHEMBL618733,1,BAO_0000218,,In vivo,,N,,Bone,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat bone in the presence of GdDTPA-BDP at 15 min,10116.0,Intermediate,,,7732,10000001.0,CHEMBL618734,1,BAO_0000218,,In vivo,,N,,Bone,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat bone in the presence of GdDTPA-BDP at 1 hr,10116.0,Intermediate,,,7733,10000001.0,CHEMBL618735,1,BAO_0000218,,In vivo,,N,,Bone,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat bone in the presence of GdDTPA-BDP at 30 min,10116.0,Intermediate,,,7734,10000001.0,CHEMBL876602,1,BAO_0000218,,In vivo,,N,,Bone,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat bone in the presence of GdDTPA-BDP at 4 hr,10116.0,Intermediate,,,7735,10000001.0,CHEMBL618736,1,BAO_0000218,,In vivo,,N,,Bone,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 15 min,10116.0,Intermediate,,,7736,10000001.0,CHEMBL618737,1,BAO_0000218,,In vivo,,N,,Bone,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 1 hr,10116.0,Intermediate,,,7737,10000001.0,CHEMBL618738,1,BAO_0000218,,In vivo,,N,,Bone,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 30 min,10116.0,Intermediate,,,7738,10000001.0,CHEMBL618739,1,BAO_0000218,,In vivo,,N,,Bone,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 4 hr,10116.0,Intermediate,,,7739,10000001.0,CHEMBL618740,1,BAO_0000218,,In vivo,,N,,Bone,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat bone in the presence of NAC Gd/0.01 M GdDTPA-HPDP,10116.0,Intermediate,,,7740,10000001.0,CHEMBL618741,1,BAO_0000218,,In vivo,,N,,Bone,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat bone in the presence of NCA Gd/0.01 M lip,10116.0,Intermediate,,,7741,10000001.0,CHEMBL618742,1,BAO_0000218,,In vivo,,N,,Bone,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat bone in the presence of NCAGd/0.01 M lig,10116.0,Intermediate,,,7742,10000001.0,CHEMBL618743,1,BAO_0000218,,In vivo,,N,,Bone,9866,Rattus norvegicus,50597,A,,1
,Half-life from rat plasma at a single oral dose of 25 mg/kg,10116.0,Intermediate,,,7743,1969.0,CHEMBL618744,1,BAO_0000218,,In vivo,,N,,Plasma,17752,Rattus norvegicus,50597,A,,1
,Half-life in male rat,10116.0,Intermediate,,,7744,,CHEMBL618745,1,BAO_0000218,,,,N,,,5610,Rattus norvegicus,50597,A,,1
,Half-life in rat after peroral administration at 10 mg/kg concentration,10116.0,Intermediate,,,7745,,CHEMBL620479,1,BAO_0000218,,In vivo,,N,,,5939,Rattus norvegicus,50597,A,,1
,Half-life in rat after peroral administration at 5 mg/kg concentration,10116.0,Intermediate,,,7746,,CHEMBL620480,1,BAO_0000218,,In vivo,,N,,,5939,Rattus norvegicus,50597,A,,1
,Half-life in rat at a dose of 3 mg/kg,10116.0,Intermediate,,,7747,,CHEMBL620481,1,BAO_0000218,,In vivo,,N,,,17771,Rattus norvegicus,50597,A,,1
,Half-life was evaluated in rats,10116.0,Intermediate,,,7748,,CHEMBL620482,1,BAO_0000218,,,,N,,,1974,Rattus norvegicus,50597,A,,1
,Half-life was measured in rat,10116.0,Intermediate,,,7749,,CHEMBL876603,1,BAO_0000218,,,,N,,,4239,Rattus norvegicus,50597,A,,1
,Half-life period for the compound was determined in rats at 50 mg/kg dose,10116.0,Intermediate,,,7750,,CHEMBL620483,1,BAO_0000218,,In vivo,,N,,,6681,Rattus norvegicus,50597,A,,1
,Half-life period in rats after intravenous administration at 5 mg/kg,10116.0,Intermediate,,,7751,,CHEMBL620484,1,BAO_0000218,,In vivo,,N,,,17752,Rattus norvegicus,50597,A,,1
,Half-life period in rat at 10 mg/kg,10116.0,Intermediate,,,7752,,CHEMBL620485,1,BAO_0000218,,In vivo,,N,,,6046,Rattus norvegicus,50597,A,,1
,"Half-life period was determined in rats at 10 mg/kg, p.o. dose",10116.0,Intermediate,,,7753,,CHEMBL620486,1,BAO_0000218,,In vivo,,N,,,6685,Rattus norvegicus,50597,A,,1
,"Half-life period was determined in rats at 20 mg/kg, i.p. dose",10116.0,Intermediate,,,7754,,CHEMBL620487,1,BAO_0000218,,In vivo,,N,,,6685,Rattus norvegicus,50597,A,,1
,"Half-life period was determined in rats at 2 mg/kg, i.v. dose",10116.0,Intermediate,,,7755,,CHEMBL620488,1,BAO_0000218,,In vivo,,N,,,6685,Rattus norvegicus,50597,A,,1
,Half-life time in rat the dose of 2 mg/kg,10116.0,Intermediate,,,7756,,CHEMBL620489,1,BAO_0000218,,In vivo,,N,,,4727,Rattus norvegicus,50597,A,,1
,Half-life was estimated from the elimination phase of the oral [C] vs time curves in 4 rats,10116.0,Intermediate,,,7757,,CHEMBL620490,1,BAO_0000218,,In vivo,,N,,,1088,Rattus norvegicus,50597,A,,1
,In vivo activity against Staphylococcus aureus when administered orally for 1 hr in rat at a dose of 15 mg/kg,10116.0,Intermediate,,,7758,,CHEMBL620491,1,BAO_0000218,,In vivo,,N,,,5610,Rattus norvegicus,50597,A,,1
,"In vivo half life of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",10116.0,Intermediate,,,7759,1969.0,CHEMBL876604,1,BAO_0000218,,In vivo,,N,,Plasma,3032,Rattus norvegicus,50597,A,,1
,Oral half life was determined,10116.0,Intermediate,,,7760,,CHEMBL620492,1,BAO_0000218,,In vivo,,N,,,5199,Rattus norvegicus,50597,A,,1
,"Pharmacokinetic Parameter, half life period measured in Female Wistar Rats at 100 mg/kg by po administration",10116.0,Intermediate,,,7761,,CHEMBL620493,1,BAO_0000218,,In vivo,,N,,,14941,Rattus norvegicus,50597,A,,1
,Pharmacokinetic property (t1/2) in rat,10116.0,Intermediate,,,7762,,CHEMBL620494,1,BAO_0000218,,In vivo,,N,,,4408,Rattus norvegicus,50597,A,,1
,Plasma elimination half-life was determined,10116.0,Intermediate,,,7763,1969.0,CHEMBL620495,1,BAO_0000218,,,,N,,Plasma,2552,Rattus norvegicus,50597,A,,1
,Plasma elimination half-life was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,10116.0,Intermediate,,,7764,1969.0,CHEMBL620496,1,BAO_0000218,,In vivo,,N,,Plasma,5199,Rattus norvegicus,50597,A,,1
,Plasma half life was observed after intravenous administration in rat,10116.0,Intermediate,,,7765,1969.0,CHEMBL620497,1,BAO_0000218,,In vivo,,N,,Plasma,15662,Rattus norvegicus,50597,A,,1
,Plasma half-life was determined,10116.0,Intermediate,,,7766,1969.0,CHEMBL620498,1,BAO_0000218,,,,N,,Plasma,1465,Rattus norvegicus,50597,A,,1
,Plasma half-life following oral administration in Fisher rats,10116.0,Intermediate,,,7767,1969.0,CHEMBL620499,1,BAO_0000218,,In vivo,,N,,Plasma,1446,Rattus norvegicus,50597,A,,1
,Plasma half-life in rat,10116.0,Intermediate,,,7768,1969.0,CHEMBL620500,1,BAO_0000218,,,,N,,Plasma,6824,Rattus norvegicus,50597,A,,1
,Plasmatic Half-life after intravenous administration to rat,10116.0,Intermediate,,,7769,1969.0,CHEMBL873809,1,BAO_0000218,,In vivo,,N,,Plasma,17533,Rattus norvegicus,50597,A,,1
,T1/2 (half life) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,10116.0,Intermediate,,,7770,,CHEMBL620501,1,BAO_0000218,,In vivo,,N,,,5979,Rattus norvegicus,50597,A,,1
,Terminal half life after intravenous administration (1 mg/kg) in rat,10116.0,Intermediate,,,7771,,CHEMBL620502,1,BAO_0000218,,In vivo,,N,,,4689,Rattus norvegicus,50597,A,,1
,Terminal half life in Rat at a oral dose of 5 mg/kg,10116.0,Intermediate,,,7772,,CHEMBL620503,1,BAO_0000218,,In vivo,,N,,,4689,Rattus norvegicus,50597,A,,1
,Terminal phase half-life was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,10116.0,Intermediate,,,7773,,CHEMBL620504,1,BAO_0000218,,In vivo,,N,,,2463,Rattus norvegicus,50597,A,,1
,Tested for half life value after intravenous administration at dose of 0.2 mg/kg in rat,10116.0,Intermediate,,,7774,,CHEMBL876605,1,BAO_0000218,,In vivo,,N,,,4883,Rattus norvegicus,50597,A,,1
,Tested for half life value after oral administration at dosage of 4 mg/kg in rat,10116.0,Intermediate,,,7775,,CHEMBL620505,1,BAO_0000218,,In vivo,,N,,,4883,Rattus norvegicus,50597,A,,1
,plasma half life was observed after intravenous administration in rat,10116.0,Intermediate,,,7776,1969.0,CHEMBL873811,1,BAO_0000218,,In vivo,,N,,Plasma,15662,Rattus norvegicus,50597,A,,1
,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,10116.0,Expert,,,7777,,CHEMBL624016,1,BAO_0000218,,In vivo,,N,,,3598,Rattus norvegicus,50597,A,,1
,Half life of compound determined in rat,10116.0,Intermediate,,,7778,,CHEMBL624017,1,BAO_0000218,,,,N,,,4576,Rattus norvegicus,50597,A,,1
,Mean residence time determined in rat,10116.0,Intermediate,,,7779,,CHEMBL624018,1,BAO_0000218,,,,N,,,4576,Rattus norvegicus,50597,A,,1
,Plasma half life determined in rat,10116.0,Intermediate,,,7780,,CHEMBL624019,1,BAO_0000218,,,,N,,,4576,Rattus norvegicus,50597,A,,1
,Compound was evaluated for Tmax in brain after intravenous administration in male rats,10116.0,Intermediate,,,7781,955.0,CHEMBL624020,1,BAO_0000218,,In vivo,,N,,Brain,4910,Rattus norvegicus,50597,A,,1
,Compound was evaluated for pharmacokinetic parameter maximum time period,10116.0,Intermediate,,,7782,,CHEMBL624201,1,BAO_0000218,,In vivo,,N,,,4891,Rattus norvegicus,50597,A,,1
,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,10116.0,Intermediate,,,7783,,CHEMBL872528,1,BAO_0000218,,In vivo,,N,,,429,Rattus norvegicus,50597,A,,1
,In vivo Tmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,10116.0,Intermediate,,,7784,,CHEMBL624202,1,BAO_0000218,,In vivo,,N,,,5974,Rattus norvegicus,50597,A,,1
,In vivo Tmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,10116.0,Intermediate,,,7785,,CHEMBL624203,1,BAO_0000218,,In vivo,,N,,,5974,Rattus norvegicus,50597,A,,1
,In vivo Tmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,10116.0,Intermediate,,,7786,,CHEMBL624350,1,BAO_0000218,,In vivo,,N,,,5974,Rattus norvegicus,50597,A,,1
,In vivo Tmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,10116.0,Intermediate,,,7787,,CHEMBL621320,1,BAO_0000218,,In vivo,,N,,,5974,Rattus norvegicus,50597,A,,1
,In vivo maximum time required for clearance of compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,10116.0,Intermediate,,,7788,,CHEMBL621321,1,BAO_0000218,,In vivo,,N,,,17582,Rattus norvegicus,50597,A,,1
,Maximum time (Tmax) required to reach Cmax in rats,10116.0,Intermediate,,,7789,,CHEMBL621322,1,BAO_0000218,,,,N,,,4026,Rattus norvegicus,50597,A,,1
,Maximum time constant was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,10116.0,Intermediate,,,7790,,CHEMBL621323,1,BAO_0000218,,In vivo,,N,,,4890,Rattus norvegicus,50597,A,,1
,Maximum time of clearance of compound in rats after peroral administration,10116.0,Intermediate,,,7791,,CHEMBL621324,1,BAO_0000218,,In vivo,,N,,,6571,Rattus norvegicus,50597,A,,1
,Maximum time at the dose of 2 mg/kg in rat,10116.0,Intermediate,,,7792,,CHEMBL621325,1,BAO_0000218,,,,N,,,4727,Rattus norvegicus,50597,A,,1
,Maximum time to achieve peak plasma concentration was determined in rat at 1 mg/kg,10116.0,Intermediate,,,7793,1969.0,CHEMBL875837,1,BAO_0000218,,In vivo,,N,,Plasma,17651,Rattus norvegicus,50597,A,,1
,Maximum time to achieve peak plasma concentration was determined in rat at 10 mg/kg,10116.0,Intermediate,,,7794,1969.0,CHEMBL621326,1,BAO_0000218,,In vivo,,N,,Plasma,17651,Rattus norvegicus,50597,A,,1
,Tmax in Guinea pig (PO dose),10116.0,Intermediate,,,7795,,CHEMBL621327,1,BAO_0000218,,In vivo,,N,,,14465,Rattus norvegicus,50597,A,,1
,"Pharmacokinetic Parameter, Tmax is the time at which maximum concentration (Cmax) is reached in Female Wistar Rats at 100 mg/kg by po administration",10116.0,Intermediate,,,7796,,CHEMBL621328,1,BAO_0000218,,In vivo,,N,,,14941,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter (Tmax) in rat,10116.0,Intermediate,,,7797,,CHEMBL621329,1,BAO_0000218,,In vivo,,N,,,5960,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter (Tmax) was estimated,10116.0,Intermediate,,,7798,,CHEMBL621330,1,BAO_0000218,,In vivo,,N,,,5022,Rattus norvegicus,50597,A,,1
,Pharmacokinetic property (Tmax) in rat,10116.0,Intermediate,,,7799,,CHEMBL621331,1,BAO_0000218,,In vivo,,N,,,4408,Rattus norvegicus,50597,A,,1
,Pharmacokinetic property (Tmax) was measured in rat at the dose of 0.32 mg/kg p.o.,10116.0,Intermediate,,,7800,,CHEMBL621332,1,BAO_0000218,,In vivo,,N,,,5983,Rattus norvegicus,50597,A,,1
,T max in Rat at a oral dose of 5 mg/kg,10116.0,Intermediate,,,7801,,CHEMBL621333,1,BAO_0000218,,In vivo,,N,,,4689,Rattus norvegicus,50597,A,,1
,T max was determined at 10 mg/kg po dose in rats,10116.0,Intermediate,,,7802,,CHEMBL621334,1,BAO_0000218,,In vivo,,N,,,2792,Rattus norvegicus,50597,A,,1
,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (run time 7 hr),10090.0,Intermediate,,,7803,,CHEMBL621335,1,BAO_0000218,,,,N,,,15011,Mus musculus,50594,A,,1
,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in dogs,9615.0,Intermediate,,,7804,,CHEMBL621336,1,BAO_0000218,,,,N,,,14180,Canis lupus familiaris,50588,A,,1
,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in rats,10116.0,Intermediate,,,7805,,CHEMBL621337,1,BAO_0000218,,,,N,,,14180,Rattus norvegicus,50597,A,,1
,Area under curve was measured after i.v. administration into Beagle dog.,9615.0,Intermediate,,,7806,,CHEMBL621338,1,BAO_0000218,,,,N,,,14599,Canis lupus familiaris,50588,A,,1
,Area under curve was measured after iv administration into Beagle dog,9615.0,Intermediate,,,7807,,CHEMBL875838,1,BAO_0000218,,,,N,,,14599,Canis lupus familiaris,50588,A,,1
,Area under curve was measured after po administration into Beagle dog,9615.0,Intermediate,,,7808,,CHEMBL621339,1,BAO_0000218,,,,N,,,14599,Canis lupus familiaris,50588,A,,1
,Area under curve was measured after po administration into Beagle dog.,9615.0,Intermediate,,,7809,,CHEMBL621340,1,BAO_0000218,,,,N,,,14599,Canis lupus familiaris,50588,A,,1
,Area under curve was measured at peroral dose of 3 mg/kg,,Autocuration,,,7810,,CHEMBL621341,1,BAO_0000218,,,,U,,,15675,,22224,A,,0
,Area under curve was measured by using concentration Vs time,,Autocuration,,,7811,,CHEMBL621342,1,BAO_0000019,,,,U,,,12706,,22224,A,,0
,Area under curve was measured by using concentration Vs time; not tested,,Autocuration,,,7812,,CHEMBL621343,1,BAO_0000019,,,,U,,,12706,,22224,A,,0
,Area under curve(AUC) was measured in mice after oral administration (50 mg/kg),10090.0,Intermediate,,,7813,,CHEMBL621344,1,BAO_0000218,,,,N,,,9750,Mus musculus,50594,A,,1
,Area under curve(AUC) was measured in mice after oral administration.,10090.0,Intermediate,,,7814,,CHEMBL621345,1,BAO_0000218,,,,N,,,9750,Mus musculus,50594,A,,1
,Area under curve(AUC) value of the compound,,Autocuration,,,7815,,CHEMBL621346,1,BAO_0000019,,,,U,,,14691,,22224,A,,0
,Area under curve(AUC) value of the compound in dogs at 0.5 mg/kg dose upon oral administration,,Autocuration,,,7816,,CHEMBL621347,1,BAO_0000218,,,,U,,,14691,,22224,A,,0
,Area under curve(AUC) value of the compound in dogs at 1 mg/kg dose upon oral administration,9615.0,Intermediate,,,7817,,CHEMBL621348,1,BAO_0000218,,,,N,,,14691,Canis lupus familiaris,50588,A,,1
,Area under curve(carotid artery) was determined by the availability in blood,,Autocuration,,,7818,178.0,CHEMBL621349,1,BAO_0000019,,,,U,,Blood,2939,,22224,A,,0
,Area under curve(carotid artery) was determined by the availability in blood; ND means no data,,Autocuration,,,7819,178.0,CHEMBL621350,1,BAO_0000019,,,,U,,Blood,2939,,22224,A,,0
,Area under curve(carotid artery) was determined by the availability in blood; No data,,Autocuration,,,7820,178.0,CHEMBL875839,1,BAO_0000019,,,,U,,Blood,2939,,22224,A,,0
,Area under curve(portal vein) was determined by the availability in blood,,Autocuration,,,7821,178.0,CHEMBL620211,1,BAO_0000019,,,,U,,Blood,2939,,22224,A,,0
,Area under curve(portal vein) was determined by the availability in blood; ND means no data,,Autocuration,,,7822,178.0,CHEMBL620212,1,BAO_0000019,,,,U,,Blood,2939,,22224,A,,0
,Area under curve(portal vein) was determined by the availability in blood; No data,,Autocuration,,,7823,178.0,CHEMBL620213,1,BAO_0000019,,,,U,,Blood,2939,,22224,A,,0
,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",9544.0,Intermediate,,,7824,1969.0,CHEMBL620214,1,BAO_0000218,,,,N,,Plasma,9552,Macaca mulatta,50797,A,,1
,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",9544.0,Intermediate,,,7825,1969.0,CHEMBL620215,1,BAO_0000218,,,,N,,Plasma,9552,Macaca mulatta,50797,A,,1
,Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose,9544.0,Intermediate,,,7826,1969.0,CHEMBL620216,1,BAO_0000218,,,,N,,Plasma,9552,Macaca mulatta,50797,A,,1
,"Area under plasma concentration vs time curve observed in female mongrel dogs after, iv administration of single 15 mg/kg dose",9615.0,Intermediate,,,7827,1969.0,CHEMBL620888,1,BAO_0000218,,,,N,,Plasma,9552,Canis lupus familiaris,50588,A,,1
,"Area under plasma concentration vs time curve observed in female mongrel dogs after, oral administration of single 15 mg/kg dose",9615.0,Intermediate,,,7828,1969.0,CHEMBL620889,1,BAO_0000218,,,,N,,Plasma,9552,Canis lupus familiaris,50588,A,,1
,Area under plasma concentration vs time curve observed in rats for 0-3 h,,Autocuration,,,7829,1969.0,CHEMBL620890,1,BAO_0000019,,,,U,,Plasma,9552,,22224,A,,0
,Area under plasma time curve determined in male rat,10116.0,Intermediate,,,7830,1969.0,CHEMBL620891,1,BAO_0000218,,,,N,,Plasma,11911,Rattus norvegicus,50597,A,,1
,Area under the MAP curve measured over 5 min.,,Autocuration,,,7831,,CHEMBL620892,1,BAO_0000019,,,,U,,,16618,,22224,A,,0
,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through iv route in mice,10090.0,Intermediate,,,7832,,CHEMBL621079,1,BAO_0000218,,,,N,,,14387,Mus musculus,50594,A,,1
,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through oral route in mice,10090.0,Intermediate,,,7833,,CHEMBL621080,1,BAO_0000218,,,,N,,,14387,Mus musculus,50594,A,,1
,Area under the concentration vs time curve in dog at 10 mg/kg oral dose,9615.0,Intermediate,,,7834,,CHEMBL621081,1,BAO_0000218,,,,N,,,12836,Canis lupus familiaris,50588,A,,1
,Area under the concentration vs time curve in hamster at 10 mg/kg oral dose,10026.0,Intermediate,,,7835,,CHEMBL621082,1,BAO_0000218,,,,N,,,12836,Cricetinae,100712,A,,1
,Area under the concentration vs time curve in rat at 10 mg/kg oral dose,10116.0,Intermediate,,,7836,,CHEMBL621083,1,BAO_0000218,,,,N,,,12836,Rattus norvegicus,50597,A,,1
,Area under the concentration-time curve from time zero to infinity after intravenous administration of 2.5 mg/kg in dogs,9615.0,Intermediate,,,7837,,CHEMBL621084,1,BAO_0000218,,,,N,,,14339,Canis lupus familiaris,50588,A,,1
,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fasted dogs,9615.0,Intermediate,,,7838,,CHEMBL621085,1,BAO_0000218,,,,N,,,14339,Canis lupus familiaris,50588,A,,1
,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fed dogs,9615.0,Intermediate,,,7839,,CHEMBL621086,1,BAO_0000218,,,,N,,,14339,Canis lupus familiaris,50588,A,,1
,Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),9615.0,Intermediate,,,7840,,CHEMBL621087,1,BAO_0000218,,,,N,,,10524,Canis lupus familiaris,50588,A,,1
,Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),9615.0,Intermediate,,,7841,,CHEMBL622607,1,BAO_0000218,,,,N,,,9994,Canis lupus familiaris,50588,A,,1
,Serum AUC in marmosets (IV dose),9615.0,Intermediate,,,7842,,CHEMBL622608,1,BAO_0000218,,,,N,,,11325,Canis lupus familiaris,50588,A,,1
,Area under the curve after intravenous administration at a dose of 10 umol/kg,,Autocuration,,,7843,,CHEMBL624481,1,BAO_0000019,,,,U,,,12536,,22224,A,,0
,Area under the curve after intravenous administration at a dose of 2 umol/kg,,Autocuration,,,7844,,CHEMBL624482,1,BAO_0000019,,,,U,,,12536,,22224,A,,0
,Area under the curve after intravenous administration at a dose of 4 umol/kg,,Autocuration,,,7845,,CHEMBL624483,1,BAO_0000019,,,,U,,,12536,,22224,A,,0
,Area under the curve after intravenous administration at a dose of 40 umol/kg,,Autocuration,,,7846,,CHEMBL624484,1,BAO_0000019,,,,U,,,12536,,22224,A,,0
,Area under the curve after intravenous administration at a dose of 5 umol/kg,,Autocuration,,,7847,,CHEMBL624485,1,BAO_0000019,,,,U,,,12536,,22224,A,,0
,Area under the curve for fumarate salt was evaluated in F344 Rats.,10116.0,Intermediate,,,7848,,CHEMBL624486,1,BAO_0000218,,,,N,,,15556,Rattus norvegicus,50597,A,,1
,Area under the curve for the compound was calculated.,,Autocuration,,,7849,,CHEMBL624487,1,BAO_0000019,,,,U,,,2809,,22224,A,,0
,Area under the curve in concentration/ time,,Autocuration,,,7850,,CHEMBL624488,1,BAO_0000019,,,,U,,,9511,,22224,A,,0
,Area under the curve administered intraintestinal in rats.,10116.0,Intermediate,,,7851,,CHEMBL624489,1,BAO_0000218,,,,N,,,12818,Rattus norvegicus,50597,A,,1
,Area under the curve administered intravenously in rats.,10116.0,Intermediate,,,7852,,CHEMBL625184,1,BAO_0000218,,,,N,,,12818,Rattus norvegicus,50597,A,,1
,Area under the curve during intravenous administration,,Autocuration,,,7853,,CHEMBL625185,1,BAO_0000019,,,,U,,,15118,,22224,A,,0
,Area under the curve during intravenous administration; Not determined,,Autocuration,,,7854,,CHEMBL875954,1,BAO_0000019,,,,U,,,15118,,22224,A,,0
,Area under the curve during systemic administration,,Autocuration,,,7855,,CHEMBL625186,1,BAO_0000019,,,,U,,,15118,,22224,A,,0
,Area under the curve during systemic administration; Not determined,,Autocuration,,,7856,,CHEMBL625187,1,BAO_0000019,,,,U,,,15118,,22224,A,,0
,Area under the curve was calculated for the compound.,,Autocuration,,,7857,,CHEMBL625188,1,BAO_0000019,,,,U,,,2632,,22224,A,,0
,Area under the curve was determined after intravenous administration of 1.8 mg/kg in male Beagle dogs,9615.0,Intermediate,,,7858,,CHEMBL625189,1,BAO_0000218,,,,N,,,14346,Canis lupus familiaris,50588,A,,1
,Area under the curve was determined after intravenous administration of 10 mg/kg in male Beagle dogs,9615.0,Intermediate,,,7859,,CHEMBL625190,1,BAO_0000218,,,,N,,,14346,Canis lupus familiaris,50588,A,,1
,Area under the curve was determined after intravenous administration of 2.5 mg/kg in male Dawley rats,10116.0,Intermediate,,,7860,,CHEMBL621733,1,BAO_0000218,,,,N,,,14346,Rattus norvegicus,50597,A,,1
,Area under the curve was determined after intravenous administration of 2.6 mg/kg in male Dawley rats,10116.0,Intermediate,,,7861,,CHEMBL621734,1,BAO_0000218,,,,N,,,14346,Rattus norvegicus,50597,A,,1
,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate after oral administration to male F344 rats,10116.0,Intermediate,,,7862,,CHEMBL621735,1,BAO_0000218,,,,N,,,11149,Rattus norvegicus,50597,A,,1
,Clearance of the drug was measured in the plasma of rat; No data,10116.0,Intermediate,,,7863,1969.0,CHEMBL621736,1,BAO_0000218,,,,N,,Plasma,17796,Rattus norvegicus,50597,A,,1
,The pharmacokinetic parameter plasma clearance in vivo in rats,10116.0,Intermediate,,,7864,1969.0,CHEMBL621737,1,BAO_0000218,,,,N,,Plasma,5247,Rattus norvegicus,50597,A,,1
,Plasma clearance at the dose of 2 mg/kg in rat,10116.0,Intermediate,,,7865,,CHEMBL621738,1,BAO_0000218,,,,N,,,4727,Rattus norvegicus,50597,A,,1
,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,10116.0,Intermediate,,,7866,,CHEMBL622806,1,BAO_0000218,,In vivo,,N,,,5654,Rattus norvegicus,50597,A,,1
,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,10116.0,Intermediate,,,7867,,CHEMBL623519,1,BAO_0000218,,In vivo,,N,,,5654,Rattus norvegicus,50597,A,,1
,CL at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,10116.0,Intermediate,,,7868,,CHEMBL623520,1,BAO_0000218,,In vivo,,N,,,17260,Rattus norvegicus,50597,A,,1
,Clearance measured after intravenous bolus administration of 50 mg/kg of compound to rats,10116.0,Intermediate,,,7869,,CHEMBL623521,1,BAO_0000218,,In vivo,,N,,,17065,Rattus norvegicus,50597,A,,1
,Clearance in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,10116.0,Intermediate,,,7870,,CHEMBL623522,1,BAO_0000218,,In vivo,,N,,,17671,Rattus norvegicus,50597,A,,1
,Clearance rate in rat,10116.0,Intermediate,,,7871,,CHEMBL623523,1,BAO_0000218,,In vivo,,N,,,6672,Rattus norvegicus,50597,A,,1
,Clearance rate in rat,10116.0,Intermediate,,,7872,,CHEMBL623690,1,BAO_0000218,,In vivo,,N,,,6673,Rattus norvegicus,50597,A,,1
,Clearance (Cl) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,10116.0,Intermediate,,,7873,,CHEMBL623691,1,BAO_0000218,,In vivo,,N,,,5978,Rattus norvegicus,50597,A,,1
,Clearance (Cl) of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,10116.0,Intermediate,,,7874,,CHEMBL623692,1,BAO_0000218,,In vivo,,N,,,5978,Rattus norvegicus,50597,A,,1
,Clearance (Cl) of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,10116.0,Intermediate,,,7875,,CHEMBL623693,1,BAO_0000218,,In vivo,,N,,,5978,Rattus norvegicus,50597,A,,1
,Clearance (Cl) of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,10116.0,Intermediate,,,7876,,CHEMBL623694,1,BAO_0000218,,In vivo,,N,,,5978,Rattus norvegicus,50597,A,,1
,Clearance of compound after iv administration of 20 mg/kg dose in rat,10116.0,Intermediate,,,7877,,CHEMBL623695,1,BAO_0000218,,In vivo,,N,,,4413,Rattus norvegicus,50597,A,,1
,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female wistar rats,10116.0,Intermediate,,,7878,,CHEMBL623696,1,BAO_0000218,,In vivo,,N,,,2661,Rattus norvegicus,50597,A,,1
,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to male wistar rats,10116.0,Intermediate,,,7879,,CHEMBL623697,1,BAO_0000218,,In vivo,,N,,,2661,Rattus norvegicus,50597,A,,1
,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,9544.0,Intermediate,,,7880,1969.0,CHEMBL623698,1,BAO_0000218,,In vivo,,U,,Plasma,5005,Macaca mulatta,22224,A,,0
,Compound was tested for its plasma clearance rate in Sprague Dawley rats,10116.0,Intermediate,,,7881,1969.0,CHEMBL623699,1,BAO_0000218,,In vivo,,U,,Plasma,5005,Rattus norvegicus,22224,A,,0
,Mean (%CV) PK parameters for CL(mL/min/kg).,10116.0,Intermediate,,,7882,,CHEMBL623700,1,BAO_0000218,,In vivo,,N,,,15765,Rattus norvegicus,50597,A,,1
,Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat,10116.0,Intermediate,,,7883,,CHEMBL623701,1,BAO_0000218,,In vivo,,N,,,3747,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter plasma clearance was determined at when a dose of 1 mg/kg is administered,10116.0,Intermediate,,,7884,1969.0,CHEMBL623702,1,BAO_0000218,,In vivo,,N,,Plasma,16366,Rattus norvegicus,50597,A,,1
,Plasma Clearance measured at steady-state following iv infusion at 0.6 mg/kg/h in rats,10116.0,Intermediate,,,7885,,CHEMBL623703,1,BAO_0000218,,In vivo,,N,,,4199,Rattus norvegicus,50597,A,,1
,Plasma clearance in rat was determined,10116.0,Intermediate,,,7886,,CHEMBL623704,1,BAO_0000218,,In vivo,,N,,,17267,Rattus norvegicus,50597,A,,1
,Plasma clearance in rat after administration of 2 mg/kg iv,10116.0,Intermediate,,,7887,,CHEMBL623705,1,BAO_0000218,,In vivo,,N,,,6535,Rattus norvegicus,50597,A,,1
,Plasma clearance in rat after administration of 2 mg/kg iv,10116.0,Intermediate,,,7888,,CHEMBL623706,1,BAO_0000218,,In vivo,,N,,,6535,Rattus norvegicus,50597,A,,1
,Plasma clearance was determined,10116.0,Intermediate,,,7889,,CHEMBL623707,1,BAO_0000218,,In vivo,,N,,,5041,Rattus norvegicus,50597,A,,1
,Plasma clearance in rat,10116.0,Intermediate,,,7890,,CHEMBL623708,1,BAO_0000218,,In vivo,,N,,,5960,Rattus norvegicus,50597,A,,1
,Plasma clearance in rat after intravenous administration at a concentration 0.5 mg/kg,10116.0,Intermediate,,,7891,,CHEMBL623709,1,BAO_0000218,,In vivo,,N,,,5937,Rattus norvegicus,50597,A,,1
,Plasma clearance in rat by iv administration,10116.0,Intermediate,,,7892,,CHEMBL623710,1,BAO_0000218,,In vivo,,N,,,5871,Rattus norvegicus,50597,A,,1
,Plasma clearance in rat by iv administration at a dose of 3 mg/kg,10116.0,Intermediate,,,7893,,CHEMBL623711,1,BAO_0000218,,In vivo,,N,,,5874,Rattus norvegicus,50597,A,,1
,Plasma clearance in rat p.o.,10116.0,Intermediate,,,7894,,CHEMBL623712,1,BAO_0000218,,In vivo,,N,,,6504,Rattus norvegicus,50597,A,,1
,Plasma clearance in rats,10116.0,Intermediate,,,7895,,CHEMBL623713,1,BAO_0000218,,In vivo,,N,,,6803,Rattus norvegicus,50597,A,,1
,Plasma clearance was determined; ND denotes no data,10116.0,Intermediate,,,7896,,CHEMBL623714,1,BAO_0000218,,In vivo,,N,,,5041,Rattus norvegicus,50597,A,,1
,Plasma clearance was determined; ND denotes not determined,10116.0,Intermediate,,,7897,,CHEMBL623715,1,BAO_0000218,,In vivo,,N,,,5041,Rattus norvegicus,50597,A,,1
,Plasma clearance was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,10116.0,Intermediate,,,7898,,CHEMBL623716,1,BAO_0000218,,In vivo,,N,,,1916,Rattus norvegicus,50597,A,,1
,Plasma clearance was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,10116.0,Intermediate,,,7899,,CHEMBL622980,1,BAO_0000218,,In vivo,,N,,,5199,Rattus norvegicus,50597,A,,1
,Plasma administration to rats,10116.0,Intermediate,,,7900,,CHEMBL622981,1,BAO_0000218,,In vivo,,N,,,16367,Rattus norvegicus,50597,A,,1
,Plasma clearance of the compound in female Sprague-Dawley rats,10116.0,Intermediate,,,7901,,CHEMBL622982,1,BAO_0000218,,In vivo,,N,,,6362,Rattus norvegicus,50597,A,,1
,Plasma clearance was observed after intravenous administration in rat,10116.0,Intermediate,,,7902,,CHEMBL622983,1,BAO_0000218,,In vivo,,N,,,15662,Rattus norvegicus,50597,A,,1
,Systemic clearance after intravenous administration (5.0 mg/kg) was determined in rat,10116.0,Intermediate,,,7903,,CHEMBL622984,1,BAO_0000218,,In vivo,,N,,,6215,Rattus norvegicus,50597,A,,1
,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in rat,10116.0,Intermediate,,,7904,,CHEMBL622985,1,BAO_0000218,,In vivo,,N,,,1466,Rattus norvegicus,50597,A,,1
,plasma clearance was observed after intravenous administration in rat,10116.0,Intermediate,,,7905,1969.0,CHEMBL623631,1,BAO_0000218,,In vivo,,N,,Plasma,15662,Rattus norvegicus,50597,A,,1
,In vivo CL/F determined,10116.0,Intermediate,,,7906,,CHEMBL623632,1,BAO_0000218,,In vivo,,N,,,4723,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter plasma clearance was determined at 2 mg/kg i.v. dose in rats,10116.0,Intermediate,,,7907,1969.0,CHEMBL623633,1,BAO_0000218,,In vivo,,N,,Plasma,2792,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter plasma clearance was determined at 5 mg/kg i.v. dose in rats,10116.0,Intermediate,,,7908,1969.0,CHEMBL623634,1,BAO_0000218,,In vivo,,N,,Plasma,2792,Rattus norvegicus,50597,A,,1
,Compound was tested for the lower blood clearance in rat,10116.0,Intermediate,,,7909,,CHEMBL623635,1,BAO_0000218,,In vivo,,N,,,5213,Rattus norvegicus,50597,A,,1
,Evaluated for the low clearance in rat (in vivo),10116.0,Intermediate,,,7910,,CHEMBL621195,1,BAO_0000218,,In vivo,,N,,,4687,Rattus norvegicus,50597,A,,1
,Pharmacokinetic property (CLb)of the compound was determined in rat,10116.0,Intermediate,,,7911,,CHEMBL621196,1,BAO_0000218,,In vivo,,N,,,3371,Rattus norvegicus,50597,A,,1
,Rapid clearance after intravenous administration in rat was determined,10116.0,Intermediate,,,7912,,CHEMBL875287,1,BAO_0000218,,In vivo,,N,,,4690,Rattus norvegicus,50597,A,,1
,Clearance measured in rat,10116.0,Intermediate,,,7913,,CHEMBL621197,1,BAO_0000218,,In vivo,,N,,,5702,Rattus norvegicus,50597,A,,1
,Compound was evaluated for plasma clearance in rat,10116.0,Intermediate,,,7914,1969.0,CHEMBL621198,1,BAO_0000218,,In vivo,,N,,Plasma,740,Rattus norvegicus,50597,A,,1
,Low plasma clearance was calculated in rat,10116.0,Intermediate,,,7915,1969.0,CHEMBL621199,1,BAO_0000218,,In vivo,,N,,Plasma,4853,Rattus norvegicus,50597,A,,1
,Pharmacokinetic property (Clp) in rat,10116.0,Intermediate,,,7916,,CHEMBL621200,1,BAO_0000218,,In vivo,,N,,,5789,Rattus norvegicus,50597,A,,1
,Plasma clearance in dog at a dose of 1 uM/kg in rat was determined,10116.0,Intermediate,,,7917,,CHEMBL621201,1,BAO_0000218,,In vivo,,N,,,4527,Rattus norvegicus,50597,A,,1
,Plasma clearance in rat at a dose of 10 uM/kg in rat was determined,10116.0,Intermediate,,,7918,,CHEMBL621202,1,BAO_0000218,,In vivo,,N,,,4527,Rattus norvegicus,50597,A,,1
,Plasma clearance after IV dosing at 0.5 mg/kg in rat,10116.0,Intermediate,,,7919,,CHEMBL621203,1,BAO_0000218,,In vivo,,N,,,6518,Rattus norvegicus,50597,A,,1
,Plasma clearance after IV dosing at 1 mg/kg in rat,10116.0,Intermediate,,,7920,,CHEMBL621204,1,BAO_0000218,,In vivo,,N,,,6518,Rattus norvegicus,50597,A,,1
,Biodistribution in rat heart in the presence of 0.01 M Gd/0.01 M GdDTPA-AEP,10116.0,Intermediate,,,7921,948.0,CHEMBL621205,1,BAO_0000218,,In vivo,,N,,Heart,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat heart in the presence of 0.01 M GdDTPA-BDP,10116.0,Intermediate,,,7922,948.0,CHEMBL621206,1,BAO_0000218,,In vivo,,N,,Heart,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat heart in the presence of 0.01 M/0.08 M GdDTPA-AEP,10116.0,Intermediate,,,7923,948.0,CHEMBL621207,1,BAO_0000218,,In vivo,,N,,Heart,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat heart in the presence of 0.05 M /0.05 M GdDTPA-AEP,10116.0,Intermediate,,,7924,948.0,CHEMBL621208,1,BAO_0000218,,In vivo,,N,,Heart,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat heart in the presence of 0.05 M Gd/0.15 M lig,10116.0,Intermediate,,,7925,948.0,CHEMBL621209,1,BAO_0000218,,In vivo,,N,,Heart,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat heart in the presence of 0.05 M GdDTPA-BDP,10116.0,Intermediate,,,7926,948.0,CHEMBL876484,1,BAO_0000218,,In vivo,,N,,Heart,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat heart in the presence of 0.05 M/0.08 M GdDTPA-HPDP,10116.0,Intermediate,,,7927,948.0,CHEMBL621210,1,BAO_0000218,,In vivo,,N,,Heart,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat heart in the presence of 0.10 M GdDTPA-BDP,10116.0,Intermediate,,,7928,948.0,CHEMBL621211,1,BAO_0000218,,In vivo,,N,,Heart,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat heart in the presence of 0.10 M/0.11 M GdDTPA-AEP,10116.0,Intermediate,,,7929,948.0,CHEMBL621212,1,BAO_0000218,,In vivo,,N,,Heart,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat heart in the presence of GdDTPA at 15 min,10116.0,Intermediate,,,7930,948.0,CHEMBL621213,1,BAO_0000218,,In vivo,,N,,Heart,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat heart in the presence of GdDTPA at 1 hr,10116.0,Intermediate,,,7931,948.0,CHEMBL621214,1,BAO_0000218,,In vivo,,N,,Heart,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat heart in the presence of GdDTPA at 30 min,10116.0,Intermediate,,,7932,948.0,CHEMBL621215,1,BAO_0000218,,In vivo,,N,,Heart,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat heart in the presence of GdDTPA at 4 hr,10116.0,Intermediate,,,7933,948.0,CHEMBL621216,1,BAO_0000218,,In vivo,,N,,Heart,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat heart in the presence of GdDTPA-BDP at 1 hr,10116.0,Intermediate,,,7934,948.0,CHEMBL621217,1,BAO_0000218,,In vivo,,N,,Heart,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat heart in the presence of GdDTPA-BDP at 30 min,10116.0,Intermediate,,,7935,948.0,CHEMBL621218,1,BAO_0000218,,In vivo,,N,,Heart,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat heart in the presence of GdDTPA-BDP at 4 hr,10116.0,Intermediate,,,7936,948.0,CHEMBL621219,1,BAO_0000218,,In vivo,,N,,Heart,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat heart in the presence of GdDTPA-BDPat 15 min,10116.0,Intermediate,,,7937,948.0,CHEMBL621220,1,BAO_0000218,,In vivo,,N,,Heart,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 1 hr,10116.0,Intermediate,,,7938,948.0,CHEMBL621221,1,BAO_0000218,,In vivo,,N,,Heart,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 30 min,10116.0,Intermediate,,,7939,948.0,CHEMBL621222,1,BAO_0000218,,In vivo,,N,,Heart,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 4 hr,10116.0,Intermediate,,,7940,948.0,CHEMBL621223,1,BAO_0000218,,In vivo,,N,,Heart,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat heart in the presence of GdDTPA-HPDPat 15 min,10116.0,Intermediate,,,7941,948.0,CHEMBL876485,1,BAO_0000218,,In vivo,,N,,Heart,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat heart in the presence of NAC Gd/0.01 M GdDTPA-HPDP,10116.0,Intermediate,,,7942,948.0,CHEMBL621224,1,BAO_0000218,,In vivo,,N,,Heart,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat heart in the presence of NCA Gd/0.01 M lip,10116.0,Intermediate,,,7943,948.0,CHEMBL621225,1,BAO_0000218,,In vivo,,N,,Heart,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat heart in the presence of NCAGd/0.01 M lig,10116.0,Intermediate,,,7944,948.0,CHEMBL621226,1,BAO_0000218,,In vivo,,N,,Heart,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat kidney in the presence of 0.01 M GdDTPA-BDP,10116.0,Intermediate,,,7945,2113.0,CHEMBL621227,1,BAO_0000218,,In vivo,,N,,Kidney,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat kidney in the presence of 0.01 M/0.01 M GdDTPA-AEP,10116.0,Intermediate,,,7946,2113.0,CHEMBL621228,1,BAO_0000218,,In vivo,,N,,Kidney,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat kidney in the presence of 0.01 M/0.08 M GdDTPA-AEP,10116.0,Intermediate,,,7947,2113.0,CHEMBL621229,1,BAO_0000218,,In vivo,,N,,Kidney,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat kidney in the presence of 0.05 M Gd/0.15 M lig,10116.0,Intermediate,,,7948,2113.0,CHEMBL621230,1,BAO_0000218,,In vivo,,N,,Kidney,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat kidney in the presence of 0.05 M GdDTPA-BDP; ND=No data,10116.0,Intermediate,,,7949,2113.0,CHEMBL621231,1,BAO_0000218,,In vivo,,N,,Kidney,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat kidney in the presence of 0.05 M/0.05 M GdDTPA-AEP,10116.0,Intermediate,,,7950,2113.0,CHEMBL621232,1,BAO_0000218,,In vivo,,N,,Kidney,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat kidney in the presence of 0.05 M/0.08 M GdDTPA-HPDP,10116.0,Intermediate,,,7951,2113.0,CHEMBL621233,1,BAO_0000218,,In vivo,,N,,Kidney,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat kidney in the presence of 0.10 M GdDTPA-BDP,10116.0,Intermediate,,,7952,2113.0,CHEMBL621234,1,BAO_0000218,,In vivo,,N,,Kidney,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat kidney in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,10116.0,Intermediate,,,7953,2113.0,CHEMBL621235,1,BAO_0000218,,In vivo,,N,,Kidney,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat kidney in the presence of NAC Gd/0.01 M GdDTPA-HPDP,10116.0,Intermediate,,,7954,2113.0,CHEMBL621236,1,BAO_0000218,,In vivo,,N,,Kidney,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat kidney in the presence of NCA Gd/0.01 M lip,10116.0,Intermediate,,,7955,2113.0,CHEMBL621237,1,BAO_0000218,,In vivo,,N,,Kidney,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat kidney in the presence of NCAGd/0.01 M lig,10116.0,Intermediate,,,7956,2113.0,CHEMBL876486,1,BAO_0000218,,In vivo,,N,,Kidney,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat l. intestine in the presence of 0.01 M carrier at 1 hr,10116.0,Intermediate,,,7957,160.0,CHEMBL622436,1,BAO_0000218,,In vivo,,N,,Intestine,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 2 hr,10116.0,Intermediate,,,7958,160.0,CHEMBL622437,1,BAO_0000218,,In vivo,,N,,Intestine,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 6 hr,10116.0,Intermediate,,,7959,160.0,CHEMBL622438,1,BAO_0000218,,In vivo,,N,,Intestine,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat liver by in the presence 50 Gd/kg at 15 min,10116.0,Intermediate,,,7960,2107.0,CHEMBL622439,1,BAO_0000218,,In vivo,,N,,Liver,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat liver by in the presence of 0.05 M Gd/0.15 M lig,10116.0,Intermediate,,,7961,2107.0,CHEMBL622440,1,BAO_0000218,,In vivo,,N,,Liver,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat liver by in the presence of NCAGd/0.01 M lig,10116.0,Intermediate,,,7962,2107.0,CHEMBL622441,1,BAO_0000218,,In vivo,,N,,Liver,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat liver in the presence of 0.001 M/0.008 M GdDTPA-AEP,10116.0,Intermediate,,,7963,2107.0,CHEMBL622442,1,BAO_0000218,,In vivo,,N,,Liver,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat liver in the presence of 0.01 M GdDTPA-BDP,10116.0,Intermediate,,,7964,2107.0,CHEMBL622443,1,BAO_0000218,,In vivo,,N,,Liver,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat liver in the presence of 0.01 M/0.01 M GdDTPA-AEP,10116.0,Intermediate,,,7965,2107.0,CHEMBL622444,1,BAO_0000218,,In vivo,,N,,Liver,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat liver in the presence of 0.05 M GdDTPA-BDP,10116.0,Intermediate,,,7966,2107.0,CHEMBL622445,1,BAO_0000218,,In vivo,,N,,Liver,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat liver in the presence of 0.05 M/0.05 M GdDTPA-AEP,10116.0,Intermediate,,,7967,2107.0,CHEMBL622446,1,BAO_0000218,,In vivo,,N,,Liver,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat liver in the presence of 0.05 M/0.08 M GdDTPA-HPDP,10116.0,Intermediate,,,7968,2107.0,CHEMBL622447,1,BAO_0000218,,In vivo,,N,,Liver,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat liver in the presence of 0.10 M GdDTPA-BDP,10116.0,Intermediate,,,7969,2107.0,CHEMBL622448,1,BAO_0000218,,In vivo,,N,,Liver,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat liver in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,10116.0,Intermediate,,,7970,2107.0,CHEMBL622449,1,BAO_0000218,,In vivo,,N,,Liver,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat liver in the presence of 50 Gd/kg at 2 hr,10116.0,Intermediate,,,7971,2107.0,CHEMBL622450,1,BAO_0000218,,In vivo,,N,,Liver,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat liver in the presence of 50 Gd/kg at at 6 hr,10116.0,Intermediate,,,7972,2107.0,CHEMBL622451,1,BAO_0000218,,In vivo,,N,,Liver,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat liver in the presence of GdDTPA at 15 min,10116.0,Intermediate,,,7973,2107.0,CHEMBL622452,1,BAO_0000218,,In vivo,,N,,Liver,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat liver in the presence of GdDTPA at 1 hr,10116.0,Intermediate,,,7974,2107.0,CHEMBL622453,1,BAO_0000218,,In vivo,,N,,Liver,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat liver in the presence of GdDTPA at 30 min,10116.0,Intermediate,,,7975,2107.0,CHEMBL622454,1,BAO_0000218,,In vivo,,N,,Liver,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat liver in the presence of GdDTPA at 4 hr,10116.0,Intermediate,,,7976,2107.0,CHEMBL622455,1,BAO_0000218,,In vivo,,N,,Liver,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat liver in the presence of GdDTPA-BDP at 15 min,10116.0,Intermediate,,,7977,2107.0,CHEMBL876024,1,BAO_0000218,,In vivo,,N,,Liver,9866,Rattus norvegicus,50597,A,,1
,T max was determined at 3 mg/kg po dose in rats,10116.0,Intermediate,,,7978,,CHEMBL622456,1,BAO_0000218,,In vivo,,N,,,2792,Rattus norvegicus,50597,A,,1
,"The Tmax value in female wistar rat at 100 mg/kg, p.o. dose",10116.0,Intermediate,,,7979,,CHEMBL622457,1,BAO_0000218,,In vivo,,N,,,15078,Rattus norvegicus,50597,A,,1
,"The Tmax value in male wistar rat at 100 mg/kg, p.o. dose",10116.0,Intermediate,,,7980,,CHEMBL622458,1,BAO_0000218,,In vivo,,N,,,15078,Rattus norvegicus,50597,A,,1
,The time to reach maximum concentration of compound was measured at the dose of 100 umol/kg,10116.0,Intermediate,,,7981,,CHEMBL622459,1,BAO_0000218,,,,N,,,15022,Rattus norvegicus,50597,A,,1
,The time to reach maximum concentration of compound was measured at the dose of 300 umol/kg,10116.0,Intermediate,,,7982,,CHEMBL873343,1,BAO_0000218,,,,N,,,15022,Rattus norvegicus,50597,A,,1
,The time to reach maximum concentration of compound was measured at the dose of 30 umol/kg,10116.0,Intermediate,,,7983,,CHEMBL622460,1,BAO_0000218,,,,N,,,15022,Rattus norvegicus,50597,A,,1
,Time for maximum plasma concentration determined in rat,10116.0,Intermediate,,,7984,1969.0,CHEMBL622461,1,BAO_0000218,,,,N,,Plasma,4576,Rattus norvegicus,50597,A,,1
,Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,10116.0,Intermediate,,,7985,1969.0,CHEMBL622462,1,BAO_0000218,,In vivo,,N,,Plasma,6681,Rattus norvegicus,50597,A,,1
,Time of maximum concentration of the drug when administered orally a dose of 10 mg/kg to a fasting rat,10116.0,Intermediate,,,7986,,CHEMBL622463,1,BAO_0000218,,In vivo,,N,,,16365,Rattus norvegicus,50597,A,,1
,Time of maximum concentration of the drug when administered orally a dose of 1 mg/kg to a fasting rat,10116.0,Intermediate,,,7987,,CHEMBL622464,1,BAO_0000218,,In vivo,,N,,,16365,Rattus norvegicus,50597,A,,1
,Time of maximum concentration of the drug when administered orally a dose of 30 mg/kg,10116.0,Intermediate,,,7988,,CHEMBL622465,1,BAO_0000218,,In vivo,,N,,,16365,Rattus norvegicus,50597,A,,1
,Time of maximum concentration of the drug when administered orally a dose of 3 mg/kg to a fasting rat,10116.0,Intermediate,,,7989,,CHEMBL622466,1,BAO_0000218,,In vivo,,N,,,16365,Rattus norvegicus,50597,A,,1
,Time of maximum concentration of the drug when administered orally at dose of 3 mg/kg,10116.0,Intermediate,,,7990,,CHEMBL622467,1,BAO_0000218,,In vivo,,N,,,16365,Rattus norvegicus,50597,A,,1
,Time of maximum plasma concentration in rat,10116.0,Intermediate,,,7991,1969.0,CHEMBL622468,1,BAO_0000218,,,,N,,Plasma,6824,Rattus norvegicus,50597,A,,1
,"Time required by compound for reaching maximum plasma concentration was determined in rats at 10 mg/kg, p.o. dose",10116.0,Intermediate,,,7992,1969.0,CHEMBL876025,1,BAO_0000218,,,,N,,Plasma,6685,Rattus norvegicus,50597,A,,1
,"Time required by compound for reaching maximum plasma concentration was determined in rats at 20 mg/kg, i.p. dose",10116.0,Intermediate,,,7993,1969.0,CHEMBL622469,1,BAO_0000218,,,,N,,Plasma,6685,Rattus norvegicus,50597,A,,1
,"Time required by compound for reaching maximum plasma concentration was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",10116.0,Intermediate,,,7994,1969.0,CHEMBL622470,1,BAO_0000218,,,,N,,Plasma,6685,Rattus norvegicus,50597,A,,1
,Time required to reach maximum concentration (Cmax) after oral administration in rat,10116.0,Intermediate,,,7995,,CHEMBL622471,1,BAO_0000218,,In vivo,,N,,,15662,Rattus norvegicus,50597,A,,1
,Time required to reach maximum concentration in rat plasma,10116.0,Intermediate,,,7996,1969.0,CHEMBL622472,1,BAO_0000218,,,,N,,Plasma,1742,Rattus norvegicus,50597,A,,1
,Time taken by the compound to achieve maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,10116.0,Intermediate,,,7997,1969.0,CHEMBL622473,1,BAO_0000218,,In vivo,,N,,Plasma,2774,Rattus norvegicus,50597,A,,1
,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,10116.0,Intermediate,,,7998,1969.0,CHEMBL624282,1,BAO_0000218,,In vivo,,N,,Plasma,5199,Rattus norvegicus,50597,A,,1
,Time taken for maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,10116.0,Intermediate,,,7999,1969.0,CHEMBL624283,1,BAO_0000218,,In vivo,,N,,Plasma,12873,Rattus norvegicus,50597,A,,1
,Time taken for maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,10116.0,Intermediate,,,8000,1969.0,CHEMBL624284,1,BAO_0000218,,In vivo,,N,,Plasma,12873,Rattus norvegicus,50597,A,,1
,Time taken to reach maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,10116.0,Intermediate,,,8001,1969.0,CHEMBL624285,1,BAO_0000218,,In vivo,,N,,Plasma,1916,Rattus norvegicus,50597,A,,1
,Time to reach Cmax after oral administration to rats,10116.0,Intermediate,,,8002,,CHEMBL624286,1,BAO_0000218,,In vivo,,N,,,16367,Rattus norvegicus,50597,A,,1
,Time to reach Cmax when a dose of 1 mg/kg is administered orally,10116.0,Intermediate,,,8003,,CHEMBL624287,1,BAO_0000218,,In vivo,,N,,,16366,Rattus norvegicus,50597,A,,1
,Time to reach maximum concentration following oral administration of 200 mg/kg in rat; value ranges from 2-4,10116.0,Intermediate,,,8004,,CHEMBL624288,1,BAO_0000218,,,,N,,,216,Rattus norvegicus,50597,A,,1
,Time to reach maximum plasma concentration was evaluated at an intravenous dose of 3 mg/kg; Not applicable,10116.0,Intermediate,,,8005,1969.0,CHEMBL624289,1,BAO_0000218,,In vivo,,N,,Plasma,6410,Rattus norvegicus,50597,A,,1
,Time to reach maximum plasma concentration was evaluated at an oral dose of 30 mg/kg,10116.0,Intermediate,,,8006,1969.0,CHEMBL873344,1,BAO_0000218,,In vivo,,N,,Plasma,6410,Rattus norvegicus,50597,A,,1
,Tmax after peroral administration (10 mg/kg) was determined in rat,10116.0,Intermediate,,,8007,,CHEMBL619623,1,BAO_0000218,,In vivo,,N,,,6215,Rattus norvegicus,50597,A,,1
,Tmax of compound determined in rat after iv administration at a dose of 10 mg/kg,10116.0,Expert,,,8008,,CHEMBL621399,1,BAO_0000218,,In vivo,,N,,,3598,Rattus norvegicus,50597,A,,1
,Tmax by oral administration at a dose of 100 uM/kg in rat was determined,10116.0,Intermediate,,,8009,,CHEMBL621400,1,BAO_0000218,,In vivo,,N,,,4527,Rattus norvegicus,50597,A,,1
,"Tmax in fischer rats at 5 mg/kg dose, administered intravenously",10116.0,Intermediate,,,8010,,CHEMBL621401,1,BAO_0000218,,In vivo,,N,,,17670,Rattus norvegicus,50597,A,,1
,Tmax was determined,10116.0,Intermediate,,,8011,,CHEMBL621402,1,BAO_0000218,,,,N,,,1465,Rattus norvegicus,50597,A,,1
,Tmax was determined,10116.0,Intermediate,,,8012,,CHEMBL621403,1,BAO_0000218,,,,N,,,2552,Rattus norvegicus,50597,A,,1
,Tmax after oral administration in rat,10116.0,Intermediate,,,8013,,CHEMBL621121,1,BAO_0000218,,In vivo,,N,,,5656,Rattus norvegicus,50597,A,,1
,Tmax after peroral administration in rats at 2.4 uM/kg,10116.0,Intermediate,,,8014,,CHEMBL872525,1,BAO_0000218,,In vivo,,N,,,17764,Rattus norvegicus,50597,A,,1
,Tmax in male rat,10116.0,Intermediate,,,8015,,CHEMBL621122,1,BAO_0000218,,,,N,,,5610,Rattus norvegicus,50597,A,,1
,Tmax in rat at 10 mg/kg,10116.0,Intermediate,,,8016,,CHEMBL621123,1,BAO_0000218,,In vivo,,N,,,6046,Rattus norvegicus,50597,A,,1
,Tmax in rat by po administration at a dose of 40 mg/kg,10116.0,Intermediate,,,8017,,CHEMBL621124,1,BAO_0000218,,In vivo,,N,,,5874,Rattus norvegicus,50597,A,,1
,Tmax in rats,10116.0,Intermediate,,,8018,,CHEMBL621125,1,BAO_0000218,,,,N,,,17596,Rattus norvegicus,50597,A,,1
,Tmax was measured in rats after peroral administration at 5 mg/kg,10116.0,Intermediate,,,8019,,CHEMBL621126,1,BAO_0000218,,In vivo,,N,,,17804,Rattus norvegicus,50597,A,,1
,Tmax value after oral dose at a dose of 10 mg/kg in rats.,10116.0,Intermediate,,,8020,,CHEMBL621127,1,BAO_0000218,,In vivo,,N,,,1908,Rattus norvegicus,50597,A,,1
,Tmax value after administration of 20 mg/Kg oral dose in rat,10116.0,Intermediate,,,8021,,CHEMBL621128,1,BAO_0000218,,In vivo,,N,,,2959,Rattus norvegicus,50597,A,,1
,Tmax value at a dose of 10 mg/kg in male SD rats,10116.0,Intermediate,,,8022,,CHEMBL618263,1,BAO_0000218,,In vivo,,N,,,6757,Rattus norvegicus,50597,A,,1
,Tmax value at a dose of 100 mg/kg in male SD rats,10116.0,Intermediate,,,8023,,CHEMBL618264,1,BAO_0000218,,In vivo,,N,,,6757,Rattus norvegicus,50597,A,,1
,Tmax value at a dose of 50 mg/kg in male SD rats,10116.0,Intermediate,,,8024,,CHEMBL618265,1,BAO_0000218,,In vivo,,N,,,6757,Rattus norvegicus,50597,A,,1
,Total concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,10116.0,Intermediate,,,8025,1969.0,CHEMBL618266,1,BAO_0000218,,In vivo,,N,,Plasma,4186,Rattus norvegicus,50597,A,,1
,time required to reach maximum concentration (Cmax) after oral administration in rat,10116.0,Intermediate,,,8026,,CHEMBL618267,1,BAO_0000218,,In vivo,,N,,,15662,Rattus norvegicus,50597,A,,1
,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg ( 0-24 hr ),10116.0,Intermediate,,,8027,1088.0,CHEMBL618450,1,BAO_0000218,,,,N,,Urine,429,Rattus norvegicus,50597,A,,1
,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg (0-24 hr),10116.0,Intermediate,,,8028,1088.0,CHEMBL618451,1,BAO_0000218,,,,N,,Urine,429,Rattus norvegicus,50597,A,,1
,Unbound plasma was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,10116.0,Intermediate,,,8029,,CHEMBL618452,1,BAO_0000218,,,,N,,,5546,Rattus norvegicus,50597,A,,1
,Amount of urine output was measured in rat at a dose of 1 mg/kg/po,10116.0,Intermediate,,,8030,1088.0,CHEMBL618453,1,BAO_0000218,,,,N,,Urine,3173,Rattus norvegicus,50597,A,,1
,Amount of urine output was measured in rat at a dose of 10 mg/kg/po,10116.0,Intermediate,,,8031,1088.0,CHEMBL618454,1,BAO_0000218,,,,N,,Urine,3173,Rattus norvegicus,50597,A,,1
,Amount of urine output was measured in rat at a dose of 10 mg/kg/po; NT-Not tested,10116.0,Intermediate,,,8032,1088.0,CHEMBL618455,1,BAO_0000218,,,,N,,Urine,3173,Rattus norvegicus,50597,A,,1
,Volume of distribution was determined in rat after a 3 mg/kg of iv dose,10116.0,Intermediate,,,8033,,CHEMBL618456,1,BAO_0000218,,In vivo,,N,,,4257,Rattus norvegicus,50597,A,,1
,Compound distribution in rat tissues was determined,10116.0,Intermediate,,,8034,,CHEMBL618457,1,BAO_0000218,,In vivo,,N,,,6011,Rattus norvegicus,50597,A,,1
,Volume of distribution was evaluated in rat,10116.0,Intermediate,,,8035,,CHEMBL618458,1,BAO_0000218,,In vivo,,N,,,5472,Rattus norvegicus,50597,A,,1
,Area under the curve was determined after intravenous administration of 2.7 mg/kg in male Dawley rats,10116.0,Intermediate,,,8036,,CHEMBL618459,1,BAO_0000218,,,,N,,,14346,Rattus norvegicus,50597,A,,1
,Area under the curve was determined after intravenous administration of 2.8 mg/kg in male Dawley rats,10116.0,Intermediate,,,8037,,CHEMBL876733,1,BAO_0000218,,,,N,,,14346,Rattus norvegicus,50597,A,,1
,Area under the curve was determined after intravenous administration of 4.9 mg/kg in male Beagle dogs,9615.0,Intermediate,,,8038,,CHEMBL618460,1,BAO_0000218,,,,N,,,14346,Canis lupus familiaris,50588,A,,1
,Area under the curve was determined after intravenous administration of 5.1 mg/kg in male Dawley rats,10116.0,Intermediate,,,8039,,CHEMBL618461,1,BAO_0000218,,,,N,,,14346,Rattus norvegicus,50597,A,,1
,Area under the curve was determined after oral administration (300 uM/Kg),,Autocuration,,,8040,,CHEMBL618462,1,BAO_0000019,,,,U,,,15469,,22224,A,,0
,Area under the curve was determined after peroral administration of 5.0 mg/kg in male Dawley rats,10116.0,Intermediate,,,8041,,CHEMBL618463,1,BAO_0000218,,,,N,,,14346,Rattus norvegicus,50597,A,,1
,Area under the curve was determined after peroral administration of 5.1 mg/kg in mal Dawley rats,10116.0,Intermediate,,,8042,,CHEMBL618464,1,BAO_0000218,,,,N,,,14346,Rattus norvegicus,50597,A,,1
,Area under the curve was determined after peroral administration of 5.1 mg/kg in male Dawley rats,10116.0,Intermediate,,,8043,,CHEMBL618465,1,BAO_0000218,,,,N,,,14346,Rattus norvegicus,50597,A,,1
,Area under the curve was determined after peroral administration of 5.2 mg/kg in mal Dawley rats,10116.0,Intermediate,,,8044,,CHEMBL618466,1,BAO_0000218,,,,N,,,14346,Rattus norvegicus,50597,A,,1
,Area under the curve was determined after peroral administration of 5.2 mg/kg in male Dawley rats,10116.0,Intermediate,,,8045,,CHEMBL618467,1,BAO_0000218,,,,N,,,14346,Rattus norvegicus,50597,A,,1
,Area under the curve was determined for the compound after iv dose of 4.97 mg/kg in rats,10116.0,Intermediate,,,8046,,CHEMBL618468,1,BAO_0000218,,,,N,,,15372,Rattus norvegicus,50597,A,,1
,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 100 mg/kg,9615.0,Intermediate,,,8047,1969.0,CHEMBL618469,1,BAO_0000218,,,,N,,Plasma,12935,Canis lupus familiaris,50588,A,,1
,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 20 mg/kg,9615.0,Intermediate,,,8048,1969.0,CHEMBL618470,1,BAO_0000218,,,,N,,Plasma,12935,Canis lupus familiaris,50588,A,,1
,Plasma drug AUC in rat (PO dose),,Autocuration,,,8049,,CHEMBL618471,1,BAO_0000218,,,,U,,,14813,,22224,A,,0
,Area under the tumor growth curve (AUC) in the B-6 Melanoma Model in C57/b1 mice at the dose of 1 mg/kg.,10090.0,Intermediate,,,8050,,CHEMBL618472,1,BAO_0000218,,,,N,,,15792,Mus musculus,50594,A,,1
,Area under was determined at a dose of 30 mg/kg,,Autocuration,,,8051,,CHEMBL618473,1,BAO_0000218,,,,U,,,3579,,22224,A,,0
,Average area under curve for compound at 1 mg/kg dose intravenous administration to Ferret,9669.0,Intermediate,,,8052,,CHEMBL621699,1,BAO_0000218,,,,N,,,12487,Mustela putorius furo,50506,A,,1
,Average area under curve for the compound at 10 mg/kg dose after intraduodenal administration to rat,10116.0,Intermediate,,,8053,,CHEMBL621700,1,BAO_0000218,,,,N,,,12487,Rattus norvegicus,50597,A,,1
,Average area under curve for the compound at 1 mg/kg dose after intravenous administration to rat,10116.0,Intermediate,,,8054,,CHEMBL621701,1,BAO_0000218,,,,N,,,12487,Rattus norvegicus,50597,A,,1
,Average area under curve at 10 mg/kg dose after intraduodenal administration to Ferret,9669.0,Intermediate,,,8055,,CHEMBL621702,1,BAO_0000218,,,,N,,,12487,Mustela putorius furo,50506,A,,1
,Average area under curve at 10 mg/kg intraduodenal administration to salt depleted dog,9615.0,Intermediate,,,8056,,CHEMBL621703,1,BAO_0000218,,,,N,,,12487,Canis lupus familiaris,50588,A,,1
,Average area under curve at 1 mg/kg intravenous administration to salt depleted dog,9615.0,Intermediate,,,8057,,CHEMBL621704,1,BAO_0000218,,,,N,,,12487,Canis lupus familiaris,50588,A,,1
,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 1.0(pmol/g/h)",10116.0,Intermediate,,,8058,,CHEMBL624259,1,BAO_0000218,,,,N,,,12902,Rattus norvegicus,50597,A,,1
,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 2.0(pmol/g/h)",10116.0,Intermediate,,,8059,,CHEMBL624260,1,BAO_0000218,,,,N,,,12902,Rattus norvegicus,50597,A,,1
,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 4.0(pmol/g/h)",10116.0,Intermediate,,,8060,,CHEMBL624430,1,BAO_0000218,,,,N,,,12902,Rattus norvegicus,50597,A,,1
,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 5.0(pmol/g/h)",10116.0,Intermediate,,,8061,,CHEMBL624431,1,BAO_0000218,,,,N,,,12902,Rattus norvegicus,50597,A,,1
,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 54.0(pmol/g/h)",10116.0,Intermediate,,,8062,,CHEMBL624432,1,BAO_0000218,,,,N,,,12902,Rattus norvegicus,50597,A,,1
,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 10.0(pmol/g/h)",10116.0,Intermediate,,,8063,,CHEMBL624433,1,BAO_0000218,,,,N,,,12902,Rattus norvegicus,50597,A,,1
,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 20.0(pmol/g/h)",10116.0,Intermediate,,,8064,,CHEMBL624434,1,BAO_0000218,,,,N,,,12902,Rattus norvegicus,50597,A,,1
,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 40.0(pmol/g/h)",10116.0,Intermediate,,,8065,,CHEMBL624435,1,BAO_0000218,,,,N,,,12902,Rattus norvegicus,50597,A,,1
,Bioavailability in mouse brain after intravenous administration of 105.1 mg/kg of dose,10090.0,Intermediate,,,8066,,CHEMBL618570,1,BAO_0000218,,,,N,,,12745,Mus musculus,50594,A,,1
,Bioavailability in mouse brain after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),10090.0,Intermediate,,,8067,,CHEMBL618571,1,BAO_0000218,,,,N,,,12745,Mus musculus,50594,A,,1
,Bioavailability in mouse brain after oral administration of 100 mg/kg of dose,10090.0,Intermediate,,,8068,,CHEMBL618572,1,BAO_0000218,,,,N,,,12745,Mus musculus,50594,A,,1
,Bioavailability in mouse brain after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),10090.0,Intermediate,,,8069,,CHEMBL618573,1,BAO_0000218,,,,N,,,12745,Mus musculus,50594,A,,1
,Bioavailability in mouse serum after intravenous administration of 105.1 mg/kg of dose,10090.0,Intermediate,,,8070,,CHEMBL619267,1,BAO_0000218,,,,N,,,12745,Mus musculus,50594,A,,1
,Bioavailability in mouse serum after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),10090.0,Intermediate,,,8071,,CHEMBL619431,1,BAO_0000218,,,,N,,,12745,Mus musculus,50594,A,,1
,Bioavailability in mouse serum after oral administration of 100 mg/kg of dose,10090.0,Intermediate,,,8072,,CHEMBL619432,1,BAO_0000218,,,,N,,,12745,Mus musculus,50594,A,,1
,Bioavailability in mouse serum after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),10090.0,Intermediate,,,8073,,CHEMBL619433,1,BAO_0000218,,,,N,,,12745,Mus musculus,50594,A,,1
,AUC in mice after oral dose (50 mg/kg),,Autocuration,,,8074,1969.0,CHEMBL619434,1,BAO_0000218,,,,U,,Plasma,13298,,22224,A,,0
,Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum,10090.0,Intermediate,,,8075,1977.0,CHEMBL619435,1,BAO_0000218,,,,N,,Serum,12226,Mus musculus,50594,A,,1
,AUC (0-4 hr) ug/ml/h,,Autocuration,,,8076,1969.0,CHEMBL619436,1,BAO_0000019,,,,U,,Plasma,12634,,22224,A,,0
,Compound at a dose of 10 mg/kg was orally administered to rats and Area under curve was reported,10116.0,Intermediate,,,8077,,CHEMBL619437,1,BAO_0000218,,,,N,,,14810,Rattus norvegicus,50597,A,,1
,Compound evaluated for AUC = Area under the nucleoside serum or brain concentration versus time curve after iv administration,,Autocuration,,,8078,,CHEMBL619438,1,BAO_0000218,,,,U,,,13889,,22224,A,,0
,Compound was evaluated for Area under curve in mice,10090.0,Intermediate,,,8079,,CHEMBL619439,1,BAO_0000218,,,,N,,,10018,Mus musculus,50594,A,,1
,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,10116.0,Intermediate,,,8080,,CHEMBL619440,1,BAO_0000218,,,,N,,,8758,Rattus norvegicus,50597,A,,1
,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,Autocuration,,,8081,,CHEMBL619441,1,BAO_0000218,,,,U,,,8758,,22224,F,,0
,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,10116.0,Intermediate,,,8082,,CHEMBL619442,1,BAO_0000218,,,,N,,,8758,Rattus norvegicus,50597,A,,1
,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 1,,Autocuration,,,8083,,CHEMBL875156,1,BAO_0000019,,,,U,,,2249,,22224,A,,0
,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 4,,Autocuration,,,8084,,CHEMBL619443,1,BAO_0000019,,,,U,,,2249,,22224,A,,0
,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 1,,Autocuration,,,8085,,CHEMBL619444,1,BAO_0000019,,,,U,,,2249,,22224,A,,0
,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 4,,Autocuration,,,8086,,CHEMBL623464,1,BAO_0000019,,,,U,,,2249,,22224,A,,0
,Compound was evaluated for area under curve when administered through oral route in mouse,10090.0,Intermediate,,,8087,,CHEMBL623465,1,BAO_0000218,,,,N,,,15115,Mus musculus,50594,A,,1
,Plasma clearance after oral administration at a dose of 2 mg/kg in rat; no data,10116.0,Intermediate,,,8088,,CHEMBL623466,1,BAO_0000218,,In vivo,,N,,,6518,Rattus norvegicus,50597,A,,1
,Plasma clearance after oral administration at a dose of 4 mg/kg in rat; no data,10116.0,Intermediate,,,8089,,CHEMBL623467,1,BAO_0000218,,In vivo,,N,,,6518,Rattus norvegicus,50597,A,,1
,Plasma clearance in rat,10116.0,Intermediate,,,8090,,CHEMBL623468,1,BAO_0000218,,In vivo,,N,,,6249,Rattus norvegicus,50597,A,,1
,Plasma clearance was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,10116.0,Intermediate,,,8091,,CHEMBL622660,1,BAO_0000218,,In vivo,,N,,,2463,Rattus norvegicus,50597,A,,1
,Plasma clearance rate in Sprague-Dawley rats,10116.0,Intermediate,,,8092,,CHEMBL622661,1,BAO_0000218,,In vivo,,N,,,4969,Rattus norvegicus,50597,A,,1
,CLtot at a dose of 4 mg/kg in Rat Plasma after iv administration,10116.0,Intermediate,,,8093,,CHEMBL622662,1,BAO_0000218,,In vivo,,N,,,17720,Rattus norvegicus,50597,F,,1
,Pharmacokinetic property (total body clearance) in rat,10116.0,Intermediate,,,8094,,CHEMBL622663,1,BAO_0000218,,In vivo,,N,,,3457,Rattus norvegicus,50597,A,,1
,Pharmacokinetic property (CLtot)of the compound was measured in rat at the dose of 0.32 mg/kg i.v.,10116.0,Intermediate,,,8095,,CHEMBL622664,1,BAO_0000218,,In vivo,,N,,,5983,Rattus norvegicus,50597,A,,1
,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,10116.0,Intermediate,,,8096,,CHEMBL622665,1,BAO_0000218,,,,N,,,6295,Rattus norvegicus,50597,A,,1
,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,10116.0,Intermediate,,,8097,,CHEMBL622666,1,BAO_0000218,,,,N,,,6296,Rattus norvegicus,50597,A,,1
,Cl in rat i.v. at 2 mg/kg concentration,10116.0,Intermediate,,,8098,,CHEMBL621615,1,BAO_0000218,,In vivo,,N,,,17686,Rattus norvegicus,50597,A,,1
,Clearance of compound after intravenous administration in rats at 24 uM/kg,10116.0,Intermediate,,,8099,,CHEMBL621616,1,BAO_0000218,,In vivo,,N,,,17764,Rattus norvegicus,50597,A,,1
,Clearance was determined,10116.0,Intermediate,,,8100,,CHEMBL621617,1,BAO_0000218,,In vivo,,N,,,5503,Rattus norvegicus,50597,A,,1
,Clearance by intravenous administration of 3.4 mg/kg in rat,10116.0,Intermediate,,,8101,,CHEMBL621618,1,BAO_0000218,,In vivo,,N,,,4368,Rattus norvegicus,50597,A,,1
,Clearance was evaluated after i.v. administration in rat at a dose of 1 mg/kg,10116.0,Intermediate,,,8102,,CHEMBL621619,1,BAO_0000218,,In vivo,,N,,,6005,Rattus norvegicus,50597,A,,1
,Clearance rate after i.v. administration in rats,10116.0,Intermediate,,,8103,,CHEMBL621620,1,BAO_0000218,,In vivo,,N,,,5031,Rattus norvegicus,50597,A,,1
,Clearance was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,10116.0,Intermediate,,,8104,,CHEMBL621786,1,BAO_0000218,,In vivo,,N,,,4890,Rattus norvegicus,50597,A,,1
,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,10116.0,Intermediate,,,8105,,CHEMBL621787,1,BAO_0000218,,In vivo,,N,,,5182,Rattus norvegicus,50597,A,,1
,Clearance (Cl) of compound after 2 h iv infusion of 8.4 mg/kg in three rat,10116.0,Intermediate,,,8106,,CHEMBL621788,1,BAO_0000218,,In vivo,,N,,,5979,Rattus norvegicus,50597,A,,1
,Clearance (Cl) after oral administration in rat,10116.0,Intermediate,,,8107,,CHEMBL621789,1,BAO_0000218,,In vivo,,N,,,5656,Rattus norvegicus,50597,A,,1
,Compound clearance in rats was measured after intravenous administration at 3 mg/kg,10116.0,Intermediate,,,8108,,CHEMBL621790,1,BAO_0000218,,In vivo,,N,,,17804,Rattus norvegicus,50597,A,,1
,Compound was tested for plasma clearance in rat,10116.0,Intermediate,,,8109,1969.0,CHEMBL621791,1,BAO_0000218,,In vivo,,N,,Plasma,4839,Rattus norvegicus,50597,A,,1
,In vitro microsome metabolism clearance in rat was determined,10116.0,Intermediate,,Microsomes,8110,,CHEMBL621792,1,BAO_0000218,,In vitro,,N,,,5041,Rattus norvegicus,50597,A,,1
,In vitro microsome metabolism clearance in rat was determined; ND denotes no data,10116.0,Intermediate,,Microsomes,8111,,CHEMBL621793,1,BAO_0000218,,In vitro,,N,,,5041,Rattus norvegicus,50597,A,,1
,In vivo Clearance (Cl) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,10116.0,Intermediate,,,8112,,CHEMBL621794,1,BAO_0000218,,In vivo,,N,,,5974,Rattus norvegicus,50597,A,,1
,In vivo plasma clearance was determined,10116.0,Intermediate,,,8113,1969.0,CHEMBL621795,1,BAO_0000218,,In vivo,,N,,Plasma,5496,Rattus norvegicus,50597,A,,1
,Pharmacokinetic property (Clearance) for the compound (5 mg/kg iv) was determined in rats,10116.0,Intermediate,,,8114,,CHEMBL621796,1,BAO_0000218,,In vivo,,N,,,5739,Rattus norvegicus,50597,A,,1
,Pharmacokinetic property (Clearance) in rat hepatocyte i.v.,10116.0,Intermediate,,,8115,2107.0,CHEMBL621797,1,BAO_0000218,,In vivo,,N,401.0,Liver,5676,Rattus norvegicus,50597,A,Hepatocyte,1
,Pharmacokinetic property (Plasma clearance) was measured in rat,10116.0,Intermediate,,,8116,,CHEMBL621798,1,BAO_0000218,,In vivo,,N,,,4239,Rattus norvegicus,50597,A,,1
,Pharmacokinetic property (clearance) in rat i.v.,10116.0,Intermediate,,,8117,,CHEMBL621799,1,BAO_0000218,,In vivo,,N,,,5676,Rattus norvegicus,50597,A,,1
,"Plasma Clearance was evaluated in rats, iv",10116.0,Intermediate,,,8118,,CHEMBL621800,1,BAO_0000218,,In vivo,,N,,,1918,Rattus norvegicus,50597,A,,1
,Plasma clearance (in vivo) in rats was determined,10116.0,Intermediate,,,8119,,CHEMBL621801,1,BAO_0000218,,In vivo,,N,,,17800,Rattus norvegicus,50597,A,,1
,Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat,10116.0,Intermediate,,,8120,,CHEMBL621802,1,BAO_0000218,,In vivo,,N,,,6056,Rattus norvegicus,50597,A,,1
,Plasma clearance was determined,10116.0,Intermediate,,,8121,,CHEMBL618596,1,BAO_0000218,,In vivo,,N,,,5496,Rattus norvegicus,50597,A,,1
,Plasma clearance in rat after peroral administration at 10 mg/kg concentration,10116.0,Intermediate,,,8122,,CHEMBL618597,1,BAO_0000218,,In vivo,,N,,,5939,Rattus norvegicus,50597,A,,1
,Plasma clearance in rat after peroral administration at 5 mg/kg concentration,10116.0,Intermediate,,,8123,,CHEMBL618598,1,BAO_0000218,,In vivo,,N,,,5939,Rattus norvegicus,50597,A,,1
,Plasma clearance in rats,10116.0,Intermediate,,,8124,,CHEMBL618599,1,BAO_0000218,,In vivo,,N,,,17752,Rattus norvegicus,50597,A,,1
,Plasma clearance rate determined in rat,10116.0,Intermediate,,,8125,,CHEMBL618600,1,BAO_0000218,,In vivo,,N,,,4576,Rattus norvegicus,50597,A,,1
,Plasma clearance was determined in rat,10116.0,Intermediate,,,8126,,CHEMBL618601,1,BAO_0000218,,In vivo,,N,,,6011,Rattus norvegicus,50597,A,,1
,Plasma clearance was determined,10116.0,Intermediate,,,8127,,CHEMBL618602,1,BAO_0000218,,In vivo,,N,,,5510,Rattus norvegicus,50597,A,,1
,Plasma clearance value in rat,10116.0,Intermediate,,,8128,,CHEMBL618603,1,BAO_0000218,,In vivo,,N,,,5948,Rattus norvegicus,50597,A,,1
,Clearance rate constant using isolated perfused rat liver (IPRL) assay,10116.0,Intermediate,,,8129,2107.0,CHEMBL618604,1,BAO_0000218,,Ex vivo,,N,,Liver,6125,Rattus norvegicus,50597,A,,1
,Clearance in rat,10116.0,Intermediate,,,8130,,CHEMBL618605,1,BAO_0000218,,In vivo,,N,,,4839,Rattus norvegicus,50597,A,,1
,Total body clearance in rat i.v. at 2 mg/kg concentration,10116.0,Intermediate,,,8131,,CHEMBL618606,1,BAO_0000218,,In vivo,,N,,,17686,Rattus norvegicus,50597,A,,1
,Clearance of compound in rats after intravenous administration,10116.0,Intermediate,,,8132,,CHEMBL618607,1,BAO_0000218,,In vivo,,N,,,6571,Rattus norvegicus,50597,A,,1
,Clearance after iv administration to rats,10116.0,Intermediate,,,8133,,CHEMBL618608,1,BAO_0000218,,In vivo,,N,,,3364,Rattus norvegicus,50597,A,,1
,Clearance at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,10116.0,Intermediate,,,8134,,CHEMBL618609,1,BAO_0000218,,In vivo,,N,,,13569,Rattus norvegicus,50597,A,,1
,Clearance at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,10116.0,Intermediate,,,8135,,CHEMBL618610,1,BAO_0000218,,In vivo,,N,,,13569,Rattus norvegicus,50597,A,,1
,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,10116.0,Intermediate,,,8136,,CHEMBL618611,1,BAO_0000218,,In vivo,,N,,,13569,Rattus norvegicus,50597,A,,1
,Clearance at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,10116.0,Intermediate,,,8137,,CHEMBL618612,1,BAO_0000218,,In vivo,,N,,,13569,Rattus norvegicus,50597,A,,1
,Clearance at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,10116.0,Intermediate,,,8138,,CHEMBL618613,1,BAO_0000218,,In vivo,,N,,,13569,Rattus norvegicus,50597,A,,1
,Clearance at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,10116.0,Intermediate,,,8139,,CHEMBL621076,1,BAO_0000218,,In vivo,,N,,,13569,Rattus norvegicus,50597,A,,1
,Clearance at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,10116.0,Intermediate,,,8140,,CHEMBL621077,1,BAO_0000218,,In vivo,,N,,,13569,Rattus norvegicus,50597,A,,1
,"Clearance in fischer rats at 5 mg/kg dose, administered intravenously",10116.0,Intermediate,,,8141,,CHEMBL621078,1,BAO_0000218,,In vivo,,N,,,17670,Rattus norvegicus,50597,A,,1
,Clearance in rat,10116.0,Intermediate,,,8142,,CHEMBL621251,1,BAO_0000218,,In vivo,,N,,,5970,Rattus norvegicus,50597,A,,1
,Clearance in rat after oral administration at 10 mg/kg,10116.0,Intermediate,,,8143,,CHEMBL621252,1,BAO_0000218,,In vivo,,N,,,6495,Rattus norvegicus,50597,A,,1
,Clearance in rat.,10116.0,Intermediate,,,8144,,CHEMBL621253,1,BAO_0000218,,In vivo,,N,,,4590,Rattus norvegicus,50597,A,,1
,Clearance rate following an oral dose of 20 mg/kg in rats,10116.0,Intermediate,,,8145,,CHEMBL621254,1,BAO_0000218,,In vivo,,N,,,6193,Rattus norvegicus,50597,A,,1
,Compound was evaluated for the rate of clearance in rat upon intravenous administration.,10116.0,Intermediate,,,8146,,CHEMBL621255,1,BAO_0000218,,In vivo,,N,,,2832,Rattus norvegicus,50597,A,,1
,Compound was tested for plasma clearance in rats after 5 mg/kg of intravenous dosing,10116.0,Intermediate,,,8147,1969.0,CHEMBL621256,1,BAO_0000218,,In vivo,,N,,Plasma,1052,Rattus norvegicus,50597,A,,1
,Biodistribution in rat liver in the presence of GdDTPA-BDP at 1 hr,10116.0,Intermediate,,,8148,2107.0,CHEMBL621257,1,BAO_0000218,,In vivo,,N,,Liver,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat liver in the presence of GdDTPA-BDP at 30 min,10116.0,Intermediate,,,8149,2107.0,CHEMBL621258,1,BAO_0000218,,In vivo,,N,,Liver,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat liver in the presence of GdDTPA-BDP at 4 hr,10116.0,Intermediate,,,8150,2107.0,CHEMBL621259,1,BAO_0000218,,In vivo,,N,,Liver,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 15 min,10116.0,Intermediate,,,8151,2107.0,CHEMBL621260,1,BAO_0000218,,In vivo,,N,,Liver,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 1 hr,10116.0,Intermediate,,,8152,2107.0,CHEMBL876494,1,BAO_0000218,,In vivo,,N,,Liver,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 30 min,10116.0,Intermediate,,,8153,2107.0,CHEMBL621261,1,BAO_0000218,,In vivo,,N,,Liver,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 4 hr,10116.0,Intermediate,,,8154,2107.0,CHEMBL621262,1,BAO_0000218,,In vivo,,N,,Liver,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat liver in the presence of NAC Gd/0.01 M GdDTPA-HPDP,10116.0,Intermediate,,,8155,2107.0,CHEMBL621263,1,BAO_0000218,,In vivo,,N,,Liver,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat liver in the presence of NCA Gd/0.01 M lip,10116.0,Intermediate,,,8156,2107.0,CHEMBL621264,1,BAO_0000218,,In vivo,,N,,Liver,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat muscle in the presence of 0.01 M GdDTPA-BDP,10116.0,Intermediate,,,8157,2385.0,CHEMBL621265,1,BAO_0000218,,In vivo,,N,,Muscle tissue,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat muscle in the presence of 0.05 M Gd/0.15 M lig,10116.0,Intermediate,,,8158,2385.0,CHEMBL621266,1,BAO_0000218,,In vivo,,N,,Muscle tissue,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat muscle in the presence of 0.05 M GdDTPA-BDP,10116.0,Intermediate,,,8159,2385.0,CHEMBL621267,1,BAO_0000218,,In vivo,,N,,Muscle tissue,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat muscle in the presence of 0.10 M GdDTPA-BDP,10116.0,Intermediate,,,8160,2385.0,CHEMBL621268,1,BAO_0000218,,In vivo,,N,,Muscle tissue,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 1 hr,10116.0,Intermediate,,,8161,2385.0,CHEMBL621269,1,BAO_0000218,,In vivo,,N,,Muscle tissue,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 4 hr,10116.0,Intermediate,,,8162,2385.0,CHEMBL621270,1,BAO_0000218,,In vivo,,N,,Muscle tissue,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 15 min,10116.0,Intermediate,,,8163,2385.0,CHEMBL621271,1,BAO_0000218,,In vivo,,N,,Muscle tissue,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 30 min,10116.0,Intermediate,,,8164,2385.0,CHEMBL621272,1,BAO_0000218,,In vivo,,N,,Muscle tissue,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 1 hr,10116.0,Intermediate,,,8165,2385.0,CHEMBL621273,1,BAO_0000218,,In vivo,,N,,Muscle tissue,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 4 hr,10116.0,Intermediate,,,8166,2385.0,CHEMBL621274,1,BAO_0000218,,In vivo,,N,,Muscle tissue,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 15 min,10116.0,Intermediate,,,8167,2385.0,CHEMBL876495,1,BAO_0000218,,In vivo,,N,,Muscle tissue,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 30 min,10116.0,Intermediate,,,8168,2385.0,CHEMBL621275,1,BAO_0000218,,In vivo,,N,,Muscle tissue,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat muscle in the presence of NCA Gd/0.01 M lip,10116.0,Intermediate,,,8169,2385.0,CHEMBL621276,1,BAO_0000218,,In vivo,,N,,Muscle tissue,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat muscle in the presence of NCAGd/0.01 M lig,10116.0,Intermediate,,,8170,2385.0,CHEMBL621277,1,BAO_0000218,,In vivo,,N,,Muscle tissue,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 2 hr,10116.0,Intermediate,,,8171,160.0,CHEMBL621278,1,BAO_0000218,,In vivo,,N,,Intestine,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 6 hr,10116.0,Intermediate,,,8172,160.0,CHEMBL621279,1,BAO_0000218,,In vivo,,N,,Intestine,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat s. intestine in the presence of NCA (No carrier added),10116.0,Intermediate,,,8173,160.0,CHEMBL621280,1,BAO_0000218,,In vivo,,N,,Intestine,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat spleen in the presence of 0.01 M GdDTPA-BDP,10116.0,Intermediate,,,8174,2106.0,CHEMBL621281,1,BAO_0000218,,In vivo,,N,,Spleen,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat spleen in the presence of 0.05 M Gd/0.15 M lig; ND=No data,10116.0,Intermediate,,,8175,2106.0,CHEMBL621282,1,BAO_0000218,,In vivo,,N,,Spleen,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat spleen in the presence of 0.05 M GdDTPA-BDP; ND=No data,10116.0,Intermediate,,,8176,2106.0,CHEMBL621283,1,BAO_0000218,,In vivo,,N,,Spleen,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat spleen in the presence of 0.10 M GdDTPA-BDP,10116.0,Intermediate,,,8177,2106.0,CHEMBL621284,1,BAO_0000218,,In vivo,,N,,Spleen,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat spleen in the presence of 50 Gd/kg at 15 min,10116.0,Intermediate,,,8178,2106.0,CHEMBL621285,1,BAO_0000218,,In vivo,,N,,Spleen,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat spleen in the presence of 50 Gd/kg at 2 hr,10116.0,Intermediate,,,8179,2106.0,CHEMBL621286,1,BAO_0000218,,In vivo,,N,,Spleen,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat spleen in the presence of 50 Gd/kg at 6 hr,10116.0,Intermediate,,,8180,2106.0,CHEMBL623220,1,BAO_0000218,,In vivo,,N,,Spleen,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat spleen in the presence of NCA Gd/0.01 M lip,10116.0,Intermediate,,,8181,2106.0,CHEMBL623221,1,BAO_0000218,,In vivo,,N,,Spleen,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat spleen in the presence of NCAGd/0.01 M lig,10116.0,Intermediate,,,8182,2106.0,CHEMBL876029,1,BAO_0000218,,In vivo,,N,,Spleen,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat stomach in the presence of 50 Gd/kg at 15 min,10116.0,Intermediate,,,8183,945.0,CHEMBL623222,1,BAO_0000218,,In vivo,,N,,Stomach,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat stomach in the presence of 50 Gd/kg at 2 hr,10116.0,Intermediate,,,8184,945.0,CHEMBL623223,1,BAO_0000218,,In vivo,,N,,Stomach,9866,Rattus norvegicus,50597,A,,1
,Biodistribution in rat stomach in the presence of 50 Gd/kg at 6 h; ND=No data,10116.0,Intermediate,,,8185,945.0,CHEMBL621445,1,BAO_0000218,,In vivo,,N,,Stomach,9866,Rattus norvegicus,50597,A,,1
,Biodistribution of [123I]-label in rat blood was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8186,178.0,CHEMBL621446,1,BAO_0000218,,In vivo,,N,,Blood,13950,Rattus norvegicus,50597,A,,1
,Biodistribution of [123I]-label in rat blood was reported at 1 hr post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8187,178.0,CHEMBL621447,1,BAO_0000218,,In vivo,,N,,Blood,13950,Rattus norvegicus,50597,A,,1
,Biodistribution of [123I]-label in rat blood was reported at 2 hr post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8188,178.0,CHEMBL619681,1,BAO_0000218,,In vivo,,N,,Blood,13950,Rattus norvegicus,50597,A,,1
,Biodistribution of [123I]-label in rat blood was reported at 24 hr post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8189,178.0,CHEMBL619682,1,BAO_0000218,,In vivo,,N,,Blood,13950,Rattus norvegicus,50597,A,,1
,Biodistribution of [123I]-label in rat blood was reported at 4 hr post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8190,178.0,CHEMBL619683,1,BAO_0000218,,In vivo,,N,,Blood,13950,Rattus norvegicus,50597,A,,1
,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8191,955.0,CHEMBL619684,1,BAO_0000218,,In vivo,,N,,Brain,13950,Rattus norvegicus,50597,A,,1
,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8192,955.0,CHEMBL619685,1,BAO_0000218,,In vivo,,N,,Brain,13950,Rattus norvegicus,50597,A,,1
,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8193,955.0,CHEMBL619686,1,BAO_0000218,,In vivo,,N,,Brain,13950,Rattus norvegicus,50597,A,,1
,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8194,955.0,CHEMBL619687,1,BAO_0000218,,In vivo,,N,,Brain,13950,Rattus norvegicus,50597,A,,1
,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8195,955.0,CHEMBL619688,1,BAO_0000218,,In vivo,,N,,Brain,13950,Rattus norvegicus,50597,A,,1
,Biodistribution of [123I]-label in rat heart was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8196,948.0,CHEMBL619689,1,BAO_0000218,,In vivo,,N,,Heart,13950,Rattus norvegicus,50597,A,,1
,Biodistribution of [123I]-label in rat heart was reported at 1 hr post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8197,948.0,CHEMBL619690,1,BAO_0000218,,In vivo,,N,,Heart,13950,Rattus norvegicus,50597,A,,1
,Biodistribution of [123I]-label in rat heart was reported at 2 hr post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8198,948.0,CHEMBL619691,1,BAO_0000218,,In vivo,,N,,Heart,13950,Rattus norvegicus,50597,A,,1
,Terminal phase volume of distribution was measured in rat after an iv dose of 1 mg/kg,10116.0,Intermediate,,,8199,,CHEMBL619692,1,BAO_0000218,,In vivo,,N,,,6062,Rattus norvegicus,50597,A,,1
,Apparent volume of the central plasma compartment (Vc) of compound determined in rat after iv administration at a dose of 10 mg/kg,10116.0,Expert,,,8200,,CHEMBL619693,1,BAO_0000218,,,,N,,,3598,Rattus norvegicus,50597,A,,1
,Vc value after IV dose at a dose of 5 mg/kg in rats.,10116.0,Intermediate,,,8201,,CHEMBL619694,1,BAO_0000218,,In vivo,,N,,,1908,Rattus norvegicus,50597,A,,1
,Apparent volume of distribution at 10 mg/kg in rat upon intravenous administration,10116.0,Intermediate,,,8202,,CHEMBL619695,1,BAO_0000218,,In vivo,,N,,,17596,Rattus norvegicus,50597,A,,1
,Compound was evaluated for pharmacokinetic parameter volume of distribution,10116.0,Intermediate,,,8203,,CHEMBL619696,1,BAO_0000218,,In vivo,,N,,,4891,Rattus norvegicus,50597,A,,1
,Compound was evaluated for volume of distribution in rat,10116.0,Intermediate,,,8204,,CHEMBL619697,1,BAO_0000218,,In vivo,,N,,,740,Rattus norvegicus,50597,A,,1
,Steady state volume distribution was determined; steady state(ss),10116.0,Intermediate,,,8205,,CHEMBL619698,1,BAO_0000218,,In vivo,,N,,,16366,Rattus norvegicus,50597,A,,1
,Steady state volume of distribution after iv administration to rats,10116.0,Intermediate,,,8206,,CHEMBL619699,1,BAO_0000218,,In vivo,,N,,,3364,Rattus norvegicus,50597,A,,1
,Steady state volume of distribution dosing at 3 mg/kg iv,10116.0,Intermediate,,,8207,,CHEMBL619700,1,BAO_0000218,,In vivo,,N,,,2552,Rattus norvegicus,50597,A,,1
,The compound was evaluated for volume of distribution in rat,10116.0,Intermediate,,,8208,,CHEMBL619701,1,BAO_0000218,,In vivo,,N,,,406,Rattus norvegicus,50597,A,,1
,The compound was tested for volume of distribution in rat,10116.0,Intermediate,,,8209,,CHEMBL619702,1,BAO_0000218,,In vivo,,N,,,12500,Rattus norvegicus,50597,A,,1
,The compound was tested for volume of distribution in rat at dose of 3-10 mgkg,10116.0,Intermediate,,,8210,,CHEMBL620335,1,BAO_0000218,,In vivo,,N,,,12500,Rattus norvegicus,50597,A,,1
,Volume distribution (VD) after oral administration in rat,10116.0,Intermediate,,,8211,,CHEMBL620336,1,BAO_0000218,,In vivo,,N,,,5656,Rattus norvegicus,50597,A,,1
,Volume distribution of compound in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,10116.0,Intermediate,,,8212,,CHEMBL620337,1,BAO_0000218,,In vivo,,N,,,17671,Rattus norvegicus,50597,A,,1
,Volume distribution in rat,10116.0,Intermediate,,,8213,,CHEMBL620520,1,BAO_0000218,,In vivo,,N,,,1094,Rattus norvegicus,50597,A,,1
,Volume distribution in rat,10116.0,Intermediate,,,8214,,CHEMBL620521,1,BAO_0000218,,In vivo,,N,,,5833,Rattus norvegicus,50597,A,,1
,Volume distribution in rat after peroral administration at 10 mg/kg,10116.0,Intermediate,,,8215,,CHEMBL875825,1,BAO_0000218,,In vivo,,N,,,5939,Rattus norvegicus,50597,A,,1
,Volume distribution in rat after peroral administration at 5 mg/kg,10116.0,Intermediate,,,8216,,CHEMBL620522,1,BAO_0000218,,In vivo,,N,,,5939,Rattus norvegicus,50597,A,,1
,Volume distribution was evaluated after i.v. administration in rat at a dose of 1 mg/kg,10116.0,Intermediate,,,8217,,CHEMBL620523,1,BAO_0000218,,In vivo,,N,,,6005,Rattus norvegicus,50597,A,,1
,Volume of distribution in rat.,10116.0,Intermediate,,,8218,,CHEMBL620524,1,BAO_0000218,,In vivo,,N,,,1696,Rattus norvegicus,50597,A,,1
,Volume of distribution in rat,10116.0,Intermediate,,,8219,,CHEMBL620525,1,BAO_0000218,,In vivo,,N,,,6672,Rattus norvegicus,50597,A,,1
,Volume of distribution in rat,10116.0,Intermediate,,,8220,,CHEMBL620526,1,BAO_0000218,,In vivo,,N,,,6673,Rattus norvegicus,50597,A,,1
,Volume of distribution in rat by iv administration,10116.0,Intermediate,,,8221,,CHEMBL620527,1,BAO_0000218,,In vivo,,N,,,5871,Rattus norvegicus,50597,A,,1
,Volume of distribution in rats,10116.0,Intermediate,,,8222,,CHEMBL620528,1,BAO_0000218,,In vivo,,N,,,6803,Rattus norvegicus,50597,A,,1
,Volume of distribution was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,10116.0,Intermediate,,,8223,,CHEMBL620529,1,BAO_0000218,,In vivo,,N,,,5199,Rattus norvegicus,50597,A,,1
,Volume distribution at the dose of 2 mg/kg in rat,10116.0,Intermediate,,,8224,,CHEMBL620530,1,BAO_0000218,,,,N,,,4727,Rattus norvegicus,50597,A,,1
,Steady state volume of distribution was determined,10116.0,Intermediate,,,8225,,CHEMBL620531,1,BAO_0000218,,In vivo,,N,,,16367,Rattus norvegicus,50597,A,,1
,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,9544.0,Intermediate,,,8226,,CHEMBL620532,1,BAO_0000218,,In vivo,,U,,,5005,Macaca mulatta,22224,A,,0
,Compound was tested for its plasma volume distribution in Sprague Dawley rats,10116.0,Intermediate,,,8227,,CHEMBL620533,1,BAO_0000218,,In vivo,,U,,,5005,Rattus norvegicus,22224,A,,0
,Compound was tested for its plasma volume distribution in Sprague Dawley rats; ND is not determined,10116.0,Intermediate,,,8228,,CHEMBL620534,1,BAO_0000218,,In vivo,,U,,,5005,Rattus norvegicus,22224,A,,0
,Mean (%CV) PK parameters for Vdss(mL/kg).,10116.0,Intermediate,,,8229,,CHEMBL620535,1,BAO_0000218,,In vivo,,N,,,15765,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter Vdss was determined at 2 mg/kg i.v. dose in rats,10116.0,Intermediate,,,8230,,CHEMBL875826,1,BAO_0000218,,In vivo,,N,,,2792,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter Vdss was determined at 5 mg/kg i.v. dose in rats,10116.0,Intermediate,,,8231,,CHEMBL620536,1,BAO_0000218,,In vivo,,N,,,2792,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,10116.0,Intermediate,,,8232,,CHEMBL620537,1,BAO_0000218,,In vivo,,N,,,5334,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter volume of distribution was reported in Sprague-Dawley rat; ND=Not determined,10116.0,Intermediate,,,8233,,CHEMBL618526,1,BAO_0000218,,In vivo,,N,,,5334,Rattus norvegicus,50597,A,,1
,Pharmacokinetic property (Vdss) for the compound (5 mg/kg iv) was determined in rats,10116.0,Intermediate,,,8234,,CHEMBL618527,1,BAO_0000218,,In vivo,,N,,,5739,Rattus norvegicus,50597,A,,1
,Pharmacokinetic property (Vdss) in rat,10116.0,Intermediate,,,8235,,CHEMBL618528,1,BAO_0000218,,In vivo,,N,,,5789,Rattus norvegicus,50597,A,,1
,Pharmacokinetic property (vdss) was measured in rat,10116.0,Intermediate,,,8236,,CHEMBL618529,1,BAO_0000218,,In vivo,,N,,,4239,Rattus norvegicus,50597,A,,1
,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in rat,10116.0,Intermediate,,,8237,,CHEMBL618530,1,BAO_0000218,,In vivo,,N,,,4709,Rattus norvegicus,50597,A,,1
,Volume of distribution in rat,10116.0,Intermediate,,,8238,,CHEMBL618531,1,BAO_0000218,,In vivo,,N,,,6642,Rattus norvegicus,50597,A,,1
,The pharmacokinetic parameter volume of distribution in vivo in rats,10116.0,Intermediate,,,8239,,CHEMBL618532,1,BAO_0000218,,In vivo,,N,,,5247,Rattus norvegicus,50597,A,,1
,Vdss at a dose of 4 mg/kg in Rat Plasma after iv administration,10116.0,Intermediate,,,8240,,CHEMBL618533,1,BAO_0000218,,In vivo,,N,,,17720,Rattus norvegicus,50597,F,,1
,Vdss in rat i.v. at 2 mg/kg concentration,10116.0,Intermediate,,,8241,,CHEMBL618534,1,BAO_0000218,,In vivo,,N,,,17686,Rattus norvegicus,50597,A,,1
,Volume distribution after intravenous administration (1 mg/kg) in rat,10116.0,Intermediate,,,8242,,CHEMBL618535,1,BAO_0000218,,In vivo,,N,,,4689,Rattus norvegicus,50597,A,,1
,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,10116.0,Intermediate,,,8243,,CHEMBL618536,1,BAO_0000218,,In vivo,,N,,,5654,Rattus norvegicus,50597,A,,1
,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,10116.0,Intermediate,,,8244,,CHEMBL618537,1,BAO_0000218,,In vivo,,N,,,5654,Rattus norvegicus,50597,A,,1
,Volume distribution at a dose of 10 uM/kg in rat was determined,10116.0,Intermediate,,,8245,,CHEMBL618538,1,BAO_0000218,,In vivo,,N,,,4527,Rattus norvegicus,50597,A,,1
,Volume distribution in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,10116.0,Intermediate,,,8246,,CHEMBL618539,1,BAO_0000218,,In vivo,,N,,,4521,Rattus norvegicus,50597,A,,1
,Volume distribution was calculated in rat,10116.0,Intermediate,,,8247,,CHEMBL618540,1,BAO_0000218,,In vivo,,N,,,6057,Rattus norvegicus,50597,A,,1
,Volume distribution was determined,10116.0,Intermediate,,,8248,,CHEMBL618541,1,BAO_0000218,,In vivo,,N,,,5510,Rattus norvegicus,50597,A,,1
,Volume of distribution after intravenous administration was evaluated in rat,10116.0,Intermediate,,,8249,,CHEMBL618542,1,BAO_0000218,,In vivo,,N,,,2938,Rattus norvegicus,50597,A,,1
,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,10116.0,Intermediate,,,8250,,CHEMBL622544,1,BAO_0000218,,In vivo,,N,,,6679,Rattus norvegicus,50597,A,,1
,"Volume of distribution at steady state was determined in rats at 10 mg/kg, p.o. dose; n/a: not applicable",10116.0,Intermediate,,,8251,,CHEMBL622545,1,BAO_0000218,,In vivo,,N,,,6685,Rattus norvegicus,50597,A,,1
,"Volume of distribution at steady state was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",10116.0,Intermediate,,,8252,,CHEMBL622546,1,BAO_0000218,,In vivo,,N,,,6685,Rattus norvegicus,50597,A,,1
,"Volume of distribution at steady state was determined in rats at 2 mg/kg, i.v. dose",10116.0,Intermediate,,,8253,,CHEMBL622547,1,BAO_0000218,,In vivo,,N,,,6685,Rattus norvegicus,50597,A,,1
,Volume of distribution in steady state was determined in rat,10116.0,Intermediate,,,8254,,CHEMBL622548,1,BAO_0000218,,In vivo,,N,,,5145,Rattus norvegicus,50597,A,,1
,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration,10116.0,Intermediate,,,8255,,CHEMBL622549,1,BAO_0000218,,In vivo,,N,,,6467,Rattus norvegicus,50597,A,,1
,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,10116.0,Intermediate,,,8256,,CHEMBL622550,1,BAO_0000218,,In vivo,,N,,,6467,Rattus norvegicus,50597,A,,1
,Compound was evaluated for area under curve when administered through oral route to mouse,10090.0,Intermediate,,,8257,,CHEMBL622551,1,BAO_0000218,,,,N,,,15115,Mus musculus,50594,A,,1
,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,10116.0,Intermediate,,,8258,,CHEMBL622552,1,BAO_0000218,,,,N,,,8758,Rattus norvegicus,50597,A,,1
,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,10116.0,Intermediate,,,8259,,CHEMBL622553,1,BAO_0000218,,,,N,,,8758,Rattus norvegicus,50597,A,,1
,Compound was evaluated for its bioavailability after oral administration (100 mg) to Beagle dogs,,Autocuration,,,8260,,CHEMBL622554,1,BAO_0000218,,In vivo,,U,,,8267,,22224,F,,0
,Compound was evaluated for its bioavailability after oral administration (200 mg) to Beagle dogs,9615.0,Intermediate,,,8261,,CHEMBL622555,1,BAO_0000218,,,,N,,,8267,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,10090.0,Intermediate,,,8262,,CHEMBL622556,1,BAO_0000218,,,,N,,,14239,Mus musculus,50594,A,,1
,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,10090.0,Intermediate,,,8263,,CHEMBL622557,1,BAO_0000218,,,,N,,,14239,Mus musculus,50594,A,,1
,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice,10090.0,Intermediate,,,8264,178.0,CHEMBL622558,1,BAO_0000218,,,,N,,Blood,10754,Mus musculus,50594,A,,1
,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice,10090.0,Intermediate,,,8265,178.0,CHEMBL622559,1,BAO_0000218,,,,N,,Blood,10754,Mus musculus,50594,A,,1
,Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.,9615.0,Intermediate,,,8266,,CHEMBL622560,1,BAO_0000218,,,,N,,,10754,Canis lupus familiaris,50588,A,,1
,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose,10116.0,Intermediate,,,8267,,CHEMBL622561,1,BAO_0000218,,,,N,,,14681,Rattus norvegicus,50597,A,,1
,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose. ,10116.0,Intermediate,,,8268,,CHEMBL622562,1,BAO_0000218,,,,N,,,14681,Rattus norvegicus,50597,A,,1
,Compound was tested for area under concentration -time curve from time 0 to time of last detectable concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,10116.0,Intermediate,,,8269,,CHEMBL622563,1,BAO_0000218,,,,N,,,14681,Rattus norvegicus,50597,A,,1
,Concentration of compound in Central nervous system,,Autocuration,,,8270,,CHEMBL622564,1,BAO_0000019,,,,U,,,13118,,22224,A,,0
,Concentration of compound in Central nervous system; Not detectable,,Autocuration,,,8271,,CHEMBL622565,1,BAO_0000019,,,,U,,,13118,,22224,A,,0
,"Concentration of diester in the blood, following oral administration in mice",10090.0,Intermediate,,,8272,,CHEMBL622566,1,BAO_0000218,,,,N,,,13318,Mus musculus,50594,A,,1
,"Concentration of monoester in the blood, following oral administration in mice",10090.0,Intermediate,,,8273,,CHEMBL624515,1,BAO_0000218,,,,N,,,13318,Mus musculus,50594,A,,1
,Concentration of the 9-[2-(Phosphonomethoxy)ethoxy]adenine in the blood following oral administration in mice,10090.0,Intermediate,,,8274,,CHEMBL624516,1,BAO_0000218,,,,N,,,13318,Mus musculus,50594,A,,1
,Evaluated for Pharmacokinetic property: Area under the curve,,Autocuration,,,8275,,CHEMBL624517,1,BAO_0000019,,,,U,,,15692,,22224,A,,0
,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after a peroral dose of 25 mg/kg in nude mice,10090.0,Intermediate,,,8276,,CHEMBL624518,1,BAO_0000218,,,,N,,,14839,Mus musculus,50594,A,,1
,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after iv dose of 25 mg/kg in nude mice,9541.0,Intermediate,,,8277,,CHEMBL624519,1,BAO_0000218,,,,N,,,14839,Macaca fascicularis,100710,A,,1
,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after iv dose of 5 mg/kg expressed as Area under the curve,9541.0,Intermediate,,,8278,,CHEMBL624520,1,BAO_0000218,,,,N,,,14839,Macaca fascicularis,100710,A,,1
,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 10 mg/kg expressed as Area under the curve,9541.0,Intermediate,,,8279,,CHEMBL624521,1,BAO_0000218,,,,N,,,14839,Macaca fascicularis,100710,A,,1
,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 5 mg/kg expressed as Area under the curve,9541.0,Intermediate,,,8280,,CHEMBL624522,1,BAO_0000218,,,,N,,,14839,Macaca fascicularis,100710,A,,1
,In vivo antitumor efficacy in cynomolgus monkeys 0-8 hours after peroral dose of 25 mg/kg expressed as Area under the curve,9541.0,Intermediate,,,8281,,CHEMBL624523,1,BAO_0000218,,,,N,,,14839,Macaca fascicularis,100710,A,,1
,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",9541.0,Intermediate,,,8282,,CHEMBL624409,1,BAO_0000218,,,,N,,,14839,Macaca fascicularis,100710,A,,1
,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-8 hr)",9541.0,Intermediate,,,8283,,CHEMBL624410,1,BAO_0000218,,,,N,,,14839,Macaca fascicularis,100710,A,,1
,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",9541.0,Intermediate,,,8284,,CHEMBL624411,1,BAO_0000218,,,,N,,,14839,Macaca fascicularis,100710,A,,1
,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, iv and the total drug exposure was determined. (0-8 hr)",9541.0,Intermediate,,,8285,,CHEMBL623531,1,BAO_0000218,,,,N,,,14839,Macaca fascicularis,100710,A,,1
,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, perorally and the total drug exposure was determined (0-8 hr)",9541.0,Intermediate,,,8286,,CHEMBL623532,1,BAO_0000218,,,,N,,,14839,Macaca fascicularis,100710,A,,1
,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, intravenously and the total drug exposure was determined (0-8 hr)",9541.0,Intermediate,,,8287,,CHEMBL623533,1,BAO_0000218,,,,N,,,14839,Macaca fascicularis,100710,A,,1
,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",9541.0,Intermediate,,,8288,,CHEMBL623534,1,BAO_0000218,,,,N,,,14839,Macaca fascicularis,100710,A,,1
,In vivo antitumor efficacy in nude mice 0-24 hr after intravenous dose of 25 mg/kg expressed as Area under the curve,10090.0,Intermediate,,,8289,,CHEMBL623535,1,BAO_0000218,,,,N,,,14839,Mus musculus,50594,A,,1
,In vivo antitumor efficacy in nude mice 0-24 hr after iperoral dose of 25 mg/kg expressed as Area under the curve,10090.0,Intermediate,,,8290,,CHEMBL623536,1,BAO_0000218,,,,N,,,14839,Mus musculus,50594,A,,1
,In vivo antitumor efficacy in nude mice 0-24 hr after iv dose of 25 mg/kg expressed as Area under the curve,10090.0,Intermediate,,,8291,,CHEMBL623537,1,BAO_0000218,,,,N,,,14839,Mus musculus,50594,A,,1
,In vivo antitumor efficacy in nude mice 0-24 hr after peroral dose of 25 mg/kg expressed as Area under the curve,10090.0,Intermediate,,,8292,,CHEMBL623538,1,BAO_0000218,,,,N,,,14839,Mus musculus,50594,A,,1
,In vivo antitumor efficacy in nude mice after peroral dose of 10 mg/kg expressed as Area under the curve,10090.0,Intermediate,,,8293,,CHEMBL623539,1,BAO_0000218,,,,N,,,14839,Mus musculus,50594,A,,1
,In vivo antitumor efficacy in nude mice after peroral dose of 25 mg/kg expressed as Area under the curve,10090.0,Intermediate,,,8294,,CHEMBL623540,1,BAO_0000218,,,,N,,,14839,Mus musculus,50594,A,,1
,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined.",10090.0,Intermediate,,,8295,,CHEMBL623541,1,BAO_0000218,,,,N,,,14839,Mus musculus,50594,A,,1
,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-24hr)",10090.0,Intermediate,,,8296,,CHEMBL623542,1,BAO_0000218,,,,N,,,14839,Mus musculus,50594,A,,1
,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-4 hr)",10090.0,Intermediate,,,8297,,CHEMBL623543,1,BAO_0000218,,,,N,,,14839,Mus musculus,50594,A,,1
,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined",10090.0,Intermediate,,,8298,,CHEMBL623544,1,BAO_0000218,,,,N,,,14839,Mus musculus,50594,A,,1
,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-24hr)",10090.0,Intermediate,,,8299,,CHEMBL623545,1,BAO_0000218,,,,N,,,14839,Mus musculus,50594,A,,1
,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-4 hr)",10090.0,Intermediate,,,8300,,CHEMBL623546,1,BAO_0000218,,,,N,,,14839,Mus musculus,50594,A,,1
,Evaluated for plasma clearance after iv administration of 5 mg/kg to male Sprague-Dawley rats,10116.0,Intermediate,,,8301,1969.0,CHEMBL623547,1,BAO_0000218,,In vivo,,N,,Plasma,5408,Rattus norvegicus,50597,A,,1
,High i.v. clearance in Dawley rats,10116.0,Intermediate,,,8302,,CHEMBL623548,1,BAO_0000218,,In vivo,,N,,,6827,Rattus norvegicus,50597,A,,1
,In vitro clearance in rat liver microsomes,10116.0,Intermediate,,Microsomes,8303,2107.0,CHEMBL623549,1,BAO_0000218,,In vitro,,N,,Liver,17538,Rattus norvegicus,50597,A,,1
,Intrinsic clearance in rat liver microsomes was determined,10116.0,Intermediate,,Microsomes,8304,2107.0,CHEMBL623550,1,BAO_0000218,,In vitro,,N,,Liver,6331,Rattus norvegicus,50597,A,,1
,Intrinsic clearance in rat hepatocytes was determined,10116.0,Intermediate,,,8305,2107.0,CHEMBL875276,1,BAO_0000218,,In vitro,,N,401.0,Liver,5948,Rattus norvegicus,50597,A,Hepatocyte,1
,Plasma Clearance was determined,10116.0,Intermediate,,,8306,,CHEMBL621872,1,BAO_0000218,,In vivo,,N,,,4026,Rattus norvegicus,50597,A,,1
,Plasma clearance after intravenous administration of 0.4 mg/kg of dose in rats was determined,10116.0,Intermediate,,,8307,,CHEMBL621873,1,BAO_0000218,,In vivo,,N,,,6647,Rattus norvegicus,50597,A,,1
,Plasma clearance in rat.,10116.0,Intermediate,,,8308,,CHEMBL621874,1,BAO_0000218,,In vivo,,N,,,1696,Rattus norvegicus,50597,A,,1
,Plasma clearance in rats,10116.0,Intermediate,,,8309,,CHEMBL621875,1,BAO_0000218,,In vivo,,N,,,6597,Rattus norvegicus,50597,A,,1
,Plasma clearance was estimated from the AUC after 5 mg/kg intravenous dosing in rats,10116.0,Intermediate,,,8310,,CHEMBL621876,1,BAO_0000218,,In vivo,,N,,,347,Rattus norvegicus,50597,A,,1
,Plasma clearance was evaluated after 10 uM/kg of intra arterial administration,10116.0,Intermediate,,,8311,,CHEMBL621877,1,BAO_0000218,,In vivo,,N,,,16423,Rattus norvegicus,50597,A,,1
,Plasma clearance was measured in rat,10116.0,Intermediate,,,8312,,CHEMBL621878,1,BAO_0000218,,In vivo,,N,,,2879,Rattus norvegicus,50597,A,,1
,Clearance after iv administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,10116.0,Intermediate,,,8313,,CHEMBL621879,1,BAO_0000218,,In vivo,,N,,,4883,Rattus norvegicus,50597,A,,1
,"Tested for the plasma clearance in Dawley rat at a dose of 1 mg/kg intravenous, 2 mg/kg orally",10116.0,Intermediate,,,8314,1969.0,CHEMBL621880,1,BAO_0000218,,In vivo,,N,,Plasma,5328,Rattus norvegicus,50597,A,,1
,The clearance rate in mature male rat at a intravenous dose of 3 mg/kg,10116.0,Intermediate,,,8315,,CHEMBL621881,1,BAO_0000218,,In vivo,,N,,,5160,Rattus norvegicus,50597,A,,1
,Total body clearance was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,10116.0,Intermediate,,,8316,,CHEMBL621882,1,BAO_0000218,,In vivo,,N,,,17582,Rattus norvegicus,50597,A,,1
,Total clearance at 1 mg/kg was determined in rat,10116.0,Intermediate,,,8317,,CHEMBL875283,1,BAO_0000218,,In vivo,,N,,,17651,Rattus norvegicus,50597,A,,1
,Total clearance at 10 mg/kg was determined in rat,10116.0,Intermediate,,,8318,,CHEMBL621883,1,BAO_0000218,,In vivo,,N,,,17651,Rattus norvegicus,50597,A,,1
,Clearance in rat,10116.0,Intermediate,,,8319,,CHEMBL621884,1,BAO_0000218,,In vivo,,N,,,6596,Rattus norvegicus,50597,A,,1
,Plasma clearance rate determined in rats,10116.0,Intermediate,,,8320,,CHEMBL621885,1,BAO_0000218,,In vivo,,N,,,4796,Rattus norvegicus,50597,A,,1
,Clearance of compound in rat was evaluated,10116.0,Intermediate,,,8321,,CHEMBL621886,1,BAO_0000218,,In vivo,,N,,,6850,Rattus norvegicus,50597,A,,1
,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,10116.0,Intermediate,,,8322,1969.0,CHEMBL621887,1,BAO_0000218,,In vivo,,N,,Plasma,5932,Rattus norvegicus,50597,A,,1
,Pharmacokinetic property (blood clearance) in rat,10116.0,Intermediate,,,8323,,CHEMBL621888,1,BAO_0000218,,In vivo,,N,,,3371,Rattus norvegicus,50597,A,,1
,Plasma clearance in rat,10116.0,Intermediate,,,8324,,CHEMBL621889,1,BAO_0000218,,In vivo,,N,,,2083,Rattus norvegicus,50597,A,,1
,Plasma clearance in rats,10116.0,Intermediate,,,8325,,CHEMBL621890,1,BAO_0000218,,In vivo,,N,,,4942,Rattus norvegicus,50597,A,,1
,Intrinsic clearance of compound against NADPH-fortified rat liver microsomes,10116.0,Intermediate,,Microsomes,8326,2107.0,CHEMBL621891,1,BAO_0000218,,In vitro,,N,,Liver,6838,Rattus norvegicus,50597,A,,1
,Clearance in Dawley rat,10116.0,Intermediate,,,8327,,CHEMBL621892,1,BAO_0000218,,In vivo,,N,,,5353,Rattus norvegicus,50597,A,,1
,Clearance rat,10116.0,Intermediate,,,8328,,CHEMBL621893,1,BAO_0000218,,In vivo,,N,,,6641,Rattus norvegicus,50597,A,,1
,Clearance rat (dosed at 0.5 mpk IV and 2.0 mpk po.),10116.0,Intermediate,,,8329,,CHEMBL621894,1,BAO_0000218,,In vivo,,N,,,6641,Rattus norvegicus,50597,A,,1
,Clearance rat; Not determined,10116.0,Intermediate,,,8330,,CHEMBL621895,1,BAO_0000218,,In vivo,,N,,,6641,Rattus norvegicus,50597,A,,1
,Clearance rate was determined in rat at a dose of 1 mpk i.v.,10116.0,Intermediate,,,8331,,CHEMBL875284,1,BAO_0000218,,In vivo,,N,,,6444,Rattus norvegicus,50597,A,,1
,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND means not determined,10116.0,Intermediate,,,8332,,CHEMBL618699,1,BAO_0000218,,In vivo,,N,,,6444,Rattus norvegicus,50597,A,,1
,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND=not determined,10116.0,Intermediate,,,8333,,CHEMBL618700,1,BAO_0000218,,In vivo,,N,,,6444,Rattus norvegicus,50597,A,,1
,Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,10116.0,Intermediate,,,8334,,CHEMBL618701,1,BAO_0000218,,In vivo,,N,,,6211,Rattus norvegicus,50597,A,,1
,"Clearance in plasma calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",10116.0,Intermediate,,,8335,1969.0,CHEMBL876600,1,BAO_0000218,,In vivo,,N,,Plasma,12873,Rattus norvegicus,50597,A,,1
,Clearance of compound in rat after 1 mg/kg i.v. administration,10116.0,Intermediate,,,8336,,CHEMBL618702,1,BAO_0000218,,In vivo,,N,,,6570,Rattus norvegicus,50597,A,,1
,Compound was evaluated for Hepatic clearance in rat,10116.0,Intermediate,,,8337,,CHEMBL618703,1,BAO_0000218,,In vivo,,N,,,3341,Rattus norvegicus,50597,A,,1
,In vivo clearance after 5 mg/kg dose,10116.0,Intermediate,,,8338,,CHEMBL618704,1,BAO_0000218,,In vivo,,N,,,4891,Rattus norvegicus,50597,A,,1
,Compound was tested for plasma clearance in rats,10116.0,Intermediate,,,8339,1969.0,CHEMBL618705,1,BAO_0000218,,In vivo,,N,,Plasma,1094,Rattus norvegicus,50597,A,,1
,Hepatic clearance after intravenous administration was evaluated in rat,10116.0,Intermediate,,,8340,,CHEMBL618706,1,BAO_0000218,,In vivo,,N,,,2938,Rattus norvegicus,50597,A,,1
,Lower clearance in rat (i.v.) at 0.5 mpk,10116.0,Intermediate,,,8341,,CHEMBL618707,1,BAO_0000218,,In vivo,,N,,,17853,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter expressed as plasma clearance in rat,10116.0,Intermediate,,,8342,1969.0,CHEMBL618708,1,BAO_0000218,,In vivo,,N,,Plasma,6049,Rattus norvegicus,50597,A,,1
,Pharmacokinetic property (Clp) in rat,10116.0,Intermediate,,,8343,,CHEMBL618709,1,BAO_0000218,,In vivo,,N,,,5789,Rattus norvegicus,50597,A,,1
,Plasma clearance in Sprague-Dawley rats,10116.0,Intermediate,,,8344,,CHEMBL618710,1,BAO_0000218,,In vivo,,N,,,4514,Rattus norvegicus,50597,A,,1
,Plasma clearance (Clp) in rat,10116.0,Intermediate,,,8345,,CHEMBL618711,1,BAO_0000218,,In vivo,,N,,,6448,Rattus norvegicus,50597,A,,1
,Plasma clearance for the compound was measured in rat after an iv dose of 1 mg/kg,10116.0,Intermediate,,,8346,,CHEMBL618712,1,BAO_0000218,,In vivo,,N,,,6062,Rattus norvegicus,50597,A,,1
,Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound,10116.0,Intermediate,,,8347,,CHEMBL618713,1,BAO_0000218,,In vivo,,N,,,5710,Rattus norvegicus,50597,A,,1
,Plasma clearance after intravenous administration of 1 mg/kg in rat,10116.0,Intermediate,,,8348,,CHEMBL618714,1,BAO_0000218,,In vivo,,N,,,4709,Rattus norvegicus,50597,A,,1
,Plasma clearance in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,10116.0,Intermediate,,,8349,,CHEMBL618715,1,BAO_0000218,,In vivo,,N,,,4521,Rattus norvegicus,50597,A,,1
,Plasma clearance in rat was determined,10116.0,Intermediate,,,8350,,CHEMBL618716,1,BAO_0000218,,In vivo,,N,,,1742,Rattus norvegicus,50597,A,,1
,Plasma clearance measured in rat,10116.0,Intermediate,,,8351,,CHEMBL876601,1,BAO_0000218,,In vivo,,N,,,6057,Rattus norvegicus,50597,A,,1
,Plasma clearance was calculated in rat,10116.0,Intermediate,,,8352,,CHEMBL618717,1,BAO_0000218,,In vivo,,N,,,6057,Rattus norvegicus,50597,A,,1
,Plasma clearance in rat,10116.0,Intermediate,,,8353,,CHEMBL618718,1,BAO_0000218,,In vivo,,N,,,5145,Rattus norvegicus,50597,A,,1
,Plasma clearance in rat,10116.0,Intermediate,,,8354,,CHEMBL618719,1,BAO_0000218,,In vivo,,N,,,5833,Rattus norvegicus,50597,A,,1
,Plasma clearance in rat,10116.0,Intermediate,,,8355,,CHEMBL618720,1,BAO_0000218,,In vivo,,N,,,6453,Rattus norvegicus,50597,A,,1
,Plasma clearance in rat,10116.0,Intermediate,,,8356,,CHEMBL618721,1,BAO_0000218,,In vivo,,N,,,6640,Rattus norvegicus,50597,A,,1
,Plasma clearance in rats,10116.0,Intermediate,,,8357,,CHEMBL621477,1,BAO_0000218,,In vivo,,N,,,6305,Rattus norvegicus,50597,A,,1
,Plasma clearance in rat,10116.0,Intermediate,,,8358,,CHEMBL621478,1,BAO_0000218,,In vivo,,N,,,6642,Rattus norvegicus,50597,A,,1
,Plasma clearance was evaluated in rat,10116.0,Intermediate,,,8359,,CHEMBL621479,1,BAO_0000218,,In vivo,,N,,,5472,Rattus norvegicus,50597,A,,1
,Plasma clearance was evaluated in rat; Not tested,10116.0,Intermediate,,,8360,,CHEMBL621480,1,BAO_0000218,,In vivo,,N,,,5472,Rattus norvegicus,50597,A,,1
,Plasma clearance rate was determined for the compound in rat,10116.0,Intermediate,,,8361,,CHEMBL621481,1,BAO_0000218,,In vivo,,N,,,5144,Rattus norvegicus,50597,A,,1
,"Plasma clearance rate was determined in rats at 10mg/kg, p.o. dose; n/a: not applicable",10116.0,Intermediate,,,8362,,CHEMBL621482,1,BAO_0000218,,In vivo,,N,,,6685,Rattus norvegicus,50597,A,,1
,"Plasma clearance rate was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",10116.0,Intermediate,,,8363,,CHEMBL621483,1,BAO_0000218,,In vivo,,N,,,6685,Rattus norvegicus,50597,A,,1
,"Plasma clearance rate was determined in rats at 2 mg/kg, i.v. dose",10116.0,Intermediate,,,8364,,CHEMBL621484,1,BAO_0000218,,In vivo,,N,,,6685,Rattus norvegicus,50597,A,,1
,Biodistribution of [123I]-label in rat heart was reported at 24 hr post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8365,948.0,CHEMBL621485,1,BAO_0000218,,In vivo,,N,,Heart,13950,Rattus norvegicus,50597,A,,1
,Biodistribution of [123I]-label in rat heart was reported at 4 hr post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8366,948.0,CHEMBL621486,1,BAO_0000218,,In vivo,,N,,Heart,13950,Rattus norvegicus,50597,A,,1
,Biodistribution of [123I]-label in rat intestine was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8367,160.0,CHEMBL621487,1,BAO_0000218,,In vivo,,N,,Intestine,13950,Rattus norvegicus,50597,A,,1
,Biodistribution of [123I]-label in rat intestine was reported at 1 hr post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8368,160.0,CHEMBL621488,1,BAO_0000218,,In vivo,,N,,Intestine,13950,Rattus norvegicus,50597,A,,1
,Biodistribution of [123I]-label in rat intestine was reported at 2 hr post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8369,160.0,CHEMBL621489,1,BAO_0000218,,In vivo,,N,,Intestine,13950,Rattus norvegicus,50597,A,,1
,Biodistribution of [123I]-label in rat intestine was reported at 24 hr post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8370,160.0,CHEMBL621490,1,BAO_0000218,,In vivo,,N,,Intestine,13950,Rattus norvegicus,50597,A,,1
,Biodistribution of [123I]-label in rat intestine was reported at 4 hr post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8371,160.0,CHEMBL621491,1,BAO_0000218,,In vivo,,N,,Intestine,13950,Rattus norvegicus,50597,A,,1
,Biodistribution of [123I]-label in rat kidneys was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8372,2113.0,CHEMBL621492,1,BAO_0000218,,In vivo,,N,,Kidney,13950,Rattus norvegicus,50597,A,,1
,Biodistribution of [123I]-label in rat kidneys was reported at 1 h post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8373,2113.0,CHEMBL621493,1,BAO_0000218,,In vivo,,N,,Kidney,13950,Rattus norvegicus,50597,A,,1
,Biodistribution of [123I]-label in rat kidneys was reported at 2 hr post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8374,2113.0,CHEMBL621494,1,BAO_0000218,,In vivo,,N,,Kidney,13950,Rattus norvegicus,50597,A,,1
,Biodistribution of [123I]-label in rat kidneys was reported at 24 hr post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8375,2113.0,CHEMBL621495,1,BAO_0000218,,In vivo,,N,,Kidney,13950,Rattus norvegicus,50597,A,,1
,Biodistribution of [123I]-label in rat kidneys was reported at 4 hr post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8376,2113.0,CHEMBL621496,1,BAO_0000218,,In vivo,,N,,Kidney,13950,Rattus norvegicus,50597,A,,1
,Biodistribution of [123I]-label in rat liver was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8377,2107.0,CHEMBL621497,1,BAO_0000218,,In vivo,,N,,Liver,13950,Rattus norvegicus,50597,A,,1
,Biodistribution of [123I]-label in rat liver was reported at 1 hr post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8378,2107.0,CHEMBL621498,1,BAO_0000218,,In vivo,,N,,Liver,13950,Rattus norvegicus,50597,A,,1
,Biodistribution of [123I]-label in rat liver was reported at 2 hr post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8379,2107.0,CHEMBL621499,1,BAO_0000218,,In vivo,,N,,Liver,13950,Rattus norvegicus,50597,A,,1
,Biodistribution of [123I]-label in rat liver was reported at 24 h post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8380,2107.0,CHEMBL618634,1,BAO_0000218,,In vivo,,N,,Liver,13950,Rattus norvegicus,50597,A,,1
,Biodistribution of [123I]-label in rat liver was reported at 4 hr post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8381,2107.0,CHEMBL618635,1,BAO_0000218,,In vivo,,N,,Liver,13950,Rattus norvegicus,50597,A,,1
,Biodistribution of [123I]-label in rat lung was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8382,2048.0,CHEMBL618636,1,BAO_0000218,,In vivo,,N,,Lung,13950,Rattus norvegicus,50597,A,,1
,Biodistribution of [123I]-label in rat lung was reported at 1 hr post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8383,2048.0,CHEMBL619737,1,BAO_0000218,,In vivo,,N,,Lung,13950,Rattus norvegicus,50597,A,,1
,Biodistribution of [123I]-label in rat lung was reported at 2 hr post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8384,2048.0,CHEMBL619738,1,BAO_0000218,,In vivo,,N,,Lung,13950,Rattus norvegicus,50597,A,,1
,Biodistribution of [123I]-label in rat lung was reported at 24 hr post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8385,2048.0,CHEMBL624329,1,BAO_0000218,,In vivo,,N,,Lung,13950,Rattus norvegicus,50597,A,,1
,Biodistribution of [123I]-label in rat lung was reported at 4 hr post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8386,2048.0,CHEMBL624330,1,BAO_0000218,,In vivo,,N,,Lung,13950,Rattus norvegicus,50597,A,,1
,Biodistribution of [123I]-label in rat muscle was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8387,2385.0,CHEMBL624331,1,BAO_0000218,,In vivo,,N,,Muscle tissue,13950,Rattus norvegicus,50597,A,,1
,Biodistribution of [123I]-label in rat muscle was reported at 1 hr post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8388,2385.0,CHEMBL624332,1,BAO_0000218,,In vivo,,N,,Muscle tissue,13950,Rattus norvegicus,50597,A,,1
,Biodistribution of [123I]-label in rat muscle was reported at 2 hr post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8389,2385.0,CHEMBL624333,1,BAO_0000218,,In vivo,,N,,Muscle tissue,13950,Rattus norvegicus,50597,A,,1
,Biodistribution of [123I]-label in rat muscle was reported at 24 hr post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8390,2385.0,CHEMBL624334,1,BAO_0000218,,In vivo,,N,,Muscle tissue,13950,Rattus norvegicus,50597,A,,1
,Biodistribution of [123I]-label in rat muscle was reported at 4 hr post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8391,2385.0,CHEMBL624335,1,BAO_0000218,,In vivo,,N,,Muscle tissue,13950,Rattus norvegicus,50597,A,,1
,Biodistribution of [123I]-label in rat spleen was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8392,2106.0,CHEMBL620016,1,BAO_0000218,,In vivo,,N,,Spleen,13950,Rattus norvegicus,50597,A,,1
,Biodistribution of [123I]-label in rat spleen was reported at 1 hr post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8393,2106.0,CHEMBL620169,1,BAO_0000218,,In vivo,,N,,Spleen,13950,Rattus norvegicus,50597,A,,1
,Biodistribution of [123I]-label in rat spleen was reported at 2 hr post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8394,2106.0,CHEMBL620170,1,BAO_0000218,,In vivo,,N,,Spleen,13950,Rattus norvegicus,50597,A,,1
,Biodistribution of [123I]-label in rat spleen was reported at 24 h post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8395,2106.0,CHEMBL620171,1,BAO_0000218,,In vivo,,N,,Spleen,13950,Rattus norvegicus,50597,A,,1
,Biodistribution of [123I]-label in rat spleen was reported at 4 hr post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8396,2106.0,CHEMBL620172,1,BAO_0000218,,In vivo,,N,,Spleen,13950,Rattus norvegicus,50597,A,,1
,Biodistribution of [123I]-label in rat stomach was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8397,945.0,CHEMBL620173,1,BAO_0000218,,In vivo,,N,,Stomach,13950,Rattus norvegicus,50597,A,,1
,Biodistribution of [123I]-label in rat stomach was reported at 1 h post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8398,945.0,CHEMBL620174,1,BAO_0000218,,In vivo,,N,,Stomach,13950,Rattus norvegicus,50597,A,,1
,Biodistribution of [123I]-label in rat stomach was reported at 2 hr post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8399,945.0,CHEMBL620175,1,BAO_0000218,,In vivo,,N,,Stomach,13950,Rattus norvegicus,50597,A,,1
,Biodistribution of [123I]-label in rat stomach was reported at 24 hr post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8400,945.0,CHEMBL620176,1,BAO_0000218,,In vivo,,N,,Stomach,13950,Rattus norvegicus,50597,A,,1
,Biodistribution of [123I]-label in rat stomach was reported at 4 hr post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8401,945.0,CHEMBL620177,1,BAO_0000218,,In vivo,,N,,Stomach,13950,Rattus norvegicus,50597,A,,1
,Distribution of [123I]-label in rat brain (cerebellum) was reported at 20 min post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8402,2037.0,CHEMBL620178,1,BAO_0000218,,,,N,,Cerebellum,13950,Rattus norvegicus,50597,A,,1
,Distribution of [123I]-label in rat brain (cerebellum) was reported at 60 min post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8403,2037.0,CHEMBL620179,1,BAO_0000218,,,,N,,Cerebellum,13950,Rattus norvegicus,50597,A,,1
,Distribution of [123I]-label in rat brain (diencephalon) was reported at 20 min post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8404,,CHEMBL620180,1,BAO_0000218,,,,N,,,13950,Rattus norvegicus,50597,A,,1
,Volume of distribution of compound in rat after 1 mg/kg i.v. administration,10116.0,Intermediate,,,8405,,CHEMBL620181,1,BAO_0000218,,In vivo,,N,,,6570,Rattus norvegicus,50597,A,,1
,Volume of distribution of compound in rats after intravenous administration,10116.0,Intermediate,,,8406,,CHEMBL620182,1,BAO_0000218,,In vivo,,N,,,6571,Rattus norvegicus,50597,A,,1
,Volume of distribution in rat,10116.0,Intermediate,,,8407,,CHEMBL620183,1,BAO_0000218,,In vivo,,N,,,6453,Rattus norvegicus,50597,A,,1
,Volume of distribution was determined in rat at a dose of 1 mpk i.v.,10116.0,Intermediate,,,8408,,CHEMBL620184,1,BAO_0000218,,In vivo,,N,,,6444,Rattus norvegicus,50597,A,,1
,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND means not determined,10116.0,Intermediate,,,8409,,CHEMBL620185,1,BAO_0000218,,In vivo,,N,,,6444,Rattus norvegicus,50597,A,,1
,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND=not determined,10116.0,Intermediate,,,8410,,CHEMBL620186,1,BAO_0000218,,In vivo,,N,,,6444,Rattus norvegicus,50597,A,,1
,Volume of distribution was determined in Dawley rat,10116.0,Intermediate,,,8411,,CHEMBL620187,1,BAO_0000218,,In vivo,,N,,,5353,Rattus norvegicus,50597,A,,1
,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,10116.0,Intermediate,,,8412,,CHEMBL620188,1,BAO_0000218,,In vivo,,N,,,5334,Rattus norvegicus,50597,A,,1
,Volume of distribution was reported in Sprague-Dawley rat,10116.0,Intermediate,,,8413,,CHEMBL620189,1,BAO_0000218,,In vivo,,N,,,5334,Rattus norvegicus,50597,A,,1
,Volumes of distribution in rat after peroral administration,10116.0,Intermediate,,,8414,,CHEMBL620190,1,BAO_0000218,,In vivo,,N,,,6641,Rattus norvegicus,50597,A,,1
,Volumes of distribution in rat after po administration,10116.0,Intermediate,,,8415,,CHEMBL620191,1,BAO_0000218,,In vivo,,N,,,6641,Rattus norvegicus,50597,A,,1
,Volumes of distribution in rat after po administration; Not determined,10116.0,Intermediate,,,8416,,CHEMBL620192,1,BAO_0000218,,In vivo,,N,,,6641,Rattus norvegicus,50597,A,,1
,Pharmacokinetic property (Volume) in rat i.v.,10116.0,Intermediate,,,8417,,CHEMBL620193,1,BAO_0000218,,In vivo,,N,,,5676,Rattus norvegicus,50597,A,,1
,Apparent volume of distribution when 3 mg/Kg dose was administered intravenously,10116.0,Intermediate,,,8418,,CHEMBL620194,1,BAO_0000218,,In vivo,,N,,,6410,Rattus norvegicus,50597,A,,1
,"Volume distribution in fischer rats at 5 mg/kg dose, administered intravenously",10116.0,Intermediate,,,8419,,CHEMBL876730,1,BAO_0000218,,In vivo,,N,,,17670,Rattus norvegicus,50597,A,,1
,Volume distribution in rat after oral administration at 10 mg/kg,10116.0,Intermediate,,,8420,,CHEMBL620195,1,BAO_0000218,,In vivo,,N,,,6495,Rattus norvegicus,50597,A,,1
,Evaluated for Volume of distribution after iv administration of 5 mg/kg to male Sprague-Dawley rats,10116.0,Intermediate,,,8421,,CHEMBL620196,1,BAO_0000218,,In vivo,,N,,,5408,Rattus norvegicus,50597,A,,1
,Tested for volume of distribution after intravenous administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,10116.0,Intermediate,,,8422,,CHEMBL620197,1,BAO_0000218,,In vivo,,N,,,4883,Rattus norvegicus,50597,A,,1
,Volume of distribution after oral administration of 6 mg/kg of dose in rats was determined,10116.0,Intermediate,,,8423,,CHEMBL620198,1,BAO_0000218,,In vivo,,N,,,6647,Rattus norvegicus,50597,A,,1
,Volume of distribution in rats,10116.0,Intermediate,,,8424,,CHEMBL620199,1,BAO_0000218,,In vivo,,N,,,6495,Rattus norvegicus,50597,A,,1
,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female wistar rats,10116.0,Intermediate,,,8425,,CHEMBL620200,1,BAO_0000218,,In vivo,,N,,,2661,Rattus norvegicus,50597,A,,1
,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to male wistar rats,10116.0,Intermediate,,,8426,,CHEMBL620201,1,BAO_0000218,,In vivo,,N,,,2661,Rattus norvegicus,50597,A,,1
,In vivo Volume distribution (Vss) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,10116.0,Intermediate,,,8427,,CHEMBL620202,1,BAO_0000218,,In vivo,,N,,,5974,Rattus norvegicus,50597,A,,1
,In vivo Volume distribution (Vss) was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,10116.0,Intermediate,,,8428,,CHEMBL620203,1,BAO_0000218,,In vivo,,N,,,5974,Rattus norvegicus,50597,A,,1
,In vivo Volume distribution (Vss) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat;no value,10116.0,Intermediate,,,8429,,CHEMBL620204,1,BAO_0000218,,In vivo,,N,,,5974,Rattus norvegicus,50597,A,,1
,In vivo Volume distribution (Vss) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,10116.0,Intermediate,,,8430,,CHEMBL620205,1,BAO_0000218,,In vivo,,N,,,5974,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter (Vss) in rat,10116.0,Intermediate,,,8431,,CHEMBL624664,1,BAO_0000218,,In vivo,,N,,,5960,Rattus norvegicus,50597,A,,1
,Pharmacokinetic property (Volume) in rat i.v.,10116.0,Intermediate,,,8432,,CHEMBL624665,1,BAO_0000218,,In vivo,,N,,,5676,Rattus norvegicus,50597,A,,1
,Pharmacokinetic property (Vss) in rat,10116.0,Intermediate,,,8433,,CHEMBL624666,1,BAO_0000218,,,,N,,,5948,Rattus norvegicus,50597,A,,1
,Steady state volume distribution (Vss) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,10116.0,Intermediate,,,8434,,CHEMBL624667,1,BAO_0000218,,In vivo,,N,,,5979,Rattus norvegicus,50597,A,,1
,Steady state volume distribution (Vss) of compound after iv administration was determined in Sprague-Dawley rat,10116.0,Intermediate,,,8435,,CHEMBL624668,1,BAO_0000218,,In vivo,,N,,,5978,Rattus norvegicus,50597,A,,1
,Steady state volume distribution (Vss) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,10116.0,Intermediate,,,8436,,CHEMBL624669,1,BAO_0000218,,In vivo,,N,,,5978,Rattus norvegicus,50597,A,,1
,Steady state volume distribution (Vss) of compound(9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,10116.0,Intermediate,,,8437,,CHEMBL624670,1,BAO_0000218,,In vivo,,N,,,5978,Rattus norvegicus,50597,A,,1
,Steady state volume distribution (Vss) of compound(9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,10116.0,Intermediate,,,8438,,CHEMBL624671,1,BAO_0000218,,In vivo,,N,,,5978,Rattus norvegicus,50597,A,,1
,Steady state volume distribution in rat,10116.0,Intermediate,,,8439,,CHEMBL624672,1,BAO_0000218,,In vivo,,N,,,6448,Rattus norvegicus,50597,A,,1
,"Steady state volume of distribution calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv.",10116.0,Intermediate,,,8440,1969.0,CHEMBL624673,1,BAO_0000218,,In vivo,,N,,Plasma,12873,Rattus norvegicus,50597,A,,1
,Steady state volume of distribution determined in rat,10116.0,Intermediate,,,8441,,CHEMBL624674,1,BAO_0000218,,In vivo,,N,,,4576,Rattus norvegicus,50597,A,,1
,Steady-state volume of distribution was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,10116.0,Intermediate,,,8442,,CHEMBL624675,1,BAO_0000218,,In vivo,,N,,,17582,Rattus norvegicus,50597,A,,1
,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in rat,10116.0,Intermediate,,,8443,,CHEMBL621728,1,BAO_0000218,,In vivo,,N,,,1466,Rattus norvegicus,50597,A,,1
,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined,10116.0,Intermediate,,,8444,,CHEMBL621729,1,BAO_0000218,,,,N,,,5182,Rattus norvegicus,50597,A,,1
,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined; NC means not calculated,10116.0,Intermediate,,,8445,,CHEMBL621730,1,BAO_0000218,,,,N,,,5182,Rattus norvegicus,50597,A,,1
,Volume distribution in rat after administration of 2 mg/kg iv,10116.0,Intermediate,,,8446,,CHEMBL621731,1,BAO_0000218,,In vivo,,N,,,6535,Rattus norvegicus,50597,A,,1
,Volume distribution in rat after administration of 2 mg/kg iv,10116.0,Intermediate,,,8447,,CHEMBL621732,1,BAO_0000218,,In vivo,,N,,,6535,Rattus norvegicus,50597,A,,1
,Volume in steady state distribution value was determined,10116.0,Intermediate,,,8448,,CHEMBL621908,1,BAO_0000218,,In vivo,,N,,,5041,Rattus norvegicus,50597,A,,1
,Volume in steady state distribution value was determined; ND denotes no data,10116.0,Intermediate,,,8449,,CHEMBL875347,1,BAO_0000218,,In vivo,,N,,,5041,Rattus norvegicus,50597,A,,1
,Volume in steady state distribution value was determined; ND denotes not determined,10116.0,Intermediate,,,8450,,CHEMBL621909,1,BAO_0000218,,In vivo,,N,,,5041,Rattus norvegicus,50597,A,,1
,Volume of distribution at a steady state measured after intravenous bolus administration of 50 mg/kg of compound to rats,10116.0,Intermediate,,,8451,,CHEMBL621910,1,BAO_0000218,,In vivo,,N,,,17065,Rattus norvegicus,50597,A,,1
,Volume of distribution at steady state was evaluated in rats,10116.0,Intermediate,,,8452,,CHEMBL621911,1,BAO_0000218,,In vivo,,N,,,6597,Rattus norvegicus,50597,A,,1
,Volume of distribution at steady state was observed after intravenous administration in rat,10116.0,Intermediate,,,8453,,CHEMBL621912,1,BAO_0000218,,In vivo,,N,,,15662,Rattus norvegicus,50597,A,,1
,Volume of distribution in steady state was determined in rat,10116.0,Intermediate,,,8454,,CHEMBL621913,1,BAO_0000218,,In vivo,,N,,,6485,Rattus norvegicus,50597,A,,1
,Volume of distribution in steady state was determined in rat,10116.0,Intermediate,,,8455,,CHEMBL621914,1,BAO_0000218,,In vivo,,N,,,17655,Rattus norvegicus,50597,A,,1
,Volume of distribution after i.v. administration,10116.0,Intermediate,,,8456,,CHEMBL621915,1,BAO_0000218,,In vivo,,N,,,6616,Rattus norvegicus,50597,A,,1
,Volume of distribution was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,10116.0,Intermediate,,,8457,,CHEMBL621916,1,BAO_0000218,,In vivo,,N,,,1916,Rattus norvegicus,50597,A,,1
,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",10090.0,Intermediate,,,8458,2107.0,CHEMBL621917,1,BAO_0000218,,In vivo,,N,,Liver,16438,Mus musculus,50594,A,,1
,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",10090.0,Intermediate,,,8459,2107.0,CHEMBL621918,1,BAO_0000218,,In vivo,,N,,Liver,16438,Mus musculus,50594,A,,1
,Biodistribution of compound (oxidized form) in spleen tissue,10090.0,Intermediate,,,8460,2106.0,CHEMBL621919,1,BAO_0000218,,In vivo,,N,,Spleen,16438,Mus musculus,50594,A,,1
,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",10090.0,Intermediate,,,8461,2106.0,CHEMBL621920,1,BAO_0000218,,In vivo,,N,,Spleen,16438,Mus musculus,50594,A,,1
,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",10090.0,Intermediate,,,8462,2106.0,CHEMBL621921,1,BAO_0000218,,In vivo,,N,,Spleen,16438,Mus musculus,50594,A,,1
,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",10090.0,Intermediate,,,8463,2106.0,CHEMBL622401,1,BAO_0000218,,In vivo,,N,,Spleen,16438,Mus musculus,50594,A,,1
,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",10090.0,Intermediate,,,8464,2106.0,CHEMBL875348,1,BAO_0000218,,In vivo,,N,,Spleen,16438,Mus musculus,50594,A,,1
,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",10090.0,Intermediate,,,8465,2106.0,CHEMBL622402,1,BAO_0000218,,In vivo,,N,,Spleen,16438,Mus musculus,50594,A,,1
,Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood,10090.0,Intermediate,,,8466,178.0,CHEMBL622403,1,BAO_0000218,,In vivo,,N,,Blood,16438,Mus musculus,50594,A,,1
,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",10090.0,Intermediate,,,8467,178.0,CHEMBL622404,1,BAO_0000218,,In vivo,,N,,Blood,16438,Mus musculus,50594,A,,1
,Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues,10090.0,Intermediate,,,8468,955.0,CHEMBL622405,1,BAO_0000218,,In vivo,,N,,Brain,16438,Mus musculus,50594,A,,1
,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO",10090.0,Intermediate,,,8469,955.0,CHEMBL622406,1,BAO_0000218,,In vivo,,N,,Brain,16438,Mus musculus,50594,A,,1
,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",10090.0,Intermediate,,,8470,955.0,CHEMBL622407,1,BAO_0000218,,In vivo,,N,,Brain,16438,Mus musculus,50594,A,,1
,Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues,10090.0,Intermediate,,,8471,948.0,CHEMBL622408,1,BAO_0000218,,In vivo,,N,,Heart,16438,Mus musculus,50594,A,,1
,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO",10090.0,Intermediate,,,8472,948.0,CHEMBL622409,1,BAO_0000218,,In vivo,,N,,Heart,16438,Mus musculus,50594,A,,1
,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO",10090.0,Intermediate,,,8473,948.0,CHEMBL622410,1,BAO_0000218,,In vivo,,N,,Heart,16438,Mus musculus,50594,A,,1
,Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney,10090.0,Intermediate,,,8474,2113.0,CHEMBL622411,1,BAO_0000218,,In vivo,,N,,Kidney,16438,Mus musculus,50594,A,,1
,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing in DMSO",10090.0,Intermediate,,,8475,2113.0,CHEMBL627864,1,BAO_0000218,,In vivo,,N,,Kidney,16438,Mus musculus,50594,A,,1
,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO",10090.0,Intermediate,,,8476,2113.0,CHEMBL627865,1,BAO_0000218,,In vivo,,N,,Kidney,16438,Mus musculus,50594,A,,1
,Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver,10090.0,Intermediate,,,8477,2107.0,CHEMBL627866,1,BAO_0000218,,In vivo,,N,,Liver,16438,Mus musculus,50594,A,,1
,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",10090.0,Intermediate,,,8478,2107.0,CHEMBL627751,1,BAO_0000218,,In vivo,,N,,Liver,16438,Mus musculus,50594,A,,1
,Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen,10090.0,Intermediate,,,8479,2106.0,CHEMBL627752,1,BAO_0000218,,In vivo,,N,,Spleen,16438,Mus musculus,50594,A,,1
,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing in DMSO",10090.0,Intermediate,,,8480,2106.0,CHEMBL627753,1,BAO_0000218,,In vivo,,N,,Spleen,16438,Mus musculus,50594,A,,1
,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",10090.0,Intermediate,,,8481,2106.0,CHEMBL627754,1,BAO_0000218,,In vivo,,N,,Spleen,16438,Mus musculus,50594,A,,1
,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK2 murine fibrosarcoma cells,10090.0,Intermediate,,,8482,,CHEMBL627755,1,BAO_0000218,,,,N,,,12467,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice (ICR) brain after 1 hour of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8483,955.0,CHEMBL627756,1,BAO_0000218,,In vivo,,N,,Brain,17208,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice (ICR) brain after 2 hours of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8484,955.0,CHEMBL627757,1,BAO_0000218,,In vivo,,N,,Brain,17208,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice (ICR) brain after 2 minutes of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8485,955.0,CHEMBL627758,1,BAO_0000218,,In vivo,,N,,Brain,17208,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice (ICR) brain after 24 hours of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8486,955.0,CHEMBL627759,1,BAO_0000218,,In vivo,,N,,Brain,17208,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice (ICR) brain after 30 minutes of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8487,955.0,CHEMBL627760,1,BAO_0000218,,In vivo,,N,,Brain,17208,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice (ICR) brain after 6 hours of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8488,955.0,CHEMBL627761,1,BAO_0000218,,In vivo,,N,,Brain,17208,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice (ICR) heart after 1 hour of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8489,948.0,CHEMBL876811,1,BAO_0000218,,In vivo,,N,,Heart,17208,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice (ICR) heart after 2 hours of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8490,948.0,CHEMBL627762,1,BAO_0000218,,In vivo,,N,,Heart,17208,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice (ICR) heart after 2 minutes of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8491,948.0,CHEMBL627763,1,BAO_0000218,,In vivo,,N,,Heart,17208,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice (ICR) heart after 24 hours of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8492,948.0,CHEMBL627764,1,BAO_0000218,,In vivo,,N,,Heart,17208,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice (ICR) heart after 30 minutes of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8493,948.0,CHEMBL627765,1,BAO_0000218,,In vivo,,N,,Heart,17208,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice (ICR) heart after 6 hours of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8494,948.0,CHEMBL627766,1,BAO_0000218,,In vivo,,N,,Heart,17208,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice (ICR) kidney after 1 hour of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8495,2113.0,CHEMBL627767,1,BAO_0000218,,In vivo,,N,,Kidney,17208,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 hours of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8496,2113.0,CHEMBL627768,1,BAO_0000218,,In vivo,,N,,Kidney,17208,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 minutes of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8497,2113.0,CHEMBL628422,1,BAO_0000218,,In vivo,,N,,Kidney,17208,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice (ICR) kidney after 24 hours of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8498,2113.0,CHEMBL628423,1,BAO_0000218,,In vivo,,N,,Kidney,17208,Mus musculus,50594,A,,1
,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing) in Dawley rat,10116.0,Intermediate,,,8499,,CHEMBL628424,1,BAO_0000218,,In vivo,,N,,,5089,Rattus norvegicus,50597,A,,1
,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing)) in Dawley rat,10116.0,Intermediate,,,8500,,CHEMBL628425,1,BAO_0000218,,In vivo,,N,,,5089,Rattus norvegicus,50597,A,,1
,Plasma clearance value was determined in rat after a 3 mg/kg of iv dose,10116.0,Intermediate,,,8501,,CHEMBL628426,1,BAO_0000218,,In vivo,,N,,,4257,Rattus norvegicus,50597,A,,1
,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,10116.0,Intermediate,,,8502,,CHEMBL628427,1,BAO_0000218,,In vivo,,N,,,6679,Rattus norvegicus,50597,A,,1
,Plasma clearance was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,10116.0,Intermediate,,,8503,,CHEMBL626938,1,BAO_0000218,,In vivo,,N,,,5546,Rattus norvegicus,50597,A,,1
,Plasma clearance was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,10116.0,Intermediate,,,8504,,CHEMBL626939,1,BAO_0000218,,In vivo,,N,,,6141,Rattus norvegicus,50597,A,,1
,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,10116.0,Intermediate,,,8505,,CHEMBL626940,1,BAO_0000218,,In vivo,,N,,,5334,Rattus norvegicus,50597,A,,1
,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,10116.0,Intermediate,,,8506,,CHEMBL626941,1,BAO_0000218,,In vivo,,N,,,5334,Rattus norvegicus,50597,A,,1
,Plasma clearance was reported in Sprague-Dawley rat,10116.0,Intermediate,,,8507,,CHEMBL626942,1,BAO_0000218,,In vivo,,N,,,5334,Rattus norvegicus,50597,A,,1
,Plasma clearance after intravenous administration (1 mg/kg) in rat,10116.0,Intermediate,,,8508,,CHEMBL876812,1,BAO_0000218,,In vivo,,N,,,4689,Rattus norvegicus,50597,A,,1
,Plasma clearance of compound in rats was evaluated,10116.0,Intermediate,,,8509,,CHEMBL626943,1,BAO_0000218,,In vivo,,N,,,6848,Rattus norvegicus,50597,A,,1
,Plasma clearance of compound in rats was evaluated; ND indicates not determined,10116.0,Intermediate,,,8510,,CHEMBL626944,1,BAO_0000218,,In vivo,,N,,,6848,Rattus norvegicus,50597,A,,1
,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration,10116.0,Intermediate,,,8511,,CHEMBL626945,1,BAO_0000218,,In vivo,,N,,,6467,Rattus norvegicus,50597,A,,1
,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,10116.0,Intermediate,,,8512,,CHEMBL626946,1,BAO_0000218,,In vivo,,N,,,6467,Rattus norvegicus,50597,A,,1
,Plasma clearance rate in Sprague-Dawley rats,10116.0,Intermediate,,,8513,,CHEMBL626856,1,BAO_0000218,,In vivo,,N,,,4956,Rattus norvegicus,50597,A,,1
,Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg),10116.0,Intermediate,,,8514,,CHEMBL626857,1,BAO_0000218,,In vivo,,N,,,5529,Rattus norvegicus,50597,A,,1
,The compound was evaluated for plasma clearance in rat,10116.0,Intermediate,,,8515,1969.0,CHEMBL626858,1,BAO_0000218,,In vivo,,N,,Plasma,406,Rattus norvegicus,50597,A,,1
,Total plasma clearance in rat,10116.0,Intermediate,,,8516,1969.0,CHEMBL627018,1,BAO_0000218,,In vivo,,N,,Plasma,17655,Rattus norvegicus,50597,A,,1
,Absorption behavior was judged by the peak blood concentration determined after oral dose of 30 mg/kg in rats.,10116.0,Intermediate,,,8517,178.0,CHEMBL625331,1,BAO_0000218,,In vivo,,N,,Blood,3293,Rattus norvegicus,50597,A,,1
,Blood level after a 10 mg/kg oral dose in rat expressed as Cmax was determined,10116.0,Intermediate,,,8518,178.0,CHEMBL625332,1,BAO_0000218,,In vivo,,N,,Blood,4075,Rattus norvegicus,50597,A,,1
,C max was determined at 10 mg/kg po dose in rats,10116.0,Intermediate,,,8519,,CHEMBL877590,1,BAO_0000218,,In vivo,,N,,,2792,Rattus norvegicus,50597,A,,1
,C max was determined at 3 mg/kg po dose in rats,10116.0,Intermediate,,,8520,,CHEMBL625333,1,BAO_0000218,,In vivo,,N,,,2792,Rattus norvegicus,50597,A,,1
,Cmax after repeated oral dose of compound at 1 mg/kg in rats,10116.0,Intermediate,,,8521,,CHEMBL625334,1,BAO_0000218,,In vivo,,N,,,17594,Rattus norvegicus,50597,A,,1
,Cmax after single intravenous bolus of 1 mg/kg in rats,10116.0,Intermediate,,,8522,,CHEMBL625335,1,BAO_0000218,,In vivo,,N,,,17594,Rattus norvegicus,50597,A,,1
,Cmax of compound at 5 mg/kg after po administration was determined in rat,10116.0,Intermediate,,,8523,,CHEMBL625336,1,BAO_0000218,,In vivo,,N,,,4762,Rattus norvegicus,50597,A,,1
,Cmax 24 hr after 10 mg/kg oral administration in rats,10116.0,Intermediate,,,8524,,CHEMBL625337,1,BAO_0000218,,In vivo,,N,,,17509,Rattus norvegicus,50597,A,,1
,Cmax 24 hr after 2 mg/kg oral administration in rats,10116.0,Intermediate,,,8525,,CHEMBL625338,1,BAO_0000218,,In vivo,,N,,,17509,Rattus norvegicus,50597,A,,1
,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in rat,10116.0,Intermediate,,,8526,1969.0,CHEMBL625339,1,BAO_0000218,,In vivo,,N,,Plasma,1466,Rattus norvegicus,50597,A,,1
,Cmax in rat after administration of 2 mg/kg iv,10116.0,Intermediate,,,8527,,CHEMBL625340,1,BAO_0000218,,In vivo,,N,,,6535,Rattus norvegicus,50597,A,,1
,Cmax in rat after administration of 2 mg/kg iv,10116.0,Intermediate,,,8528,,CHEMBL625341,1,BAO_0000218,,In vivo,,N,,,6535,Rattus norvegicus,50597,A,,1
,Cmax in rats determined 6 hours after oral dosing of 20 mg/kg,10116.0,Intermediate,,,8529,,CHEMBL622687,1,BAO_0000218,,In vivo,,N,,,3169,Rattus norvegicus,50597,A,,1
,Cmax wa determined in rat plasma at 30 mg/kg after po administration,10116.0,Intermediate,,,8530,1969.0,CHEMBL622688,1,BAO_0000218,,In vivo,,N,,Plasma,6515,Rattus norvegicus,50597,A,,1
,Cmax was calculated as maximum concentration reached in the blood after oral administration to male F344 rats,10116.0,Intermediate,,,8531,178.0,CHEMBL622689,1,BAO_0000218,,In vivo,,N,,Blood,11149,Rattus norvegicus,50597,A,,1
,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate after oral administration to male F344 rats,10116.0,Intermediate,,,8532,178.0,CHEMBL620295,1,BAO_0000218,,In vivo,,N,,Blood,11149,Rattus norvegicus,50597,A,,1
,Cmax after 10 mg/kg oral administration in rat,10116.0,Intermediate,,,8533,,CHEMBL620296,1,BAO_0000218,,In vivo,,N,,,17858,Rattus norvegicus,50597,A,,1
,Cmax after IV dosing at 0.5 mg/kg in rat; no data,10116.0,Intermediate,,,8534,,CHEMBL620297,1,BAO_0000218,,In vivo,,N,,,6518,Rattus norvegicus,50597,A,,1
,Cmax after IV dosing at 1 mg/kg in rat; no data,10116.0,Intermediate,,,8535,,CHEMBL620298,1,BAO_0000218,,In vivo,,N,,,6518,Rattus norvegicus,50597,A,,1
,Cmax after oral administration at 20 mpk in rats,10116.0,Intermediate,,,8536,,CHEMBL620299,1,BAO_0000218,,In vivo,,N,,,4426,Rattus norvegicus,50597,A,,1
,Cmax after oral administration at 20 mpk in rats; Not performed.,10116.0,Intermediate,,,8537,,CHEMBL620300,1,BAO_0000218,,In vivo,,N,,,4426,Rattus norvegicus,50597,A,,1
,Cmax after oral administration at 20 mpk in rats d; Not performed.,10116.0,Intermediate,,,8538,,CHEMBL620301,1,BAO_0000218,,In vivo,,N,,,4426,Rattus norvegicus,50597,A,,1
,Cmax after oral administration in rat,10116.0,Intermediate,,,8539,,CHEMBL620302,1,BAO_0000218,,In vivo,,N,,,5656,Rattus norvegicus,50597,A,,1
,Cmax after oral administration at a dose of 2 mg/kg in rat,10116.0,Intermediate,,,8540,,CHEMBL620303,1,BAO_0000218,,In vivo,,N,,,6518,Rattus norvegicus,50597,A,,1
,Cmax after oral administration at a dose of 4 mg/kg in rat,10116.0,Intermediate,,,8541,,CHEMBL620304,1,BAO_0000218,,In vivo,,N,,,6518,Rattus norvegicus,50597,A,,1
,Cmax in rats after 20 mg/kg oral dose,10116.0,Intermediate,,,8542,,CHEMBL620305,1,BAO_0000218,,In vivo,,N,,,6113,Rattus norvegicus,50597,A,,1
,Cmax after peroral administration in rats at 2.4 uM/kg,10116.0,Intermediate,,,8543,,CHEMBL620306,1,BAO_0000218,,In vivo,,N,,,17764,Rattus norvegicus,50597,A,,1
,Cmax at the dose of 2 mg/Kg administered perorally in rats,10116.0,Intermediate,,,8544,,CHEMBL620307,1,BAO_0000218,,In vivo,,N,,,4756,Rattus norvegicus,50597,A,,1
,Cmax at the dose of 5 mg/Kg administered perorally in rats,10116.0,Intermediate,,,8545,,CHEMBL620308,1,BAO_0000218,,In vivo,,N,,,4756,Rattus norvegicus,50597,A,,1
,Cmax by administering at 20 mg/kg p.o. in rats,10116.0,Intermediate,,,8546,,CHEMBL620309,1,BAO_0000218,,In vivo,,N,,,6402,Rattus norvegicus,50597,A,,1
,Cmax in male rat,10116.0,Intermediate,,,8547,,CHEMBL620310,1,BAO_0000218,,In vivo,,N,,,5610,Rattus norvegicus,50597,A,,1
,Cmax in rat,10116.0,Intermediate,,,8548,,CHEMBL620311,1,BAO_0000218,,In vivo,,N,,,5207,Rattus norvegicus,50597,A,,1
,Cmax in rat,10116.0,Intermediate,,,8549,,CHEMBL620312,1,BAO_0000218,,In vivo,,N,,,6011,Rattus norvegicus,50597,A,,1
,Cmax in rat,10116.0,Intermediate,,,8550,,CHEMBL620313,1,BAO_0000218,,In vivo,,N,,,6504,Rattus norvegicus,50597,A,,1
,Cmax in rat at 10 mg/kg,10116.0,Intermediate,,,8551,,CHEMBL620314,1,BAO_0000218,,In vivo,,N,,,6046,Rattus norvegicus,50597,A,,1
,Cmax in rat at the dose of 1 mg/kg i.v.,10116.0,Intermediate,,,8552,,CHEMBL620315,1,BAO_0000218,,In vivo,,N,,,6504,Rattus norvegicus,50597,A,,1
,Cmax in rat by po administration at a dose of 40 mg/kg,10116.0,Intermediate,,,8553,,CHEMBL620316,1,BAO_0000218,,In vivo,,N,,,5874,Rattus norvegicus,50597,A,,1
,Cmax in rat p.o. at 20 mg/kg concentration,10116.0,Intermediate,,,8554,,CHEMBL620317,1,BAO_0000218,,In vivo,,N,,,17686,Rattus norvegicus,50597,A,,1
,Cmax in rats,10116.0,Intermediate,,,8555,,CHEMBL620318,1,BAO_0000218,,In vivo,,N,,,5836,Rattus norvegicus,50597,A,,1
,Cmax in rats,10116.0,Intermediate,,,8556,,CHEMBL620319,1,BAO_0000218,,In vivo,,N,,,17596,Rattus norvegicus,50597,A,,1
,Cmax was evaluated after 20 uM/kg of peroral administration,10116.0,Intermediate,,,8557,,CHEMBL620320,1,BAO_0000218,,In vivo,,N,,,16423,Rattus norvegicus,50597,A,,1
,Cmax was measured in rats after peroral administration at 3 mg/kg,10116.0,Intermediate,,,8558,,CHEMBL620321,1,BAO_0000218,,In vivo,,N,,,17804,Rattus norvegicus,50597,A,,1
,Cmax value after oral dose at a dose of 10 mg/kg in rats.,10116.0,Intermediate,,,8559,,CHEMBL620322,1,BAO_0000218,,In vivo,,N,,,1908,Rattus norvegicus,50597,A,,1
,Distribution of [123I]-label in rat brain (diencephalon) was reported at 60 min post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8560,,CHEMBL620323,1,BAO_0000218,,,,N,,,13950,Rattus norvegicus,50597,A,,1
,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8561,1870.0,CHEMBL620324,1,BAO_0000218,,,,N,,Frontal cortex,13950,Rattus norvegicus,50597,A,,1
,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8562,1870.0,CHEMBL620325,1,BAO_0000218,,,,N,,Frontal cortex,13950,Rattus norvegicus,50597,A,,1
,Distribution of [123I]-label in rat brain (hippocampus) was reported at 20 min post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8563,10000000.0,CHEMBL620326,1,BAO_0000218,,,,N,,Hippocampus,13950,Rattus norvegicus,50597,A,,1
,Distribution of [123I]-label in rat brain (hippocampus) was reported at 60 min post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8564,10000000.0,CHEMBL620327,1,BAO_0000218,,,,N,,Hippocampus,13950,Rattus norvegicus,50597,A,,1
,Distribution of [123I]-label in rat brain (medulla pons) was reported at 20 min post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8565,,CHEMBL620328,1,BAO_0000218,,,,N,,,13950,Rattus norvegicus,50597,A,,1
,Distribution of [123I]-label in rat brain (medulla pons) was reported at 60 min post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8566,,CHEMBL620329,1,BAO_0000218,,,,N,,,13950,Rattus norvegicus,50597,A,,1
,Distribution of [123I]-label in rat brain (midbrain) was reported at 20 min post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8567,1891.0,CHEMBL620330,1,BAO_0000218,,,,N,,Midbrain,13950,Rattus norvegicus,50597,A,,1
,Distribution of [123I]-label in rat brain (midbrain) was reported at 60 min post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8568,1891.0,CHEMBL875286,1,BAO_0000218,,,,N,,Midbrain,13950,Rattus norvegicus,50597,A,,1
,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8569,,CHEMBL620331,1,BAO_0000218,,,,N,,,13950,Rattus norvegicus,50597,A,,1
,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8570,,CHEMBL620332,1,BAO_0000218,,,,N,,,13950,Rattus norvegicus,50597,A,,1
,Distribution of [123I]-label in rat brain (striatum) was reported at 20 min post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8571,2435.0,CHEMBL620333,1,BAO_0000218,,,,N,,Striatum,13950,Rattus norvegicus,50597,A,,1
,Distribution of [123I]-label in rat brain (striatum) was reported at 60 min post injection. Value shown is %ID/g of tissue,10116.0,Intermediate,,,8572,2435.0,CHEMBL620334,1,BAO_0000218,,,,N,,Striatum,13950,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,10116.0,Intermediate,,,8573,178.0,CHEMBL621015,1,BAO_0000218,,,,N,,Blood,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,10116.0,Intermediate,,,8574,178.0,CHEMBL621016,1,BAO_0000218,,,,N,,Blood,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,10116.0,Intermediate,,,8575,178.0,CHEMBL621191,1,BAO_0000218,,,,N,,Blood,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,10116.0,Intermediate,,,8576,178.0,CHEMBL621192,1,BAO_0000218,,,,N,,Blood,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,10116.0,Intermediate,,,8577,178.0,CHEMBL621193,1,BAO_0000218,,,,N,,Blood,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,10116.0,Intermediate,,,8578,178.0,CHEMBL621194,1,BAO_0000218,,,,N,,Blood,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,10116.0,Intermediate,,,8579,178.0,CHEMBL624204,1,BAO_0000218,,,,N,,Blood,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,10116.0,Intermediate,,,8580,178.0,CHEMBL624205,1,BAO_0000218,,,,N,,Blood,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,10116.0,Intermediate,,,8581,178.0,CHEMBL624206,1,BAO_0000218,,,,N,,Blood,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,10116.0,Intermediate,,,8582,178.0,CHEMBL624207,1,BAO_0000218,,,,N,,Blood,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,10116.0,Intermediate,,,8583,178.0,CHEMBL624208,1,BAO_0000218,,,,N,,Blood,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,10116.0,Intermediate,,,8584,178.0,CHEMBL624209,1,BAO_0000218,,,,N,,Blood,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,10116.0,Intermediate,,,8585,178.0,CHEMBL624210,1,BAO_0000218,,,,N,,Blood,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,10116.0,Intermediate,,,8586,178.0,CHEMBL624211,1,BAO_0000218,,,,N,,Blood,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,10116.0,Intermediate,,,8587,178.0,CHEMBL624212,1,BAO_0000218,,,,N,,Blood,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,10116.0,Intermediate,,,8588,178.0,CHEMBL624213,1,BAO_0000218,,,,N,,Blood,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,10116.0,Intermediate,,,8589,178.0,CHEMBL876611,1,BAO_0000218,,,,N,,Blood,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,10116.0,Intermediate,,,8590,178.0,CHEMBL624214,1,BAO_0000218,,,,N,,Blood,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,10116.0,Intermediate,,,8591,178.0,CHEMBL624215,1,BAO_0000218,,,,N,,Blood,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,10116.0,Intermediate,,,8592,178.0,CHEMBL624216,1,BAO_0000218,,,,N,,Blood,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,10116.0,Intermediate,,,8593,178.0,CHEMBL624217,1,BAO_0000218,,,,N,,Blood,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,10116.0,Intermediate,,,8594,178.0,CHEMBL624218,1,BAO_0000218,,,,N,,Blood,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,10116.0,Intermediate,,,8595,178.0,CHEMBL624219,1,BAO_0000218,,,,N,,Blood,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,10116.0,Intermediate,,,8596,178.0,CHEMBL624220,1,BAO_0000218,,,,N,,Blood,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,10116.0,Intermediate,,,8597,178.0,CHEMBL624221,1,BAO_0000218,,,,N,,Blood,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,10116.0,Intermediate,,,8598,,CHEMBL624222,1,BAO_0000218,,,,N,,,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,10116.0,Intermediate,,,8599,,CHEMBL624223,1,BAO_0000218,,,,N,,,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,10116.0,Intermediate,,,8600,,CHEMBL624224,1,BAO_0000218,,,,N,,,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,10116.0,Intermediate,,,8601,,CHEMBL624225,1,BAO_0000218,,,,N,,,16434,Rattus norvegicus,50597,A,,1
,Volume of solubility in solution after intravenous administration in rats at 24 uM/kg,10116.0,Intermediate,,,8602,,CHEMBL622420,1,BAO_0000218,,In vivo,,N,,,17764,Rattus norvegicus,50597,A,,1
,Volume of steady state distribution after i.v. administration in rats,10116.0,Intermediate,,,8603,,CHEMBL622421,1,BAO_0000218,,In vivo,,N,,,5031,Rattus norvegicus,50597,A,,1
,Vss after intravenous administration (5.0 mg/kg) was determined in rat,10116.0,Intermediate,,,8604,,CHEMBL622422,1,BAO_0000218,,In vivo,,N,,,6215,Rattus norvegicus,50597,A,,1
,Vss in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,10116.0,Intermediate,,,8605,,CHEMBL622423,1,BAO_0000218,,In vivo,,N,,,17671,Rattus norvegicus,50597,A,,1
,Vss was determined,10116.0,Intermediate,,,8606,,CHEMBL622424,1,BAO_0000218,,In vivo,,N,,,17752,Rattus norvegicus,50597,A,,1
,Vss in rat,10116.0,Intermediate,,,8607,,CHEMBL622425,1,BAO_0000218,,In vivo,,N,,,6596,Rattus norvegicus,50597,A,,1
,Vss was evaluated after 10 uM/kg of intra arterial administration,10116.0,Intermediate,,,8608,,CHEMBL876612,1,BAO_0000218,,In vivo,,N,,,16423,Rattus norvegicus,50597,A,,1
,volume of distribution at steady state was observed after intravenous administration in rat,10116.0,Intermediate,,,8609,,CHEMBL622426,1,BAO_0000218,,In vivo,,N,,,15662,Rattus norvegicus,50597,A,,1
,Volume of distribution was measured in rat after an iv dose of 1 mg/kg,10116.0,Intermediate,,,8610,,CHEMBL622427,1,BAO_0000218,,In vivo,,N,,,6062,Rattus norvegicus,50597,A,,1
,Pharmacokinetic (PK) parameter Vz in rat,10116.0,Intermediate,,,8611,,CHEMBL622428,1,BAO_0000218,,In vivo,,N,,,5874,Rattus norvegicus,50597,A,,1
,Volume distribution in rats,10116.0,Intermediate,,,8612,,CHEMBL622429,1,BAO_0000218,,In vivo,,N,,,4942,Rattus norvegicus,50597,A,,1
,Volume of distribution in rat; No data,10116.0,Intermediate,,,8613,,CHEMBL622430,1,BAO_0000218,,In vivo,,N,,,17796,Rattus norvegicus,50597,A,,1
,Volume of distribution was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,10116.0,Intermediate,,,8614,,CHEMBL622431,1,BAO_0000218,,In vivo,,N,,,4890,Rattus norvegicus,50597,A,,1
,% absorption predicted from in vitro rat ileum transport studies,10116.0,Intermediate,,,8615,2116.0,CHEMBL622432,1,BAO_0000218,,,,N,,Ileum,15765,Rattus norvegicus,50597,A,,1
,Bioavailability at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,10116.0,Intermediate,,,8616,,CHEMBL622433,1,BAO_0000218,,In vivo,,N,,,13569,Rattus norvegicus,50597,A,,1
,Bioavailability at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,10116.0,Intermediate,,,8617,,CHEMBL622434,1,BAO_0000218,,In vivo,,N,,,13569,Rattus norvegicus,50597,A,,1
,Bioavailability at an iv dose of 14 mg/Kg and po dose of 28 mg/Kg,10116.0,Intermediate,,,8618,,CHEMBL622435,1,BAO_0000218,,In vivo,,N,,,13569,Rattus norvegicus,50597,A,,1
,Bioavailability (dose 15 mg/kg i.v. and 30 mg/kg p.o.),10116.0,Intermediate,,,8619,,CHEMBL618748,1,BAO_0000218,,In vivo,,N,,,13569,Rattus norvegicus,50597,A,,1
,Bioavailability at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,10116.0,Intermediate,,,8620,,CHEMBL618749,1,BAO_0000218,,In vivo,,N,,,13569,Rattus norvegicus,50597,A,,1
,Bioavailability at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,10116.0,Intermediate,,,8621,,CHEMBL618750,1,BAO_0000218,,In vivo,,N,,,13569,Rattus norvegicus,50597,A,,1
,Bioavailability at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,10116.0,Intermediate,,,8622,,CHEMBL618751,1,BAO_0000218,,In vivo,,N,,,13569,Rattus norvegicus,50597,A,,1
,Bioavailability at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,10116.0,Intermediate,,,8623,,CHEMBL618752,1,BAO_0000218,,In vivo,,N,,,13569,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,8624,,CHEMBL618753,1,BAO_0000218,,In vivo,,N,,,4576,Rattus norvegicus,50597,A,,1
,Oral bioavailability estimated by measurement of the circulating plasma levels of BMS-183920 after intravenous and oral dosing to rats for 4 determinations,10116.0,Intermediate,,,8625,1969.0,CHEMBL618754,1,BAO_0000218,,In vivo,,N,,Plasma,750,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,8626,,CHEMBL618755,1,BAO_0000218,,In vivo,,N,,,750,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,8627,,CHEMBL618756,1,BAO_0000218,,In vivo,,N,,,4590,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,8628,,CHEMBL618757,1,BAO_0000218,,In vivo,,N,,,1716,Rattus norvegicus,50597,A,,1
,Bioavailability in rat,10116.0,Intermediate,,,8629,,CHEMBL618758,1,BAO_0000218,,In vivo,,N,,,1974,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat (dose 30 mg/kg),10116.0,Intermediate,,,8630,,CHEMBL621088,1,BAO_0000218,,In vivo,,N,,,4502,Rattus norvegicus,50597,A,,1
,Pharmacokinetic property (cLogP) in rat,10116.0,Intermediate,,,8631,,CHEMBL621089,1,BAO_0000218,,,,N,,,3371,Rattus norvegicus,50597,A,,1
,Hyperglycemic activity and change in blood glucose concentration was reported 2 hours after administration of 100 mg/Kg perorally,10116.0,Intermediate,,,8632,178.0,CHEMBL621090,1,BAO_0000218,,,,N,,Blood,9099,Rattus norvegicus,50597,F,,1
,Hyperglycemic activity and change in blood glucose concentration was reported 4 hours after administration of 100 mg/Kg perorally,10116.0,Intermediate,,,8633,178.0,CHEMBL621091,1,BAO_0000218,,,,N,,Blood,9099,Rattus norvegicus,50597,F,,1
,Clearance in rat.,10116.0,Intermediate,,,8634,,CHEMBL876731,1,BAO_0000218,,In vivo,,N,,,4590,Rattus norvegicus,50597,A,,1
,Compound was evaluated for its clearance when administered intravenously in rat,10116.0,Intermediate,,,8635,,CHEMBL621092,1,BAO_0000218,,In vivo,,N,,,3184,Rattus norvegicus,50597,A,,1
,Plasma clearance in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,10116.0,Intermediate,,,8636,,CHEMBL621093,1,BAO_0000218,,In vivo,,N,,,16456,Rattus norvegicus,50597,A,,1
,Blood: Brain distribution ratio is determined in rat,10116.0,Intermediate,,,8637,,CHEMBL621094,1,BAO_0000218,,,,N,,,4199,Rattus norvegicus,50597,A,,1
,Blood: Brain distribution ratio is determined in rat; NQ: non quantifable,10116.0,Intermediate,,,8638,,CHEMBL621095,1,BAO_0000218,,,,N,,,4199,Rattus norvegicus,50597,A,,1
,Blood: Brain distribution ratio is determined in rat; NQ:non quantifable,10116.0,Intermediate,,,8639,,CHEMBL621096,1,BAO_0000218,,,,N,,,4199,Rattus norvegicus,50597,A,,1
,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",10116.0,Intermediate,,,8640,2113.0,CHEMBL621097,1,BAO_0000218,,In vivo,,N,,Kidney,8677,Rattus norvegicus,50597,A,,1
,Percent dose excreted in 0-48 hours administered ip to male rat,10116.0,Intermediate,,,8641,,CHEMBL621098,1,BAO_0000218,,,,N,,,7449,Rattus norvegicus,50597,F,,1
,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,8642,2037.0,CHEMBL621099,1,BAO_0000218,,,,N,,Cerebellum,11977,Rattus norvegicus,50597,A,,1
,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,8643,2037.0,CHEMBL621100,1,BAO_0000218,,,,N,,Cerebellum,11977,Rattus norvegicus,50597,A,,1
,Uptake of radioligand [125I]-FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),10116.0,Intermediate,,,8644,2037.0,CHEMBL621101,1,BAO_0000218,,,,N,,Cerebellum,11977,Rattus norvegicus,50597,A,,1
,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,8645,2037.0,CHEMBL621102,1,BAO_0000218,,,,N,,Cerebellum,11977,Rattus norvegicus,50597,A,,1
,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,8646,2037.0,CHEMBL876732,1,BAO_0000218,,,,N,,Cerebellum,11977,Rattus norvegicus,50597,A,,1
,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 120 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,8647,,CHEMBL621103,1,BAO_0000218,,,,N,,,11977,Rattus norvegicus,50597,A,,1
,Uptake of radioligand [125I]FIDA1 by cortex in rat after 2 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,8648,,CHEMBL621104,1,BAO_0000218,,,,N,,,11977,Rattus norvegicus,50597,A,,1
,Uptake of radioligand [125I]FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 2 rats),10116.0,Intermediate,,,8649,,CHEMBL621105,1,BAO_0000218,,,,N,,,11977,Rattus norvegicus,50597,A,,1
,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,8650,,CHEMBL621106,1,BAO_0000218,,,,N,,,11977,Rattus norvegicus,50597,A,,1
,Uptake of radioligand [125I]FIDA1 by cortex in rat after 60 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,8651,,CHEMBL621107,1,BAO_0000218,,,,N,,,11977,Rattus norvegicus,50597,A,,1
,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,8652,,CHEMBL621108,1,BAO_0000218,,,,N,,,11977,Rattus norvegicus,50597,A,,1
,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,8653,,CHEMBL621109,1,BAO_0000218,,,,N,,,11977,Rattus norvegicus,50597,A,,1
,Biodistribution of radioactivity in normal mice (ICR) kidney after 30 minutes of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8654,2113.0,CHEMBL621110,1,BAO_0000218,,In vivo,,N,,Kidney,17208,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice (ICR) kidney after 6 hours of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8655,2113.0,CHEMBL621111,1,BAO_0000218,,In vivo,,N,,Kidney,17208,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice (ICR) liver after 1 hour of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8656,2107.0,CHEMBL622541,1,BAO_0000218,,In vivo,,N,,Liver,17208,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice (ICR) liver after 2 hours of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8657,2107.0,CHEMBL622542,1,BAO_0000218,,In vivo,,N,,Liver,17208,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice (ICR) liver after 2 minutes of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8658,2107.0,CHEMBL622543,1,BAO_0000218,,In vivo,,N,,Liver,17208,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice (ICR) liver after 24 hours of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8659,2107.0,CHEMBL624412,1,BAO_0000218,,In vivo,,N,,Liver,17208,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice (ICR) liver after 30 minutes of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8660,2107.0,CHEMBL624413,1,BAO_0000218,,In vivo,,N,,Liver,17208,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice (ICR) liver after 6 hours of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8661,2107.0,CHEMBL624414,1,BAO_0000218,,In vivo,,N,,Liver,17208,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice (ICR) lung after 1 hour of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8662,2048.0,CHEMBL624415,1,BAO_0000218,,In vivo,,N,,Lung,17208,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice (ICR) lung after 2 hours of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8663,2048.0,CHEMBL624416,1,BAO_0000218,,In vivo,,N,,Lung,17208,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice (ICR) lung after 2 minutes of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8664,2048.0,CHEMBL624417,1,BAO_0000218,,In vivo,,N,,Lung,17208,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice (ICR) lung after 24 hours of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8665,2048.0,CHEMBL624418,1,BAO_0000218,,In vivo,,N,,Lung,17208,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice (ICR) lung after 30 minutes of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8666,2048.0,CHEMBL624419,1,BAO_0000218,,In vivo,,N,,Lung,17208,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice (ICR) lung after 6 hours of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8667,2048.0,CHEMBL624420,1,BAO_0000218,,In vivo,,N,,Lung,17208,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice (ICR) muscle after 1 hr of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8668,2385.0,CHEMBL624421,1,BAO_0000218,,In vivo,,N,,Muscle tissue,17208,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 hours of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8669,2385.0,CHEMBL624422,1,BAO_0000218,,In vivo,,N,,Muscle tissue,17208,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 minutes of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8670,2385.0,CHEMBL624423,1,BAO_0000218,,In vivo,,N,,Muscle tissue,17208,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice (ICR) muscle after 24 hours of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8671,2385.0,CHEMBL625123,1,BAO_0000218,,In vivo,,N,,Muscle tissue,17208,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice (ICR) muscle after 30 minutes of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8672,2385.0,CHEMBL625124,1,BAO_0000218,,In vivo,,N,,Muscle tissue,17208,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice (ICR) muscle after 6 hours of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8673,2385.0,CHEMBL625125,1,BAO_0000218,,In vivo,,N,,Muscle tissue,17208,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice (ICR) skin after 1 hour of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8674,14.0,CHEMBL625126,1,BAO_0000218,,In vivo,,N,,Zone of skin,17208,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice (ICR) skin after 2 hours of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8675,14.0,CHEMBL626947,1,BAO_0000218,,In vivo,,N,,Zone of skin,17208,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice (ICR) skin after 2 minutes of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8676,14.0,CHEMBL626948,1,BAO_0000218,,In vivo,,N,,Zone of skin,17208,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice (ICR) skin after 24 hours of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8677,14.0,CHEMBL626949,1,BAO_0000218,,In vivo,,N,,Zone of skin,17208,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice (ICR) skin after 30 minutes of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8678,14.0,CHEMBL626950,1,BAO_0000218,,In vivo,,N,,Zone of skin,17208,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice (ICR) skin after 6 hours of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8679,14.0,CHEMBL626951,1,BAO_0000218,,In vivo,,N,,Zone of skin,17208,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice (ICR) spleen after 1 hour of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8680,2106.0,CHEMBL626952,1,BAO_0000218,,In vivo,,N,,Spleen,17208,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 hours of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8681,2106.0,CHEMBL626953,1,BAO_0000218,,In vivo,,N,,Spleen,17208,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 minutes of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8682,2106.0,CHEMBL626954,1,BAO_0000218,,In vivo,,N,,Spleen,17208,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice (ICR) spleen after 24 hours of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8683,2106.0,CHEMBL626955,1,BAO_0000218,,In vivo,,N,,Spleen,17208,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice (ICR) spleen after 30 minutes of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8684,2106.0,CHEMBL626956,1,BAO_0000218,,In vivo,,N,,Spleen,17208,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice (ICR) spleen after 6 hours of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8685,2106.0,CHEMBL626957,1,BAO_0000218,,In vivo,,N,,Spleen,17208,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice blood after 1 hour of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8686,178.0,CHEMBL626958,1,BAO_0000218,,In vivo,,N,,Blood,17208,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice blood after 2 hours of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8687,178.0,CHEMBL626959,1,BAO_0000218,,In vivo,,N,,Blood,17208,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice blood after 2 minutes of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8688,178.0,CHEMBL626960,1,BAO_0000218,,In vivo,,N,,Blood,17208,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice blood after 24 hours of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8689,178.0,CHEMBL626961,1,BAO_0000218,,In vivo,,N,,Blood,17208,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice blood after 30 minutes of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8690,178.0,CHEMBL627589,1,BAO_0000218,,In vivo,,N,,Blood,17208,Mus musculus,50594,A,,1
,Biodistribution of radioactivity in normal mice blood after 6 hours of intravenous injection of [125I]-16(IMPY),10090.0,Intermediate,,,8691,178.0,CHEMBL627590,1,BAO_0000218,,In vivo,,N,,Blood,17208,Mus musculus,50594,A,,1
,Time taken for EC90 was determined when tested in mouse,10090.0,Intermediate,,,8692,,CHEMBL627591,1,BAO_0000218,,,,N,,,3132,Mus musculus,50594,A,,1
,Time taken for EC90 was determined when tested in mouse at dose 25 mg/kg,10090.0,Intermediate,,,8693,,CHEMBL627592,1,BAO_0000218,,,,N,,,3132,Mus musculus,50594,A,,1
,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),10090.0,Intermediate,,,8694,,CHEMBL627593,1,BAO_0000218,,In vivo,,N,,,16597,Mus musculus,50594,A,,1
,Half life in mice,10090.0,Intermediate,,,8695,,CHEMBL627594,1,BAO_0000218,,,,N,,,5727,Mus musculus,50594,A,,1
,Half life period in mouse after 10 mg/Kg dose,10090.0,Intermediate,,,8696,,CHEMBL876813,1,BAO_0000218,,In vivo,,N,,,5302,Mus musculus,50594,A,,1
,Half life period in mouse after 10 mg/kg dose,10090.0,Intermediate,,,8697,,CHEMBL627595,1,BAO_0000218,,In vivo,,N,,,5302,Mus musculus,50594,A,,1
,Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,10090.0,Intermediate,,,8698,,CHEMBL627596,1,BAO_0000218,,In vivo,,N,,,6348,Mus musculus,50594,A,,1
,Cmax value at 5 mg/kg po was determined in rat,10116.0,Intermediate,,,8699,,CHEMBL627597,1,BAO_0000218,,In vivo,,N,,,5964,Rattus norvegicus,50597,A,,1
,Cmax value evaluated in rat,10116.0,Intermediate,,,8700,,CHEMBL627598,1,BAO_0000218,,In vivo,,N,,,6078,Rattus norvegicus,50597,A,,1
,Cmax value was calculated by applying at a dose of 10 mg/Kg ip in rat brain,10116.0,Intermediate,,,8701,955.0,CHEMBL627599,1,BAO_0000218,,In vivo,,N,,Brain,5206,Rattus norvegicus,50597,A,,1
,Cmax value after administration of 20 mg/Kg oral dose in rat,10116.0,Intermediate,,,8702,,CHEMBL627600,1,BAO_0000218,,In vivo,,N,,,2959,Rattus norvegicus,50597,A,,1
,Cmax value at 1 mg/kg po in rat,10116.0,Intermediate,,,8703,,CHEMBL627601,1,BAO_0000218,,In vivo,,N,,,5964,Rattus norvegicus,50597,A,,1
,Cmax value at 5 mg/kg po in rat,10116.0,Intermediate,,,8704,,CHEMBL627776,1,BAO_0000218,,In vivo,,N,,,5964,Rattus norvegicus,50597,A,,1
,Cmax value at a dose of 10 mg/kg in male SD rats,10116.0,Intermediate,,,8705,,CHEMBL627777,1,BAO_0000218,,In vivo,,N,,,6757,Rattus norvegicus,50597,A,,1
,Cmax value at a dose of 100 mg/kg in male SD rats,10116.0,Intermediate,,,8706,,CHEMBL627778,1,BAO_0000218,,In vivo,,N,,,6757,Rattus norvegicus,50597,A,,1
,Cmax value at a dose of 50 mg/kg in male SD rats,10116.0,Intermediate,,,8707,,CHEMBL627779,1,BAO_0000218,,In vivo,,N,,,6757,Rattus norvegicus,50597,A,,1
,Cmax value in rats at 10 mg/kg,10116.0,Intermediate,,,8708,,CHEMBL876814,1,BAO_0000218,,In vivo,,N,,,17617,Rattus norvegicus,50597,A,,1
,Cmax value was evaluated in rats at a dose of 20 mg/kg,10116.0,Intermediate,,,8709,,CHEMBL627780,1,BAO_0000218,,In vivo,,N,,,1445,Rattus norvegicus,50597,A,,1
,Cmax value was determined after peroral administration of 20 mg/kg in rat,10116.0,Intermediate,,,8710,,CHEMBL627781,1,BAO_0000218,,In vivo,,N,,,6082,Rattus norvegicus,50597,A,,1
,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,10116.0,Intermediate,,,8711,,CHEMBL627782,1,BAO_0000218,,In vivo,,N,,,1446,Rattus norvegicus,50597,A,,1
,Compound was evaluated for its pharmacokinetic parameter maximum plasma concentration (Cmax) after oral administration to rats,10116.0,Intermediate,,,8712,1969.0,CHEMBL627783,1,BAO_0000218,,In vivo,,N,,Plasma,5407,Rattus norvegicus,50597,A,,1
,Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration,10116.0,Intermediate,,,8713,1969.0,CHEMBL627784,1,BAO_0000218,,In vivo,,N,,Plasma,2690,Rattus norvegicus,50597,A,,1
,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female wistar rats,10116.0,Intermediate,,,8714,,CHEMBL627785,1,BAO_0000218,,In vivo,,N,,,2661,Rattus norvegicus,50597,A,,1
,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to male wistar rats,10116.0,Intermediate,,,8715,,CHEMBL627786,1,BAO_0000218,,In vivo,,N,,,2661,Rattus norvegicus,50597,A,,1
,Compound was evaluated for pharmacokinetic parameter maximum plasma concentration,10116.0,Intermediate,,,8716,1969.0,CHEMBL627787,1,BAO_0000218,,In vivo,,N,,Plasma,4891,Rattus norvegicus,50597,A,,1
,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 0.5 hr,10116.0,Intermediate,,,8717,1969.0,CHEMBL627788,1,BAO_0000218,,In vivo,,N,,Plasma,2807,Rattus norvegicus,50597,A,,1
,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 1 hr,10116.0,Intermediate,,,8718,1969.0,CHEMBL626579,1,BAO_0000218,,In vivo,,N,,Plasma,2807,Rattus norvegicus,50597,A,,1
,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 2 hr,10116.0,Intermediate,,,8719,1969.0,CHEMBL626580,1,BAO_0000218,,In vivo,,N,,Plasma,2807,Rattus norvegicus,50597,A,,1
,Compound was evaluated for the pharmacokinetic property in rats after an oral dose of 10 mg/kg,10116.0,Intermediate,,,8720,,CHEMBL876815,1,BAO_0000218,,In vivo,,N,,,3634,Rattus norvegicus,50597,A,,1
,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 1 hr,10116.0,Intermediate,,,8721,1969.0,CHEMBL626581,1,BAO_0000218,,In vivo,,N,,Plasma,1881,Rattus norvegicus,50597,A,,1
,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 2 hr,10116.0,Intermediate,,,8722,1969.0,CHEMBL626582,1,BAO_0000218,,In vivo,,N,,Plasma,1881,Rattus norvegicus,50597,A,,1
,Evaluated for pharmacokinetic parameter Cmax in rat at the dose 50 mg/kg,10116.0,Intermediate,,,8723,,CHEMBL626583,1,BAO_0000218,,In vivo,,N,,,429,Rattus norvegicus,50597,A,,1
,In vivo Cmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,10116.0,Intermediate,,,8724,,CHEMBL626205,1,BAO_0000218,,In vivo,,N,,,5974,Rattus norvegicus,50597,A,,1
,In vivo Cmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,10116.0,Intermediate,,,8725,,CHEMBL626206,1,BAO_0000218,,In vivo,,N,,,5974,Rattus norvegicus,50597,A,,1
,In vivo Cmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,10116.0,Intermediate,,,8726,,CHEMBL626207,1,BAO_0000218,,In vivo,,N,,,5974,Rattus norvegicus,50597,A,,1
,In vivo Cmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,10116.0,Intermediate,,,8727,,CHEMBL623882,1,BAO_0000218,,In vivo,,N,,,5974,Rattus norvegicus,50597,A,,1
,Maximal concentration in male Sprague-Dawley rats after 5 mg/kg intravenous dose,10116.0,Intermediate,,,8728,,CHEMBL623883,1,BAO_0000218,,In vivo,,N,,,17582,Rattus norvegicus,50597,A,,1
,Maximal concentration in male Sprague-Dawley rats after 10 mg/kg oral dose,10116.0,Intermediate,,,8729,,CHEMBL623884,1,BAO_0000218,,In vivo,,N,,,17582,Rattus norvegicus,50597,A,,1
,"In vivo maximum concentration of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",10116.0,Intermediate,,,8730,1969.0,CHEMBL623885,1,BAO_0000218,,In vivo,,N,,Plasma,3032,Rattus norvegicus,50597,A,,1
,In vivo maximum concentration in rat plasma exposure after oral administration 50 mg/kg,10116.0,Intermediate,,,8731,1969.0,CHEMBL623886,1,BAO_0000218,,In vivo,,N,,Plasma,6295,Rattus norvegicus,50597,A,,1
,Maximal concentration in rat was determined,10116.0,Intermediate,,,8732,,CHEMBL623887,1,BAO_0000218,,In vivo,,N,,,6619,Rattus norvegicus,50597,A,,1
,Maximal concentration after i.v. administration,10116.0,Intermediate,,,8733,,CHEMBL623888,1,BAO_0000218,,In vivo,,N,,,6616,Rattus norvegicus,50597,A,,1
,Maximal concentration (Cmax) in the rat plasma at a dose of 10 mg/kg,10116.0,Intermediate,,,8734,1969.0,CHEMBL623889,1,BAO_0000218,,In vivo,,N,,Plasma,3249,Rattus norvegicus,50597,A,,1
,Maximal plasma concentration in rat after oral administration at 50 mg/kg,10116.0,Intermediate,,,8735,1969.0,CHEMBL623890,1,BAO_0000218,,In vivo,,N,,Plasma,17791,Rattus norvegicus,50597,A,,1
,Cmax in rat plasma after oral dose (50 mg/Kg),10116.0,Intermediate,,,8736,1969.0,CHEMBL623891,1,BAO_0000218,,In vivo,,N,,Plasma,17791,Rattus norvegicus,50597,A,,1
,Maximal plasma concentration was determined.,10116.0,Intermediate,,,8737,1969.0,CHEMBL623892,1,BAO_0000218,,In vivo,,N,,Plasma,1360,Rattus norvegicus,50597,A,,1
,Maximal plasma drug concentration was determined,10116.0,Intermediate,,,8738,1969.0,CHEMBL623893,1,BAO_0000218,,In vivo,,N,,Plasma,2552,Rattus norvegicus,50597,A,,1
,Maximal concentration in rats after peroral administration,10116.0,Intermediate,,,8739,,CHEMBL877616,1,BAO_0000218,,In vivo,,N,,,6571,Rattus norvegicus,50597,A,,1
,Maximum concentration in rat after 2 mg/kg peroral administration,10116.0,Intermediate,,,8740,,CHEMBL623894,1,BAO_0000218,,In vivo,,N,,,6570,Rattus norvegicus,50597,A,,1
,Maximum concentration in rat plasma after 5 mg/kg oral gavage,10116.0,Intermediate,,,8741,1969.0,CHEMBL623895,1,BAO_0000218,,In vivo,,N,,Plasma,6567,Rattus norvegicus,50597,A,,1
,Maximum concentration of compound in rat was evaluated.,10116.0,Intermediate,,,8742,,CHEMBL623896,1,BAO_0000218,,In vivo,,N,,,3031,Rattus norvegicus,50597,A,,1
,Maximum concentration at 0.5 hr by peroral administration at a dose of 20 mg/kg in rats,10116.0,Intermediate,,,8743,,CHEMBL623897,1,BAO_0000218,,In vivo,,N,,,3436,Rattus norvegicus,50597,A,,1
,Maximum concentration at 2 hr by peroral administration at a dose of 20 mg/kg in rats,10116.0,Intermediate,,,8744,,CHEMBL623898,1,BAO_0000218,,In vivo,,N,,,3436,Rattus norvegicus,50597,A,,1
,Maximum concentration at 4 hr after administration of 5 mg/kg dose peroral in rat,10116.0,Intermediate,,,8745,,CHEMBL623899,1,BAO_0000218,,In vivo,,N,,,2083,Rattus norvegicus,50597,A,,1
,Maximum concentration at 4 hr by peroral administration at a dose of 20 mg/kg in rats,10116.0,Intermediate,,,8746,,CHEMBL623900,1,BAO_0000218,,In vivo,,N,,,3436,Rattus norvegicus,50597,A,,1
,Maximum concentration by oral administration at a dose of 100 uM/kg in rat was determined,10116.0,Intermediate,,,8747,,CHEMBL623901,1,BAO_0000218,,In vivo,,N,,,4527,Rattus norvegicus,50597,A,,1
,Maximum concentration was evaluated in rats,10116.0,Intermediate,,,8748,,CHEMBL623902,1,BAO_0000218,,In vivo,,N,,,1974,Rattus norvegicus,50597,A,,1
,Maximum concentration in CSF at 30 min following 24 mg/kg subcutaneous dose in rats,10116.0,Intermediate,,,8749,1359.0,CHEMBL623903,1,BAO_0000218,,In vivo,,N,,Cerebrospinal fluid,3307,Rattus norvegicus,50597,A,,1
,Maximum concentration in plasma at 30 min following 24 mg/kg subcutaneous dose in rats,10116.0,Intermediate,,,8750,1969.0,CHEMBL623904,1,BAO_0000218,,In vivo,,N,,Plasma,3307,Rattus norvegicus,50597,A,,1
,Maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,10116.0,Intermediate,,,8751,1969.0,CHEMBL877617,1,BAO_0000218,,In vivo,,N,,Plasma,1916,Rattus norvegicus,50597,A,,1
,Maximum concentration in portal vein was determined at a concentration of 10 mg/kg in rats,10116.0,Intermediate,,,8752,,CHEMBL623905,1,BAO_0000218,,In vivo,,N,,,1500,Rattus norvegicus,50597,A,,1
,Maximum concentration in portal vein was determined at a concentration of 20 mg/kg in rats,10116.0,Intermediate,,,8753,,CHEMBL623906,1,BAO_0000218,,In vivo,,N,,,1500,Rattus norvegicus,50597,A,,1
,Maximum concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,10116.0,Intermediate,,,8754,1969.0,CHEMBL623907,1,BAO_0000218,,In vivo,,N,,Plasma,4186,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,10116.0,Intermediate,,,8755,,CHEMBL623908,1,BAO_0000218,,,,N,,,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 30 min.,10116.0,Intermediate,,,8756,,CHEMBL623909,1,BAO_0000218,,,,N,,,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,10116.0,Intermediate,,,8757,,CHEMBL623910,1,BAO_0000218,,,,N,,,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,10116.0,Intermediate,,,8758,,CHEMBL623911,1,BAO_0000218,,,,N,,,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,10116.0,Intermediate,,,8759,,CHEMBL623912,1,BAO_0000218,,,,N,,,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,10116.0,Intermediate,,,8760,,CHEMBL624616,1,BAO_0000218,,,,N,,,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,10116.0,Intermediate,,,8761,,CHEMBL624617,1,BAO_0000218,,,,N,,,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,10116.0,Intermediate,,,8762,,CHEMBL624618,1,BAO_0000218,,,,N,,,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,10116.0,Intermediate,,,8763,,CHEMBL624619,1,BAO_0000218,,,,N,,,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,10116.0,Intermediate,,,8764,,CHEMBL624794,1,BAO_0000218,,,,N,,,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,10116.0,Intermediate,,,8765,,CHEMBL624795,1,BAO_0000218,,,,N,,,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,10116.0,Intermediate,,,8766,,CHEMBL623921,1,BAO_0000218,,,,N,,,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,10116.0,Intermediate,,,8767,,CHEMBL623922,1,BAO_0000218,,,,N,,,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,10116.0,Intermediate,,,8768,,CHEMBL623923,1,BAO_0000218,,,,N,,,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,10116.0,Intermediate,,,8769,,CHEMBL623924,1,BAO_0000218,,,,N,,,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,10116.0,Intermediate,,,8770,,CHEMBL623925,1,BAO_0000218,,,,N,,,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,10116.0,Intermediate,,,8771,,CHEMBL623926,1,BAO_0000218,,,,N,,,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,10116.0,Intermediate,,,8772,,CHEMBL623927,1,BAO_0000218,,,,N,,,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,10116.0,Intermediate,,,8773,,CHEMBL623928,1,BAO_0000218,,,,N,,,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,10116.0,Intermediate,,,8774,,CHEMBL623929,1,BAO_0000218,,,,N,,,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,10116.0,Intermediate,,,8775,,CHEMBL623930,1,BAO_0000218,,,,N,,,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,10116.0,Intermediate,,,8776,955.0,CHEMBL623931,1,BAO_0000218,,,,N,,Brain,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,10116.0,Intermediate,,,8777,955.0,CHEMBL622165,1,BAO_0000218,,,,N,,Brain,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,10116.0,Intermediate,,,8778,955.0,CHEMBL621249,1,BAO_0000218,,,,N,,Brain,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,10116.0,Intermediate,,,8779,955.0,CHEMBL621250,1,BAO_0000218,,,,N,,Brain,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,10116.0,Intermediate,,,8780,955.0,CHEMBL621448,1,BAO_0000218,,,,N,,Brain,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,10116.0,Intermediate,,,8781,955.0,CHEMBL621449,1,BAO_0000218,,,,N,,Brain,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,10116.0,Intermediate,,,8782,955.0,CHEMBL621450,1,BAO_0000218,,,,N,,Brain,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,10116.0,Intermediate,,,8783,955.0,CHEMBL621451,1,BAO_0000218,,,,N,,Brain,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,10116.0,Intermediate,,,8784,955.0,CHEMBL621452,1,BAO_0000218,,,,N,,Brain,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,10116.0,Intermediate,,,8785,955.0,CHEMBL621453,1,BAO_0000218,,,,N,,Brain,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,10116.0,Intermediate,,,8786,955.0,CHEMBL621454,1,BAO_0000218,,,,N,,Brain,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,10116.0,Intermediate,,,8787,955.0,CHEMBL621455,1,BAO_0000218,,,,N,,Brain,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,10116.0,Intermediate,,,8788,955.0,CHEMBL621456,1,BAO_0000218,,,,N,,Brain,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,10116.0,Intermediate,,,8789,955.0,CHEMBL625145,1,BAO_0000218,,,,N,,Brain,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,10116.0,Intermediate,,,8790,955.0,CHEMBL875847,1,BAO_0000218,,,,N,,Brain,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,10116.0,Intermediate,,,8791,955.0,CHEMBL625146,1,BAO_0000218,,,,N,,Brain,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,10116.0,Intermediate,,,8792,955.0,CHEMBL625147,1,BAO_0000218,,,,N,,Brain,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,10116.0,Intermediate,,,8793,955.0,CHEMBL625148,1,BAO_0000218,,,,N,,Brain,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,10116.0,Intermediate,,,8794,955.0,CHEMBL625149,1,BAO_0000218,,,,N,,Brain,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,10116.0,Intermediate,,,8795,955.0,CHEMBL625150,1,BAO_0000218,,,,N,,Brain,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,10116.0,Intermediate,,,8796,955.0,CHEMBL625151,1,BAO_0000218,,,,N,,Brain,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,10116.0,Intermediate,,,8797,955.0,CHEMBL625152,1,BAO_0000218,,,,N,,Brain,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,10116.0,Intermediate,,,8798,955.0,CHEMBL625153,1,BAO_0000218,,,,N,,Brain,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,10116.0,Intermediate,,,8799,955.0,CHEMBL625154,1,BAO_0000218,,,,N,,Brain,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,10116.0,Intermediate,,,8800,955.0,CHEMBL625155,1,BAO_0000218,,,,N,,Brain,16435,Rattus norvegicus,50597,A,,1
,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 30 minutes after an intravenous injection is given (average of 2 rats),10116.0,Intermediate,,,8801,,CHEMBL625156,1,BAO_0000218,,,,N,,,11977,Rattus norvegicus,50597,A,,1
,Uptake of radioligand [125I]-FIDA1 by hippo-campus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,8802,,CHEMBL624354,1,BAO_0000218,,,,N,,,11977,Rattus norvegicus,50597,A,,1
,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,8803,10000000.0,CHEMBL624355,1,BAO_0000218,,,,N,,Hippocampus,11977,Rattus norvegicus,50597,A,,1
,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,8804,10000000.0,CHEMBL624356,1,BAO_0000218,,,,N,,Hippocampus,11977,Rattus norvegicus,50597,A,,1
,Uptake of radioligand [125I]-FIDA1 by hippocampus in rat after 30 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,8805,10000000.0,CHEMBL624357,1,BAO_0000218,,,,N,,Hippocampus,11977,Rattus norvegicus,50597,A,,1
,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,8806,10000000.0,CHEMBL624358,1,BAO_0000218,,,,N,,Hippocampus,11977,Rattus norvegicus,50597,A,,1
,Uptake of radioligand [125I]FIDA1 by striatum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,8807,2435.0,CHEMBL624359,1,BAO_0000218,,,,N,,Striatum,11977,Rattus norvegicus,50597,A,,1
,Uptake of radioligand [125I]FIDA1 by striatum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,8808,2435.0,CHEMBL624360,1,BAO_0000218,,,,N,,Striatum,11977,Rattus norvegicus,50597,A,,1
,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),10116.0,Intermediate,,,8809,2435.0,CHEMBL624361,1,BAO_0000218,,,,N,,Striatum,11977,Rattus norvegicus,50597,A,,1
,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,8810,2435.0,CHEMBL624362,1,BAO_0000218,,,,N,,Striatum,11977,Rattus norvegicus,50597,A,,1
,Uptake of radioligand [125I]FIDA1 by striatum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,8811,2435.0,CHEMBL624363,1,BAO_0000218,,,,N,,Striatum,11977,Rattus norvegicus,50597,A,,1
,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 120 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,8812,178.0,CHEMBL624364,1,BAO_0000218,,In vivo,,N,,Blood,11977,Rattus norvegicus,50597,A,,1
,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 2 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,8813,178.0,CHEMBL624365,1,BAO_0000218,,In vivo,,N,,Blood,11977,Rattus norvegicus,50597,A,,1
,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 30 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,8814,178.0,CHEMBL624366,1,BAO_0000218,,In vivo,,N,,Blood,11977,Rattus norvegicus,50597,A,,1
,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 60 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,8815,178.0,CHEMBL624367,1,BAO_0000218,,In vivo,,N,,Blood,11977,Rattus norvegicus,50597,A,,1
,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 120 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,8816,955.0,CHEMBL624368,1,BAO_0000218,,In vivo,,N,,Brain,11977,Rattus norvegicus,50597,A,,1
,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 2 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,8817,955.0,CHEMBL624369,1,BAO_0000218,,In vivo,,N,,Brain,11977,Rattus norvegicus,50597,A,,1
,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 2 rats),10116.0,Intermediate,,,8818,955.0,CHEMBL624370,1,BAO_0000218,,In vivo,,N,,Brain,11977,Rattus norvegicus,50597,A,,1
,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,8819,955.0,CHEMBL625069,1,BAO_0000218,,In vivo,,N,,Brain,11977,Rattus norvegicus,50597,A,,1
,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 60 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,8820,955.0,CHEMBL625070,1,BAO_0000218,,In vivo,,N,,Brain,11977,Rattus norvegicus,50597,A,,1
,Biodistribution of radioligand [125I]-FIDA1 in heart of rat after 120 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,8821,948.0,CHEMBL626051,1,BAO_0000218,,In vivo,,N,,Heart,11977,Rattus norvegicus,50597,A,,1
,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 2 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,8822,948.0,CHEMBL626052,1,BAO_0000218,,In vivo,,N,,Heart,11977,Rattus norvegicus,50597,A,,1
,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 2 rats),10116.0,Intermediate,,,8823,948.0,CHEMBL626053,1,BAO_0000218,,In vivo,,N,,Heart,11977,Rattus norvegicus,50597,A,,1
,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,8824,948.0,CHEMBL626054,1,BAO_0000218,,In vivo,,N,,Heart,11977,Rattus norvegicus,50597,A,,1
,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 60 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,8825,948.0,CHEMBL626055,1,BAO_0000218,,In vivo,,N,,Heart,11977,Rattus norvegicus,50597,A,,1
,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 120 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,8826,2113.0,CHEMBL626056,1,BAO_0000218,,In vivo,,N,,Kidney,11977,Rattus norvegicus,50597,A,,1
,Biodistribution of radioligand [125I]-FIDA1 in kidney of rat after 2 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,8827,2113.0,CHEMBL626057,1,BAO_0000218,,In vivo,,N,,Kidney,11977,Rattus norvegicus,50597,A,,1
,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 30 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,8828,2113.0,CHEMBL625193,1,BAO_0000218,,In vivo,,N,,Kidney,11977,Rattus norvegicus,50597,A,,1
,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 60 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,8829,2113.0,CHEMBL625194,1,BAO_0000218,,In vivo,,N,,Kidney,11977,Rattus norvegicus,50597,A,,1
,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 120 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,8830,2107.0,CHEMBL625195,1,BAO_0000218,,In vivo,,N,,Liver,11977,Rattus norvegicus,50597,A,,1
,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,8831,2107.0,CHEMBL625196,1,BAO_0000218,,In vivo,,N,,Liver,11977,Rattus norvegicus,50597,A,,1
,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 2 rats),10116.0,Intermediate,,,8832,2107.0,CHEMBL625197,1,BAO_0000218,,In vivo,,N,,Liver,11977,Rattus norvegicus,50597,A,,1
,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,8833,2107.0,CHEMBL625198,1,BAO_0000218,,In vivo,,N,,Liver,11977,Rattus norvegicus,50597,A,,1
,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 60 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,8834,2107.0,CHEMBL627929,1,BAO_0000218,,In vivo,,N,,Liver,11977,Rattus norvegicus,50597,A,,1
,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 120 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,8835,2048.0,CHEMBL627074,1,BAO_0000218,,In vivo,,N,,Lung,11977,Rattus norvegicus,50597,A,,1
,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 2 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,8836,2048.0,CHEMBL627075,1,BAO_0000218,,In vivo,,N,,Lung,11977,Rattus norvegicus,50597,A,,1
,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 2 rats),10116.0,Intermediate,,,8837,2048.0,CHEMBL627076,1,BAO_0000218,,In vivo,,N,,Lung,11977,Rattus norvegicus,50597,A,,1
,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,8838,2048.0,CHEMBL627077,1,BAO_0000218,,In vivo,,N,,Lung,11977,Rattus norvegicus,50597,A,,1
,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 60 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,8839,2048.0,CHEMBL627078,1,BAO_0000218,,In vivo,,N,,Lung,11977,Rattus norvegicus,50597,A,,1
,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 2 rats),10116.0,Intermediate,,,8840,2385.0,CHEMBL627079,1,BAO_0000218,,In vivo,,N,,Muscle tissue,11977,Rattus norvegicus,50597,A,,1
,Half life (t1/2) determined at a dose 10 mg/kg administered intraperitoneally to mice,10090.0,Intermediate,,,8841,,CHEMBL873824,1,BAO_0000218,,In vivo,,N,,,4573,Mus musculus,50594,A,,1
,Half life in mouse plasma was determined at dose 25 mg/kg,10090.0,Intermediate,,,8842,1969.0,CHEMBL627080,1,BAO_0000218,,In vivo,,N,,Plasma,3132,Mus musculus,50594,A,,1
,Half life was determined,10090.0,Intermediate,,,8843,,CHEMBL627081,1,BAO_0000218,,,,N,,,17718,Mus musculus,50594,A,,1
,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,10090.0,Intermediate,,,8844,,CHEMBL627082,1,BAO_0000218,,In vivo,,N,,,17728,Mus musculus,50594,A,,1
,Half-life in male mice after 1 mg/kg intravenous dose,10090.0,Intermediate,,,8845,,CHEMBL627083,1,BAO_0000218,,In vivo,,N,,,5961,Mus musculus,50594,A,,1
,Half life in mice plasma,10090.0,Intermediate,,,8847,1969.0,CHEMBL627085,1,BAO_0000218,,,,N,,Plasma,17731,Mus musculus,50594,A,,1
,Half life in mouse,10090.0,Intermediate,,,8848,,CHEMBL627086,1,BAO_0000218,,,,N,,,17592,Mus musculus,50594,A,,1
,Half life in mouse plasma at dose 25 mg/kg,10090.0,Intermediate,,,8849,1969.0,CHEMBL627087,1,BAO_0000218,,In vivo,,N,,Plasma,3132,Mus musculus,50594,A,,1
,Half life when injected i.p. in mice at a dose of 50 mg/kg was determined,10090.0,Intermediate,,,8850,,CHEMBL627088,1,BAO_0000218,,In vivo,,N,,,17729,Mus musculus,50594,A,,1
,Half life when injected intravenously in mice at a dose of 20 mg/kg was determined,10090.0,Intermediate,,,8851,,CHEMBL627089,1,BAO_0000218,,In vivo,,N,,,17729,Mus musculus,50594,A,,1
,Half life when injected perorally in mice at a dose of 50 mg/kg was determined,10090.0,Intermediate,,,8852,,CHEMBL627090,1,BAO_0000218,,In vivo,,N,,,17729,Mus musculus,50594,A,,1
,Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),10090.0,Intermediate,,,8853,,CHEMBL627091,1,BAO_0000218,,In vivo,,N,,,3277,Mus musculus,50594,A,,1
,"Half life was evaluated at 5 mg/kg of compound dose, administered perorally in mice",10090.0,Intermediate,,,8854,,CHEMBL627092,1,BAO_0000218,,In vivo,,N,,,3760,Mus musculus,50594,A,,1
,"Half life was evaluated at 50 mg/kg of compound dose, administered perorally in mice",10090.0,Intermediate,,,8855,,CHEMBL876785,1,BAO_0000218,,In vivo,,N,,,3760,Mus musculus,50594,A,,1
,Half-life by iv administration in mouse,10090.0,Intermediate,,,8856,,CHEMBL627093,1,BAO_0000218,,In vivo,,N,,,2862,Mus musculus,50594,A,,1
,Half-life by oral administration in mouse,10090.0,Intermediate,,,8857,,CHEMBL627094,1,BAO_0000218,,In vivo,,N,,,2862,Mus musculus,50594,A,,1
,Half-life in mice,10090.0,Intermediate,,,8858,,CHEMBL627095,1,BAO_0000218,,,,N,,,5980,Mus musculus,50594,A,,1
,Half-life using mouse brain homogenate,10090.0,Intermediate,,,8859,955.0,CHEMBL627096,1,BAO_0000218,,,,N,,Brain,6159,Mus musculus,50594,A,,1
,Half-life was measured in mice,10090.0,Intermediate,,,8860,,CHEMBL627097,1,BAO_0000218,,,,N,,,6254,Mus musculus,50594,A,,1
,Half-life was measured in mouse after an iv dose of 1 mg/kg,10090.0,Intermediate,,,8861,,CHEMBL627098,1,BAO_0000218,,In vivo,,N,,,6062,Mus musculus,50594,A,,1
,Half-life period was determined in mouse blood,10090.0,Intermediate,,,8862,178.0,CHEMBL627099,1,BAO_0000218,,,,N,,Blood,1574,Mus musculus,50594,A,,1
,"Half-times of inhibition of PEP in in an ex vivo enzyme studies, using mice brain",10090.0,Intermediate,,,8863,955.0,CHEMBL627100,1,BAO_0000218,,,,N,,Brain,56,Mus musculus,50594,A,,1
,Plasma half life in mouse,10090.0,Intermediate,,,8864,1969.0,CHEMBL627101,1,BAO_0000218,,,,N,,Plasma,993,Mus musculus,50594,A,,1
,Stability of the peptide in the presence of mouse serum,10090.0,Intermediate,,,8865,,CHEMBL627102,1,BAO_0000218,,,,N,,,6652,Mus musculus,50594,A,,1
,Terminal half life of compound was determined in mouse,10090.0,Intermediate,,,8866,,CHEMBL627103,1,BAO_0000218,,,,N,,,17852,Mus musculus,50594,A,,1
,Terminal half life was evaluated in mice after intravenous administration,10090.0,Intermediate,,,8867,,CHEMBL627104,1,BAO_0000218,,In vivo,,N,,,2675,Mus musculus,50594,A,,1
,Terminal half life was evaluated in mice after oral administration,10090.0,Intermediate,,,8868,,CHEMBL627105,1,BAO_0000218,,In vivo,,N,,,2675,Mus musculus,50594,A,,1
,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 5.,10090.0,Intermediate,,,8869,,CHEMBL876786,1,BAO_0000218,,,,N,,,499,Mus musculus,50594,A,,1
,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7.,10090.0,Intermediate,,,8870,,CHEMBL873825,1,BAO_0000218,,,,N,,,499,Mus musculus,50594,A,,1
,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7; ND means no data,10090.0,Intermediate,,,8871,,CHEMBL627106,1,BAO_0000218,,,,N,,,499,Mus musculus,50594,A,,1
,half life period is evaluated by administering intravenously at 25 mg/kg in mice,10090.0,Intermediate,,,8872,,CHEMBL626336,1,BAO_0000218,,In vivo,,N,,,14239,Mus musculus,50594,A,,1
,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice",10090.0,Intermediate,,,8873,,CHEMBL877462,1,BAO_0000218,,In vivo,,N,,,5506,Mus musculus,50594,A,,1
,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice; NC: not calculable",10090.0,Intermediate,,,8874,,CHEMBL626337,1,BAO_0000218,,In vivo,,N,,,5506,Mus musculus,50594,A,,1
,Half life after intraperitoneal administration of 100 mg/kg in mice,10090.0,Intermediate,,,8875,,CHEMBL626338,1,BAO_0000218,,,,N,,,17734,Mus musculus,50594,A,,1
,Half life in BALB/C mice at the dose of 20 mg/kg by i.p. administration,10090.0,Intermediate,,,8876,,CHEMBL626339,1,BAO_0000218,,In vivo,,N,,,17728,Mus musculus,50594,A,,1
,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,10090.0,Intermediate,,,8877,,CHEMBL626340,1,BAO_0000218,,In vivo,,N,,,17728,Mus musculus,50594,A,,1
,Half life in BALB/C mice at the dose of 20 mg/kg by p.o. administration,10090.0,Intermediate,,,8878,,CHEMBL625377,1,BAO_0000218,,In vivo,,N,,,17728,Mus musculus,50594,A,,1
,Half life in BALB/C mice at the dose of 50 mg/kg by i.p. administration,10090.0,Intermediate,,,8879,,CHEMBL625378,1,BAO_0000218,,In vivo,,N,,,17728,Mus musculus,50594,A,,1
,Half life in BALB/C mice at the dose of 50 mg/kg by p.o. administration,10090.0,Intermediate,,,8880,,CHEMBL625379,1,BAO_0000218,,In vivo,,N,,,17728,Mus musculus,50594,A,,1
,Metabolism of compound in mini pig S9 microsomes ('+''indicates <20% largest observed peak),9823.0,Autocuration,,Microsomes,8881,,CHEMBL625380,1,BAO_0000251,,,,U,,,14294,Sus scrofa,22224,A,,0
,Metabolism of compound in mini pig S9 microsomes ('++++' indicates largest observed peak),9823.0,Autocuration,,Microsomes,8882,,CHEMBL625381,1,BAO_0000251,,,,U,,,14294,Sus scrofa,22224,A,,0
,Stability to porcine renal DHP-I,9823.0,Autocuration,,,8883,,CHEMBL625382,1,BAO_0000019,,,,U,,,6056,Sus scrofa,22224,A,,0
,Compound was tested for its half-life period at an intravenous dose of 30 ug/kg,9823.0,Autocuration,,,8884,,CHEMBL873828,1,BAO_0000218,,In vivo,,U,,,1317,Sus scrofa,22224,A,,0
,Compound was tested for its half-life period at an intravenous dose of 3 ug/kg,9823.0,Autocuration,,,8885,,CHEMBL625383,1,BAO_0000218,,In vivo,,U,,,1317,Sus scrofa,22224,A,,0
,Half-life of the parent prodrug in porcine esterase solution,9823.0,Autocuration,,,8886,,CHEMBL625384,1,BAO_0000019,,,,U,,,5229,Sus scrofa,22224,A,,0
,"First order rate constant, k was determined in in pig liver Esterase",9823.0,Autocuration,,,8887,,CHEMBL625385,1,BAO_0000019,,,,U,,,4231,Sus scrofa,22224,A,,0
,Half life of the in pig liver Esterase,9823.0,Autocuration,,,8888,2107.0,CHEMBL625386,1,BAO_0000221,,,,U,,Liver,4231,Sus scrofa,22224,A,,0
,Tested for half life period at 37 degree Celsius in PBS buffer at 11.8 pH containing porcine liver esterase,9823.0,Autocuration,,,8889,2107.0,CHEMBL623571,1,BAO_0000221,,,,U,,Liver,5318,Sus scrofa,22224,A,,0
,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH containing porcine liver esterase,9823.0,Autocuration,,,8890,2107.0,CHEMBL623572,1,BAO_0000221,,,,U,,Liver,5318,Sus scrofa,22224,A,,0
,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH in containing porcine liver esterase,9823.0,Autocuration,,,8891,2107.0,CHEMBL623573,1,BAO_0000221,,,,U,,Liver,5318,Sus scrofa,22224,A,,0
,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay,9823.0,Autocuration,,,8892,2107.0,CHEMBL623574,1,BAO_0000221,,,,U,,Liver,3305,Sus scrofa,22224,A,,0
,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay; ND is not determined,9823.0,Autocuration,,,8893,2107.0,CHEMBL623575,1,BAO_0000221,,,,U,,Liver,3305,Sus scrofa,22224,A,,0
,Half-life in the presence of pig liver esterase(PLE) was evaluated.,9823.0,Autocuration,,,8894,2107.0,CHEMBL623749,1,BAO_0000221,,,,U,,Liver,2842,Sus scrofa,22224,A,,0
,Half-life in the presence of pig liver esterase(PLE) was evaluated; Stable,9823.0,Autocuration,,,8895,2107.0,CHEMBL623750,1,BAO_0000221,,,,U,,Liver,2842,Sus scrofa,22224,A,,0
,Half-life in vitro in pig liver,9823.0,Autocuration,,,8896,2107.0,CHEMBL623751,1,BAO_0000221,,In vitro,,U,,Liver,889,Sus scrofa,22224,A,,0
,Half-life time was determined for esterase-catalyzed hydrolysis of the phenol ester bond in porcine liver esterase,9823.0,Autocuration,,,8897,2107.0,CHEMBL623752,1,BAO_0000221,,,,U,,Liver,1904,Sus scrofa,22224,A,,0
,Maximum concentration in rat plasma after administration of 50 mg/kg dose through subcutaneous route,10116.0,Intermediate,,,8898,1969.0,CHEMBL623753,1,BAO_0000218,,In vivo,,N,,Plasma,4186,Rattus norvegicus,50597,A,,1
,Maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,10116.0,Intermediate,,,8899,1969.0,CHEMBL623754,1,BAO_0000218,,In vivo,,N,,Plasma,2774,Rattus norvegicus,50597,A,,1
,Maximum concentration in rat plasma was determined,10116.0,Intermediate,,,8900,1969.0,CHEMBL623755,1,BAO_0000218,,In vivo,,N,,Plasma,1742,Rattus norvegicus,50597,A,,1
,Maximum concentration in rats,10116.0,Intermediate,,,8901,,CHEMBL623756,1,BAO_0000218,,In vivo,,N,,,3169,Rattus norvegicus,50597,A,,1
,Maximum concentration in rats at 1-2 hours,10116.0,Intermediate,,,8902,,CHEMBL623757,1,BAO_0000218,,In vivo,,N,,,3169,Rattus norvegicus,50597,A,,1
,Maximum concentration in rats at 1 hr was determined when dosed at 20 mg/Kg perorally,10116.0,Intermediate,,,8903,,CHEMBL623758,1,BAO_0000218,,In vivo,,N,,,2081,Rattus norvegicus,50597,A,,1
,Maximum concentration in whole brain at 30 min following 24 mg/kg subcutaneous dose in rats,10116.0,Intermediate,,,8904,955.0,CHEMBL623759,1,BAO_0000218,,In vivo,,N,,Brain,3307,Rattus norvegicus,50597,A,,1
,Maximum concentration at the dose of 2 mg/kg in rat,10116.0,Intermediate,,,8905,,CHEMBL623760,1,BAO_0000218,,In vivo,,N,,,4727,Rattus norvegicus,50597,A,,1
,Maximum concentration was evaluated in rats,10116.0,Intermediate,,,8906,,CHEMBL623761,1,BAO_0000218,,In vivo,,N,,,6597,Rattus norvegicus,50597,A,,1
,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 10 mg/kg to a fasting rat,10116.0,Intermediate,,,8907,1969.0,CHEMBL623762,1,BAO_0000218,,In vivo,,N,,Plasma,16365,Rattus norvegicus,50597,A,,1
,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 1 mg/kg to a fasting rat,10116.0,Intermediate,,,8908,1969.0,CHEMBL877594,1,BAO_0000218,,In vivo,,N,,Plasma,16365,Rattus norvegicus,50597,A,,1
,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 30 mg/kg,10116.0,Intermediate,,,8909,1969.0,CHEMBL623763,1,BAO_0000218,,In vivo,,N,,Plasma,16365,Rattus norvegicus,50597,A,,1
,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg,10116.0,Intermediate,,,8910,1969.0,CHEMBL623764,1,BAO_0000218,,In vivo,,N,,Plasma,16365,Rattus norvegicus,50597,A,,1
,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg to a fasting rat,10116.0,Intermediate,,,8911,1969.0,CHEMBL623765,1,BAO_0000218,,In vivo,,N,,Plasma,16365,Rattus norvegicus,50597,A,,1
,Maximum concentration value was evaluated for high sustained blood levels in rat after 1 hr of administration,10116.0,Intermediate,,,8912,178.0,CHEMBL623766,1,BAO_0000218,,In vivo,,N,,Blood,2591,Rattus norvegicus,50597,A,,1
,Maximum concentration value was evaluated for high sustained blood levels in rat after 2 hr of administration,10116.0,Intermediate,,,8913,178.0,CHEMBL623767,1,BAO_0000218,,In vivo,,N,,Blood,2591,Rattus norvegicus,50597,A,,1
,Maximum concentration value was evaluated for high sustained blood levels in rat after 30 min of administration,10116.0,Intermediate,,,8914,178.0,CHEMBL623768,1,BAO_0000218,,In vivo,,N,,Blood,2591,Rattus norvegicus,50597,A,,1
,Maximum plasma concentration (Cmax) of compound (19.2 mg/kg) after po administration was determined Sprague-Dawley rat,10116.0,Intermediate,,,8915,1969.0,CHEMBL623769,1,BAO_0000218,,In vivo,,N,,Plasma,5978,Rattus norvegicus,50597,A,,1
,Maximum plasma concentration (Cmax) of compound (19.76 mg/kg) after po administration was determined Sprague-Dawley rat,10116.0,Intermediate,,,8916,1969.0,CHEMBL623770,1,BAO_0000218,,In vivo,,N,,Plasma,5978,Rattus norvegicus,50597,A,,1
,Maximum plasma concentration (Cmax) of compound (20.73 mg/kg) after po administration was determined Sprague-Dawley rat,10116.0,Intermediate,,,8917,1969.0,CHEMBL623771,1,BAO_0000218,,In vivo,,N,,Plasma,5978,Rattus norvegicus,50597,A,,1
,Maximum plasma concentration (Cmax) of compound (25 mg/kg) after po administration was determined Sprague-Dawley rat,10116.0,Intermediate,,,8918,1969.0,CHEMBL623772,1,BAO_0000218,,In vivo,,N,,Plasma,5978,Rattus norvegicus,50597,A,,1
,Maximum plasma concentration (Cmax) of compound (9.83 mg/kg) after iv administration was determined Sprague-Dawley rat,10116.0,Intermediate,,,8919,1969.0,CHEMBL623773,1,BAO_0000218,,In vivo,,N,,Plasma,5978,Rattus norvegicus,50597,A,,1
,Maximum plasma concentration (Cmax) of compound (9.84 mg/kg) after iv administration was determined Sprague-Dawley rat,10116.0,Intermediate,,,8920,1969.0,CHEMBL623774,1,BAO_0000218,,In vivo,,N,,Plasma,5978,Rattus norvegicus,50597,A,,1
,Maximum plasma concentration (Cmax) of compound (9.92 mg/kg) after iv administration was determined Sprague-Dawley rat,10116.0,Intermediate,,,8921,1969.0,CHEMBL623775,1,BAO_0000218,,In vivo,,N,,Plasma,5978,Rattus norvegicus,50597,A,,1
,Cmax in rat (PO dose),10116.0,Intermediate,,,8922,,CHEMBL623776,1,BAO_0000218,,In vivo,,N,,,14465,Rattus norvegicus,50597,A,,1
,Maximum plasma concentration determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,10116.0,Intermediate,,,8923,1969.0,CHEMBL622191,1,BAO_0000218,,In vivo,,N,,Plasma,4723,Rattus norvegicus,50597,A,,1
,Maximum plasma concentration determined after 3 mg/kg oral administration in potassium oxonate treated rats,10116.0,Intermediate,,,8924,1969.0,CHEMBL622192,1,BAO_0000218,,In vivo,,N,,Plasma,4723,Rattus norvegicus,50597,A,,1
,Maximum plasma concentration determined in rat,10116.0,Intermediate,,,8925,1969.0,CHEMBL622193,1,BAO_0000218,,In vivo,,N,,Plasma,4576,Rattus norvegicus,50597,A,,1
,Maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,10116.0,Intermediate,,,8926,1969.0,CHEMBL622194,1,BAO_0000218,,In vivo,,N,,Plasma,12873,Rattus norvegicus,50597,A,,1
,Maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,10116.0,Intermediate,,,8927,1969.0,CHEMBL622195,1,BAO_0000218,,In vivo,,N,,Plasma,12873,Rattus norvegicus,50597,A,,1
,Maximum plasma concentration in rat,10116.0,Intermediate,,,8928,1969.0,CHEMBL622196,1,BAO_0000218,,In vivo,,N,,Plasma,6824,Rattus norvegicus,50597,A,,1
,Maximum plasma concentration measured after intravenous bolus administration of 50 mg/kg of compound to rats,10116.0,Intermediate,,,8929,1969.0,CHEMBL622197,1,BAO_0000218,,In vivo,,N,,Plasma,17065,Rattus norvegicus,50597,A,,1
,Maximum plasma concentration of compound present in rats at the dose of 37 mg/kg in 15 min,10116.0,Intermediate,,,8930,1969.0,CHEMBL622198,1,BAO_0000218,,In vivo,,N,,Plasma,2932,Rattus norvegicus,50597,A,,1
,Maximum plasma concentration of compound present in rats at the dose of 38 mg/kg in 15 min,10116.0,Intermediate,,,8931,1969.0,CHEMBL622199,1,BAO_0000218,,In vivo,,N,,Plasma,2932,Rattus norvegicus,50597,A,,1
,Maximum plasma concentration of compound was measured in rat,10116.0,Intermediate,,,8932,1969.0,CHEMBL622200,1,BAO_0000218,,In vivo,,N,,Plasma,2879,Rattus norvegicus,50597,A,,1
,Maximum plasma concentration after 20 mg/kg oral administration in rat,10116.0,Intermediate,,,8933,1969.0,CHEMBL622201,1,BAO_0000218,,In vivo,,N,,Plasma,2864,Rattus norvegicus,50597,A,,1
,Maximum plasma concentration after oral administration to rats,10116.0,Intermediate,,,8934,1969.0,CHEMBL623990,1,BAO_0000218,,In vivo,,N,,Plasma,16367,Rattus norvegicus,50597,A,,1
,Maximum plasma concentration at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,10116.0,Intermediate,,,8935,1969.0,CHEMBL623991,1,BAO_0000218,,In vivo,,N,,Plasma,17717,Rattus norvegicus,50597,A,,1
,"Maximum plasma concentration at a concentration of 3 mg/kg in rats, intravenously",10116.0,Intermediate,,,8936,1969.0,CHEMBL623992,1,BAO_0000218,,In vivo,,N,,Plasma,17717,Rattus norvegicus,50597,A,,1
,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,10116.0,Intermediate,,,8937,1969.0,CHEMBL623993,1,BAO_0000218,,In vivo,,N,,Plasma,17717,Rattus norvegicus,50597,A,,1
,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with control,10116.0,Intermediate,,,8938,1969.0,CHEMBL623994,1,BAO_0000218,,In vivo,,N,,Plasma,17717,Rattus norvegicus,50597,A,,1
,Maximum plasma concentration at a dose of 100 mg/kg in Rat Plasma after iv administration,10116.0,Intermediate,,,8939,1969.0,CHEMBL623995,1,BAO_0000218,,In vivo,,N,,Plasma,17720,Rattus norvegicus,50597,F,,1
,Maximum plasma concentration at a dose of 4 mg/kg in Rat Plasma after iv administration,10116.0,Intermediate,,,8940,1969.0,CHEMBL623996,1,BAO_0000218,,In vivo,,N,,Plasma,17720,Rattus norvegicus,50597,F,,1
,Maximum plasma concentration at a dose of 50 mg/kg in Rat Plasma after iv administration,10116.0,Intermediate,,,8941,1969.0,CHEMBL623997,1,BAO_0000218,,In vivo,,N,,Plasma,17720,Rattus norvegicus,50597,F,,1
,Maximum plasma concentration dosed orally in rats,10116.0,Intermediate,,,8942,1969.0,CHEMBL623998,1,BAO_0000218,,In vivo,,N,,Plasma,4516,Rattus norvegicus,50597,A,,1
,Maximum plasma concentration dosed orally in rats after 6 hours,10116.0,Intermediate,,,8943,1969.0,CHEMBL623999,1,BAO_0000218,,In vivo,,N,,Plasma,4516,Rattus norvegicus,50597,A,,1
,Maximum plasma concentration dosed orally in rats after 6 hours; ND is not detected,10116.0,Intermediate,,,8944,1969.0,CHEMBL624000,1,BAO_0000218,,In vivo,,N,,Plasma,4516,Rattus norvegicus,50597,A,,1
,Maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,10116.0,Intermediate,,,8945,1969.0,CHEMBL624001,1,BAO_0000218,,In vivo,,N,,Plasma,5199,Rattus norvegicus,50597,A,,1
,Maximum plasma concentration in rat after po administration,10116.0,Intermediate,,,8946,1969.0,CHEMBL624002,1,BAO_0000218,,In vivo,,N,,Plasma,17538,Rattus norvegicus,50597,A,,1
,"Maximum plasma concentration in rats at 10 mg/kg, p.o. dose",10116.0,Intermediate,,,8947,1969.0,CHEMBL624003,1,BAO_0000218,,In vivo,,N,,Plasma,6685,Rattus norvegicus,50597,A,,1
,"Maximum plasma concentration in rats at 20mg/kg, i.p. dose",10116.0,Intermediate,,,8948,1969.0,CHEMBL624004,1,BAO_0000218,,In vivo,,N,,Plasma,6685,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,10116.0,Intermediate,,,8949,948.0,CHEMBL624005,1,BAO_0000218,,,,N,,Heart,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,10116.0,Intermediate,,,8950,948.0,CHEMBL624006,1,BAO_0000218,,,,N,,Heart,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,10116.0,Intermediate,,,8951,948.0,CHEMBL624007,1,BAO_0000218,,,,N,,Heart,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,10116.0,Intermediate,,,8952,948.0,CHEMBL624008,1,BAO_0000218,,,,N,,Heart,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,10116.0,Intermediate,,,8953,948.0,CHEMBL624009,1,BAO_0000218,,,,N,,Heart,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,10116.0,Intermediate,,,8954,948.0,CHEMBL874387,1,BAO_0000218,,,,N,,Heart,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,10116.0,Intermediate,,,8955,948.0,CHEMBL624010,1,BAO_0000218,,,,N,,Heart,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,10116.0,Intermediate,,,8956,948.0,CHEMBL624011,1,BAO_0000218,,,,N,,Heart,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,10116.0,Intermediate,,,8957,948.0,CHEMBL624012,1,BAO_0000218,,,,N,,Heart,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,10116.0,Intermediate,,,8958,948.0,CHEMBL624013,1,BAO_0000218,,,,N,,Heart,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,10116.0,Intermediate,,,8959,948.0,CHEMBL624736,1,BAO_0000218,,,,N,,Heart,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,10116.0,Intermediate,,,8960,948.0,CHEMBL624737,1,BAO_0000218,,,,N,,Heart,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,10116.0,Intermediate,,,8961,948.0,CHEMBL624738,1,BAO_0000218,,,,N,,Heart,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,10116.0,Intermediate,,,8962,948.0,CHEMBL624739,1,BAO_0000218,,,,N,,Heart,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,10116.0,Intermediate,,,8963,948.0,CHEMBL624740,1,BAO_0000218,,,,N,,Heart,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,10116.0,Intermediate,,,8964,948.0,CHEMBL624896,1,BAO_0000218,,,,N,,Heart,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,10116.0,Intermediate,,,8965,948.0,CHEMBL624897,1,BAO_0000218,,,,N,,Heart,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,10116.0,Intermediate,,,8966,948.0,CHEMBL624108,1,BAO_0000218,,,,N,,Heart,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,10116.0,Intermediate,,,8967,948.0,CHEMBL624109,1,BAO_0000218,,,,N,,Heart,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,10116.0,Intermediate,,,8968,948.0,CHEMBL624110,1,BAO_0000218,,,,N,,Heart,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,10116.0,Intermediate,,,8969,948.0,CHEMBL624111,1,BAO_0000218,,,,N,,Heart,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,10116.0,Intermediate,,,8970,948.0,CHEMBL624112,1,BAO_0000218,,,,N,,Heart,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,10116.0,Intermediate,,,8971,948.0,CHEMBL624113,1,BAO_0000218,,,,N,,Heart,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,10116.0,Intermediate,,,8972,948.0,CHEMBL619709,1,BAO_0000218,,,,N,,Heart,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,10116.0,Intermediate,,,8973,948.0,CHEMBL619710,1,BAO_0000218,,,,N,,Heart,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,10116.0,Intermediate,,,8974,2113.0,CHEMBL619711,1,BAO_0000218,,,,N,,Kidney,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,10116.0,Intermediate,,,8975,2113.0,CHEMBL619712,1,BAO_0000218,,,,N,,Kidney,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,10116.0,Intermediate,,,8976,2113.0,CHEMBL619713,1,BAO_0000218,,,,N,,Kidney,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,10116.0,Intermediate,,,8977,2113.0,CHEMBL619714,1,BAO_0000218,,,,N,,Kidney,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,10116.0,Intermediate,,,8978,2113.0,CHEMBL619715,1,BAO_0000218,,,,N,,Kidney,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,10116.0,Intermediate,,,8979,2113.0,CHEMBL619716,1,BAO_0000218,,,,N,,Kidney,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,10116.0,Intermediate,,,8980,2113.0,CHEMBL619717,1,BAO_0000218,,,,N,,Kidney,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,10116.0,Intermediate,,,8981,2113.0,CHEMBL619718,1,BAO_0000218,,,,N,,Kidney,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,10116.0,Intermediate,,,8982,2113.0,CHEMBL619719,1,BAO_0000218,,,,N,,Kidney,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,10116.0,Intermediate,,,8983,2113.0,CHEMBL875329,1,BAO_0000218,,,,N,,Kidney,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,10116.0,Intermediate,,,8984,2113.0,CHEMBL619720,1,BAO_0000218,,,,N,,Kidney,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,10116.0,Intermediate,,,8985,2113.0,CHEMBL619721,1,BAO_0000218,,,,N,,Kidney,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,10116.0,Intermediate,,,8986,2113.0,CHEMBL619722,1,BAO_0000218,,,,N,,Kidney,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,10116.0,Intermediate,,,8987,2113.0,CHEMBL619723,1,BAO_0000218,,,,N,,Kidney,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,10116.0,Intermediate,,,8988,2113.0,CHEMBL619724,1,BAO_0000218,,,,N,,Kidney,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,10116.0,Intermediate,,,8989,2113.0,CHEMBL619725,1,BAO_0000218,,,,N,,Kidney,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,10116.0,Intermediate,,,8990,2113.0,CHEMBL619726,1,BAO_0000218,,,,N,,Kidney,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,10116.0,Intermediate,,,8991,2113.0,CHEMBL619727,1,BAO_0000218,,,,N,,Kidney,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,10116.0,Intermediate,,,8992,2113.0,CHEMBL619728,1,BAO_0000218,,,,N,,Kidney,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,10116.0,Intermediate,,,8993,2113.0,CHEMBL619729,1,BAO_0000218,,,,N,,Kidney,16435,Rattus norvegicus,50597,A,,1
,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,8994,2385.0,CHEMBL619730,1,BAO_0000218,,In vivo,,N,,Muscle tissue,11977,Rattus norvegicus,50597,A,,1
,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 2 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,8995,2385.0,CHEMBL619731,1,BAO_0000218,,In vivo,,N,,Muscle tissue,11977,Rattus norvegicus,50597,A,,1
,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 2 rats),10116.0,Intermediate,,,8996,2385.0,CHEMBL619732,1,BAO_0000218,,In vivo,,N,,Muscle tissue,11977,Rattus norvegicus,50597,A,,1
,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,8997,2385.0,CHEMBL619733,1,BAO_0000218,,In vivo,,N,,Muscle tissue,11977,Rattus norvegicus,50597,A,,1
,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 60 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,8998,2385.0,CHEMBL619734,1,BAO_0000218,,In vivo,,N,,Muscle tissue,11977,Rattus norvegicus,50597,A,,1
,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 120 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,8999,14.0,CHEMBL619735,1,BAO_0000218,,In vivo,,N,,Zone of skin,11977,Rattus norvegicus,50597,A,,1
,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 2 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,9000,14.0,CHEMBL875330,1,BAO_0000218,,In vivo,,N,,Zone of skin,11977,Rattus norvegicus,50597,A,,1
,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 2 rats),10116.0,Intermediate,,,9001,14.0,CHEMBL628465,1,BAO_0000218,,In vivo,,N,,Zone of skin,11977,Rattus norvegicus,50597,A,,1
,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,9002,14.0,CHEMBL628466,1,BAO_0000218,,In vivo,,N,,Zone of skin,11977,Rattus norvegicus,50597,A,,1
,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 60 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,9003,14.0,CHEMBL628467,1,BAO_0000218,,In vivo,,N,,Zone of skin,11977,Rattus norvegicus,50597,A,,1
,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 120 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,9004,2106.0,CHEMBL628468,1,BAO_0000218,,In vivo,,N,,Spleen,11977,Rattus norvegicus,50597,A,,1
,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 2 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,9005,2106.0,CHEMBL628469,1,BAO_0000218,,In vivo,,N,,Spleen,11977,Rattus norvegicus,50597,A,,1
,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 2 rats),10116.0,Intermediate,,,9006,2106.0,CHEMBL628470,1,BAO_0000218,,In vivo,,N,,Spleen,11977,Rattus norvegicus,50597,A,,1
,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,9007,2106.0,CHEMBL628471,1,BAO_0000218,,In vivo,,N,,Spleen,11977,Rattus norvegicus,50597,A,,1
,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 60 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,9008,2106.0,CHEMBL628472,1,BAO_0000218,,In vivo,,N,,Spleen,11977,Rattus norvegicus,50597,A,,1
,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 120 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,9009,2046.0,CHEMBL625191,1,BAO_0000218,,In vivo,,N,,Thyroid gland,11977,Rattus norvegicus,50597,A,,1
,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 2 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,9010,2046.0,CHEMBL625192,1,BAO_0000218,,In vivo,,N,,Thyroid gland,11977,Rattus norvegicus,50597,A,,1
,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 2 rats),10116.0,Intermediate,,,9011,2046.0,CHEMBL875337,1,BAO_0000218,,In vivo,,N,,Thyroid gland,11977,Rattus norvegicus,50597,A,,1
,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,9012,2046.0,CHEMBL626341,1,BAO_0000218,,In vivo,,N,,Thyroid gland,11977,Rattus norvegicus,50597,A,,1
,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 60 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,9013,2046.0,CHEMBL626342,1,BAO_0000218,,In vivo,,N,,Thyroid gland,11977,Rattus norvegicus,50597,A,,1
,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),10116.0,Intermediate,,,9014,2107.0,CHEMBL621943,1,BAO_0000218,,In vivo,,N,,Liver,11977,Rattus norvegicus,50597,A,,1
,Half life in rats,10116.0,Intermediate,,,9015,,CHEMBL621944,1,BAO_0000218,,,,N,,,3748,Rattus norvegicus,50597,A,,1
,Mean percent inhibition of joint damage reduction in fasted rats at 35 mg/kg administered orally twice daily,10116.0,Intermediate,,,9016,,CHEMBL621945,1,BAO_0000218,,,,N,,,15765,Rattus norvegicus,50597,A,,1
,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver),10116.0,Intermediate,,,9017,,CHEMBL621946,1,BAO_0000218,,,,N,,,4871,Rattus norvegicus,50597,A,,1
,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver); ND=Not determined,10116.0,Intermediate,,,9018,,CHEMBL621947,1,BAO_0000218,,,,N,,,4871,Rattus norvegicus,50597,A,,1
,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver),10116.0,Intermediate,,,9019,,CHEMBL621948,1,BAO_0000218,,,,N,,,4872,Rattus norvegicus,50597,A,,1
,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver); ND=Not determined,10116.0,Intermediate,,,9020,,CHEMBL621949,1,BAO_0000218,,,,N,,,4872,Rattus norvegicus,50597,A,,1
,Rate constant (k) of clearance from isolated perfused rat liver (IPRL),10116.0,Intermediate,,,9021,,CHEMBL621950,1,BAO_0000218,,,,N,,,5413,Rattus norvegicus,50597,A,,1
,Tested for rate of clearance from isolated perfused rat liver (IPRL) and expressed in terms of rate constant (k); not determined,10116.0,Intermediate,,,9022,,CHEMBL621951,1,BAO_0000218,,,,N,,,5413,Rattus norvegicus,50597,A,,1
,Maximal blood concentration after oral administration of a 30 uM/kg dose of compound,10116.0,Intermediate,,,9023,178.0,CHEMBL621952,1,BAO_0000218,,In vivo,,N,,Blood,15272,Rattus norvegicus,50597,A,,1
,Stability (%) in rat liver microsomes,10116.0,Intermediate,,,9024,2107.0,CHEMBL621953,1,BAO_0000218,,,,N,,Liver,4689,Rattus norvegicus,50597,A,,1
,Area under curve was calculated after intravenous administration,10116.0,Intermediate,,,9025,,CHEMBL621954,1,BAO_0000218,,,,N,,,6057,Rattus norvegicus,50597,A,,1
,Area under the curve was calculated after iv administration in rat,10116.0,Intermediate,,,9026,,CHEMBL621955,1,BAO_0000218,,,,N,,,6057,Rattus norvegicus,50597,A,,1
,Area under the curve was calculated in rat after peroral administration,10116.0,Intermediate,,,9027,,CHEMBL621956,1,BAO_0000218,,,,N,,,6057,Rattus norvegicus,50597,A,,1
,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,10116.0,Intermediate,,,9028,,CHEMBL621957,1,BAO_0000218,,,,N,,,6211,Rattus norvegicus,50597,A,,1
,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg,10116.0,Intermediate,,,9029,,CHEMBL621958,1,BAO_0000218,,,,N,,,5710,Rattus norvegicus,50597,A,,1
,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral of 2 mg/Kg,10116.0,Intermediate,,,9030,,CHEMBL621959,1,BAO_0000218,,,,N,,,5710,Rattus norvegicus,50597,A,,1
,Dose-normalized area under curve in rat (i.v.) at 0.5 mpk,10116.0,Intermediate,,,9031,,CHEMBL621960,1,BAO_0000218,,,,N,,,17853,Rattus norvegicus,50597,A,,1
,Dose-normalized area under curve in rat (p.o.) at 2.0 mpk,10116.0,Intermediate,,,9032,,CHEMBL621961,1,BAO_0000218,,,,N,,,17853,Rattus norvegicus,50597,A,,1
,p value of the compound,10116.0,Intermediate,,,9033,,CHEMBL621962,1,BAO_0000218,,,,N,,,15765,Rattus norvegicus,50597,A,,1
,p value of the compound,10116.0,Intermediate,,,9034,,CHEMBL876787,1,BAO_0000218,,,,N,,,15765,Rattus norvegicus,50597,F,,1
,p value of the compound,10116.0,Intermediate,,,9035,,CHEMBL621963,1,BAO_0000218,,,,N,,,15765,Rattus norvegicus,50597,A,,1
,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),10116.0,Intermediate,,,9036,945.0,CHEMBL622637,1,BAO_0000218,,,,N,,Stomach,6175,Rattus norvegicus,50597,A,,1
,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (20 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),10116.0,Intermediate,,,9037,945.0,CHEMBL622638,1,BAO_0000218,,,,N,,Stomach,6175,Rattus norvegicus,50597,A,,1
,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),10116.0,Intermediate,,,9038,945.0,CHEMBL626561,1,BAO_0000218,,,,N,,Stomach,6175,Rattus norvegicus,50597,A,,1
,Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic),9986.0,Autocuration,,,9039,,CHEMBL626562,1,BAO_0000019,,,,U,,,7991,Oryctolagus cuniculus,22224,F,,0
,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg ( 0-4 hr ),9986.0,Autocuration,,,9040,,CHEMBL626563,1,BAO_0000218,,,,U,,,429,Oryctolagus cuniculus,22224,A,,0
,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg (0-4 hr ),9986.0,Autocuration,,,9041,,CHEMBL626564,1,BAO_0000218,,,,U,,,429,Oryctolagus cuniculus,22224,A,,0
,Clearance was measured at the concentration of 1.11 mg/kg in rabbit blood sample,9986.0,Autocuration,,,9042,,CHEMBL626565,1,BAO_0000218,,In vivo,,U,,,6253,Oryctolagus cuniculus,22224,A,,0
,Clearance was measured at the concentration of 2.0 mg/kg in rabbit blood sample,9986.0,Autocuration,,,9043,,CHEMBL626566,1,BAO_0000218,,In vivo,,U,,,6253,Oryctolagus cuniculus,22224,A,,0
,Clearance rate in rabbits,9986.0,Autocuration,,,9044,,CHEMBL626567,1,BAO_0000218,,In vivo,,U,,,3615,Oryctolagus cuniculus,22224,A,,0
,Plasma clearance was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,9986.0,Autocuration,,,9045,,CHEMBL626568,1,BAO_0000218,,In vivo,,U,,,4059,Oryctolagus cuniculus,22224,A,,0
,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,9986.0,Autocuration,,,9046,,CHEMBL626569,1,BAO_0000218,,In vivo,,U,,,5124,Oryctolagus cuniculus,22224,A,,0
,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,9986.0,Autocuration,,,9047,,CHEMBL626570,1,BAO_0000218,,In vivo,,U,,,5124,Oryctolagus cuniculus,22224,A,,0
,Clearance in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,9986.0,Autocuration,,,9048,,CHEMBL626571,1,BAO_0000218,,In vivo,,U,,,5124,Oryctolagus cuniculus,22224,A,,0
,Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg,9986.0,Autocuration,,,9049,,CHEMBL626572,1,BAO_0000218,,In vivo,,U,,,429,Oryctolagus cuniculus,22224,A,,0
,Maximum plasma concentration was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,9986.0,Autocuration,,,9050,1969.0,CHEMBL626573,1,BAO_0000218,,In vivo,,U,,Plasma,4059,Oryctolagus cuniculus,22224,A,,0
,Oxidation by dutch rabbit liver microsomes in presence of NADPH/O2,9986.0,Autocuration,,Microsomes,9051,2107.0,CHEMBL626574,1,BAO_0000251,,,,U,,Liver,9659,Oryctolagus cuniculus,22224,A,,0
,Oxidation by dutch rabbit liver microsomes in presence of cumene hydroperoxide,9986.0,Autocuration,,Microsomes,9052,2107.0,CHEMBL626575,1,BAO_0000251,,,,U,,Liver,9659,Oryctolagus cuniculus,22224,A,,0
,Dose at which bioavailability of intravenously administered compound was tested in rabbit,9986.0,Autocuration,,,9053,,CHEMBL626576,1,BAO_0000218,,,,U,,,3639,Oryctolagus cuniculus,22224,A,,0
,Dose at which bioavailability of perorally administered compound was tested in rabbit,9986.0,Autocuration,,,9054,,CHEMBL626577,1,BAO_0000218,,,,U,,,3639,Oryctolagus cuniculus,22224,A,,0
,The compound was tested for its bioavailability in rabbit (by oral dosage).,9986.0,Autocuration,,,9055,,CHEMBL626578,1,BAO_0000218,,In vivo,,U,,,3639,Oryctolagus cuniculus,22224,A,,0
,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,9986.0,Autocuration,,,9056,,CHEMBL625263,1,BAO_0000218,,In vivo,,U,,,5124,Oryctolagus cuniculus,22224,A,,0
,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,9986.0,Autocuration,,,9057,,CHEMBL625264,1,BAO_0000218,,In vivo,,U,,,5124,Oryctolagus cuniculus,22224,A,,0
,Mean retention time in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,9986.0,Autocuration,,,9058,,CHEMBL625265,1,BAO_0000218,,In vivo,,U,,,5124,Oryctolagus cuniculus,22224,A,,0
,Metabolism of compound in rabbit S9 microsomes ('+''indicates <20% largest observed peak),9986.0,Autocuration,,Microsomes,9059,,CHEMBL625266,1,BAO_0000251,,,,U,,,14294,Oryctolagus cuniculus,22224,A,,0
,Metabolism of compound in rabbit S9 microsomes ('++++' indicates largest observed peak),9986.0,Autocuration,,Microsomes,9060,,CHEMBL876796,1,BAO_0000251,,,,U,,,14294,Oryctolagus cuniculus,22224,A,,0
,Evaluated for pharmacokinetic parameter half-life in rabbit at the dose 20 mg/kg,9986.0,Autocuration,,,9061,,CHEMBL625267,1,BAO_0000218,,In vivo,,U,,,429,Oryctolagus cuniculus,22224,A,,0
,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,9986.0,Autocuration,,,9062,1969.0,CHEMBL625268,1,BAO_0000218,,In vivo,,U,,Plasma,5124,Oryctolagus cuniculus,22224,A,,0
,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,9986.0,Autocuration,,,9063,1969.0,CHEMBL625269,1,BAO_0000218,,In vivo,,U,,Plasma,5124,Oryctolagus cuniculus,22224,A,,0
,Plasma half-life in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,9986.0,Autocuration,,,9064,1969.0,CHEMBL624689,1,BAO_0000218,,In vivo,,U,,Plasma,5124,Oryctolagus cuniculus,22224,A,,0
,Evaluated for pharmacokinetic parameter tmax in rabbit at the dose 20 mg/kg,9986.0,Autocuration,,,9065,,CHEMBL624690,1,BAO_0000218,,In vivo,,U,,,429,Oryctolagus cuniculus,22224,A,,0
,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg ( 0-24 hr ),9986.0,Autocuration,,,9066,1088.0,CHEMBL624691,1,BAO_0000218,,,,U,,Urine,429,Oryctolagus cuniculus,22224,A,,0
,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg (0-24 hr),9986.0,Autocuration,,,9067,1088.0,CHEMBL624692,1,BAO_0000218,,,,U,,Urine,429,Oryctolagus cuniculus,22224,A,,0
,The compound was evaluated for volume of distribution in rabbit at a dose of 5 mg/kg/h administered i.v.,9986.0,Autocuration,,,9068,,CHEMBL624693,1,BAO_0000218,,In vivo,,U,,,4059,Oryctolagus cuniculus,22224,A,,0
,Volume of distribution after intravenous administration of 1 mg/kg/h in dog,9986.0,Autocuration,,,9069,,CHEMBL624694,1,BAO_0000218,,In vivo,,U,,,4137,Oryctolagus cuniculus,22224,A,,0
,In vitro Biological half-life in crude homogenate of rabbit renal cortex,9986.0,Autocuration,,,9070,,CHEMBL877596,1,BAO_0000221,,In vitro,,U,,,11672,Oryctolagus cuniculus,22224,A,,0
,Time within which only 10% of the drug was degraded,9986.0,Autocuration,,,9071,,CHEMBL624695,1,BAO_0000019,,,,U,,,12886,Oryctolagus cuniculus,22224,A,,0
,Half life period in rabbit liver homogenate,9986.0,Autocuration,,,9072,2107.0,CHEMBL624696,1,BAO_0000221,,,,U,,Liver,3853,Oryctolagus cuniculus,22224,A,,0
,Half life value in rabbits,9986.0,Autocuration,,,9073,,CHEMBL624697,1,BAO_0000019,,,,U,,,3615,Oryctolagus cuniculus,22224,A,,0
,Half-life was measured at the concentration of 1.11 mg/kg in rabbit blood sample,9986.0,Autocuration,,,9074,178.0,CHEMBL624698,1,BAO_0000218,,In vivo,,U,,Blood,6253,Oryctolagus cuniculus,22224,A,,0
,Half-life was measured at the concentration of 2.0 mg/kg in rabbit blood sample,9986.0,Autocuration,,,9075,178.0,CHEMBL624699,1,BAO_0000218,,In vivo,,U,,Blood,6253,Oryctolagus cuniculus,22224,A,,0
,Half-life period in rabbits following intravenous administration at 2 mg/kg,9986.0,Autocuration,,,9076,,CHEMBL624700,1,BAO_0000218,,In vivo,,U,,,6077,Oryctolagus cuniculus,22224,A,,0
,AUC 0-8 hr value in rats at 10 mg/kg,10116.0,Intermediate,,,9077,1969.0,CHEMBL622903,1,BAO_0000218,,,,N,,Plasma,17617,Rattus norvegicus,50597,A,,1
,AUC after administration at 2000 mg/kg/day in rats,10116.0,Intermediate,,,9078,1969.0,CHEMBL622904,1,BAO_0000218,,,,N,,Plasma,17594,Rattus norvegicus,50597,A,,1
,AUC of compound for a 2 mpk po dose of the sodium salt in rats.,10116.0,Intermediate,,,9079,1969.0,CHEMBL622905,1,BAO_0000218,,,,N,,Plasma,6149,Rattus norvegicus,50597,A,,1
,AUC at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,10116.0,Intermediate,,,9080,1969.0,CHEMBL622906,1,BAO_0000218,,,,N,,Plasma,17260,Rattus norvegicus,50597,A,,1
,AUC at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,10116.0,Intermediate,,,9081,1969.0,CHEMBL622907,1,BAO_0000218,,,,N,,Plasma,17260,Rattus norvegicus,50597,A,,1
,AUC in rat after oral administration at 10.5 mg/kg dose,10116.0,Intermediate,,,9082,1969.0,CHEMBL622908,1,BAO_0000218,,,,N,,Plasma,6644,Rattus norvegicus,50597,A,,1
,AUC in rat after oral administration at 11.2 mg/kg dose,10116.0,Intermediate,,,9083,1969.0,CHEMBL622909,1,BAO_0000218,,,,N,,Plasma,6644,Rattus norvegicus,50597,A,,1
,AUC in rat after oral administration at 9.7 mg/kg dose,10116.0,Intermediate,,,9084,1969.0,CHEMBL622910,1,BAO_0000218,,,,N,,Plasma,6644,Rattus norvegicus,50597,A,,1
,AUC in rat brain after oral administration at 10 mg/kg,10116.0,Intermediate,,,9085,955.0,CHEMBL622911,1,BAO_0000218,,,,N,,Brain,6495,Rattus norvegicus,50597,A,,1
,AUC in rat p.o.,10116.0,Intermediate,,,9086,1969.0,CHEMBL622912,1,BAO_0000218,,,,N,,Plasma,6504,Rattus norvegicus,50597,A,,1
,AUC in rat p.o. at 20 mg/kg concentration,10116.0,Intermediate,,,9087,1969.0,CHEMBL622913,1,BAO_0000218,,,,N,,Plasma,17686,Rattus norvegicus,50597,A,,1
,AUC in rat plasma after oral administration at 10 mg/kg,10116.0,Intermediate,,,9088,1969.0,CHEMBL622914,1,BAO_0000218,,,,N,,Plasma,6495,Rattus norvegicus,50597,A,,1
,AUC in rats,10116.0,Intermediate,,,9089,1969.0,CHEMBL622915,1,BAO_0000218,,,,N,,Plasma,216,Rattus norvegicus,50597,A,,1
,AUC value after IV dose at a dose of 5 mg/kg in rats.,10116.0,Intermediate,,,9090,1969.0,CHEMBL622916,1,BAO_0000218,,,,N,,Plasma,1908,Rattus norvegicus,50597,A,,1
,AUC value after oral dose at a dose of 10 mg/kg in rats.,10116.0,Intermediate,,,9091,1969.0,CHEMBL622917,1,BAO_0000218,,,,N,,Plasma,1908,Rattus norvegicus,50597,A,,1
,"Maximum plasma concentration in rats at 2 mg/kg, i.v. dose; n/a: not applicable",10116.0,Intermediate,,,9092,1969.0,CHEMBL622918,1,BAO_0000218,,In vivo,,N,,Plasma,6685,Rattus norvegicus,50597,A,,1
,Maximum plasma concentration in rats when a oral dose of 200 mg/kg was given,10116.0,Intermediate,,,9093,1969.0,CHEMBL622919,1,BAO_0000218,,In vivo,,N,,Plasma,216,Rattus norvegicus,50597,A,,1
,Maximum plasma concentration was evaluated in rat,10116.0,Intermediate,,,9094,1969.0,CHEMBL622920,1,BAO_0000218,,In vivo,,N,,Plasma,6049,Rattus norvegicus,50597,A,,1
,Maximum plasma concentration was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,10116.0,Intermediate,,,9095,1969.0,CHEMBL622921,1,BAO_0000218,,In vivo,,N,,Plasma,2463,Rattus norvegicus,50597,A,,1
,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,10116.0,Intermediate,,,9096,1969.0,CHEMBL622922,1,BAO_0000218,,In vivo,,N,,Plasma,6679,Rattus norvegicus,50597,A,,1
,Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,10116.0,Intermediate,,,9097,1969.0,CHEMBL622923,1,BAO_0000218,,In vivo,,N,,Plasma,6681,Rattus norvegicus,50597,A,,1
,Maximum plasma concentration was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,10116.0,Intermediate,,,9098,1969.0,CHEMBL877604,1,BAO_0000218,,In vivo,,N,,Plasma,4890,Rattus norvegicus,50597,A,,1
,Maximum plasma concentration was evaluated in rats at an intravenous dose of 3 mg/kg,10116.0,Intermediate,,,9099,1969.0,CHEMBL622924,1,BAO_0000218,,In vivo,,N,,Plasma,6410,Rattus norvegicus,50597,A,,1
,Maximum plasma concentration was evaluated in rats at an oral dose of 30 mg/kg,10116.0,Intermediate,,,9100,1969.0,CHEMBL622925,1,BAO_0000218,,In vivo,,N,,Plasma,6410,Rattus norvegicus,50597,A,,1
,Maximum plasma concentration was measured when a dose of 1 mg/kg is administered orally,10116.0,Intermediate,,,9101,1969.0,CHEMBL622926,1,BAO_0000218,,In vivo,,N,,Plasma,16366,Rattus norvegicus,50597,A,,1
,Maximum plasma concentration (Cmax) in rat (in vivo) at a dose of 10 mg/kg,10116.0,Intermediate,,,9102,1969.0,CHEMBL623625,1,BAO_0000218,,In vivo,,N,,Plasma,6227,Rattus norvegicus,50597,A,,1
,Maximum plasma drug concentration of compound determined in rat after iv administration at a dose of 10 mg/kg,10116.0,Expert,,,9103,1969.0,CHEMBL623626,1,BAO_0000218,,In vivo,,N,,Plasma,3598,Rattus norvegicus,50597,A,,1
,Maximum plasma drug concentration was determined,10116.0,Intermediate,,,9104,1969.0,CHEMBL623627,1,BAO_0000218,,In vivo,,N,,Plasma,1465,Rattus norvegicus,50597,A,,1
,Maximum concentration by intravenous administration of 3.4 mg/kg in rat,10116.0,Intermediate,,,9105,,CHEMBL623628,1,BAO_0000218,,In vivo,,N,,,4368,Rattus norvegicus,50597,A,,1
,Mean peak plasma concentration was observed after intravenous administration in rat,10116.0,Intermediate,,,9106,1969.0,CHEMBL623629,1,BAO_0000218,,In vivo,,N,,Plasma,15662,Rattus norvegicus,50597,A,,1
,Mean peak plasma concentration was observed after oral administration in rat,10116.0,Intermediate,,,9107,1969.0,CHEMBL623630,1,BAO_0000218,,In vivo,,N,,Plasma,15662,Rattus norvegicus,50597,A,,1
,Peak concentration (Cmax) at a dose of 10 mg/kg in rats,10116.0,Intermediate,,,9108,,CHEMBL623804,1,BAO_0000218,,In vivo,,N,,,5355,Rattus norvegicus,50597,A,,1
,Peak concentration (Cmax) at a dose of 20 mg/kg in rats,10116.0,Intermediate,,,9109,,CHEMBL623805,1,BAO_0000218,,In vivo,,N,,,5355,Rattus norvegicus,50597,A,,1
,Peak oral plasma concentration was determined in rats by oral administration,10116.0,Intermediate,,,9110,1969.0,CHEMBL623806,1,BAO_0000218,,In vivo,,N,,Plasma,1567,Rattus norvegicus,50597,A,,1
,Peak plasma concentration (Cmax) was determined,10116.0,Intermediate,,,9111,1969.0,CHEMBL623807,1,BAO_0000218,,In vivo,,N,,Plasma,4026,Rattus norvegicus,50597,A,,1
,Peak plasma concentration (Cmax) following an oral dose of 20 mg/kg in rats,10116.0,Intermediate,,,9112,1969.0,CHEMBL623808,1,BAO_0000218,,In vivo,,N,,Plasma,6193,Rattus norvegicus,50597,A,,1
,Peak plasma concentration (Cmax) in rats,10116.0,Intermediate,,,9113,1969.0,CHEMBL623809,1,BAO_0000218,,In vivo,,N,,Plasma,4026,Rattus norvegicus,50597,A,,1
,Peak plasma concentration at 1 mg/kg peroral administration,10116.0,Intermediate,,,9114,1969.0,CHEMBL623810,1,BAO_0000218,,In vivo,,N,,Plasma,6485,Rattus norvegicus,50597,A,,1
,Peak plasma concentration in rat,10116.0,Intermediate,,,9115,1969.0,CHEMBL623811,1,BAO_0000218,,In vivo,,N,,Plasma,17655,Rattus norvegicus,50597,A,,1
,"Pharmacokinetic Parameter, Cmax is observed maximum plasma concentration in Female Wistar Rats at 100 mg/kg by po administration",10116.0,Intermediate,,,9116,1969.0,CHEMBL623812,1,BAO_0000218,,In vivo,,N,,Plasma,14941,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter Cmax was measured after administration into rat at 10 mg/kg,10116.0,Intermediate,,,9117,,CHEMBL877605,1,BAO_0000218,,In vivo,,N,,,5394,Rattus norvegicus,50597,A,,1
,Pharmacokinetic property (Cmax) in rat,10116.0,Intermediate,,,9118,,CHEMBL623813,1,BAO_0000218,,In vivo,,N,,,4408,Rattus norvegicus,50597,A,,1
,Pharmacokinetic property (Cmax) was measured in rat at the dose of 0.32 mg/kg p.o.,10116.0,Intermediate,,,9119,,CHEMBL623814,1,BAO_0000218,,In vivo,,N,,,5983,Rattus norvegicus,50597,A,,1
,Cmax in rat after 3mg/kg oral dose,10116.0,Intermediate,,,9120,,CHEMBL623815,1,BAO_0000218,,In vivo,,N,,,4878,Rattus norvegicus,50597,A,,1
,Clearance in Sprague-Dawley rats after 2mg/kg oral dose,10116.0,Intermediate,,,9121,,CHEMBL623816,1,BAO_0000218,,In vivo,Sprague-Dawley,N,,,5862,Rattus norvegicus,50597,A,,1
,Cmax in rats after 20 mg/kg oral dose,10116.0,Intermediate,,,9122,,CHEMBL623145,1,BAO_0000218,,In vivo,,N,,,4517,Rattus norvegicus,50597,A,,1
,Cmax in rat plasma after 30mg/kg oral dose,10116.0,Intermediate,,,9123,1969.0,CHEMBL623146,1,BAO_0000218,,In vivo,,N,,Plasma,5932,Rattus norvegicus,50597,A,,1
,Plasma concentration after oral administration of 100 mg/kg to rats,10116.0,Intermediate,,,9124,1969.0,CHEMBL623147,1,BAO_0000218,,In vivo,,N,,Plasma,5436,Rattus norvegicus,50597,A,,1
,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,10116.0,Intermediate,,,9125,955.0,CHEMBL623042,1,BAO_0000218,,In vivo,,N,,Brain,4910,Rattus norvegicus,50597,A,,1
,Tested for the Cmax in rat at 10 mg/kg per orally,10116.0,Intermediate,,,9126,,CHEMBL623043,1,BAO_0000218,,In vivo,,N,,,4950,Rattus norvegicus,50597,A,,1
,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",10116.0,Intermediate,,,9127,,CHEMBL623044,1,BAO_0000218,,In vivo,,N,,,15078,Rattus norvegicus,50597,A,,1
,"The Cmax value in male wistar rat at 100 mg/kg, p.o. dose",10116.0,Intermediate,,,9128,,CHEMBL623045,1,BAO_0000218,,In vivo,,N,,,15078,Rattus norvegicus,50597,A,,1
,Bioavailability as oral Cmax in rats at 30 mins,10116.0,Intermediate,,,9129,,CHEMBL623046,1,BAO_0000218,,In vivo,,N,,,3360,Rattus norvegicus,50597,A,,1
,Bioavailability as oral Cmax in rats at 6hr,10116.0,Intermediate,,,9130,,CHEMBL623226,1,BAO_0000218,,In vivo,,N,,,3360,Rattus norvegicus,50597,A,,1
,The maximum concentration of compound was measured at the dose of 100 umol/kg,10116.0,Intermediate,,,9131,,CHEMBL623227,1,BAO_0000218,,In vivo,,N,,,15022,Rattus norvegicus,50597,A,,1
,The maximum concentration of compound was measured at the dose of 300 umol/kg,10116.0,Intermediate,,,9132,,CHEMBL623228,1,BAO_0000218,,In vivo,,N,,,15022,Rattus norvegicus,50597,A,,1
,The maximum concentration of compound was measured at the dose of 30 umol/kg,10116.0,Intermediate,,,9133,,CHEMBL623229,1,BAO_0000218,,In vivo,,N,,,15022,Rattus norvegicus,50597,A,,1
,The maximum plasma levels for the compounds were determined by LC-MS.,10116.0,Intermediate,,,9134,1969.0,CHEMBL623230,1,BAO_0000218,,In vivo,,N,,Plasma,5160,Rattus norvegicus,50597,A,,1
,mean peak plasma concentration was observed after intravenous administration in rat,10116.0,Intermediate,,,9135,1969.0,CHEMBL623231,1,BAO_0000218,,In vivo,,N,,Plasma,15662,Rattus norvegicus,50597,A,,1
,mean peak plasma concentration was observed after oral administration in rat,10116.0,Intermediate,,,9136,1969.0,CHEMBL623232,1,BAO_0000218,,In vivo,,N,,Plasma,15662,Rattus norvegicus,50597,A,,1
,Concentration in the plasma after intravenous administration of 1 mg/kg in rat,10116.0,Intermediate,,,9137,,CHEMBL623233,1,BAO_0000218,,,,N,,,4709,Rattus norvegicus,50597,A,,1
,Concentration in plasma (portal) following oral dose in rats at 0.25 hr,10116.0,Intermediate,,,9138,,CHEMBL623234,1,BAO_0000218,,,,N,,,3535,Rattus norvegicus,50597,A,,1
,Concentration in plasma (portal) following oral dose in rats at 1 hr,10116.0,Intermediate,,,9139,,CHEMBL623235,1,BAO_0000218,,,,N,,,3535,Rattus norvegicus,50597,A,,1
,Concentration in plasma (portal) following oral dose in rats at 2 hr,10116.0,Intermediate,,,9140,,CHEMBL623236,1,BAO_0000218,,,,N,,,3535,Rattus norvegicus,50597,A,,1
,Concentration in plasma (systemic) following oral dose in rats at 0.25 hr,10116.0,Intermediate,,,9141,,CHEMBL623237,1,BAO_0000218,,,,N,,,3535,Rattus norvegicus,50597,A,,1
,Concentration in plasma (systemic) following oral dose in rats at 1 hr,10116.0,Intermediate,,,9142,,CHEMBL623238,1,BAO_0000218,,,,N,,,3535,Rattus norvegicus,50597,A,,1
,Concentration in plasma (systemic) following oral dose in rats at 2 hr,10116.0,Intermediate,,,9143,,CHEMBL623239,1,BAO_0000218,,,,N,,,3535,Rattus norvegicus,50597,A,,1
,Compound was evaluated for the plasma concentration in rats versus time curves (AUC) in vivo,10116.0,Intermediate,,,9144,1969.0,CHEMBL623240,1,BAO_0000218,,In vivo,,U,,Plasma,5005,Rattus norvegicus,22224,A,,0
,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 2 hours",10116.0,Intermediate,,,9145,1898.0,CHEMBL623241,1,BAO_0000218,,,,N,,Hypothalamus,6326,Rattus norvegicus,50597,A,,1
,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 6 hours",10116.0,Intermediate,,,9146,1898.0,CHEMBL623242,1,BAO_0000218,,,,N,,Hypothalamus,6326,Rattus norvegicus,50597,A,,1
,"Concentration (30 mg/kg, p.o.) in rat plasma after 2 hours",10116.0,Intermediate,,,9147,,CHEMBL874394,1,BAO_0000218,,,,N,,,6326,Rattus norvegicus,50597,A,,1
,"Concentration (30 mg/kg, p.o.) in rat plasma after 6 hours",10116.0,Intermediate,,,9148,,CHEMBL623243,1,BAO_0000218,,,,N,,,6326,Rattus norvegicus,50597,A,,1
,Kidney concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,10116.0,Intermediate,,,9149,,CHEMBL623244,1,BAO_0000218,,,,N,,,17411,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,10116.0,Intermediate,,,9150,2113.0,CHEMBL623245,1,BAO_0000218,,,,N,,Kidney,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,10116.0,Intermediate,,,9151,2113.0,CHEMBL623246,1,BAO_0000218,,,,N,,Kidney,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,10116.0,Intermediate,,,9152,2113.0,CHEMBL623247,1,BAO_0000218,,,,N,,Kidney,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,10116.0,Intermediate,,,9153,2113.0,CHEMBL623248,1,BAO_0000218,,,,N,,Kidney,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,10116.0,Intermediate,,,9154,2113.0,CHEMBL623249,1,BAO_0000218,,,,N,,Kidney,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,10116.0,Intermediate,,,9155,2107.0,CHEMBL625072,1,BAO_0000218,,,,N,,Liver,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,10116.0,Intermediate,,,9156,2107.0,CHEMBL625073,1,BAO_0000218,,,,N,,Liver,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,10116.0,Intermediate,,,9157,2107.0,CHEMBL625074,1,BAO_0000218,,,,N,,Liver,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,10116.0,Intermediate,,,9158,2107.0,CHEMBL625075,1,BAO_0000218,,,,N,,Liver,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min.,10116.0,Intermediate,,,9159,2107.0,CHEMBL625076,1,BAO_0000218,,,,N,,Liver,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,10116.0,Intermediate,,,9160,2107.0,CHEMBL625077,1,BAO_0000218,,,,N,,Liver,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,10116.0,Intermediate,,,9161,2107.0,CHEMBL625078,1,BAO_0000218,,,,N,,Liver,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,10116.0,Intermediate,,,9162,2107.0,CHEMBL874395,1,BAO_0000218,,,,N,,Liver,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,10116.0,Intermediate,,,9163,2107.0,CHEMBL625079,1,BAO_0000218,,,,N,,Liver,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,10116.0,Intermediate,,,9164,2107.0,CHEMBL625080,1,BAO_0000218,,,,N,,Liver,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,10116.0,Intermediate,,,9165,2107.0,CHEMBL625081,1,BAO_0000218,,,,N,,Liver,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,10116.0,Intermediate,,,9166,2107.0,CHEMBL625082,1,BAO_0000218,,,,N,,Liver,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,10116.0,Intermediate,,,9167,2107.0,CHEMBL625083,1,BAO_0000218,,,,N,,Liver,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,10116.0,Intermediate,,,9168,2107.0,CHEMBL625084,1,BAO_0000218,,,,N,,Liver,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,10116.0,Intermediate,,,9169,2107.0,CHEMBL625085,1,BAO_0000218,,,,N,,Liver,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,10116.0,Intermediate,,,9170,2107.0,CHEMBL625086,1,BAO_0000218,,,,N,,Liver,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,10116.0,Intermediate,,,9171,2107.0,CHEMBL625087,1,BAO_0000218,,,,N,,Liver,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,10116.0,Intermediate,,,9172,2107.0,CHEMBL625088,1,BAO_0000218,,,,N,,Liver,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,10116.0,Intermediate,,,9173,2107.0,CHEMBL622205,1,BAO_0000218,,,,N,,Liver,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,10116.0,Intermediate,,,9174,2107.0,CHEMBL622206,1,BAO_0000218,,,,N,,Liver,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,10116.0,Intermediate,,,9175,2107.0,CHEMBL622207,1,BAO_0000218,,,,N,,Liver,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,10116.0,Intermediate,,,9176,2107.0,CHEMBL622366,1,BAO_0000218,,,,N,,Liver,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,10116.0,Intermediate,,,9177,2107.0,CHEMBL622367,1,BAO_0000218,,,,N,,Liver,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,10116.0,Intermediate,,,9178,2107.0,CHEMBL875331,1,BAO_0000218,,,,N,,Liver,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,10116.0,Intermediate,,,9179,2107.0,CHEMBL622368,1,BAO_0000218,,,,N,,Liver,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,10116.0,Intermediate,,,9180,2048.0,CHEMBL622369,1,BAO_0000218,,,,N,,Lung,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,10116.0,Intermediate,,,9181,2048.0,CHEMBL622370,1,BAO_0000218,,,,N,,Lung,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,10116.0,Intermediate,,,9182,2048.0,CHEMBL622371,1,BAO_0000218,,,,N,,Lung,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,10116.0,Intermediate,,,9183,2048.0,CHEMBL622372,1,BAO_0000218,,,,N,,Lung,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,10116.0,Intermediate,,,9184,2048.0,CHEMBL622373,1,BAO_0000218,,,,N,,Lung,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,10116.0,Intermediate,,,9185,2048.0,CHEMBL622374,1,BAO_0000218,,,,N,,Lung,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,10116.0,Intermediate,,,9186,2048.0,CHEMBL622375,1,BAO_0000218,,,,N,,Lung,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,10116.0,Intermediate,,,9187,2048.0,CHEMBL622376,1,BAO_0000218,,,,N,,Lung,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,10116.0,Intermediate,,,9188,2048.0,CHEMBL622377,1,BAO_0000218,,,,N,,Lung,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,10116.0,Intermediate,,,9189,2048.0,CHEMBL622378,1,BAO_0000218,,,,N,,Lung,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,10116.0,Intermediate,,,9190,2048.0,CHEMBL622379,1,BAO_0000218,,,,N,,Lung,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,10116.0,Intermediate,,,9191,2048.0,CHEMBL622380,1,BAO_0000218,,,,N,,Lung,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,10116.0,Intermediate,,,9192,2048.0,CHEMBL622381,1,BAO_0000218,,,,N,,Lung,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,10116.0,Intermediate,,,9193,2048.0,CHEMBL622382,1,BAO_0000218,,,,N,,Lung,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min,10116.0,Intermediate,,,9194,2048.0,CHEMBL622383,1,BAO_0000218,,,,N,,Lung,16434,Rattus norvegicus,50597,A,,1
,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured ( 5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),10116.0,Intermediate,,,9195,945.0,CHEMBL875332,1,BAO_0000218,,,,N,,Stomach,6175,Rattus norvegicus,50597,A,,1
,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),10116.0,Intermediate,,,9196,945.0,CHEMBL622384,1,BAO_0000218,,,,N,,Stomach,6175,Rattus norvegicus,50597,A,,1
,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (2.5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),10116.0,Intermediate,,,9197,945.0,CHEMBL622385,1,BAO_0000218,,,,N,,Stomach,6175,Rattus norvegicus,50597,A,,1
,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),10116.0,Intermediate,,,9198,945.0,CHEMBL622386,1,BAO_0000218,,,,N,,Stomach,6175,Rattus norvegicus,50597,A,,1
,The compound was tested for the plasma binding in rat,10116.0,Intermediate,,,9199,,CHEMBL622387,1,BAO_0000218,,,,N,,,10839,Rattus norvegicus,50597,A,,1
,"Plasma concentration after intravenous aministration at 1hr, (1 mg/kg, n=3)",10116.0,Intermediate,,,9200,,CHEMBL622388,1,BAO_0000218,,,,N,,,16459,Rattus norvegicus,50597,A,,1
,"Plasma concentration after intravenous aministration at 30 min. (1 mg/kg, n=3)",10116.0,Intermediate,,,9201,,CHEMBL622389,1,BAO_0000218,,,,N,,,16459,Rattus norvegicus,50597,A,,1
,"Plasma concentration after intravenous aministration at 60 min. (1 mg/kg, n=3)",10116.0,Intermediate,,,9202,,CHEMBL622390,1,BAO_0000218,,,,N,,,16459,Rattus norvegicus,50597,A,,1
,Plasma concentration after oral aministration at 1 hr. (10 mg/kg),10116.0,Intermediate,,,9203,,CHEMBL622391,1,BAO_0000218,,,,N,,,16459,Rattus norvegicus,50597,A,,1
,Plasma concentration after oral aministration at 2 hr. (10 mg/kg),10116.0,Intermediate,,,9204,,CHEMBL622392,1,BAO_0000218,,,,N,,,16459,Rattus norvegicus,50597,A,,1
,Plasma concentration after oral aministration at 4 hr. (10 mg/kg),10116.0,Intermediate,,,9205,,CHEMBL622393,1,BAO_0000218,,,,N,,,16459,Rattus norvegicus,50597,A,,1
,Plasma level at 2 hr after administration of the compound,10116.0,Intermediate,,,9206,,CHEMBL622394,1,BAO_0000218,,,,N,,,3278,Rattus norvegicus,50597,A,,1
,plasma level at 2 hr after administration of the compound,10116.0,Intermediate,,,9207,,CHEMBL622395,1,BAO_0000218,,,,N,,,3278,Rattus norvegicus,50597,A,,1
,Stability in rat serum measured as % recovery at 1 min,10116.0,Intermediate,,,9208,1977.0,CHEMBL622396,1,BAO_0000218,,,,N,,Serum,4684,Rattus norvegicus,50597,A,,1
,Stability in rat serum measured as % recovery at 10 min,10116.0,Intermediate,,,9209,1977.0,CHEMBL624894,1,BAO_0000218,,,,N,,Serum,4684,Rattus norvegicus,50597,A,,1
,Stability in rat serum measured as % recovery at 10 mins,10116.0,Intermediate,,,9210,1977.0,CHEMBL624895,1,BAO_0000218,,,,N,,Serum,4684,Rattus norvegicus,50597,A,,1
,Stability in rat serum measured as % recovery at 2 hr,10116.0,Intermediate,,,9211,1977.0,CHEMBL624058,1,BAO_0000218,,,,N,,Serum,4684,Rattus norvegicus,50597,A,,1
,Stability in rat serum measured as % recovery at 3 min,10116.0,Intermediate,,,9212,1977.0,CHEMBL624059,1,BAO_0000218,,,,N,,Serum,4684,Rattus norvegicus,50597,A,,1
,Stability in rat serum measured as % recovery at 3 mins,10116.0,Intermediate,,,9213,1977.0,CHEMBL624060,1,BAO_0000218,,,,N,,Serum,4684,Rattus norvegicus,50597,A,,1
,Stability in rat serum measured as % recovery at 5 min,10116.0,Intermediate,,,9214,1977.0,CHEMBL624061,1,BAO_0000218,,,,N,,Serum,4684,Rattus norvegicus,50597,A,,1
,Stability in rat serum measured as % recovery at 5 mins,10116.0,Intermediate,,,9215,1977.0,CHEMBL624062,1,BAO_0000218,,,,N,,Serum,4684,Rattus norvegicus,50597,A,,1
,Alpha-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,10116.0,Intermediate,,,9216,,CHEMBL624063,1,BAO_0000218,,In vivo,,N,,,16456,Rattus norvegicus,50597,A,,1
,Beta-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,10116.0,Intermediate,,,9217,,CHEMBL624064,1,BAO_0000218,,In vivo,,N,,,16456,Rattus norvegicus,50597,A,,1
,Half life in plasma was determined against ovariectomized rats; t 1/2 (h) is short in plasma,10116.0,Intermediate,,,9218,1969.0,CHEMBL624065,1,BAO_0000218,,,,N,,Plasma,723,Rattus norvegicus,50597,A,,1
,Half life in plasma was determined against ovariectomized rats; t1/2 is longer in plasma.,10116.0,Intermediate,,,9219,1969.0,CHEMBL624066,1,BAO_0000218,,,,N,,Plasma,723,Rattus norvegicus,50597,A,,1
,Half life tested in mature male rat at a dose of 30 mg/kg,10116.0,Intermediate,,,9220,,CHEMBL877490,1,BAO_0000218,,In vivo,,N,,,5160,Rattus norvegicus,50597,A,,1
,Half life after intravenous administration of 1 mg/kg in rat,10116.0,Intermediate,,,9221,,CHEMBL874442,1,BAO_0000218,,In vivo,,N,,,4709,Rattus norvegicus,50597,A,,1
,Half life period after administration (30 mg/kg) in rat,10116.0,Intermediate,,,9222,,CHEMBL626890,1,BAO_0000218,,In vivo,,N,,,5633,Rattus norvegicus,50597,A,,1
,Half life period in rat after 5 mg/Kg dose,10116.0,Intermediate,,,9223,,CHEMBL626891,1,BAO_0000218,,In vivo,,N,,,5302,Rattus norvegicus,50597,A,,1
,Half life period in rat after 5 mg/kg dose,10116.0,Intermediate,,,9224,,CHEMBL626892,1,BAO_0000218,,In vivo,,N,,,5302,Rattus norvegicus,50597,A,,1
,Half life period was determined,10116.0,Intermediate,,,9225,,CHEMBL626893,1,BAO_0000218,,,,N,,,17791,Rattus norvegicus,50597,A,,1
,Half life period was evaluated in rat,10116.0,Intermediate,,,9226,,CHEMBL626894,1,BAO_0000218,,,,N,,,17791,Rattus norvegicus,50597,A,,1
,Half life period was evaluated in rat; 0.5-1.0,10116.0,Intermediate,,,9227,,CHEMBL626895,1,BAO_0000218,,,,N,,,17791,Rattus norvegicus,50597,A,,1
,Half life period was evaluated in rat; 5.9-7.5,10116.0,Intermediate,,,9228,,CHEMBL626896,1,BAO_0000218,,,,N,,,17791,Rattus norvegicus,50597,A,,1
,Half-life in rat plasma,10116.0,Intermediate,,,9229,1969.0,CHEMBL626897,1,BAO_0000218,,,,N,,Plasma,14512,Rattus norvegicus,50597,A,,1
,Half-life time in rat was determined,10116.0,Intermediate,,,9230,,CHEMBL626898,1,BAO_0000218,,,,N,,,6230,Rattus norvegicus,50597,A,,1
,Terminal half-life after iv administration to rats,10116.0,Intermediate,,,9231,,CHEMBL626899,1,BAO_0000218,,In vivo,,N,,,3364,Rattus norvegicus,50597,A,,1
,Tested for iv terminal half-life dosed as a solution in male Han Wistar rats,10116.0,Intermediate,,,9232,,CHEMBL626900,1,BAO_0000218,,In vivo,,N,,,6874,Rattus norvegicus,50597,A,,1
,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg,10116.0,Intermediate,,,9233,,CHEMBL626901,1,BAO_0000218,,,,N,,,857,Rattus norvegicus,50597,A,,1
,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg (iv),10116.0,Intermediate,,,9234,,CHEMBL626902,1,BAO_0000218,,In vivo,,N,,,858,Rattus norvegicus,50597,A,,1
,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 5 umol/kg (iv),10116.0,Intermediate,,,9235,,CHEMBL626903,1,BAO_0000218,,In vivo,,N,,,858,Rattus norvegicus,50597,A,,1
,Time for peak concentration (tmax) at a dose of 10 mg/kg in rats,10116.0,Intermediate,,,9236,,CHEMBL874443,1,BAO_0000218,,In vivo,,N,,,5355,Rattus norvegicus,50597,A,,1
,Time for peak concentration (tmax) at a dose of 20 mg/kg in rats,10116.0,Intermediate,,,9237,,CHEMBL626904,1,BAO_0000218,,In vivo,,N,,,5355,Rattus norvegicus,50597,A,,1
,Half life in rats,10116.0,Intermediate,,,9238,,CHEMBL626905,1,BAO_0000218,,,,N,,,6305,Rattus norvegicus,50597,A,,1
,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 4 mg/kg to rat,10116.0,Intermediate,,,9239,1969.0,CHEMBL873830,1,BAO_0000218,,In vivo,,N,,Plasma,13501,Rattus norvegicus,50597,A,,1
,Apparent half-life after single intravenous bolus of 1 mg/kg in rats,10116.0,Intermediate,,,9240,,CHEMBL626906,1,BAO_0000218,,In vivo,,N,,,17594,Rattus norvegicus,50597,A,,1
,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,10116.0,Intermediate,,,9241,1969.0,CHEMBL631076,1,BAO_0000218,,In vivo,,N,,Plasma,4186,Rattus norvegicus,50597,A,,1
,Biological half-life was measured in plasma of rats,10116.0,Intermediate,,,9242,1969.0,CHEMBL631077,1,BAO_0000218,,,,N,,Plasma,2932,Rattus norvegicus,50597,A,,1
,Circulatory half life measured after intravenous bolus administration of 50 mg/kg of compound to rats,10116.0,Intermediate,,,9243,,CHEMBL631078,1,BAO_0000218,,In vivo,,N,,,17065,Rattus norvegicus,50597,A,,1
,Compound demonstarted an oral bioavailability of 6% with the half-life time as given in rats.,10116.0,Intermediate,,,9244,,CHEMBL631079,1,BAO_0000218,,In vivo,,N,,,15765,Rattus norvegicus,50597,A,,1
,Compound was evaluated for half life (t1/2) upon intravenous administration of 1 mg/Kg in rats,10116.0,Intermediate,,,9245,,CHEMBL631080,1,BAO_0000218,,In vivo,,N,,,2713,Rattus norvegicus,50597,A,,1
,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to female wistar rats,10116.0,Intermediate,,,9246,,CHEMBL631081,1,BAO_0000218,,In vivo,,N,,,2661,Rattus norvegicus,50597,A,,1
,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to male wistar rats,10116.0,Intermediate,,,9247,,CHEMBL631239,1,BAO_0000218,,In vivo,,N,,,2661,Rattus norvegicus,50597,A,,1
,Compound was evaluated for plasma half life in rat,10116.0,Intermediate,,,9248,1969.0,CHEMBL631240,1,BAO_0000218,,,,N,,Plasma,740,Rattus norvegicus,50597,A,,1
,AUC value at a dose of 5 mg/kg (p.o.) in rats,10116.0,Intermediate,,,9249,1969.0,CHEMBL631241,1,BAO_0000218,,,,N,,Plasma,6597,Rattus norvegicus,50597,A,,1
,AUC value after administration of 20 mg/Kg oral dose in rat,10116.0,Intermediate,,,9250,1969.0,CHEMBL631242,1,BAO_0000218,,,,N,,Plasma,2959,Rattus norvegicus,50597,A,,1
,AUC0-24 after repeated oral dose of compound at 1 mg/kg in rats,10116.0,Intermediate,,,9251,1969.0,CHEMBL631243,1,BAO_0000218,,,,N,,Plasma,17594,Rattus norvegicus,50597,A,,1
,AUC0-96 after administration at 50 mg/kg,10116.0,Intermediate,,,9252,1969.0,CHEMBL874444,1,BAO_0000218,,,,N,,Plasma,17596,Rattus norvegicus,50597,A,,1
,AUC0-infinity after single intravenous bolus of 1 mg/kg in rats,10116.0,Intermediate,,,9253,1969.0,CHEMBL631244,1,BAO_0000218,,,,N,,Plasma,17594,Rattus norvegicus,50597,A,,1
,"Absorption behavior was judged by the area under the curve, determined after oral dose of 30 mg/kg in rats.",10116.0,Intermediate,,,9254,,CHEMBL631245,1,BAO_0000218,,,,N,,,3293,Rattus norvegicus,50597,A,,1
,Area under curve (0-24 hr) at a dose of 10 mg/kg in male SD rats,10116.0,Intermediate,,,9255,,CHEMBL627162,1,BAO_0000218,,,,N,,,6757,Rattus norvegicus,50597,A,,1
,Area under curve (0-24 hr) at a dose of 100 mg/kg in male SD rats,10116.0,Intermediate,,,9256,,CHEMBL627163,1,BAO_0000218,,,,N,,,6757,Rattus norvegicus,50597,A,,1
,Area under curve (0-24 hr) at a dose of 50 mg/kg in male SD rats,10116.0,Intermediate,,,9257,,CHEMBL627164,1,BAO_0000218,,,,N,,,6757,Rattus norvegicus,50597,A,,1
,Area under curve (AUC) at a dose 1 mg/kg was determined in rat kidney,10116.0,Intermediate,,,9258,2113.0,CHEMBL627165,1,BAO_0000218,,,,N,,Kidney,5979,Rattus norvegicus,50597,A,,1
,Area under curve (AUC) at a dose 1 mg/kg was determined in rat liver,10116.0,Intermediate,,,9259,,CHEMBL627166,1,BAO_0000218,,,,N,,,5979,Rattus norvegicus,50597,A,,1
,Area under curve (AUC) at a dose 1 mg/kg was determined in rat lung,10116.0,Intermediate,,,9260,,CHEMBL627167,1,BAO_0000218,,,,N,,,5979,Rattus norvegicus,50597,A,,1
,Area under curve (AUC) at a dose of 30 mg/kg in rats,10116.0,Intermediate,,,9261,,CHEMBL627822,1,BAO_0000218,,,,N,,,4026,Rattus norvegicus,50597,A,,1
,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,10116.0,Intermediate,,,9262,,CHEMBL627823,1,BAO_0000218,,,,N,,,5355,Rattus norvegicus,50597,A,,1
,Area under curve (AUC) was calculated using trapezoidal rule. at a dose of 10 mg/kg in rats,10116.0,Intermediate,,,9263,,CHEMBL627824,1,BAO_0000218,,,,N,,,5355,Rattus norvegicus,50597,A,,1
,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,10116.0,Intermediate,,,9264,,CHEMBL627825,1,BAO_0000218,,,,N,,,5355,Rattus norvegicus,50597,A,,1
,Area under curve (AUC0-24 h) after administration (30 mg/kg) in rat,10116.0,Intermediate,,,9265,,CHEMBL627826,1,BAO_0000218,,,,N,,,5633,Rattus norvegicus,50597,A,,1
,Area under curve (Pharmacokinetic property) was determined,10116.0,Intermediate,,,9266,,CHEMBL627827,1,BAO_0000218,,,,N,,,1716,Rattus norvegicus,50597,A,,1
,Area under curve (Pharmacokinetic property) of the compound; Not determined,10116.0,Intermediate,,,9267,,CHEMBL627828,1,BAO_0000218,,,,N,,,1716,Rattus norvegicus,50597,A,,1
,Area under curve after intravenous administration (1 mg/kg) in rat,10116.0,Intermediate,,,9268,,CHEMBL627829,1,BAO_0000218,,,,N,,,4689,Rattus norvegicus,50597,A,,1
,Area under curve by intravenous administration at a dose of 10 uM/kg in rat was determined,10116.0,Intermediate,,,9269,,CHEMBL627830,1,BAO_0000218,,,,N,,,4527,Rattus norvegicus,50597,A,,1
,Area under curve by oral administration at a dose of 100 uM/kg in rat was determined,10116.0,Intermediate,,,9270,,CHEMBL627831,1,BAO_0000218,,,,N,,,4527,Rattus norvegicus,50597,A,,1
,Area under curve in male SD rats was observed after oral administration in rat,10116.0,Intermediate,,,9271,,CHEMBL627832,1,BAO_0000218,,,,N,,,15662,Rattus norvegicus,50597,A,,1
,Area under curve of compound after iv administration of 20 mg/kg dose in rat,10116.0,Intermediate,,,9272,,CHEMBL627833,1,BAO_0000218,,,,N,,,4413,Rattus norvegicus,50597,A,,1
,Area under curve of compound determined in rat after iv administration at a dose of 10 mg/kg,10116.0,Expert,,,9273,,CHEMBL627834,1,BAO_0000218,,,,N,,,3598,Rattus norvegicus,50597,A,,1
,Area under curve of compound from zero time to infinity determined in rat after iv administration at a dose of 10 mg/kg,10116.0,Expert,,,9274,,CHEMBL628004,1,BAO_0000218,,,,N,,,3598,Rattus norvegicus,50597,A,,1
,Area under curve at 5 mg/kg po was determined in rat,10116.0,Intermediate,,,9275,,CHEMBL628005,1,BAO_0000218,,,,N,,,5964,Rattus norvegicus,50597,A,,1
,Area under curve in Rat at a oral dose of 5 mg/kg,10116.0,Intermediate,,,9276,,CHEMBL628006,1,BAO_0000218,,,,N,,,4689,Rattus norvegicus,50597,A,,1
,Area under curve in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,10116.0,Intermediate,,,9277,,CHEMBL628007,1,BAO_0000218,,,,N,,,4186,Rattus norvegicus,50597,A,,1
,Area under curve was determined,10116.0,Intermediate,,,9278,,CHEMBL625676,1,BAO_0000218,,,,N,,,5510,Rattus norvegicus,50597,A,,1
,Area under curve after 10 mg/kg oral administration in rat at 0-24 hr,10116.0,Intermediate,,,9279,,CHEMBL631309,1,BAO_0000218,,,,N,,,17858,Rattus norvegicus,50597,A,,1
,Area under curve after intravenous administration at 3 mg/kg,10116.0,Intermediate,,,9280,,CHEMBL631310,1,BAO_0000218,,,,N,,,17804,Rattus norvegicus,50597,A,,1
,Area under curve after peroral administration at 10 mg/kg in rat for 0-6 h,10116.0,Intermediate,,,9281,,CHEMBL631311,1,BAO_0000218,,,,N,,,6106,Rattus norvegicus,50597,A,,1
,Area under curve at 4 hr in rat,10116.0,Intermediate,,,9282,,CHEMBL631312,1,BAO_0000218,,,,N,,,5964,Rattus norvegicus,50597,A,,1
,Area under curve at a dose of 30 mg/kg,10116.0,Intermediate,,,9283,,CHEMBL631313,1,BAO_0000218,,,,N,,,4026,Rattus norvegicus,50597,A,,1
,Area under curve at the dose of 2 mg/Kg administered perorally in rats,10116.0,Intermediate,,,9284,,CHEMBL631314,1,BAO_0000218,,,,N,,,4756,Rattus norvegicus,50597,A,,1
,Area under curve at the dose of 5 mg/Kg administered perorally in rats,10116.0,Intermediate,,,9285,,CHEMBL631315,1,BAO_0000218,,,,N,,,4756,Rattus norvegicus,50597,A,,1
,Area under curve for a 2-mpk po dose in SD rats,10116.0,Intermediate,,,9286,,CHEMBL631316,1,BAO_0000218,,,,N,,,5862,Rattus norvegicus,50597,A,,1
,Area under curve in SD rats,10116.0,Intermediate,,,9287,,CHEMBL631317,1,BAO_0000218,,,,N,,,5862,Rattus norvegicus,50597,A,,1
,Area under curve in rat after oral administration at 13 mg/kg dose,10116.0,Intermediate,,,9288,,CHEMBL874471,1,BAO_0000218,,,,N,,,6644,Rattus norvegicus,50597,A,,1
,Area under curve in rat by po administration at 0-24 hr,10116.0,Intermediate,,,9289,,CHEMBL631318,1,BAO_0000218,,,,N,,,5871,Rattus norvegicus,50597,A,,1
,Area under curve in rat plasma,10116.0,Intermediate,,,9290,1969.0,CHEMBL631319,1,BAO_0000218,,,,N,,Plasma,5919,Rattus norvegicus,50597,A,,1
,Area under curve in rat plasma for 0-4 hr after peroral administration at 10 mg/kg,10116.0,Intermediate,,,9291,,CHEMBL631320,1,BAO_0000218,,,,N,,,5939,Rattus norvegicus,50597,A,,1
,Area under curve in rat plasma for 0-4 hr after peroral administration at 5 mg/kg,10116.0,Intermediate,,,9292,,CHEMBL631321,1,BAO_0000218,,,,N,,,5939,Rattus norvegicus,50597,A,,1
,Area under curve was evaluated in rat at 3 mg/kg dose administered intravenously,10116.0,Intermediate,,,9293,,CHEMBL631322,1,BAO_0000218,,,,N,,,10,Rattus norvegicus,50597,A,,1
,Area under curve was measured from the graph obtained from concentration Vs time after oral administration to male F344 rats,10116.0,Intermediate,,,9294,,CHEMBL631323,1,BAO_0000218,,,,N,,,11149,Rattus norvegicus,50597,A,,1
,Area under curve value in rat at a dose of 5 mg/kg,10116.0,Intermediate,,,9295,,CHEMBL631324,1,BAO_0000218,,,,N,,,5302,Rattus norvegicus,50597,A,,1
,Area under curve was determined after oral administration in rats,10116.0,Intermediate,,,9296,,CHEMBL631325,1,BAO_0000218,,,,N,,,17796,Rattus norvegicus,50597,A,,1
,Area under curve was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,10116.0,Intermediate,,,9297,,CHEMBL631326,1,BAO_0000218,,,,N,,,4890,Rattus norvegicus,50597,A,,1
,Area under curve was determined after peroral administration in rat,10116.0,Intermediate,,,9298,,CHEMBL631327,1,BAO_0000218,,,,N,,,6011,Rattus norvegicus,50597,A,,1
,Area under curve was determined at a dose 30 mpk administered orally.,10116.0,Intermediate,,,9299,,CHEMBL631328,1,BAO_0000218,,,,N,,,5375,Rattus norvegicus,50597,A,,1
,Area under curve was determined for compound after intravenous administration in rats at 24 uM/kg,10116.0,Intermediate,,,9300,,CHEMBL631329,1,BAO_0000218,,,,N,,,17764,Rattus norvegicus,50597,A,,1
,Area under curve was determined for the compound by intravenous administration of 3.4 mg/kg in rat,10116.0,Intermediate,,,9301,,CHEMBL627217,1,BAO_0000218,,,,N,,,4368,Rattus norvegicus,50597,A,,1
,Area under curve was determined in male rat,10116.0,Intermediate,,,9302,,CHEMBL626352,1,BAO_0000218,,,,N,,,5610,Rattus norvegicus,50597,A,,1
,Area under curve was determined in rat after PO administration,10116.0,Intermediate,,,9303,,CHEMBL626353,1,BAO_0000218,,,,N,,,5833,Rattus norvegicus,50597,A,,1
,Area under curve was determined in rat after a 3 mg/kg of oral dose,10116.0,Intermediate,,,9304,,CHEMBL626354,1,BAO_0000218,,,,N,,,4257,Rattus norvegicus,50597,A,,1
,Area under curve was determined in rat after oral administration at a concentration 1 mg/kg,10116.0,Intermediate,,,9305,,CHEMBL626355,1,BAO_0000218,,,,N,,,5937,Rattus norvegicus,50597,A,,1
,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg,10116.0,Intermediate,,,9306,,CHEMBL626356,1,BAO_0000218,,,,N,,,5932,Rattus norvegicus,50597,A,,1
,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg; NA= Not active,10116.0,Intermediate,,,9307,,CHEMBL626357,1,BAO_0000218,,,,N,,,5932,Rattus norvegicus,50597,A,,1
,Liver concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,10116.0,Intermediate,,,9308,,CHEMBL626358,1,BAO_0000218,,,,N,,,17411,Rattus norvegicus,50597,A,,1
,Lung concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,10116.0,Intermediate,,,9309,,CHEMBL626359,1,BAO_0000218,,,,N,,,17411,Rattus norvegicus,50597,A,,1
,Peak plasma concentration in rat at a dose of 3 mg/kg,10116.0,Intermediate,,,9310,1969.0,CHEMBL626360,1,BAO_0000218,,,,N,,Plasma,17771,Rattus norvegicus,50597,A,,1
,Plasma concentration at 2 hr in rats was evaluated.,10116.0,Intermediate,,,9311,,CHEMBL626361,1,BAO_0000218,,,,N,,,1628,Rattus norvegicus,50597,A,,1
,Plasma concentration at 2 hr in rats was evaluated; Not available,10116.0,Intermediate,,,9312,,CHEMBL626362,1,BAO_0000218,,,,N,,,1628,Rattus norvegicus,50597,A,,1
,Serum concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,10116.0,Intermediate,,,9313,,CHEMBL626363,1,BAO_0000218,,,,N,,,17411,Rattus norvegicus,50597,A,,1
,Tested for concentration in brain after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,10116.0,Intermediate,,,9314,,CHEMBL626970,1,BAO_0000218,,,,N,,,4910,Rattus norvegicus,50597,A,,1
,Tested for concentration in brain after 2 hrs of intravenous administration (5 mg/kg) to male rats,10116.0,Intermediate,,,9315,,CHEMBL626971,1,BAO_0000218,,,,N,,,4910,Rattus norvegicus,50597,A,,1
,Tested for plasma concentration after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,10116.0,Intermediate,,,9316,1969.0,CHEMBL626972,1,BAO_0000218,,,,N,,Plasma,4910,Rattus norvegicus,50597,A,,1
,Tested for plasma concentration after 2 hrs of intravenous administration (5 mg/kg) to male rats,10116.0,Intermediate,,,9317,1969.0,CHEMBL626973,1,BAO_0000218,,,,N,,Plasma,4910,Rattus norvegicus,50597,A,,1
,Tested for plasma concentration in the after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,10116.0,Intermediate,,,9318,1969.0,CHEMBL626974,1,BAO_0000218,,,,N,,Plasma,4910,Rattus norvegicus,50597,A,,1
,Tested for plasma concentration in the after 2 hrs of intravenous administration (5 mg/kg) to male rats,10116.0,Intermediate,,,9319,1969.0,CHEMBL874592,1,BAO_0000218,,,,N,,Plasma,4910,Rattus norvegicus,50597,A,,1
,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C,10116.0,Intermediate,,,9320,,CHEMBL626975,1,BAO_0000218,,,,N,,,5510,Rattus norvegicus,50597,A,,1
,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Converted to an unknown compound,10116.0,Intermediate,,,9321,,CHEMBL626976,1,BAO_0000218,,,,N,,,5510,Rattus norvegicus,50597,A,,1
,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not determined,10116.0,Intermediate,,,9322,,CHEMBL626977,1,BAO_0000218,,,,N,,,5510,Rattus norvegicus,50597,A,,1
,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not tested,10116.0,Intermediate,,,9323,,CHEMBL626978,1,BAO_0000218,,,,N,,,5510,Rattus norvegicus,50597,A,,1
,PK study was carried to determine the relative absorption ranking in rat.,10116.0,Intermediate,,,9324,,CHEMBL626979,1,BAO_0000218,,,,N,,,16427,Rattus norvegicus,50597,A,,1
,Maximum plasma concentration in Rat at a oral dose of 5 mg/kg,10116.0,Intermediate,,,9325,1969.0,CHEMBL626980,1,BAO_0000218,,In vivo,,N,,Plasma,4689,Rattus norvegicus,50597,A,,1
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.57-0.75 % dose/g",10116.0,Intermediate,,,9326,178.0,CHEMBL626981,1,BAO_0000218,,,,N,,Blood,11450,Rattus norvegicus,50597,A,,1
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.63 % dose/g",10116.0,Intermediate,,,9327,178.0,CHEMBL626982,1,BAO_0000218,,,,N,,Blood,11450,Rattus norvegicus,50597,A,,1
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.40-0.55 % dose/g",10116.0,Intermediate,,,9328,178.0,CHEMBL626983,1,BAO_0000218,,,,N,,Blood,11450,Rattus norvegicus,50597,A,,1
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.28-0.37% dose/g",10116.0,Intermediate,,,9329,178.0,CHEMBL622522,1,BAO_0000218,,,,N,,Blood,11450,Rattus norvegicus,50597,A,,1
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.56-0.74 % dose/g",10116.0,Intermediate,,,9330,178.0,CHEMBL622523,1,BAO_0000218,,,,N,,Blood,11450,Rattus norvegicus,50597,A,,1
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from % dose/g",10116.0,Intermediate,,,9331,178.0,CHEMBL622524,1,BAO_0000218,,,,N,,Blood,11450,Rattus norvegicus,50597,A,,1
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.20-2.85 % dose/g",10116.0,Intermediate,,,9332,955.0,CHEMBL622525,1,BAO_0000218,,,,N,,Brain,11450,Rattus norvegicus,50597,A,,1
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.16-1.76 % dose/g",10116.0,Intermediate,,,9333,955.0,CHEMBL622526,1,BAO_0000218,,,,N,,Brain,11450,Rattus norvegicus,50597,A,,1
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.96-3.72 % dose/g",10116.0,Intermediate,,,9334,955.0,CHEMBL619849,1,BAO_0000218,,,,N,,Brain,11450,Rattus norvegicus,50597,A,,1
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.57-3.59 % dose/g",10116.0,Intermediate,,,9335,955.0,CHEMBL619850,1,BAO_0000218,,,,N,,Brain,11450,Rattus norvegicus,50597,A,,1
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.36-1.53 % dose/g",10116.0,Intermediate,,,9336,955.0,CHEMBL623864,1,BAO_0000218,,,,N,,Brain,11450,Rattus norvegicus,50597,A,,1
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.81-1.08 % dose/g",10116.0,Intermediate,,,9337,955.0,CHEMBL623865,1,BAO_0000218,,,,N,,Brain,11450,Rattus norvegicus,50597,A,,1
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.84-0.98 % dose/g",10116.0,Intermediate,,,9338,948.0,CHEMBL623866,1,BAO_0000218,,,,N,,Heart,11450,Rattus norvegicus,50597,A,,1
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.53 % dose/g",10116.0,Intermediate,,,9339,948.0,CHEMBL623867,1,BAO_0000218,,,,N,,Heart,11450,Rattus norvegicus,50597,A,,1
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.22-1.48 % dose/g",10116.0,Intermediate,,,9340,948.0,CHEMBL877615,1,BAO_0000218,,,,N,,Heart,11450,Rattus norvegicus,50597,A,,1
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.85-1.13 % dose/g",10116.0,Intermediate,,,9341,948.0,CHEMBL623868,1,BAO_0000218,,,,N,,Heart,11450,Rattus norvegicus,50597,A,,1
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.55-0.63 % dose/g",10116.0,Intermediate,,,9342,948.0,CHEMBL623869,1,BAO_0000218,,,,N,,Heart,11450,Rattus norvegicus,50597,A,,1
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.33-0.42 % dose/g",10116.0,Intermediate,,,9343,948.0,CHEMBL623870,1,BAO_0000218,,,,N,,Heart,11450,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,10116.0,Intermediate,,,9344,2048.0,CHEMBL623871,1,BAO_0000218,,,,N,,Lung,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,10116.0,Intermediate,,,9345,2048.0,CHEMBL623872,1,BAO_0000218,,,,N,,Lung,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,10116.0,Intermediate,,,9346,2048.0,CHEMBL622129,1,BAO_0000218,,,,N,,Lung,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,10116.0,Intermediate,,,9347,2048.0,CHEMBL622130,1,BAO_0000218,,,,N,,Lung,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,10116.0,Intermediate,,,9348,2048.0,CHEMBL622131,1,BAO_0000218,,,,N,,Lung,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,10116.0,Intermediate,,,9349,2048.0,CHEMBL622132,1,BAO_0000218,,,,N,,Lung,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,10116.0,Intermediate,,,9350,2048.0,CHEMBL622133,1,BAO_0000218,,,,N,,Lung,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,10116.0,Intermediate,,,9351,2048.0,CHEMBL622134,1,BAO_0000218,,,,N,,Lung,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,10116.0,Intermediate,,,9352,2048.0,CHEMBL622135,1,BAO_0000218,,,,N,,Lung,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,10116.0,Intermediate,,,9353,2048.0,CHEMBL622136,1,BAO_0000218,,,,N,,Lung,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,10116.0,Intermediate,,,9354,2385.0,CHEMBL622137,1,BAO_0000218,,,,N,,Muscle tissue,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,10116.0,Intermediate,,,9355,2385.0,CHEMBL622138,1,BAO_0000218,,,,N,,Muscle tissue,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,10116.0,Intermediate,,,9356,2385.0,CHEMBL623017,1,BAO_0000218,,,,N,,Muscle tissue,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,10116.0,Intermediate,,,9357,2385.0,CHEMBL623018,1,BAO_0000218,,,,N,,Muscle tissue,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,10116.0,Intermediate,,,9358,2385.0,CHEMBL623019,1,BAO_0000218,,,,N,,Muscle tissue,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,10116.0,Intermediate,,,9359,2385.0,CHEMBL623020,1,BAO_0000218,,,,N,,Muscle tissue,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min.,10116.0,Intermediate,,,9360,2385.0,CHEMBL623021,1,BAO_0000218,,,,N,,Muscle tissue,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,10116.0,Intermediate,,,9361,2385.0,CHEMBL623022,1,BAO_0000218,,,,N,,Muscle tissue,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,10116.0,Intermediate,,,9362,2385.0,CHEMBL623023,1,BAO_0000218,,,,N,,Muscle tissue,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,10116.0,Intermediate,,,9363,2385.0,CHEMBL623024,1,BAO_0000218,,,,N,,Muscle tissue,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,10116.0,Intermediate,,,9364,2385.0,CHEMBL623025,1,BAO_0000218,,,,N,,Muscle tissue,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,10116.0,Intermediate,,,9365,2385.0,CHEMBL620545,1,BAO_0000218,,,,N,,Muscle tissue,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,10116.0,Intermediate,,,9366,2385.0,CHEMBL620546,1,BAO_0000218,,,,N,,Muscle tissue,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,10116.0,Intermediate,,,9367,2385.0,CHEMBL620547,1,BAO_0000218,,,,N,,Muscle tissue,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,10116.0,Intermediate,,,9368,2385.0,CHEMBL620548,1,BAO_0000218,,,,N,,Muscle tissue,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,10116.0,Intermediate,,,9369,2385.0,CHEMBL620549,1,BAO_0000218,,,,N,,Muscle tissue,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,10116.0,Intermediate,,,9370,2385.0,CHEMBL620550,1,BAO_0000218,,,,N,,Muscle tissue,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,10116.0,Intermediate,,,9371,2385.0,CHEMBL620551,1,BAO_0000218,,,,N,,Muscle tissue,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,10116.0,Intermediate,,,9372,2385.0,CHEMBL620552,1,BAO_0000218,,,,N,,Muscle tissue,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,10116.0,Intermediate,,,9373,2385.0,CHEMBL620553,1,BAO_0000218,,,,N,,Muscle tissue,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,10116.0,Intermediate,,,9374,2385.0,CHEMBL620554,1,BAO_0000218,,,,N,,Muscle tissue,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,10116.0,Intermediate,,,9375,2385.0,CHEMBL875845,1,BAO_0000218,,,,N,,Muscle tissue,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,10116.0,Intermediate,,,9376,2385.0,CHEMBL620555,1,BAO_0000218,,,,N,,Muscle tissue,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,10116.0,Intermediate,,,9377,2385.0,CHEMBL620556,1,BAO_0000218,,,,N,,Muscle tissue,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,10116.0,Intermediate,,,9378,2385.0,CHEMBL620557,1,BAO_0000218,,,,N,,Muscle tissue,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,10116.0,Intermediate,,,9379,,CHEMBL620558,1,BAO_0000218,,,,N,,,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,10116.0,Intermediate,,,9380,,CHEMBL620559,1,BAO_0000218,,,,N,,,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,10116.0,Intermediate,,,9381,,CHEMBL622939,1,BAO_0000218,,,,N,,,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,10116.0,Intermediate,,,9382,,CHEMBL622940,1,BAO_0000218,,,,N,,,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,10116.0,Intermediate,,,9383,,CHEMBL622941,1,BAO_0000218,,,,N,,,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,10116.0,Intermediate,,,9384,,CHEMBL622942,1,BAO_0000218,,,,N,,,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,10116.0,Intermediate,,,9385,,CHEMBL622943,1,BAO_0000218,,,,N,,,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,10116.0,Intermediate,,,9386,,CHEMBL622944,1,BAO_0000218,,,,N,,,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,10116.0,Intermediate,,,9387,,CHEMBL622945,1,BAO_0000218,,,,N,,,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,10116.0,Intermediate,,,9388,,CHEMBL622946,1,BAO_0000218,,,,N,,,16435,Rattus norvegicus,50597,A,,1
,Compound was evaluated for terminal half life in rat,10116.0,Intermediate,,,9389,,CHEMBL622947,1,BAO_0000218,,,,N,,,3341,Rattus norvegicus,50597,A,,1
,Compound was evaluated in vivo in rat for the plasma half-life at a iv dose of 3 mg/kg and oral dose of 10 mg/kg and experiment by using concentration vs time curve,10116.0,Intermediate,,,9390,1969.0,CHEMBL622948,1,BAO_0000218,,In vivo,,N,,Plasma,3634,Rattus norvegicus,50597,A,,1
,Compound was evaluated in vivo in rat for the plasma half-life at a oral dose of 20 mg/kg experiment by using concentration vs time curve,10116.0,Intermediate,,,9391,1969.0,CHEMBL622949,1,BAO_0000218,,In vivo,,N,,Plasma,3634,Rattus norvegicus,50597,A,,1
,Compound was tested for its half life in rat,10116.0,Intermediate,,,9392,,CHEMBL622950,1,BAO_0000218,,,,N,,,4839,Rattus norvegicus,50597,A,,1
,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,9544.0,Intermediate,,,9393,1969.0,CHEMBL622951,1,BAO_0000218,,In vivo,,U,,Plasma,5005,Macaca mulatta,22224,A,,0
,Compound was tested for its plasma half life in Sprague Dawley rats,10116.0,Intermediate,,,9394,1969.0,CHEMBL622952,1,BAO_0000366,,,,U,,Plasma,5005,Rattus norvegicus,22224,A,,0
,Compound was tested for its plasma half life in Sprague Dawley rats; ND is not determined,10116.0,Intermediate,,,9395,1969.0,CHEMBL622953,1,BAO_0000366,,,,U,,Plasma,5005,Rattus norvegicus,22224,A,,0
,Compound was tested for plasma half-life period in rat,10116.0,Intermediate,,,9396,1969.0,CHEMBL873818,1,BAO_0000218,,,,N,,Plasma,1094,Rattus norvegicus,50597,A,,1
,Elimination half life after i.v. administration of compound in rats,10116.0,Intermediate,,,9397,,CHEMBL622954,1,BAO_0000218,,In vivo,,N,,,5031,Rattus norvegicus,50597,A,,1
,Elimination half-life after IV dosing at 0.5 mg/kg in rat,10116.0,Intermediate,,,9398,,CHEMBL622955,1,BAO_0000218,,In vivo,,N,,,6518,Rattus norvegicus,50597,A,,1
,Elimination half-life after IV dosing at 1 mg/kg in rat,10116.0,Intermediate,,,9399,,CHEMBL875229,1,BAO_0000218,,In vivo,,N,,,6518,Rattus norvegicus,50597,A,,1
,Elimination half-life after oral administration at a dose of 2 mg/kg in rat,10116.0,Intermediate,,,9400,,CHEMBL622956,1,BAO_0000218,,In vivo,,N,,,6518,Rattus norvegicus,50597,A,,1
,Elimination half-life after oral administration at a dose of 4 mg/kg in rat,10116.0,Intermediate,,,9401,,CHEMBL622957,1,BAO_0000218,,In vivo,,N,,,6518,Rattus norvegicus,50597,A,,1
,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,10116.0,Intermediate,,,9402,955.0,CHEMBL622958,1,BAO_0000218,,In vivo,,N,,Brain,5408,Rattus norvegicus,50597,A,,1
,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,10116.0,Intermediate,,,9403,1969.0,CHEMBL622959,1,BAO_0000218,,In vivo,,N,,Plasma,5408,Rattus norvegicus,50597,A,,1
,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,10116.0,Intermediate,,,9404,955.0,CHEMBL622960,1,BAO_0000218,,In vivo,,N,,Brain,5408,Rattus norvegicus,50597,A,,1
,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,10116.0,Intermediate,,,9405,1969.0,CHEMBL622961,1,BAO_0000218,,In vivo,,N,,Plasma,5408,Rattus norvegicus,50597,A,,1
,Evaluated for the half life in rat (in vivo),10116.0,Intermediate,,,9406,,CHEMBL622962,1,BAO_0000218,,In vivo,,N,,,4687,Rattus norvegicus,50597,A,,1
,Hafl life in rat,10116.0,Intermediate,,,9407,,CHEMBL622963,1,BAO_0000218,,,,N,,,6640,Rattus norvegicus,50597,A,,1
,Hafl life rat,10116.0,Intermediate,,,9408,,CHEMBL622964,1,BAO_0000218,,,,N,,,6640,Rattus norvegicus,50597,A,,1
,Hafl life rat,10116.0,Intermediate,,,9409,,CHEMBL622965,1,BAO_0000218,,,,N,,,6641,Rattus norvegicus,50597,A,,1
,Hafl life rat; Not determined,10116.0,Intermediate,,,9410,,CHEMBL622966,1,BAO_0000218,,,,N,,,6640,Rattus norvegicus,50597,A,,1
,Hafl life rat; Not determined,10116.0,Intermediate,,,9411,,CHEMBL622967,1,BAO_0000218,,,,N,,,6641,Rattus norvegicus,50597,A,,1
,Half life in kidney was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,10116.0,Intermediate,,,9412,2113.0,CHEMBL622968,1,BAO_0000218,,In vivo,,N,,Kidney,17411,Rattus norvegicus,50597,A,,1
,Half life in liver was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,10116.0,Intermediate,,,9413,2107.0,CHEMBL622969,1,BAO_0000218,,In vivo,,N,,Liver,17411,Rattus norvegicus,50597,A,,1
,Half life in lung was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,10116.0,Intermediate,,,9414,2048.0,CHEMBL875327,1,BAO_0000218,,In vivo,,N,,Lung,17411,Rattus norvegicus,50597,A,,1
,Half life in rat after 1 mg/kg i.v. administration,10116.0,Intermediate,,,9415,,CHEMBL628638,1,BAO_0000218,,In vivo,,N,,,6570,Rattus norvegicus,50597,A,,1
,Half life in rat after 2 mg/kg peroral administration,10116.0,Intermediate,,,9416,,CHEMBL628639,1,BAO_0000218,,In vivo,,N,,,6570,Rattus norvegicus,50597,A,,1
,Half life in serum was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,10116.0,Intermediate,,,9417,,CHEMBL625840,1,BAO_0000218,,In vivo,,N,,,17411,Rattus norvegicus,50597,A,,1
,Half life of 10 mg/kg oral dose determined in rats,10116.0,Intermediate,,,9418,,CHEMBL625841,1,BAO_0000218,,In vivo,,N,,,4722,Rattus norvegicus,50597,A,,1
,Half life of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,10116.0,Intermediate,,,9419,,CHEMBL625842,1,BAO_0000218,,In vivo,,N,,,5978,Rattus norvegicus,50597,A,,1
,Half life of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,10116.0,Intermediate,,,9420,,CHEMBL625843,1,BAO_0000218,,In vivo,,N,,,5978,Rattus norvegicus,50597,A,,1
,Half life of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,10116.0,Intermediate,,,9421,,CHEMBL625844,1,BAO_0000218,,In vivo,,N,,,5978,Rattus norvegicus,50597,A,,1
,Half life of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,10116.0,Intermediate,,,9422,,CHEMBL873822,1,BAO_0000218,,In vivo,,N,,,5978,Rattus norvegicus,50597,A,,1
,Half life of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,10116.0,Intermediate,,,9423,,CHEMBL625845,1,BAO_0000218,,In vivo,,N,,,5978,Rattus norvegicus,50597,A,,1
,Half life of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,10116.0,Intermediate,,,9424,,CHEMBL627059,1,BAO_0000218,,In vivo,,N,,,5978,Rattus norvegicus,50597,A,,1
,Half life of compound (9.84 mg/kg) after po administration was determined in Sprague-Dawley rat,10116.0,Intermediate,,,9425,,CHEMBL627060,1,BAO_0000218,,In vivo,,N,,,5978,Rattus norvegicus,50597,A,,1
,Half life of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,10116.0,Intermediate,,,9426,,CHEMBL627061,1,BAO_0000218,,In vivo,,N,,,5978,Rattus norvegicus,50597,A,,1
,Half life of compound at 5 mg/kg after po administration was determined in rat,10116.0,Intermediate,,,9427,,CHEMBL627709,1,BAO_0000218,,In vivo,,N,,,4762,Rattus norvegicus,50597,A,,1
,Half life of compound determined after intravenous administration to rat,10116.0,Intermediate,,,9428,,CHEMBL627710,1,BAO_0000218,,In vivo,,N,,,5327,Rattus norvegicus,50597,A,,1
,Half life of compound was determined in rat,10116.0,Intermediate,,,9429,,CHEMBL627711,1,BAO_0000218,,,,N,,,4847,Rattus norvegicus,50597,A,,1
,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,10116.0,Intermediate,,,9430,1969.0,CHEMBL627712,1,BAO_0000218,,In vivo,,N,,Plasma,17720,Rattus norvegicus,50597,A,,1
,Half life determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,10116.0,Intermediate,,,9431,,CHEMBL627713,1,BAO_0000218,,In vivo,,N,,,4723,Rattus norvegicus,50597,A,,1
,Half life determined after 3 mg/kg oral administration in potassium oxonate treated rats,10116.0,Intermediate,,,9432,,CHEMBL627714,1,BAO_0000218,,In vivo,,N,,,4723,Rattus norvegicus,50597,A,,1
,Half life determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,9541.0,Intermediate,,,9433,,CHEMBL627889,1,BAO_0000218,,In vivo,,U,,,4256,Macaca fascicularis,22224,A,,0
,Half life determined in rat by intravenous administration,10116.0,Intermediate,,,9434,,CHEMBL627890,1,BAO_0000218,,In vivo,,U,,,4256,Rattus norvegicus,22224,A,,0
,Half life determined in rats after iv administration,10116.0,Intermediate,,,9435,,CHEMBL627891,1,BAO_0000218,,In vivo,,N,,,4722,Rattus norvegicus,50597,A,,1
,Half life in rat plasma after administration of 2 mg/kg iv,10116.0,Intermediate,,,9436,1969.0,CHEMBL627892,1,BAO_0000218,,In vivo,,N,,Plasma,6535,Rattus norvegicus,50597,A,,1
,Half life in rat plasma after administration of 2 mg/kg iv,10116.0,Intermediate,,,9437,1969.0,CHEMBL627893,1,BAO_0000218,,In vivo,,N,,Plasma,6535,Rattus norvegicus,50597,A,,1
,Half life in rat plasma was determined,10116.0,Intermediate,,,9438,1969.0,CHEMBL627894,1,BAO_0000218,,,,N,,Plasma,1435,Rattus norvegicus,50597,A,,1
,Half life in rat plasma was determined; NA means not applicable,10116.0,Intermediate,,,9439,1969.0,CHEMBL627895,1,BAO_0000218,,,,N,,Plasma,1435,Rattus norvegicus,50597,A,,1
,Half life in rat was tested,10116.0,Intermediate,,,9440,,CHEMBL627896,1,BAO_0000218,,,,N,,,5206,Rattus norvegicus,50597,A,,1
,Half life measured in rat plasma,10116.0,Intermediate,,,9441,1969.0,CHEMBL627897,1,BAO_0000218,,,,N,,Plasma,6080,Rattus norvegicus,50597,A,,1
,Half life recorded in rats,10116.0,Intermediate,,,9442,,CHEMBL627898,1,BAO_0000218,,,,N,,,4449,Rattus norvegicus,50597,A,,1
,Half life was calculated,10116.0,Intermediate,,,9443,,CHEMBL627899,1,BAO_0000218,,,,N,,,6057,Rattus norvegicus,50597,A,,1
,Half life was calculated in rat,10116.0,Intermediate,,,9444,,CHEMBL873823,1,BAO_0000218,,,,N,,,6057,Rattus norvegicus,50597,A,,1
,Half life was determined,10116.0,Intermediate,,,9445,,CHEMBL627900,1,BAO_0000218,,,,N,,,3747,Rattus norvegicus,50597,A,,1
,Half life after 10 mg/kg oral administration in rat,10116.0,Intermediate,,,9446,,CHEMBL627901,1,BAO_0000218,,In vivo,,N,,,17858,Rattus norvegicus,50597,A,,1
,Half life after administering orally a dose of 10 mg/kg to a fasting rat,10116.0,Intermediate,,,9447,,CHEMBL627902,1,BAO_0000218,,In vivo,,N,,,16365,Rattus norvegicus,50597,A,,1
,Half life after administering orally a dose of 30 mg/kg,10116.0,Intermediate,,,9448,,CHEMBL627903,1,BAO_0000218,,In vivo,,N,,,16365,Rattus norvegicus,50597,A,,1
,Area under the curve (Concentration) was determined for the compound as AUC with limits 0-8 after i.v. administration in rats,10116.0,Intermediate,,,9449,,CHEMBL627904,1,BAO_0000218,,,,N,,,5031,Rattus norvegicus,50597,A,,1
,Area under the curve determined under pharmacokinetic behavior of the 10 mg/kg oral dose of compound for 0-6 hours,10116.0,Intermediate,,,9450,,CHEMBL627905,1,BAO_0000218,,,,N,,,4722,Rattus norvegicus,50597,A,,1
,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in rat,10116.0,Intermediate,,,9451,,CHEMBL627906,1,BAO_0000218,,,,N,,,6078,Rattus norvegicus,50597,A,,1
,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in rat,10116.0,Intermediate,,,9452,,CHEMBL627907,1,BAO_0000218,,,,N,,,6078,Rattus norvegicus,50597,A,,1
,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg,10116.0,Intermediate,,,9453,,CHEMBL876783,1,BAO_0000218,,,,N,,,6078,Rattus norvegicus,50597,A,,1
,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg; activity was not determined,10116.0,Intermediate,,,9454,,CHEMBL627908,1,BAO_0000218,,,,N,,,6078,Rattus norvegicus,50597,A,,1
,Area under the curve measured after intravenous bolus administration of 50 mg/kg of compound to rats,10116.0,Intermediate,,,9455,,CHEMBL627909,1,BAO_0000218,,,,N,,,17065,Rattus norvegicus,50597,A,,1
,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats,10116.0,Intermediate,,,9456,,CHEMBL627910,1,BAO_0000218,,,,N,,,1353,Rattus norvegicus,50597,A,,1
,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-1),10116.0,Intermediate,,,9457,,CHEMBL627911,1,BAO_0000218,,,,N,,,1353,Rattus norvegicus,50597,A,,1
,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-2),10116.0,Intermediate,,,9458,,CHEMBL627912,1,BAO_0000218,,,,N,,,1353,Rattus norvegicus,50597,A,,1
,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-5),10116.0,Intermediate,,,9459,,CHEMBL627913,1,BAO_0000218,,,,N,,,1353,Rattus norvegicus,50597,A,,1
,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(5-10),10116.0,Intermediate,,,9460,,CHEMBL627914,1,BAO_0000218,,,,N,,,1353,Rattus norvegicus,50597,A,,1
,Area under the curve was evaluated after 10 uM/kg of intra arterial administration,10116.0,Intermediate,,,9461,,CHEMBL627915,1,BAO_0000218,,,,N,,,16423,Rattus norvegicus,50597,A,,1
,Area under the curve was evaluated after 20 uM/kg of peroral administration,10116.0,Intermediate,,,9462,,CHEMBL627916,1,BAO_0000218,,,,N,,,16423,Rattus norvegicus,50597,A,,1
,Area under the curve was measured in rat after an iv dose of 1 mg/kg,10116.0,Intermediate,,,9463,,CHEMBL627917,1,BAO_0000218,,,,N,,,6062,Rattus norvegicus,50597,A,,1
,Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat,10116.0,Intermediate,,,9464,,CHEMBL627918,1,BAO_0000218,,,,N,,,6056,Rattus norvegicus,50597,A,,1
,Area under the curve was determined by administering the compound at a dose of 1 mg/kg intravenously in male wistar rat,10116.0,Intermediate,,,9465,,CHEMBL627919,1,BAO_0000218,,,,N,,,5182,Rattus norvegicus,50597,A,,1
,Area under the curve was evaluated at an intravenous dose of 3 mg/kg,10116.0,Intermediate,,,9466,,CHEMBL627920,1,BAO_0000218,,,,N,,,6410,Rattus norvegicus,50597,A,,1
,Area under the curve was evaluated at an oral dose of 30 mg/kg,10116.0,Intermediate,,,9467,,CHEMBL627921,1,BAO_0000218,,,,N,,,6410,Rattus norvegicus,50597,A,,1
,Area under the effect time curves from time 0-24 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,10116.0,Intermediate,,,9468,,CHEMBL627922,1,BAO_0000218,,,,N,,,4723,Rattus norvegicus,50597,A,,1
,Area under the effect time curves from time 0-24 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,10116.0,Intermediate,,,9469,,CHEMBL876784,1,BAO_0000218,,,,N,,,4723,Rattus norvegicus,50597,A,,1
,Area under the effect time curves from time 0-6 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,10116.0,Intermediate,,,9470,,CHEMBL627923,1,BAO_0000218,,,,N,,,4723,Rattus norvegicus,50597,A,,1
,Area under the effect time curves from time 0-6 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,10116.0,Intermediate,,,9471,,CHEMBL626208,1,BAO_0000218,,,,N,,,4723,Rattus norvegicus,50597,A,,1
,Area under the effect time curves from time 0-infinity hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,10116.0,Intermediate,,,9472,,CHEMBL626209,1,BAO_0000218,,,,N,,,4723,Rattus norvegicus,50597,A,,1
,Area under the effect time curves from time 0-infinity hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,10116.0,Intermediate,,,9473,,CHEMBL626210,1,BAO_0000218,,,,N,,,4723,Rattus norvegicus,50597,A,,1
,Area under the plasma concentration curve was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,10116.0,Intermediate,,,9474,1969.0,CHEMBL627994,1,BAO_0000218,,,,N,,Plasma,2463,Rattus norvegicus,50597,A,,1
,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in rat,10116.0,Intermediate,,,9475,,CHEMBL627995,1,BAO_0000218,,,,N,,,4709,Rattus norvegicus,50597,A,,1
,Blood level after a 10 mg/kg oral dose in rat expressed as AUC was determined,10116.0,Intermediate,,,9476,,CHEMBL627996,1,BAO_0000218,,,,N,,,4075,Rattus norvegicus,50597,A,,1
,Compound at a dose 10 mg/kg was administered orally to rat and the pharmacokinetic parameter area under curve (AUC) was measured,10116.0,Intermediate,,,9477,,CHEMBL627997,1,BAO_0000218,,,,N,,,5394,Rattus norvegicus,50597,A,,1
,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female wistar rats,10116.0,Intermediate,,,9478,,CHEMBL627998,1,BAO_0000218,,,,N,,,2661,Rattus norvegicus,50597,A,,1
,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to male wistar rats,10116.0,Intermediate,,,9479,,CHEMBL628640,1,BAO_0000218,,,,N,,,2661,Rattus norvegicus,50597,A,,1
,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female wistar rats,10116.0,Intermediate,,,9480,,CHEMBL628641,1,BAO_0000218,,,,N,,,2661,Rattus norvegicus,50597,A,,1
,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to male wistar rats,10116.0,Intermediate,,,9481,,CHEMBL628642,1,BAO_0000218,,,,N,,,2661,Rattus norvegicus,50597,A,,1
,Compound was evaluated for area under the curve expressed as (h*ug/ml),10116.0,Intermediate,,,9482,,CHEMBL628643,1,BAO_0000218,,,,N,,,17791,Rattus norvegicus,50597,A,,1
,Compound was tested for area under curve in rat,10116.0,Intermediate,,,9483,,CHEMBL628644,1,BAO_0000218,,,,N,,,2591,Rattus norvegicus,50597,A,,1
,Concentration in rat plasma after 5 mg/kg oral gavage for 8 hours,10116.0,Intermediate,,,9484,,CHEMBL628645,1,BAO_0000218,,,,N,,,6567,Rattus norvegicus,50597,A,,1
,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,10116.0,Intermediate,,,9485,,CHEMBL628646,1,BAO_0000218,,,,N,,,6211,Rattus norvegicus,50597,A,,1
,Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg),10116.0,Intermediate,,,9486,,CHEMBL628647,1,BAO_0000218,,,,N,,,5529,Rattus norvegicus,50597,A,,1
,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,10116.0,Intermediate,,,9487,,CHEMBL628648,1,BAO_0000218,,,,N,,,5408,Rattus norvegicus,50597,A,,1
,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,10116.0,Intermediate,,,9488,,CHEMBL625358,1,BAO_0000218,,,,N,,,5408,Rattus norvegicus,50597,A,,1
,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,10116.0,Intermediate,,,9489,,CHEMBL625359,1,BAO_0000218,,,,N,,,5408,Rattus norvegicus,50597,A,,1
,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,10116.0,Intermediate,,,9490,,CHEMBL625360,1,BAO_0000218,,,,N,,,5408,Rattus norvegicus,50597,A,,1
,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg ( 0-8 hr ),10116.0,Intermediate,,,9491,,CHEMBL625361,1,BAO_0000218,,,,N,,,429,Rattus norvegicus,50597,A,,1
,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr ),10116.0,Intermediate,,,9492,,CHEMBL625362,1,BAO_0000218,,,,N,,,429,Rattus norvegicus,50597,A,,1
,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr),10116.0,Intermediate,,,9493,,CHEMBL625363,1,BAO_0000218,,,,N,,,429,Rattus norvegicus,50597,A,,1
,Hepatic portal AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,10116.0,Intermediate,,,9494,,CHEMBL625364,1,BAO_0000218,,,,N,,,4796,Rattus norvegicus,50597,A,,1
,In vivo Area under curve (AUC) was determined after intravenous administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,10116.0,Intermediate,,,9495,,CHEMBL625365,1,BAO_0000218,,,,N,,,5974,Rattus norvegicus,50597,A,,1
,In vivo Area under curve (AUC) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,10116.0,Intermediate,,,9496,,CHEMBL625366,1,BAO_0000218,,,,N,,,5974,Rattus norvegicus,50597,A,,1
,In vivo Area under curve (AUC) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,10116.0,Intermediate,,,9497,,CHEMBL625367,1,BAO_0000218,,,,N,,,5974,Rattus norvegicus,50597,A,,1
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.98-2.56 % dose/g",10116.0,Intermediate,,,9498,2113.0,CHEMBL625368,1,BAO_0000218,,,,N,,Kidney,11450,Rattus norvegicus,50597,A,,1
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.15-1.43 % dose/g",10116.0,Intermediate,,,9499,2113.0,CHEMBL625369,1,BAO_0000218,,,,N,,Kidney,11450,Rattus norvegicus,50597,A,,1
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.43-4.52 % dose/g",10116.0,Intermediate,,,9500,2113.0,CHEMBL625370,1,BAO_0000218,,,,N,,Kidney,11450,Rattus norvegicus,50597,A,,1
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.12-3.14 % dose/g",10116.0,Intermediate,,,9501,2113.0,CHEMBL625371,1,BAO_0000218,,,,N,,Kidney,11450,Rattus norvegicus,50597,A,,1
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.40-1.60 % dose/g",10116.0,Intermediate,,,9502,2113.0,CHEMBL625372,1,BAO_0000218,,,,N,,Kidney,11450,Rattus norvegicus,50597,A,,1
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.74-0.85 % dose/g",10116.0,Intermediate,,,9503,2113.0,CHEMBL625373,1,BAO_0000218,,,,N,,Kidney,11450,Rattus norvegicus,50597,A,,1
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.31-1.45 % dose/g",10116.0,Intermediate,,,9504,2107.0,CHEMBL625374,1,BAO_0000218,,,,N,,Liver,11450,Rattus norvegicus,50597,A,,1
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.90 % dose/g",10116.0,Intermediate,,,9505,2107.0,CHEMBL877593,1,BAO_0000218,,,,N,,Liver,11450,Rattus norvegicus,50597,A,,1
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.02-2.78 % dose/g",10116.0,Intermediate,,,9506,2107.0,CHEMBL625375,1,BAO_0000218,,,,N,,Liver,11450,Rattus norvegicus,50597,A,,1
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.64-2.38 % dose/g",10116.0,Intermediate,,,9507,2107.0,CHEMBL625376,1,BAO_0000218,,,,N,,Liver,11450,Rattus norvegicus,50597,A,,1
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.95-1.07 % dose/g",10116.0,Intermediate,,,9508,2107.0,CHEMBL621973,1,BAO_0000218,,,,N,,Liver,11450,Rattus norvegicus,50597,A,,1
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.61-0.81 % dose/g",10116.0,Intermediate,,,9509,2107.0,CHEMBL621974,1,BAO_0000218,,,,N,,Liver,11450,Rattus norvegicus,50597,A,,1
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 5.01-7.13 % dose/g",10116.0,Intermediate,,,9510,2048.0,CHEMBL621975,1,BAO_0000218,,,,N,,Lung,11450,Rattus norvegicus,50597,A,,1
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.51-3.71 % dose/g",10116.0,Intermediate,,,9511,2048.0,CHEMBL622166,1,BAO_0000218,,,,N,,Lung,11450,Rattus norvegicus,50597,A,,1
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 10.84-13.77 % dose/g",10116.0,Intermediate,,,9512,2048.0,CHEMBL622167,1,BAO_0000218,,,,N,,Lung,11450,Rattus norvegicus,50597,A,,1
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.92-8.51% dose/g",10116.0,Intermediate,,,9513,2048.0,CHEMBL622168,1,BAO_0000218,,,,N,,Lung,11450,Rattus norvegicus,50597,A,,1
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.37-3.94 % dose/g",10116.0,Intermediate,,,9514,2048.0,CHEMBL622169,1,BAO_0000218,,,,N,,Lung,11450,Rattus norvegicus,50597,A,,1
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.87-2.12 % dose/g",10116.0,Intermediate,,,9515,2048.0,CHEMBL622170,1,BAO_0000218,,,,N,,Lung,11450,Rattus norvegicus,50597,A,,1
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 37.97-75.23 % dose/g",10116.0,Intermediate,,,9516,2046.0,CHEMBL622171,1,BAO_0000218,,,,N,,Thyroid gland,11450,Rattus norvegicus,50597,A,,1
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.03-36.88 % dose/g",10116.0,Intermediate,,,9517,2046.0,CHEMBL622172,1,BAO_0000218,,,,N,,Thyroid gland,11450,Rattus norvegicus,50597,A,,1
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 13.20-17.31 % dose/g",10116.0,Intermediate,,,9518,2046.0,CHEMBL622173,1,BAO_0000218,,,,N,,Thyroid gland,11450,Rattus norvegicus,50597,A,,1
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 7.87-16.51 % dose/g",10116.0,Intermediate,,,9519,2046.0,CHEMBL622174,1,BAO_0000218,,,,N,,Thyroid gland,11450,Rattus norvegicus,50597,A,,1
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 81.37-166.09 % dose/g",10116.0,Intermediate,,,9520,2046.0,CHEMBL622175,1,BAO_0000218,,,,N,,Thyroid gland,11450,Rattus norvegicus,50597,A,,1
,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 31.90-39.98 % dose/g",10116.0,Intermediate,,,9521,2046.0,CHEMBL622176,1,BAO_0000218,,,,N,,Thyroid gland,11450,Rattus norvegicus,50597,A,,1
,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.41-0.83 % dose/g",10116.0,Intermediate,,,9522,2046.0,CHEMBL622177,1,BAO_0000218,,,,N,,Thyroid gland,11450,Rattus norvegicus,50597,A,,1
,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.05-0.38 % dose/g",10116.0,Intermediate,,,9523,2046.0,CHEMBL622178,1,BAO_0000218,,,,N,,Thyroid gland,11450,Rattus norvegicus,50597,A,,1
,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.16-0.20 % dose/g",10116.0,Intermediate,,,9524,2046.0,CHEMBL622179,1,BAO_0000218,,,,N,,Thyroid gland,11450,Rattus norvegicus,50597,A,,1
,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.17 % dose/g",10116.0,Intermediate,,,9525,2046.0,CHEMBL622180,1,BAO_0000218,,,,N,,Thyroid gland,11450,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,10116.0,Intermediate,,,9526,,CHEMBL622181,1,BAO_0000218,,,,N,,,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,10116.0,Intermediate,,,9527,,CHEMBL622182,1,BAO_0000218,,,,N,,,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,10116.0,Intermediate,,,9528,,CHEMBL622183,1,BAO_0000218,,,,N,,,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,10116.0,Intermediate,,,9529,,CHEMBL622184,1,BAO_0000218,,,,N,,,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,10116.0,Intermediate,,,9530,,CHEMBL622185,1,BAO_0000218,,,,N,,,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,10116.0,Intermediate,,,9531,,CHEMBL622186,1,BAO_0000218,,,,N,,,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,10116.0,Intermediate,,,9532,,CHEMBL622187,1,BAO_0000218,,,,N,,,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,10116.0,Intermediate,,,9533,,CHEMBL625002,1,BAO_0000218,,,,N,,,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min,10116.0,Intermediate,,,9534,,CHEMBL622090,1,BAO_0000218,,,,N,,,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,10116.0,Intermediate,,,9535,,CHEMBL622091,1,BAO_0000218,,,,N,,,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,10116.0,Intermediate,,,9536,,CHEMBL622092,1,BAO_0000218,,,,N,,,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,10116.0,Intermediate,,,9537,,CHEMBL622093,1,BAO_0000218,,,,N,,,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,10116.0,Intermediate,,,9538,,CHEMBL622094,1,BAO_0000218,,,,N,,,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,10116.0,Intermediate,,,9539,,CHEMBL622095,1,BAO_0000218,,,,N,,,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,10116.0,Intermediate,,,9540,,CHEMBL622264,1,BAO_0000218,,,,N,,,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,10116.0,Intermediate,,,9541,2106.0,CHEMBL622265,1,BAO_0000218,,,,N,,Spleen,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,10116.0,Intermediate,,,9542,2106.0,CHEMBL622266,1,BAO_0000218,,,,N,,Spleen,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,10116.0,Intermediate,,,9543,2106.0,CHEMBL622267,1,BAO_0000218,,,,N,,Spleen,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,10116.0,Intermediate,,,9544,2106.0,CHEMBL622268,1,BAO_0000218,,,,N,,Spleen,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,10116.0,Intermediate,,,9545,2106.0,CHEMBL622269,1,BAO_0000218,,,,N,,Spleen,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,10116.0,Intermediate,,,9546,2106.0,CHEMBL625071,1,BAO_0000218,,,,N,,Spleen,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,10116.0,Intermediate,,,9547,2106.0,CHEMBL621621,1,BAO_0000218,,,,N,,Spleen,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,10116.0,Intermediate,,,9548,2106.0,CHEMBL621622,1,BAO_0000218,,,,N,,Spleen,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,10116.0,Intermediate,,,9549,2106.0,CHEMBL621623,1,BAO_0000218,,,,N,,Spleen,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,10116.0,Intermediate,,,9550,2106.0,CHEMBL621624,1,BAO_0000218,,,,N,,Spleen,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,10116.0,Intermediate,,,9551,2106.0,CHEMBL621625,1,BAO_0000218,,,,N,,Spleen,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,10116.0,Intermediate,,,9552,2106.0,CHEMBL621626,1,BAO_0000218,,,,N,,Spleen,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,10116.0,Intermediate,,,9553,2106.0,CHEMBL621627,1,BAO_0000218,,,,N,,Spleen,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,10116.0,Intermediate,,,9554,2106.0,CHEMBL621628,1,BAO_0000218,,,,N,,Spleen,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,10116.0,Intermediate,,,9555,2106.0,CHEMBL875328,1,BAO_0000218,,,,N,,Spleen,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,10116.0,Intermediate,,,9556,2106.0,CHEMBL621629,1,BAO_0000218,,,,N,,Spleen,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,10116.0,Intermediate,,,9557,2106.0,CHEMBL621630,1,BAO_0000218,,,,N,,Spleen,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,10116.0,Intermediate,,,9558,2106.0,CHEMBL621631,1,BAO_0000218,,,,N,,Spleen,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,10116.0,Intermediate,,,9559,2106.0,CHEMBL621632,1,BAO_0000218,,,,N,,Spleen,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,10116.0,Intermediate,,,9560,2106.0,CHEMBL621633,1,BAO_0000218,,,,N,,Spleen,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,10116.0,Intermediate,,,9561,2106.0,CHEMBL621634,1,BAO_0000218,,,,N,,Spleen,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,10116.0,Intermediate,,,9562,2106.0,CHEMBL621635,1,BAO_0000218,,,,N,,Spleen,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,10116.0,Intermediate,,,9563,2106.0,CHEMBL621636,1,BAO_0000218,,,,N,,Spleen,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,10116.0,Intermediate,,,9564,2106.0,CHEMBL621637,1,BAO_0000218,,,,N,,Spleen,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,10116.0,Intermediate,,,9565,2106.0,CHEMBL621638,1,BAO_0000218,,,,N,,Spleen,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,10116.0,Intermediate,,,9566,,CHEMBL618883,1,BAO_0000218,,,,N,,,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,10116.0,Intermediate,,,9567,,CHEMBL618884,1,BAO_0000218,,,,N,,,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,10116.0,Intermediate,,,9568,,CHEMBL628627,1,BAO_0000218,,,,N,,,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,10116.0,Intermediate,,,9569,,CHEMBL628628,1,BAO_0000218,,,,N,,,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,10116.0,Intermediate,,,9570,,CHEMBL628629,1,BAO_0000218,,,,N,,,16434,Rattus norvegicus,50597,A,,1
,Half life after administering orally a dose of 3 mg/kg,10116.0,Intermediate,,,9571,,CHEMBL628630,1,BAO_0000218,,In vivo,,N,,,16365,Rattus norvegicus,50597,A,,1
,Half life after administering orally a dose of 3 mg/kg to a fasting rat,10116.0,Intermediate,,,9572,,CHEMBL628631,1,BAO_0000218,,In vivo,,N,,,16365,Rattus norvegicus,50597,A,,1
,Half life after administering intravenously a dose of 1 mg/kg,10116.0,Intermediate,,,9573,,CHEMBL628632,1,BAO_0000218,,In vivo,,N,,,16365,Rattus norvegicus,50597,A,,1
,Half life after oral dosing in rats,10116.0,Intermediate,,,9574,,CHEMBL628633,1,BAO_0000218,,In vivo,,N,,,526,Rattus norvegicus,50597,A,,1
,Half life after the administered orally a dose of 1 mg/kg to a fasting rat,10116.0,Intermediate,,,9575,,CHEMBL628634,1,BAO_0000218,,In vivo,,N,,,16365,Rattus norvegicus,50597,A,,1
,Half life by intravenous administration of 3.4 mg/kg in rat,10116.0,Intermediate,,,9576,,CHEMBL627789,1,BAO_0000218,,In vivo,,N,,,4368,Rattus norvegicus,50597,A,,1
,Half life in rat,10116.0,Intermediate,,,9577,,CHEMBL627790,1,BAO_0000218,,,,N,,,3371,Rattus norvegicus,50597,A,,1
,Half life in rat,10116.0,Intermediate,,,9578,,CHEMBL627791,1,BAO_0000218,,,,N,,,6448,Rattus norvegicus,50597,A,,1
,Half life in rat,10116.0,Intermediate,,,9579,,CHEMBL627792,1,BAO_0000218,,,,N,,,6453,Rattus norvegicus,50597,A,,1
,Half life in rat after intravenous administration of the compound,10116.0,Intermediate,,,9580,,CHEMBL627793,1,BAO_0000218,,In vivo,,N,,,4353,Rattus norvegicus,50597,A,,1
,Half life in rat after intravenous administration of the compound; nf:unable to estimate plasma elimination half life,10116.0,Intermediate,,,9581,1969.0,CHEMBL627794,1,BAO_0000218,,In vivo,,N,,Plasma,4353,Rattus norvegicus,50597,A,,1
,Half life in rat after po administration of the compound,10116.0,Intermediate,,,9582,,CHEMBL627795,1,BAO_0000218,,In vivo,,N,,,4353,Rattus norvegicus,50597,A,,1
,Half life in rat after po administration of the compound; ND means Not determined,10116.0,Intermediate,,,9583,,CHEMBL627796,1,BAO_0000218,,In vivo,,N,,,4353,Rattus norvegicus,50597,A,,1
,Half life in rat after po administration of the compound; nf: unable to estimate plasma elimination half life,10116.0,Intermediate,,,9584,1969.0,CHEMBL875335,1,BAO_0000218,,In vivo,,N,,Plasma,4353,Rattus norvegicus,50597,A,,1
,Half life in rat after po administration of the compound; nf:unable to estimate plasma elimination half life,10116.0,Intermediate,,,9585,1969.0,CHEMBL627797,1,BAO_0000218,,In vivo,,N,,Plasma,4353,Rattus norvegicus,50597,A,,1
,Half life in rat i.v.,10116.0,Intermediate,,,9586,,CHEMBL627798,1,BAO_0000218,,In vivo,,N,,,5789,Rattus norvegicus,50597,A,,1
,Half life in rat i.v. at 2 mg/kg concentration,10116.0,Intermediate,,,9587,,CHEMBL627799,1,BAO_0000218,,In vivo,,N,,,17686,Rattus norvegicus,50597,A,,1
,Half life in rats,10116.0,Intermediate,,,9588,,CHEMBL627800,1,BAO_0000218,,,,N,,,6495,Rattus norvegicus,50597,A,,1
,Half life in rats after intravenous administration,10116.0,Intermediate,,,9589,,CHEMBL627801,1,BAO_0000218,,In vivo,,N,,,484,Rattus norvegicus,50597,A,,1
,Half life in rats at the dose of 1.0 mpk by i.v. administration,10116.0,Intermediate,,,9590,,CHEMBL627802,1,BAO_0000218,,In vivo,,N,,,6467,Rattus norvegicus,50597,A,,1
,Half life in rat,10116.0,Expert,,,9591,,CHEMBL627803,1,BAO_0000218,,,,N,,,6642,Rattus norvegicus,50597,A,,1
,Half life was evaluated after intravenous administration to rats,10116.0,Intermediate,,,9592,,CHEMBL873820,1,BAO_0000218,,In vivo,,N,,,16367,Rattus norvegicus,50597,A,,1
,Half life was evaluated by addition of 2 mM of 2-mercaptoethanol for inactivation of semicarbazide-sensitive amine oxidase (SSAO),10116.0,Intermediate,,,9593,,CHEMBL627804,1,BAO_0000218,,,,N,,,1369,Rattus norvegicus,50597,A,,1
,Half life was evaluated in rat,10116.0,Intermediate,,,9594,,CHEMBL627805,1,BAO_0000218,,,,N,,,5472,Rattus norvegicus,50597,A,,1
,Half life was evaluated in rat,10116.0,Intermediate,,,9595,,CHEMBL627806,1,BAO_0000218,,,,N,,,6049,Rattus norvegicus,50597,A,,1
,Half life was evaluated in rat; Not tested,10116.0,Intermediate,,,9596,,CHEMBL627107,1,BAO_0000218,,,,N,,,5472,Rattus norvegicus,50597,A,,1
,Half life was evaluated when a dose of 1 mg/kg was administered intravenously to rats,10116.0,Intermediate,,,9597,,CHEMBL627108,1,BAO_0000218,,In vivo,,N,,,16366,Rattus norvegicus,50597,A,,1
,Half life was measured as time taken to reach the half of the initial dose in air pouch exudate after oral administration to male F344 rats,10116.0,Intermediate,,,9598,,CHEMBL627109,1,BAO_0000218,,In vivo,,N,,,11149,Rattus norvegicus,50597,A,,1
,Half life was measured as time taken to reach the half of the initial dose in the blood after oral administration to male F344 rats,10116.0,Intermediate,,,9599,178.0,CHEMBL627110,1,BAO_0000218,,In vivo,,N,,Blood,11149,Rattus norvegicus,50597,A,,1
,Half life was measured in monkey at dose of 10 mg/kg by po administration,9443.0,Intermediate,,,9600,,CHEMBL627111,1,BAO_0000218,,In vivo,,U,,,2891,Primates,22224,A,,0
,Half life was measured in monkey at dose of 10 mg/kg by po administration,9443.0,Intermediate,,,9601,,CHEMBL627112,1,BAO_0000218,,In vivo,,U,,,2891,Primates,22224,A,,0
,Half life was measured in rat at dose of 30 mg/kg by iv administration,10116.0,Intermediate,,,9602,,CHEMBL627113,1,BAO_0000218,,In vivo,,U,,,2891,Rattus norvegicus,22224,A,,0
,Half life was measured in rat at dose of 30 mg/kg by po administration,10116.0,Intermediate,,,9603,,CHEMBL627114,1,BAO_0000218,,In vivo,,U,,,2891,Rattus norvegicus,22224,A,,0
,Half life (t1/2) was determined,10116.0,Intermediate,,,9604,,CHEMBL627115,1,BAO_0000218,,,,N,,,4026,Rattus norvegicus,50597,A,,1
,Half life period at a dose of 10 uM/kg in rat was determined,10116.0,Intermediate,,,9605,,CHEMBL627116,1,BAO_0000218,,,,N,,,4527,Rattus norvegicus,50597,A,,1
,Half life period by oral administration at a dose of 100 uM/kg in rat was determined; ND is not determined,10116.0,Intermediate,,,9606,,CHEMBL627117,1,BAO_0000218,,In vivo,,N,,,4527,Rattus norvegicus,50597,A,,1
,Half life period was determined,10116.0,Intermediate,,,9607,,CHEMBL627118,1,BAO_0000218,,,,N,,,5503,Rattus norvegicus,50597,A,,1
,Half life period after intravenous administration at 20 mpk in rats,10116.0,Intermediate,,,9608,,CHEMBL627119,1,BAO_0000218,,In vivo,,N,,,4426,Rattus norvegicus,50597,A,,1
,Half life period after intravenous administration at 20 mpk in rats; Not performed.,10116.0,Intermediate,,,9609,,CHEMBL627120,1,BAO_0000218,,In vivo,,N,,,4426,Rattus norvegicus,50597,A,,1
,Half life period after intravenous administration in rat,10116.0,Intermediate,,,9610,,CHEMBL626922,1,BAO_0000218,,In vivo,,N,,,6109,Rattus norvegicus,50597,A,,1
,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,10116.0,Intermediate,,,9611,,CHEMBL626923,1,BAO_0000218,,In vivo,,N,,,5654,Rattus norvegicus,50597,A,,1
,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,10116.0,Intermediate,,,9612,,CHEMBL626924,1,BAO_0000218,,In vivo,,N,,,5654,Rattus norvegicus,50597,A,,1
,Half life period in 80% rat plasma at 37 degree Centigrade,10116.0,Intermediate,,,9613,1969.0,CHEMBL626925,1,BAO_0000218,,,,N,,Plasma,4755,Rattus norvegicus,50597,A,,1
,Half life period in SD rats,10116.0,Intermediate,,,9614,,CHEMBL626926,1,BAO_0000218,,,,N,,,5862,Rattus norvegicus,50597,A,,1
,Half life period in human plasma at 25 degree Celsius temperature (pH 7.4),10116.0,Intermediate,,,9615,1969.0,CHEMBL626927,1,BAO_0000218,,,,N,,Plasma,1515,Rattus norvegicus,50597,A,,1
,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4),10116.0,Intermediate,,,9616,1969.0,CHEMBL626928,1,BAO_0000218,,,,N,,Plasma,1515,Rattus norvegicus,50597,A,,1
,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,10116.0,Intermediate,,,9617,1969.0,CHEMBL626929,1,BAO_0000218,,,,N,,Plasma,1515,Rattus norvegicus,50597,A,,1
,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,10116.0,Intermediate,,,9618,1969.0,CHEMBL626930,1,BAO_0000218,,,,N,,Plasma,1515,Rattus norvegicus,50597,A,,1
,Half life period in rat,10116.0,Intermediate,,,9619,,CHEMBL626931,1,BAO_0000218,,,,N,,,5960,Rattus norvegicus,50597,A,,1
,Half life period in rat,10116.0,Intermediate,,,9620,,CHEMBL626932,1,BAO_0000218,,,,N,,,6103,Rattus norvegicus,50597,A,,1
,Half life period in rat,10116.0,Intermediate,,,9621,,CHEMBL626933,1,BAO_0000218,,,,N,,,6317,Rattus norvegicus,50597,A,,1
,Half life period in rat after oral administration at 10.5 mg/kg dose,10116.0,Intermediate,,,9622,,CHEMBL873826,1,BAO_0000218,,In vivo,,N,,,6644,Rattus norvegicus,50597,A,,1
,Half life period in rat after oral administration at 11.2 mg/kg dose,10116.0,Intermediate,,,9623,,CHEMBL626934,1,BAO_0000218,,In vivo,,N,,,6644,Rattus norvegicus,50597,A,,1
,Half life period in rat after oral administration at 13 mg/kg dose,10116.0,Intermediate,,,9624,,CHEMBL626935,1,BAO_0000218,,In vivo,,N,,,6644,Rattus norvegicus,50597,A,,1
,Half life period in rat after oral administration at 9.7 mg/kg dose,10116.0,Intermediate,,,9625,,CHEMBL626936,1,BAO_0000218,,In vivo,,N,,,6644,Rattus norvegicus,50597,A,,1
,In vivo Area under curve (AUC) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,10116.0,Intermediate,,,9626,,CHEMBL626937,1,BAO_0000218,,,,N,,,5974,Rattus norvegicus,50597,A,,1
,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,10116.0,Intermediate,,,9627,,CHEMBL625906,1,BAO_0000218,,,,N,,,6295,Rattus norvegicus,50597,A,,1
,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,10116.0,Intermediate,,,9628,,CHEMBL625907,1,BAO_0000218,,,,N,,,6296,Rattus norvegicus,50597,A,,1
,PK study was carried to determine AUC (area under curve) value in rat,10116.0,Intermediate,,,9629,,CHEMBL625908,1,BAO_0000218,,,,N,,,16427,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter AUC after intravenous administration to rats,10116.0,Intermediate,,,9630,,CHEMBL625909,1,BAO_0000218,,,,N,,,16367,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter AUC after oral administration to rats,10116.0,Intermediate,,,9631,,CHEMBL625910,1,BAO_0000218,,,,N,,,16367,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter AUC was evaluated intravenous administration of 3 mg/kg,10116.0,Intermediate,,,9632,,CHEMBL625911,1,BAO_0000218,,,,N,,,16365,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter AUC was evaluated when a dose of 10 mg/kg is administered orally to a fasting rat,10116.0,Intermediate,,,9633,,CHEMBL625912,1,BAO_0000218,,,,N,,,16365,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter AUC was evaluated when a dose of 1 mg/kg is administered orally to a fasting rat,10116.0,Intermediate,,,9634,,CHEMBL626538,1,BAO_0000218,,,,N,,,16365,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter AUC was evaluated when a dose of 30 mg/kg is administered orally,10116.0,Intermediate,,,9635,,CHEMBL876794,1,BAO_0000218,,,,N,,,16365,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally,10116.0,Intermediate,,,9636,,CHEMBL626539,1,BAO_0000218,,,,N,,,16365,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally to a fasting rat,10116.0,Intermediate,,,9637,,CHEMBL626540,1,BAO_0000218,,,,N,,,16365,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter area under curve (AUC) was measured after administration into monkey at 3 mg/kg,10116.0,Intermediate,,,9638,,CHEMBL626541,1,BAO_0000218,,,,N,,,5394,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter area under curve (AUC) was measured after administration into rat at 10 mg/kg,10116.0,Intermediate,,,9639,,CHEMBL626542,1,BAO_0000218,,,,N,,,5394,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter area under curve was determined at 10 mg/kg po dose in rats,10116.0,Intermediate,,,9640,,CHEMBL626543,1,BAO_0000218,,,,N,,,2792,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter area under curve was determined at 2 mg/kg i.v. dose in rats,10116.0,Intermediate,,,9641,,CHEMBL626544,1,BAO_0000218,,,,N,,,2792,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter area under curve was determined at 3 mg/kg po dose in rats,10116.0,Intermediate,,,9642,,CHEMBL626545,1,BAO_0000218,,,,N,,,2792,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter area under curve was determined at 5 mg/kg i.v. dose in rats,10116.0,Intermediate,,,9643,,CHEMBL626546,1,BAO_0000218,,,,N,,,2792,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter area under curve was reported,10116.0,Intermediate,,,9644,,CHEMBL626547,1,BAO_0000218,,,,N,,,5334,Rattus norvegicus,50597,A,,1
,Pharmacokinetic property (AUC) in rat,10116.0,Intermediate,,,9645,,CHEMBL626548,1,BAO_0000218,,,,N,,,4408,Rattus norvegicus,50597,A,,1
,Pharmacokinetic property (AUC) was measured in rat at the dose of 0.32 mg/kg p.o.,10116.0,Intermediate,,,9646,,CHEMBL626549,1,BAO_0000218,,,,N,,,5983,Rattus norvegicus,50597,A,,1
,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.,10116.0,Intermediate,,,9647,,CHEMBL626550,1,BAO_0000218,,,,N,,,4397,Rattus norvegicus,50597,A,,1
,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.; Not tested,10116.0,Intermediate,,,9648,,CHEMBL626551,1,BAO_0000218,,,,N,,,4397,Rattus norvegicus,50597,A,,1
,Pharmacokinetic property was determined,10116.0,Intermediate,,,9649,,CHEMBL623777,1,BAO_0000218,,,,N,,,5491,Rattus norvegicus,50597,A,,1
,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg,10116.0,Intermediate,,,9650,,CHEMBL623778,1,BAO_0000218,,,,N,,,5491,Rattus norvegicus,50597,A,,1
,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg; Not tested,10116.0,Intermediate,,,9651,,CHEMBL623779,1,BAO_0000218,,,,N,,,5491,Rattus norvegicus,50597,A,,1
,Pharmacokinetic property( plasma concentration) was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,10116.0,Intermediate,,,9652,1969.0,CHEMBL623780,1,BAO_0000218,,,,N,,Plasma,4199,Rattus norvegicus,50597,A,,1
,Pharmacokinetic property( plasma concentration) was determined upon 2 mg/kg in 1% methylcellulose peroral administration in rats,10116.0,Intermediate,,,9653,1969.0,CHEMBL622015,1,BAO_0000218,,,,N,,Plasma,4199,Rattus norvegicus,50597,A,,1
,Pharmacokinetic property( plasma concentration) was determined upon 3 mg/kg in 1% methylcellulose peroral administration in rats,10116.0,Intermediate,,,9654,1969.0,CHEMBL622016,1,BAO_0000218,,,,N,,Plasma,4199,Rattus norvegicus,50597,A,,1
,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.25 h",10116.0,Intermediate,,,9655,,CHEMBL622017,1,BAO_0000218,,,,N,,,5173,Rattus norvegicus,50597,A,,1
,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.5 h",10116.0,Intermediate,,,9656,,CHEMBL622018,1,BAO_0000218,,,,N,,,5173,Rattus norvegicus,50597,A,,1
,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 1 h",10116.0,Intermediate,,,9657,,CHEMBL622019,1,BAO_0000218,,,,N,,,5173,Rattus norvegicus,50597,A,,1
,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 2 h",10116.0,Intermediate,,,9658,,CHEMBL622020,1,BAO_0000218,,,,N,,,5173,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered intravenously,10116.0,Intermediate,,,9659,,CHEMBL622021,1,BAO_0000218,,,,N,,,16366,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered orally,10116.0,Intermediate,,,9660,,CHEMBL622022,1,BAO_0000218,,,,N,,,16366,Rattus norvegicus,50597,A,,1
,Plasma concentration expressed as area under curve after intravenous administration was determined in rat,10116.0,Intermediate,,,9661,,CHEMBL622023,1,BAO_0000218,,,,N,,,5327,Rattus norvegicus,50597,A,,1
,Plasma concentration for the compound was determined in rats at 50 mg/kg dose,10116.0,Intermediate,,,9662,,CHEMBL622024,1,BAO_0000218,,,,N,,,6681,Rattus norvegicus,50597,A,,1
,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of solution (formulation of compound),10116.0,Intermediate,,,9663,,CHEMBL622693,1,BAO_0000218,,,,N,,,12873,Rattus norvegicus,50597,A,,1
,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of suspension (formulation of compound),10116.0,Intermediate,,,9664,,CHEMBL622694,1,BAO_0000218,,,,N,,,12873,Rattus norvegicus,50597,A,,1
,"Plasma concentration was determined in rats at 10 mg/kg, p.o. dose",10116.0,Intermediate,,,9665,,CHEMBL622695,1,BAO_0000218,,,,N,,,6685,Rattus norvegicus,50597,A,,1
,"Plasma concentration was determined in rats at 20 mg/kg, i.p. dose",10116.0,Intermediate,,,9666,,CHEMBL622696,1,BAO_0000218,,,,N,,,6685,Rattus norvegicus,50597,A,,1
,"Plasma concentration was determined in rats at 2 mg/kg, i.v. dose",10116.0,Intermediate,,,9667,,CHEMBL622697,1,BAO_0000218,,,,N,,,6685,Rattus norvegicus,50597,A,,1
,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (20 mg/kg, 30 min pre-treatment)",10116.0,Intermediate,,,9668,,CHEMBL622874,1,BAO_0000218,,,,N,,,6619,Rattus norvegicus,50597,A,,1
,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (30 mg/kg, 30 min pre-treatment)",10116.0,Intermediate,,,9669,,CHEMBL622875,1,BAO_0000218,,,,N,,,6619,Rattus norvegicus,50597,A,,1
,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,10116.0,Intermediate,,,9670,,CHEMBL622876,1,BAO_0000218,,,,N,,,10363,Rattus norvegicus,50597,A,,1
,Systemic AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,10116.0,Intermediate,,,9671,,CHEMBL622877,1,BAO_0000218,,,,N,,,4796,Rattus norvegicus,50597,A,,1
,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,10116.0,Intermediate,,,9672,,CHEMBL622878,1,BAO_0000218,,,,N,,,4910,Rattus norvegicus,50597,A,,1
,Tested for plasma concentration after intravenous administration (4.7 mg/kg) to male rats,10116.0,Intermediate,,,9673,1969.0,CHEMBL622879,1,BAO_0000218,,,,N,,Plasma,4910,Rattus norvegicus,50597,A,,1
,Tested for the pharmacokinetic parameter in rat and expressed as area under curve,10116.0,Intermediate,,,9674,,CHEMBL877602,1,BAO_0000218,,,,N,,,4839,Rattus norvegicus,50597,A,,1
,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",10116.0,Intermediate,,,9675,,CHEMBL622880,1,BAO_0000218,,,,N,,,15078,Rattus norvegicus,50597,A,,1
,"The AUC(0-infinitive) value in male wistar rat at 100 mg/kg, p.o. dose",10116.0,Intermediate,,,9676,,CHEMBL622881,1,BAO_0000218,,,,N,,,15078,Rattus norvegicus,50597,A,,1
,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",10116.0,Intermediate,,,9677,,CHEMBL622882,1,BAO_0000218,,,,N,,,15078,Rattus norvegicus,50597,A,,1
,"The AUC(0-t)value in male wistar rat at 100 mg/kg, p.o. dose",10116.0,Intermediate,,,9678,,CHEMBL622883,1,BAO_0000218,,,,N,,,15078,Rattus norvegicus,50597,A,,1
,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.16-2.39% dose/g",10116.0,Intermediate,,,9679,2046.0,CHEMBL622884,1,BAO_0000218,,,,N,,Thyroid gland,11450,Rattus norvegicus,50597,A,,1
,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.99-1.40 % dose/g",10116.0,Intermediate,,,9680,2046.0,CHEMBL622885,1,BAO_0000218,,,,N,,Thyroid gland,11450,Rattus norvegicus,50597,A,,1
,Antidiuretic activity expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,10116.0,Intermediate,,,9681,,CHEMBL622886,1,BAO_0000218,,,,N,,,8151,Rattus norvegicus,50597,A,,1
,Antidiuretic activity expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,10116.0,Intermediate,,,9682,,CHEMBL622887,1,BAO_0000218,,,,N,,,8151,Rattus norvegicus,50597,A,,1
,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,10116.0,Intermediate,,,9683,1088.0,CHEMBL622888,1,BAO_0000218,,,,N,,Urine,8151,Rattus norvegicus,50597,A,,1
,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",10116.0,Intermediate,,,9684,178.0,CHEMBL622889,1,BAO_0000218,,In vivo,,N,,Blood,8677,Rattus norvegicus,50597,A,,1
,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",10116.0,Intermediate,,,9685,178.0,CHEMBL622890,1,BAO_0000218,,In vivo,,N,,Blood,8677,Rattus norvegicus,50597,A,,1
,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",10116.0,Intermediate,,,9686,178.0,CHEMBL622891,1,BAO_0000218,,In vivo,,N,,Blood,8677,Rattus norvegicus,50597,A,,1
,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",10116.0,Intermediate,,,9687,178.0,CHEMBL877603,1,BAO_0000218,,In vivo,,N,,Blood,8677,Rattus norvegicus,50597,A,,1
,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",10116.0,Intermediate,,,9688,955.0,CHEMBL622892,1,BAO_0000218,,In vivo,,N,,Brain,8677,Rattus norvegicus,50597,A,,1
,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",10116.0,Intermediate,,,9689,955.0,CHEMBL622893,1,BAO_0000218,,In vivo,,N,,Brain,8677,Rattus norvegicus,50597,A,,1
,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",10116.0,Intermediate,,,9690,955.0,CHEMBL622894,1,BAO_0000218,,In vivo,,N,,Brain,8677,Rattus norvegicus,50597,A,,1
,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",10116.0,Intermediate,,,9691,955.0,CHEMBL622895,1,BAO_0000218,,In vivo,,N,,Brain,8677,Rattus norvegicus,50597,A,,1
,Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration.,10116.0,Intermediate,,,9692,955.0,CHEMBL622896,1,BAO_0000218,,In vivo,,N,,Brain,8677,Rattus norvegicus,50597,A,,1
,"Biodistribution in Sprague-Dawley rat heart 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",10116.0,Intermediate,,,9693,948.0,CHEMBL622897,1,BAO_0000218,,In vivo,,N,,Heart,8677,Rattus norvegicus,50597,A,,1
,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",10116.0,Intermediate,,,9694,948.0,CHEMBL622898,1,BAO_0000218,,In vivo,,N,,Heart,8677,Rattus norvegicus,50597,A,,1
,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",10116.0,Intermediate,,,9695,948.0,CHEMBL622899,1,BAO_0000218,,In vivo,,N,,Heart,8677,Rattus norvegicus,50597,A,,1
,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",10116.0,Intermediate,,,9696,2113.0,CHEMBL622900,1,BAO_0000218,,In vivo,,N,,Kidney,8677,Rattus norvegicus,50597,A,,1
,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",10116.0,Intermediate,,,9697,2113.0,CHEMBL624114,1,BAO_0000218,,In vivo,,N,,Kidney,8677,Rattus norvegicus,50597,A,,1
,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",10116.0,Intermediate,,,9698,2113.0,CHEMBL624115,1,BAO_0000218,,In vivo,,N,,Kidney,8677,Rattus norvegicus,50597,A,,1
,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",10116.0,Intermediate,,,9699,2113.0,CHEMBL624116,1,BAO_0000218,,In vivo,,N,,Kidney,8677,Rattus norvegicus,50597,A,,1
,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",10116.0,Intermediate,,,9700,2107.0,CHEMBL624117,1,BAO_0000218,,In vivo,,N,,Liver,8677,Rattus norvegicus,50597,A,,1
,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",10116.0,Intermediate,,,9701,2107.0,CHEMBL624118,1,BAO_0000218,,In vivo,,N,,Liver,8677,Rattus norvegicus,50597,A,,1
,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",10116.0,Intermediate,,,9702,2107.0,CHEMBL624119,1,BAO_0000218,,In vivo,,N,,Liver,8677,Rattus norvegicus,50597,A,,1
,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",10116.0,Intermediate,,,9703,2107.0,CHEMBL624120,1,BAO_0000218,,In vivo,,N,,Liver,8677,Rattus norvegicus,50597,A,,1
,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",10116.0,Intermediate,,,9704,2048.0,CHEMBL624121,1,BAO_0000218,,In vivo,,N,,Lung,8677,Rattus norvegicus,50597,A,,1
,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",10116.0,Intermediate,,,9705,2048.0,CHEMBL624122,1,BAO_0000218,,In vivo,,N,,Lung,8677,Rattus norvegicus,50597,A,,1
,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",10116.0,Intermediate,,,9706,2048.0,CHEMBL624123,1,BAO_0000218,,In vivo,,N,,Lung,8677,Rattus norvegicus,50597,A,,1
,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",10116.0,Intermediate,,,9707,2048.0,CHEMBL624124,1,BAO_0000218,,In vivo,,N,,Lung,8677,Rattus norvegicus,50597,A,,1
,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",10116.0,Intermediate,,,9708,2385.0,CHEMBL624125,1,BAO_0000218,,In vivo,,N,,Muscle tissue,8677,Rattus norvegicus,50597,A,,1
,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",10116.0,Intermediate,,,9709,2385.0,CHEMBL624126,1,BAO_0000218,,In vivo,,N,,Muscle tissue,8677,Rattus norvegicus,50597,A,,1
,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",10116.0,Intermediate,,,9710,2385.0,CHEMBL624127,1,BAO_0000218,,In vivo,,N,,Muscle tissue,8677,Rattus norvegicus,50597,A,,1
,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",10116.0,Intermediate,,,9711,2385.0,CHEMBL624128,1,BAO_0000218,,In vivo,,N,,Muscle tissue,8677,Rattus norvegicus,50597,A,,1
,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",10116.0,Intermediate,,,9712,14.0,CHEMBL624129,1,BAO_0000218,,In vivo,,N,,Zone of skin,8677,Rattus norvegicus,50597,A,,1
,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",10116.0,Intermediate,,,9713,14.0,CHEMBL624130,1,BAO_0000218,,In vivo,,N,,Zone of skin,8677,Rattus norvegicus,50597,A,,1
,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",10116.0,Intermediate,,,9714,14.0,CHEMBL622340,1,BAO_0000218,,In vivo,,N,,Zone of skin,8677,Rattus norvegicus,50597,A,,1
,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",10116.0,Intermediate,,,9715,14.0,CHEMBL622341,1,BAO_0000218,,In vivo,,N,,Zone of skin,8677,Rattus norvegicus,50597,A,,1
,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",10116.0,Intermediate,,,9716,160.0,CHEMBL622342,1,BAO_0000218,,In vivo,,N,,Intestine,8677,Rattus norvegicus,50597,A,,1
,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",10116.0,Intermediate,,,9717,160.0,CHEMBL622343,1,BAO_0000218,,In vivo,,N,,Intestine,8677,Rattus norvegicus,50597,A,,1
,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",10116.0,Intermediate,,,9718,160.0,CHEMBL622344,1,BAO_0000218,,In vivo,,N,,Intestine,8677,Rattus norvegicus,50597,A,,1
,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",10116.0,Intermediate,,,9719,160.0,CHEMBL622345,1,BAO_0000218,,In vivo,,N,,Intestine,8677,Rattus norvegicus,50597,A,,1
,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",10116.0,Intermediate,,,9720,2106.0,CHEMBL622346,1,BAO_0000218,,In vivo,,N,,Spleen,8677,Rattus norvegicus,50597,A,,1
,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",10116.0,Intermediate,,,9721,2106.0,CHEMBL622347,1,BAO_0000218,,In vivo,,N,,Spleen,8677,Rattus norvegicus,50597,A,,1
,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",10116.0,Intermediate,,,9722,2106.0,CHEMBL622348,1,BAO_0000218,,In vivo,,N,,Spleen,8677,Rattus norvegicus,50597,A,,1
,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",10116.0,Intermediate,,,9723,2106.0,CHEMBL622349,1,BAO_0000218,,In vivo,,N,,Spleen,8677,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,10116.0,Intermediate,,,9724,,CHEMBL622350,1,BAO_0000218,,,,N,,,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,10116.0,Intermediate,,,9725,,CHEMBL622351,1,BAO_0000218,,,,N,,,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,10116.0,Intermediate,,,9726,,CHEMBL622352,1,BAO_0000218,,,,N,,,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,10116.0,Intermediate,,,9727,,CHEMBL622353,1,BAO_0000218,,,,N,,,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,10116.0,Intermediate,,,9728,,CHEMBL622354,1,BAO_0000218,,,,N,,,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,10116.0,Intermediate,,,9729,,CHEMBL622355,1,BAO_0000218,,,,N,,,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,10116.0,Intermediate,,,9730,,CHEMBL622356,1,BAO_0000218,,,,N,,,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,10116.0,Intermediate,,,9731,,CHEMBL622357,1,BAO_0000218,,,,N,,,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,10116.0,Intermediate,,,9732,,CHEMBL622358,1,BAO_0000218,,,,N,,,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,10116.0,Intermediate,,,9733,,CHEMBL622359,1,BAO_0000218,,,,N,,,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,10116.0,Intermediate,,,9734,,CHEMBL874393,1,BAO_0000218,,,,N,,,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,10116.0,Intermediate,,,9735,,CHEMBL622872,1,BAO_0000218,,,,N,,,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,10116.0,Intermediate,,,9736,,CHEMBL622873,1,BAO_0000218,,,,N,,,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,10116.0,Intermediate,,,9737,,CHEMBL623047,1,BAO_0000218,,,,N,,,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,10116.0,Intermediate,,,9738,,CHEMBL623048,1,BAO_0000218,,,,N,,,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,10116.0,Intermediate,,,9739,,CHEMBL623049,1,BAO_0000218,,,,N,,,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,10116.0,Intermediate,,,9740,,CHEMBL623050,1,BAO_0000218,,,,N,,,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,10116.0,Intermediate,,,9741,,CHEMBL623051,1,BAO_0000218,,,,N,,,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,10116.0,Intermediate,,,9742,,CHEMBL623052,1,BAO_0000218,,,,N,,,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,10116.0,Intermediate,,,9743,,CHEMBL626343,1,BAO_0000218,,,,N,,,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,10116.0,Intermediate,,,9744,,CHEMBL626344,1,BAO_0000218,,,,N,,,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,10116.0,Intermediate,,,9745,,CHEMBL626345,1,BAO_0000218,,,,N,,,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,10116.0,Intermediate,,,9746,,CHEMBL626346,1,BAO_0000218,,,,N,,,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,10116.0,Intermediate,,,9747,,CHEMBL626347,1,BAO_0000218,,,,N,,,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,10116.0,Intermediate,,,9748,,CHEMBL626348,1,BAO_0000218,,,,N,,,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,10116.0,Intermediate,,,9749,,CHEMBL626349,1,BAO_0000218,,,,N,,,16434,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,10116.0,Intermediate,,,9750,,CHEMBL626350,1,BAO_0000218,,,,N,,,16435,Rattus norvegicus,50597,F,,1
,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,10116.0,Intermediate,,,9751,,CHEMBL626351,1,BAO_0000218,,,,N,,,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,10116.0,Intermediate,,,9752,,CHEMBL627650,1,BAO_0000218,,,,N,,,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,10116.0,Intermediate,,,9753,,CHEMBL627651,1,BAO_0000218,,,,N,,,16435,Rattus norvegicus,50597,F,,1
,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,10116.0,Intermediate,,,9754,,CHEMBL627652,1,BAO_0000218,,,,N,,,16435,Rattus norvegicus,50597,A,,1
,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,10116.0,Intermediate,,,9755,,CHEMBL627653,1,BAO_0000218,,,,N,,,16435,Rattus norvegicus,50597,A,,1
,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr blocked time interval,10116.0,Intermediate,,,9756,,CHEMBL627654,1,BAO_0000218,,,,N,,,13091,Rattus norvegicus,50597,A,,1
,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr low time interval,10116.0,Intermediate,,,9757,,CHEMBL627835,1,BAO_0000218,,,,N,,,13091,Rattus norvegicus,50597,A,,1
,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr time interval,10116.0,Intermediate,,,9758,,CHEMBL627836,1,BAO_0000218,,,,N,,,13091,Rattus norvegicus,50597,A,,1
,Tissue biodistribution into estrogen-primed immature female rat blood at 3 hr time interval,10116.0,Intermediate,,,9759,,CHEMBL627837,1,BAO_0000218,,,,N,,,13091,Rattus norvegicus,50597,A,,1
,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr blocked time interval,10116.0,Intermediate,,,9760,,CHEMBL627838,1,BAO_0000218,,,,N,,,13091,Rattus norvegicus,50597,A,,1
,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr low time interval,10116.0,Intermediate,,,9761,,CHEMBL875338,1,BAO_0000218,,,,N,,,13091,Rattus norvegicus,50597,A,,1
,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr time interval,10116.0,Intermediate,,,9762,,CHEMBL627839,1,BAO_0000218,,,,N,,,13091,Rattus norvegicus,50597,A,,1
,Tissue biodistribution into estrogen-primed immature female rat bone at 3 hr time interval,10116.0,Intermediate,,,9763,,CHEMBL627840,1,BAO_0000218,,,,N,,,13091,Rattus norvegicus,50597,A,,1
,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr blocked time interval,10116.0,Intermediate,,,9764,,CHEMBL627841,1,BAO_0000218,,,,N,,,13091,Rattus norvegicus,50597,A,,1
,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr low time interval,10116.0,Intermediate,,,9765,,CHEMBL627842,1,BAO_0000218,,,,N,,,13091,Rattus norvegicus,50597,A,,1
,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr time interval,10116.0,Intermediate,,,9766,,CHEMBL627843,1,BAO_0000218,,,,N,,,13091,Rattus norvegicus,50597,A,,1
,Tissue biodistribution into estrogen-primed immature female rat brain at 3 hr time interval,10116.0,Intermediate,,,9767,,CHEMBL627844,1,BAO_0000218,,,,N,,,13091,Rattus norvegicus,50597,A,,1
,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr blocked time interval,10116.0,Intermediate,,,9768,,CHEMBL627845,1,BAO_0000218,,,,N,,,13091,Rattus norvegicus,50597,A,,1
,Half life period in rat by iv administration at a dose of 3 mg/kg,10116.0,Intermediate,,,9769,,CHEMBL627846,1,BAO_0000218,,In vivo,,N,,,5874,Rattus norvegicus,50597,A,,1
,Half life period in rat plasma at 25 degree Centigrade temperature (pH 7.4),10116.0,Intermediate,,,9770,1969.0,CHEMBL627847,1,BAO_0000218,,,,N,,Plasma,1515,Rattus norvegicus,50597,A,,1
,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4),10116.0,Intermediate,,,9771,1969.0,CHEMBL873821,1,BAO_0000218,,,,N,,Plasma,1515,Rattus norvegicus,50597,A,,1
,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,10116.0,Intermediate,,,9772,1969.0,CHEMBL626079,1,BAO_0000218,,,,N,,Plasma,1515,Rattus norvegicus,50597,A,,1
,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,10116.0,Intermediate,,,9773,1969.0,CHEMBL626080,1,BAO_0000218,,,,N,,Plasma,1515,Rattus norvegicus,50597,A,,1
,Half life period was evaluated in rat plasma,10116.0,Intermediate,,,9774,1969.0,CHEMBL626081,1,BAO_0000218,,,,N,,Plasma,5491,Rattus norvegicus,50597,A,,1
,Half life period was evaluated in rat plasma; Not tested,10116.0,Intermediate,,,9775,1969.0,CHEMBL875344,1,BAO_0000218,,,,N,,Plasma,5491,Rattus norvegicus,50597,A,,1
,Half life period was evaluated in rats,10116.0,Intermediate,,,9776,,CHEMBL626082,1,BAO_0000218,,,,N,,,1918,Rattus norvegicus,50597,A,,1
,"Half life period was evaluated in rats, iv",10116.0,Intermediate,,,9777,,CHEMBL626250,1,BAO_0000218,,In vivo,,N,,,1918,Rattus norvegicus,50597,A,,1
,Half life period after intravenous administration at 5 mg/kg in rat,10116.0,Intermediate,,,9778,,CHEMBL626251,1,BAO_0000218,,In vivo,,N,,,6113,Rattus norvegicus,50597,A,,1
,Half life period was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,10116.0,Intermediate,,,9779,,CHEMBL626252,1,BAO_0000218,,In vivo,,N,,,5546,Rattus norvegicus,50597,A,,1
,Half life period was determined in rat after iv administration at a dose of 5 mg/kg,10116.0,Intermediate,,,9780,,CHEMBL626253,1,BAO_0000218,,In vivo,,N,,,5553,Rattus norvegicus,50597,A,,1
,Half life stability of compound was evaluated in rat plasma,10116.0,Intermediate,,,9781,1969.0,CHEMBL626254,1,BAO_0000218,,,,N,,Plasma,4188,Rattus norvegicus,50597,A,,1
,Half life time after intravenous administration (5.0 mg/kg) was determined in rat,10116.0,Intermediate,,,9782,,CHEMBL626255,1,BAO_0000218,,In vivo,,N,,,6215,Rattus norvegicus,50597,A,,1
,Half life time was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,10116.0,Intermediate,,,9783,,CHEMBL626256,1,BAO_0000218,,In vivo,,N,,,6141,Rattus norvegicus,50597,A,,1
,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,10116.0,Intermediate,,,9784,,CHEMBL626257,1,BAO_0000218,,In vivo,,N,,,5182,Rattus norvegicus,50597,A,,1
,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat; NC means not calculated,10116.0,Intermediate,,,9785,,CHEMBL626258,1,BAO_0000218,,In vivo,,N,,,5182,Rattus norvegicus,50597,A,,1
,Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v.,10116.0,Intermediate,,,9786,,CHEMBL626259,1,BAO_0000218,,In vivo,,N,,,5710,Rattus norvegicus,50597,A,,1
,Half in rat i.v.,10116.0,Intermediate,,,9787,,CHEMBL626260,1,BAO_0000218,,In vivo,,N,,,5789,Rattus norvegicus,50597,A,,1
,Half period in rat after intravenous administration,10116.0,Intermediate,,,9788,,CHEMBL875345,1,BAO_0000218,,In vivo,,N,,,6011,Rattus norvegicus,50597,A,,1
,Half-life after repeated oral dose of compound at 1 mg/kg in rats,10116.0,Intermediate,,,9789,,CHEMBL626261,1,BAO_0000218,,In vivo,,N,,,17594,Rattus norvegicus,50597,A,,1
,Half-life measured in in vitro Cathepsin B assay in rat liver,10116.0,Intermediate,,,9790,2107.0,CHEMBL626262,1,BAO_0000218,,In vitro,,N,,Liver,12357,Rattus norvegicus,50597,A,,1
,Half-life of compound was determined in rats,10116.0,Intermediate,,,9791,,CHEMBL626263,1,BAO_0000218,,,,N,,,5210,Rattus norvegicus,50597,A,,1
,Half-life at 10 mg/kg in rat upon intravenous administration,10116.0,Intermediate,,,9792,,CHEMBL625270,1,BAO_0000218,,In vivo,,N,,,17596,Rattus norvegicus,50597,A,,1
,Half-life determined in rat,10116.0,Intermediate,,,9793,,CHEMBL625271,1,BAO_0000218,,,,N,,,6672,Rattus norvegicus,50597,A,,1
,Half-life determined in rat,10116.0,Intermediate,,,9794,,CHEMBL625272,1,BAO_0000218,,,,N,,,6673,Rattus norvegicus,50597,A,,1
,Half-life in brain after intravenous administration (4.7 mg/kg) to male rats,10116.0,Intermediate,,,9795,955.0,CHEMBL625273,1,BAO_0000218,,In vivo,,N,,Brain,4910,Rattus norvegicus,50597,A,,1
,"Half-life in chemical and enzymatic hydrolysis, in 80% rat plasma",10116.0,Intermediate,,,9796,1969.0,CHEMBL625274,1,BAO_0000218,,,,N,,Plasma,3741,Rattus norvegicus,50597,A,,1
,Half-life in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,10116.0,Intermediate,,,9797,,CHEMBL625275,1,BAO_0000218,,In vivo,,N,,,17671,Rattus norvegicus,50597,A,,1
,Half-life in plasma after intravenous administration (4.7 mg/kg) to male rats,10116.0,Intermediate,,,9798,1969.0,CHEMBL625276,1,BAO_0000218,,In vivo,,N,,Plasma,4910,Rattus norvegicus,50597,A,,1
,Half-life in rat plasma,10116.0,Intermediate,,,9799,1969.0,CHEMBL625277,1,BAO_0000218,,,,N,,Plasma,17537,Rattus norvegicus,50597,A,,1
,Half-life in rat plasma was determined,10116.0,Intermediate,,,9800,1969.0,CHEMBL625278,1,BAO_0000218,,,,N,,Plasma,4965,Rattus norvegicus,50597,A,,1
,Half-life in rat plasma; Not tested,10116.0,Intermediate,,,9801,1969.0,CHEMBL625279,1,BAO_0000218,,,,N,,Plasma,17537,Rattus norvegicus,50597,A,,1
,Half-life in rat serum,10116.0,Intermediate,,,9802,1977.0,CHEMBL625280,1,BAO_0000218,,,,N,,Serum,6124,Rattus norvegicus,50597,A,,1
,Half-life in rat serum; na is not available,10116.0,Intermediate,,,9803,1977.0,CHEMBL876797,1,BAO_0000218,,,,N,,Serum,6124,Rattus norvegicus,50597,A,,1
,Half-life was calculated in rat,10116.0,Intermediate,,,9804,,CHEMBL625281,1,BAO_0000218,,,,N,,,6078,Rattus norvegicus,50597,A,,1
,Half-life was calculated in rat plasma,10116.0,Intermediate,,,9805,1969.0,CHEMBL873827,1,BAO_0000218,,,,N,,Plasma,17668,Rattus norvegicus,50597,A,,1
,Half-life was determined,10116.0,Intermediate,,,9806,,CHEMBL625282,1,BAO_0000218,,,,N,,,3185,Rattus norvegicus,50597,A,,1
,Half-life was determined,10116.0,Intermediate,,,9807,,CHEMBL625283,1,BAO_0000218,,,,N,,,4883,Rattus norvegicus,50597,A,,1
,Half-life after administration of 20 mg/Kg oral dose in rat,10116.0,Intermediate,,,9808,,CHEMBL625284,1,BAO_0000218,,In vivo,,N,,,2959,Rattus norvegicus,50597,A,,1
,Half-life after administration of 3.2 mg/kg intravenously in male rat,10116.0,Intermediate,,,9809,,CHEMBL625285,1,BAO_0000218,,In vivo,,N,,,4029,Rattus norvegicus,50597,A,,1
,Half-life after intravenous administration in female rat,10116.0,Intermediate,,,9810,,CHEMBL625286,1,BAO_0000218,,In vivo,,N,,,4029,Rattus norvegicus,50597,A,,1
,Half-life after intravenous administration in male rat,10116.0,Intermediate,,,9811,,CHEMBL625287,1,BAO_0000218,,In vivo,,N,,,4029,Rattus norvegicus,50597,A,,1
,Half-life after intravenous dose in rat,10116.0,Intermediate,,,9812,,CHEMBL625288,1,BAO_0000218,,In vivo,,N,,,6180,Rattus norvegicus,50597,A,,1
,Half-life in a rat liver homogenate preparation,10116.0,Intermediate,,,9813,2107.0,CHEMBL625289,1,BAO_0000218,,,,N,,Liver,1557,Rattus norvegicus,50597,A,,1
,Half-life in plasma of rat,10116.0,Intermediate,,,9814,1969.0,CHEMBL625290,1,BAO_0000218,,,,N,,Plasma,12500,Rattus norvegicus,50597,A,,1
,Half-life in plasma of rat at dose of 3-10 mgkg,10116.0,Intermediate,,,9815,1969.0,CHEMBL876798,1,BAO_0000218,,,,N,,Plasma,12500,Rattus norvegicus,50597,A,,1
,Half-life in rat,10116.0,Intermediate,,,9816,,CHEMBL625291,1,BAO_0000218,,,,N,,,5064,Rattus norvegicus,50597,A,,1
,Half-life in rat,10116.0,Intermediate,,,9817,,CHEMBL625292,1,BAO_0000218,,,,N,,,5145,Rattus norvegicus,50597,A,,1
,Half-life in rat,10116.0,Intermediate,,,9818,,CHEMBL625293,1,BAO_0000218,,,,N,,,5147,Rattus norvegicus,50597,A,,1
,Half-life in rat,10116.0,Intermediate,,,9819,,CHEMBL622832,1,BAO_0000218,,,,N,,,5833,Rattus norvegicus,50597,A,,1
,Half-life in rat,10116.0,Intermediate,,,9820,,CHEMBL622833,1,BAO_0000218,,,,N,,,6596,Rattus norvegicus,50597,A,,1
,Half-life in rat,10116.0,Intermediate,,,9821,,CHEMBL622834,1,BAO_0000218,,,,N,,,17655,Rattus norvegicus,50597,A,,1
,Half-life in rat after oral administration at 10 mg/kg,10116.0,Intermediate,,,9822,,CHEMBL622835,1,BAO_0000218,,In vivo,,N,,,6495,Rattus norvegicus,50597,A,,1
,Half-life in rat after po administration at a dose of 10 mg/kg,10116.0,Intermediate,,,9823,,CHEMBL622836,1,BAO_0000218,,In vivo,,N,,,17538,Rattus norvegicus,50597,A,,1
,Half-life in rat after po administration at a dose of 10 mg/kg; nd is not determined,10116.0,Intermediate,,,9824,,CHEMBL622837,1,BAO_0000218,,In vivo,,N,,,17538,Rattus norvegicus,50597,A,,1
,Half-life in rat at 3 mg/kg dose administered intravenously,10116.0,Intermediate,,,9825,,CHEMBL622838,1,BAO_0000218,,In vivo,,N,,,10,Rattus norvegicus,50597,A,,1
,Half-life in rat brain homogenate,10116.0,Intermediate,,,9826,955.0,CHEMBL622839,1,BAO_0000218,,,,N,,Brain,17669,Rattus norvegicus,50597,A,,1
,Half-life in rat plasma,10116.0,Intermediate,,,9827,1969.0,CHEMBL622840,1,BAO_0000218,,,,N,,Plasma,17065,Rattus norvegicus,50597,A,,1
,Half-life in rats,10116.0,Intermediate,,,9828,,CHEMBL622841,1,BAO_0000218,,,,N,,,4333,Rattus norvegicus,50597,A,,1
,Half-life in Dawley rats,10116.0,Intermediate,,,9829,,CHEMBL622842,1,BAO_0000218,,,,N,,,6827,Rattus norvegicus,50597,A,,1
,Half-life in vitro in rat plasma,10116.0,Intermediate,,,9830,1969.0,CHEMBL622843,1,BAO_0000218,,In vitro,,N,,Plasma,889,Rattus norvegicus,50597,A,,1
,Half-life in vitro in rat plasma; No detectable degradation over 2 hr; no detectable degradation over 2 hours,10116.0,Intermediate,,,9831,1969.0,CHEMBL622844,1,BAO_0000218,,In vitro,,N,,Plasma,889,Rattus norvegicus,50597,A,,1
,"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat",10116.0,Intermediate,,,9832,,CHEMBL622845,1,BAO_0000218,,,,N,,,3747,Rattus norvegicus,50597,A,,1
,The area under the curve of compound was measured at the dose of 100 umol/kg,10116.0,Intermediate,,,9833,,CHEMBL622846,1,BAO_0000218,,,,N,,,15022,Rattus norvegicus,50597,A,,1
,The area under the curve of compound was measured at the dose of 300 umol/kg,10116.0,Intermediate,,,9834,,CHEMBL622847,1,BAO_0000218,,,,N,,,15022,Rattus norvegicus,50597,A,,1
,The area under the curve of compound was measured at the dose of 30 umol/kg,10116.0,Intermediate,,,9835,,CHEMBL622848,1,BAO_0000218,,,,N,,,15022,Rattus norvegicus,50597,A,,1
,Bioavailability as oral AUC in rats,10116.0,Intermediate,,,9836,,CHEMBL622849,1,BAO_0000218,,In vivo,,N,,,3360,Rattus norvegicus,50597,A,,1
,The plasma concentration versus time curve (AUC) was determined,10116.0,Intermediate,,,9837,1969.0,CHEMBL622850,1,BAO_0000218,,,,N,,Plasma,5334,Rattus norvegicus,50597,A,,1
,Total concentration in kidney was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,10116.0,Intermediate,,,9838,,CHEMBL876807,1,BAO_0000218,,,,N,,,17411,Rattus norvegicus,50597,A,,1
,Total concentration in liver was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,10116.0,Intermediate,,,9839,,CHEMBL622851,1,BAO_0000218,,,,N,,,17411,Rattus norvegicus,50597,A,,1
,Total concentration in lung was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,10116.0,Intermediate,,,9840,,CHEMBL622852,1,BAO_0000218,,,,N,,,17411,Rattus norvegicus,50597,A,,1
,Total concentration in rat after 1 mg/kg i.v. administration in 24 hours,10116.0,Intermediate,,,9841,,CHEMBL622853,1,BAO_0000218,,,,N,,,6570,Rattus norvegicus,50597,A,,1
,Total concentration in rat after 2 mg/kg peroral administration in 24 hours,10116.0,Intermediate,,,9842,,CHEMBL622854,1,BAO_0000218,,,,N,,,6570,Rattus norvegicus,50597,A,,1
,Total concentration in serum was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,10116.0,Intermediate,,,9843,,CHEMBL622855,1,BAO_0000218,,,,N,,,17411,Rattus norvegicus,50597,A,,1
,"Pharmacokinetic Parameter, AUC (0-infinity) is the area under the plasma concentration versus time curve extrapolated to infinity in Female Wistar Rats at 100 mg/kg by po administration",10116.0,Intermediate,,,9844,1969.0,CHEMBL622856,1,BAO_0000218,,,,N,,Plasma,14941,Rattus norvegicus,50597,A,,1
,"Pharmacokinetic Parameter, AUC (0-t) is the area under the plasma concentration versus time curve in Female Wistar Rats at 100 mg/kg by po administration",10116.0,Intermediate,,,9845,1969.0,CHEMBL622857,1,BAO_0000218,,,,N,,Plasma,14941,Rattus norvegicus,50597,A,,1
,AUC in rat after po administration at a dose of 10 mg/kg,10116.0,Intermediate,,,9846,1969.0,CHEMBL622858,1,BAO_0000218,,,,N,,Plasma,17538,Rattus norvegicus,50597,A,,1
,Area under the plasma concentration-time curve in rats after oral administration at 25 mg/kg,10116.0,Intermediate,,,9847,1969.0,CHEMBL622859,1,BAO_0000218,,,,N,,Plasma,17752,Rattus norvegicus,50597,A,,1
,Area under curve value 24 hr after 10 mg/kg iv administration in rats,10116.0,Intermediate,,,9848,,CHEMBL622860,1,BAO_0000218,,,,N,,,17509,Rattus norvegicus,50597,A,,1
,Area under curve value 24 hr after 10 mg/kg oral administration in rats,10116.0,Intermediate,,,9849,,CHEMBL622861,1,BAO_0000218,,,,N,,,17509,Rattus norvegicus,50597,A,,1
,Area under curve value 24 hr after 2 mg/kg iv administration in rats,10116.0,Intermediate,,,9850,,CHEMBL622862,1,BAO_0000218,,,,N,,,17509,Rattus norvegicus,50597,A,,1
,Area under curve value 24 hr after 2 mg/kg oral administration in rats,10116.0,Intermediate,,,9851,,CHEMBL622863,1,BAO_0000218,,,,N,,,17509,Rattus norvegicus,50597,A,,1
,Area under curve value 6 hr after po administration in rat,10116.0,Intermediate,,,9852,,CHEMBL623817,1,BAO_0000218,,,,N,,,17509,Rattus norvegicus,50597,A,,1
,Area under the curve at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,10116.0,Intermediate,,,9853,,CHEMBL623818,1,BAO_0000218,,,,N,,,17717,Rattus norvegicus,50597,A,,1
,"Area under the curve at a concentration of 3 mg/kg in rats, intravenously",10116.0,Intermediate,,,9854,,CHEMBL623819,1,BAO_0000218,,,,N,,,17717,Rattus norvegicus,50597,A,,1
,Area under the curve at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,10116.0,Intermediate,,,9855,,CHEMBL623820,1,BAO_0000218,,,,N,,,17717,Rattus norvegicus,50597,A,,1
,Area under the curve at a concentration of 60 mg/kg perorally in rats along with control,10116.0,Intermediate,,,9856,,CHEMBL623821,1,BAO_0000218,,,,N,,,17717,Rattus norvegicus,50597,A,,1
,AUC normalized for dose (AUCN) in rat,10116.0,Intermediate,,,9857,1969.0,CHEMBL623822,1,BAO_0000218,,,,N,,Plasma,6642,Rattus norvegicus,50597,A,,1
,Area under curve in rat after p.o. administration,10116.0,Intermediate,,,9858,,CHEMBL623823,1,BAO_0000218,,,,N,,,6640,Rattus norvegicus,50597,A,,1
,Area under curve in rat after p.o. administration,10116.0,Intermediate,,,9859,,CHEMBL623824,1,BAO_0000218,,,,N,,,6641,Rattus norvegicus,50597,A,,1
,Area under curve in rat after p.o. administration; Not determined,10116.0,Intermediate,,,9860,,CHEMBL623825,1,BAO_0000218,,,,N,,,6641,Rattus norvegicus,50597,A,,1
,Area under curve in rat after peroral administration,10116.0,Intermediate,,,9861,,CHEMBL622070,1,BAO_0000218,,,,N,,,6641,Rattus norvegicus,50597,A,,1
,Area under curve (carotid artery) value of the compound,10116.0,Intermediate,,,9862,,CHEMBL622071,1,BAO_0000218,,,,N,,,3603,Rattus norvegicus,50597,A,,1
,Bioavailability expressed as the area under curve of rat carotid artery,10116.0,Intermediate,,,9863,,CHEMBL622072,1,BAO_0000218,,,,N,,,3550,Rattus norvegicus,50597,A,,1
,Area under curve in male SD rats was observed after intravenous administration in rat,10116.0,Intermediate,,,9864,,CHEMBL622073,1,BAO_0000218,,,,N,,,15662,Rattus norvegicus,50597,A,,1
,Area under curve of the compound was determined,10116.0,Intermediate,,,9865,,CHEMBL622074,1,BAO_0000218,,,,N,,,17720,Rattus norvegicus,50597,A,,1
,Compound was evaluated for its pharmacokinetic parameter maximum area under curve AUCmax,10116.0,Intermediate,,,9866,,CHEMBL622075,1,BAO_0000218,,,,N,,,5407,Rattus norvegicus,50597,A,,1
,Area under the plasma concentration-time curve in rats after oral administration at 20 mg/kg,10116.0,Intermediate,,,9867,1969.0,CHEMBL622076,1,BAO_0000218,,,,N,,Plasma,17752,Rattus norvegicus,50597,A,,1
,Area under the plasma concentration-time curve in rats following oral administration at 20 mg/kg,10116.0,Intermediate,,,9868,1969.0,CHEMBL622077,1,BAO_0000218,,,,N,,Plasma,17752,Rattus norvegicus,50597,A,,1
,Area under curve (portal vein) value of the compound,10116.0,Intermediate,,,9869,,CHEMBL622078,1,BAO_0000218,,,,N,,,3603,Rattus norvegicus,50597,A,,1
,Bioavailability expressed as the area under curve of rat portal vein,10116.0,Intermediate,,,9870,,CHEMBL622079,1,BAO_0000218,,,,N,,,3550,Rattus norvegicus,50597,A,,1
,Area Under plasma concentration time curve in rat upon peroral administration,10116.0,Intermediate,,,9871,1969.0,CHEMBL622080,1,BAO_0000218,,,,N,,Plasma,17655,Rattus norvegicus,50597,A,,1
,In vivo area under curve was determined for the compound after i.v. administration at a dose of 5 mg/kg in rats,10116.0,Intermediate,,,9872,,CHEMBL877612,1,BAO_0000218,,,,N,,,17582,Rattus norvegicus,50597,A,,1
,In vivo area under curve was determined for the compound after oral (po) administration at a dose of 10 mg/kg in rats,10116.0,Intermediate,,,9873,,CHEMBL622081,1,BAO_0000218,,,,N,,,17582,Rattus norvegicus,50597,A,,1
,Compound was evaluated for oral bioavailability in rats,10116.0,Intermediate,,,9874,,CHEMBL622082,1,BAO_0000218,,,,N,,,17791,Rattus norvegicus,50597,A,,1
,Compound was evaluated for oral bioavailability in rats after iv administration,10116.0,Intermediate,,,9875,,CHEMBL622083,1,BAO_0000218,,,,N,,,17791,Rattus norvegicus,50597,A,,1
,Compound was evaluated for oral bioavailability in rats; 30-80,10116.0,Intermediate,,,9876,,CHEMBL622084,1,BAO_0000218,,,,N,,,17791,Rattus norvegicus,50597,A,,1
,Compound was evaluated for oral bioavailability in rats; 50-60,10116.0,Intermediate,,,9877,,CHEMBL622085,1,BAO_0000218,,,,N,,,17791,Rattus norvegicus,50597,A,,1
,Compound was evaluated for oral bioavailability in rats; no data,10116.0,Intermediate,,,9878,,CHEMBL622086,1,BAO_0000218,,,,N,,,17791,Rattus norvegicus,50597,A,,1
,Compound was evaluated for oral bioavailability in rats; peptide,10116.0,Intermediate,,,9879,,CHEMBL622087,1,BAO_0000218,,,,N,,,17791,Rattus norvegicus,50597,A,,1
,"Distribution of radioactivity in blood of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.03",10116.0,Intermediate,,,9880,178.0,CHEMBL622088,1,BAO_0000218,,,,N,,Blood,7768,Rattus norvegicus,50597,A,,1
,"Distribution of radioactivity in blood of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range-0.9-1.03",10116.0,Intermediate,,,9881,178.0,CHEMBL622089,1,BAO_0000218,,,,N,,Blood,7768,Rattus norvegicus,50597,A,,1
,"Distribution of radioactivity in blood of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.88-1.15",10116.0,Intermediate,,,9882,178.0,CHEMBL623685,1,BAO_0000218,,,,N,,Blood,7768,Rattus norvegicus,50597,A,,1
,"Distribution of radioactivity in blood of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range = 0.71-0.87",10116.0,Intermediate,,,9883,178.0,CHEMBL623686,1,BAO_0000218,,,,N,,Blood,7768,Rattus norvegicus,50597,A,,1
,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",10116.0,Intermediate,,,9884,945.0,CHEMBL623687,1,BAO_0000218,,In vivo,,N,,Stomach,8677,Rattus norvegicus,50597,A,,1
,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",10116.0,Intermediate,,,9885,945.0,CHEMBL623688,1,BAO_0000218,,In vivo,,N,,Stomach,8677,Rattus norvegicus,50597,A,,1
,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",10116.0,Intermediate,,,9886,945.0,CHEMBL623689,1,BAO_0000218,,In vivo,,N,,Stomach,8677,Rattus norvegicus,50597,A,,1
,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",10116.0,Intermediate,,,9887,945.0,CHEMBL622485,1,BAO_0000218,,In vivo,,N,,Stomach,8677,Rattus norvegicus,50597,A,,1
,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",10116.0,Intermediate,,,9888,2046.0,CHEMBL622486,1,BAO_0000218,,In vivo,,N,,Thyroid gland,8677,Rattus norvegicus,50597,A,,1
,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",10116.0,Intermediate,,,9889,2046.0,CHEMBL877613,1,BAO_0000218,,In vivo,,N,,Thyroid gland,8677,Rattus norvegicus,50597,A,,1
,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",10116.0,Intermediate,,,9890,2046.0,CHEMBL622487,1,BAO_0000218,,In vivo,,N,,Thyroid gland,8677,Rattus norvegicus,50597,A,,1
,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",10116.0,Intermediate,,,9891,2046.0,CHEMBL622488,1,BAO_0000218,,In vivo,,N,,Thyroid gland,8677,Rattus norvegicus,50597,A,,1
,"Biodistribution in Sprague-Dawley rats heart 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",10116.0,Intermediate,,,9892,948.0,CHEMBL622489,1,BAO_0000218,,In vivo,,N,,Heart,8677,Rattus norvegicus,50597,A,,1
,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,10116.0,Intermediate,,,9893,1088.0,CHEMBL622490,1,BAO_0000218,,,,N,,Urine,6899,Rattus norvegicus,50597,A,,1
,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,10116.0,Intermediate,,,9894,1088.0,CHEMBL622491,1,BAO_0000218,,,,N,,Urine,6899,Rattus norvegicus,50597,A,,1
,Compound was evaluated for percent dose tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in liver,10116.0,Intermediate,,,9895,2107.0,CHEMBL622492,1,BAO_0000218,,,,N,,Liver,6899,Rattus norvegicus,50597,A,,1
,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,10116.0,Intermediate,,,9896,1088.0,CHEMBL622493,1,BAO_0000218,,,,N,,Urine,6899,Rattus norvegicus,50597,A,,1
,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,10116.0,Intermediate,,,9897,1088.0,CHEMBL622494,1,BAO_0000218,,,,N,,Urine,6899,Rattus norvegicus,50597,A,,1
,"Compound was evaluated for the biodistribution in Sprague-Dawley rats in muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",10116.0,Intermediate,,,9898,2385.0,CHEMBL622495,1,BAO_0000218,,,,N,,Muscle tissue,8677,Rattus norvegicus,50597,A,,1
,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in rat kidney,10116.0,Intermediate,,,9899,,CHEMBL622496,1,BAO_0000218,,,,N,,,6899,Rattus norvegicus,50597,A,,1
,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,10116.0,Intermediate,,,9900,1088.0,CHEMBL622497,1,BAO_0000218,,,,N,,Urine,6899,Rattus norvegicus,50597,A,,1
,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by rats,10116.0,Intermediate,,,9901,,CHEMBL622498,1,BAO_0000218,,,,N,,,2189,Rattus norvegicus,50597,A,,1
,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats,10116.0,Intermediate,,,9902,1088.0,CHEMBL624918,1,BAO_0000218,,,,N,,Urine,2189,Rattus norvegicus,50597,A,,1
,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats; NA is <10% inhibition at 1 uM for binding data,10116.0,Intermediate,,,9903,1088.0,CHEMBL624919,1,BAO_0000218,,,,N,,Urine,2189,Rattus norvegicus,50597,A,,1
,Biodistribution of compound in rat blood after 5 min of administration,10116.0,Intermediate,,,9904,178.0,CHEMBL624920,1,BAO_0000218,,In vivo,,N,,Blood,10839,Rattus norvegicus,50597,A,,1
,Biodistribution of compound in rat blood after 5 min of administration.,10116.0,Intermediate,,,9905,178.0,CHEMBL624921,1,BAO_0000218,,In vivo,,N,,Blood,10839,Rattus norvegicus,50597,A,,1
,Biodistribution of compound in rat brain after 5 min of administration,10116.0,Intermediate,,,9906,955.0,CHEMBL624922,1,BAO_0000218,,In vivo,,N,,Brain,10839,Rattus norvegicus,50597,A,,1
,Biodistribution of compound in rat heart after 5 min of administration,10116.0,Intermediate,,,9907,948.0,CHEMBL624923,1,BAO_0000218,,In vivo,,N,,Heart,10839,Rattus norvegicus,50597,A,,1
,Biodistribution of compound in rat heart after 5 min of administration.,10116.0,Intermediate,,,9908,948.0,CHEMBL624924,1,BAO_0000218,,In vivo,,N,,Heart,10839,Rattus norvegicus,50597,A,,1
,Biodistribution of compound in rat kidney after 5 min of administration,10116.0,Intermediate,,,9909,2113.0,CHEMBL624925,1,BAO_0000218,,In vivo,,N,,Kidney,10839,Rattus norvegicus,50597,A,,1
,Biodistribution of compound in rat kidney after 5 min of administration.,10116.0,Intermediate,,,9910,2113.0,CHEMBL624926,1,BAO_0000218,,In vivo,,N,,Kidney,10839,Rattus norvegicus,50597,A,,1
,Biodistribution of compound in rat liver after 5 min of administration,10116.0,Intermediate,,,9911,2107.0,CHEMBL624927,1,BAO_0000218,,In vivo,,N,,Liver,10839,Rattus norvegicus,50597,A,,1
,Biodistribution of compound in rat liver after 5 min of administration.,10116.0,Intermediate,,,9912,2107.0,CHEMBL874402,1,BAO_0000218,,In vivo,,N,,Liver,10839,Rattus norvegicus,50597,A,,1
,Biodistribution of compound in rat lung after 5 min of administration,10116.0,Intermediate,,,9913,2048.0,CHEMBL624928,1,BAO_0000218,,In vivo,,N,,Lung,10839,Rattus norvegicus,50597,A,,1
,Biodistribution of compound in rat lung after 5 min of administration.,10116.0,Intermediate,,,9914,2048.0,CHEMBL624929,1,BAO_0000218,,In vivo,,N,,Lung,10839,Rattus norvegicus,50597,A,,1
,Biodistribution of compound in rat muscle after 5 min of administration,10116.0,Intermediate,,,9915,2385.0,CHEMBL624930,1,BAO_0000218,,In vivo,,N,,Muscle tissue,10839,Rattus norvegicus,50597,A,,1
,Biodistribution of compound in rat muscle after 5 min of administration.,10116.0,Intermediate,,,9916,2385.0,CHEMBL624931,1,BAO_0000218,,In vivo,,N,,Muscle tissue,10839,Rattus norvegicus,50597,A,,1
,In vivo heart distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,10116.0,Intermediate,,,9917,948.0,CHEMBL624932,1,BAO_0000218,,,,N,,Heart,4043,Rattus norvegicus,50597,A,,1
,In vivo heart distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,10116.0,Intermediate,,,9918,948.0,CHEMBL624933,1,BAO_0000218,,,,N,,Heart,4043,Rattus norvegicus,50597,A,,1
,In vivo liver distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,10116.0,Intermediate,,,9919,2107.0,CHEMBL624934,1,BAO_0000218,,,,N,,Liver,4043,Rattus norvegicus,50597,A,,1
,In vivo liver distribution of total doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,10116.0,Intermediate,,,9920,2107.0,CHEMBL624935,1,BAO_0000218,,,,N,,Liver,4043,Rattus norvegicus,50597,A,,1
,In vivo plasma distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,10116.0,Intermediate,,,9921,,CHEMBL624936,1,BAO_0000218,,,,N,,,4043,Rattus norvegicus,50597,A,,1
,In vivo plasma distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,10116.0,Intermediate,,,9922,,CHEMBL624937,1,BAO_0000218,,,,N,,,4043,Rattus norvegicus,50597,A,,1
,In vivo spleen distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,10116.0,Intermediate,,,9923,2106.0,CHEMBL624938,1,BAO_0000218,,,,N,,Spleen,4043,Rattus norvegicus,50597,A,,1
,In vivo spleen distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,10116.0,Intermediate,,,9924,2106.0,CHEMBL624939,1,BAO_0000218,,,,N,,Spleen,4043,Rattus norvegicus,50597,A,,1
,In vivo tumor distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,10116.0,Intermediate,,,9925,,CHEMBL624940,1,BAO_0000218,,,,N,,,4043,Rattus norvegicus,50597,A,,1
,In vivo tumor distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,10116.0,Intermediate,,,9926,,CHEMBL874403,1,BAO_0000218,,,,N,,,4043,Rattus norvegicus,50597,A,,1
,Compound was tested for the duration that the plasma drug concentrations remained above the IC95,10116.0,Intermediate,,,9927,,CHEMBL624941,1,BAO_0000218,,,,N,,,1446,Rattus norvegicus,50597,A,,1
,Dose required to lower urine osmolality to 300 mOsm/kg in rat,10116.0,Intermediate,,,9928,1088.0,CHEMBL624942,1,BAO_0000218,,,,N,,Urine,9971,Rattus norvegicus,50597,A,,1
,Dose required to lower urine osmolality to 300 mOsm/kg in rat; NT=Not tested,10116.0,Intermediate,,,9929,1088.0,CHEMBL624943,1,BAO_0000218,,,,N,,Urine,9971,Rattus norvegicus,50597,A,,1
,% Bioavailability after 1 day of the drug administration in rats,10116.0,Intermediate,,,9930,,CHEMBL624944,1,BAO_0000218,,In vivo,,N,,,5765,Rattus norvegicus,50597,A,,1
,% Bioavailability after 4 day of the drug administration in rats,10116.0,Intermediate,,,9931,,CHEMBL624945,1,BAO_0000218,,In vivo,,N,,,5765,Rattus norvegicus,50597,A,,1
,Absolute bioavailability was evaluated in rat,10116.0,Intermediate,,,9932,,CHEMBL624946,1,BAO_0000218,,In vivo,,N,,,4257,Rattus norvegicus,50597,A,,1
,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr low time interval,10116.0,Intermediate,,,9933,,CHEMBL624947,1,BAO_0000218,,,,N,,,13091,Rattus norvegicus,50597,A,,1
,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr time interval,10116.0,Intermediate,,,9934,,CHEMBL624948,1,BAO_0000218,,,,N,,,13091,Rattus norvegicus,50597,A,,1
,Tissue biodistribution into estrogen-primed immature female rat fat at 3 hr time interval,10116.0,Intermediate,,,9935,,CHEMBL624949,1,BAO_0000218,,,,N,,,13091,Rattus norvegicus,50597,A,,1
,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr blocked time interval,10116.0,Intermediate,,,9936,2113.0,CHEMBL622025,1,BAO_0000218,,,,N,,Kidney,13091,Rattus norvegicus,50597,A,,1
,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr low time interval,10116.0,Intermediate,,,9937,2113.0,CHEMBL622026,1,BAO_0000218,,,,N,,Kidney,13091,Rattus norvegicus,50597,A,,1
,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr time interval,10116.0,Intermediate,,,9938,2113.0,CHEMBL622027,1,BAO_0000218,,,,N,,Kidney,13091,Rattus norvegicus,50597,A,,1
,Tissue biodistribution into estrogen-primed immature female rat kidney at 3 hr time interval,10116.0,Intermediate,,,9939,2113.0,CHEMBL622028,1,BAO_0000218,,,,N,,Kidney,13091,Rattus norvegicus,50597,A,,1
,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr blocked time interval,10116.0,Intermediate,,,9940,2107.0,CHEMBL622029,1,BAO_0000218,,,,N,,Liver,13091,Rattus norvegicus,50597,A,,1
,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr low time interval,10116.0,Intermediate,,,9941,2107.0,CHEMBL622208,1,BAO_0000218,,,,N,,Liver,13091,Rattus norvegicus,50597,A,,1
,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr time interval,10116.0,Intermediate,,,9942,2107.0,CHEMBL622209,1,BAO_0000218,,,,N,,Liver,13091,Rattus norvegicus,50597,A,,1
,Tissue biodistribution into estrogen-primed immature female rat liver at 3 hr time interval,10116.0,Intermediate,,,9943,2107.0,CHEMBL622210,1,BAO_0000218,,,,N,,Liver,13091,Rattus norvegicus,50597,A,,1
,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr blocked time interval,10116.0,Intermediate,,,9944,,CHEMBL622211,1,BAO_0000218,,,,N,,,13091,Rattus norvegicus,50597,A,,1
,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr low time interval,10116.0,Intermediate,,,9945,,CHEMBL622212,1,BAO_0000218,,,,N,,,13091,Rattus norvegicus,50597,A,,1
,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr time interval,10116.0,Intermediate,,,9946,,CHEMBL622213,1,BAO_0000218,,,,N,,,13091,Rattus norvegicus,50597,A,,1
,Tissue biodistribution into estrogen-primed immature female rat lung at 3 hr time interval,10116.0,Intermediate,,,9947,,CHEMBL874404,1,BAO_0000218,,,,N,,,13091,Rattus norvegicus,50597,A,,1
,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr blocked time interval,10116.0,Intermediate,,,9948,2385.0,CHEMBL620452,1,BAO_0000218,,,,N,,Muscle tissue,13091,Rattus norvegicus,50597,A,,1
,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr low time interval,10116.0,Intermediate,,,9949,2385.0,CHEMBL620453,1,BAO_0000218,,,,N,,Muscle tissue,13091,Rattus norvegicus,50597,A,,1
,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr time interval,10116.0,Intermediate,,,9950,2385.0,CHEMBL620454,1,BAO_0000218,,,,N,,Muscle tissue,13091,Rattus norvegicus,50597,A,,1
,Tissue biodistribution into estrogen-primed immature female rat muscle at 3 hr time interval,10116.0,Intermediate,,,9951,2385.0,CHEMBL624067,1,BAO_0000218,,,,N,,Muscle tissue,13091,Rattus norvegicus,50597,A,,1
,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr blocked time interval,10116.0,Intermediate,,,9952,,CHEMBL624068,1,BAO_0000218,,,,N,,,13091,Rattus norvegicus,50597,A,,1
,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr low time interval,10116.0,Intermediate,,,9953,992.0,CHEMBL624069,1,BAO_0000218,,,,N,,Female gonad,13091,Rattus norvegicus,50597,A,,1
,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr time interval,10116.0,Intermediate,,,9954,992.0,CHEMBL624070,1,BAO_0000218,,,,N,,Female gonad,13091,Rattus norvegicus,50597,A,,1
,Tissue biodistribution into estrogen-primed immature female rat ovaries at 3 hr time interval,10116.0,Intermediate,,,9955,992.0,CHEMBL624071,1,BAO_0000218,,,,N,,Female gonad,13091,Rattus norvegicus,50597,A,,1
,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr blocked time interval,10116.0,Intermediate,,,9956,995.0,CHEMBL624072,1,BAO_0000218,,,,N,,Uterus,13091,Rattus norvegicus,50597,A,,1
,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr low time interval,10116.0,Intermediate,,,9957,995.0,CHEMBL624073,1,BAO_0000218,,,,N,,Uterus,13091,Rattus norvegicus,50597,A,,1
,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr time interval,10116.0,Intermediate,,,9958,995.0,CHEMBL624788,1,BAO_0000218,,,,N,,Uterus,13091,Rattus norvegicus,50597,A,,1
,Tissue biodistribution into estrogen-primed immature female rat uterus at 3 hr time interval,10116.0,Intermediate,,,9959,995.0,CHEMBL624789,1,BAO_0000218,,,,N,,Uterus,13091,Rattus norvegicus,50597,A,,1
,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr blocked time interval,10116.0,Intermediate,,,9960,,CHEMBL624790,1,BAO_0000218,,,,N,,,13091,Rattus norvegicus,50597,A,,1
,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr low time interval,10116.0,Intermediate,,,9961,,CHEMBL624791,1,BAO_0000218,,,,N,,,13091,Rattus norvegicus,50597,A,,1
,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr time interval,10116.0,Intermediate,,,9962,,CHEMBL624792,1,BAO_0000218,,,,N,,,13091,Rattus norvegicus,50597,A,,1
,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 3 hr time interval,10116.0,Intermediate,,,9963,,CHEMBL624793,1,BAO_0000218,,,,N,,,13091,Rattus norvegicus,50597,A,,1
,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr blocked time interval,10116.0,Intermediate,,,9964,2385.0,CHEMBL877491,1,BAO_0000218,,,,N,,Muscle tissue,13091,Rattus norvegicus,50597,A,,1
,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr low time interval,10116.0,Intermediate,,,9965,2385.0,CHEMBL624957,1,BAO_0000218,,,,N,,Muscle tissue,13091,Rattus norvegicus,50597,A,,1
,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr time interval,10116.0,Intermediate,,,9966,2385.0,CHEMBL624958,1,BAO_0000218,,,,N,,Muscle tissue,13091,Rattus norvegicus,50597,A,,1
,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 3 hr time interval,10116.0,Intermediate,,,9967,2385.0,CHEMBL624959,1,BAO_0000218,,,,N,,Muscle tissue,13091,Rattus norvegicus,50597,A,,1
,Dissociation constant was determined,10116.0,Intermediate,,,9968,,CHEMBL624960,1,BAO_0000218,,,,N,,,11977,Rattus norvegicus,50597,A,,1
,"Pharmacokinetic Parameter, Kel is elimination rate constant in Female Wistar Rats at 100 mg/kg by po administration",10116.0,Intermediate,,,9969,,CHEMBL624961,1,BAO_0000218,,,,N,,,14941,Rattus norvegicus,50597,A,,1
,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",10116.0,Intermediate,,,9970,,CHEMBL624962,1,BAO_0000218,,,,N,,,15078,Rattus norvegicus,50597,A,,1
,"The Kel value in male wistar rat at 100 mg/kg, p.o. dose",10116.0,Intermediate,,,9971,,CHEMBL624963,1,BAO_0000218,,,,N,,,15078,Rattus norvegicus,50597,A,,1
,Observed rate constant in 80% rat plasma at 37 degree Centigrade,10116.0,Intermediate,,,9972,,CHEMBL624964,1,BAO_0000218,,,,N,,,4755,Rattus norvegicus,50597,A,,1
,LogP value was evaluated in the in situ rat gut perfusion assay,10116.0,Intermediate,,,9973,,CHEMBL624965,1,BAO_0000218,,,,N,,,589,Rattus norvegicus,50597,A,,1
,In vivo retention time was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,10116.0,Intermediate,,,9974,,CHEMBL624966,1,BAO_0000218,,In vivo,,N,,,17582,Rattus norvegicus,50597,A,,1
,Mean residence time (Pharmacokinetic property) after i.v. administration in rats,10116.0,Intermediate,,,9975,,CHEMBL624967,1,BAO_0000218,,In vivo,,N,,,5031,Rattus norvegicus,50597,A,,1
,Mean-residence time of compound after intravenous administration in rats at 24 uM/kg,10116.0,Intermediate,,,9976,,CHEMBL624968,1,BAO_0000218,,In vivo,,N,,,17764,Rattus norvegicus,50597,A,,1
,Mean residence time at a dose of 4 mg/kg in Rat Plasma after iv administration,10116.0,Intermediate,,,9977,,CHEMBL624969,1,BAO_0000218,,,,N,,,17720,Rattus norvegicus,50597,A,,1
,Streptococcal cell wall-washed arthritis model in rats at 10.0 mg/kg peroral dose,10116.0,Expert,,,9978,,CHEMBL624970,1,BAO_0000218,,,,N,,,2862,Rattus norvegicus,50597,F,,1
,Half-life was evaluated after 10 uM/kg of intra arterial administration,10116.0,Intermediate,,,9979,,CHEMBL624971,1,BAO_0000218,,,,N,,,16423,Rattus norvegicus,50597,A,,1
,Half-life was evaluated after 20 uM/kg of peroral administration,10116.0,Intermediate,,,9980,,CHEMBL624972,1,BAO_0000218,,In vivo,,N,,,16423,Rattus norvegicus,50597,A,,1
,Half-life was evaluated after i.v. administration in rat at a dose of 1 mg/kg,10116.0,Intermediate,,,9981,,CHEMBL624973,1,BAO_0000218,,In vivo,,N,,,6005,Rattus norvegicus,50597,A,,1
,Half-life was evaluated in plasma of rat,10116.0,Intermediate,,,9982,1969.0,CHEMBL624974,1,BAO_0000218,,,,N,,Plasma,2938,Rattus norvegicus,50597,A,,1
,Half-life was evaluated in rats at an intravenous dose of 3 mg/kg,10116.0,Intermediate,,,9983,,CHEMBL624975,1,BAO_0000218,,In vivo,,N,,,6410,Rattus norvegicus,50597,A,,1
,Half-life was evaluated in rats at an oral dose of 30 mg/kg,10116.0,Intermediate,,,9984,,CHEMBL877492,1,BAO_0000218,,In vivo,,N,,,6410,Rattus norvegicus,50597,A,,1
,Half-life was measured in rat after an iv dose of 1 mg/kg,10116.0,Intermediate,,,9985,,CHEMBL624976,1,BAO_0000218,,In vivo,,N,,,6062,Rattus norvegicus,50597,A,,1
,Half-life period of compound in rats after peroral administration,10116.0,Intermediate,,,9986,,CHEMBL624977,1,BAO_0000218,,In vivo,,N,,,6571,Rattus norvegicus,50597,A,,1
,Half-life period of compound was measured in rat plasma.,10116.0,Intermediate,,,9987,1969.0,CHEMBL626848,1,BAO_0000218,,,,N,,Plasma,3136,Rattus norvegicus,50597,A,,1
,Half-life period of compound was measured in rat plasma; ND is not determined,10116.0,Intermediate,,,9988,1969.0,CHEMBL626849,1,BAO_0000218,,,,N,,Plasma,3136,Rattus norvegicus,50597,A,,1
,Half-life period of compound was measured in rat plasma; not determined,10116.0,Intermediate,,,9989,1969.0,CHEMBL626850,1,BAO_0000218,,,,N,,Plasma,3136,Rattus norvegicus,50597,A,,1
,Half-life period in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,10116.0,Intermediate,,,9990,,CHEMBL626851,1,BAO_0000218,,In vivo,,N,,,4521,Rattus norvegicus,50597,A,,1
,Half-life period in rat by iv administration,10116.0,Intermediate,,,9991,,CHEMBL626852,1,BAO_0000218,,In vivo,,N,,,5871,Rattus norvegicus,50597,A,,1
,Half-life period in rats following intravenous administration at 2 mg/kg,10116.0,Intermediate,,,9992,,CHEMBL626853,1,BAO_0000218,,In vivo,,N,,,6077,Rattus norvegicus,50597,A,,1
,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,10116.0,Intermediate,,,9993,,CHEMBL626854,1,BAO_0000218,,In vivo,,N,,,6679,Rattus norvegicus,50597,A,,1
,Half-life period was determined for the compound in rat,10116.0,Intermediate,,,9994,,CHEMBL627486,1,BAO_0000218,,,,N,,,5144,Rattus norvegicus,50597,A,,1
,"Half-life period was evaluated in rat, after administering 1 mg/kg intravenously",10116.0,Intermediate,,,9995,,CHEMBL627487,1,BAO_0000218,,In vivo,,N,,,4498,Rattus norvegicus,50597,A,,1
,"Half-life period was evaluated in rat, after administering 10 mg/kg orally",10116.0,Intermediate,,,9996,,CHEMBL627488,1,BAO_0000218,,In vivo,,N,,,4498,Rattus norvegicus,50597,A,,1
,Half-life value after IV dose at a dose of 5 mg/kg in rats.,10116.0,Intermediate,,,9997,,CHEMBL627489,1,BAO_0000218,,In vivo,,N,,,1908,Rattus norvegicus,50597,A,,1
,Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,10116.0,Intermediate,,,9998,,CHEMBL627490,1,BAO_0000218,,In vivo,,N,,,6211,Rattus norvegicus,50597,A,,1
,Half-life was determined in rat after intravenous administration (0.5 mg/kg),10116.0,Intermediate,,,9999,,CHEMBL873829,1,BAO_0000218,,In vivo,,N,,,5529,Rattus norvegicus,50597,A,,1
,Half-life was determined in rat at a dose of 1 mpk i.v.,10116.0,Intermediate,,,10000,,CHEMBL627655,1,BAO_0000218,,In vivo,,N,,,6444,Rattus norvegicus,50597,A,,1
,Half-life was determined in rat at a dose of 1 mpk i.v.; ND means not determined,10116.0,Intermediate,,,10001,,CHEMBL625994,1,BAO_0000218,,In vivo,,N,,,6444,Rattus norvegicus,50597,A,,1
,Half-life was determined in rat at a dose of 1 mpk i.v.; ND=not determined,10116.0,Intermediate,,,10002,,CHEMBL625995,1,BAO_0000218,,In vivo,,N,,,6444,Rattus norvegicus,50597,A,,1
,Half-life in rat,10116.0,Intermediate,,,10003,,CHEMBL625996,1,BAO_0000218,,,,N,,,5207,Rattus norvegicus,50597,A,,1
,In vitro half life in rat plasma,10116.0,Intermediate,,,10004,1969.0,CHEMBL625850,1,BAO_0000218,,In vitro,,N,,Plasma,530,Rattus norvegicus,50597,A,,1
,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in rat plasma",10116.0,Intermediate,,,10005,1969.0,CHEMBL625851,1,BAO_0000218,,In vitro,,N,,Plasma,1116,Rattus norvegicus,50597,A,,1
,In vitro half life in rat,10116.0,Intermediate,,,10006,,CHEMBL625852,1,BAO_0000218,,In vitro,,N,,,3219,Rattus norvegicus,50597,A,,1
,In vivo half life period after intravenous administration in rat,10116.0,Intermediate,,,10007,,CHEMBL625853,1,BAO_0000218,,In vivo,,N,,,6109,Rattus norvegicus,50597,A,,1
,In vivo half-life period for compound after i.v. administration at a dose of 5 mg/kg was measured in rats,10116.0,Intermediate,,,10008,,CHEMBL625854,1,BAO_0000218,,In vivo,,N,,,17582,Rattus norvegicus,50597,A,,1
,In vivo half-life period for compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,10116.0,Intermediate,,,10009,,CHEMBL874450,1,BAO_0000218,,In vivo,,N,,,17582,Rattus norvegicus,50597,A,,1
,In vivo t1/2 was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,10116.0,Intermediate,,,10010,,CHEMBL625855,1,BAO_0000218,,In vivo,,N,,,5974,Rattus norvegicus,50597,A,,1
,In vivo t1/2 was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,10116.0,Intermediate,,,10011,,CHEMBL625856,1,BAO_0000218,,In vivo,,N,,,5974,Rattus norvegicus,50597,A,,1
,In vivo t1/2 was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,10116.0,Intermediate,,,10012,,CHEMBL625857,1,BAO_0000218,,In vivo,,N,,,5974,Rattus norvegicus,50597,A,,1
,In vivo t1/2 was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,10116.0,Intermediate,,,10013,,CHEMBL873831,1,BAO_0000218,,In vivo,,N,,,5974,Rattus norvegicus,50597,A,,1
,Longer half-life in rat (i.v.) at 0.5 mpk,10116.0,Intermediate,,,10014,,CHEMBL625858,1,BAO_0000218,,In vivo,,N,,,17853,Rattus norvegicus,50597,A,,1
,Longer half-life in rat (p.o.) at 2.0 mpk,10116.0,Intermediate,,,10015,,CHEMBL625859,1,BAO_0000218,,In vivo,,N,,,17853,Rattus norvegicus,50597,A,,1
,Pharmacokinetic property (half life) in rat,10116.0,Intermediate,,,10016,,CHEMBL625860,1,BAO_0000218,,,,N,,,3457,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter half-life was determined at 10 mg/kg po dose in rats,10116.0,Intermediate,,,10017,,CHEMBL625861,1,BAO_0000218,,In vivo,,N,,,2792,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter half-life was determined at 2 mg/kg i.v. dose in rats,10116.0,Intermediate,,,10018,,CHEMBL625862,1,BAO_0000218,,In vivo,,N,,,2792,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter half-life was determined at 3 mg/kg po dose in rats,10116.0,Intermediate,,,10019,,CHEMBL625863,1,BAO_0000218,,In vivo,,N,,,2792,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter half-life was determined at 5 mg/kg i.v. dose in rats,10116.0,Intermediate,,,10020,,CHEMBL625864,1,BAO_0000218,,In vivo,,N,,,2792,Rattus norvegicus,50597,A,,1
,Pharmacokinetic property (t1/2) for the compound (5 mg/kg iv) was determined in rats,10116.0,Intermediate,,,10021,,CHEMBL625865,1,BAO_0000218,,In vivo,,N,,,5739,Rattus norvegicus,50597,A,,1
,Pharmacokinetic half time was determined intravenously in rats.,10116.0,Intermediate,,,10022,,CHEMBL625866,1,BAO_0000218,,In vivo,,N,,,15765,Rattus norvegicus,50597,A,,1
,Plasma half life in rat after 5 mg/kg oral gavage; 6-8 hours,10116.0,Intermediate,,,10023,1969.0,CHEMBL625867,1,BAO_0000218,,In vivo,,N,,Plasma,6567,Rattus norvegicus,50597,A,,1
,Plasma half life of hydrolysis of the compound,10116.0,Intermediate,,,10024,1969.0,CHEMBL625868,1,BAO_0000218,,,,N,,Plasma,2448,Rattus norvegicus,50597,A,,1
,Plasma half life was reported after a intravenous dose of 1 mg/kg in Dawley rat,10116.0,Intermediate,,,10025,1969.0,CHEMBL625869,1,BAO_0000218,,In vivo,,N,,Plasma,5423,Rattus norvegicus,50597,A,,1
,Plasma half life period was calculated in rat,10116.0,Intermediate,,,10026,1969.0,CHEMBL874451,1,BAO_0000218,,,,N,,Plasma,4853,Rattus norvegicus,50597,A,,1
,Plasma half-life in Sprague-Dawley rats,10116.0,Intermediate,,,10027,1969.0,CHEMBL625870,1,BAO_0000218,,,,N,,Plasma,4514,Rattus norvegicus,50597,A,,1
,Plasma half-life in Sprague-Dawley rats; Not determined,10116.0,Intermediate,,,10028,1969.0,CHEMBL625871,1,BAO_0000218,,,,N,,Plasma,4514,Rattus norvegicus,50597,A,,1
,Plasma half-life in rats,10116.0,Intermediate,,,10029,1969.0,CHEMBL625872,1,BAO_0000218,,,,N,,Plasma,1500,Rattus norvegicus,50597,A,,1
,Plasma half-life in rats; <MQL,10116.0,Intermediate,,,10030,1969.0,CHEMBL625873,1,BAO_0000218,,,,N,,Plasma,1500,Rattus norvegicus,50597,A,,1
,Plasma half-life period (0-8 h) was determined,10116.0,Intermediate,,,10031,1969.0,CHEMBL625874,1,BAO_0000218,,,,N,,Plasma,5334,Rattus norvegicus,50597,A,,1
,Plasma half-life period (0-8 h) was determined in Sprague-Dawley rat,10116.0,Intermediate,,,10032,1969.0,CHEMBL625875,1,BAO_0000218,,,,N,,Plasma,5334,Rattus norvegicus,50597,A,,1
,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,10116.0,Intermediate,,,10033,1969.0,CHEMBL625876,1,BAO_0000218,,In vivo,,N,,Plasma,5334,Rattus norvegicus,50597,A,,1
,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,10116.0,Intermediate,,,10034,1969.0,CHEMBL631258,1,BAO_0000218,,In vivo,,N,,Plasma,5334,Rattus norvegicus,50597,A,,1
,Plasma half-life was determined in Sprague-Dawley rats after 0-8 h administration of the compound,10116.0,Intermediate,,,10035,1969.0,CHEMBL631259,1,BAO_0000218,,,,N,,Plasma,4956,Rattus norvegicus,50597,A,,1
,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr administration of the compound; Not determined,10116.0,Intermediate,,,10036,1969.0,CHEMBL631260,1,BAO_0000218,,,,N,,Plasma,4956,Rattus norvegicus,50597,A,,1
,"Distribution of radioactivity in blood of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.68-1.03",10116.0,Intermediate,,,10037,178.0,CHEMBL631261,1,BAO_0000218,,,,N,,Blood,7768,Rattus norvegicus,50597,A,,1
,"Distribution of radioactivity in blood of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.45-0.48",10116.0,Intermediate,,,10038,178.0,CHEMBL631262,1,BAO_0000218,,,,N,,Blood,7768,Rattus norvegicus,50597,A,,1
,"Distribution of radioactivity in blood of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range-0.81-1",10116.0,Intermediate,,,10039,178.0,CHEMBL631263,1,BAO_0000218,,,,N,,Blood,7768,Rattus norvegicus,50597,A,,1
,"Distribution of radioactivity in brain tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.007-0.008",10116.0,Intermediate,,,10040,,CHEMBL631264,1,BAO_0000218,,,,N,,,7768,Rattus norvegicus,50597,A,,1
,"Distribution of radioactivity in brain tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.18-0.22",10116.0,Intermediate,,,10041,,CHEMBL631265,1,BAO_0000218,,,,N,,,7768,Rattus norvegicus,50597,A,,1
,"Distribution of radioactivity in brain tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.77-0.97",10116.0,Intermediate,,,10042,,CHEMBL631266,1,BAO_0000218,,,,N,,,7768,Rattus norvegicus,50597,A,,1
,"Distribution of radioactivity in brain tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.08-0.13",10116.0,Intermediate,,,10043,,CHEMBL631267,1,BAO_0000218,,,,N,,,7768,Rattus norvegicus,50597,A,,1
,"Distribution of radioactivity in brain tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.25-0.37",10116.0,Intermediate,,,10044,,CHEMBL631268,1,BAO_0000218,,,,N,,,7768,Rattus norvegicus,50597,A,,1
,"Distribution of radioactivity in brain tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.04",10116.0,Intermediate,,,10045,,CHEMBL631269,1,BAO_0000218,,,,N,,,7768,Rattus norvegicus,50597,A,,1
,"Distribution of radioactivity in brain tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.74-0.94",10116.0,Intermediate,,,10046,,CHEMBL631270,1,BAO_0000218,,,,N,,,7768,Rattus norvegicus,50597,A,,1
,"Distribution of radioactivity in heart tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",10116.0,Intermediate,,,10047,948.0,CHEMBL631271,1,BAO_0000218,,,,N,,Heart,7768,Rattus norvegicus,50597,A,,1
,"Distribution of radioactivity in heart tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.5-0.63",10116.0,Intermediate,,,10048,948.0,CHEMBL631272,1,BAO_0000218,,,,N,,Heart,7768,Rattus norvegicus,50597,A,,1
,"Distribution of radioactivity in heart tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.35-1.55",10116.0,Intermediate,,,10049,948.0,CHEMBL631273,1,BAO_0000218,,,,N,,Heart,7768,Rattus norvegicus,50597,A,,1
,"Distribution of radioactivity in heart tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.24-0.38",10116.0,Intermediate,,,10050,948.0,CHEMBL631274,1,BAO_0000218,,,,N,,Heart,7768,Rattus norvegicus,50597,A,,1
,"Distribution of radioactivity in heart tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.55-0.82",10116.0,Intermediate,,,10051,948.0,CHEMBL631275,1,BAO_0000218,,,,N,,Heart,7768,Rattus norvegicus,50597,A,,1
,"Distribution of radioactivity in heart tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.16-0.2",10116.0,Intermediate,,,10052,948.0,CHEMBL626984,1,BAO_0000218,,,,N,,Heart,7768,Rattus norvegicus,50597,A,,1
,"Distribution of radioactivity in heart tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.13-1.29",10116.0,Intermediate,,,10053,948.0,CHEMBL626985,1,BAO_0000218,,,,N,,Heart,7768,Rattus norvegicus,50597,A,,1
,"Distribution of radioactivity in liver tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",10116.0,Intermediate,,,10054,2107.0,CHEMBL626986,1,BAO_0000218,,,,N,,Liver,7768,Rattus norvegicus,50597,A,,1
,"Distribution of radioactivity in liver tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.71-0.93",10116.0,Intermediate,,,10055,2107.0,CHEMBL626987,1,BAO_0000218,,,,N,,Liver,7768,Rattus norvegicus,50597,A,,1
,"Distribution of radioactivity in liver tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.91-3.53",10116.0,Intermediate,,,10056,2107.0,CHEMBL626988,1,BAO_0000218,,,,N,,Liver,7768,Rattus norvegicus,50597,A,,1
,"Distribution of radioactivity in liver tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.42-0.62",10116.0,Intermediate,,,10057,2107.0,CHEMBL626989,1,BAO_0000218,,,,N,,Liver,7768,Rattus norvegicus,50597,A,,1
,"Distribution of radioactivity in liver tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.97-1.41",10116.0,Intermediate,,,10058,2107.0,CHEMBL626990,1,BAO_0000218,,,,N,,Liver,7768,Rattus norvegicus,50597,A,,1
,"Distribution of radioactivity in liver tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.19-0.23",10116.0,Intermediate,,,10059,2107.0,CHEMBL626991,1,BAO_0000218,,,,N,,Liver,7768,Rattus norvegicus,50597,A,,1
,"Distribution of radioactivity in liver tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.49-2.82",10116.0,Intermediate,,,10060,2107.0,CHEMBL626992,1,BAO_0000218,,,,N,,Liver,7768,Rattus norvegicus,50597,A,,1
,"Distribution of radioactivity in lung tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.03",10116.0,Intermediate,,,10061,2048.0,CHEMBL626993,1,BAO_0000218,,,,N,,Lung,7768,Rattus norvegicus,50597,A,,1
,"Distribution of radioactivity in lung tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.66-0.77",10116.0,Intermediate,,,10062,2048.0,CHEMBL874593,1,BAO_0000218,,,,N,,Lung,7768,Rattus norvegicus,50597,A,,1
,"Distribution of radioactivity in lung tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.17-1.42",10116.0,Intermediate,,,10063,2048.0,CHEMBL626994,1,BAO_0000218,,,,N,,Lung,7768,Rattus norvegicus,50597,A,,1
,"Distribution of radioactivity in lung tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.47-0.58",10116.0,Intermediate,,,10064,2048.0,CHEMBL626995,1,BAO_0000218,,,,N,,Lung,7768,Rattus norvegicus,50597,A,,1
,"Distribution of radioactivity in lung tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.65-0.87",10116.0,Intermediate,,,10065,2048.0,CHEMBL626190,1,BAO_0000218,,,,N,,Lung,7768,Rattus norvegicus,50597,A,,1
,"Distribution of radioactivity in lung tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.28-0.31",10116.0,Intermediate,,,10066,2048.0,CHEMBL626191,1,BAO_0000218,,,,N,,Lung,7768,Rattus norvegicus,50597,A,,1
,"Distribution of radioactivity in lung tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.98-1.22",10116.0,Intermediate,,,10067,2048.0,CHEMBL626364,1,BAO_0000218,,,,N,,Lung,7768,Rattus norvegicus,50597,A,,1
,"Distribution of radioactivity in thyroid tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 406-499",10116.0,Intermediate,,,10068,2046.0,CHEMBL626365,1,BAO_0000218,,,,N,,Thyroid gland,7768,Rattus norvegicus,50597,A,,1
,"Distribution of radioactivity in thyroid tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 53.0-96",10116.0,Intermediate,,,10069,2046.0,CHEMBL626366,1,BAO_0000218,,,,N,,Thyroid gland,7768,Rattus norvegicus,50597,A,,1
,"Distribution of radioactivity in thyroid tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.65-8.0.8",10116.0,Intermediate,,,10070,2046.0,CHEMBL626367,1,BAO_0000218,,,,N,,Thyroid gland,7768,Rattus norvegicus,50597,A,,1
,"Distribution of radioactivity in thyroid tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 92-159",10116.0,Intermediate,,,10071,2046.0,CHEMBL626368,1,BAO_0000218,,,,N,,Thyroid gland,7768,Rattus norvegicus,50597,A,,1
,"Distribution of radioactivity in thyroid tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 18.74-30.84",10116.0,Intermediate,,,10072,2046.0,CHEMBL626369,1,BAO_0000218,,,,N,,Thyroid gland,7768,Rattus norvegicus,50597,A,,1
,"Distribution of radioactivity in thyroid tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 156-207",10116.0,Intermediate,,,10073,2046.0,CHEMBL626370,1,BAO_0000218,,,,N,,Thyroid gland,7768,Rattus norvegicus,50597,A,,1
,"Bioavailability (F) was evaluated in rat, after administering 1 mg/kg intravenously",10116.0,Intermediate,,,10074,,CHEMBL626371,1,BAO_0000218,,In vivo,,N,,,4498,Rattus norvegicus,50597,A,,1
,"Bioavailability (F) was evaluated in rat, after administering 10 mg/kg orally",10116.0,Intermediate,,,10075,,CHEMBL626372,1,BAO_0000218,,In vivo,,N,,,4498,Rattus norvegicus,50597,A,,1
,Bioavailability after a dose of 10 mg/kg p.o.,10116.0,Intermediate,,,10076,,CHEMBL626373,1,BAO_0000218,,In vivo,,N,,,3603,Rattus norvegicus,50597,A,,1
,Bioavailability after peroral administration (10 mg/kg) was determined in rat,10116.0,Intermediate,,,10077,,CHEMBL626374,1,BAO_0000218,,In vivo,,N,,,6215,Rattus norvegicus,50597,A,,1
,Bioavailability in fasted male administration of 2 mg/Kg of compound p.o.,10116.0,Intermediate,,,10078,,CHEMBL626375,1,BAO_0000218,,In vivo,,N,,,5710,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg),10116.0,Intermediate,,,10079,,CHEMBL626376,1,BAO_0000218,,In vivo,,N,,,5710,Rattus norvegicus,50597,A,,1
,Bioavailability in rat po was determined,10116.0,Intermediate,,,10080,,CHEMBL626377,1,BAO_0000218,,In vivo,,N,,,5676,Rattus norvegicus,50597,A,,1
,Bioavailability of compound at 10 mg/kg in rat after oral administration,10116.0,Intermediate,,,10081,,CHEMBL626378,1,BAO_0000218,,In vivo,,N,,,17667,Rattus norvegicus,50597,A,,1
,Bioavailability of compound at 3 mg/kg in rat after i.v. administration,10116.0,Intermediate,,,10082,,CHEMBL626379,1,BAO_0000218,,In vivo,,N,,,17667,Rattus norvegicus,50597,A,,1
,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),10116.0,Intermediate,,,10083,,CHEMBL626380,1,BAO_0000218,,In vivo,,N,,,6848,Rattus norvegicus,50597,A,,1
,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),10116.0,Intermediate,,,10084,,CHEMBL626381,1,BAO_0000218,,In vivo,,N,,,6848,Rattus norvegicus,50597,A,,1
,Bioavailability in rat,10116.0,Intermediate,,,10085,,CHEMBL626382,1,BAO_0000218,,In vivo,,N,,,17267,Rattus norvegicus,50597,A,,1
,Bioavailability in rat (Sprague-Dawley) (female),10116.0,Intermediate,,,10086,,CHEMBL626383,1,BAO_0000218,,In vivo,,N,,,6362,Rattus norvegicus,50597,A,,1
,Bioavailability in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,10116.0,Intermediate,,,10087,,CHEMBL874652,1,BAO_0000218,,In vivo,,N,,,17671,Rattus norvegicus,50597,A,,1
,Bioavailability in rat (Sprague-Dawley) (male) (dose 10-20 mg/kg),10116.0,Intermediate,,,10088,,CHEMBL626384,1,BAO_0000218,,In vivo,,N,,,17671,Rattus norvegicus,50597,A,,1
,Bioavailability in rat (Sprague-Dawley) (male) (dose 1 mg/kg i.v. and 3 mg/kg p.o.) measured from 0.3 to 6 hr,10116.0,Intermediate,,,10089,,CHEMBL626385,1,BAO_0000218,,In vivo,,N,,,4333,Rattus norvegicus,50597,A,,1
,Bioavailability in rat at an oral dose of 2 mg/kg,10116.0,Intermediate,,,10090,,CHEMBL626386,1,BAO_0000218,,In vivo,,N,,,6077,Rattus norvegicus,50597,A,,1
,Bioavailability in rat,10116.0,Intermediate,,,10091,,CHEMBL626387,1,BAO_0000218,,In vivo,,N,,,3278,Rattus norvegicus,50597,A,,1
,Bioavailability in rat,10116.0,Intermediate,,,10092,,CHEMBL626388,1,BAO_0000218,,In vivo,,N,,,5964,Rattus norvegicus,50597,A,,1
,Bioavailability in rat,10116.0,Intermediate,,,10093,,CHEMBL626389,1,BAO_0000218,,In vivo,,N,,,4884,Rattus norvegicus,50597,A,,1
,Bioavailability in rat,10116.0,Intermediate,,,10094,,CHEMBL626390,1,BAO_0000218,,In vivo,,N,,,4905,Rattus norvegicus,50597,A,,1
,Bioavailability in rat was reported at the dose of 6 mg/kg in 25% PEG-300,10116.0,Intermediate,,,10095,,CHEMBL626391,1,BAO_0000218,,In vivo,,N,,,4884,Rattus norvegicus,50597,A,,1
,Bioavailability in rat,10116.0,Intermediate,,,10096,,CHEMBL626392,1,BAO_0000218,,In vivo,,N,,,6850,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10097,,CHEMBL626393,1,BAO_0000218,,In vivo,,N,,,2864,Rattus norvegicus,50597,A,,1
,Bioavailability was determined in rat,10116.0,Intermediate,,,10098,,CHEMBL623026,1,BAO_0000218,,In vivo,,N,,,5780,Rattus norvegicus,50597,A,,1
,Bioavailability,10116.0,Intermediate,,,10099,,CHEMBL623027,1,BAO_0000218,,In vivo,,N,,,1465,Rattus norvegicus,50597,A,,1
,Bioavailability,10116.0,Intermediate,,,10100,,CHEMBL623028,1,BAO_0000218,,In vivo,,N,,,5199,Rattus norvegicus,50597,A,,1
,Bioavailability in rat after 1 day dosing,10116.0,Intermediate,,,10101,,CHEMBL623029,1,BAO_0000218,,In vivo,,N,,,5765,Rattus norvegicus,50597,A,,1
,Bioavailability in rat after 4 day dosing,10116.0,Intermediate,,,10102,,CHEMBL623030,1,BAO_0000218,,In vivo,,N,,,5765,Rattus norvegicus,50597,A,,1
,Bioavailability after IV dosing at 0.5 mg/kg in rat; no data,10116.0,Intermediate,,,10103,,CHEMBL623031,1,BAO_0000218,,In vivo,,N,,,6518,Rattus norvegicus,50597,A,,1
,Bioavailability after IV dosing at 1 mg/kg in rat; no data,10116.0,Intermediate,,,10104,,CHEMBL623032,1,BAO_0000218,,In vivo,,N,,,6518,Rattus norvegicus,50597,A,,1
,Bioavailability after oral administration at a dose of 2 mg/kg in rat,10116.0,Intermediate,,,10105,,CHEMBL623033,1,BAO_0000218,,In vivo,,N,,,6518,Rattus norvegicus,50597,A,,1
,Bioavailability after oral administration at a dose of 4 mg/kg in rat,10116.0,Intermediate,,,10106,,CHEMBL623034,1,BAO_0000218,,In vivo,,N,,,6518,Rattus norvegicus,50597,A,,1
,Bioavailability at 4 hr after administration of 5 mg/kg dose peroral in rat,10116.0,Intermediate,,,10107,,CHEMBL623035,1,BAO_0000218,,In vivo,,N,,,2083,Rattus norvegicus,50597,A,,1
,Bioavailability at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,10116.0,Intermediate,,,10108,,CHEMBL623036,1,BAO_0000218,,In vivo,,N,,,17260,Rattus norvegicus,50597,A,,1
,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),10116.0,Intermediate,,,10109,,CHEMBL623037,1,BAO_0000218,,In vivo,,N,,,4956,Rattus norvegicus,50597,A,,1
,Bioavailability by intravenous administration of 3.4 mg/kg in rat,10116.0,Intermediate,,,10110,,CHEMBL623038,1,BAO_0000218,,In vivo,,N,,,4368,Rattus norvegicus,50597,A,,1
,Bioavailability from rat plasma at a single oral dose of 25 mg/kg,10116.0,Intermediate,,,10111,1969.0,CHEMBL874385,1,BAO_0000218,,In vivo,,N,,Plasma,17752,Rattus norvegicus,50597,A,,1
,Bioavailability in rat (Fisher) (fasted),10116.0,Intermediate,,,10112,,CHEMBL623039,1,BAO_0000218,,In vivo,,N,,,1446,Rattus norvegicus,50597,A,,1
,Bioavailability in monkey after po administration of 10 mg/kg dose,9443.0,Intermediate,,,10113,,CHEMBL623040,1,BAO_0000218,,In vivo,,U,,,2891,Primates,22224,A,,0
,Oral bioavailability in monkey (dose 10 mg/kg),9443.0,Intermediate,,,10114,,CHEMBL623041,1,BAO_0000218,,In vivo,,U,,,2891,Primates,22224,A,,0
,Bioavailability in rat,10116.0,Intermediate,,,10115,,CHEMBL623741,1,BAO_0000218,,In vivo,,N,,,6672,Rattus norvegicus,50597,A,,1
,Bioavailability in rat,10116.0,Intermediate,,,10116,,CHEMBL623742,1,BAO_0000218,,In vivo,,N,,,6673,Rattus norvegicus,50597,A,,1
,Bioavailability in rat,10116.0,Intermediate,,,10117,,CHEMBL623743,1,BAO_0000218,,In vivo,,N,,,17655,Rattus norvegicus,50597,A,,1
,Bioavailability in rat,10116.0,Intermediate,,,10118,,CHEMBL623744,1,BAO_0000218,,In vivo,,N,,,17796,Rattus norvegicus,50597,A,,1
,Bioavailability in rat (dose 2.0 mg/kg p.o.),10116.0,Intermediate,,,10119,,CHEMBL623745,1,BAO_0000218,,In vivo,,N,,,17853,Rattus norvegicus,50597,A,,1
,Bioavailability in rat (dose 5 mg/kg p.o. and 1 mg/kg i.v.),10116.0,Intermediate,,,10120,,CHEMBL623746,1,BAO_0000218,,In vivo,,N,,,4521,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat (dose 5 mg/kg p.o.),10116.0,Intermediate,,,10121,,CHEMBL623747,1,BAO_0000218,,In vivo,,N,,,4940,Rattus norvegicus,50597,A,,1
,Bioavailability in rat after po administration of 30 mg/kg dose,10116.0,Intermediate,,,10122,,CHEMBL623748,1,BAO_0000218,,In vivo,,U,,,2891,Rattus norvegicus,22224,A,,0
,Bioavailability in rat after po administration of 30 mg/kg dose,10116.0,Intermediate,,,10123,,CHEMBL623916,1,BAO_0000218,,In vivo,,U,,,2891,Rattus norvegicus,22224,A,,0
,Bioavailability in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,10116.0,Intermediate,,,10124,,CHEMBL623917,1,BAO_0000218,,In vivo,,N,,,4521,Rattus norvegicus,50597,A,,1
,Bioavailability in rat (dose 2 mg/kg i.v.),10116.0,Intermediate,,,10125,,CHEMBL623918,1,BAO_0000218,,In vivo,,N,,,17686,Rattus norvegicus,50597,A,,1
,Bioavailability in rat,10116.0,Intermediate,,,10126,,CHEMBL874386,1,BAO_0000218,,In vivo,,N,,,17796,Rattus norvegicus,50597,A,,1
,Bioavailability in rat; Only traces detected in rat plasma,10116.0,Intermediate,,,10127,1969.0,CHEMBL623919,1,BAO_0000218,,In vivo,,N,,Plasma,17796,Rattus norvegicus,50597,A,,1
,Bioavailability in rat,10116.0,Intermediate,,,10128,,CHEMBL623920,1,BAO_0000218,,In vivo,,N,,,5064,Rattus norvegicus,50597,A,,1
,Bioavailability upon oral administration of compound,10116.0,Intermediate,,,10129,,CHEMBL623148,1,BAO_0000218,,In vivo,,N,,,5147,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat (Sprague-Dawley) (dose 15 mg/kg),10116.0,Intermediate,,,10130,,CHEMBL623149,1,BAO_0000218,,In vivo,,N,,,1916,Rattus norvegicus,50597,A,,1
,Bioavailability in rat,10116.0,Intermediate,,,10131,,CHEMBL623150,1,BAO_0000218,,In vivo,,N,,,6049,Rattus norvegicus,50597,A,,1
,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fasting state",10116.0,Intermediate,,,10132,,CHEMBL623151,1,BAO_0000218,,In vivo,,N,,,1445,Rattus norvegicus,50597,A,,1
,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fed state",10116.0,Intermediate,,,10133,,CHEMBL623152,1,BAO_0000218,,In vivo,,N,,,1445,Rattus norvegicus,50597,A,,1
,Streptococcal cell wall-washed arthritis model in rats at 3.0 mg/kg peroral dose,10116.0,Expert,,,10134,,CHEMBL623153,1,BAO_0000218,,,,N,,,2862,Rattus norvegicus,50597,F,,1
,Streptococcal cell wall-washed arthritis model in rats at 30.0 mg/kg peroral dose,10116.0,Expert,,,10135,,CHEMBL623154,1,BAO_0000218,,,,N,,,2862,Rattus norvegicus,50597,F,,1
,In vitro and metabolic stability was determined,10116.0,Intermediate,,,10136,,CHEMBL623155,1,BAO_0000218,,,,N,,,4194,Rattus norvegicus,50597,A,,1
,In vitro metabolic stability in rat hepatocytes,10116.0,Intermediate,,,10137,,CHEMBL623156,1,BAO_0000218,,,,N,,,4194,Rattus norvegicus,50597,A,,1
,In vitro metabolic stability in rat was measured as pmol/min/mg/protein,10116.0,Intermediate,,,10138,,CHEMBL623157,1,BAO_0000218,,,,N,,,5486,Rattus norvegicus,50597,A,,1
,Metabolic rate for compound was observed in rat hepatocytes,10116.0,Intermediate,,,10139,2107.0,CHEMBL623158,1,BAO_0000218,,In vitro,,N,401.0,Liver,17582,Rattus norvegicus,50597,A,Hepatocyte,1
,In vitro metabolic stability determined after 30 min of incubation in rat hepatic microsomes,10116.0,Intermediate,,,10140,,CHEMBL623159,1,BAO_0000218,,,,N,,,5600,Rattus norvegicus,50597,A,,1
,Metabolism of compound in rat S9 microsomes ('+''indicates <20% largest observed peak),10116.0,Intermediate,,,10141,,CHEMBL874390,1,BAO_0000218,,,,N,,,14294,Rattus norvegicus,50597,A,,1
,Metabolism of compound in rat S9 microsomes ('++++' indicates largest observed peak),10116.0,Intermediate,,,10142,,CHEMBL623160,1,BAO_0000218,,,,N,,,14294,Rattus norvegicus,50597,A,,1
,Metabolism of compound in rat S9 microsomes; Trace,10116.0,Intermediate,,,10143,,CHEMBL623161,1,BAO_0000218,,,,N,,,14294,Rattus norvegicus,50597,A,,1
,Metabolism was measured as percent loss at 4 hr in rat hepatocytes,10116.0,Intermediate,,,10144,,CHEMBL623162,1,BAO_0000218,,,,N,,,17847,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HIAA,10116.0,Intermediate,,,10145,,CHEMBL623163,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HT,10116.0,Intermediate,,,10146,,CHEMBL623164,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DA,10116.0,Intermediate,,,10147,,CHEMBL623165,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DOPAC,10116.0,Intermediate,,,10148,,CHEMBL623166,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex HVA,10116.0,Intermediate,,,10149,,CHEMBL624983,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex NE,10116.0,Intermediate,,,10150,,CHEMBL624984,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Hippocampus 5-HIAA,10116.0,Intermediate,,,10151,,CHEMBL624985,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus 5-HT,10116.0,Intermediate,,,10152,,CHEMBL622970,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below level of detection,10116.0,Intermediate,,,10153,,CHEMBL622971,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below the levels of detection,10116.0,Intermediate,,,10154,,CHEMBL622972,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below level of detection,10116.0,Intermediate,,,10155,,CHEMBL622973,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below the levels of detection,10116.0,Intermediate,,,10156,,CHEMBL622974,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below level of detection,10116.0,Intermediate,,,10157,,CHEMBL622975,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below the levels of detection,10116.0,Intermediate,,,10158,,CHEMBL622976,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus NE,10116.0,Intermediate,,,10159,,CHEMBL622977,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HIAA,10116.0,Intermediate,,,10160,,CHEMBL624351,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HT,10116.0,Intermediate,,,10161,,CHEMBL624352,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,10116.0,Intermediate,,,10162,,CHEMBL624353,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DOPAC,10116.0,Intermediate,,,10163,,CHEMBL622397,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex HVA,10116.0,Intermediate,,,10164,,CHEMBL622398,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex NE,10116.0,Intermediate,,,10165,,CHEMBL622399,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,10116.0,Intermediate,,,10166,,CHEMBL622400,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HIAA,10116.0,Intermediate,,,10167,,CHEMBL628428,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HT,10116.0,Intermediate,,,10168,,CHEMBL628590,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below level of detection,10116.0,Intermediate,,,10169,,CHEMBL628591,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below the levels of detection,10116.0,Intermediate,,,10170,,CHEMBL628592,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,10116.0,Intermediate,,,10171,,CHEMBL628593,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection,10116.0,Intermediate,,,10172,,CHEMBL875333,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,10116.0,Intermediate,,,10173,,CHEMBL628594,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr of administration,10116.0,Intermediate,,,10174,1969.0,CHEMBL628595,1,BAO_0000218,,,,N,,Plasma,4969,Rattus norvegicus,50597,A,,1
,Stability in rat plasma was determined,10116.0,Intermediate,,,10175,1969.0,CHEMBL628596,1,BAO_0000218,,,,N,,Plasma,6737,Rattus norvegicus,50597,A,,1
,Stability in rat plasma was determined; ND= no data,10116.0,Intermediate,,,10176,1969.0,CHEMBL628597,1,BAO_0000218,,,,N,,Plasma,6737,Rattus norvegicus,50597,A,,1
,Tested for plasma half life period in rat (0-8 hr),10116.0,Intermediate,,,10177,1969.0,CHEMBL628598,1,BAO_0000218,,,,N,,Plasma,5089,Rattus norvegicus,50597,A,,1
,Tested for plasma half life period in rat (0-8 hr); Not determined,10116.0,Intermediate,,,10178,1969.0,CHEMBL628599,1,BAO_0000218,,,,N,,Plasma,5089,Rattus norvegicus,50597,A,,1
,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in rat,10116.0,Intermediate,,,10179,,CHEMBL628600,1,BAO_0000218,,In vivo,,N,,,1466,Rattus norvegicus,50597,A,,1
,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in rat,10116.0,Intermediate,,,10180,,CHEMBL628601,1,BAO_0000218,,In vivo,,N,,,1466,Rattus norvegicus,50597,A,,1
,Tested for the half life in rat,10116.0,Intermediate,,,10181,,CHEMBL628602,1,BAO_0000218,,,,N,,,4950,Rattus norvegicus,50597,A,,1
,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase,10116.0,Intermediate,,,10182,,CHEMBL628603,1,BAO_0000218,,In vitro,,N,,,2412,Rattus norvegicus,50597,A,,1
,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase; ND=Not determined,10116.0,Intermediate,,,10183,,CHEMBL628604,1,BAO_0000218,,In vitro,,N,,,2412,Rattus norvegicus,50597,A,,1
,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase,10116.0,Intermediate,,,10184,,CHEMBL628605,1,BAO_0000218,,In vitro,,N,,,2412,Rattus norvegicus,50597,A,,1
,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase; ND=Not determined,10116.0,Intermediate,,,10185,,CHEMBL628606,1,BAO_0000218,,In vitro,,N,,,2412,Rattus norvegicus,50597,A,,1
,Tested in vitro for the time for half reactivation against rat small intestinal sucrase,10116.0,Intermediate,,,10186,,CHEMBL628607,1,BAO_0000218,,In vitro,,N,,,2412,Rattus norvegicus,50597,A,,1
,The biological half life the compound was measured at the dose of 100 umol/kg,10116.0,Intermediate,,,10187,,CHEMBL628608,1,BAO_0000218,,,,N,,,15022,Rattus norvegicus,50597,A,,1
,The biological half life the compound was measured at the dose of 30 umol/kg,10116.0,Intermediate,,,10188,,CHEMBL628609,1,BAO_0000218,,,,N,,,15022,Rattus norvegicus,50597,A,,1
,The compound was evaluated for plasma half life period in rat,10116.0,Intermediate,,,10189,1969.0,CHEMBL628610,1,BAO_0000218,,,,N,,Plasma,406,Rattus norvegicus,50597,A,,1
,"The half life value in female wistar rat at 100 mg/kg, p.o. dose",10116.0,Intermediate,,,10190,,CHEMBL873819,1,BAO_0000218,,In vivo,,N,,,15078,Rattus norvegicus,50597,A,,1
,"The half life value in male wistar rat at 100 mg/kg, p.o. dose",10116.0,Intermediate,,,10191,,CHEMBL628611,1,BAO_0000218,,In vivo,,N,,,15078,Rattus norvegicus,50597,A,,1
,The pharmacokinetic parameter half-life period in vivo in rats,10116.0,Intermediate,,,10192,,CHEMBL628612,1,BAO_0000218,,In vivo,,N,,,5247,Rattus norvegicus,50597,A,,1
,"The pharmacokinetic property, Half-life was determined",10116.0,Intermediate,,,10193,,CHEMBL628613,1,BAO_0000218,,In vivo,,N,,,5041,Rattus norvegicus,50597,A,,1
,"The pharmacokinetic property, Half-life in rat in vivo",10116.0,Intermediate,,,10194,,CHEMBL628614,1,BAO_0000218,,In vivo,,N,,,5041,Rattus norvegicus,50597,A,,1
,"The pharmacokinetic property, Half-life was determined; ND denotes no data",10116.0,Intermediate,,,10195,,CHEMBL628615,1,BAO_0000218,,In vivo,,N,,,5041,Rattus norvegicus,50597,A,,1
,"The pharmacokinetic property, Half-life was determined; ND denotes not determined",10116.0,Intermediate,,,10196,,CHEMBL628616,1,BAO_0000218,,In vivo,,N,,,5041,Rattus norvegicus,50597,A,,1
,The plasma half life period in rats,10116.0,Intermediate,,,10197,1969.0,CHEMBL627924,1,BAO_0000218,,,,N,,Plasma,3918,Rattus norvegicus,50597,A,,1
,The release rate of the free drug from the substrate in rat liver lysosomal preparation by rat liver lysosomal assay,10116.0,Intermediate,,,10198,2107.0,CHEMBL627925,1,BAO_0000218,,,,N,,Liver,2906,Rattus norvegicus,50597,A,,1
,half life in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,10116.0,Intermediate,,,10199,,CHEMBL627926,1,BAO_0000218,,In vivo,,N,,,6467,Rattus norvegicus,50597,A,,1
,t1/2 (apparent elimination)of the compound was determined,10116.0,Intermediate,,,10200,,CHEMBL627927,1,BAO_0000218,,,,N,,,5510,Rattus norvegicus,50597,A,,1
,t1/2 value in rat,10116.0,Intermediate,,,10201,,CHEMBL627928,1,BAO_0000218,,,,N,,,3788,Rattus norvegicus,50597,A,,1
,Half life in rat,10116.0,Intermediate,,,10202,,CHEMBL627539,1,BAO_0000218,,,,N,,,17796,Rattus norvegicus,50597,A,,1
,"Half life period calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",10116.0,Intermediate,,,10203,1969.0,CHEMBL876790,1,BAO_0000218,,In vivo,,N,,Plasma,12873,Rattus norvegicus,50597,A,,1
,Pharmacokinetic property (t1/2beta) was measured in rat at the dose of 0.32 mg/kg i.v.,10116.0,Intermediate,,,10204,,CHEMBL858186,1,BAO_0000218,,In vivo,,N,,,5983,Rattus norvegicus,50597,A,,1
,Half-life period in fasted rats,10116.0,Intermediate,,,10205,,CHEMBL627540,1,BAO_0000218,,,,N,,,15765,Rattus norvegicus,50597,A,,1
,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female wistar rats,10116.0,Intermediate,,,10206,,CHEMBL627541,1,BAO_0000218,,In vivo,,N,,,2661,Rattus norvegicus,50597,A,,1
,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to male wistar rats,10116.0,Intermediate,,,10207,,CHEMBL627715,1,BAO_0000218,,In vivo,,N,,,2661,Rattus norvegicus,50597,A,,1
,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,10116.0,Intermediate,,,10208,,CHEMBL627716,1,BAO_0000218,,In vivo,,N,,,429,Rattus norvegicus,50597,A,,1
,Maximum time required to achieve Cmax was determined in rat,10116.0,Intermediate,,,10209,,CHEMBL627717,1,BAO_0000218,,,,N,,,17655,Rattus norvegicus,50597,A,,1
,Time calculated to reach Cmax at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,10116.0,Intermediate,,,10210,,CHEMBL627718,1,BAO_0000218,,In vivo,,N,,,17717,Rattus norvegicus,50597,A,,1
,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,10116.0,Intermediate,,,10211,,CHEMBL627719,1,BAO_0000218,,In vivo,,N,,,17717,Rattus norvegicus,50597,A,,1
,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with control,10116.0,Intermediate,,,10212,,CHEMBL627720,1,BAO_0000218,,In vivo,,N,,,17717,Rattus norvegicus,50597,A,,1
,Time to reach maximum concentration in rat after 2 mg/kg peroral administration,10116.0,Intermediate,,,10213,,CHEMBL627721,1,BAO_0000218,,In vivo,,N,,,6570,Rattus norvegicus,50597,A,,1
,Time to reach maximum concentration in rat after 2 mg/kg peroral administration; 4-6,10116.0,Intermediate,,,10214,,CHEMBL627722,1,BAO_0000218,,In vivo,,N,,,6570,Rattus norvegicus,50597,A,,1
,Tmax of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,10116.0,Intermediate,,,10215,,CHEMBL627723,1,BAO_0000218,,In vivo,,N,,,5978,Rattus norvegicus,50597,A,,1
,Tmax of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,10116.0,Intermediate,,,10216,,CHEMBL626058,1,BAO_0000218,,In vivo,,N,,,5978,Rattus norvegicus,50597,A,,1
,Tmax of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,10116.0,Intermediate,,,10217,,CHEMBL626059,1,BAO_0000218,,In vivo,,N,,,5978,Rattus norvegicus,50597,A,,1
,Tmax of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,10116.0,Intermediate,,,10218,,CHEMBL626060,1,BAO_0000218,,In vivo,,N,,,5978,Rattus norvegicus,50597,A,,1
,Tmax at a dose of 4 mg/kg in Rat Plasma after iv administration,10116.0,Intermediate,,,10219,1969.0,CHEMBL626061,1,BAO_0000218,,In vivo,,N,,Plasma,17720,Rattus norvegicus,50597,A,,1
,Tmax determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,10116.0,Intermediate,,,10220,,CHEMBL876791,1,BAO_0000218,,In vivo,,N,,,4723,Rattus norvegicus,50597,A,,1
,Tmax determined after 3 mg/kg oral administration in potassium oxonate treated rats,10116.0,Intermediate,,,10221,,CHEMBL626062,1,BAO_0000218,,In vivo,,N,,,4723,Rattus norvegicus,50597,A,,1
,Tmax at the dose of 2 mg/Kg administered perorally in rats,10116.0,Intermediate,,,10222,,CHEMBL626063,1,BAO_0000218,,In vivo,,N,,,4756,Rattus norvegicus,50597,A,,1
,Tmax at the dose of 5 mg/Kg administered perorally in rats,10116.0,Intermediate,,,10223,,CHEMBL626064,1,BAO_0000218,,In vivo,,N,,,4756,Rattus norvegicus,50597,A,,1
,tmax at a dose of 100 mg/kg in Rat Plasma after iv administration,10116.0,Intermediate,,,10224,1969.0,CHEMBL626065,1,BAO_0000218,,In vivo,,N,,Plasma,17720,Rattus norvegicus,50597,A,,1
,tmax at a dose of 50 mg/kg in Rat Plasma after iv administration,10116.0,Intermediate,,,10225,1969.0,CHEMBL626066,1,BAO_0000218,,In vivo,,N,,Plasma,17720,Rattus norvegicus,50597,A,,1
,tmax upon peroral administration of 10.0 mg/Kg dose in rat,10116.0,Intermediate,,,10226,,CHEMBL626067,1,BAO_0000218,,In vivo,,N,,,1466,Rattus norvegicus,50597,A,,1
,Percent total excretion of 3-(thiomethyl)acetaminophen glucuronide,10116.0,Intermediate,,,10227,,CHEMBL626068,1,BAO_0000218,,,,N,,,7449,Rattus norvegicus,50597,F,,1
,Percent total excretion of 3-(thiomethyl)acetaminophen sulfate,10116.0,Intermediate,,,10228,,CHEMBL626069,1,BAO_0000218,,,,N,,,7449,Rattus norvegicus,50597,F,,1
,Percent total excretion of 3-methoxyacetaminophen glucuronide,10116.0,Intermediate,,,10229,,CHEMBL626070,1,BAO_0000218,,,,N,,,7449,Rattus norvegicus,50597,F,,1
,Percent total excretion of N-methoxyacetaminophen glucuronide,10116.0,Intermediate,,,10230,,CHEMBL626071,1,BAO_0000218,,,,N,,,7449,Rattus norvegicus,50597,F,,1
,Percent total excretion of N-methoxyacetaminophen sulfate,10116.0,Intermediate,,,10231,,CHEMBL626072,1,BAO_0000218,,,,N,,,7449,Rattus norvegicus,50597,F,,1
,Percent total excretion of acetaminophen,10116.0,Intermediate,,,10232,,CHEMBL626073,1,BAO_0000218,,,,N,,,7449,Rattus norvegicus,50597,F,,1
,"Distribution of radioactivity in thyroid tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.19-7.22",10116.0,Intermediate,,,10233,2046.0,CHEMBL626741,1,BAO_0000218,,,,N,,Thyroid gland,7768,Rattus norvegicus,50597,A,,1
,"Percent instability was measured by Rat S9 liver slice metabolism assay, in vitro",10116.0,Intermediate,,,10234,,CHEMBL626742,1,BAO_0000218,,,,N,,,17655,Rattus norvegicus,50597,A,,1
,Plasma clearance following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats,10116.0,Intermediate,,,10235,,CHEMBL626743,1,BAO_0000218,,,,N,,,17735,Rattus norvegicus,50597,A,,1
,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,10116.0,Intermediate,,,10236,,CHEMBL876792,1,BAO_0000218,,,,N,,,5960,Rattus norvegicus,50597,A,,1
,Volume of distribution following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,10116.0,Intermediate,,,10237,,CHEMBL626744,1,BAO_0000218,,,,N,,,17735,Rattus norvegicus,50597,A,,1
,Compound was tested for antidiuretic activity in rats,10116.0,Intermediate,,,10238,,CHEMBL626745,1,BAO_0000218,,,,N,,,7116,Rattus norvegicus,50597,A,,1
,AUC in rat after 3mg/kg oral dose,10116.0,Intermediate,,,10239,1969.0,CHEMBL626746,1,BAO_0000218,,In vivo,,N,,Plasma,4878,Rattus norvegicus,50597,A,,1
,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 10 mg/kg,10116.0,Intermediate,,,10240,,CHEMBL626747,1,BAO_0000218,,,,N,,,5939,Rattus norvegicus,50597,A,,1
,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 5 mg/kg,10116.0,Intermediate,,,10241,,CHEMBL626748,1,BAO_0000218,,,,N,,,5939,Rattus norvegicus,50597,A,,1
,Bioavailability administered orally at a dose of 10 mg/kg to rats,10116.0,Intermediate,,,10242,,CHEMBL626749,1,BAO_0000218,,,,N,,,16367,Rattus norvegicus,50597,A,,1
,Oral Bioavailability was determined,10116.0,Intermediate,,,10243,,CHEMBL626750,1,BAO_0000218,,,,N,,,16366,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10244,,CHEMBL626751,1,BAO_0000218,,,,N,,,4426,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat; Not performed.,10116.0,Intermediate,,,10245,,CHEMBL626913,1,BAO_0000218,,,,N,,,4426,Rattus norvegicus,50597,A,,1
,Bioavailability,10116.0,Intermediate,,,10246,,CHEMBL626914,1,BAO_0000218,,,,N,,,5041,Rattus norvegicus,50597,A,,1
,Bioavailability was determined; ND denotes no data,10116.0,Intermediate,,,10247,,CHEMBL626915,1,BAO_0000218,,,,N,,,5041,Rattus norvegicus,50597,A,,1
,Biliary excretion when administered intravenously at a dose of 2.5 mg/kg in rats,10116.0,Intermediate,,,10248,,CHEMBL626916,1,BAO_0000218,,,,N,,,1500,Rattus norvegicus,50597,A,,1
,Biliary excretion when administered intravenously at a dose of 5 mg/kg in rats,10116.0,Intermediate,,,10249,,CHEMBL626917,1,BAO_0000218,,,,N,,,1500,Rattus norvegicus,50597,A,,1
,Binding towards rat plasma protein at 10 uM,10116.0,Intermediate,,,10250,,CHEMBL626918,1,BAO_0000218,,,,N,,,17409,Rattus norvegicus,50597,A,,1
,Binding towards rat plasma protein at 100 uM,10116.0,Intermediate,,,10251,,CHEMBL626919,1,BAO_0000218,,,,N,,,17409,Rattus norvegicus,50597,A,,1
,Bioavailability in rat (dose 20 mg/kg p.o.),10116.0,Intermediate,,,10252,,CHEMBL626920,1,BAO_0000218,,In vivo,,N,,,2959,Rattus norvegicus,50597,A,,1
,Bioavailability was determined after oral administration of compound 18 at a dose of 4 mg/kg to rat,10116.0,Intermediate,,,10253,,CHEMBL621976,1,BAO_0000218,,In vivo,,N,,,13501,Rattus norvegicus,50597,A,,1
,Bioavailability in rat after 5 mg/kg oral gavage,10116.0,Intermediate,,,10254,,CHEMBL877599,1,BAO_0000218,,In vivo,,N,,,6567,Rattus norvegicus,50597,A,,1
,Bioavailability in rat,10116.0,Intermediate,,,10255,,CHEMBL621977,1,BAO_0000218,,In vivo,,N,,,6571,Rattus norvegicus,50597,A,,1
,Bioavailability in rat (dose 1 mg/kg i.v.),10116.0,Intermediate,,,10256,,CHEMBL621978,1,BAO_0000218,,In vivo,,N,,,6715,Rattus norvegicus,50597,A,,1
,Bioavailability in rat (dose 3 mg/kg p.o.),10116.0,Intermediate,,,10257,,CHEMBL621979,1,BAO_0000218,,In vivo,,N,,,6715,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10258,,CHEMBL621980,1,BAO_0000218,,In vivo,,N,,,2932,Rattus norvegicus,50597,A,,1
,Bioavailability of the compound in rats after administration of 30 mg/kg,10116.0,Intermediate,,,10259,,CHEMBL621981,1,BAO_0000218,,In vivo,,N,,,4171,Rattus norvegicus,50597,A,,1
,Bioavailability after administration of 10 mg/kg in rats,10116.0,Intermediate,,,10260,,CHEMBL621982,1,BAO_0000218,,In vivo,,N,,,17509,Rattus norvegicus,50597,A,,1
,Bioavailability after administration of 2 mg/kg in rats,10116.0,Intermediate,,,10261,,CHEMBL882953,1,BAO_0000218,,In vivo,,N,,,17509,Rattus norvegicus,50597,A,,1
,Bioavailability by oral administration at a dose of 100 uM/kg in rat was determined,10116.0,Intermediate,,,10262,,CHEMBL621983,1,BAO_0000218,,In vivo,,N,,,4527,Rattus norvegicus,50597,A,,1
,Bioavailability in dogs was determined; high,10116.0,Intermediate,,,10263,,CHEMBL621984,1,BAO_0000218,,In vivo,,N,,,4026,Rattus norvegicus,50597,A,,1
,Bioavailability in monkey after intravenous administration at 1 mpk,10116.0,Intermediate,,,10264,,CHEMBL621985,1,BAO_0000218,,In vivo,,N,,,6659,Rattus norvegicus,50597,A,,1
,Bioavailability in monkey after peroral administration at 10 mpk,10116.0,Intermediate,,,10265,,CHEMBL621986,1,BAO_0000218,,In vivo,,N,,,6659,Rattus norvegicus,50597,A,,1
,Bioavailability in rat after intravenous administration at 1 mpk,10116.0,Intermediate,,,10266,,CHEMBL621987,1,BAO_0000218,,In vivo,,N,,,6659,Rattus norvegicus,50597,A,,1
,Bioavailability in rat after intravenous administration at 2 mpk,10116.0,Intermediate,,,10267,,CHEMBL877600,1,BAO_0000218,,In vivo,,N,,,6659,Rattus norvegicus,50597,F,,1
,Bioavailability in rat after peroral administration at 30 mpk,10116.0,Intermediate,,,10268,,CHEMBL621988,1,BAO_0000218,,In vivo,,N,,,6659,Rattus norvegicus,50597,A,,1
,Bioavailability in rat after peroral administration at at 100 mpk,10116.0,Intermediate,,,10269,,CHEMBL621989,1,BAO_0000218,,In vivo,,N,,,6659,Rattus norvegicus,50597,F,,1
,Bioavailability in rats was evaluated,10116.0,Intermediate,,,10270,,CHEMBL621990,1,BAO_0000218,,In vivo,,N,,,6597,Rattus norvegicus,50597,A,,1
,Bioavailability was calculated after an intravenous dose of 0.3 mg/Kg in rats after 6 hr,10116.0,Intermediate,,,10271,,CHEMBL621991,1,BAO_0000218,,In vivo,,N,,,1202,Rattus norvegicus,50597,A,,1
,Bioavailability was calculated after an intravenous dose of 1 mg/Kg in rats after 6 hr,10116.0,Intermediate,,,10272,,CHEMBL621992,1,BAO_0000218,,In vivo,,N,,,1202,Rattus norvegicus,50597,A,,1
,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 4 hr,10116.0,Intermediate,,,10273,,CHEMBL621993,1,BAO_0000218,,In vivo,,N,,,1202,Rattus norvegicus,50597,A,,1
,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 6 hr,10116.0,Intermediate,,,10274,,CHEMBL621994,1,BAO_0000218,,In vivo,,N,,,1202,Rattus norvegicus,50597,A,,1
,Bioavailability in rat,10116.0,Intermediate,,,10275,,CHEMBL621995,1,BAO_0000218,,In vivo,,N,,,5207,Rattus norvegicus,50597,A,,1
,Bioavailability in rat,10116.0,Intermediate,,,10276,,CHEMBL621996,1,BAO_0000218,,In vivo,,N,,,5970,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat (dose 10 mg/kg),10116.0,Intermediate,,,10277,,CHEMBL621997,1,BAO_0000218,,In vivo,,N,,,17538,Rattus norvegicus,50597,A,,1
,Bioavailability in rat after po administration at a dose of 10 mg/kg; nd is not determined,10116.0,Intermediate,,,10278,,CHEMBL621998,1,BAO_0000218,,In vivo,,N,,,17538,Rattus norvegicus,50597,A,,1
,Bioavailability upon peroral administration of 10.0 mg/Kg dose in rat,10116.0,Intermediate,,,10279,,CHEMBL621999,1,BAO_0000218,,In vivo,,N,,,1466,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10280,,CHEMBL622000,1,BAO_0000218,,In vivo,,N,,,2879,Rattus norvegicus,50597,A,,1
,Bioavailability was measured in rat after oral administration; 2-4,10116.0,Intermediate,,,10281,,CHEMBL622001,1,BAO_0000218,,In vivo,,N,,,2879,Rattus norvegicus,50597,A,,1
,Bioavailability was measured in rat after oral administration; 3-7,10116.0,Intermediate,,,10282,,CHEMBL622002,1,BAO_0000218,,In vivo,,N,,,2879,Rattus norvegicus,50597,A,,1
,Bioavailability in rat (intraduodenal administration),10116.0,Intermediate,,,10283,,CHEMBL622003,1,BAO_0000218,,In vivo,,N,,,3777,Rattus norvegicus,50597,A,,1
,Bioavailability in rat (intraduodenal administration),10116.0,Intermediate,,,10284,,CHEMBL877601,1,BAO_0000218,,In vivo,,N,,,3777,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10285,,CHEMBL624871,1,BAO_0000218,,In vivo,,N,,,3777,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10286,,CHEMBL622004,1,BAO_0000218,,In vivo,,N,,,3777,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg p.o.),10116.0,Intermediate,,,10287,,CHEMBL882954,1,BAO_0000218,,In vivo,,N,,,5423,Rattus norvegicus,50597,A,,1
,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally,10116.0,Intermediate,,,10288,,CHEMBL622005,1,BAO_0000218,,In vivo,,N,,,16365,Rattus norvegicus,50597,A,,1
,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally to a fasting rat,10116.0,Intermediate,,,10289,,CHEMBL622006,1,BAO_0000218,,In vivo,,N,,,16365,Rattus norvegicus,50597,A,,1
,Bioavailability was measured in rat,10116.0,Intermediate,,,10290,,CHEMBL622007,1,BAO_0000218,,In vivo,,N,,,4239,Rattus norvegicus,50597,A,,1
,Bioavailability was reported,10116.0,Intermediate,,,10291,,CHEMBL622008,1,BAO_0000218,,In vivo,,N,,,5438,Rattus norvegicus,50597,A,,1
,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),10116.0,Intermediate,,,10292,,CHEMBL622009,1,BAO_0000218,,In vivo,,N,,,5334,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),10116.0,Intermediate,,,10293,,CHEMBL622010,1,BAO_0000218,,In vivo,,N,,,5334,Rattus norvegicus,50597,A,,1
,Bioavailability was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,10116.0,Intermediate,,,10294,,CHEMBL622011,1,BAO_0000218,,In vivo,,N,,,4199,Rattus norvegicus,50597,A,,1
,Bioavailability in rat (dose 2 mg/kg in 1% methylcellulose p.o.),10116.0,Intermediate,,,10295,,CHEMBL622012,1,BAO_0000218,,In vivo,,N,,,4199,Rattus norvegicus,50597,A,,1
,Bioavailability in rat (dose 3 mg/kg in 1% methylcellulose ),10116.0,Intermediate,,,10296,,CHEMBL622013,1,BAO_0000218,,In vivo,,N,,,4199,Rattus norvegicus,50597,A,,1
,Bioavailability was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,10116.0,Intermediate,,,10297,,CHEMBL622014,1,BAO_0000218,,In vivo,,N,,,4890,Rattus norvegicus,50597,A,,1
,Bioavailability was determined at 3 mg/kg po dose in rats,10116.0,Intermediate,,,10298,,CHEMBL624749,1,BAO_0000218,,In vivo,,N,,,2792,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat (dose 2 mg/kg),10116.0,Intermediate,,,10299,,CHEMBL624750,1,BAO_0000218,,In vivo,,N,,,5529,Rattus norvegicus,50597,A,,1
,"Bioavailability was determined in rats at 10 mg/kg, p.o. dose",10116.0,Intermediate,,,10300,,CHEMBL624751,1,BAO_0000218,,In vivo,,N,,,6685,Rattus norvegicus,50597,A,,1
,"Bioavailability was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",10116.0,Intermediate,,,10301,,CHEMBL624752,1,BAO_0000218,,In vivo,,N,,,6685,Rattus norvegicus,50597,A,,1
,"Bioavailability was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",10116.0,Intermediate,,,10302,,CHEMBL624753,1,BAO_0000218,,In vivo,,N,,,6685,Rattus norvegicus,50597,A,,1
,Bioavailability was evaluated in rat after peroral administration at a dose of 1 mg/kg,10116.0,Intermediate,,,10303,,CHEMBL624754,1,BAO_0000218,,In vivo,,N,,,6005,Rattus norvegicus,50597,A,,1
,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,10116.0,Intermediate,,,10304,,CHEMBL624755,1,BAO_0000218,,In vivo,,N,,,6410,Rattus norvegicus,50597,A,,1
,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,10116.0,Intermediate,,,10305,,CHEMBL624756,1,BAO_0000218,,In vivo,,N,,,6410,Rattus norvegicus,50597,A,,1
,Bioavailability in rat,10116.0,Intermediate,,,10306,,CHEMBL624757,1,BAO_0000218,,In vivo,,N,,,6103,Rattus norvegicus,50597,A,,1
,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,10116.0,Intermediate,,,10307,,CHEMBL624758,1,BAO_0000218,,In vivo,,N,,,6410,Rattus norvegicus,50597,A,,1
,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,10116.0,Intermediate,,,10308,,CHEMBL622270,1,BAO_0000218,,In vivo,,N,,,6410,Rattus norvegicus,50597,A,,1
,Bioavailability in rat (Sprague-Dawley),10116.0,Intermediate,,,10309,,CHEMBL622271,1,BAO_0000218,,In vivo,,N,,,5353,Rattus norvegicus,50597,A,,1
,Bioavailability in rat at the dose of 2 mg/kg,10116.0,Intermediate,,,10310,,CHEMBL622272,1,BAO_0000218,,In vivo,,N,,,4727,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10311,,CHEMBL622273,1,BAO_0000218,,In vivo,,N,,,17804,Rattus norvegicus,50597,A,,1
,Bioavailability in rat (cannulated) (dose 2 mg/kg),10116.0,Intermediate,,,10312,,CHEMBL622274,1,BAO_0000218,,In vivo,,N,,,5809,Rattus norvegicus,50597,A,,1
,Bioavailability value of compound in rats was determined after peroral administration,10116.0,Intermediate,,,10313,,CHEMBL622275,1,BAO_0000218,,In vivo,,N,,,17804,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat (dose 20 mg/kg),10116.0,Intermediate,,,10314,,CHEMBL622276,1,BAO_0000218,,In vivo,,N,,,3634,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10315,,CHEMBL622277,1,BAO_0000218,,In vivo,,N,,,3341,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat (dose 5 mg/kg),10116.0,Intermediate,,,10316,,CHEMBL622278,1,BAO_0000218,,In vivo,,N,,,2690,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10317,,CHEMBL622279,1,BAO_0000218,,In vivo,,N,,,3184,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10318,,CHEMBL622280,1,BAO_0000218,,In vivo,,N,,,740,Rattus norvegicus,50597,A,,1
,Compound was evaluated for oral bioavailability in rats; 15-27 %,10116.0,Intermediate,,,10319,,CHEMBL624083,1,BAO_0000218,,In vivo,,N,,,1806,Rattus norvegicus,50597,A,,1
,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 18 h,10116.0,Intermediate,,,10320,,CHEMBL624084,1,BAO_0000218,,In vivo,,N,,,4891,Rattus norvegicus,50597,A,,1
,Compound was evaluated for pharmacokinetic property in rats after an oral dose of 10 mg/kg and the value was reported as oral bioavailability (F),10116.0,Intermediate,,,10321,,CHEMBL624085,1,BAO_0000218,,In vivo,,N,,,3634,Rattus norvegicus,50597,A,,1
,Compound was tested for bioavailability in rats,10116.0,Intermediate,,,10322,,CHEMBL624086,1,BAO_0000218,,In vivo,,N,,,64,Rattus norvegicus,50597,A,,1
,Bioavailability in rat,10116.0,Intermediate,,,10323,,CHEMBL624087,1,BAO_0000218,,In vivo,,N,,,4839,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10324,,CHEMBL624088,1,BAO_0000218,,In vivo,,N,,,1094,Rattus norvegicus,50597,A,,1
,Compound was tested for oral bioavailability in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po.,9544.0,Intermediate,,,10325,,CHEMBL624089,1,BAO_0000218,,In vivo,,U,,,5005,Macaca mulatta,22224,A,,0
,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),10116.0,Intermediate,,,10326,,CHEMBL624090,1,BAO_0000218,,In vivo,,U,,,5005,Rattus norvegicus,22224,A,,0
,Evaluated for the bioavailability in rat (in vivo),10116.0,Intermediate,,,10327,,CHEMBL624091,1,BAO_0000218,,In vivo,,N,,,4687,Rattus norvegicus,50597,A,,1
,F value of compound in rats was determined after peroral administration,10116.0,Intermediate,,,10328,,CHEMBL624092,1,BAO_0000218,,In vivo,,N,,,17804,Rattus norvegicus,50597,A,,1
,In vivo Oral bioavailability (F)was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,10116.0,Intermediate,,,10329,,CHEMBL624093,1,BAO_0000218,,In vivo,,N,,,5974,Rattus norvegicus,50597,A,,1
,In vivo Oral bioavailability (F)was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,10116.0,Intermediate,,,10330,,CHEMBL624094,1,BAO_0000218,,In vivo,,N,,,5974,Rattus norvegicus,50597,A,,1
,In vivo Oral bioavailability (F)was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,10116.0,Intermediate,,,10331,,CHEMBL624095,1,BAO_0000218,,In vivo,,N,,,5974,Rattus norvegicus,50597,A,,1
,In vivo Oral bioavailability (F)was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,10116.0,Intermediate,,,10332,,CHEMBL624096,1,BAO_0000218,,In vivo,,N,,,5974,Rattus norvegicus,50597,A,,1
,"In vivo percent of absolute bioavailability obtained from blood plasma levels analyzed by means of GC/MS (dose 5 uM/kg i.v. and 40 uM/kg, p.o.)",10116.0,Intermediate,,,10333,,CHEMBL624097,1,BAO_0000218,,In vivo,,N,,,1088,Rattus norvegicus,50597,A,,1
,Maximum fall in carotid flow in rat,10116.0,Intermediate,,,10334,,CHEMBL624098,1,BAO_0000218,,In vivo,,N,,,1742,Rattus norvegicus,50597,A,,1
,Oral Bioavailability after intravenous administration (1 mg/kg) in rat,10116.0,Intermediate,,,10335,,CHEMBL874392,1,BAO_0000218,,In vivo,,N,,,4689,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat (dose 5 mg/kg),10116.0,Intermediate,,,10336,,CHEMBL624099,1,BAO_0000218,,In vivo,,N,,,2463,Rattus norvegicus,50597,A,,1
,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,10116.0,Intermediate,,,10337,,CHEMBL624100,1,BAO_0000218,,In vivo,,N,,,5654,Rattus norvegicus,50597,A,,1
,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,10116.0,Intermediate,,,10338,,CHEMBL624101,1,BAO_0000218,,In vivo,,N,,,5654,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat (male Wistar),10116.0,Intermediate,,,10339,,CHEMBL624102,1,BAO_0000218,,In vivo,,N,,,6874,Rattus norvegicus,50597,A,,1
,Oral bioavailability after administration (30 mg/kg) in rat; good,10116.0,Intermediate,,,10340,,CHEMBL624103,1,BAO_0000218,,In vivo,,N,,,5633,Rattus norvegicus,50597,A,,1
,Oral bioavailability at the dose of 2 mg/kg in rat,10116.0,Intermediate,,,10341,,CHEMBL624104,1,BAO_0000218,,In vivo,,N,,,5496,Rattus norvegicus,50597,A,,1
,Oral bioavailability determined in rats,10116.0,Intermediate,,,10342,,CHEMBL624105,1,BAO_0000218,,In vivo,,N,,,2358,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat (Sprague-Dawley) (male) (dose 50 mg/kg p.o.),10116.0,Intermediate,,,10343,,CHEMBL624106,1,BAO_0000218,,In vivo,,N,,,16456,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat (dose single 10 mg/kg),10116.0,Intermediate,,,10344,,CHEMBL624107,1,BAO_0000218,,In vivo,,N,,,5302,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat (dose single 10 mg/kg),10116.0,Intermediate,,,10345,,CHEMBL623943,1,BAO_0000218,,In vivo,,N,,,5302,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat (dose 5 mg/kg,10116.0,Intermediate,,,10346,,CHEMBL623944,1,BAO_0000218,,In vivo,,N,,,5302,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection,10116.0,Intermediate,,,10347,,CHEMBL623945,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus NE,10116.0,Intermediate,,,10348,,CHEMBL623946,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HIAA,10116.0,Intermediate,,,10349,,CHEMBL623947,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HT,10116.0,Intermediate,,,10350,,CHEMBL623948,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DA,10116.0,Intermediate,,,10351,,CHEMBL623949,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DOPAC,10116.0,Intermediate,,,10352,,CHEMBL623950,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex HVA,10116.0,Intermediate,,,10353,,CHEMBL874398,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex NE,10116.0,Intermediate,,,10354,,CHEMBL623951,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HIAA,10116.0,Intermediate,,,10355,,CHEMBL623952,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HT,10116.0,Intermediate,,,10356,,CHEMBL623953,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below level of detection,10116.0,Intermediate,,,10357,,CHEMBL623954,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below the levels of detection,10116.0,Intermediate,,,10358,,CHEMBL623955,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below level of detection,10116.0,Intermediate,,,10359,,CHEMBL623956,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below the levels of detection,10116.0,Intermediate,,,10360,,CHEMBL627807,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below level of detection,10116.0,Intermediate,,,10361,,CHEMBL627808,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below the levels of detection,10116.0,Intermediate,,,10362,,CHEMBL627809,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus NE,10116.0,Intermediate,,,10363,,CHEMBL627810,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HIAA",10116.0,Intermediate,,,10364,,CHEMBL627811,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HT",10116.0,Intermediate,,,10365,,CHEMBL627812,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DA",10116.0,Intermediate,,,10366,,CHEMBL627813,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DOPAC",10116.0,Intermediate,,,10367,,CHEMBL627814,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex HVA",10116.0,Intermediate,,,10368,,CHEMBL875336,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex NE",10116.0,Intermediate,,,10369,,CHEMBL627815,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus 5-HIAA",10116.0,Intermediate,,,10370,,CHEMBL627816,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,"Momoamine and metabolic levels observed at 3 h postdrug against, at a dose of 20 mg/kg Hippocampus 5-HT",10116.0,Intermediate,,,10371,,CHEMBL627817,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DA; below the levels of detection",10116.0,Intermediate,,,10372,,CHEMBL627818,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection",10116.0,Intermediate,,,10373,,CHEMBL627819,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection",10116.0,Intermediate,,,10374,,CHEMBL627820,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus NE",10116.0,Intermediate,,,10375,,CHEMBL627821,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HIAA,10116.0,Intermediate,,,10376,,CHEMBL628464,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HT,10116.0,Intermediate,,,10377,,CHEMBL626239,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex DA,10116.0,Intermediate,,,10378,,CHEMBL626240,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed at 3 h postdrug against at a dose of 20 mg/kg Frontal cortex DOPAC,10116.0,Intermediate,,,10379,,CHEMBL626241,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex HVA,10116.0,Intermediate,,,10380,,CHEMBL626242,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex NE,10116.0,Intermediate,,,10381,,CHEMBL626243,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HIAA,10116.0,Intermediate,,,10382,,CHEMBL626244,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HT; below level of detection,10116.0,Intermediate,,,10383,,CHEMBL626907,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DA; below level of detection,10116.0,Intermediate,,,10384,,CHEMBL626908,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,10116.0,Intermediate,,,10385,,CHEMBL626909,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,10116.0,Intermediate,,,10386,,CHEMBL626910,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,Percent total excretion of acetaminophen cysteine conjugate,10116.0,Intermediate,,,10387,,CHEMBL875342,1,BAO_0000218,,,,N,,,7449,Rattus norvegicus,50597,F,,1
,Percent total excretion of acetaminophen glucuronide,10116.0,Intermediate,,,10388,,CHEMBL626911,1,BAO_0000218,,,,N,,,7449,Rattus norvegicus,50597,F,,1
,Percent total excretion of acetaminophen sulfate,10116.0,Intermediate,,,10389,,CHEMBL626912,1,BAO_0000218,,,,N,,,7449,Rattus norvegicus,50597,F,,1
,Percent total excretion of acetaminophen-mercapturic acid,10116.0,Intermediate,,,10390,,CHEMBL627065,1,BAO_0000218,,,,N,,,7449,Rattus norvegicus,50597,F,,1
,Amount of urine output was measured in rat at a dose of 10 mg/kg administered orally,10116.0,Intermediate,,,10391,1088.0,CHEMBL627066,1,BAO_0000218,,,,N,,Urine,3172,Rattus norvegicus,50597,A,,1
,Volume of distribution in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,10116.0,Intermediate,,,10392,,CHEMBL627067,1,BAO_0000218,,In vivo,,N,,,16456,Rattus norvegicus,50597,A,,1
,Biodistribution of compound in rat muscle after 5 min of administration,8656.0,Autocuration,,,10393,2385.0,CHEMBL627068,1,BAO_0000218,,In vivo,,U,,Muscle tissue,10839,ratrat,22224,A,,0
,Biodistribution of compound in rat muscle after 5 min of administration.,8656.0,Autocuration,,,10394,2385.0,CHEMBL627069,1,BAO_0000218,,In vivo,,U,,Muscle tissue,10839,ratrat,22224,A,,0
,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),9940.0,Autocuration,,,10395,,CHEMBL627070,1,BAO_0000218,,In vivo,,U,,,5334,Ovis aries,22224,A,,0
,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),9940.0,Autocuration,,,10396,,CHEMBL627071,1,BAO_0000218,,In vivo,,U,,,5334,Ovis aries,22224,A,,0
,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),9940.0,Autocuration,,,10397,,CHEMBL627072,1,BAO_0000218,,In vivo,,U,,,5334,Ovis aries,22224,A,,0
,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),9940.0,Autocuration,,,10398,,CHEMBL627073,1,BAO_0000218,,In vivo,,U,,,5334,Ovis aries,22224,A,,0
,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),9940.0,Autocuration,,,10399,,CHEMBL625387,1,BAO_0000218,,In vivo,,U,,,5334,Ovis aries,22224,A,,0
,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),9940.0,Autocuration,,,10400,,CHEMBL625388,1,BAO_0000218,,In vivo,,U,,,5334,Ovis aries,22224,A,,0
,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),9940.0,Autocuration,,,10401,1969.0,CHEMBL625389,1,BAO_0000218,,In vivo,,U,,Plasma,5334,Ovis aries,22224,A,,0
,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),9940.0,Autocuration,,,10402,1969.0,CHEMBL875343,1,BAO_0000218,,In vivo,,U,,Plasma,5334,Ovis aries,22224,A,,0
,Biological half life period of compound was measured against snake venom phosphodiesterase (SVPDE),8570.0,Intermediate,,,10403,,CHEMBL876795,1,BAO_0000218,,,,N,,,1735,Serpentes,50497,A,,1
,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards snake venom (SV-PDE) at a concentration of 4 microg,8570.0,Intermediate,,,10404,,CHEMBL626552,1,BAO_0000218,,,,N,,,1469,Serpentes,50497,A,,1
,Enzymatic stability was assessed with snake venom phosphodiesterase (SV PDE) exonuclase,8570.0,Intermediate,,,10405,,CHEMBL626553,1,BAO_0000218,,,,N,,,1336,Serpentes,50497,A,,1
,The human biological plasma half life of the compound,9606.0,Autocuration,,,10406,1969.0,CHEMBL626554,1,BAO_0000366,,,,U,,Plasma,12403,Homo sapiens,22224,A,,0
,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,10116.0,Intermediate,,,10407,1088.0,CHEMBL626555,1,BAO_0000218,,,,N,,Urine,8151,Rattus norvegicus,50597,A,,1
,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 120 min after iv administration compound,10116.0,Intermediate,,,10408,,CHEMBL626556,1,BAO_0000218,,,,N,,,8004,Rattus norvegicus,50597,A,,1
,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 15 after iv administration of compound,10116.0,Intermediate,,,10409,,CHEMBL626557,1,BAO_0000218,,,,N,,,8004,Rattus norvegicus,50597,A,,1
,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 240 min after iv administration compound,10116.0,Intermediate,,,10410,,CHEMBL626558,1,BAO_0000218,,,,N,,,8004,Rattus norvegicus,50597,A,,1
,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 30 min after iv administration of compound,10116.0,Intermediate,,,10411,,CHEMBL626559,1,BAO_0000218,,,,N,,,8004,Rattus norvegicus,50597,A,,1
,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 5 min after iv administration of compound,10116.0,Intermediate,,,10412,,CHEMBL626560,1,BAO_0000218,,,,N,,,8004,Rattus norvegicus,50597,A,,1
,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 60 min after iv administration of compound,10116.0,Intermediate,,,10413,,CHEMBL876803,1,BAO_0000218,,,,N,,,8004,Rattus norvegicus,50597,A,,1
,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 120 min after iv administration compound,10116.0,Intermediate,,,10414,,CHEMBL627964,1,BAO_0000218,,,,N,,,8004,Rattus norvegicus,50597,A,,1
,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 15 min after iv administration of compound,10116.0,Intermediate,,,10415,,CHEMBL627965,1,BAO_0000218,,,,N,,,8004,Rattus norvegicus,50597,A,,1
,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 240 min after iv administration compound,10116.0,Intermediate,,,10416,,CHEMBL627966,1,BAO_0000218,,,,N,,,8004,Rattus norvegicus,50597,A,,1
,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 30 min after iv administration of compound,10116.0,Intermediate,,,10417,,CHEMBL627967,1,BAO_0000218,,,,N,,,8004,Rattus norvegicus,50597,A,,1
,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 5 min after iv administration of compound,10116.0,Intermediate,,,10418,,CHEMBL627968,1,BAO_0000218,,,,N,,,8004,Rattus norvegicus,50597,A,,1
,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 60 min after iv administration of compound,10116.0,Intermediate,,,10419,,CHEMBL627969,1,BAO_0000218,,,,N,,,8004,Rattus norvegicus,50597,A,,1
,Distribution of Se-75 activity in Liver of female Sprague-Dawley Rat 5 min after iv administration of compound,10116.0,Intermediate,,,10420,,CHEMBL627970,1,BAO_0000218,,,,N,,,8004,Rattus norvegicus,50597,A,,1
,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 120 min after iv administration of compound,10116.0,Intermediate,,,10421,178.0,CHEMBL627971,1,BAO_0000218,,,,N,,Blood,8004,Rattus norvegicus,50597,A,,1
,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 240 min after iv administration of compound,10116.0,Intermediate,,,10422,178.0,CHEMBL627972,1,BAO_0000218,,,,N,,Blood,8004,Rattus norvegicus,50597,A,,1
,Dissociation constant against binding to human cyclophilin A,9606.0,Expert,,,10423,,CHEMBL856029,1,BAO_0000357,,,,D,,,15917,Homo sapiens,180,B,,9
,Michaelis-Menten constant for inhibitory activity against bovine liver glyoxalase II,9913.0,Expert,,,10424,,CHEMBL627973,1,BAO_0000019,,,,H,,,12396,Bos taurus,11591,B,,8
,-Log C was determined by performing the electroshock minimum test,,Autocuration,,,10425,,CHEMBL627974,1,BAO_0000019,,,,U,,,7065,,22224,A,,0
,-Log C was determined by performing the foot shock test,,Autocuration,,,10426,,CHEMBL627975,1,BAO_0000019,,,,U,,,7065,,22224,A,,0
,-Log C was determined by performing the incl screen test,,Autocuration,,,10427,,CHEMBL627976,1,BAO_0000019,,,,U,,,7065,,22224,A,,0
,-Log C was determined by performing the maximum electroshock test,,Autocuration,,,10428,,CHEMBL627977,1,BAO_0000019,,,,U,,,7065,,22224,A,,0
,-Log C was determined by performing the pentylenetetrazole test,,Autocuration,,,10429,,CHEMBL627978,1,BAO_0000019,,,,U,,,7065,,22224,A,,0
,Tested for experimental arotinoid inhibitory dose,,Autocuration,,,10430,,CHEMBL627979,1,BAO_0000019,,,,U,,,12415,,22224,A,,0
,Negative log transformed activity,,Autocuration,,,10431,,CHEMBL876804,1,BAO_0000019,,,,U,,,10256,,22224,A,,0
,"Negative log of Langmuir's alpha constant (-log alpha), which is inversely proportional to the effective binding constant (protein binding)",,Autocuration,,,10432,,CHEMBL627980,1,BAO_0000019,,,,U,,,7991,,22224,A,,0
,Dissociation constant was evaluated on guinea pig bladder at M3 muscarinic receptor,10141.0,Intermediate,,,10433,,CHEMBL627981,1,BAO_0000218,,,,N,,,14342,Cavia porcellus,50512,A,,1
,Dissociation constant was evaluated on guinea pig heart (force) at M2 muscarinic receptor,10141.0,Intermediate,,,10434,,CHEMBL627982,1,BAO_0000218,,,,N,,,14342,Cavia porcellus,50512,A,,1
,Dissociation constant was evaluated on guinea pig heart (rate) at M2 muscarinic receptor,10141.0,Intermediate,,,10435,,CHEMBL627983,1,BAO_0000218,,,,N,,,14342,Cavia porcellus,50512,A,,1
,Dissociation constant was evaluated on guinea pig ileum at M3 muscarinic receptor,10141.0,Intermediate,,,10436,2116.0,CHEMBL627984,1,BAO_0000218,,,,N,,Ileum,14342,Cavia porcellus,50512,A,,1
,Solubility in water was determined; values expressed as -log,,Autocuration,,,10437,,CHEMBL627985,1,BAO_0000100,,,,U,,,6047,,22229,P,,0
,Ratio of Kcat to that of Km was determined,,Autocuration,,,10438,,CHEMBL627986,1,BAO_0000019,,,,U,,,17269,,22224,A,,0
,Observed first order rate constant,,Autocuration,,,10439,,CHEMBL627987,1,BAO_0000019,,,,U,,,10026,,22224,A,,0
,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours,,Autocuration,,,10440,,CHEMBL627988,1,BAO_0000019,,,,U,,,14583,,22224,A,,0
,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female wistar rats,10116.0,Intermediate,,,10441,,CHEMBL627989,1,BAO_0000218,,In vivo,,N,,,2661,Rattus norvegicus,50597,A,,1
,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to male wistar rats,10116.0,Intermediate,,,10442,,CHEMBL627990,1,BAO_0000218,,In vivo,,N,,,2661,Rattus norvegicus,50597,A,,1
,Oral Bioavailability after administration of 10 mg/kg in male rat,10116.0,Intermediate,,,10443,,CHEMBL876805,1,BAO_0000218,,In vivo,,N,,,4029,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat (dose 10 mg/kg i.v. and 50 mg/kg p.o.),10116.0,Intermediate,,,10444,,CHEMBL627991,1,BAO_0000218,,In vivo,,N,,,17735,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10445,,CHEMBL627992,1,BAO_0000218,,In vivo,,N,,,4576,Rattus norvegicus,50597,A,,1
,Oral bioavailability after oral (po) administration at a dose of 10 mg/kg was measured in rats,10116.0,Intermediate,,,10446,,CHEMBL627993,1,BAO_0000218,,In vivo,,N,,,17582,Rattus norvegicus,50597,A,,1
,Oral bioavailability at 1 mg/kg was determined in rat,10116.0,Intermediate,,,10447,,CHEMBL622817,1,BAO_0000218,,In vivo,,N,,,17651,Rattus norvegicus,50597,A,,1
,Oral bioavailability at 10 mg/kg was determined in rat,10116.0,Intermediate,,,10448,,CHEMBL622818,1,BAO_0000218,,In vivo,,N,,,17651,Rattus norvegicus,50597,A,,1
,"Oral bioavailability in fischer rats at 30 mg/kg dose, administered perorally",10116.0,Intermediate,,,10449,,CHEMBL622819,1,BAO_0000218,,In vivo,,N,,,17670,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10450,,CHEMBL872267,1,BAO_0000218,,In vivo,,N,,,5045,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10451,,CHEMBL622820,1,BAO_0000218,,In vivo,,N,,,1696,Rattus norvegicus,50597,A,,1
,Oral bioavailability after intravenous administration in rats at 24 uM/kg,10116.0,Intermediate,,,10452,,CHEMBL622821,1,BAO_0000218,,In vivo,,N,,,17764,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10453,,CHEMBL622822,1,BAO_0000218,,In vivo,,N,,,6448,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10454,,CHEMBL622823,1,BAO_0000218,,In vivo,,N,,,6596,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10455,,CHEMBL622824,1,BAO_0000218,,In vivo,,N,,,17547,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat at a dose of 3 mg/kg,10116.0,Intermediate,,,10456,,CHEMBL622825,1,BAO_0000218,,In vivo,,N,,,17771,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat after oral administration at 10 mg/kg,10116.0,Intermediate,,,10457,,CHEMBL622901,1,BAO_0000218,,In vivo,,N,,,6495,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10458,,CHEMBL622902,1,BAO_0000218,,In vivo,,N,,,4558,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10459,,CHEMBL621844,1,BAO_0000218,,In vivo,,N,,,17596,Rattus norvegicus,50597,A,,1
,Oral bioavailability in Dawley rats,10116.0,Intermediate,,,10460,,CHEMBL621845,1,BAO_0000218,,In vivo,,N,,,6827,Rattus norvegicus,50597,A,,1
,Oral bioavailability,10116.0,Intermediate,,,10461,,CHEMBL621846,1,BAO_0000218,,In vivo,,N,,,4026,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat (dose 30 mg/kg),10116.0,Intermediate,,,10462,,CHEMBL621847,1,BAO_0000218,,In vivo,,N,,,10,Rattus norvegicus,50597,A,,1
,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,10116.0,Intermediate,,,10463,,CHEMBL877609,1,BAO_0000218,,In vivo,,N,,,17717,Rattus norvegicus,50597,A,,1
,Bioavailability in rat (dose 3 mg/kg i.v.),10116.0,Intermediate,,,10464,,CHEMBL621848,1,BAO_0000218,,In vivo,,N,,,17717,Rattus norvegicus,50597,A,,1
,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,10116.0,Intermediate,,,10465,,CHEMBL621849,1,BAO_0000218,,In vivo,,N,,,17717,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat (dose 60 mg/kg p.o.),10116.0,Intermediate,,,10466,,CHEMBL622030,1,BAO_0000218,,In vivo,,N,,,17717,Rattus norvegicus,50597,A,,1
,Percent oral bioavailability determined in rats,10116.0,Intermediate,,,10467,,CHEMBL622031,1,BAO_0000218,,In vivo,,N,,,4796,Rattus norvegicus,50597,A,,1
,Tested for percent bioavailability after oral administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,10116.0,Intermediate,,,10468,,CHEMBL622032,1,BAO_0000218,,In vivo,,N,,,4883,Rattus norvegicus,50597,A,,1
,The compound was evaluated for bioavailability in rats; 32-51,10116.0,Intermediate,,,10469,,CHEMBL622033,1,BAO_0000218,,In vivo,,N,,,2137,Rattus norvegicus,50597,A,,1
,Bioavailability in rat (dose 20 mg/kg p.o.),10116.0,Intermediate,,,10470,,CHEMBL622034,1,BAO_0000218,,In vivo,,N,,,2959,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10471,,CHEMBL622035,1,BAO_0000218,,In vivo,,N,,,1361,Rattus norvegicus,50597,A,,1
,Bioavailability percent in rat at the dose of 2 mg/kg,10116.0,Intermediate,,,10472,,CHEMBL882966,1,BAO_0000218,,In vivo,,N,,,4727,Rattus norvegicus,50597,A,,1
,Bioavailability was evaluated after 20 uM/kg of peroral administration,10116.0,Intermediate,,,10473,,CHEMBL622036,1,BAO_0000218,,In vivo,,N,,,16423,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10474,,CHEMBL622037,1,BAO_0000218,,In vivo,,N,,,5206,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10475,,CHEMBL622038,1,BAO_0000218,,In vivo,,N,,,6448,Rattus norvegicus,50597,A,,1
,Bioavailability in rats,10116.0,Intermediate,,,10476,,CHEMBL622039,1,BAO_0000218,,In vivo,,N,,,17723,Rattus norvegicus,50597,A,,1
,Biodistribution of radiolabeled compound in rat blood after 24 hr postinjection activity expressed as %ID/Organ,10116.0,Intermediate,,,10477,178.0,CHEMBL622040,1,BAO_0000218,,In vivo,,N,,Blood,17738,Rattus norvegicus,50597,A,,1
,Biodistribution of radiolabeled compound in rat blood after 24 hr activity expressed as %ID/Organ,10116.0,Intermediate,,,10478,178.0,CHEMBL622041,1,BAO_0000218,,In vivo,,N,,Blood,17738,Rattus norvegicus,50597,A,,1
,Biodistribution of radiolabeled compound in rat blood after 2 hr activity expressed as %ID/Organ,10116.0,Intermediate,,,10479,178.0,CHEMBL622042,1,BAO_0000218,,In vivo,,N,,Blood,17738,Rattus norvegicus,50597,A,,1
,Biodistribution of radiolabeled compound in rat blood after 30 min activity expressed as %ID/Organ,10116.0,Intermediate,,,10480,178.0,CHEMBL622043,1,BAO_0000218,,In vivo,,N,,Blood,17738,Rattus norvegicus,50597,A,,1
,Biodistribution of radiolabeled compound in rat blood after 5 min activity expressed as %ID/Organ,10116.0,Intermediate,,,10481,178.0,CHEMBL622044,1,BAO_0000218,,In vivo,,N,,Blood,17738,Rattus norvegicus,50597,A,,1
,Biodistribution of radiolabeled compound in rat bone after 24 hr activity expressed as %ID/Organ,10116.0,Intermediate,,,10482,10000001.0,CHEMBL622045,1,BAO_0000218,,In vivo,,N,,Bone,17738,Rattus norvegicus,50597,A,,1
,Biodistribution of radiolabeled compound in rat bone after 2 hr activity expressed as %ID/Organ,10116.0,Intermediate,,,10483,10000001.0,CHEMBL622046,1,BAO_0000218,,In vivo,,N,,Bone,17738,Rattus norvegicus,50597,A,,1
,Biodistribution of radiolabeled compound in rat bone after 30 min activity expressed as %ID/Organ,10116.0,Intermediate,,,10484,10000001.0,CHEMBL622047,1,BAO_0000218,,In vivo,,N,,Bone,17738,Rattus norvegicus,50597,A,,1
,Biodistribution of radiolabeled compound in rat bone after 5 min activity expressed as %ID/Organ,10116.0,Intermediate,,,10485,10000001.0,CHEMBL877610,1,BAO_0000218,,In vivo,,N,,Bone,17738,Rattus norvegicus,50597,A,,1
,Biodistribution of radiolabeled compound in rat brain after 24 hr activity expressed as %ID/Organ,10116.0,Intermediate,,,10486,955.0,CHEMBL622048,1,BAO_0000218,,In vivo,,N,,Brain,17738,Rattus norvegicus,50597,A,,1
,Biodistribution of radiolabeled compound in rat brain after 2 hr activity expressed as %ID/Organ,10116.0,Intermediate,,,10487,955.0,CHEMBL622049,1,BAO_0000218,,In vivo,,N,,Brain,17738,Rattus norvegicus,50597,A,,1
,Biodistribution of radiolabeled compound in rat brain after 30 min activity expressed as %ID/Organ,10116.0,Intermediate,,,10488,955.0,CHEMBL622050,1,BAO_0000218,,In vivo,,N,,Brain,17738,Rattus norvegicus,50597,A,,1
,Biodistribution of radiolabeled compound in rat brain after 5 min activity expressed as %ID/Organ,10116.0,Intermediate,,,10489,955.0,CHEMBL622051,1,BAO_0000218,,In vivo,,N,,Brain,17738,Rattus norvegicus,50597,A,,1
,Biodistribution of radiolabeled compound in rat fat after 24 hr activity expressed as %ID/Organ,10116.0,Intermediate,,,10490,,CHEMBL622052,1,BAO_0000218,,In vivo,,N,,,17738,Rattus norvegicus,50597,A,,1
,Biodistribution of radiolabeled compound in rat fat after 2 hr activity expressed as %ID/Organ,10116.0,Intermediate,,,10491,,CHEMBL622053,1,BAO_0000218,,In vivo,,N,,,17738,Rattus norvegicus,50597,A,,1
,Biodistribution of radiolabeled compound in rat fat after 30 min activity expressed as %ID/Organ,10116.0,Intermediate,,,10492,,CHEMBL622054,1,BAO_0000218,,In vivo,,N,,,17738,Rattus norvegicus,50597,A,,1
,Biodistribution of radiolabeled compound in rat fat after 5 min activity expressed as %ID/Organ,10116.0,Intermediate,,,10493,,CHEMBL622055,1,BAO_0000218,,In vivo,,N,,,17738,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rats was determined; High,10116.0,Intermediate,,,10494,,CHEMBL622056,1,BAO_0000218,,In vivo,,N,,,5237,Rattus norvegicus,50597,A,,1
,Oral bioavailability in the rat was determined,10116.0,Intermediate,,,10495,,CHEMBL622057,1,BAO_0000218,,In vivo,,N,,,5503,Rattus norvegicus,50597,A,,1
,Oral bioavailability measured by the ratio of intravenous to oral area under concentration.,10116.0,Intermediate,,,10496,,CHEMBL628008,1,BAO_0000218,,In vivo,,N,,,15765,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat (dose 10 mg/kg p.o. and 3 mg/kg i.v.),10116.0,Intermediate,,,10497,,CHEMBL622058,1,BAO_0000218,,In vivo,,N,,,15660,Rattus norvegicus,50597,A,,1
,Oral bioavailability of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,10116.0,Intermediate,,,10498,,CHEMBL622059,1,BAO_0000218,,In vivo,,N,,,5978,Rattus norvegicus,50597,A,,1
,Oral bioavailability of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,10116.0,Intermediate,,,10499,,CHEMBL622060,1,BAO_0000218,,In vivo,,N,,,5978,Rattus norvegicus,50597,A,,1
,Oral bioavailability of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,10116.0,Intermediate,,,10500,,CHEMBL622061,1,BAO_0000218,,In vivo,,N,,,5978,Rattus norvegicus,50597,A,,1
,Oral bioavailability of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,10116.0,Intermediate,,,10501,,CHEMBL622062,1,BAO_0000218,,In vivo,,N,,,5978,Rattus norvegicus,50597,A,,1
,Oral bioavailability of compound at a dose of 20 mg/kg was determined after oral administration in rat,10116.0,Intermediate,,,10502,,CHEMBL622063,1,BAO_0000218,,In vivo,,N,,,5656,Rattus norvegicus,50597,A,,1
,Oral bioavailability of compound determined in rat after iv administration at a dose of 10 mg/kg,10116.0,Expert,,,10503,,CHEMBL877611,1,BAO_0000218,,In vivo,,N,,,3598,Rattus norvegicus,50597,A,,1
,Oral bioavailability of compound in Sprague Dawley rats,10116.0,Intermediate,,,10504,,CHEMBL622064,1,BAO_0000218,,In vivo,,N,,,4216,Rattus norvegicus,50597,A,,1
,Oral bioavailability of compound in rat,10116.0,Intermediate,,,10505,,CHEMBL622065,1,BAO_0000218,,In vivo,,N,,,17839,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat (dose 2 mg/kg),10116.0,Intermediate,,,10506,,CHEMBL622066,1,BAO_0000218,,In vivo,,N,,,6570,Rattus norvegicus,50597,A,,1
,Oral bioavailability of compound in rat was determined,10116.0,Intermediate,,,10507,,CHEMBL622067,1,BAO_0000218,,In vivo,,N,,,5334,Rattus norvegicus,50597,A,,1
,Oral bioavailability of compound in rats,10116.0,Intermediate,,,10508,,CHEMBL622068,1,BAO_0000218,,In vivo,,N,,,6886,Rattus norvegicus,50597,A,,1
,Oral bioavailability of compound was determined in rats,10116.0,Intermediate,,,10509,,CHEMBL622069,1,BAO_0000218,,In vivo,,N,,,5210,Rattus norvegicus,50597,A,,1
,Oral bioavailability at a dose of 30 mg/kg in rats,10116.0,Intermediate,,,10510,,CHEMBL624796,1,BAO_0000218,,In vivo,,N,,,4170,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat (dose 10 mg/kg),10116.0,Intermediate,,,10511,,CHEMBL624797,1,BAO_0000218,,In vivo,,N,,,6028,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat (dose 10 mg/kg),10116.0,Intermediate,,,10512,,CHEMBL623053,1,BAO_0000218,,In vivo,,N,,,6028,Rattus norvegicus,50597,A,,1
,Oral bioavailability evaluated in rat,10116.0,Intermediate,,,10513,,CHEMBL623054,1,BAO_0000218,,In vivo,,N,,,6078,Rattus norvegicus,50597,A,,1
,Oral bioavailability in fasted rat,10116.0,Intermediate,,,10514,,CHEMBL623055,1,BAO_0000218,,In vivo,,N,,,6168,Rattus norvegicus,50597,A,,1
,Oral bioavailability in fed rat,10116.0,Intermediate,,,10515,,CHEMBL623056,1,BAO_0000218,,In vivo,,N,,,6168,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat (mature male) (dose 30 mg/kg),10116.0,Intermediate,,,10516,,CHEMBL623057,1,BAO_0000218,,In vivo,,N,,,5160,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10517,,CHEMBL623058,1,BAO_0000218,,In vivo,,N,,,6057,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat (dose 10 mg/kg p.o.),10116.0,Intermediate,,,10518,,CHEMBL623059,1,BAO_0000218,,In vivo,,N,,,6535,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat after administration of 10 mg/kg po,10116.0,Intermediate,,,10519,,CHEMBL623060,1,BAO_0000218,,In vivo,,N,,,6535,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10520,,CHEMBL623061,1,BAO_0000218,,In vivo,,N,,,4194,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10521,,CHEMBL623062,1,BAO_0000218,,In vivo,,N,,,6230,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10522,,CHEMBL623063,1,BAO_0000218,,In vivo,,N,,,6619,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10523,,CHEMBL623064,1,BAO_0000218,,In vivo,,N,,,17607,Rattus norvegicus,50597,A,,1
,Oral bioavailability in ratrs,10116.0,Intermediate,,,10524,,CHEMBL623065,1,BAO_0000218,,In vivo,,N,,,4942,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10525,,CHEMBL623066,1,BAO_0000218,,In vivo,,N,,,4942,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10526,,CHEMBL623067,1,BAO_0000218,,In vivo,,N,,,6646,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rats was determined; High,10116.0,Intermediate,,,10527,,CHEMBL623068,1,BAO_0000218,,In vivo,,N,,,5237,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10528,,CHEMBL623069,1,BAO_0000218,,In vivo,,N,,,6646,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10529,,CHEMBL623070,1,BAO_0000218,,In vivo,,N,,,4449,Rattus norvegicus,50597,A,,1
,Oral bioavailability was calculated in rat,10116.0,Intermediate,,,10530,,CHEMBL623071,1,BAO_0000218,,In vivo,,N,,,6057,Rattus norvegicus,50597,A,,1
,Oral bioavailability,10116.0,Intermediate,,,10531,,CHEMBL623072,1,BAO_0000218,,In vivo,,N,,,2552,Rattus norvegicus,50597,A,,1
,Oral bioavailability,10116.0,Intermediate,,,10532,,CHEMBL623073,1,BAO_0000218,,In vivo,,N,,,5496,Rattus norvegicus,50597,A,,1
,Oral bioavailability,10116.0,Intermediate,,,10533,,CHEMBL623074,1,BAO_0000218,,In vivo,,N,,,6484,Rattus norvegicus,50597,A,,1
,Oral bioavailability,10116.0,Intermediate,,,10534,,CHEMBL623075,1,BAO_0000218,,In vivo,,N,,,6485,Rattus norvegicus,50597,A,,1
,Oral bioavailability after i.v. administration,10116.0,Intermediate,,,10535,,CHEMBL623076,1,BAO_0000218,,In vivo,,N,,,6616,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),10116.0,Intermediate,,,10536,,CHEMBL623077,1,BAO_0000218,,In vivo,,N,,,4969,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat (Sprague-Dawley),10116.0,Intermediate,,,10537,,CHEMBL623078,1,BAO_0000218,,In vivo,,N,,,5862,Rattus norvegicus,50597,A,,1
,Oral bioavailability in Sprague-Dawley rats,10116.0,Intermediate,,,10538,,CHEMBL623079,1,BAO_0000218,,In vivo,,N,,,4514,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),10116.0,Intermediate,,,10539,,CHEMBL623080,1,BAO_0000218,,In vivo,,N,,,4514,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),10116.0,Intermediate,,,10540,,CHEMBL623081,1,BAO_0000218,,In vivo,,N,,,4514,Rattus norvegicus,50597,A,,1
,Oral bioavailability in Sprague-Dawley rats at a dose of 2 mg/kg by po administration,10116.0,Intermediate,,,10541,,CHEMBL623082,1,BAO_0000218,,In vivo,,N,,,5546,Rattus norvegicus,50597,A,,1
,Oral bioavailability in fasted rat,10116.0,Intermediate,,,10542,,CHEMBL874400,1,BAO_0000218,,In vivo,,N,,,6168,Rattus norvegicus,50597,A,,1
,Oral bioavailability in fed rat,10116.0,Intermediate,,,10543,,CHEMBL623083,1,BAO_0000218,,In vivo,,N,,,6168,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10544,,CHEMBL623084,1,BAO_0000218,,In vivo,,N,,,3624,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10545,,CHEMBL623085,1,BAO_0000218,,In vivo,,N,,,5213,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10546,,CHEMBL623086,1,BAO_0000218,,In vivo,,N,,,5496,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10547,,CHEMBL623087,1,BAO_0000218,,In vivo,,N,,,5553,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10548,,CHEMBL623088,1,BAO_0000218,,In vivo,,N,,,5833,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10549,,CHEMBL623089,1,BAO_0000218,,In vivo,,N,,,5836,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10550,,CHEMBL623090,1,BAO_0000218,,In vivo,,N,,,5865,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10551,,CHEMBL623091,1,BAO_0000218,,In vivo,,N,,,5960,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10552,,CHEMBL623092,1,BAO_0000218,,In vivo,,N,,,6249,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10553,,CHEMBL623093,1,BAO_0000218,,In vivo,,N,,,6448,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10554,,CHEMBL874401,1,BAO_0000218,,In vivo,,N,,,6453,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10555,,CHEMBL623094,1,BAO_0000218,,In vivo,,N,,,6640,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10556,,CHEMBL623095,1,BAO_0000218,,In vivo,,N,,,17607,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat after peroral administration at 10 mg/kg,10116.0,Intermediate,,,10557,,CHEMBL623096,1,BAO_0000218,,In vivo,,N,,,5939,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat after peroral administration at 5 mg/kg,10116.0,Intermediate,,,10558,,CHEMBL624913,1,BAO_0000218,,In vivo,,N,,,5939,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat (dose 2.8 mg/kg p.o.),10116.0,Intermediate,,,10559,,CHEMBL624914,1,BAO_0000218,,In vivo,,N,,,6281,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat by po administration at a dose of 40 mg/kg,10116.0,Intermediate,,,10560,,CHEMBL624915,1,BAO_0000218,,In vivo,,N,,,5874,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat; Not measured,10116.0,Intermediate,,,10561,,CHEMBL624916,1,BAO_0000218,,In vivo,,N,,,5213,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10562,,CHEMBL624917,1,BAO_0000218,,In vivo,,N,,,4964,Rattus norvegicus,50597,A,,1
,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus NE,10116.0,Intermediate,,,10563,,CHEMBL625157,1,BAO_0000218,,,,N,,,11020,Rattus norvegicus,50597,A,,1
,In vitro metabolic potential in rat liver microsomes,10116.0,Intermediate,,,10564,2107.0,CHEMBL625158,1,BAO_0000218,,,,N,,Liver,6251,Rattus norvegicus,50597,A,,1
,"Oral availability was tested for plasma levels at a dose of 40 mg/kg, after 6 hr of in fed fisher rats.",10116.0,Intermediate,,,10565,,CHEMBL625159,1,BAO_0000218,,In vivo,,N,,,1568,Rattus norvegicus,50597,A,,1
,"In vivo percentage mean absolute bioavailability of compound in rat after an oral dose of 10 mg/kg (in water, N=4)",10116.0,Intermediate,,,10566,,CHEMBL625160,1,BAO_0000218,,In vivo,,N,,,3032,Rattus norvegicus,50597,A,,1
,Oral bioavailability of intravenously administered compound (3 mg/kg) was tested in rats,10116.0,Intermediate,,,10567,,CHEMBL625161,1,BAO_0000218,,In vivo,,N,,,3748,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10568,,CHEMBL625162,1,BAO_0000218,,In vivo,,N,,,401,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10569,,CHEMBL625163,1,BAO_0000218,,In vivo,,N,,,6512,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rats at 10 mg/kg,10116.0,Intermediate,,,10570,,CHEMBL625164,1,BAO_0000218,,In vivo,,N,,,17617,Rattus norvegicus,50597,A,,1
,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,10116.0,Intermediate,,,10571,,CHEMBL625165,1,BAO_0000218,,In vivo,,N,,,6679,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10572,,CHEMBL625166,1,BAO_0000218,,In vivo,,N,,,6742,Rattus norvegicus,50597,A,,1
,Tested for effective permeability across the rat intestinal membrane using mass balance analysis,10116.0,Intermediate,,,10573,,CHEMBL625167,1,BAO_0000218,,,,N,,,589,Rattus norvegicus,50597,A,,1
,Tested for effective permeability across the rat intestinal membrane using mass balance analysis at 0.01 mM concentration,10116.0,Intermediate,,,10574,,CHEMBL625168,1,BAO_0000218,,,,N,,,589,Rattus norvegicus,50597,A,,1
,Plasma clearance of the compound,10116.0,Intermediate,,,10575,,CHEMBL625169,1,BAO_0000218,,In vivo,,N,,,3185,Rattus norvegicus,50597,A,,1
,Plasma clearance at 10 mg/kg in rat upon intravenous administration,10116.0,Intermediate,,,10576,,CHEMBL626264,1,BAO_0000218,,In vivo,,N,,,17596,Rattus norvegicus,50597,A,,1
,Plasma clearance upon intravenous administration of 1 mg/Kg in rats,10116.0,Intermediate,,,10577,,CHEMBL626265,1,BAO_0000218,,In vivo,,N,,,2713,Rattus norvegicus,50597,A,,1
,The compound was tested for plasma clearance in rat,10116.0,Intermediate,,,10578,1969.0,CHEMBL626266,1,BAO_0000218,,In vivo,,N,,Plasma,12500,Rattus norvegicus,50597,A,,1
,The compound was tested for plasma clearance in rat at dose of 3-10 mgkg,10116.0,Intermediate,,,10579,1969.0,CHEMBL626267,1,BAO_0000218,,In vivo,,N,,Plasma,12500,Rattus norvegicus,50597,A,,1
,Plasma concentration upon oral administration of 1 mg/Kg in rats,10116.0,Intermediate,,,10580,,CHEMBL626268,1,BAO_0000218,,,,N,,,2713,Rattus norvegicus,50597,A,,1
,Peak plasma level between 0.5 and 1.0 hour in Dawley rats; value ranges from 1021-2551,10116.0,Intermediate,,,10581,,CHEMBL626269,1,BAO_0000218,,,,N,,,1446,Rattus norvegicus,50597,A,,1
,Plasma level after intravenous administration in rat model of FeCl3-induced carotid thrombosis,10116.0,Intermediate,,,10582,,CHEMBL626270,1,BAO_0000218,,,,N,,,6227,Rattus norvegicus,50597,A,,1
,Plasma protein binding was determined after intravenous administration of 1 mg/kg in rat,10116.0,Intermediate,,,10583,,CHEMBL626271,1,BAO_0000218,,,,N,,,4709,Rattus norvegicus,50597,A,,1
,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1",10116.0,Intermediate,,,10584,,CHEMBL626272,1,BAO_0000218,,,,N,,,5510,Rattus norvegicus,50597,A,,1
,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",10116.0,Intermediate,,,10585,,CHEMBL626273,1,BAO_0000218,,,,N,,,5510,Rattus norvegicus,50597,A,,1
,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",10116.0,Intermediate,,,10586,,CHEMBL875346,1,BAO_0000218,,,,N,,,5510,Rattus norvegicus,50597,A,,1
,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not stable",10116.0,Intermediate,,,10587,,CHEMBL626274,1,BAO_0000218,,,,N,,,5510,Rattus norvegicus,50597,A,,1
,Compound was tested for protein binding in rat plasma,10116.0,Intermediate,,,10588,,CHEMBL626275,1,BAO_0000218,,,,N,,,4514,Rattus norvegicus,50597,A,,1
,Compound was evaluated for absorption of radioligand following oral administration to bile duct cannulated rat. ,10116.0,Intermediate,,,10589,,CHEMBL624646,1,BAO_0000218,,,,N,,,2713,Rattus norvegicus,50597,A,,1
,Compound was evaluated for absorption of radioligand upon oral administration to bile duct cannulated rats,10116.0,Intermediate,,,10590,,CHEMBL624647,1,BAO_0000218,,,,N,,,2713,Rattus norvegicus,50597,A,,1
,In vitro metabolism in rat liver microsomes was evaluated to determine diminishing of glucuronidation rate,10116.0,Intermediate,,,10591,2107.0,CHEMBL624648,1,BAO_0000218,,,,N,,Liver,5340,Rattus norvegicus,50597,A,,1
,Area under curve ratio was determined (po/iv) in rat,10116.0,Intermediate,,,10592,,CHEMBL624649,1,BAO_0000218,,,,N,,,12058,Rattus norvegicus,50597,A,,1
,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 15 mins after i.v. administration,10116.0,Intermediate,,,10593,,CHEMBL624650,1,BAO_0000218,,,,N,,,11195,Rattus norvegicus,50597,A,,1
,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 2 mins after i.v. administration,10116.0,Intermediate,,,10594,,CHEMBL624651,1,BAO_0000218,,,,N,,,11195,Rattus norvegicus,50597,A,,1
,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 65 mins after i.v. administration,10116.0,Intermediate,,,10595,,CHEMBL624652,1,BAO_0000218,,,,N,,,11195,Rattus norvegicus,50597,A,,1
,Compound was tested for brain/plasma ratio after oral administration at 10 mg/kg,10116.0,Intermediate,,,10596,,CHEMBL624653,1,BAO_0000218,,,,N,,,6495,Rattus norvegicus,50597,A,,1
,Ratio of AUCbrain to AUCplasma,10116.0,Intermediate,,,10597,,CHEMBL624654,1,BAO_0000218,,,,N,,,6078,Rattus norvegicus,50597,A,,1
,Ratio of brain to plasma,10116.0,Intermediate,,,10598,,CHEMBL624655,1,BAO_0000218,,,,N,,,5656,Rattus norvegicus,50597,A,,1
,Ratio of the AUC values of brain and plasma after intravenous administration (4.7 mg/kg) to male rats was evaluated,10116.0,Intermediate,,,10599,,CHEMBL624656,1,BAO_0000218,,,,N,,,4910,Rattus norvegicus,50597,A,,1
,Ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,10116.0,Intermediate,,,10600,,CHEMBL624657,1,BAO_0000218,,,,N,,,4910,Rattus norvegicus,50597,A,,1
,Ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,10116.0,Intermediate,,,10601,,CHEMBL624658,1,BAO_0000218,,,,N,,,4910,Rattus norvegicus,50597,A,,1
,Selectivity ratio for biodistribution in brain and blood of rats after 15 minutes; Expressed as percent dose/gram ratio,10116.0,Intermediate,,,10602,,CHEMBL624659,1,BAO_0000218,,,,N,,,10130,Rattus norvegicus,50597,A,,1
,Selectivity ratio for biodistribution in brain and blood of rats after 2 minutes; Expressed as percent dose/gram ratio,10116.0,Intermediate,,,10603,,CHEMBL624660,1,BAO_0000218,,,,N,,,10130,Rattus norvegicus,50597,A,,1
,Selectivity ratio for biodistribution in brain and blood of rats after 60 minutes; Expressed as percent dose/gram ratio,10116.0,Intermediate,,,10604,,CHEMBL624661,1,BAO_0000218,,,,N,,,10130,Rattus norvegicus,50597,A,,1
,Steady state brain :blood ratio was determined,10116.0,Intermediate,,,10605,,CHEMBL624662,1,BAO_0000218,,,,N,,,5213,Rattus norvegicus,50597,A,,1
,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,10116.0,Intermediate,,,10606,,CHEMBL625199,1,BAO_0000218,,,,N,,,4910,Rattus norvegicus,50597,A,,1
,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,10116.0,Intermediate,,,10607,,CHEMBL625200,1,BAO_0000218,,,,N,,,4910,Rattus norvegicus,50597,A,,1
,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats,10116.0,Intermediate,,,10608,,CHEMBL625201,1,BAO_0000218,,,,N,,,4910,Rattus norvegicus,50597,A,,1
,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,10116.0,Intermediate,,,10609,,CHEMBL625202,1,BAO_0000218,,,,N,,,4910,Rattus norvegicus,50597,A,,1
,Percentage recovery after 3h incubation with rat hapatocytes was determined,10116.0,Intermediate,,,10610,,CHEMBL625203,1,BAO_0000218,,,,N,,,2083,Rattus norvegicus,50597,A,,1
,Percentage recovery in rat hepatic microsomal fractions under oxidative conditions after 1 hour,10116.0,Intermediate,,,10611,,CHEMBL625204,1,BAO_0000218,,,,N,,,2082,Rattus norvegicus,50597,A,,1
,Percentage recovery in rhesus monkey hepatic microsomal fractions under oxidative conditions after 1 hour,10116.0,Intermediate,,,10612,,CHEMBL625205,1,BAO_0000218,,,,N,,,2082,Rattus norvegicus,50597,A,,1
,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats,10116.0,Intermediate,,,10613,,CHEMBL625206,1,BAO_0000218,,,,N,,,6351,Rattus norvegicus,50597,A,,1
,"Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured, No site available for protein conjugation.",,Autocuration,,,10614,,CHEMBL625207,1,BAO_0000019,,,,U,,,14583,,22224,A,,0
,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured.,,Autocuration,,,10615,,CHEMBL625208,1,BAO_0000019,,,,U,,,14583,,22224,A,,0
,In vivo absorption in Caco-2 cell line monolayers was determined,9606.0,Intermediate,,,10616,,CHEMBL625209,1,BAO_0000218,,,,N,495.0,,4608,Homo sapiens,50587,A,Caco-2,1
,Calculated partition coefficient (clogP),,Autocuration,,,10617,,CHEMBL625210,1,BAO_0000100,,,,U,,,13668,,22229,P,,0
,Area under curve was determine after peroral administration at 10 mpk in Rat,10116.0,Intermediate,,,10618,,CHEMBL625211,1,BAO_0000218,,,,N,,,5669,Rattus norvegicus,50597,A,,1
,Area under curve was determine after peroral administration at 10 mpk in Rhesus,9544.0,Intermediate,,,10619,,CHEMBL625212,1,BAO_0000218,,,,N,,,5669,Macaca mulatta,50797,A,,1
,Area under curve was determine after peroral administration at 160 mpk in Rat,10116.0,Intermediate,,,10620,,CHEMBL625213,1,BAO_0000218,,,,N,,,5669,Rattus norvegicus,50597,A,,1
,Area under curve was determine after peroral administration at 20 mpk in Rat,10116.0,Intermediate,,,10621,,CHEMBL625214,1,BAO_0000218,,,,N,,,5669,Rattus norvegicus,50597,A,,1
,Area under curve was determine after peroral administration at 50 mpk in Rat,10116.0,Intermediate,,,10622,,CHEMBL874542,1,BAO_0000218,,,,N,,,5669,Rattus norvegicus,50597,A,,1
,Calculated partition coefficient (clogP) (AlogP),,Autocuration,,,10623,,CHEMBL625215,1,BAO_0000100,,,,U,,,6472,,22229,P,,0
,Activated partial thromboplastin time measured,,Autocuration,,,10624,,CHEMBL625216,1,BAO_0000019,,,,U,,,15106,,22224,A,,0
,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4),,Autocuration,,,10625,,CHEMBL625217,1,BAO_0000100,,,,U,,,15207,,22224,P,,0
,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4); ND=Not determined (AS mg/mL),,Autocuration,,,10626,,CHEMBL625218,1,BAO_0000100,,,,U,,,15207,,22224,P,,0
,AUC (Area under curve) was determined after intravenous administration at a dose 1 mg/kg in dog,9615.0,Intermediate,,,10627,1969.0,CHEMBL622864,1,BAO_0000218,,,,N,,Plasma,13941,Canis lupus familiaris,50588,A,,1
,AUC (Area under curve) was determined after intravenous administration at a dose 2 mg/kg in rat.,10116.0,Intermediate,,,10628,1969.0,CHEMBL622865,1,BAO_0000218,,,,N,,Plasma,13941,Rattus norvegicus,50597,A,,1
,AUC (Area under curve) was determined after peroral administration at a dose 10 mg/kg in rat.,10116.0,Intermediate,,,10629,1969.0,CHEMBL622866,1,BAO_0000218,,,,N,,Plasma,13941,Rattus norvegicus,50597,A,,1
,AUC (Area under curve) was determined after peroral administration at a dose 5 mg/kg in dog,9615.0,Intermediate,,,10630,1969.0,CHEMBL622867,1,BAO_0000218,,,,N,,Plasma,13941,Canis lupus familiaris,50588,A,,1
,AUC (ng h/mL) value after oral administration of 10 mg/kg in guinea pig.,10141.0,Intermediate,,,10631,1969.0,CHEMBL876808,1,BAO_0000218,,,,N,,Plasma,15240,Cavia porcellus,50512,A,,1
,AUC in brain,,Autocuration,,,10632,955.0,CHEMBL627725,1,BAO_0000019,,,,U,,Brain,10655,,22224,A,,0
,AUC in serum,,Autocuration,,,10633,1977.0,CHEMBL627726,1,BAO_0000019,,,,U,,Serum,10655,,22224,A,,0
,AUC was determined,,Autocuration,,,10634,1969.0,CHEMBL627727,1,BAO_0000019,,,,U,,Plasma,6504,,22224,A,,0
,AUC of the compound.,,Autocuration,,,10635,1969.0,CHEMBL627728,1,BAO_0000019,,,,U,,Plasma,10615,,22224,A,,0
,AUC value (0-4 hr),,Autocuration,,,10636,1969.0,CHEMBL627729,1,BAO_0000019,,,,U,,Plasma,10353,,22224,A,,0
,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 150 uMol/kg,",,Autocuration,,,10637,1969.0,CHEMBL627730,1,BAO_0000019,,,,U,,Plasma,14907,,22224,A,,0
,AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,,Autocuration,,,10638,1969.0,CHEMBL627731,1,BAO_0000019,,,,U,,Plasma,14907,,22224,A,,0
,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,",,Autocuration,,,10639,1969.0,CHEMBL627732,1,BAO_0000019,,,,U,,Plasma,14907,,22224,A,,0
,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 700 uMol/kg,",,Autocuration,,,10640,1969.0,CHEMBL627733,1,BAO_0000019,,,,U,,Plasma,14907,,22224,A,,0
,AUC(area under curve) was determined after intravenous administration in rats,10116.0,Intermediate,,,10641,1969.0,CHEMBL627734,1,BAO_0000218,,,,N,,Plasma,16359,Rattus norvegicus,50597,A,,1
,AUC(area under curve) was determined after oral administration in rats,10116.0,Intermediate,,,10642,1969.0,CHEMBL627735,1,BAO_0000218,,,,N,,Plasma,16359,Rattus norvegicus,50597,A,,1
,AUC(ng h/mL)values after oral administration of 10 mg/kg in guinea pig.,10141.0,Intermediate,,,10643,1969.0,CHEMBL627736,1,BAO_0000218,,,,N,,Plasma,15240,Cavia porcellus,50512,A,,1
,AUC(ng h/mL)values after oral administration of 10 mg/kg in rat.,10116.0,Intermediate,,,10644,1969.0,CHEMBL876809,1,BAO_0000218,,,,N,,Plasma,15240,Rattus norvegicus,50597,A,,1
,Area Under Curve after oral dosing of 100 uM/Kg,,Autocuration,,,10645,,CHEMBL627737,1,BAO_0000019,,,,U,,,15469,,22224,A,,0
,Area Under Curve after oral dosing of 30 uM/Kg,,Autocuration,,,10646,,CHEMBL627738,1,BAO_0000019,,,,U,,,15469,,22224,A,,0
,Area Under Curve was measured by ploting the graph between concentration verses time,,Autocuration,,,10647,,CHEMBL627739,1,BAO_0000019,,,,U,,,13520,,22224,A,,0
,Area under concentration-time curve of compound was determined in dog at 25 mg/kg orally,9615.0,Intermediate,,,10648,,CHEMBL626143,1,BAO_0000218,,,,N,,,17025,Canis lupus familiaris,50588,A,,1
,Area under concentration-time curve of compound was determined in monkey at 25 mg/kg orally,314293.0,Autocuration,,,10649,,CHEMBL626144,1,BAO_0000218,,,,U,,,17025,Simiiformes,22224,A,,0
,Area under concentration-time curve of compound was determined in rabbit at 25 mg/kg orally,9986.0,Intermediate,,,10650,,CHEMBL626145,1,BAO_0000218,,,,N,,,17025,Oryctolagus cuniculus,50592,A,,1
,Area under concentration-time curve of compound was determined in rat at 25 mg/kg orally,10116.0,Intermediate,,,10651,,CHEMBL626146,1,BAO_0000218,,,,N,,,17025,Rattus norvegicus,50597,A,,1
,Area under curve (AUC) is the drug concentrations in blood samples of rats with arterial catheters at 5 min and 12 hr plotted against time,10116.0,Intermediate,,,10652,178.0,CHEMBL626147,1,BAO_0000218,,,,N,,Blood,12032,Rattus norvegicus,50597,A,,1
,Area under curve (AUC) was determined,,Autocuration,,,10653,,CHEMBL626148,1,BAO_0000019,,,,U,,,10291,,22224,A,,0
,Area under curve (AUC) following ip administration at 1 mg/kg,,Autocuration,,,10654,,CHEMBL626149,1,BAO_0000218,,,,U,,,5767,,22224,A,,0
,Area under curve (AUC) was determined; ND is Not determined,,Autocuration,,,10655,,CHEMBL626150,1,BAO_0000019,,,,U,,,1434,,22224,A,,0
,Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound,9615.0,Intermediate,,,10656,,CHEMBL626151,1,BAO_0000218,,,,N,,,14925,Canis lupus familiaris,50588,A,,1
,Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound,9615.0,Intermediate,,,10657,,CHEMBL626152,1,BAO_0000218,,,,N,,,14925,Canis lupus familiaris,50588,A,,1
,Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound,9615.0,Intermediate,,,10658,,CHEMBL626153,1,BAO_0000218,,,,N,,,14925,Canis lupus familiaris,50588,A,,1
,Area under curve (AUR) was determined,,Autocuration,,,10659,,CHEMBL626154,1,BAO_0000019,,,,U,,,1434,,22224,A,,0
,Area under curve at 1 uM/dg administered intravenously,,Autocuration,,,10660,,CHEMBL626155,1,BAO_0000019,,,,U,,,11883,,22224,A,,0
,Area under curve at 10 uM/dg administered perorally,,Autocuration,,,10661,,CHEMBL626156,1,BAO_0000019,,,,U,,,11883,,22224,A,,0
,Area under curve at 2 uM/dg administered intravenously,,Autocuration,,,10662,,CHEMBL626157,1,BAO_0000019,,,,U,,,11883,,22224,A,,0
,Area under curve at 20 uM/dg administered perorally,,Autocuration,,,10663,,CHEMBL626158,1,BAO_0000019,,,,U,,,11883,,22224,A,,0
,Area under curve at a peroral dose of 3 mg/kg in dog,9615.0,Intermediate,,,10664,,CHEMBL626159,1,BAO_0000218,,,,N,,,15233,Canis lupus familiaris,50588,A,,1
,Area under curve at a peroral dose of 3 mg/kg in rat,10116.0,Intermediate,,,10665,,CHEMBL626160,1,BAO_0000218,,,,N,,,15233,Rattus norvegicus,50597,A,,1
,Area under curve at an iv dose of 1 mg/kg in dog,9615.0,Intermediate,,,10666,,CHEMBL626161,1,BAO_0000218,,,,N,,,15233,Canis lupus familiaris,50588,A,,1
,Area under curve at an iv dose of 1 mg/kg in rat,10116.0,Intermediate,,,10667,,CHEMBL626162,1,BAO_0000218,,,,N,,,15233,Rattus norvegicus,50597,A,,1
,Area under curve gives the effective duration for the angiotensin II antagonist effect of the compound.,,Autocuration,,,10668,,CHEMBL626163,1,BAO_0000019,,,,U,,,12978,,22224,A,,0
,Area under curve gives the effective duration for the angiotensin II antagonist effect.,,Autocuration,,,10669,,CHEMBL626164,1,BAO_0000019,,,,U,,,12978,,22224,A,,0
,Area under curve measured as conc vs time after intravenous administration to mice.,10090.0,Intermediate,,,10670,,CHEMBL626165,1,BAO_0000218,,,,N,,,11355,Mus musculus,50594,A,,1
,Area under curve measured as conc vs time after peroral administration to mice.,10090.0,Intermediate,,,10671,,CHEMBL626166,1,BAO_0000218,,,,N,,,11355,Mus musculus,50594,A,,1
,Area under curve of acid 2a was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,9615.0,Intermediate,,,10672,,CHEMBL626167,1,BAO_0000218,,,,N,,,12923,Canis lupus familiaris,50588,A,,1
,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by capsule method in dog,9615.0,Intermediate,,,10673,,CHEMBL626168,1,BAO_0000218,,,,N,,,12923,Canis lupus familiaris,50588,A,,1
,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by gavage method in dog,9615.0,Intermediate,,,10674,,CHEMBL877463,1,BAO_0000218,,,,N,,,12923,Canis lupus familiaris,50588,A,,1
,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by capsule method in dog,9615.0,Intermediate,,,10675,,CHEMBL626169,1,BAO_0000218,,,,N,,,12923,Canis lupus familiaris,50588,A,,1
,Biodistribution of radiolabeled compound in rat heart after 24 hr activity expressed as %ID/Organ,10116.0,Intermediate,,,10676,948.0,CHEMBL626170,1,BAO_0000218,,In vivo,,N,,Heart,17738,Rattus norvegicus,50597,A,,1
,Biodistribution of radiolabeled compound in rat heart after 2 hr activity expressed as %ID/Organ,10116.0,Intermediate,,,10677,948.0,CHEMBL626171,1,BAO_0000218,,In vivo,,N,,Heart,17738,Rattus norvegicus,50597,A,,1
,Biodistribution of radiolabeled compound in rat heart after 30 min activity expressed as %ID/Organ,10116.0,Intermediate,,,10678,948.0,CHEMBL626172,1,BAO_0000218,,In vivo,,N,,Heart,17738,Rattus norvegicus,50597,A,,1
,Biodistribution of radiolabeled compound in rat heart after 5 min activity expressed as %ID/Organ,10116.0,Intermediate,,,10679,948.0,CHEMBL626173,1,BAO_0000218,,In vivo,,N,,Heart,17738,Rattus norvegicus,50597,A,,1
,Biodistribution of radiolabeled compound in rat kidney after 24 hr postinjection activity expressed as %ID/Organ,10116.0,Intermediate,,,10680,2113.0,CHEMBL626174,1,BAO_0000218,,In vivo,,N,,Kidney,17738,Rattus norvegicus,50597,A,,1
,Biodistribution of radiolabeled compound in rat kidney after 24 hr activity expressed as %ID/Organ,10116.0,Intermediate,,,10681,2113.0,CHEMBL626175,1,BAO_0000218,,In vivo,,N,,Kidney,17738,Rattus norvegicus,50597,A,,1
,Biodistribution of radiolabeled compound in rat kidney after 2 hr activity expressed as %ID/Organ,10116.0,Intermediate,,,10682,2113.0,CHEMBL626176,1,BAO_0000218,,In vivo,,N,,Kidney,17738,Rattus norvegicus,50597,A,,1
,Biodistribution of radiolabeled compound in rat kidney after 30 min activity expressed as %ID/Organ,10116.0,Intermediate,,,10683,2113.0,CHEMBL626177,1,BAO_0000218,,In vivo,,N,,Kidney,17738,Rattus norvegicus,50597,A,,1
,Biodistribution of radiolabeled compound in rat kidney after 5 min activity expressed as %ID/Organ,10116.0,Intermediate,,,10684,2113.0,CHEMBL622499,1,BAO_0000218,,In vivo,,N,,Kidney,17738,Rattus norvegicus,50597,A,,1
,Biodistribution of radiolabeled compound in rat liver after 24 hr postinjection activity expressed as %ID/Organ,10116.0,Intermediate,,,10685,2107.0,CHEMBL622500,1,BAO_0000218,,In vivo,,N,,Liver,17738,Rattus norvegicus,50597,A,,1
,Biodistribution of radiolabeled compound in rat liver after 24 hr activity expressed as %ID/Organ,10116.0,Intermediate,,,10686,2107.0,CHEMBL622501,1,BAO_0000218,,In vivo,,N,,Liver,17738,Rattus norvegicus,50597,A,,1
,Biodistribution of radiolabeled compound in rat liver after 2 hr activity expressed as %ID/Organ,10116.0,Intermediate,,,10687,2107.0,CHEMBL622502,1,BAO_0000218,,In vivo,,N,,Liver,17738,Rattus norvegicus,50597,A,,1
,Biodistribution of radiolabeled compound in rat liver after 30 min activity expressed as %ID/Organ,10116.0,Intermediate,,,10688,2107.0,CHEMBL622503,1,BAO_0000218,,In vivo,,N,,Liver,17738,Rattus norvegicus,50597,A,,1
,Biodistribution of radiolabeled compound in rat liver after 5 min activity expressed as %ID/Organ,10116.0,Intermediate,,,10689,2107.0,CHEMBL877614,1,BAO_0000218,,In vivo,,N,,Liver,17738,Rattus norvegicus,50597,A,,1
,Biodistribution of radiolabeled compound in rat lung after 24 hr activity expressed as %ID/Organ,10116.0,Intermediate,,,10690,2048.0,CHEMBL624839,1,BAO_0000218,,In vivo,,N,,Lung,17738,Rattus norvegicus,50597,A,,1
,Biodistribution of radiolabeled compound in rat lung after 2 hr activity expressed as %ID/Organ,10116.0,Intermediate,,,10691,2048.0,CHEMBL624840,1,BAO_0000218,,In vivo,,N,,Lung,17738,Rattus norvegicus,50597,A,,1
,Biodistribution of radiolabeled compound in rat lung after 30 min activity expressed as %ID/Organ,10116.0,Intermediate,,,10692,2048.0,CHEMBL624841,1,BAO_0000218,,In vivo,,N,,Lung,17738,Rattus norvegicus,50597,A,,1
,Biodistribution of radiolabeled compound in rat lung after 5 min activity expressed as %ID/Organ,10116.0,Intermediate,,,10693,2048.0,CHEMBL624842,1,BAO_0000218,,In vivo,,N,,Lung,17738,Rattus norvegicus,50597,A,,1
,Biodistribution of radiolabeled compound in rat muscle after 24 hr activity expressed as %ID/Organ,10116.0,Intermediate,,,10694,2385.0,CHEMBL624843,1,BAO_0000218,,In vivo,,N,,Muscle tissue,17738,Rattus norvegicus,50597,A,,1
,Biodistribution of radiolabeled compound in rat muscle after 2 hr activity expressed as %ID/Organ,10116.0,Intermediate,,,10695,2385.0,CHEMBL624844,1,BAO_0000218,,In vivo,,N,,Muscle tissue,17738,Rattus norvegicus,50597,A,,1
,Biodistribution of radiolabeled compound in rat muscle after 30 min activity expressed as %ID/Organ,10116.0,Intermediate,,,10696,2385.0,CHEMBL624845,1,BAO_0000218,,In vivo,,N,,Muscle tissue,17738,Rattus norvegicus,50597,A,,1
,Biodistribution of radiolabeled compound in rat muscle after 5 min activity expressed as %ID/Organ,10116.0,Intermediate,,,10697,2385.0,CHEMBL621904,1,BAO_0000218,,In vivo,,N,,Muscle tissue,17738,Rattus norvegicus,50597,A,,1
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 15 mins after i.v. administration,10116.0,Intermediate,,,10698,178.0,CHEMBL621905,1,BAO_0000218,,In vivo,,N,,Blood,11195,Rattus norvegicus,50597,A,,1
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 2 mins after i.v. administration,10116.0,Intermediate,,,10699,178.0,CHEMBL874382,1,BAO_0000218,,In vivo,,N,,Blood,11195,Rattus norvegicus,50597,A,,1
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 65 mins after i.v. administration,10116.0,Intermediate,,,10700,178.0,CHEMBL621906,1,BAO_0000218,,In vivo,,N,,Blood,11195,Rattus norvegicus,50597,A,,1
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 15 mins after i.v. administration,10116.0,Intermediate,,,10701,955.0,CHEMBL621907,1,BAO_0000218,,In vivo,,N,,Brain,11195,Rattus norvegicus,50597,A,,1
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 2 mins after i.v. administration,10116.0,Intermediate,,,10702,955.0,CHEMBL622096,1,BAO_0000218,,In vivo,,N,,Brain,11195,Rattus norvegicus,50597,A,,1
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 65 mins after i.v. administration,10116.0,Intermediate,,,10703,955.0,CHEMBL622097,1,BAO_0000218,,In vivo,,N,,Brain,11195,Rattus norvegicus,50597,A,,1
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 15 mins after i.v. administration,10116.0,Intermediate,,,10704,948.0,CHEMBL622098,1,BAO_0000218,,In vivo,,N,,Heart,11195,Rattus norvegicus,50597,A,,1
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 2 mins after i.v. administration,10116.0,Intermediate,,,10705,948.0,CHEMBL622099,1,BAO_0000218,,In vivo,,N,,Heart,11195,Rattus norvegicus,50597,A,,1
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 65 mins after i.v. administration,10116.0,Intermediate,,,10706,948.0,CHEMBL622100,1,BAO_0000218,,In vivo,,N,,Heart,11195,Rattus norvegicus,50597,A,,1
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 15 mins after i.v. administration,10116.0,Intermediate,,,10707,2113.0,CHEMBL622101,1,BAO_0000218,,In vivo,,N,,Kidney,11195,Rattus norvegicus,50597,A,,1
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 2 mins after i.v. administration,10116.0,Intermediate,,,10708,2113.0,CHEMBL622102,1,BAO_0000218,,In vivo,,N,,Kidney,11195,Rattus norvegicus,50597,A,,1
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 65 mins after i.v. administration,10116.0,Intermediate,,,10709,2113.0,CHEMBL622103,1,BAO_0000218,,In vivo,,N,,Kidney,11195,Rattus norvegicus,50597,A,,1
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 15 mins after i.v. administration,10116.0,Intermediate,,,10710,2107.0,CHEMBL622104,1,BAO_0000218,,In vivo,,N,,Liver,11195,Rattus norvegicus,50597,A,,1
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 2 mins after i.v. administration,10116.0,Intermediate,,,10711,2107.0,CHEMBL622105,1,BAO_0000218,,In vivo,,N,,Liver,11195,Rattus norvegicus,50597,A,,1
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 65 mins after i.v. administration,10116.0,Intermediate,,,10712,2107.0,CHEMBL622106,1,BAO_0000218,,In vivo,,N,,Liver,11195,Rattus norvegicus,50597,A,,1
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 15 mins after i.v. administration,10116.0,Intermediate,,,10713,2048.0,CHEMBL622107,1,BAO_0000218,,In vivo,,N,,Lung,11195,Rattus norvegicus,50597,A,,1
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 2 mins after i.v. administration,10116.0,Intermediate,,,10714,2048.0,CHEMBL622108,1,BAO_0000218,,In vivo,,N,,Lung,11195,Rattus norvegicus,50597,A,,1
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 65 mins after i.v. administration,10116.0,Intermediate,,,10715,2048.0,CHEMBL622109,1,BAO_0000218,,In vivo,,N,,Lung,11195,Rattus norvegicus,50597,A,,1
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 15 mins after i.v. administration,10116.0,Intermediate,,,10716,2385.0,CHEMBL622110,1,BAO_0000218,,In vivo,,N,,Muscle tissue,11195,Rattus norvegicus,50597,A,,1
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 2 mins after i.v. administration,10116.0,Intermediate,,,10717,2385.0,CHEMBL622111,1,BAO_0000218,,In vivo,,N,,Muscle tissue,11195,Rattus norvegicus,50597,A,,1
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 65 mins after i.v. administration,10116.0,Intermediate,,,10718,2385.0,CHEMBL874383,1,BAO_0000218,,In vivo,,N,,Muscle tissue,11195,Rattus norvegicus,50597,A,,1
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 15 mins after i.v. administration,10116.0,Intermediate,,,10719,14.0,CHEMBL622112,1,BAO_0000218,,In vivo,,N,,Zone of skin,11195,Rattus norvegicus,50597,A,,1
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 2 mins after i.v. administration,10116.0,Intermediate,,,10720,14.0,CHEMBL622113,1,BAO_0000218,,In vivo,,N,,Zone of skin,11195,Rattus norvegicus,50597,A,,1
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 65 mins after i.v. administration,10116.0,Intermediate,,,10721,14.0,CHEMBL622114,1,BAO_0000218,,In vivo,,N,,Zone of skin,11195,Rattus norvegicus,50597,A,,1
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 15 mins after i.v. administration,10116.0,Intermediate,,,10722,2106.0,CHEMBL622115,1,BAO_0000218,,In vivo,,N,,Spleen,11195,Rattus norvegicus,50597,A,,1
,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 2 mins after i.v. administration,10116.0,Intermediate,,,10723,2106.0,CHEMBL622116,1,BAO_0000218,,In vivo,,N,,Spleen,11195,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10724,,CHEMBL622117,1,BAO_0000218,,In vivo,,N,,,6193,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10725,,CHEMBL622118,1,BAO_0000218,,In vivo,,N,,,6803,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rats at 6 mg/kg,10116.0,Intermediate,,,10726,,CHEMBL622119,1,BAO_0000218,,In vivo,,N,,,6647,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat (dose 6 mg/kg),10116.0,Intermediate,,,10727,,CHEMBL622120,1,BAO_0000218,,In vivo,,N,,,6647,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rats at 6 mg/kg dose; Not tested,10116.0,Intermediate,,,10728,,CHEMBL622121,1,BAO_0000218,,In vivo,,N,,,6647,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10729,,CHEMBL622122,1,BAO_0000218,,In vivo,,N,,,6640,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10730,,CHEMBL622123,1,BAO_0000218,,In vivo,,N,,,6641,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10731,,CHEMBL622124,1,BAO_0000218,,In vivo,,N,,,6641,Rattus norvegicus,50597,A,,1
,Bioavailability in rat,10116.0,Intermediate,,,10732,,CHEMBL622125,1,BAO_0000218,,In vivo,,N,,,6642,Rattus norvegicus,50597,A,,1
,Oral bioavailability,10116.0,Intermediate,,,10733,,CHEMBL622126,1,BAO_0000218,,In vivo,,N,,,5472,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),10116.0,Intermediate,,,10734,,CHEMBL620455,1,BAO_0000218,,In vivo,,N,,,6141,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10735,,CHEMBL620456,1,BAO_0000218,,In vivo,,N,,,4390,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10736,,CHEMBL620457,1,BAO_0000218,,In vivo,,N,,,5472,Rattus norvegicus,50597,A,,1
,Oral bioavailability was evaluated; Not tested,10116.0,Intermediate,,,10737,,CHEMBL620458,1,BAO_0000218,,In vivo,,N,,,5472,Rattus norvegicus,50597,A,,1
,Oral bioavailability,10116.0,Intermediate,,,10738,,CHEMBL620459,1,BAO_0000218,,In vivo,,N,,,5438,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat by oral dosing,10116.0,Intermediate,,,10739,,CHEMBL620460,1,BAO_0000218,,In vivo,,N,,,4883,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat (dose 10 mg/kg p.o.),10116.0,Intermediate,,,10740,,CHEMBL620461,1,BAO_0000218,,In vivo,,N,,,1908,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat (Sprague-Dawley),10116.0,Intermediate,,,10741,,CHEMBL620462,1,BAO_0000218,,In vivo,,N,,,4853,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),10116.0,Intermediate,,,10742,,CHEMBL620463,1,BAO_0000218,,In vivo,,N,,,4853,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),10116.0,Intermediate,,,10743,,CHEMBL620464,1,BAO_0000218,,In vivo,,N,,,4853,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),10116.0,Intermediate,,,10744,,CHEMBL620465,1,BAO_0000218,,In vivo,,N,,,4853,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg p.o.),10116.0,Intermediate,,,10745,,CHEMBL620466,1,BAO_0000218,,In vivo,,N,,,4853,Rattus norvegicus,50597,A,,1
,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 1 mg/kg,10116.0,Intermediate,,,10746,,CHEMBL620467,1,BAO_0000218,,In vivo,,N,,,4853,Rattus norvegicus,50597,A,,1
,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 2 mg/kg,10116.0,Intermediate,,,10747,,CHEMBL620468,1,BAO_0000218,,In vivo,,N,,,4853,Rattus norvegicus,50597,A,,1
,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in solution form,10116.0,Intermediate,,,10748,,CHEMBL620469,1,BAO_0000218,,In vivo,,N,,,12873,Rattus norvegicus,50597,A,,1
,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in suspension form,10116.0,Intermediate,,,10749,,CHEMBL620470,1,BAO_0000218,,In vivo,,N,,,12873,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10750,,CHEMBL620471,1,BAO_0000218,,In vivo,,N,,,3169,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10751,,CHEMBL620472,1,BAO_0000218,,In vivo,,N,,,6305,Rattus norvegicus,50597,A,,1
,Oral bioavailability of compound at 5 mg/kg after po administration was determined in rat,10116.0,Intermediate,,,10752,,CHEMBL620473,1,BAO_0000218,,In vivo,,N,,,4762,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10753,,CHEMBL620474,1,BAO_0000218,,In vivo,,N,,,17847,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg),10116.0,Intermediate,,,10754,,CHEMBL620475,1,BAO_0000218,,In vivo,,N,,,6211,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10755,,CHEMBL620476,1,BAO_0000218,,In vivo,,N,,,6011,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10756,,CHEMBL620477,1,BAO_0000218,,In vivo,,N,,,6317,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat after oral administration at 10.5 mg/kg dose,10116.0,Intermediate,,,10757,,CHEMBL620478,1,BAO_0000218,,In vivo,,N,,,6644,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat after oral administration at 11.2 mg/kg dose,10116.0,Intermediate,,,10758,,CHEMBL618768,1,BAO_0000218,,In vivo,,N,,,6644,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat after oral administration at 13 mg/kg dose,10116.0,Intermediate,,,10759,,CHEMBL618769,1,BAO_0000218,,In vivo,,N,,,6644,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat after oral administration at 9.7 mg/kg dose,10116.0,Intermediate,,,10760,,CHEMBL618770,1,BAO_0000218,,In vivo,,N,,,6644,Rattus norvegicus,50597,A,,1
,Oral bioavailability (dose 20 mg/kg p.o.),10116.0,Intermediate,,,10761,,CHEMBL618771,1,BAO_0000218,,In vivo,,N,,,6113,Rattus norvegicus,50597,A,,1
,Oral bioavailability was determined in rat after oral administration at a concentration 1 mg/kg,10116.0,Intermediate,,,10762,,CHEMBL618772,1,BAO_0000218,,In vivo,,N,,,5937,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat at 10 mg/kg of the compound,10116.0,Intermediate,,,10763,,CHEMBL618773,1,BAO_0000218,,In vivo,,N,,,5711,Rattus norvegicus,50597,A,,1
,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,10116.0,Intermediate,,,10764,,CHEMBL875842,1,BAO_0000218,,In vivo,,N,,,17717,Rattus norvegicus,50597,A,,1
,Bioavailability in rat (dose 3 mg/kg i.v.),10116.0,Intermediate,,,10765,,CHEMBL618774,1,BAO_0000218,,In vivo,,N,,,17717,Rattus norvegicus,50597,A,,1
,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,10116.0,Intermediate,,,10766,,CHEMBL618775,1,BAO_0000218,,In vivo,,N,,,17717,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat (dose 60 mg/kg p.o.),10116.0,Intermediate,,,10767,,CHEMBL618776,1,BAO_0000218,,In vivo,,N,,,17717,Rattus norvegicus,50597,A,,1
,Percent bioavailability (F) in rats after iv administration,10116.0,Intermediate,,,10768,,CHEMBL618777,1,BAO_0000218,,In vivo,,N,,,4722,Rattus norvegicus,50597,A,,1
,Percent bioavailability (F) in rats after oral dose of 10 mg/kg,10116.0,Intermediate,,,10769,,CHEMBL618778,1,BAO_0000218,,In vivo,,N,,,4722,Rattus norvegicus,50597,A,,1
,Bioavailability in rat (dose 5 uM/kg p.o.),10116.0,Intermediate,,,10770,,CHEMBL618779,1,BAO_0000218,,In vivo,,N,,,4353,Rattus norvegicus,50597,A,,1
,Oral bioavailability,10116.0,Intermediate,,,10771,,CHEMBL618780,1,BAO_0000218,,In vivo,,N,,,15662,Rattus norvegicus,50597,A,,1
,Bioavailability in rat (dose 2 mg/kg p.o.),10116.0,Intermediate,,,10772,,CHEMBL618781,1,BAO_0000218,,In vivo,,N,,,4756,Rattus norvegicus,50597,A,,1
,Percent bioavailability at the dose of 5 mg/Kg administered perorally in rats,10116.0,Intermediate,,,10773,,CHEMBL618782,1,BAO_0000218,,In vivo,,N,,,4756,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat (dose 20 mg/kg),10116.0,Intermediate,,,10774,,CHEMBL618783,1,BAO_0000218,,In vivo,,N,,,3436,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10775,,CHEMBL618784,1,BAO_0000218,,In vivo,,N,,,17800,Rattus norvegicus,50597,A,,1
,Percent oral bioavailability evaluated in rat,10116.0,Intermediate,,,10776,,CHEMBL618785,1,BAO_0000218,,In vivo,,N,,,15762,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10777,,CHEMBL618786,1,BAO_0000218,,In vivo,,N,,,5089,Rattus norvegicus,50597,A,,1
,Percent oral bioavailability in rat; Not determined,10116.0,Intermediate,,,10778,,CHEMBL618787,1,BAO_0000218,,In vivo,,N,,,5089,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Intermediate,,,10779,,CHEMBL618788,1,BAO_0000218,,In vivo,,N,,,3185,Rattus norvegicus,50597,A,,1
,Bioavailability in rat,10116.0,Intermediate,,,10780,,CHEMBL618789,1,BAO_0000218,,In vivo,,N,,,5145,Rattus norvegicus,50597,A,,1
,Pharmacokinetic property (oral bioavailability) in rat (dose given as a solution),10116.0,Intermediate,,,10781,,CHEMBL618790,1,BAO_0000218,,In vivo,,N,,,3457,Rattus norvegicus,50597,A,,1
,Pharmacokinetic property (oral bioavailability) in rat (dose given as a suspension),10116.0,Intermediate,,,10782,,CHEMBL618791,1,BAO_0000218,,In vivo,,N,,,3457,Rattus norvegicus,50597,A,,1
,Pharmacokinetic property (F) was measured in rat at the dose of 0.32 mg/kg,10116.0,Intermediate,,,10783,,CHEMBL875843,1,BAO_0000218,,In vivo,,N,,,5983,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat (dose 20 mg/kg p.o.),10116.0,Intermediate,,,10784,,CHEMBL618792,1,BAO_0000218,,In vivo,,N,,,5739,Rattus norvegicus,50597,A,,1
,Cmax at a dose of 30 mg/kg in rat,10116.0,Intermediate,,,10785,,CHEMBL623395,1,BAO_0000218,,In vivo,,N,,,3579,Rattus norvegicus,50597,A,,1
,Cmax in monkeys at a dose of 1 mg/kg,314293.0,Autocuration,,,10786,,CHEMBL623396,1,BAO_0000218,,In vivo,,U,,,17788,Simiiformes,22224,A,,0
,Cmax in rat,10116.0,Intermediate,,,10787,,CHEMBL623397,1,BAO_0000218,,In vivo,,N,,,14956,Rattus norvegicus,50597,A,,1
,Cmax in rats at a dose of 1 mg/kg,10116.0,Intermediate,,,10788,,CHEMBL623398,1,BAO_0000218,,In vivo,,N,,,17788,Rattus norvegicus,50597,A,,1
,Cmax was measured in mice after an oral dose of 50 mg/kg.,10090.0,Intermediate,,,10789,,CHEMBL623399,1,BAO_0000218,,In vivo,,N,,,9750,Mus musculus,50594,A,,1
,"Cmax value at a dose of 12.7 uM/kg, po",,Autocuration,,,10790,,CHEMBL623400,1,BAO_0000218,,In vivo,,U,,,12767,,22224,A,,0
,"Cmax value at a dose of 6.3 uM/kg, iv",,Autocuration,,,10791,,CHEMBL623401,1,BAO_0000218,,In vivo,,U,,,12767,,22224,A,,0
,"Cmax value at a dose of 7.1 uM/kg, iv",,Autocuration,,,10792,,CHEMBL623402,1,BAO_0000218,,In vivo,,U,,,12767,,22224,A,,0
,Cmax value of compound was determined after 1 hr,,Autocuration,,,10793,,CHEMBL623403,1,BAO_0000218,,In vivo,,U,,,12703,,22224,A,,0
,Cmax value of the compound,,Autocuration,,,10794,,CHEMBL623404,1,BAO_0000218,,In vivo,,U,,,15778,,22224,A,,0
,Cmax value administered intraintestinal in rats.,10116.0,Intermediate,,,10795,,CHEMBL625997,1,BAO_0000218,,In vivo,,N,,,12818,Rattus norvegicus,50597,A,,1
,Cmax value administered perorally was determined in rat; Not determined,10116.0,Intermediate,,,10796,,CHEMBL625998,1,BAO_0000218,,In vivo,,N,,,14964,Rattus norvegicus,50597,A,,1
,Cmax value at the dose of 2.3 mg/kg,,Autocuration,,,10797,,CHEMBL625999,1,BAO_0000218,,In vivo,,U,,,15808,,22224,A,,0
,Cmax value at the dose of 5 mg/kg,,Autocuration,,,10798,,CHEMBL626000,1,BAO_0000218,,In vivo,,U,,,15808,,22224,A,,0
,Cmax value in the period of 8 hr after dosing. ,,Autocuration,,,10799,,CHEMBL626001,1,BAO_0000218,,In vivo,,U,,,15778,,22224,A,,0
,Cmax value at a oral dose of 20 mg/kg; Not tested,,Autocuration,,,10800,,CHEMBL626002,1,BAO_0000218,,In vivo,,U,,,3715,,22224,A,,0
,Cmax value at a oral dose of 20 mg/kg,,Autocuration,,,10801,,CHEMBL626003,1,BAO_0000218,,In vivo,,U,,,3715,,22224,A,,0
,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,10116.0,Intermediate,,,10802,,CHEMBL626004,1,BAO_0000218,,In vivo,,N,,,1446,Rattus norvegicus,50597,A,,1
,Cmax(ng /mL)values after oral administration of 10 mg/kg in guinea pig.,10141.0,Intermediate,,,10803,,CHEMBL626005,1,BAO_0000218,,In vivo,,N,,,15240,Cavia porcellus,50512,A,,1
,Cmax(ng /mL)values after oral administration of 10 mg/kg in rat.,10116.0,Intermediate,,,10804,,CHEMBL626006,1,BAO_0000218,,In vivo,,N,,,15240,Rattus norvegicus,50597,A,,1
,Compound at a dose of 10 mg/kg was orally administered to rats and maximum plasma concentration was reported,10116.0,Intermediate,,,10805,1969.0,CHEMBL626007,1,BAO_0000218,,In vivo,,N,,Plasma,14810,Rattus norvegicus,50597,A,,1
,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,10090.0,Intermediate,,,10806,1969.0,CHEMBL626008,1,BAO_0000218,,In vivo,,N,,Plasma,14239,Mus musculus,50594,A,,1
,Compound was evaluated for maximum plasma concentration levels in dogs for the orally delivered compound in 0.05 M citric acid,9615.0,Intermediate,,,10807,2107.0,CHEMBL626009,1,BAO_0000218,,In vivo,,N,,Liver,12555,Canis lupus familiaris,50588,A,,1
,Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.,9615.0,Intermediate,,,10808,,CHEMBL626010,1,BAO_0000218,,In vivo,,N,,,10754,Canis lupus familiaris,50588,A,,1
,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a intramuscular administration 40 mg/kg in mice,10090.0,Intermediate,,,10809,178.0,CHEMBL626011,1,BAO_0000218,,In vivo,,N,,Blood,10754,Mus musculus,50594,A,,1
,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice,10090.0,Intermediate,,,10810,178.0,CHEMBL626012,1,BAO_0000218,,In vivo,,N,,Blood,10754,Mus musculus,50594,A,,1
,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration of 40 mg/kg in mice,10090.0,Intermediate,,,10811,178.0,CHEMBL626013,1,BAO_0000218,,In vivo,,N,,Blood,10754,Mus musculus,50594,A,,1
,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice,10090.0,Intermediate,,,10812,178.0,CHEMBL626014,1,BAO_0000218,,In vivo,,N,,Blood,10754,Mus musculus,50594,A,,1
,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice.,10090.0,Intermediate,,,10813,178.0,CHEMBL877496,1,BAO_0000218,,In vivo,,N,,Blood,10754,Mus musculus,50594,A,,1
,Compound was tested Growth Hormone(GH) release after 0.5 mg/kg administration (Po) in Beagle dogs,9615.0,Intermediate,,,10814,,CHEMBL626015,1,BAO_0000218,,In vivo,,N,,,14600,Canis lupus familiaris,50588,F,,1
,Compound was tested Growth Hormone(GH) release after 10 mg/kg administration (Po) in Beagle dogs,9615.0,Intermediate,,,10815,,CHEMBL626016,1,BAO_0000218,,In vivo,,N,,,14600,Canis lupus familiaris,50588,F,,1
,Compound was tested Growth Hormone(GH) release after 2.5 mg/kg administration (Po) in Beagle dogs,9615.0,Intermediate,,,10816,,CHEMBL626017,1,BAO_0000218,,In vivo,,N,,,14600,Canis lupus familiaris,50588,F,,1
,Bioavailability as maximal plasma concentration in dogs,9615.0,Intermediate,,,10817,1969.0,CHEMBL626018,1,BAO_0000218,,In vivo,,N,,Plasma,13543,Canis lupus familiaris,50588,A,,1
,Bioavailability as maximal plasma concentration in dogs,9615.0,Intermediate,,,10818,1969.0,CHEMBL626692,1,BAO_0000218,,In vivo,,N,,Plasma,13543,Canis lupus familiaris,50588,A,,1
,Bioavailability as maximal plasma concentration in rats,10116.0,Intermediate,,,10819,1969.0,CHEMBL626693,1,BAO_0000218,,In vivo,,N,,Plasma,13543,Rattus norvegicus,50597,A,,1
,Bioavailability as maximal plasma concentration in rats,10116.0,Autocuration,,,10820,1969.0,CHEMBL626694,1,BAO_0000218,,In vivo,,U,,Plasma,13543,Rattus norvegicus,22224,A,,0
,Compound was tested for maximum blood concentration after 0.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,9615.0,Intermediate,,,10821,178.0,CHEMBL626695,1,BAO_0000218,,In vivo,,N,,Blood,14600,Canis lupus familiaris,50588,A,,1
,Compound was tested for maximum blood concentration after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,9615.0,Intermediate,,,10822,178.0,CHEMBL626696,1,BAO_0000218,,In vivo,,N,,Blood,14600,Canis lupus familiaris,50588,A,,1
,Compound was tested for maximum blood concentration after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,9615.0,Intermediate,,,10823,178.0,CHEMBL626697,1,BAO_0000218,,In vivo,,N,,Blood,14600,Canis lupus familiaris,50588,A,,1
,Compound was tested for maximum concentration in blood after 0.5 mg/kg administration (Po) in Beagle dogs; nd = Not Detectable,9615.0,Intermediate,,,10824,178.0,CHEMBL626859,1,BAO_0000218,,In vivo,,N,,Blood,14600,Canis lupus familiaris,50588,A,,1
,Compound was tested for maximum concentration in blood after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,9615.0,Intermediate,,,10825,178.0,CHEMBL626860,1,BAO_0000218,,In vivo,,N,,Blood,14600,Canis lupus familiaris,50588,A,,1
,Compound was tested for maximum concentration in blood after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,9615.0,Intermediate,,,10826,178.0,CHEMBL626861,1,BAO_0000218,,In vivo,,N,,Blood,14600,Canis lupus familiaris,50588,A,,1
,Compound was tested for maximum observed concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,10116.0,Intermediate,,,10827,,CHEMBL626296,1,BAO_0000218,,In vivo,,N,,,14681,Rattus norvegicus,50597,A,,1
,Compound was tested for the max. conc. when administered perorally(po) 30 mg/kg,,Autocuration,,,10828,,CHEMBL626297,1,BAO_0000218,,In vivo,,U,,,15905,,22224,A,,0
,Compound was tested for the max. plasma conc. when administered intraperitoneally (ip) 30 mg/kg.,,Autocuration,,,10829,1969.0,CHEMBL626298,1,BAO_0000218,,In vivo,,U,,Plasma,15905,,22224,A,,0
,"Drug plasma level in rat was determined on the last day of dosing at 1,2,4.8 and 24 hr and ED50 was evaluated",10116.0,Intermediate,,,10830,1969.0,CHEMBL626299,1,BAO_0000218,,In vivo,,N,,Plasma,13304,Rattus norvegicus,50597,A,,1
,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats after 30 min.,10116.0,Intermediate,,,10831,1969.0,CHEMBL626300,1,BAO_0000218,,In vivo,,N,,Plasma,15137,Rattus norvegicus,50597,A,,1
,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats after 30 min.,10116.0,Intermediate,,,10832,1969.0,CHEMBL626301,1,BAO_0000218,,In vivo,,N,,Plasma,15137,Rattus norvegicus,50597,A,,1
,Effect of ip administration of compound on plasma concentration of corticosterone (CTS) in rats after 30 min.,10116.0,Intermediate,,,10833,1969.0,CHEMBL626962,1,BAO_0000218,,In vivo,,N,,Plasma,15137,Rattus norvegicus,50597,A,,1
,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats after 30 min.,10116.0,Intermediate,,,10834,1969.0,CHEMBL626963,1,BAO_0000218,,In vivo,,N,,Plasma,15137,Rattus norvegicus,50597,A,,1
,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats after 30 min.,10116.0,Intermediate,,,10835,1969.0,CHEMBL626964,1,BAO_0000218,,In vivo,,N,,Plasma,15137,Rattus norvegicus,50597,A,,1
,In vivo antitumor efficacy expressed as maximum plasma concentration 0.4 hr after a peroral dose of 25 mg/kg in cynomolgus monkeys,9541.0,Intermediate,,,10836,1969.0,CHEMBL626965,1,BAO_0000218,,In vivo,,N,,Plasma,14839,Macaca fascicularis,100710,A,,1
,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,10090.0,Intermediate,,,10837,1969.0,CHEMBL626966,1,BAO_0000218,,In vivo,,N,,Plasma,14839,Mus musculus,50594,A,,1
,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,10090.0,Intermediate,,,10838,1969.0,CHEMBL626967,1,BAO_0000218,,In vivo,,N,,Plasma,14839,Mus musculus,50594,A,,1
,In vivo antitumor efficacy expressed as maximum plasma concentration after a peroral dose of 10 mg/kg in cynomolgus monkeys,9541.0,Intermediate,,,10839,1969.0,CHEMBL626968,1,BAO_0000218,,In vivo,,N,,Plasma,14839,Macaca fascicularis,100710,A,,1
,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.89-1.24,10116.0,Intermediate,,,10840,948.0,CHEMBL626969,1,BAO_0000218,,,,N,,Heart,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-2.58,10116.0,Intermediate,,,10841,948.0,CHEMBL627126,1,BAO_0000218,,,,N,,Heart,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.24-0.28,10116.0,Intermediate,,,10842,948.0,CHEMBL631276,1,BAO_0000218,,,,N,,Heart,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.52-0.62,10116.0,Intermediate,,,10843,948.0,CHEMBL631277,1,BAO_0000218,,,,N,,Heart,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.68-0.84,10116.0,Intermediate,,,10844,948.0,CHEMBL631278,1,BAO_0000218,,,,N,,Heart,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.75-1.03,10116.0,Intermediate,,,10845,948.0,CHEMBL874457,1,BAO_0000218,,,,N,,Heart,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.96-2.46,10116.0,Intermediate,,,10846,948.0,CHEMBL631279,1,BAO_0000218,,,,N,,Heart,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.36-0.42,10116.0,Intermediate,,,10847,948.0,CHEMBL631280,1,BAO_0000218,,,,N,,Heart,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.82,10116.0,Intermediate,,,10848,948.0,CHEMBL631281,1,BAO_0000218,,,,N,,Heart,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.24-1.46,10116.0,Intermediate,,,10849,948.0,CHEMBL631968,1,BAO_0000218,,,,N,,Heart,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.36-3.96,10116.0,Intermediate,,,10850,948.0,CHEMBL631969,1,BAO_0000218,,,,N,,Heart,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.24-0.29,10116.0,Intermediate,,,10851,948.0,CHEMBL631970,1,BAO_0000218,,,,N,,Heart,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.39-0.74,10116.0,Intermediate,,,10852,948.0,CHEMBL631971,1,BAO_0000218,,,,N,,Heart,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.79-0.85,10116.0,Intermediate,,,10853,948.0,CHEMBL631972,1,BAO_0000218,,,,N,,Heart,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.64-0.86,10116.0,Intermediate,,,10854,948.0,CHEMBL630435,1,BAO_0000218,,,,N,,Heart,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.68-2.23,10116.0,Intermediate,,,10855,948.0,CHEMBL630436,1,BAO_0000218,,,,N,,Heart,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.19-0.23,10116.0,Intermediate,,,10856,948.0,CHEMBL630437,1,BAO_0000218,,,,N,,Heart,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.22-0.29,10116.0,Intermediate,,,10857,948.0,CHEMBL630438,1,BAO_0000218,,,,N,,Heart,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.75,10116.0,Intermediate,,,10858,948.0,CHEMBL630439,1,BAO_0000218,,,,N,,Heart,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.42-1.82,10116.0,Intermediate,,,10859,2113.0,CHEMBL630440,1,BAO_0000218,,,,N,,Kidney,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-3.12,10116.0,Intermediate,,,10860,2113.0,CHEMBL630441,1,BAO_0000218,,,,N,,Kidney,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.62-0.92,10116.0,Intermediate,,,10861,2113.0,CHEMBL630442,1,BAO_0000218,,,,N,,Kidney,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.12-2.04,10116.0,Intermediate,,,10862,2113.0,CHEMBL625234,1,BAO_0000218,,,,N,,Kidney,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.59-2.03,10116.0,Intermediate,,,10863,2113.0,CHEMBL625235,1,BAO_0000218,,,,N,,Kidney,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.14-1.4,10116.0,Intermediate,,,10864,2113.0,CHEMBL625236,1,BAO_0000218,,,,N,,Kidney,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.56-1.83,10116.0,Intermediate,,,10865,2113.0,CHEMBL625237,1,BAO_0000218,,,,N,,Kidney,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.73,10116.0,Intermediate,,,10866,2113.0,CHEMBL626125,1,BAO_0000218,,,,N,,Kidney,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.67-2.11,10116.0,Intermediate,,,10867,2113.0,CHEMBL626126,1,BAO_0000218,,,,N,,Kidney,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.64-3.43,10116.0,Intermediate,,,10868,2113.0,CHEMBL626127,1,BAO_0000218,,,,N,,Kidney,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.18-4.74,10116.0,Intermediate,,,10869,2113.0,CHEMBL626128,1,BAO_0000218,,,,N,,Kidney,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.62-1.13,10116.0,Intermediate,,,10870,2113.0,CHEMBL626129,1,BAO_0000218,,,,N,,Kidney,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.73-2.64,10116.0,Intermediate,,,10871,2113.0,CHEMBL626130,1,BAO_0000218,,,,N,,Kidney,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 13.02-19.07,10116.0,Intermediate,,,10872,2113.0,CHEMBL626131,1,BAO_0000218,,,,N,,Kidney,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.89-1.19,10116.0,Intermediate,,,10873,2113.0,CHEMBL626132,1,BAO_0000218,,,,N,,Kidney,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.17-1.48,10116.0,Intermediate,,,10874,2113.0,CHEMBL626752,1,BAO_0000218,,,,N,,Kidney,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.48-0.72,10116.0,Intermediate,,,10875,2113.0,CHEMBL626753,1,BAO_0000218,,,,N,,Kidney,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.57,10116.0,Intermediate,,,10876,2113.0,CHEMBL626754,1,BAO_0000218,,,,N,,Kidney,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.99-1.24,10116.0,Intermediate,,,10877,2113.0,CHEMBL626755,1,BAO_0000218,,,,N,,Kidney,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.23-1.78,10116.0,Intermediate,,,10878,2107.0,CHEMBL626756,1,BAO_0000218,,,,N,,Liver,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.43-2.92,10116.0,Intermediate,,,10879,2107.0,CHEMBL626757,1,BAO_0000218,,,,N,,Liver,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.81-1.18,10116.0,Intermediate,,,10880,2107.0,CHEMBL626758,1,BAO_0000218,,,,N,,Liver,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.37-1.74,10116.0,Intermediate,,,10881,2107.0,CHEMBL626759,1,BAO_0000218,,,,N,,Liver,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 4.01-4.81,10116.0,Intermediate,,,10882,2107.0,CHEMBL626760,1,BAO_0000218,,,,N,,Liver,8418,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),9615.0,Intermediate,,,10883,,CHEMBL626394,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration,9615.0,Intermediate,,,10884,,CHEMBL626395,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration (0-6 hr),9615.0,Intermediate,,,10885,,CHEMBL626396,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),9615.0,Intermediate,,,10886,,CHEMBL626397,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),9615.0,Intermediate,,,10887,,CHEMBL626398,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),9615.0,Intermediate,,,10888,,CHEMBL626399,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration,10116.0,Intermediate,,,10889,,CHEMBL874653,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),10116.0,Intermediate,,,10890,,CHEMBL626400,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),10116.0,Intermediate,,,10891,,CHEMBL626401,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),10116.0,Intermediate,,,10892,,CHEMBL626402,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),10116.0,Intermediate,,,10893,,CHEMBL626403,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),10116.0,Intermediate,,,10894,,CHEMBL626404,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration,10116.0,Intermediate,,,10895,,CHEMBL626405,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),10116.0,Intermediate,,,10896,,CHEMBL625529,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),10116.0,Intermediate,,,10897,,CHEMBL625530,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),10116.0,Intermediate,,,10898,,CHEMBL625531,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),10116.0,Intermediate,,,10899,,CHEMBL625532,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),10116.0,Intermediate,,,10900,,CHEMBL625533,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration,10116.0,Intermediate,,,10901,,CHEMBL875474,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),10116.0,Intermediate,,,10902,,CHEMBL625534,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),10116.0,Intermediate,,,10903,,CHEMBL625535,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),10116.0,Intermediate,,,10904,,CHEMBL625536,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),10116.0,Intermediate,,,10905,,CHEMBL625537,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),10116.0,Intermediate,,,10906,,CHEMBL625538,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration,10116.0,Intermediate,,,10907,,CHEMBL625539,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),10116.0,Intermediate,,,10908,,CHEMBL625540,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),10116.0,Intermediate,,,10909,,CHEMBL625541,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),10116.0,Intermediate,,,10910,,CHEMBL625542,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),10116.0,Intermediate,,,10911,,CHEMBL625543,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),10116.0,Intermediate,,,10912,,CHEMBL625544,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.312 mg/kg after ip administration,9615.0,Intermediate,,,10913,,CHEMBL625545,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),9615.0,Intermediate,,,10914,,CHEMBL625546,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.625 mg/kg after ip administration,9615.0,Intermediate,,,10915,,CHEMBL625547,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),9615.0,Intermediate,,,10916,,CHEMBL625548,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),9615.0,Intermediate,,,10917,,CHEMBL625549,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),9615.0,Intermediate,,,10918,,CHEMBL625550,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),9615.0,Intermediate,,,10919,,CHEMBL625551,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),9615.0,Intermediate,,,10920,,CHEMBL875475,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),9615.0,Intermediate,,,10921,,CHEMBL625552,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),9615.0,Intermediate,,,10922,,CHEMBL625553,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),9615.0,Intermediate,,,10923,,CHEMBL625554,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),9615.0,Intermediate,,,10924,,CHEMBL625555,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),9615.0,Intermediate,,,10925,,CHEMBL625556,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration,9615.0,Intermediate,,,10926,,CHEMBL624986,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),9615.0,Intermediate,,,10927,,CHEMBL624987,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),9615.0,Intermediate,,,10928,,CHEMBL624988,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -2/-14,9615.0,Intermediate,,,10929,1637.0,CHEMBL624989,1,BAO_0000218,,In vivo,,N,,Artery,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -4/-4,9615.0,Intermediate,,,10930,1637.0,CHEMBL624990,1,BAO_0000218,,In vivo,,N,,Artery,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; 4/7,9615.0,Intermediate,,,10931,1637.0,CHEMBL874391,1,BAO_0000218,,In vivo,,N,,Artery,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3/10 range; -3/0/4,9615.0,Intermediate,,,10932,1637.0,CHEMBL624991,1,BAO_0000218,,In vivo,,N,,Artery,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; -6/0,9615.0,Intermediate,,,10933,1637.0,CHEMBL624992,1,BAO_0000218,,In vivo,,N,,Artery,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 10/31,9615.0,Intermediate,,,10934,1637.0,CHEMBL624993,1,BAO_0000218,,In vivo,,N,,Artery,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 11/-19,9615.0,Intermediate,,,10935,1637.0,CHEMBL624994,1,BAO_0000218,,In vivo,,N,,Artery,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 14/6,9615.0,Intermediate,,,10936,1637.0,CHEMBL624995,1,BAO_0000218,,In vivo,,N,,Artery,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/25,9615.0,Intermediate,,,10937,1637.0,CHEMBL624996,1,BAO_0000218,,In vivo,,N,,Artery,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/3,9615.0,Intermediate,,,10938,1637.0,CHEMBL624997,1,BAO_0000218,,In vivo,,N,,Artery,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 2/16,9615.0,Intermediate,,,10939,1637.0,CHEMBL624998,1,BAO_0000218,,In vivo,,N,,Artery,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 6/2,9615.0,Intermediate,,,10940,1637.0,CHEMBL624999,1,BAO_0000218,,In vivo,,N,,Artery,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 7/26,9615.0,Intermediate,,,10941,1637.0,CHEMBL882955,1,BAO_0000218,,In vivo,,N,,Artery,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/49,9615.0,Intermediate,,,10942,1637.0,CHEMBL625000,1,BAO_0000218,,In vivo,,N,,Artery,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/8,9615.0,Intermediate,,,10943,1637.0,CHEMBL625001,1,BAO_0000218,,In vivo,,N,,Artery,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 9/-18,9615.0,Intermediate,,,10944,1637.0,CHEMBL625089,1,BAO_0000218,,In vivo,,N,,Artery,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/60 range; 13/23,9615.0,Intermediate,,,10945,1637.0,CHEMBL625090,1,BAO_0000218,,In vivo,,N,,Artery,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3 range,9615.0,Intermediate,,,10946,1637.0,CHEMBL625091,1,BAO_0000218,,In vivo,,N,,Artery,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3/10 range; -7/-11,9615.0,Intermediate,,,10947,1637.0,CHEMBL625092,1,BAO_0000218,,In vivo,,N,,Artery,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 1/3 dose range; 6/-7,9615.0,Intermediate,,,10948,1637.0,CHEMBL625093,1,BAO_0000218,,In vivo,,N,,Artery,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 10/30 dose range; -13/19,9615.0,Intermediate,,,10949,1637.0,CHEMBL625094,1,BAO_0000218,,In vivo,,N,,Artery,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 3/10 dose range; 30/47,9615.0,Intermediate,,,10950,1637.0,CHEMBL625095,1,BAO_0000218,,In vivo,,N,,Artery,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for its bioavailability in the dogs,9615.0,Intermediate,,,10951,,CHEMBL625096,1,BAO_0000218,,In vivo,,N,,,2249,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for its bioavailability in the rats,10116.0,Intermediate,,,10952,,CHEMBL625097,1,BAO_0000218,,In vivo,,N,,,2249,Rattus norvegicus,50597,A,,1
,Compound was evaluated for oral bioavailability,,Autocuration,,,10953,,CHEMBL882956,1,BAO_0000218,,In vivo,,U,,,17515,,22224,A,,0
,Compound was evaluated for percentage of Oral bioavailability in rats,10116.0,Intermediate,,,10954,,CHEMBL625098,1,BAO_0000218,,In vivo,,N,,,14541,Rattus norvegicus,50597,A,,1
,Bioavailability in guinea pig,10141.0,Autocuration,,,10955,,CHEMBL625099,1,BAO_0000218,,In vivo,,U,,,12797,Cavia porcellus,22224,A,,0
,Compound was evaluated for the oral bioavailability in rat,10116.0,Intermediate,,,10956,,CHEMBL625100,1,BAO_0000218,,In vivo,,N,,,12797,Rattus norvegicus,50597,A,,1
,Compound was evaluated for the oral bioavailability in dog,9615.0,Intermediate,,,10957,,CHEMBL625101,1,BAO_0000218,,In vivo,,N,,,12797,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for the oral bioavailability in rat,10116.0,Intermediate,,,10958,,CHEMBL874396,1,BAO_0000218,,In vivo,,N,,,12797,Rattus norvegicus,50597,A,,1
,Bioavailability in dog (dosed i.v.),9615.0,Autocuration,,,10959,,CHEMBL625102,1,BAO_0000218,,In vivo,,U,,,11727,Canis lupus familiaris,22224,F,,0
,Compound was tested for in vivo bioavailability in dog,9615.0,Intermediate,,,10960,,CHEMBL625103,1,BAO_0000218,,In vivo,,N,,,13249,Canis lupus familiaris,50588,A,,1
,Compound was tested for in vivo bioavailability in hamsters,10026.0,Intermediate,,,10961,,CHEMBL625104,1,BAO_0000218,,In vivo,,N,,,13249,Cricetinae,100712,A,,1
,Compound was tested for in vivo bioavailability in monkey,314293.0,Autocuration,,,10962,,CHEMBL625105,1,BAO_0000218,,In vivo,,U,,,13249,Simiiformes,22224,A,,0
,Compound was tested for in vivo bioavailability in rat,10116.0,Intermediate,,,10963,,CHEMBL625106,1,BAO_0000218,,In vivo,,N,,,13249,Rattus norvegicus,50597,A,,1
,Oral bioavailability in mouse,10090.0,Autocuration,,,10964,,CHEMBL625107,1,BAO_0000218,,In vivo,,U,,,9552,Mus musculus,22224,A,,0
,Compound was tested for percent of oral bioavailability in mice; 56-74,10090.0,Intermediate,,,10965,,CHEMBL625108,1,BAO_0000218,,In vivo,,N,,,9552,Mus musculus,50594,A,,1
,Oral bioavailability in mouse (nude) (dose of 25 mg/kg),10090.0,Autocuration,,,10966,,CHEMBL625109,1,BAO_0000218,,In vivo,,U,,,14839,Mus musculus,22224,A,,0
,Bioavailability in cynomolgus monkey (dose 25 mg/kg i.v.),9541.0,Autocuration,,,10967,,CHEMBL625110,1,BAO_0000218,,In vivo,,U,,,14839,Macaca fascicularis,22224,A,,0
,Bioavailability in cynomolgus monkey (dose 5 mg/kg i.v.),9541.0,Autocuration,,,10968,,CHEMBL625111,1,BAO_0000218,,In vivo,,U,,,14839,Macaca fascicularis,22224,A,,0
,Oral bioavailability in mouse (nude) (dose 25 mg/kg i.v.),10090.0,Intermediate,,,10969,,CHEMBL625112,1,BAO_0000218,,In vivo,,N,,,14839,Mus musculus,50594,A,,1
,Oral bioavailability in nude mice,10090.0,Intermediate,,,10970,,CHEMBL875334,1,BAO_0000218,,In vivo,,N,,,14839,Mus musculus,50594,A,,1
,Bioavailability in monkey (i.d. dosing),9443.0,Autocuration,,,10971,,CHEMBL628617,1,BAO_0000218,,In vivo,,U,,,11219,Primates,22224,A,,0
,Bioavailability in rat,10116.0,Autocuration,,,10972,,CHEMBL628618,1,BAO_0000218,,In vivo,,U,,,9552,Rattus norvegicus,22224,A,,0
,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 10%,,Autocuration,,,10973,,CHEMBL628619,1,BAO_0000218,,In vivo,,U,,,11732,,22224,A,,0
,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 20%,,Autocuration,,,10974,,CHEMBL628620,1,BAO_0000218,,In vivo,,U,,,11732,,22224,A,,0
,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",9541.0,Intermediate,,,10975,,CHEMBL628621,1,BAO_0000218,,In vivo,,N,,,14839,Macaca fascicularis,100710,A,,1
,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",9541.0,Intermediate,,,10976,,CHEMBL628622,1,BAO_0000218,,In vivo,,N,,,14839,Macaca fascicularis,100710,A,,1
,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",9541.0,Intermediate,,,10977,,CHEMBL628623,1,BAO_0000218,,In vivo,,N,,,14839,Macaca fascicularis,100710,A,,1
,Maximal plasma concentration in cynomolgus monkeys after 10 mg/kg oral dose,9541.0,Intermediate,,,10978,1969.0,CHEMBL628624,1,BAO_0000218,,In vivo,,N,,Plasma,14839,Macaca fascicularis,100710,A,,1
,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,10090.0,Intermediate,,,10979,1969.0,CHEMBL628625,1,BAO_0000218,,In vivo,,N,,Plasma,14839,Mus musculus,50594,A,,1
,Maximal plasma concentration in cynomolgus monkeys after 5 mg/kg oral dose,9541.0,Intermediate,,,10980,1969.0,CHEMBL628626,1,BAO_0000218,,In vivo,,N,,Plasma,14839,Macaca fascicularis,100710,A,,1
,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,10090.0,Intermediate,,,10981,1969.0,CHEMBL627041,1,BAO_0000218,,In vivo,,N,,Plasma,14839,Mus musculus,50594,A,,1
,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,10090.0,Intermediate,,,10982,1969.0,CHEMBL627042,1,BAO_0000218,,In vivo,,N,,Plasma,14839,Mus musculus,50594,A,,1
,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,10090.0,Intermediate,,,10983,1969.0,CHEMBL627043,1,BAO_0000218,,In vivo,,N,,Plasma,14839,Mus musculus,50594,A,,1
,In vivo evaluation of maximum plasma concentration at a dose of 10 mg/kg,,Autocuration,,,10984,1969.0,CHEMBL627044,1,BAO_0000218,,In vivo,,U,,Plasma,13932,,22224,A,,0
,Cmax in mouse plasma,10090.0,Intermediate,,,10985,1969.0,CHEMBL627045,1,BAO_0000218,,In vivo,,N,,Plasma,11637,Mus musculus,50594,A,,1
,Max plasma concentration was measured by 40 mg/kg dose of peroral administration.,,Autocuration,,,10986,1969.0,CHEMBL627046,1,BAO_0000218,,In vivo,,U,,Plasma,11637,,22224,A,,0
,Maximal plasma concentration in rat,10116.0,Intermediate,,,10987,1969.0,CHEMBL627047,1,BAO_0000218,,In vivo,,N,,Plasma,13960,Rattus norvegicus,50597,A,,1
,Maximal plasma level when administered 1 mg/kg perorally (po) in rat,10116.0,Intermediate,,,10988,1969.0,CHEMBL627048,1,BAO_0000218,,In vivo,,N,,Plasma,15905,Rattus norvegicus,50597,A,,1
,Maximum concentration at an intraduodenal dose of 5.2 mg/kg in rat,10116.0,Intermediate,,,10989,,CHEMBL627049,1,BAO_0000218,,In vivo,,N,,,14062,Rattus norvegicus,50597,A,,1
,Maximum concentration at an intraduodenal dose of 6.6 mg/kg in rat,10116.0,Intermediate,,,10990,,CHEMBL627050,1,BAO_0000218,,In vivo,,N,,,14062,Rattus norvegicus,50597,A,,1
,Maximum concentration at an intravenous dose of 5.5 mg/kg in rat,10116.0,Intermediate,,,10991,,CHEMBL627051,1,BAO_0000218,,In vivo,,N,,,14062,Rattus norvegicus,50597,A,,1
,Maximum concentration at an intravenous dose of 6.5 mg/kg in rat,10116.0,Intermediate,,,10992,,CHEMBL627052,1,BAO_0000218,,In vivo,,N,,,14062,Rattus norvegicus,50597,A,,1
,Maximum concentration at an peroral dose of 6.2 mg/kg in rat,10116.0,Intermediate,,,10993,,CHEMBL627053,1,BAO_0000218,,In vivo,,N,,,14062,Rattus norvegicus,50597,A,,1
,Maximum concentration at an peroral dose of 6.3 mg/kg in rat,10116.0,Intermediate,,,10994,,CHEMBL627054,1,BAO_0000218,,In vivo,,N,,,14062,Rattus norvegicus,50597,A,,1
,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,10090.0,Intermediate,,,10995,,CHEMBL627055,1,BAO_0000218,,In vivo,,N,,,15011,Mus musculus,50594,A,,1
,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,10090.0,Intermediate,,,10996,,CHEMBL627056,1,BAO_0000218,,In vivo,,N,,,15011,Mus musculus,50594,A,,1
,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),10090.0,Intermediate,,,10997,,CHEMBL627057,1,BAO_0000218,,In vivo,,N,,,15011,Mus musculus,50594,A,,1
,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,10090.0,Intermediate,,,10998,,CHEMBL627058,1,BAO_0000218,,In vivo,,N,,,15011,Mus musculus,50594,A,,1
,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,10090.0,Intermediate,,,10999,,CHEMBL626211,1,BAO_0000218,,In vivo,,N,,,15011,Mus musculus,50594,A,,1
,Maximum Concentration of the compound.,,Autocuration,,,11000,,CHEMBL626212,1,BAO_0000218,,In vivo,,U,,,10291,,22224,A,,0
,Maximum Concentration was measured after iv administration into Beagle dog,9615.0,Intermediate,,,11001,,CHEMBL626213,1,BAO_0000218,,In vivo,,N,,,14599,Canis lupus familiaris,50588,A,,1
,Maximum Concentration was measured after iv administration into Beagle dog.,9615.0,Intermediate,,,11002,,CHEMBL626214,1,BAO_0000218,,In vivo,,N,,,14599,Canis lupus familiaris,50588,A,,1
,Maximum Concentration was measured after po administration into Beagle dog,9615.0,Intermediate,,,11003,,CHEMBL626215,1,BAO_0000218,,In vivo,,N,,,14599,Canis lupus familiaris,50588,A,,1
,Maximum Concentration was measured after po administration into Beagle dog.,9615.0,Intermediate,,,11004,,CHEMBL626216,1,BAO_0000218,,In vivo,,N,,,14599,Canis lupus familiaris,50588,A,,1
,Maximum blood level reached after an dose of 10.6 uM/kg intravenously,,Autocuration,,,11005,178.0,CHEMBL626217,1,BAO_0000218,,In vivo,,U,,Blood,12767,,22224,A,,0
,Maximum blood level reached after an iv dose of 12.2 uM/kg,,Autocuration,,,11006,178.0,CHEMBL626218,1,BAO_0000218,,In vivo,,U,,Blood,12767,,22224,A,,0
,Maximum blood level reached after an oral dose 14.7 uM/kg oral route,,Autocuration,,,11007,178.0,CHEMBL626219,1,BAO_0000218,,In vivo,,U,,Blood,12767,,22224,A,,0
,Maximum blood level reached after an oral dose of 14.7 uM/kg intravenous route,,Autocuration,,,11008,178.0,CHEMBL626220,1,BAO_0000218,,In vivo,,U,,Blood,12767,,22224,A,,0
,Maximum blood level reached after an oral dose of 5.0 mg/kg,,Autocuration,,,11009,178.0,CHEMBL626221,1,BAO_0000218,,In vivo,,U,,Blood,12767,,22224,A,,0
,Maximum blood level reached at dose of 10.6 uM/kg orally,,Autocuration,,,11010,178.0,CHEMBL626222,1,BAO_0000218,,In vivo,,U,,Blood,12767,,22224,A,,0
,Maximum concentration (Cmax) in guinea pigs at 2 mg/kg after oral administration,10141.0,Intermediate,,,11011,,CHEMBL626223,1,BAO_0000218,,In vivo,,N,,,14706,Cavia porcellus,50512,A,,1
,Maximum concentration (Cmax) in guinea pigs at 3 mg/kg after oral administration,10141.0,Intermediate,,,11012,,CHEMBL626224,1,BAO_0000218,,In vivo,,N,,,14706,Cavia porcellus,50512,A,,1
,Maximum concentration achieved in rat brain when administered intraperitoneally at a dose of 10 mg/kg,10116.0,Intermediate,,,11013,955.0,CHEMBL626225,1,BAO_0000218,,In vivo,,N,,Brain,14793,Rattus norvegicus,50597,A,,1
,Maximum concentration achieved in rat brain when administered intravenously at a dose of 10 mg/kg,10116.0,Intermediate,,,11014,955.0,CHEMBL626226,1,BAO_0000218,,In vivo,,N,,Brain,14793,Rattus norvegicus,50597,A,,1
,Maximum concentration achieved in rat brain when administered perorally at a dose of 100 mg/kg,10116.0,Intermediate,,,11015,955.0,CHEMBL626227,1,BAO_0000218,,In vivo,,N,,Brain,14793,Rattus norvegicus,50597,A,,1
,Maximum concentration achieved in rat brain when administered perorally at a dose of 10 mg/kg,10116.0,Intermediate,,,11016,955.0,CHEMBL626228,1,BAO_0000218,,In vivo,,N,,Brain,14793,Rattus norvegicus,50597,A,,1
,Maximum concentration achieved in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,10116.0,Intermediate,,,11017,,CHEMBL626229,1,BAO_0000218,,In vivo,,N,,,14793,Rattus norvegicus,50597,A,,1
,Maximum concentration achieved in rat plasma when administered intravenously at a dose of 10 mg/kg,10116.0,Intermediate,,,11018,,CHEMBL626921,1,BAO_0000218,,In vivo,,N,,,14793,Rattus norvegicus,50597,A,,1
,Maximum concentration achieved in rat plasma when administered perorally at a dose of 100 mg/kg,10116.0,Intermediate,,,11019,,CHEMBL876793,1,BAO_0000218,,In vivo,,N,,,14793,Rattus norvegicus,50597,A,,1
,Maximum concentration achieved in rat plasma when administered perorally at a dose of 10 mg/kg,10116.0,Intermediate,,,11020,,CHEMBL625309,1,BAO_0000218,,In vivo,,N,,,14793,Rattus norvegicus,50597,A,,1
,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),1423.0,Intermediate,,,11021,,CHEMBL625310,1,BAO_0000218,,In vivo,,N,,,10524,Bacillus subtilis,50278,A,,1
,Maximum concentration determined in monkeys dosed intravenously with 30 mg/kg,314293.0,Autocuration,,,11022,,CHEMBL625311,1,BAO_0000218,,In vivo,,U,,,11871,Simiiformes,22224,A,,0
,Maximum concentration determined in rats dosed intravenously with 20 mg/kg,10116.0,Intermediate,,,11023,,CHEMBL625312,1,BAO_0000218,,In vivo,,N,,,11871,Rattus norvegicus,50597,A,,1
,Maximum concentration for the bioavailability at a dose of 20 mg/kg administered orally,,Autocuration,,,11024,,CHEMBL625313,1,BAO_0000218,,In vivo,,U,,,3437,,22224,A,,0
,Maximum concentration in male CD-1 mice after sc administration of 20 mg/kg,10090.0,Intermediate,,,11025,,CHEMBL625314,1,BAO_0000218,,In vivo,,N,,,12038,Mus musculus,50594,A,,1
,Maximum concentration in male rats after iv administration of 20 mg/kg,10116.0,Intermediate,,,11026,,CHEMBL625315,1,BAO_0000218,,In vivo,,N,,,12038,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.06-1.29,10116.0,Intermediate,,,11027,2107.0,CHEMBL625316,1,BAO_0000218,,,,N,,Liver,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.77-2.08,10116.0,Intermediate,,,11028,2107.0,CHEMBL625317,1,BAO_0000218,,,,N,,Liver,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.89,10116.0,Intermediate,,,11029,2107.0,CHEMBL625318,1,BAO_0000218,,,,N,,Liver,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.57-1.66,10116.0,Intermediate,,,11030,2107.0,CHEMBL625319,1,BAO_0000218,,,,N,,Liver,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.06-2.71,10116.0,Intermediate,,,11031,2107.0,CHEMBL625320,1,BAO_0000218,,,,N,,Liver,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.98-3.22,10116.0,Intermediate,,,11032,2107.0,CHEMBL625321,1,BAO_0000218,,,,N,,Liver,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.73-1.45,10116.0,Intermediate,,,11033,2107.0,CHEMBL625322,1,BAO_0000218,,,,N,,Liver,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.03-1.31,10116.0,Intermediate,,,11034,2107.0,CHEMBL876801,1,BAO_0000218,,,,N,,Liver,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 6.76-10.44,10116.0,Intermediate,,,11035,2107.0,CHEMBL625323,1,BAO_0000218,,,,N,,Liver,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.47-1.17,10116.0,Intermediate,,,11036,2107.0,CHEMBL625324,1,BAO_0000218,,,,N,,Liver,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.12-1.44,10116.0,Intermediate,,,11037,2107.0,CHEMBL625325,1,BAO_0000218,,,,N,,Liver,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.38-0.57,10116.0,Intermediate,,,11038,2107.0,CHEMBL625326,1,BAO_0000218,,,,N,,Liver,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.75-1.14,10116.0,Intermediate,,,11039,2107.0,CHEMBL625327,1,BAO_0000218,,,,N,,Liver,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 1.36-1.74,10116.0,Intermediate,,,11040,2107.0,CHEMBL625328,1,BAO_0000218,,,,N,,Liver,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.5,10116.0,Intermediate,,,11041,2048.0,CHEMBL625329,1,BAO_0000218,,,,N,,Lung,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 3.10-3.77,10116.0,Intermediate,,,11042,2048.0,CHEMBL625330,1,BAO_0000218,,,,N,,Lung,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.4-0.54,10116.0,Intermediate,,,11043,2048.0,CHEMBL627774,1,BAO_0000218,,,,N,,Lung,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.58-0.86,10116.0,Intermediate,,,11044,2048.0,CHEMBL627775,1,BAO_0000218,,,,N,,Lung,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.77-0.86,10116.0,Intermediate,,,11045,2048.0,CHEMBL627949,1,BAO_0000218,,,,N,,Lung,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.86-1.13,10116.0,Intermediate,,,11046,2048.0,CHEMBL627950,1,BAO_0000218,,,,N,,Lung,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 2.26-2.89,10116.0,Intermediate,,,11047,2048.0,CHEMBL627951,1,BAO_0000218,,,,N,,Lung,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.7,10116.0,Intermediate,,,11048,2048.0,CHEMBL627952,1,BAO_0000218,,,,N,,Lung,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.6-0.66,10116.0,Intermediate,,,11049,2048.0,CHEMBL627953,1,BAO_0000218,,,,N,,Lung,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.35-1.74,10116.0,Intermediate,,,11050,2048.0,CHEMBL627954,1,BAO_0000218,,,,N,,Lung,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.62-7.08,10116.0,Intermediate,,,11051,2048.0,CHEMBL627955,1,BAO_0000218,,,,N,,Lung,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.47-0.56,10116.0,Intermediate,,,11052,2048.0,CHEMBL627956,1,BAO_0000218,,,,N,,Lung,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.54-1.07,10116.0,Intermediate,,,11053,2048.0,CHEMBL876802,1,BAO_0000218,,,,N,,Lung,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.76-0.91,10116.0,Intermediate,,,11054,2048.0,CHEMBL627957,1,BAO_0000218,,,,N,,Lung,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.61-0.86,10116.0,Intermediate,,,11055,2048.0,CHEMBL627958,1,BAO_0000218,,,,N,,Lung,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 2.11-3.79,10116.0,Intermediate,,,11056,2048.0,CHEMBL627959,1,BAO_0000218,,,,N,,Lung,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.3-0.36,10116.0,Intermediate,,,11057,2048.0,CHEMBL627960,1,BAO_0000218,,,,N,,Lung,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.36-0.44,10116.0,Intermediate,,,11058,2048.0,CHEMBL627961,1,BAO_0000218,,,,N,,Lung,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.5-0.65,10116.0,Intermediate,,,11059,2048.0,CHEMBL627962,1,BAO_0000218,,,,N,,Lung,8418,Rattus norvegicus,50597,A,,1
,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,10116.0,Intermediate,,,11060,,CHEMBL627963,1,BAO_0000218,,,,N,,,9796,Rattus norvegicus,50597,A,,1
,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,10116.0,Intermediate,,,11061,,CHEMBL624759,1,BAO_0000218,,,,N,,,9796,Rattus norvegicus,50597,A,,1
,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,10116.0,Intermediate,,,11062,,CHEMBL624760,1,BAO_0000218,,,,N,,,9796,Rattus norvegicus,50597,A,,1
,Distribution of radiolabeled compound in intestinal contents of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,10116.0,Intermediate,,,11063,,CHEMBL624761,1,BAO_0000218,,,,N,,,9796,Rattus norvegicus,50597,A,,1
,Distribution of radiolabeled compound in intestinal contents of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,10116.0,Intermediate,,,11064,,CHEMBL877607,1,BAO_0000218,,,,N,,,9796,Rattus norvegicus,50597,A,,1
,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,10116.0,Intermediate,,,11065,2107.0,CHEMBL624762,1,BAO_0000218,,,,N,,Liver,9796,Rattus norvegicus,50597,A,,1
,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,10116.0,Intermediate,,,11066,2107.0,CHEMBL624763,1,BAO_0000218,,,,N,,Liver,9796,Rattus norvegicus,50597,A,,1
,Distribution of radiolabeled compound in liver of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,10116.0,Intermediate,,,11067,2107.0,CHEMBL624764,1,BAO_0000218,,,,N,,Liver,9796,Rattus norvegicus,50597,A,,1
,Distribution of radiolabeled compound in liver of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,10116.0,Intermediate,,,11068,2107.0,CHEMBL624765,1,BAO_0000218,,,,N,,Liver,9796,Rattus norvegicus,50597,A,,1
,Distribution of radiolabeled compound in liver of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,10116.0,Intermediate,,,11069,2107.0,CHEMBL624766,1,BAO_0000218,,,,N,,Liver,9796,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),9615.0,Intermediate,,,11070,,CHEMBL624767,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration,9615.0,Intermediate,,,11071,,CHEMBL624768,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),9615.0,Intermediate,,,11072,,CHEMBL624769,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),9615.0,Intermediate,,,11073,,CHEMBL624770,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),9615.0,Intermediate,,,11074,,CHEMBL624771,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),9615.0,Intermediate,,,11075,,CHEMBL624772,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration,10116.0,Intermediate,,,11076,,CHEMBL624773,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),10116.0,Intermediate,,,11077,,CHEMBL624774,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),10116.0,Intermediate,,,11078,,CHEMBL624775,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),10116.0,Intermediate,,,11079,,CHEMBL624776,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),10116.0,Intermediate,,,11080,,CHEMBL624777,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),10116.0,Intermediate,,,11081,,CHEMBL624778,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration,10116.0,Intermediate,,,11082,,CHEMBL624779,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),10116.0,Intermediate,,,11083,,CHEMBL624780,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),10116.0,Intermediate,,,11084,,CHEMBL624781,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),10116.0,Intermediate,,,11085,,CHEMBL877608,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),10116.0,Intermediate,,,11086,,CHEMBL624782,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),10116.0,Intermediate,,,11087,,CHEMBL624783,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration,10116.0,Intermediate,,,11088,,CHEMBL624784,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),10116.0,Intermediate,,,11089,,CHEMBL624785,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),10116.0,Intermediate,,,11090,,CHEMBL624786,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),10116.0,Intermediate,,,11091,,CHEMBL624787,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),10116.0,Intermediate,,,11092,,CHEMBL628676,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration,10116.0,Intermediate,,,11093,,CHEMBL621842,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),10116.0,Intermediate,,,11094,,CHEMBL621843,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),10116.0,Intermediate,,,11095,,CHEMBL623873,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),10116.0,Intermediate,,,11096,,CHEMBL623874,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),10116.0,Intermediate,,,11097,,CHEMBL623875,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),10116.0,Intermediate,,,11098,,CHEMBL623876,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.312 mg/kg after ip administration,9615.0,Intermediate,,,11099,,CHEMBL623877,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),9615.0,Intermediate,,,11100,,CHEMBL623878,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.625 mg/kg after ip administration,9615.0,Intermediate,,,11101,,CHEMBL623879,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),9615.0,Intermediate,,,11102,,CHEMBL623880,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),9615.0,Intermediate,,,11103,,CHEMBL623881,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),9615.0,Intermediate,,,11104,,CHEMBL623957,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),9615.0,Intermediate,,,11105,,CHEMBL623958,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),9615.0,Intermediate,,,11106,,CHEMBL623959,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),9615.0,Intermediate,,,11107,,CHEMBL623960,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),9615.0,Intermediate,,,11108,,CHEMBL623961,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),9615.0,Intermediate,,,11109,,CHEMBL623962,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),9615.0,Intermediate,,,11110,,CHEMBL624676,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),9615.0,Intermediate,,,11111,,CHEMBL624677,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration,9615.0,Intermediate,,,11112,,CHEMBL624678,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),9615.0,Intermediate,,,11113,,CHEMBL624679,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),9615.0,Intermediate,,,11114,,CHEMBL624680,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 27%,,Autocuration,,,11115,,CHEMBL624849,1,BAO_0000218,,In vivo,,U,,,11732,,22224,A,,0
,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 4%,,Autocuration,,,11116,,CHEMBL624850,1,BAO_0000218,,In vivo,,U,,,11732,,22224,A,,0
,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 54%,,Autocuration,,,11117,,CHEMBL874399,1,BAO_0000218,,In vivo,,U,,,11732,,22224,A,,0
,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 72%,,Autocuration,,,11118,,CHEMBL624851,1,BAO_0000218,,In vivo,,U,,,11732,,22224,A,,0
,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 76%,,Autocuration,,,11119,,CHEMBL624852,1,BAO_0000218,,In vivo,,U,,,11732,,22224,A,,0
,Oral bioavailability in rat (dose 10 mg/kg),10116.0,Autocuration,,,11120,,CHEMBL624853,1,BAO_0000218,,In vivo,,U,,,13359,Rattus norvegicus,22224,A,,0
,Oral bioavailability in rat (Sprague-Dawley),10116.0,Autocuration,,,11121,,CHEMBL624854,1,BAO_0000218,,In vivo,,U,,,16618,Rattus norvegicus,22224,A,,0
,Oral bioavailability in rat,10116.0,Autocuration,,,11122,,CHEMBL624855,1,BAO_0000218,,In vivo,,U,,,13960,Rattus norvegicus,22224,A,,0
,Oral bioavailability in rats was determined in vivo,10116.0,Autocuration,,,11123,,CHEMBL624856,1,BAO_0000218,,In vivo,,U,,,13917,Rattus norvegicus,22224,A,,0
,Oral bioavailability in dog,9615.0,Autocuration,,,11124,,CHEMBL882957,1,BAO_0000218,,In vivo,,U,,,14266,Canis lupus familiaris,22224,A,,0
,Oral bioavailability of compound in monkey,314293.0,Autocuration,,,11125,,CHEMBL624857,1,BAO_0000218,,In vivo,,U,,,12359,Simiiformes,22224,A,,0
,Oral bioavailability of compound in rat,10116.0,Intermediate,,,11126,,CHEMBL622202,1,BAO_0000218,,In vivo,,N,,,12359,Rattus norvegicus,50597,A,,1
,Bioavailability in rat of PMEA prodrug,10116.0,Autocuration,,,11127,,CHEMBL622203,1,BAO_0000218,,In vivo,,U,,,12359,Rattus norvegicus,22224,A,,0
,Oral bioavailability of compound was evaluated relative to that of PMEA in rat; Not determined due to lack of solubility,10116.0,Intermediate,,,11128,,CHEMBL625522,1,BAO_0000218,,In vivo,,N,,,12359,Rattus norvegicus,50597,A,,1
,Serum conc at 3 hours following 25 mg/kg dose,9544.0,Autocuration,,,11129,,CHEMBL622868,1,BAO_0000218,,In vivo,,U,,,10791,Macaca mulatta,22224,A,,0
,Urine conc 0-5 hours following 25 mg/kg dose,9544.0,Autocuration,,,11130,1088.0,CHEMBL622869,1,BAO_0000218,,In vivo,,U,,Urine,10791,Macaca mulatta,22224,A,,0
,Urine conc 0-24 hours following 25 mg/kg dose,9544.0,Autocuration,,,11131,1088.0,CHEMBL622870,1,BAO_0000218,,In vivo,,U,,Urine,10791,Macaca mulatta,22224,A,,0
,Oral bioavailability in African green monkeys; 20-25,9534.0,Autocuration,,,11132,,CHEMBL622871,1,BAO_0000218,,In vivo,,U,,,138,Chlorocebus aethiops,22224,A,,0
,Oral bioavailability in cynomolgus monkey.,9541.0,Intermediate,,,11133,,CHEMBL620560,1,BAO_0000218,,In vivo,,N,,,14521,Macaca fascicularis,100710,A,,1
,Oral bioavailability in dog,9615.0,Autocuration,,,11134,,CHEMBL620561,1,BAO_0000218,,In vivo,,U,,,13953,Canis lupus familiaris,22224,A,,0
,Oral bioavailability in dog at 10 mg/kg oral dose,9615.0,Intermediate,,,11135,,CHEMBL620562,1,BAO_0000218,,In vivo,,N,,,12836,Canis lupus familiaris,50588,A,,1
,Oral bioavailability in hamster at 10 mg/kg oral dose,10026.0,Intermediate,,,11136,,CHEMBL620563,1,BAO_0000218,,In vivo,,N,,,12836,Cricetinae,100712,A,,1
,Oral bioavailability in rat at 10 mg/kg oral dose,10116.0,Intermediate,,,11137,,CHEMBL620564,1,BAO_0000218,,In vivo,,N,,,12836,Rattus norvegicus,50597,A,,1
,Oral bioavailability in rat,10116.0,Autocuration,,,11138,,CHEMBL872265,1,BAO_0000218,,In vivo,,U,,,14521,Rattus norvegicus,22224,A,,0
,Oral bioavailability in rat,10116.0,Autocuration,,,11139,,CHEMBL620565,1,BAO_0000218,,In vivo,,U,,,13953,Rattus norvegicus,22224,A,,0
,Oral bioavailability,9347.0,Autocuration,,,11140,,CHEMBL620566,1,BAO_0000218,,In vivo,,U,,,6799,Eutheria,22224,A,,0
,Oral bioavailability was determined; range 49-102%,,Autocuration,,,11141,,CHEMBL620567,1,BAO_0000218,,In vivo,,U,,,11311,,22224,A,,0
,Oral bioavailability was determined in dogs,9615.0,Intermediate,,,11142,,CHEMBL620568,1,BAO_0000218,,In vivo,,N,,,4013,Canis lupus familiaris,50588,A,,1
,Oral bioavailability in rat,10116.0,Autocuration,,,11143,,CHEMBL620569,1,BAO_0000218,,In vivo,,U,,,4013,Rattus norvegicus,22224,A,,0
,Oral bioavailability,9347.0,Autocuration,,,11144,,CHEMBL620570,1,BAO_0000218,,In vivo,,U,,,17591,Eutheria,22224,A,,0
,Oral bioavailability was determined; Not orally available,,Autocuration,,,11145,,CHEMBL620571,1,BAO_0000218,,In vivo,,U,,,17591,,22224,A,,0
,Percent bioavailability was administered by using 0.4% Methyl cellulose (MC) as vehicle to nude mice at a dose of 25 mg/kg (micronized sample),10090.0,Intermediate,,,11146,,CHEMBL620572,1,BAO_0000218,,In vivo,,N,,,15011,Mus musculus,50594,A,,1
,Bioavailability in mouse (nude) (dose 0.4% Methylcellulose (MC) as vehicle 25 mg/kg),10090.0,Autocuration,,,11147,,CHEMBL620573,1,BAO_0000218,,In vivo,,U,,,15011,Mus musculus,22224,A,,0
,Bioavailability in mouse (nude) using 20% aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle 25 mg/kg,10090.0,Autocuration,,,11148,,CHEMBL620574,1,BAO_0000218,,In vivo,,U,,,15011,Mus musculus,22224,A,,0
,Oral bioavailability in Rhesus monkey,9544.0,Autocuration,,,11149,,CHEMBL620575,1,BAO_0000218,,In vivo,,U,,,9552,Macaca mulatta,22224,A,,0
,Oral bioavailability in dog (female mongrel),9615.0,Autocuration,,,11150,,CHEMBL620576,1,BAO_0000218,,In vivo,,U,,,9552,Canis lupus familiaris,22224,A,,0
,Percent oral bioavailability of perorally administered compound (30 mg/kg) was tested,,Autocuration,,,11151,,CHEMBL875846,1,BAO_0000218,,In vivo,,U,,,3639,,22224,A,,0
,Oral bioavailability in dog,9615.0,Autocuration,,,11152,,CHEMBL620577,1,BAO_0000218,,In vivo,,U,,,13397,Canis lupus familiaris,22224,A,,0
,Percentage Bioavailability was evaluated.,,Autocuration,,,11153,,CHEMBL620578,1,BAO_0000218,,In vivo,,U,,,3031,,22224,A,,0
,Bioavailability in rat administered i.d.,10116.0,Autocuration,,,11154,,CHEMBL620579,1,BAO_0000218,,In vivo,,U,,,12818,Rattus norvegicus,22224,A,,0
,Bioavailability,9347.0,Autocuration,,,11155,,CHEMBL621248,1,BAO_0000218,,In vivo,,U,,,4847,Eutheria,22224,A,,0
,Bioavailability in dog (male Beagle) i.v. administration,9615.0,Autocuration,,,11156,,CHEMBL625390,1,BAO_0000218,,In vivo,,U,,,12421,Canis lupus familiaris,22224,A,,0
,"Bioavailability in rat (dose 20 mg/kg p.o. in 1% methocel, and 5 mg/kg i.v. in PEG400)",10116.0,Autocuration,,,11157,,CHEMBL625391,1,BAO_0000218,,In vivo,,U,,,11966,Rattus norvegicus,22224,A,,0
,Bioavailability in monkey (dose 10 mg/kg i.d. or 0.3 mg/kg i.v.),9443.0,Autocuration,,,11158,,CHEMBL872266,1,BAO_0000218,,In vivo,,U,,,11218,Primates,22224,A,,0
,Oral bioavailability in rat (Sprague-Dawley) (male),10116.0,Autocuration,,,11159,,CHEMBL625392,1,BAO_0000218,,In vivo,,U,,,13129,Rattus norvegicus,22224,A,,0
,The oral bioavailability was measured on rats after oral administration,10116.0,Intermediate,,,11160,,CHEMBL625393,1,BAO_0000218,,In vivo,,N,,,12350,Rattus norvegicus,50597,A,,1
,Bioavailability was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,10116.0,Intermediate,,,11161,,CHEMBL625394,1,BAO_0000218,,In vivo,,N,,,2231,Rattus norvegicus,50597,A,,1
,Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,9544.0,Intermediate,,,11162,,CHEMBL625395,1,BAO_0000218,,In vivo,,N,,,2231,Macaca mulatta,50797,A,,1
,Bioavailability in rat (dose 10 mg/kg i.d.),10116.0,Autocuration,,,11163,,CHEMBL625396,1,BAO_0000218,,In vivo,,U,,,12187,Rattus norvegicus,22224,A,,0
,Bioavailability in dog (male Beagle) i.v. administration,9615.0,Autocuration,,,11164,,CHEMBL625397,1,BAO_0000218,,In vivo,,U,,,12421,Canis lupus familiaris,22224,A,,0
,Biodistribution in CD-1 mice was determined after 1 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),10090.0,Intermediate,,,11165,,CHEMBL625398,1,BAO_0000218,,In vivo,,N,,,13256,Mus musculus,50594,A,,1
,Biodistribution in CD-1 mice was determined after 1 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),10090.0,Intermediate,,,11166,178.0,CHEMBL625399,1,BAO_0000218,,In vivo,,N,,Blood,13256,Mus musculus,50594,A,,1
,Biodistribution in CD-1 mice was determined after 1 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),10090.0,Intermediate,,,11167,2037.0,CHEMBL626074,1,BAO_0000218,,In vivo,,N,,Cerebellum,13256,Mus musculus,50594,A,,1
,Biodistribution in CD-1 mice was determined after 1 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),10090.0,Intermediate,,,11168,,CHEMBL626075,1,BAO_0000218,,In vivo,,N,,,13256,Mus musculus,50594,A,,1
,Maximum concentration in plasma (Cmax) was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,10116.0,Intermediate,,,11169,1969.0,CHEMBL626076,1,BAO_0000218,,In vivo,,N,,Plasma,2231,Rattus norvegicus,50597,A,,1
,Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,9544.0,Intermediate,,,11170,1969.0,CHEMBL626077,1,BAO_0000218,,In vivo,,N,,Plasma,2231,Macaca mulatta,50797,A,,1
,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 1 mg/kg in rat (normalized to a 1 mg/kg dose),10116.0,Intermediate,,,11171,178.0,CHEMBL626078,1,BAO_0000218,,In vivo,,N,,Blood,12178,Rattus norvegicus,50597,A,,1
,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 2.5 mg/kg in rat (normalized to a 1 mg/kg dose),,Autocuration,,,11172,178.0,CHEMBL625846,1,BAO_0000218,,In vivo,,U,,Blood,12178,,22224,A,,0
,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 5.0 mg/kg GP (normalized to a 1 mg/kg dose),,Autocuration,,,11173,178.0,CHEMBL625847,1,BAO_0000218,,In vivo,,U,,Blood,12178,,22224,A,,0
,Maximum concentration observed in rats at an oral dose of 50 mg/kg,10116.0,Expert,,,11174,,CHEMBL625848,1,BAO_0000218,,In vivo,,N,,,15633,Rattus norvegicus,50597,A,,1
,Maximum concentration of compound in plasma administered orally to rats,10116.0,Intermediate,,,11175,1969.0,CHEMBL625849,1,BAO_0000218,,In vivo,,N,,Plasma,14258,Rattus norvegicus,50597,A,,1
,"Maximum concentration (10 mg/kg, orally) in plasma of dogs",9615.0,Intermediate,,,11176,1969.0,CHEMBL626023,1,BAO_0000218,,In vivo,,N,,Plasma,14224,Canis lupus familiaris,50588,A,,1
,"Maximum concentration (10 mg/kg, perorally) in plasma of dogs",9615.0,Intermediate,,,11177,1969.0,CHEMBL626024,1,BAO_0000218,,In vivo,,N,,Plasma,14224,Canis lupus familiaris,50588,A,,1
,"Maximum concentration (5 mg/kg, intravenously) in plasma of dogs",9615.0,Intermediate,,,11178,1969.0,CHEMBL626025,1,BAO_0000218,,In vivo,,N,,Plasma,14224,Canis lupus familiaris,50588,A,,1
,Maximum concentration after 10 mg/kg by oral administration,,Autocuration,,,11179,,CHEMBL626026,1,BAO_0000218,,In vivo,,U,,,5566,,22224,A,,0
,Maximum concentration at a dose of 1.5 mg/kg,,Autocuration,,,11180,,CHEMBL626027,1,BAO_0000218,,In vivo,,U,,,16935,,22224,A,,0
,Maximum concentration at a dose of 2.0 mg/kg,,Autocuration,,,11181,,CHEMBL626028,1,BAO_0000218,,In vivo,,U,,,16935,,22224,A,,0
,Maximum concentration in dog plasma,9615.0,Intermediate,,,11182,1969.0,CHEMBL626029,1,BAO_0000218,,In vivo,,N,,Plasma,14224,Canis lupus familiaris,50588,A,,1
,Maximum concentration in plasma after administration of 10 umol/kg dose perorally,,Autocuration,,,11183,1969.0,CHEMBL626030,1,BAO_0000218,,In vivo,,U,,Plasma,12536,,22224,A,,0
,Maximum concentration in plasma after administration of 2 umol/kg dose intravenously,,Autocuration,,,11184,1969.0,CHEMBL626031,1,BAO_0000218,,In vivo,,U,,Plasma,12536,,22224,A,,0
,Maximum concentration in plasma after administration of 4 umol/kg dose intravenously,,Autocuration,,,11185,1969.0,CHEMBL626032,1,BAO_0000218,,In vivo,,U,,Plasma,12536,,22224,A,,0
,Maximum concentration in plasma after administration of 40 umol/kg dose perorally,,Autocuration,,,11186,1969.0,CHEMBL626033,1,BAO_0000218,,In vivo,,U,,Plasma,12536,,22224,A,,0
,Maximum concentration in plasma after administration of 5 umol/kg dose intravenously,,Autocuration,,,11187,1969.0,CHEMBL626034,1,BAO_0000218,,In vivo,,U,,Plasma,12536,,22224,A,,0
,Maximum concentration in plasma after oral administration in dog (25 mg/kg),9615.0,Intermediate,,,11188,1969.0,CHEMBL626035,1,BAO_0000218,,In vivo,,N,,Plasma,9994,Canis lupus familiaris,50588,A,,1
,Maximum concentration in plasma at Tmax,,Autocuration,,,11189,1969.0,CHEMBL626036,1,BAO_0000218,,In vivo,,U,,Plasma,1434,,22224,A,,0
,Maximum concentration in plasma recorded 0-6 hr post dose in dog at 10 mg/kg oral dose,9615.0,Expert,,,11190,1969.0,CHEMBL626037,1,BAO_0000218,,In vivo,,N,,Plasma,12836,Canis lupus familiaris,50588,A,,1
,Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose,10026.0,Intermediate,,,11191,1969.0,CHEMBL626038,1,BAO_0000218,,In vivo,,N,,Plasma,12836,Cricetinae,100712,A,,1
,Maximum concentration in plasma recorded in the period 0-6 hr post dose in rat at 10 mg/kg oral dose,10116.0,Intermediate,,,11192,1969.0,CHEMBL626039,1,BAO_0000218,,In vivo,,N,,Plasma,12836,Rattus norvegicus,50597,A,,1
,Maximum concentration in plasma was determined by oral administration to rats at 20 mg/kg,10116.0,Intermediate,,,11193,1969.0,CHEMBL626040,1,BAO_0000218,,In vivo,,N,,Plasma,12545,Rattus norvegicus,50597,A,,1
,Maximum concentration present in the rabbit plasma following peroral administration of 10 mg/kg,9986.0,Intermediate,,,11194,1969.0,CHEMBL626041,1,BAO_0000218,,In vivo,,N,,Plasma,13856,Oryctolagus cuniculus,50592,A,,1
,Maximum concentration was calculated,,Autocuration,,,11195,,CHEMBL626042,1,BAO_0000218,,In vivo,,U,,,3550,,22224,A,,0
,Maximum concentration was calculated.,,Autocuration,,,11196,,CHEMBL626043,1,BAO_0000218,,In vivo,,U,,,2632,,22224,A,,0
,Maximum concentration at a peroral dose of 10 mg/kg,,Autocuration,,,11197,,CHEMBL626044,1,BAO_0000218,,In vivo,,U,,,5566,,22224,A,,0
,Maximum concentration of the drug at 10 uM/dg administered perorally,,Autocuration,,,11198,,CHEMBL626045,1,BAO_0000218,,In vivo,,U,,,11883,,22224,A,,0
,Maximum concentration of the drug at 2 uM/dg administered intravenously,,Autocuration,,,11199,,CHEMBL626046,1,BAO_0000218,,In vivo,,U,,,11883,,22224,A,,0
,"Maximum concentration of the unchanged compound in dog plasma, recorded in the period 0-6 hr post dose.",9615.0,Intermediate,,,11200,1969.0,CHEMBL626047,1,BAO_0000218,,In vivo,,N,,Plasma,14122,Canis lupus familiaris,50588,A,,1
,"Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose.",10026.0,Intermediate,,,11201,1969.0,CHEMBL626048,1,BAO_0000218,,In vivo,,N,,Plasma,14122,Cricetinae,100712,A,,1
,"Maximum concentration of the unchanged compound in rat plasma, recorded in the period 0-6 hr post dose.",10116.0,Intermediate,,,11202,1969.0,CHEMBL626049,1,BAO_0000218,,In vivo,,N,,Plasma,14122,Rattus norvegicus,50597,A,,1
,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 60 mg/kg oral dose,10116.0,Intermediate,,,11203,1969.0,CHEMBL626050,1,BAO_0000218,,In vivo,,N,,Plasma,12542,Rattus norvegicus,50597,A,,1
,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in dog at 5 mg/kg oral dose,9615.0,Intermediate,,,11204,1969.0,CHEMBL874541,1,BAO_0000218,,In vivo,,N,,Plasma,12542,Canis lupus familiaris,50588,A,,1
,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose,10026.0,Intermediate,,,11205,1969.0,CHEMBL622826,1,BAO_0000218,,In vivo,,N,,Plasma,12542,Cricetinae,100712,A,,1
,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose,10026.0,Intermediate,,,11206,1969.0,CHEMBL622827,1,BAO_0000218,,In vivo,,N,,Plasma,12542,Cricetinae,100712,A,,1
,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 25 mg/kg oral dose,10116.0,Intermediate,,,11207,1969.0,CHEMBL622828,1,BAO_0000218,,In vivo,,N,,Plasma,12542,Rattus norvegicus,50597,A,,1
,Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing,10116.0,Intermediate,,,11208,1969.0,CHEMBL622829,1,BAO_0000218,,In vivo,,N,,Plasma,14080,Rattus norvegicus,50597,A,,1
,Maximum concentration reached following intravenous administration in male rat,10116.0,Intermediate,,,11209,,CHEMBL876806,1,BAO_0000218,,In vivo,,N,,,11911,Rattus norvegicus,50597,A,,1
,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 10 mg/kg dosage administered perorally in dog,9615.0,Intermediate,,,11210,,CHEMBL622830,1,BAO_0000218,,In vivo,,N,,,13204,Canis lupus familiaris,50588,A,,1
,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 5 mg/kg dosage administered perorally in rats,10116.0,Intermediate,,,11211,,CHEMBL622831,1,BAO_0000218,,In vivo,,N,,,13204,Rattus norvegicus,50597,A,,1
,Maximum concentration was measured after peroral administration of 10 mg/kg of drug in male Beagle dogs,9615.0,Intermediate,,,11212,,CHEMBL626794,1,BAO_0000218,,In vivo,,N,,,14346,Canis lupus familiaris,50588,A,,1
,Maximum concentration was measured after peroral administration of 5.0 mg/kg of drug in male Dawley rats,10116.0,Intermediate,,,11213,,CHEMBL626795,1,BAO_0000218,,In vivo,,N,,,14346,Rattus norvegicus,50597,A,,1
,Maximum concentration was measured after peroral administration of 5.1 mg/kg of drug in male Dawley rats,10116.0,Intermediate,,,11214,,CHEMBL626796,1,BAO_0000218,,In vivo,,N,,,14346,Rattus norvegicus,50597,A,,1
,Maximum concentration was measured after peroral administration of 5.2 mg/kg of drug in male Dawley rats,10116.0,Intermediate,,,11215,,CHEMBL626797,1,BAO_0000218,,In vivo,,N,,,14346,Rattus norvegicus,50597,A,,1
,Maximum drug concentration is determined after oral dosing in rats.,10116.0,Intermediate,,,11216,,CHEMBL626798,1,BAO_0000218,,In vivo,,N,,,14127,Rattus norvegicus,50597,A,,1
,Maximum observed concentration in oral (5 mg/kg) fasted dogs,9615.0,Intermediate,,,11217,,CHEMBL626799,1,BAO_0000218,,In vivo,,N,,,14339,Canis lupus familiaris,50588,A,,1
,Maximum observed concentration in oral (5 mg/kg) fed dogs,9615.0,Intermediate,,,11218,,CHEMBL626800,1,BAO_0000218,,In vivo,,N,,,14339,Canis lupus familiaris,50588,A,,1
,Maximum plasma concentration,,Autocuration,,,11219,1969.0,CHEMBL626801,1,BAO_0000218,,In vivo,,U,,Plasma,13494,,22224,A,,0
,Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug,10116.0,Intermediate,,,11220,1969.0,CHEMBL876816,1,BAO_0000218,,In vivo,,N,,Plasma,14925,Rattus norvegicus,50597,A,,1
,Maximum plasma concentration following oral administration of 26.3 mg/kg in rats,10116.0,Intermediate,,,11221,1969.0,CHEMBL626802,1,BAO_0000218,,In vivo,,N,,Plasma,14474,Rattus norvegicus,50597,A,,1
,Maximum plasma concentration following oral administration of 3.8 mg/kg in Beagle dog,9615.0,Intermediate,,,11222,1969.0,CHEMBL626803,1,BAO_0000218,,In vivo,,N,,Plasma,14474,Canis lupus familiaris,50588,A,,1
,Maximum plasma concentration following oral administration of 30 umol/kg,,Autocuration,,,11223,1969.0,CHEMBL626804,1,BAO_0000218,,In vivo,,U,,Plasma,13917,,22224,A,,0
,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose,10116.0,Intermediate,,,11224,1969.0,CHEMBL626805,1,BAO_0000218,,,,N,,Plasma,9796,Rattus norvegicus,50597,A,,1
,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,10116.0,Intermediate,,,11225,1969.0,CHEMBL626309,1,BAO_0000218,,,,N,,Plasma,9796,Rattus norvegicus,50597,A,,1
,Distribution of radiolabeled compound in plasma of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,10116.0,Intermediate,,,11226,1969.0,CHEMBL626310,1,BAO_0000218,,,,N,,Plasma,9796,Rattus norvegicus,50597,A,,1
,Distribution of radiolabeled compound in plasma of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,10116.0,Intermediate,,,11227,1969.0,CHEMBL626311,1,BAO_0000218,,,,N,,Plasma,9796,Rattus norvegicus,50597,A,,1
,Distribution of radiolabeled compound in plasma of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,10116.0,Intermediate,,,11228,1969.0,CHEMBL626312,1,BAO_0000218,,,,N,,Plasma,9796,Rattus norvegicus,50597,A,,1
,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,10116.0,Intermediate,,,11229,995.0,CHEMBL626313,1,BAO_0000218,,,,N,,Uterus,9796,Rattus norvegicus,50597,A,,1
,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,10116.0,Intermediate,,,11230,995.0,CHEMBL626314,1,BAO_0000218,,,,N,,Uterus,9796,Rattus norvegicus,50597,A,,1
,Distribution of radiolabeled compound in uterus of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,10116.0,Intermediate,,,11231,995.0,CHEMBL626315,1,BAO_0000218,,,,N,,Uterus,9796,Rattus norvegicus,50597,A,,1
,Distribution of radiolabeled compound in uterus of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,10116.0,Intermediate,,,11232,995.0,CHEMBL626316,1,BAO_0000218,,,,N,,Uterus,9796,Rattus norvegicus,50597,A,,1
,Distribution of radiolabeled compound in uterus of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,10116.0,Intermediate,,,11233,995.0,CHEMBL626317,1,BAO_0000218,,,,N,,Uterus,9796,Rattus norvegicus,50597,A,,1
,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Minus (-),10116.0,Intermediate,,,11234,,CHEMBL626318,1,BAO_0000218,,,,N,,,8363,Rattus norvegicus,50597,A,,1
,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Plus (+),10116.0,Intermediate,,,11235,,CHEMBL626319,1,BAO_0000218,,,,N,,,8363,Rattus norvegicus,50597,A,,1
,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Minus (-),10116.0,Intermediate,,,11236,,CHEMBL626320,1,BAO_0000218,,,,N,,,8363,Rattus norvegicus,50597,A,,1
,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Plus (+),10116.0,Intermediate,,,11237,,CHEMBL875053,1,BAO_0000218,,,,N,,,8363,Rattus norvegicus,50597,A,,1
,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Minus (-),10116.0,Intermediate,,,11238,,CHEMBL626321,1,BAO_0000218,,,,N,,,8363,Rattus norvegicus,50597,A,,1
,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Plus (+),10116.0,Intermediate,,,11239,,CHEMBL626322,1,BAO_0000218,,,,N,,,8363,Rattus norvegicus,50597,A,,1
,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Minus (-),10116.0,Intermediate,,,11240,,CHEMBL626323,1,BAO_0000218,,,,N,,,8363,Rattus norvegicus,50597,A,,1
,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Plus (+),10116.0,Intermediate,,,11241,,CHEMBL626324,1,BAO_0000218,,,,N,,,8363,Rattus norvegicus,50597,A,,1
,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Minus (-),10116.0,Intermediate,,,11242,,CHEMBL626325,1,BAO_0000218,,,,N,,,8363,Rattus norvegicus,50597,A,,1
,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Plus (+),10116.0,Intermediate,,,11243,,CHEMBL626326,1,BAO_0000218,,,,N,,,8363,Rattus norvegicus,50597,A,,1
,Distribution of rat erythrocytes for tube 7 on rate of aging in 2 mL of cell suspension; Plus (+),10116.0,Intermediate,,,11244,,CHEMBL626327,1,BAO_0000218,,,,N,,,8363,Rattus norvegicus,50597,A,,1
,Distribution of rat erythrocytes for tube 1 on rate of aging in 2 mL of cell suspension; Minus (-),10116.0,Intermediate,,,11245,,CHEMBL626328,1,BAO_0000218,,,,N,,,8363,Rattus norvegicus,50597,A,,1
,"Distribution in blood of rat 5 min after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11246,178.0,CHEMBL626329,1,BAO_0000218,,,,N,,Blood,8684,Rattus norvegicus,50597,A,,1
,"Distribution in blood of rat, 15 min after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11247,178.0,CHEMBL626330,1,BAO_0000218,,,,N,,Blood,8684,Rattus norvegicus,50597,A,,1
,"Distribution in blood of rat, 1 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11248,178.0,CHEMBL626331,1,BAO_0000218,,,,N,,Blood,8684,Rattus norvegicus,50597,A,,1
,"Distribution in blood of rat, 2 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11249,178.0,CHEMBL626332,1,BAO_0000218,,,,N,,Blood,8684,Rattus norvegicus,50597,A,,1
,"Distribution in blood of rat, 30 min after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11250,178.0,CHEMBL626333,1,BAO_0000218,,,,N,,Blood,8684,Rattus norvegicus,50597,A,,1
,"Distribution in blood of rat, 4 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11251,178.0,CHEMBL626334,1,BAO_0000218,,,,N,,Blood,8684,Rattus norvegicus,50597,A,,1
,"Distribution in blood of rat, 6 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11252,178.0,CHEMBL626335,1,BAO_0000218,,,,N,,Blood,8684,Rattus norvegicus,50597,A,,1
,"Distribution in blood of rat, 8 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11253,178.0,CHEMBL624798,1,BAO_0000218,,,,N,,Blood,8684,Rattus norvegicus,50597,A,,1
,"Distribution in brain of rat, 15 min after intravenous administered, injected dose/gm",10116.0,Intermediate,,,11254,955.0,CHEMBL624799,1,BAO_0000218,,,,N,,Brain,8684,Rattus norvegicus,50597,A,,1
,"Distribution in brain of rat, 1 hr after intravenous administered, injected dose/gm",10116.0,Intermediate,,,11255,955.0,CHEMBL624800,1,BAO_0000218,,,,N,,Brain,8684,Rattus norvegicus,50597,A,,1
,"Distribution in brain of rat, 2 hr after intravenous administered, injected dose/gm",10116.0,Intermediate,,,11256,955.0,CHEMBL624801,1,BAO_0000218,,,,N,,Brain,8684,Rattus norvegicus,50597,A,,1
,"Distribution in brain of rat, 30 min after intravenous administered, injected dose/gm",10116.0,Intermediate,,,11257,955.0,CHEMBL624802,1,BAO_0000218,,,,N,,Brain,8684,Rattus norvegicus,50597,A,,1
,"Distribution in brain of rat, 4 hr after intravenous administered, injected dose/gm",10116.0,Intermediate,,,11258,955.0,CHEMBL624803,1,BAO_0000218,,,,N,,Brain,8684,Rattus norvegicus,50597,A,,1
,"Distribution in brain of rat, 5 min after intravenous administered, injected dose/gm",10116.0,Intermediate,,,11259,955.0,CHEMBL624804,1,BAO_0000218,,,,N,,Brain,8684,Rattus norvegicus,50597,A,,1
,"Distribution in brain of rat, 6 hr after intravenous administered, injected dose/gm",10116.0,Intermediate,,,11260,955.0,CHEMBL624805,1,BAO_0000218,,,,N,,Brain,8684,Rattus norvegicus,50597,A,,1
,"Distribution in brain of rat, 8 hr after intravenous administered, injected dose/gm",10116.0,Intermediate,,,11261,955.0,CHEMBL624806,1,BAO_0000218,,,,N,,Brain,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat fat 15 min after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11262,,CHEMBL624807,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat fat 1 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11263,,CHEMBL624808,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat fat 2 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11264,,CHEMBL624809,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat fat 30 min after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11265,,CHEMBL624810,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat fat 4 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11266,,CHEMBL877618,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat fat 5 min after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11267,,CHEMBL624811,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat fat 6 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11268,,CHEMBL624812,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat fat 8 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11269,,CHEMBL624813,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat heart 15 min after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11270,,CHEMBL624814,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat heart 1 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11271,,CHEMBL624815,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat heart 2 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11272,,CHEMBL624816,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat heart 30 min after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11273,,CHEMBL624817,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),9615.0,Intermediate,,,11274,,CHEMBL624818,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration,9615.0,Intermediate,,,11275,,CHEMBL624819,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),9615.0,Intermediate,,,11276,,CHEMBL624820,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),9615.0,Intermediate,,,11277,,CHEMBL624821,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),9615.0,Intermediate,,,11278,,CHEMBL624822,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),9615.0,Intermediate,,,11279,,CHEMBL624823,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Observed diffusion coefficient in organic solvent for Escherichia coli,562.0,Intermediate,,,11280,,CHEMBL624824,1,BAO_0000218,,,,N,,,15599,Escherichia coli,50212,A,,1
,"Concentration of compound in blood of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",10116.0,Intermediate,,,11281,178.0,CHEMBL624825,1,BAO_0000218,,,,N,,Blood,9614,Rattus norvegicus,50597,A,,1
,"Concentration of compound in blood of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",10116.0,Intermediate,,,11282,178.0,CHEMBL624826,1,BAO_0000218,,,,N,,Blood,9614,Rattus norvegicus,50597,A,,1
,"Concentration of compound in left atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",10116.0,Intermediate,,,11283,2081.0,CHEMBL876817,1,BAO_0000218,,,,N,,Cardiac atrium,9614,Rattus norvegicus,50597,A,,1
,"Concentration of compound in left atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",10116.0,Intermediate,,,11284,2081.0,CHEMBL624827,1,BAO_0000218,,,,N,,Cardiac atrium,9614,Rattus norvegicus,50597,A,,1
,"Concentration of compound in left ventricle of of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",10116.0,Intermediate,,,11285,,CHEMBL624828,1,BAO_0000218,,,,N,,,9614,Rattus norvegicus,50597,A,,1
,"Concentration of compound in left ventricle of of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",10116.0,Intermediate,,,11286,,CHEMBL624829,1,BAO_0000218,,,,N,,,9614,Rattus norvegicus,50597,A,,1
,"Concentration of compound in liver of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",10116.0,Intermediate,,,11287,2107.0,CHEMBL624830,1,BAO_0000218,,,,N,,Liver,9614,Rattus norvegicus,50597,A,,1
,"Concentration of compound in liver of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",10116.0,Intermediate,,,11288,2107.0,CHEMBL624831,1,BAO_0000218,,,,N,,Liver,9614,Rattus norvegicus,50597,A,,1
,"Concentration of compound in right atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",10116.0,Intermediate,,,11289,2081.0,CHEMBL624832,1,BAO_0000218,,,,N,,Cardiac atrium,9614,Rattus norvegicus,50597,A,,1
,"Concentration of compound in right atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",10116.0,Intermediate,,,11290,2081.0,CHEMBL624833,1,BAO_0000218,,,,N,,Cardiac atrium,9614,Rattus norvegicus,50597,A,,1
,"Concentration of compound in right ventricle of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",10116.0,Intermediate,,,11291,,CHEMBL624834,1,BAO_0000218,,,,N,,,9614,Rattus norvegicus,50597,A,,1
,"Concentration of compound in right ventricle of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",10116.0,Intermediate,,,11292,,CHEMBL624835,1,BAO_0000218,,,,N,,,9614,Rattus norvegicus,50597,A,,1
,"Concentration of compound in spleen of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",10116.0,Intermediate,,,11293,2106.0,CHEMBL624836,1,BAO_0000218,,,,N,,Spleen,9614,Rattus norvegicus,50597,A,,1
,"Concentration of compound in spleen of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",10116.0,Intermediate,,,11294,2106.0,CHEMBL624837,1,BAO_0000218,,,,N,,Spleen,9614,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity of radiolabeled compound in blood of female rats 30 minutes after intravenous administration,10116.0,Intermediate,,,11295,178.0,CHEMBL624838,1,BAO_0000218,,,,N,,Blood,9071,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity of radiolabeled compound in blood of female rats 5 minutes after intravenous administration,10116.0,Intermediate,,,11296,178.0,CHEMBL622188,1,BAO_0000218,,,,N,,Blood,9071,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration,10116.0,Intermediate,,,11297,948.0,CHEMBL622189,1,BAO_0000218,,,,N,,Heart,9071,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration at,10116.0,Intermediate,,,11298,948.0,CHEMBL622190,1,BAO_0000218,,,,N,,Heart,9071,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity of radiolabeled compound in heart of female rats 5 minutes after intravenous administration,10116.0,Intermediate,,,11299,948.0,CHEMBL625170,1,BAO_0000218,,,,N,,Heart,9071,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,10116.0,Intermediate,,,11300,2113.0,CHEMBL625171,1,BAO_0000218,,,,N,,Kidney,9071,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,10116.0,Intermediate,,,11301,2113.0,CHEMBL625172,1,BAO_0000218,,,,N,,Kidney,9071,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity of radiolabeled compound in kidney of female rats 5 minutes after intravenous administration,10116.0,Intermediate,,,11302,2113.0,CHEMBL625173,1,BAO_0000218,,,,N,,Kidney,9071,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity of radiolabeled compound in liver of female rats 30 minutes after intravenous administration,10116.0,Intermediate,,,11303,2107.0,CHEMBL625174,1,BAO_0000218,,,,N,,Liver,9071,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration,10116.0,Intermediate,,,11304,2107.0,CHEMBL625175,1,BAO_0000218,,,,N,,Liver,9071,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration at,10116.0,Intermediate,,,11305,2107.0,CHEMBL625176,1,BAO_0000218,,,,N,,Liver,9071,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,10116.0,Intermediate,,,11306,2048.0,CHEMBL625177,1,BAO_0000218,,,,N,,Lung,9071,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration,10116.0,Intermediate,,,11307,2048.0,CHEMBL625178,1,BAO_0000218,,,,N,,Lung,9071,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration at,10116.0,Intermediate,,,11308,2048.0,CHEMBL625179,1,BAO_0000218,,,,N,,Lung,9071,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,10116.0,Intermediate,,,11309,2048.0,CHEMBL625180,1,BAO_0000218,,,,N,,Lung,9071,Rattus norvegicus,50597,A,,1
,"Original dose appeared in the bile as unchanged compound, which was eliminated at a fairly constant rate over the first 4 hr following the iv administration",,Autocuration,,,11310,,CHEMBL625181,1,BAO_0000218,,,,U,,,10677,,22224,A,,0
,Percentage of dose recovered after 0-6 hr in the urine of mice was measured.,10090.0,Intermediate,,,11311,1088.0,CHEMBL625182,1,BAO_0000218,,,,N,,Urine,9750,Mus musculus,50594,A,,1
,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,10116.0,Intermediate,,,11312,,CHEMBL625183,1,BAO_0000218,,,,N,,,8319,Rattus norvegicus,50597,A,,1
,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,10116.0,Intermediate,,,11313,,CHEMBL875848,1,BAO_0000218,,,,N,,,8319,Rattus norvegicus,50597,A,,1
,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,10116.0,Intermediate,,,11314,,CHEMBL622260,1,BAO_0000218,,,,N,,,8319,Rattus norvegicus,50597,A,,1
,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,10116.0,Intermediate,,,11315,,CHEMBL622261,1,BAO_0000218,,,,N,,,8319,Rattus norvegicus,50597,A,,1
,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,10116.0,Intermediate,,,11316,,CHEMBL622262,1,BAO_0000218,,,,N,,,8319,Rattus norvegicus,50597,A,,1
,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,10116.0,Intermediate,,,11317,2113.0,CHEMBL622263,1,BAO_0000218,,,,N,,Kidney,8319,Rattus norvegicus,50597,A,,1
,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,10116.0,Intermediate,,,11318,2113.0,CHEMBL622418,1,BAO_0000218,,,,N,,Kidney,8319,Rattus norvegicus,50597,A,,1
,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,10116.0,Intermediate,,,11319,2107.0,CHEMBL622419,1,BAO_0000218,,,,N,,Liver,8319,Rattus norvegicus,50597,A,,1
,Biodistribution in CD-1 mice was determined after 1 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),10090.0,Intermediate,,,11320,,CHEMBL623388,1,BAO_0000218,,In vivo,,N,,,13256,Mus musculus,50594,A,,1
,Biodistribution in CD-1 mice was determined after 1 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),10090.0,Intermediate,,,11321,2107.0,CHEMBL623389,1,BAO_0000218,,In vivo,,N,,Liver,13256,Mus musculus,50594,A,,1
,Biodistribution in CD-1 mice was determined after 1 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),10090.0,Intermediate,,,11322,,CHEMBL623390,1,BAO_0000218,,In vivo,,N,,,13256,Mus musculus,50594,A,,1
,Biodistribution in CD-1 mice was determined after 120 minutes in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),10090.0,Intermediate,,,11323,,CHEMBL623391,1,BAO_0000218,,In vivo,,N,,,13256,Mus musculus,50594,A,,1
,Biodistribution in CD-1 mice was determined after 120 minutes in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),10090.0,Intermediate,,,11324,178.0,CHEMBL623392,1,BAO_0000218,,In vivo,,N,,Blood,13256,Mus musculus,50594,A,,1
,Biodistribution in CD-1 mice was determined after 120 minutes in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),10090.0,Intermediate,,,11325,2037.0,CHEMBL623393,1,BAO_0000218,,In vivo,,N,,Cerebellum,13256,Mus musculus,50594,A,,1
,Biodistribution in CD-1 mice was determined after 120 minutes in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),10090.0,Intermediate,,,11326,,CHEMBL623394,1,BAO_0000218,,In vivo,,N,,,13256,Mus musculus,50594,A,,1
,Biodistribution in CD-1 mice was determined after 120 minutes in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),10090.0,Intermediate,,,11327,,CHEMBL618885,1,BAO_0000218,,In vivo,,N,,,13256,Mus musculus,50594,A,,1
,Biodistribution in CD-1 mice was determined after 120 minutes in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),10090.0,Intermediate,,,11328,2107.0,CHEMBL618886,1,BAO_0000218,,In vivo,,N,,Liver,13256,Mus musculus,50594,A,,1
,Biodistribution in CD-1 mice was determined after 120 minutes in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),10090.0,Intermediate,,,11329,,CHEMBL618887,1,BAO_0000218,,In vivo,,N,,,13256,Mus musculus,50594,A,,1
,Biodistribution in CD-1 mice was determined after 30 minutes in Striatum (expressed as percent injected dose per gram normalized to a 25 g mouse),10090.0,Intermediate,,,11330,,CHEMBL619535,1,BAO_0000218,,In vivo,,N,,,13256,Mus musculus,50594,A,,1
,Biodistribution in CD-1 mice was determined after 30 minutes in blood (expressed as percent injected dose per gram normalized to a 25 g mouse),10090.0,Intermediate,,,11331,178.0,CHEMBL619536,1,BAO_0000218,,In vivo,,N,,Blood,13256,Mus musculus,50594,A,,1
,Biodistribution in CD-1 mice was determined after 30 minutes in cerebellum (expressed as percent injected dose per gram normalized to a 25 g mouse),10090.0,Intermediate,,,11332,2037.0,CHEMBL619537,1,BAO_0000218,,In vivo,,N,,Cerebellum,13256,Mus musculus,50594,A,,1
,Biodistribution in CD-1 mice was determined after 30 minutes in cortex (expressed as percent injected dose per gram normalized to a 25 g mouse),10090.0,Intermediate,,,11333,,CHEMBL619705,1,BAO_0000218,,In vivo,,N,,,13256,Mus musculus,50594,A,,1
,Biodistribution in CD-1 mice was determined after 30 minutes in femur (expressed as percent injected dose per gram normalized to a 25 g mouse),10090.0,Intermediate,,,11334,,CHEMBL619706,1,BAO_0000218,,In vivo,,N,,,13256,Mus musculus,50594,A,,1
,Biodistribution in CD-1 mice was determined after 30 minutes in liver (expressed as percent injected dose per gram normalized to a 25 g mouse),10090.0,Intermediate,,,11335,2107.0,CHEMBL619707,1,BAO_0000218,,In vivo,,N,,Liver,13256,Mus musculus,50594,A,,1
,Biodistribution in CD-1 mice was determined after 30 minutes in lung (expressed as percent injected dose per gram normalized to a 25 g mouse),10090.0,Intermediate,,,11336,,CHEMBL619708,1,BAO_0000218,,In vivo,,N,,,13256,Mus musculus,50594,A,,1
,Biodistribution in CD-1 mice was determined after 5 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),10090.0,Intermediate,,,11337,,CHEMBL625219,1,BAO_0000218,,In vivo,,N,,,13256,Mus musculus,50594,A,,1
,Biodistribution in CD-1 mice was determined after 5 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),10090.0,Intermediate,,,11338,178.0,CHEMBL625220,1,BAO_0000218,,In vivo,,N,,Blood,13256,Mus musculus,50594,A,,1
,Biodistribution in CD-1 mice was determined after 5 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),10090.0,Intermediate,,,11339,2037.0,CHEMBL625221,1,BAO_0000218,,In vivo,,N,,Cerebellum,13256,Mus musculus,50594,A,,1
,Biodistribution in CD-1 mice was determined after 5 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),10090.0,Intermediate,,,11340,,CHEMBL625222,1,BAO_0000218,,In vivo,,N,,,13256,Mus musculus,50594,A,,1
,Biodistribution in CD-1 mice was determined after 5 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),10090.0,Intermediate,,,11341,,CHEMBL625223,1,BAO_0000218,,In vivo,,N,,,13256,Mus musculus,50594,A,,1
,Biodistribution in CD-1 mice was determined after 5 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),10090.0,Intermediate,,,11342,2107.0,CHEMBL625224,1,BAO_0000218,,In vivo,,N,,Liver,13256,Mus musculus,50594,A,,1
,Biodistribution in CD-1 mice was determined after 5 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),10090.0,Intermediate,,,11343,,CHEMBL625225,1,BAO_0000218,,In vivo,,N,,,13256,Mus musculus,50594,A,,1
,Biodistribution in Rat blood after 24 hours of iv administration,10116.0,Intermediate,,,11344,178.0,CHEMBL625226,1,BAO_0000218,,In vivo,,N,,Blood,8829,Rattus norvegicus,50597,A,,1
,Biodistribution in Rat blood after 24 hours of iv administration; per g of tissue,10116.0,Intermediate,,,11345,178.0,CHEMBL625227,1,BAO_0000218,,In vivo,,N,,Blood,8829,Rattus norvegicus,50597,A,,1
,Biodistribution in Rat blood after 30 minutes of iv administration,10116.0,Intermediate,,,11346,178.0,CHEMBL625228,1,BAO_0000218,,In vivo,,N,,Blood,8829,Rattus norvegicus,50597,A,,1
,Biodistribution in Rat blood after 30 minutes of iv administration; per g of tissue,10116.0,Intermediate,,,11347,178.0,CHEMBL875354,1,BAO_0000218,,In vivo,,N,,Blood,8829,Rattus norvegicus,50597,A,,1
,Biodistribution in Rat blood after 5 minutes of iv administration,10116.0,Intermediate,,,11348,178.0,CHEMBL625229,1,BAO_0000218,,In vivo,,N,,Blood,8829,Rattus norvegicus,50597,A,,1
,Biodistribution in Rat blood after 5 minutes of iv administration; per g of tissue,10116.0,Intermediate,,,11349,178.0,CHEMBL625230,1,BAO_0000218,,In vivo,,N,,Blood,8829,Rattus norvegicus,50597,A,,1
,Biodistribution in Rat heart after 24 hours of iv administration,10116.0,Intermediate,,,11350,948.0,CHEMBL625231,1,BAO_0000218,,In vivo,,N,,Heart,8829,Rattus norvegicus,50597,A,,1
,Biodistribution in Rat heart after 24 hours of iv administration; per g of tissue,10116.0,Intermediate,,,11351,948.0,CHEMBL625900,1,BAO_0000218,,In vivo,,N,,Heart,8829,Rattus norvegicus,50597,A,,1
,Biodistribution in Rat heart after 30 minutes of iv administration,10116.0,Intermediate,,,11352,948.0,CHEMBL625901,1,BAO_0000218,,In vivo,,N,,Heart,8829,Rattus norvegicus,50597,A,,1
,Biodistribution in Rat heart after 30 minutes of iv administration; per g of tissue,10116.0,Intermediate,,,11353,948.0,CHEMBL625902,1,BAO_0000218,,In vivo,,N,,Heart,8829,Rattus norvegicus,50597,A,,1
,Biodistribution in Rat heart after 5 minutes of iv administration,10116.0,Intermediate,,,11354,948.0,CHEMBL625903,1,BAO_0000218,,In vivo,,N,,Heart,8829,Rattus norvegicus,50597,A,,1
,Biodistribution in Rat heart after 5 minutes of iv administration; per g of tissue,10116.0,Intermediate,,,11355,948.0,CHEMBL625904,1,BAO_0000218,,In vivo,,N,,Heart,8829,Rattus norvegicus,50597,A,,1
,Biodistribution in Rat liver after 24 hours of iv administration,10116.0,Intermediate,,,11356,2107.0,CHEMBL625905,1,BAO_0000218,,In vivo,,N,,Liver,8829,Rattus norvegicus,50597,A,,1
,Biodistribution in Rat liver after 24 hours of iv administration; per g of tissue,10116.0,Intermediate,,,11357,2107.0,CHEMBL627861,1,BAO_0000218,,In vivo,,N,,Liver,8829,Rattus norvegicus,50597,A,,1
,Biodistribution in Rat liver after 30 minutes of iv administration,10116.0,Intermediate,,,11358,2107.0,CHEMBL627862,1,BAO_0000218,,In vivo,,N,,Liver,8829,Rattus norvegicus,50597,A,,1
,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,10116.0,Intermediate,,,11359,2107.0,CHEMBL627863,1,BAO_0000218,,In vivo,,N,,Liver,8829,Rattus norvegicus,50597,A,,1
,Biodistribution in Rat liver after 30 minutes of iv administration,10116.0,Intermediate,,,11360,2107.0,CHEMBL627769,1,BAO_0000218,,In vivo,,N,,Liver,8829,Rattus norvegicus,50597,A,,1
,Maximum plasma concentration in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,9615.0,Intermediate,,,11361,1969.0,CHEMBL627770,1,BAO_0000218,,In vivo,,N,,Plasma,13249,Canis lupus familiaris,50588,A,,1
,Cmax in cynomolgus monkey (PO dose),9541.0,Intermediate,,,11362,,CHEMBL627771,1,BAO_0000218,,In vivo,,N,,,13622,Macaca fascicularis,100710,A,,1
,Cmax in rat (PO dose),10116.0,Intermediate,,,11363,,CHEMBL627772,1,BAO_0000218,,In vivo,,N,,,13622,Rattus norvegicus,50597,A,,1
,Cmax in rat (PO dose),10116.0,Intermediate,,,11364,,CHEMBL627773,1,BAO_0000218,,In vivo,,N,,,13622,Rattus norvegicus,50597,A,,1
,Maximum plasma concentration in rats after an oral dose of 5 mg/kg,10116.0,Intermediate,,,11365,1969.0,CHEMBL621922,1,BAO_0000218,,In vivo,,N,,Plasma,13494,Rattus norvegicus,50597,A,,1
,Cmax in rat plasma after oral dose (10 mg/kg),10116.0,Intermediate,,,11366,1969.0,CHEMBL621923,1,BAO_0000218,,In vivo,,N,,Plasma,12170,Rattus norvegicus,50597,A,,1
,Cmax in plasma after oral dose (10 mg/kg),,Autocuration,,,11367,1969.0,CHEMBL621924,1,BAO_0000218,,In vivo,,U,,Plasma,12170,,22224,A,,0
,Maximum plasma concentration of compound was determined in dog at 25 mg/kg orally,9615.0,Intermediate,,,11368,1969.0,CHEMBL621925,1,BAO_0000218,,In vivo,,N,,Plasma,17025,Canis lupus familiaris,50588,A,,1
,Maximum plasma concentration of compound was determined in monkey at 25 mg/kg orally,314293.0,Autocuration,,,11369,1969.0,CHEMBL621926,1,BAO_0000218,,In vivo,,U,,Plasma,17025,Simiiformes,22224,A,,0
,Maximum plasma concentration of compound was determined in rabbit at 25 mg/kg orally,9986.0,Intermediate,,,11370,1969.0,CHEMBL621927,1,BAO_0000218,,In vivo,,N,,Plasma,17025,Oryctolagus cuniculus,50592,A,,1
,Maximum plasma concentration of compound was determined in rat at 25 mg/kg orally,10116.0,Intermediate,,,11371,1969.0,CHEMBL621928,1,BAO_0000218,,In vivo,,N,,Plasma,17025,Rattus norvegicus,50597,A,,1
,Maximum plasma concentration after p.o. (10 mpk) administration in rats.,10116.0,Intermediate,,,11372,1969.0,CHEMBL621929,1,BAO_0000218,,In vivo,,N,,Plasma,14187,Rattus norvegicus,50597,A,,1
,Maximum plasma concentration (Cmax) after p.o. administration of 200 mg/kg in mice,10090.0,Intermediate,,,11373,1969.0,CHEMBL621930,1,BAO_0000218,,In vivo,,N,,Plasma,14816,Mus musculus,50594,A,,1
,Maximum plasma concentration after oral dosing in rat,10116.0,Intermediate,,,11374,1969.0,CHEMBL621931,1,BAO_0000218,,In vivo,,N,,Plasma,17820,Rattus norvegicus,50597,A,,1
,Maximum plasma concentration evaluated in 100% PEG solution at a dose of 20 mg/kg orally,,Autocuration,,,11375,1969.0,CHEMBL621932,1,BAO_0000218,,In vivo,,U,,Plasma,14380,,22224,A,,0
,Maximum plasma concentration evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,Autocuration,,,11376,1969.0,CHEMBL621933,1,BAO_0000218,,In vivo,,U,,Plasma,14380,,22224,A,,0
,Maximum plasma concentration in dogs at 0.5 mg/kg dose upon oral administration,9615.0,Intermediate,,,11377,1969.0,CHEMBL621934,1,BAO_0000218,,In vivo,,N,,Plasma,14691,Canis lupus familiaris,50588,A,,1
,Maximum plasma concentration in dogs at 1 mg/kg dose upon oral administration,9615.0,Intermediate,,,11378,1969.0,CHEMBL621935,1,BAO_0000218,,In vivo,,N,,Plasma,14691,Canis lupus familiaris,50588,A,,1
,Maximum plasma concentration in rat upon oral administration of 40 mg/kg,10116.0,Intermediate,,,11379,1969.0,CHEMBL621936,1,BAO_0000218,,In vivo,,N,,Plasma,13375,Rattus norvegicus,50597,A,,1
,Maximum plasma concentration was determined,,Autocuration,,,11380,1969.0,CHEMBL621937,1,BAO_0000218,,In vivo,,U,,Plasma,6236,,22224,A,,0
,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,Autocuration,,,11381,1969.0,CHEMBL621938,1,BAO_0000218,,In vivo,,U,,Plasma,14380,,22224,A,,0
,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,Autocuration,,,11382,1969.0,CHEMBL621939,1,BAO_0000218,,In vivo,,U,,Plasma,14380,,22224,A,,0
,Maximum plasma concentration was evaluated in 10% of PEG suspension at a dose of 20 mg/kg orally,,Autocuration,,,11383,1969.0,CHEMBL621940,1,BAO_0000218,,In vivo,,U,,Plasma,14380,,22224,A,,0
,Maximum plasma concentration was evaluated in 100% of PEG solution at a dose of 20 mg/kg orally,,Autocuration,,,11384,1969.0,CHEMBL621941,1,BAO_0000218,,In vivo,,U,,Plasma,14380,,22224,A,,0
,Maximum plasma concentration was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,,Autocuration,,,11385,1969.0,CHEMBL621942,1,BAO_0000218,,In vivo,,U,,Plasma,14380,,22224,A,,0
,Maximum plasma concentration was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,Autocuration,,,11386,1969.0,CHEMBL626178,1,BAO_0000218,,In vivo,,U,,Plasma,14380,,22224,A,,0
,Maximum plasma concentration was evaluated in Hp-beta-CD solution at a dose of 20 mg/kg orally,,Autocuration,,,11387,1969.0,CHEMBL626179,1,BAO_0000218,,In vivo,,U,,Plasma,14380,,22224,A,,0
,Maximum plasma concentration was evaluated in saline solution at a dose of 20 mg/kg orally,,Autocuration,,,11388,1969.0,CHEMBL626180,1,BAO_0000218,,In vivo,,U,,Plasma,14380,,22224,A,,0
,Plasma Cmax in rat (PO dose),10116.0,Intermediate,,,11389,1969.0,CHEMBL626181,1,BAO_0000218,,In vivo,,N,,Plasma,13622,Rattus norvegicus,50597,A,,1
,Maximum serum concentration after po dose of 5.22 mg/kg in rats,10116.0,Intermediate,,,11390,,CHEMBL626182,1,BAO_0000218,,In vivo,,N,,,15372,Rattus norvegicus,50597,A,,1
,Maximum serum concentration after po dose of 5.46 mg/kg in rats,10116.0,Intermediate,,,11391,,CHEMBL626183,1,BAO_0000218,,In vivo,,N,,,15372,Rattus norvegicus,50597,A,,1
,Maximum serum concentration was determined for the compound after po dose of 5.01 mg/kg in rats,10116.0,Intermediate,,,11392,,CHEMBL626184,1,BAO_0000218,,In vivo,,N,,,15372,Rattus norvegicus,50597,A,,1
,Maximum serum concentration was determined for the compound after po dose of 5.03 mg/kg in rats,10116.0,Intermediate,,,11393,,CHEMBL626185,1,BAO_0000218,,In vivo,,N,,,15372,Rattus norvegicus,50597,A,,1
,Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.,9615.0,Intermediate,,,11394,1969.0,CHEMBL626186,1,BAO_0000218,,In vivo,,N,,Plasma,14925,Canis lupus familiaris,50588,A,,1
,Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.,9615.0,Intermediate,,,11395,1969.0,CHEMBL877589,1,BAO_0000218,,In vivo,,N,,Plasma,14925,Canis lupus familiaris,50588,A,,1
,Maximum concentration of the drug at 1 uM/dg administered intravenously,,Autocuration,,,11396,,CHEMBL626187,1,BAO_0000218,,In vivo,,U,,,11883,,22224,A,,0
,Maximum concentration of the drug at 20 uM/dg administered perorally,,Autocuration,,,11397,,CHEMBL626188,1,BAO_0000218,,In vivo,,U,,,11883,,22224,A,,0
,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg,,Autocuration,,,11398,,CHEMBL626189,1,BAO_0000218,,In vivo,,U,,,13391,,22224,A,,0
,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,,Autocuration,,,11399,178.0,CHEMBL626855,1,BAO_0000218,,In vivo,,U,,Blood,13391,,22224,A,,0
,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,,Autocuration,,,11400,178.0,CHEMBL623781,1,BAO_0000218,,In vivo,,U,,Blood,13391,,22224,A,,0
,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,,Autocuration,,,11401,178.0,CHEMBL623782,1,BAO_0000218,,In vivo,,U,,Blood,13391,,22224,A,,0
,Oral absorption expressed as peak plasma conc (Cmax) after oral dosing of 50 mg/kg in rat,10116.0,Intermediate,,,11402,1969.0,CHEMBL623783,1,BAO_0000218,,In vivo,,N,,Plasma,16360,Rattus norvegicus,50597,A,,1
,Cmax in dog plasma after 1mg/kg oral dose,9615.0,Intermediate,,,11403,1969.0,CHEMBL623784,1,BAO_0000218,,In vivo,,N,,Plasma,3673,Canis lupus familiaris,50588,A,,1
,Bioavailability as maximal plasma concentration in dogs after 2.5 mg/kg oral dose,9615.0,Intermediate,,,11404,1969.0,CHEMBL623785,1,BAO_0000218,,In vivo,,N,,Plasma,14431,Canis lupus familiaris,50588,A,,1
,Bioavailability as maximal plasma concentration in rats after 10 mg/kg oral dose,10116.0,Intermediate,,,11405,1969.0,CHEMBL623786,1,BAO_0000218,,In vivo,,N,,Plasma,14431,Rattus norvegicus,50597,A,,1
,Oral maximum concentration in rat,10116.0,Intermediate,,,11406,,CHEMBL623787,1,BAO_0000218,,In vivo,,N,,,14964,Rattus norvegicus,50597,A,,1
,Oral maximum concentration in rat,10116.0,Intermediate,,,11407,,CHEMBL623788,1,BAO_0000218,,In vivo,,N,,,14964,Rattus norvegicus,50597,A,,1
,Oral plasma concentration in mice at 100 mg/kg dosage within 4-hr time frame.,10090.0,Intermediate,,,11408,1969.0,CHEMBL623789,1,BAO_0000218,,In vivo,,N,,Plasma,14209,Mus musculus,50594,A,,1
,Peak concentration in blood after intravenous administration to mice,10090.0,Intermediate,,,11409,178.0,CHEMBL623790,1,BAO_0000218,,In vivo,,N,,Blood,11355,Mus musculus,50594,A,,1
,Peak concentration in blood after peroral administration to mice,10090.0,Intermediate,,,11410,178.0,CHEMBL623791,1,BAO_0000218,,In vivo,,N,,Blood,11355,Mus musculus,50594,A,,1
,Peak concentration in rat plasma was determined,10116.0,Intermediate,,,11411,1969.0,CHEMBL623792,1,BAO_0000218,,In vivo,,N,,Plasma,11966,Rattus norvegicus,50597,A,,1
,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of monkey after oral administration of 0.05 mmol/kg,314293.0,Autocuration,,,11412,1969.0,CHEMBL623793,1,BAO_0000218,,In vivo,,U,,Plasma,8918,Simiiformes,22224,A,,0
,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of mouse after oral administration of 0.05 mmol/kg,10090.0,Intermediate,,,11413,1969.0,CHEMBL623794,1,BAO_0000218,,In vivo,,N,,Plasma,8918,Mus musculus,50594,A,,1
,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of rat after oral administration of 0.05 mmol/kg,10116.0,Intermediate,,,11414,1969.0,CHEMBL623795,1,BAO_0000218,,In vivo,,N,,Plasma,8918,Rattus norvegicus,50597,A,,1
,"Distribution in rat heart 4 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11415,,CHEMBL623796,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat heart 5 min after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11416,,CHEMBL623797,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat heart 6 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11417,,CHEMBL623798,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat heart 8 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11418,,CHEMBL623799,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat intestine 15 min after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11419,160.0,CHEMBL624490,1,BAO_0000218,,,,N,,Intestine,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat intestine 1 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11420,160.0,CHEMBL624491,1,BAO_0000218,,,,N,,Intestine,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat intestine 2 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11421,160.0,CHEMBL624492,1,BAO_0000218,,,,N,,Intestine,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat intestine 30 min after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11422,160.0,CHEMBL624493,1,BAO_0000218,,,,N,,Intestine,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat intestine 4 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11423,160.0,CHEMBL877595,1,BAO_0000218,,,,N,,Intestine,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat intestine 5 min after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11424,160.0,CHEMBL624494,1,BAO_0000218,,,,N,,Intestine,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat intestine 6 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11425,160.0,CHEMBL624495,1,BAO_0000218,,,,N,,Intestine,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat intestine 8 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11426,160.0,CHEMBL624681,1,BAO_0000218,,,,N,,Intestine,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat kidney, 15 min after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11427,,CHEMBL624682,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat kidney, 1 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11428,,CHEMBL624683,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat kidney, 2 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11429,,CHEMBL624684,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat kidney, 30 min after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11430,,CHEMBL624685,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat kidney, 4 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11431,,CHEMBL624686,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat kidney, 5 min after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11432,,CHEMBL624687,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat kidney, 6 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11433,,CHEMBL624688,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat kidney, 8 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11434,,CHEMBL627161,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat liver 15 min after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11435,,CHEMBL622127,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat liver 1 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11436,,CHEMBL622128,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat liver 2 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11437,,CHEMBL874384,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat liver 30 min after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11438,,CHEMBL624898,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat liver 4 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11439,,CHEMBL624899,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat liver 5 min after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11440,,CHEMBL624900,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat liver 6 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11441,,CHEMBL624901,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat liver 8 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11442,,CHEMBL624902,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat lungs 15 min after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11443,,CHEMBL624903,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat lungs 1 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11444,,CHEMBL624904,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat lungs 2 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11445,,CHEMBL624905,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat lungs 30 min after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11446,,CHEMBL624906,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat lungs 4 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11447,,CHEMBL624907,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat lungs 5 min after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11448,,CHEMBL624908,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat lungs 6 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11449,,CHEMBL624909,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat lungs 8 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11450,,CHEMBL624910,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat muscle 15 min after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11451,2385.0,CHEMBL624911,1,BAO_0000218,,,,N,,Muscle tissue,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat muscle 1 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11452,2385.0,CHEMBL874388,1,BAO_0000218,,,,N,,Muscle tissue,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat muscle 2 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11453,2385.0,CHEMBL624912,1,BAO_0000218,,,,N,,Muscle tissue,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat muscle 30 min after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11454,2385.0,CHEMBL622930,1,BAO_0000218,,,,N,,Muscle tissue,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat muscle 4 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11455,2385.0,CHEMBL623121,1,BAO_0000218,,,,N,,Muscle tissue,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat muscle 5 min after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11456,2385.0,CHEMBL623122,1,BAO_0000218,,,,N,,Muscle tissue,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat muscle 6 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11457,2385.0,CHEMBL623123,1,BAO_0000218,,,,N,,Muscle tissue,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat muscle 8 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11458,2385.0,CHEMBL623124,1,BAO_0000218,,,,N,,Muscle tissue,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat pancreas 15 min after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11459,,CHEMBL623125,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat pancreas 1 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11460,,CHEMBL623126,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat pancreas 2 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11461,,CHEMBL623127,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat pancreas 30 min after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11462,,CHEMBL623128,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat pancreas 4 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11463,,CHEMBL623129,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat pancreas 5 min after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11464,,CHEMBL623130,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat pancreas 6 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11465,,CHEMBL623131,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat pancreas 8 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11466,,CHEMBL623132,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,10116.0,Intermediate,,,11467,2107.0,CHEMBL623133,1,BAO_0000218,,,,N,,Liver,8319,Rattus norvegicus,50597,A,,1
,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,10116.0,Intermediate,,,11468,,CHEMBL623134,1,BAO_0000218,,,,N,,,8319,Rattus norvegicus,50597,A,,1
,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,10116.0,Intermediate,,,11469,,CHEMBL874389,1,BAO_0000218,,,,N,,,8319,Rattus norvegicus,50597,A,,1
,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,10116.0,Intermediate,,,11470,,CHEMBL623135,1,BAO_0000218,,,,N,,,8319,Rattus norvegicus,50597,A,,1
,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,10116.0,Intermediate,,,11471,,CHEMBL623136,1,BAO_0000218,,,,N,,,8319,Rattus norvegicus,50597,A,,1
,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,10116.0,Intermediate,,,11472,,CHEMBL623137,1,BAO_0000218,,,,N,,,8319,Rattus norvegicus,50597,A,,1
,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,10116.0,Intermediate,,,11473,,CHEMBL623138,1,BAO_0000218,,,,N,,,8319,Rattus norvegicus,50597,A,,1
,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,10116.0,Intermediate,,,11474,2113.0,CHEMBL623139,1,BAO_0000218,,,,N,,Kidney,8319,Rattus norvegicus,50597,A,,1
,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,10116.0,Intermediate,,,11475,2113.0,CHEMBL623140,1,BAO_0000218,,,,N,,Kidney,8319,Rattus norvegicus,50597,A,,1
,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,10116.0,Intermediate,,,11476,2107.0,CHEMBL623141,1,BAO_0000218,,,,N,,Liver,8319,Rattus norvegicus,50597,A,,1
,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,10116.0,Intermediate,,,11477,2107.0,CHEMBL623142,1,BAO_0000218,,,,N,,Liver,8319,Rattus norvegicus,50597,A,,1
,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,10116.0,Intermediate,,,11478,,CHEMBL623143,1,BAO_0000218,,,,N,,,8319,Rattus norvegicus,50597,A,,1
,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in mouse.,10090.0,Intermediate,,,11479,1088.0,CHEMBL623144,1,BAO_0000218,,,,N,,Urine,14571,Mus musculus,50594,A,,1
,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in rat.,10116.0,Intermediate,,,11480,1088.0,CHEMBL623405,1,BAO_0000218,,,,N,,Urine,14571,Rattus norvegicus,50597,A,,1
,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,10116.0,Intermediate,,,11481,,CHEMBL624074,1,BAO_0000218,,,,N,,,8319,Rattus norvegicus,50597,A,,1
,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,10116.0,Intermediate,,,11482,,CHEMBL624075,1,BAO_0000218,,,,N,,,8319,Rattus norvegicus,50597,A,,1
,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,10116.0,Intermediate,,,11483,,CHEMBL624076,1,BAO_0000218,,,,N,,,8319,Rattus norvegicus,50597,A,,1
,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,10116.0,Intermediate,,,11484,,CHEMBL624077,1,BAO_0000218,,,,N,,,8319,Rattus norvegicus,50597,A,,1
,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,10116.0,Intermediate,,,11485,,CHEMBL624078,1,BAO_0000218,,,,N,,,8319,Rattus norvegicus,50597,A,,1
,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,10116.0,Intermediate,,,11486,2113.0,CHEMBL624079,1,BAO_0000218,,,,N,,Kidney,8319,Rattus norvegicus,50597,A,,1
,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,10116.0,Intermediate,,,11487,2113.0,CHEMBL624261,1,BAO_0000218,,,,N,,Kidney,8319,Rattus norvegicus,50597,A,,1
,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,10116.0,Intermediate,,,11488,,CHEMBL624262,1,BAO_0000218,,,,N,,,8319,Rattus norvegicus,50597,A,,1
,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,10116.0,Intermediate,,,11489,,CHEMBL624263,1,BAO_0000218,,,,N,,,8319,Rattus norvegicus,50597,A,,1
,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,10116.0,Intermediate,,,11490,,CHEMBL624264,1,BAO_0000218,,,,N,,,8319,Rattus norvegicus,50597,A,,1
,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,10116.0,Intermediate,,,11491,,CHEMBL624265,1,BAO_0000218,,,,N,,,8319,Rattus norvegicus,50597,A,,1
,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,10116.0,Intermediate,,,11492,,CHEMBL624266,1,BAO_0000218,,,,N,,,8319,Rattus norvegicus,50597,A,,1
,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,10116.0,Intermediate,,,11493,,CHEMBL624267,1,BAO_0000218,,,,N,,,8319,Rattus norvegicus,50597,A,,1
,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,10116.0,Intermediate,,,11494,,CHEMBL624268,1,BAO_0000218,,,,N,,,8319,Rattus norvegicus,50597,A,,1
,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,10116.0,Intermediate,,,11495,,CHEMBL875227,1,BAO_0000218,,,,N,,,8319,Rattus norvegicus,50597,A,,1
,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,10116.0,Intermediate,,,11496,2113.0,CHEMBL624269,1,BAO_0000218,,,,N,,Kidney,8319,Rattus norvegicus,50597,A,,1
,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,10116.0,Intermediate,,,11497,2113.0,CHEMBL624270,1,BAO_0000218,,,,N,,Kidney,8319,Rattus norvegicus,50597,A,,1
,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,10116.0,Intermediate,,,11498,,CHEMBL624271,1,BAO_0000218,,,,N,,,8319,Rattus norvegicus,50597,A,,1
,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,10116.0,Intermediate,,,11499,,CHEMBL624272,1,BAO_0000218,,,,N,,,8319,Rattus norvegicus,50597,A,,1
,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,10116.0,Intermediate,,,11500,,CHEMBL624273,1,BAO_0000218,,,,N,,,8319,Rattus norvegicus,50597,A,,1
,Urinary excretion in rat after 0-4 hours of oral administration at 50 mg/kg,10116.0,Intermediate,,,11501,1088.0,CHEMBL624274,1,BAO_0000218,,,,N,,Urine,12064,Rattus norvegicus,50597,A,,1
,Urinary excretion in rat after 4-8 hours of oral administration at 50 mg/kg,10116.0,Intermediate,,,11502,1088.0,CHEMBL624275,1,BAO_0000218,,,,N,,Urine,12064,Rattus norvegicus,50597,A,,1
,Urinary excretion in rat after 8-24 hours of oral administration at 50 mg/kg,10116.0,Intermediate,,,11503,1088.0,CHEMBL624276,1,BAO_0000218,,,,N,,Urine,12064,Rattus norvegicus,50597,A,,1
,Urinary recovery expressed as percentage dose in male rats after iv administration of 20 mg/kg,10116.0,Intermediate,,,11504,1088.0,CHEMBL624277,1,BAO_0000218,,,,N,,Urine,12038,Rattus norvegicus,50597,A,,1
,% dose converted to 2-amino-5-chlorophenyl sulfate,,Autocuration,,,11505,,CHEMBL624278,1,BAO_0000019,,,,U,,,14314,,22224,A,,0
,% dose converted to 4-(S-amino-N-{[(4-chlorophenyl)amino]carbonyl}sulfonimidoyl)benzoic acid (compound 41),,Autocuration,,,11506,,CHEMBL624279,1,BAO_0000019,,,,U,,,14314,,22224,A,,0
,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",10116.0,Intermediate,,,11507,1988.0,CHEMBL624280,1,BAO_0000218,,,,N,,Feces,11488,Rattus norvegicus,50597,A,,1
,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",10116.0,Intermediate,,,11508,1988.0,CHEMBL624281,1,BAO_0000218,,,,N,,Feces,11488,Rattus norvegicus,50597,A,,1
,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",10116.0,Intermediate,,,11509,1988.0,CHEMBL622933,1,BAO_0000218,,,,N,,Feces,11488,Rattus norvegicus,50597,A,,1
,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",10116.0,Intermediate,,,11510,1988.0,CHEMBL622934,1,BAO_0000218,,,,N,,Feces,11488,Rattus norvegicus,50597,A,,1
,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,10116.0,Intermediate,,,11511,2107.0,CHEMBL622935,1,BAO_0000218,,In vivo,,N,,Liver,8829,Rattus norvegicus,50597,A,,1
,Biodistribution in Rat liver after 5 minutes of iv administration,10116.0,Intermediate,,,11512,2107.0,CHEMBL622936,1,BAO_0000218,,In vivo,,N,,Liver,8829,Rattus norvegicus,50597,A,,1
,Biodistribution in Rat liver after 5 minutes of iv administration; per g of tissue,10116.0,Intermediate,,,11513,2107.0,CHEMBL875228,1,BAO_0000218,,In vivo,,N,,Liver,8829,Rattus norvegicus,50597,A,,1
,Biodistribution in Rat lung after 24 hours of iv administration,10116.0,Intermediate,,,11514,2048.0,CHEMBL622937,1,BAO_0000218,,In vivo,,N,,Lung,8829,Rattus norvegicus,50597,A,,1
,Biodistribution in Rat lung after 24 hours of iv administration; per g of tissue,10116.0,Intermediate,,,11515,2048.0,CHEMBL622938,1,BAO_0000218,,In vivo,,N,,Lung,8829,Rattus norvegicus,50597,A,,1
,Biodistribution in Rat lung after 30 minutes of iv administration,10116.0,Intermediate,,,11516,2048.0,CHEMBL619736,1,BAO_0000218,,In vivo,,N,,Lung,8829,Rattus norvegicus,50597,A,,1
,Biodistribution in Rat lung after 30 minutes of iv administration; per g of tissue,10116.0,Intermediate,,,11517,2048.0,CHEMBL625117,1,BAO_0000218,,In vivo,,N,,Lung,8829,Rattus norvegicus,50597,A,,1
,Biodistribution in Rat lung after 5 minutes of iv administration,10116.0,Intermediate,,,11518,2048.0,CHEMBL625118,1,BAO_0000218,,In vivo,,N,,Lung,8829,Rattus norvegicus,50597,A,,1
,Biodistribution in Rat lung after 5 minutes of iv administration; per g of tissue,10116.0,Intermediate,,,11519,2048.0,CHEMBL625119,1,BAO_0000218,,In vivo,,N,,Lung,8829,Rattus norvegicus,50597,A,,1
,"Biodistribution in rat cerebellum, expressed as percent I.D./g tissue",10116.0,Intermediate,,,11520,2037.0,CHEMBL625120,1,BAO_0000218,,In vivo,,N,,Cerebellum,14972,Rattus norvegicus,50597,A,,1
,"Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue",10116.0,Intermediate,,,11521,,CHEMBL625121,1,BAO_0000218,,In vivo,,N,,,14972,Rattus norvegicus,50597,A,,1
,"Biodistribution in rat thalamus, expressed as percent I.D./g tissue",10116.0,Intermediate,,,11522,10000006.0,CHEMBL625122,1,BAO_0000218,,In vivo,,N,,Thalamus,14972,Rattus norvegicus,50597,A,,1
,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 2 min,10116.0,Intermediate,,,11523,178.0,CHEMBL622204,1,BAO_0000218,,In vivo,,N,,Blood,14608,Rattus norvegicus,50597,A,,1
,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 30 min,10116.0,Intermediate,,,11524,178.0,CHEMBL877503,1,BAO_0000218,,In vivo,,N,,Blood,14608,Rattus norvegicus,50597,A,,1
,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 60 min,10116.0,Intermediate,,,11525,178.0,CHEMBL627127,1,BAO_0000218,,In vivo,,N,,Blood,14608,Rattus norvegicus,50597,A,,1
,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 2 min,,Autocuration,,,11526,10000000.0,CHEMBL627128,1,BAO_0000218,,In vivo,,U,,Hippocampus,14608,,22224,A,,0
,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 30 min,,Autocuration,,,11527,10000000.0,CHEMBL627129,1,BAO_0000218,,In vivo,,U,,Hippocampus,14608,,22224,A,,0
,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 60 min,,Autocuration,,,11528,10000000.0,CHEMBL627130,1,BAO_0000218,,In vivo,,U,,Hippocampus,14608,,22224,A,,0
,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 2 min,10116.0,Intermediate,,,11529,955.0,CHEMBL627131,1,BAO_0000218,,In vivo,,N,,Brain,14608,Rattus norvegicus,50597,A,,1
,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 30 min,10116.0,Intermediate,,,11530,955.0,CHEMBL627132,1,BAO_0000218,,In vivo,,N,,Brain,14608,Rattus norvegicus,50597,A,,1
,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 60 min,10116.0,Intermediate,,,11531,955.0,CHEMBL627133,1,BAO_0000218,,In vivo,,N,,Brain,14608,Rattus norvegicus,50597,A,,1
,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 2 min,10116.0,Intermediate,,,11532,2037.0,CHEMBL627134,1,BAO_0000218,,In vivo,,N,,Cerebellum,14608,Rattus norvegicus,50597,A,,1
,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 30 min,10116.0,Intermediate,,,11533,2037.0,CHEMBL627135,1,BAO_0000218,,In vivo,,N,,Cerebellum,14608,Rattus norvegicus,50597,A,,1
,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 60 min,10116.0,Intermediate,,,11534,2037.0,CHEMBL627136,1,BAO_0000218,,In vivo,,N,,Cerebellum,14608,Rattus norvegicus,50597,A,,1
,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 2 min,10116.0,Intermediate,,,11535,,CHEMBL628435,1,BAO_0000218,,In vivo,,N,,,14608,Rattus norvegicus,50597,A,,1
,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 30 min,10116.0,Intermediate,,,11536,,CHEMBL628436,1,BAO_0000218,,In vivo,,N,,,14608,Rattus norvegicus,50597,A,,1
,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 60 min,10116.0,Intermediate,,,11537,,CHEMBL628437,1,BAO_0000218,,In vivo,,N,,,14608,Rattus norvegicus,50597,A,,1
,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 2 min,10116.0,Intermediate,,,11538,948.0,CHEMBL628438,1,BAO_0000218,,In vivo,,N,,Heart,14608,Rattus norvegicus,50597,A,,1
,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 30 min,10116.0,Intermediate,,,11539,948.0,CHEMBL628439,1,BAO_0000218,,In vivo,,N,,Heart,14608,Rattus norvegicus,50597,A,,1
,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 60 min,10116.0,Intermediate,,,11540,948.0,CHEMBL628440,1,BAO_0000218,,In vivo,,N,,Heart,14608,Rattus norvegicus,50597,A,,1
,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 2 min,10116.0,Intermediate,,,11541,10000000.0,CHEMBL628441,1,BAO_0000218,,In vivo,,N,,Hippocampus,14608,Rattus norvegicus,50597,A,,1
,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 30 min,10116.0,Intermediate,,,11542,10000000.0,CHEMBL628442,1,BAO_0000218,,In vivo,,N,,Hippocampus,14608,Rattus norvegicus,50597,A,,1
,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 60 min,10116.0,Intermediate,,,11543,10000000.0,CHEMBL628443,1,BAO_0000218,,In vivo,,N,,Hippocampus,14608,Rattus norvegicus,50597,A,,1
,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 2 min,10116.0,Intermediate,,,11544,2113.0,CHEMBL628444,1,BAO_0000218,,In vivo,,N,,Kidney,14608,Rattus norvegicus,50597,A,,1
,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 30 min,10116.0,Intermediate,,,11545,2113.0,CHEMBL628445,1,BAO_0000218,,In vivo,,N,,Kidney,14608,Rattus norvegicus,50597,A,,1
,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 60 min,10116.0,Intermediate,,,11546,2113.0,CHEMBL877504,1,BAO_0000218,,In vivo,,N,,Kidney,14608,Rattus norvegicus,50597,A,,1
,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 2 min,10116.0,Intermediate,,,11547,2107.0,CHEMBL628446,1,BAO_0000218,,In vivo,,N,,Liver,14608,Rattus norvegicus,50597,A,,1
,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 30 min,10116.0,Intermediate,,,11548,2107.0,CHEMBL626874,1,BAO_0000218,,In vivo,,N,,Liver,14608,Rattus norvegicus,50597,A,,1
,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 60 min,10116.0,Intermediate,,,11549,2107.0,CHEMBL626875,1,BAO_0000218,,In vivo,,N,,Liver,14608,Rattus norvegicus,50597,A,,1
,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 2 min,10116.0,Intermediate,,,11550,2048.0,CHEMBL626876,1,BAO_0000218,,In vivo,,N,,Lung,14608,Rattus norvegicus,50597,A,,1
,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 30 min,10116.0,Intermediate,,,11551,2048.0,CHEMBL626877,1,BAO_0000218,,In vivo,,N,,Lung,14608,Rattus norvegicus,50597,A,,1
,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 60 min,10116.0,Intermediate,,,11552,2048.0,CHEMBL626878,1,BAO_0000218,,In vivo,,N,,Lung,14608,Rattus norvegicus,50597,A,,1
,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 2 min,10116.0,Intermediate,,,11553,2385.0,CHEMBL626879,1,BAO_0000218,,In vivo,,N,,Muscle tissue,14608,Rattus norvegicus,50597,A,,1
,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of monkey after oral administration of 0.05 mmol/kg,314293.0,Autocuration,,,11554,1969.0,CHEMBL626880,1,BAO_0000218,,In vivo,,U,,Plasma,8918,Simiiformes,22224,A,,0
,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of mouse after oral administration of 0.05 mmol/kg,10090.0,Intermediate,,,11555,1969.0,CHEMBL626881,1,BAO_0000218,,In vivo,,N,,Plasma,8918,Mus musculus,50594,A,,1
,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of rat after oral administration of 0.05 mmol/kg,10116.0,Intermediate,,,11556,1969.0,CHEMBL626882,1,BAO_0000218,,In vivo,,N,,Plasma,8918,Rattus norvegicus,50597,A,,1
,Peak plasma concentration was measured in dogs,9615.0,Intermediate,,,11557,1969.0,CHEMBL626883,1,BAO_0000218,,In vivo,,N,,Plasma,14470,Canis lupus familiaris,50588,A,,1
,Pharmacokinetic Parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,10116.0,Intermediate,,,11558,,CHEMBL626884,1,BAO_0000218,,In vivo,,N,,,14393,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,10116.0,Intermediate,,,11559,,CHEMBL626885,1,BAO_0000218,,In vivo,,N,,,14886,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,10116.0,Intermediate,,,11560,,CHEMBL626886,1,BAO_0000218,,In vivo,,N,,,14886,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,10116.0,Intermediate,,,11561,,CHEMBL626887,1,BAO_0000218,,In vivo,,N,,,14886,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,10116.0,Intermediate,,,11562,,CHEMBL626888,1,BAO_0000218,,In vivo,,N,,,14393,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter Cmax determined after intravenous administration of 15 mg/kg to dog,9615.0,Intermediate,,,11563,,CHEMBL626889,1,BAO_0000218,,In vivo,,N,,,13465,Canis lupus familiaris,50588,A,,1
,Pharmacokinetic parameter Cmax determined after intravenous administration of 25 mg/kg to monkey,314293.0,Autocuration,,,11564,,CHEMBL626761,1,BAO_0000218,,In vivo,,U,,,13465,Simiiformes,22224,A,,0
,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg abd antacid (CaCO3 dosed orally 10 min prior to and 60 min postdosing) to dog,9615.0,Intermediate,,,11565,,CHEMBL626762,1,BAO_0000218,,In vivo,,N,,,13465,Canis lupus familiaris,50588,A,,1
,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg to dog,9615.0,Intermediate,,,11566,,CHEMBL626763,1,BAO_0000218,,In vivo,,N,,,13465,Canis lupus familiaris,50588,A,,1
,Pharmacokinetic parameter Cmax determined after intravenous administration of 50 mg/kg to rat,10116.0,Intermediate,,,11567,,CHEMBL626764,1,BAO_0000218,,In vivo,,N,,,13465,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter Cmax determined after intravenous administration of 60 mg/kg to rat,10116.0,Intermediate,,,11568,,CHEMBL626765,1,BAO_0000218,,In vivo,,N,,,13465,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to dog,9615.0,Intermediate,,,11569,,CHEMBL626766,1,BAO_0000218,,In vivo,,N,,,13465,Canis lupus familiaris,50588,A,,1
,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat,10116.0,Intermediate,,,11570,,CHEMBL626767,1,BAO_0000218,,In vivo,,N,,,13465,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat; No levels,10116.0,Intermediate,,,11571,,CHEMBL626768,1,BAO_0000218,,In vivo,,N,,,13465,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter Cmax determined after peroral administration of 15 mg/kg to dog,9615.0,Intermediate,,,11572,,CHEMBL626769,1,BAO_0000218,,In vivo,,N,,,13465,Canis lupus familiaris,50588,A,,1
,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to dog,9615.0,Intermediate,,,11573,,CHEMBL874463,1,BAO_0000218,,In vivo,,N,,,13465,Canis lupus familiaris,50588,A,,1
,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey,314293.0,Autocuration,,,11574,,CHEMBL626770,1,BAO_0000218,,In vivo,,U,,,13465,Simiiformes,22224,A,,0
,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey; No levels,314293.0,Autocuration,,,11575,,CHEMBL626771,1,BAO_0000218,,In vivo,,U,,,13465,Simiiformes,22224,A,,0
,Pharmacokinetic parameter Cmax determined after peroral administration of 50 mg/kg to rat,10116.0,Intermediate,,,11576,,CHEMBL626772,1,BAO_0000218,,In vivo,,N,,,13465,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter Cmax for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,9541.0,Intermediate,,,11577,,CHEMBL626773,1,BAO_0000218,,In vivo,,N,,,14731,Macaca fascicularis,100710,A,,1
,Pharmacokinetic parameter Cmax for the compound was evaluated in nude mice after oral administration. ,10090.0,Intermediate,,,11578,,CHEMBL626774,1,BAO_0000218,,In vivo,,N,,,14731,Mus musculus,50594,A,,1
,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 375 mg/kg,9615.0,Intermediate,,,11579,,CHEMBL626775,1,BAO_0000218,,In vivo,,N,,,13376,Canis lupus familiaris,50588,A,,1
,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 500 mg/kg,9615.0,Intermediate,,,11580,,CHEMBL626776,1,BAO_0000218,,In vivo,,N,,,13376,Canis lupus familiaris,50588,A,,1
,Maximum concentration (Cmax) in rat when administered orally,10116.0,Intermediate,,,11581,,CHEMBL626777,1,BAO_0000218,,In vivo,,N,,,14443,Rattus norvegicus,50597,A,,1
,Maximal concentration in monkey plasma after 25 mg/kg oral dose,314293.0,Autocuration,,,11582,1969.0,CHEMBL626778,1,BAO_0000218,,In vivo,,U,,Plasma,13465,Simiiformes,22224,A,,0
,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.17-0.20)",10116.0,Autocuration,,,11583,,CHEMBL626779,1,BAO_0000218,,In vivo,,U,,,16359,Rattus norvegicus,22224,A,,0
,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.4-0.8)",10116.0,Autocuration,,,11584,,CHEMBL626780,1,BAO_0000218,,In vivo,,U,,,16359,Rattus norvegicus,22224,A,,0
,Cmax in rat plasma after single 5 mg/kg oral cassette gavage dose,,Autocuration,,,11585,1969.0,CHEMBL626781,1,BAO_0000218,,In vivo,,U,,Plasma,15618,,22224,A,,0
,Pharmacokinetic profile Cmax was evaluated in rats,10116.0,Intermediate,,,11586,,CHEMBL632164,1,BAO_0000218,,In vivo,,N,,,14554,Rattus norvegicus,50597,A,,1
,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg),9615.0,Intermediate,,,11587,,CHEMBL632165,1,BAO_0000218,,In vivo,,N,,,11537,Canis lupus familiaris,50588,A,,1
,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg),10090.0,Intermediate,,,11588,,CHEMBL632166,1,BAO_0000218,,In vivo,,N,,,11537,Mus musculus,50594,A,,1
,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to dog (25 mg/kg),9615.0,Intermediate,,,11589,,CHEMBL632167,1,BAO_0000218,,In vivo,,N,,,11537,Canis lupus familiaris,50588,A,,1
,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to mice (50 mg/kg),10090.0,Intermediate,,,11590,,CHEMBL632168,1,BAO_0000218,,In vivo,,N,,,11537,Mus musculus,50594,A,,1
,Cmax in rat plasma,10116.0,Autocuration,,,11591,1969.0,CHEMBL632169,1,BAO_0000218,,In vivo,,U,,Plasma,2021,Rattus norvegicus,22224,A,,0
,Cmax in dog plasma after 30mg/kg oral dose,9615.0,Intermediate,,,11592,1969.0,CHEMBL632170,1,BAO_0000218,,In vivo,,N,,Plasma,5932,Canis lupus familiaris,50588,A,,1
,Cmax in rat plasma after 30mg/kg oral dose,10116.0,Intermediate,,,11593,1969.0,CHEMBL632171,1,BAO_0000218,,In vivo,,N,,Plasma,5932,Rattus norvegicus,50597,A,,1
,Plasma level in rats at 30 mg/kg,10116.0,Intermediate,,,11594,1969.0,CHEMBL632172,1,BAO_0000218,,In vivo,,N,,Plasma,17320,Rattus norvegicus,50597,A,,1
,Tested for maximum plasma concentration in mice,10090.0,Intermediate,,,11595,1969.0,CHEMBL632173,1,BAO_0000218,,In vivo,,N,,Plasma,15831,Mus musculus,50594,A,,1
,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",10116.0,Intermediate,,,11596,,CHEMBL632174,1,BAO_0000218,,In vivo,,N,,,15078,Rattus norvegicus,50597,A,,1
,The Cmax values in female wistar rats.,10116.0,Intermediate,,,11597,,CHEMBL632175,1,BAO_0000218,,In vivo,,N,,,14941,Rattus norvegicus,50597,A,,1
,The Peak plasma concentration was measured in dogs after oral administration of 1 mg/kg dose,9615.0,Intermediate,,,11598,1969.0,CHEMBL632176,1,BAO_0000218,,In vivo,,N,,Plasma,15343,Canis lupus familiaris,50588,A,,1
,The Peak plasma concentration was measured in rats after oral administration of 1 mg/kg dose,10116.0,Intermediate,,,11599,1969.0,CHEMBL632177,1,BAO_0000218,,In vivo,,N,,Plasma,15343,Rattus norvegicus,50597,A,,1
,The compound tested for maximum observed plasma concentration in rats and is expressed in microgram/mL.,10116.0,Intermediate,,,11600,1969.0,CHEMBL632178,1,BAO_0000218,,In vivo,,N,,Plasma,14856,Rattus norvegicus,50597,A,,1
,The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat.,10116.0,Intermediate,,,11601,,CHEMBL632179,1,BAO_0000218,,In vivo,,N,,,13129,Rattus norvegicus,50597,A,,1
,The compound was tested for maximum blood level reached in rats at 15.9 uM/kg after peroral administration.,10116.0,Intermediate,,,11602,178.0,CHEMBL632180,1,BAO_0000218,,In vivo,,N,,Blood,13098,Rattus norvegicus,50597,A,,1
,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after intravenous administration.,10116.0,Intermediate,,,11603,178.0,CHEMBL632181,1,BAO_0000218,,In vivo,,N,,Blood,13098,Rattus norvegicus,50597,A,,1
,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after peroral administration.,10116.0,Intermediate,,,11604,178.0,CHEMBL632182,1,BAO_0000218,,In vivo,,N,,Blood,13098,Rattus norvegicus,50597,A,,1
,The maximum concentration observed (Cmax) in the blood sample at indicated time point (tmax) at a dose 50 mg/Kg administered orally in mice.,10090.0,Autocuration,,,11605,178.0,CHEMBL632183,1,BAO_0000218,,In vivo,,U,,Blood,15478,Mus musculus,22224,A,,0
,The maximum concentration of the compound was measured in dog at dose 5 mg/kg after peroral administration.,9615.0,Intermediate,,,11606,,CHEMBL632184,1,BAO_0000218,,In vivo,,N,,,15341,Canis lupus familiaris,50588,A,,1
,The maximum concentration of the compound was measured in rat at dose 1 mg/kg after peroral administration.,10116.0,Intermediate,,,11607,,CHEMBL874470,1,BAO_0000218,,In vivo,,N,,,15341,Rattus norvegicus,50597,A,,1
,"Distribution in rat skin 15 min after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11608,,CHEMBL631302,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat skin 1 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11609,,CHEMBL631303,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat skin 2 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11610,,CHEMBL631304,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat skin 30 min after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11611,,CHEMBL631305,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat skin 4 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11612,,CHEMBL631306,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat skin 5 min after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11613,,CHEMBL631307,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat skin 6 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11614,,CHEMBL631308,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat skin 8 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11615,,CHEMBL625557,1,BAO_0000218,,,,N,,,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat spleen 15 min after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11616,2106.0,CHEMBL625558,1,BAO_0000218,,,,N,,Spleen,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat spleen 1 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11617,2106.0,CHEMBL625559,1,BAO_0000218,,,,N,,Spleen,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat spleen 2 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11618,2106.0,CHEMBL625560,1,BAO_0000218,,,,N,,Spleen,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat spleen 30 min after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11619,2106.0,CHEMBL625561,1,BAO_0000218,,,,N,,Spleen,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat spleen 4 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11620,2106.0,CHEMBL625562,1,BAO_0000218,,,,N,,Spleen,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat spleen 5 min after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11621,2106.0,CHEMBL875320,1,BAO_0000218,,,,N,,Spleen,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat spleen 6 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11622,2106.0,CHEMBL625563,1,BAO_0000218,,,,N,,Spleen,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat spleen 8 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11623,2106.0,CHEMBL625564,1,BAO_0000218,,,,N,,Spleen,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat uterus 15 min after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11624,995.0,CHEMBL625565,1,BAO_0000218,,,,N,,Uterus,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat uterus 1 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11625,995.0,CHEMBL625566,1,BAO_0000218,,,,N,,Uterus,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat uterus 2 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11626,995.0,CHEMBL625567,1,BAO_0000218,,,,N,,Uterus,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat uterus 30 min after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11627,995.0,CHEMBL625568,1,BAO_0000218,,,,N,,Uterus,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat uterus 4 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11628,995.0,CHEMBL628217,1,BAO_0000218,,,,N,,Uterus,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat uterus 5 min after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11629,995.0,CHEMBL628218,1,BAO_0000218,,,,N,,Uterus,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat uterus 6 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11630,995.0,CHEMBL628219,1,BAO_0000218,,,,N,,Uterus,8684,Rattus norvegicus,50597,A,,1
,"Distribution in rat uterus 8 hr after intravenous administration, injected dose/gm",10116.0,Intermediate,,,11631,995.0,CHEMBL628220,1,BAO_0000218,,,,N,,Uterus,8684,Rattus norvegicus,50597,A,,1
,Distribution in the blood after 120 min of intravenous administration,,Autocuration,,,11632,,CHEMBL628221,1,BAO_0000019,,,,U,,,8926,,22224,A,,0
,Distribution in the blood after 15 min of intravenous administration,,Autocuration,,,11633,,CHEMBL628222,1,BAO_0000019,,,,U,,,8926,,22224,A,,0
,Distribution in the blood after 30 min of intravenous administration,,Autocuration,,,11634,,CHEMBL628223,1,BAO_0000019,,,,U,,,8926,,22224,A,,0
,Distribution in the blood after 5 min of intravenous administration,,Autocuration,,,11635,,CHEMBL628224,1,BAO_0000019,,,,U,,,8926,,22224,A,,0
,Distribution in the blood after 60 min of intravenous administration,,Autocuration,,,11636,,CHEMBL628225,1,BAO_0000019,,,,U,,,8926,,22224,A,,0
,Distribution in the blood after 90 min of intravenous administration,,Autocuration,,,11637,,CHEMBL628226,1,BAO_0000019,,,,U,,,8926,,22224,A,,0
,Distribution in the bone after 120 min of intravenous administration,,Autocuration,,,11638,,CHEMBL628227,1,BAO_0000019,,,,U,,,8926,,22224,A,,0
,Distribution in the bone after 15 min of intravenous administration,,Autocuration,,,11639,,CHEMBL875481,1,BAO_0000019,,,,U,,,8926,,22224,A,,0
,Distribution in the bone after 30 min of intravenous administration,,Autocuration,,,11640,,CHEMBL628228,1,BAO_0000019,,,,U,,,8926,,22224,A,,0
,Distribution in the bone after 5 min of intravenous administration,,Autocuration,,,11641,,CHEMBL628229,1,BAO_0000019,,,,U,,,8926,,22224,A,,0
,Distribution in the bone after 60 min of intravenous administration,,Autocuration,,,11642,,CHEMBL628230,1,BAO_0000019,,,,U,,,8926,,22224,A,,0
,Distribution in the bone after 90 min of intravenous administration,,Autocuration,,,11643,,CHEMBL628231,1,BAO_0000019,,,,U,,,8926,,22224,A,,0
,Distribution in the heart after 120 min of intravenous administration,,Autocuration,,,11644,,CHEMBL628232,1,BAO_0000019,,,,U,,,8926,,22224,A,,0
,Distribution in the heart after 15 min of intravenous administration,,Autocuration,,,11645,,CHEMBL628233,1,BAO_0000019,,,,U,,,8926,,22224,A,,0
,Distribution in the heart after 30 min of intravenous administration,,Autocuration,,,11646,,CHEMBL628234,1,BAO_0000019,,,,U,,,8926,,22224,A,,0
,Distribution in the heart after 5 min of intravenous administration,,Autocuration,,,11647,,CHEMBL628235,1,BAO_0000019,,,,U,,,8926,,22224,A,,0
,Distribution in the heart after 60 min of intravenous administration,,Autocuration,,,11648,,CHEMBL628236,1,BAO_0000019,,,,U,,,8926,,22224,A,,0
,Distribution in the heart after 90 min of intravenous administration,,Autocuration,,,11649,,CHEMBL628237,1,BAO_0000019,,,,U,,,8926,,22224,A,,0
,Distribution in the kidneys after 120 min of intravenous administration,,Autocuration,,,11650,,CHEMBL628238,1,BAO_0000019,,,,U,,,8926,,22224,A,,0
,Distribution in the kidneys after 15 min of intravenous administration,,Autocuration,,,11651,,CHEMBL628239,1,BAO_0000019,,,,U,,,8926,,22224,A,,0
,Distribution in the kidneys after 30 min of intravenous administration,,Autocuration,,,11652,,CHEMBL628240,1,BAO_0000019,,,,U,,,8926,,22224,A,,0
,Distribution in the kidneys after 5 min of intravenous administration,,Autocuration,,,11653,,CHEMBL628241,1,BAO_0000019,,,,U,,,8926,,22224,A,,0
,Distribution in the kidneys after 60 min of intravenous administration,,Autocuration,,,11654,,CHEMBL628242,1,BAO_0000019,,,,U,,,8926,,22224,A,,0
,Distribution in the kidneys after 90 min of intravenous administration,,Autocuration,,,11655,,CHEMBL875482,1,BAO_0000019,,,,U,,,8926,,22224,A,,0
,Distribution in the liver after 120 min of intravenous administration,,Autocuration,,,11656,,CHEMBL628243,1,BAO_0000019,,,,U,,,8926,,22224,A,,0
,Distribution in the liver after 15 min of intravenous administration,,Autocuration,,,11657,,CHEMBL628244,1,BAO_0000019,,,,U,,,8926,,22224,A,,0
,Distribution in the liver after 30 min of intravenous administration,,Autocuration,,,11658,,CHEMBL628245,1,BAO_0000019,,,,U,,,8926,,22224,A,,0
,Distribution in the liver after 5 min of intravenous administration,,Autocuration,,,11659,,CHEMBL628246,1,BAO_0000019,,,,U,,,8926,,22224,A,,0
,Distribution in the liver after 60 min of intravenous administration,,Autocuration,,,11660,,CHEMBL628247,1,BAO_0000019,,,,U,,,8926,,22224,A,,0
,Distribution in the liver after 90 min of intravenous administration,,Autocuration,,,11661,,CHEMBL628248,1,BAO_0000019,,,,U,,,8926,,22224,A,,0
,Distribution in the lung after 120 min of intravenous administration,,Autocuration,,,11662,,CHEMBL628249,1,BAO_0000019,,,,U,,,8926,,22224,A,,0
,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, iv and the total drug exposure was determined. (0-24hr)",10090.0,Intermediate,,,11663,,CHEMBL625452,1,BAO_0000218,,,,N,,,14839,Mus musculus,50594,A,,1
,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, perorally and the total drug exposure was determined (0-24hr)",10090.0,Intermediate,,,11664,,CHEMBL625453,1,BAO_0000218,,,,N,,,14839,Mus musculus,50594,A,,1
,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, iv and the total drug exposure was determined. (0-24hr)",10090.0,Intermediate,,,11665,,CHEMBL625454,1,BAO_0000218,,,,N,,,14839,Mus musculus,50594,A,,1
,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, perorally and the total drug exposure was determined (0-24hr)",10090.0,Intermediate,,,11666,,CHEMBL623844,1,BAO_0000218,,,,N,,,14839,Mus musculus,50594,A,,1
,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 1 mg/kg (normalized to a 1 mg/kg dose) in rat,10116.0,Intermediate,,,11667,,CHEMBL623845,1,BAO_0000218,,,,N,,,12178,Rattus norvegicus,50597,A,,1
,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 2.5 mg/kg (normalized to a 1 mg/kg dose) in rat,10116.0,Intermediate,,,11668,,CHEMBL623846,1,BAO_0000218,,,,N,,,12178,Rattus norvegicus,50597,A,,1
,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 5.0 mg/kg (normalized to a 1 mg/kg dose) GP,,Autocuration,,,11669,,CHEMBL623847,1,BAO_0000218,,,,U,,,12178,,22224,A,,0
,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,9541.0,Intermediate,,,11670,,CHEMBL623848,1,BAO_0000218,,,,N,,,12186,Macaca fascicularis,100710,A,,1
,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,9541.0,Intermediate,,,11671,,CHEMBL623849,1,BAO_0000218,,,,N,,,12186,Macaca fascicularis,100710,A,,1
,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,9541.0,Intermediate,,,11672,,CHEMBL623850,1,BAO_0000218,,,,N,,,12186,Macaca fascicularis,100710,A,,1
,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,9541.0,Intermediate,,,11673,,CHEMBL623851,1,BAO_0000218,,,,N,,,12186,Macaca fascicularis,100710,A,,1
,Integrated area under the plasma drug level-time curve was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,314293.0,Autocuration,,,11674,,CHEMBL623852,1,BAO_0000218,,,,U,,,12187,Simiiformes,22224,A,,0
,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,9669.0,Intermediate,,,11675,,CHEMBL624551,1,BAO_0000218,,,,N,,,12187,Mustela putorius furo,50506,A,,1
,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",9669.0,Intermediate,,,11676,,CHEMBL624552,1,BAO_0000218,,,,N,,,12187,Mustela putorius furo,50506,A,,1
,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,314293.0,Autocuration,,,11677,,CHEMBL624553,1,BAO_0000218,,,,U,,,12187,Simiiformes,22224,A,,0
,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey determined by renin inhibition assay,314293.0,Autocuration,,,11678,,CHEMBL624554,1,BAO_0000218,,,,U,,,12187,Simiiformes,22224,A,,0
,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,10116.0,Intermediate,,,11679,,CHEMBL624555,1,BAO_0000218,,,,N,,,12187,Rattus norvegicus,50597,A,,1
,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",10116.0,Intermediate,,,11680,,CHEMBL624741,1,BAO_0000218,,,,N,,,12187,Rattus norvegicus,50597,A,,1
,"Intravenous integrated area under the concentration vs time curve, for compound in dog plasma",9615.0,Intermediate,,,11681,,CHEMBL624742,1,BAO_0000218,,,,N,,,14122,Canis lupus familiaris,50588,A,,1
,"Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma",10026.0,Intermediate,,,11682,,CHEMBL624743,1,BAO_0000218,,,,N,,,14122,Cricetinae,100712,A,,1
,"Intravenous integrated area under the concentration vs time curve, for compound in rat plasma",10116.0,Intermediate,,,11683,,CHEMBL877606,1,BAO_0000218,,,,N,,,14122,Rattus norvegicus,50597,A,,1
,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg,,Autocuration,,,11684,,CHEMBL624744,1,BAO_0000218,,,,U,,,13391,,22224,A,,0
,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,,Autocuration,,,11685,178.0,CHEMBL624745,1,BAO_0000218,,,,U,,Blood,13391,,22224,A,,0
,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,,Autocuration,,,11686,178.0,CHEMBL624746,1,BAO_0000218,,,,U,,Blood,13391,,22224,A,,0
,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,,Autocuration,,,11687,178.0,CHEMBL624747,1,BAO_0000218,,,,U,,Blood,13391,,22224,A,,0
,Oral absorption expressed as Area under curve was determined,,Autocuration,,,11688,,CHEMBL624748,1,BAO_0000019,,,,U,,,16360,,22224,A,,0
,Oral absorption kinetics (AUC) was determined after administration of compound orally at 1 mg/kg in dogs,9615.0,Intermediate,,,11689,,CHEMBL622504,1,BAO_0000218,,,,N,,,3673,Canis lupus familiaris,50588,A,,1
,"Oral integrated area under the concentration vs time curve, for compound in dog plasma",9615.0,Intermediate,,,11690,,CHEMBL622505,1,BAO_0000218,,,,N,,,14122,Canis lupus familiaris,50588,A,,1
,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",10026.0,Intermediate,,,11691,,CHEMBL622506,1,BAO_0000218,,,,N,,,14122,Cricetinae,100712,A,,1
,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",10026.0,Intermediate,,,11692,,CHEMBL622507,1,BAO_0000218,,,,N,,,14122,Cricetinae,100712,A,,1
,"Oral integrated area under the concentration vs time curve, for compound in rat plasma",10116.0,Intermediate,,,11693,,CHEMBL622508,1,BAO_0000218,,,,N,,,14122,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound,,Autocuration,,,11694,,CHEMBL622509,1,BAO_0000019,,,,U,,,13889,,22224,A,,0
,Pharmacokinetic Parameter [Area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,10116.0,Intermediate,,,11695,,CHEMBL622510,1,BAO_0000218,,,,N,,,14393,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter (AUC) was determined after administering 1 mg/kg of compound intravenously in rat no.3 belonging to phenotype EM (extensive metabolizer),10116.0,Intermediate,,,11696,,CHEMBL622511,1,BAO_0000218,,,,N,,,17279,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,9541.0,Intermediate,,,11697,,CHEMBL622512,1,BAO_0000218,,,,N,,,14548,Macaca fascicularis,100710,A,,1
,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,9541.0,Intermediate,,,11698,,CHEMBL622513,1,BAO_0000218,,,,N,,,14548,Macaca fascicularis,100710,A,,1
,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered po at 5 mg/kg concentration,9541.0,Intermediate,,,11699,,CHEMBL622514,1,BAO_0000218,,,,N,,,14548,Macaca fascicularis,100710,A,,1
,Pharmacokinetic parameter AUC calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,9615.0,Intermediate,,,11700,,CHEMBL622515,1,BAO_0000218,,,,N,,,14548,Canis lupus familiaris,50588,A,,1
,Pharmacokinetic parameter AUC calculated in dog when the compound was administered po at 5 mg/kg concentration,9615.0,Intermediate,,,11701,,CHEMBL622516,1,BAO_0000218,,,,N,,,14548,Canis lupus familiaris,50588,A,,1
,Pharmacokinetic parameter AUC calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,10116.0,Intermediate,,,11702,,CHEMBL622517,1,BAO_0000218,,,,N,,,14548,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 12 mg/kg concentration,10116.0,Intermediate,,,11703,,CHEMBL622518,1,BAO_0000218,,,,N,,,14548,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 20 mg/kg concentration,10116.0,Intermediate,,,11704,,CHEMBL622519,1,BAO_0000218,,,,N,,,14548,Rattus norvegicus,50597,A,,1
,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 30 min,10116.0,Intermediate,,,11705,2385.0,CHEMBL622520,1,BAO_0000218,,In vivo,,N,,Muscle tissue,14608,Rattus norvegicus,50597,A,,1
,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 60 min,10116.0,Intermediate,,,11706,2385.0,CHEMBL622521,1,BAO_0000218,,In vivo,,N,,Muscle tissue,14608,Rattus norvegicus,50597,A,,1
,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 2 min,10090.0,Intermediate,,,11707,14.0,CHEMBL625113,1,BAO_0000218,,In vivo,,N,,Zone of skin,14608,Mus musculus,50594,A,,1
,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 30 min,10116.0,Intermediate,,,11708,14.0,CHEMBL625114,1,BAO_0000218,,In vivo,,N,,Zone of skin,14608,Rattus norvegicus,50597,A,,1
,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 60 min,10116.0,Intermediate,,,11709,14.0,CHEMBL874397,1,BAO_0000218,,In vivo,,N,,Zone of skin,14608,Rattus norvegicus,50597,A,,1
,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 2 min,10116.0,Intermediate,,,11710,2106.0,CHEMBL625115,1,BAO_0000218,,In vivo,,N,,Spleen,14608,Rattus norvegicus,50597,A,,1
,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 30 min,10116.0,Intermediate,,,11711,2106.0,CHEMBL625116,1,BAO_0000218,,In vivo,,N,,Spleen,14608,Rattus norvegicus,50597,A,,1
,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 60 min,10116.0,Intermediate,,,11712,2106.0,CHEMBL623932,1,BAO_0000218,,In vivo,,N,,Spleen,14608,Rattus norvegicus,50597,A,,1
,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 2 min,10116.0,Intermediate,,,11713,2435.0,CHEMBL623933,1,BAO_0000218,,In vivo,,N,,Striatum,14608,Rattus norvegicus,50597,A,,1
,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 30 min,10116.0,Intermediate,,,11714,2435.0,CHEMBL623934,1,BAO_0000218,,In vivo,,N,,Striatum,14608,Rattus norvegicus,50597,A,,1
,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 60 min,10116.0,Intermediate,,,11715,2435.0,CHEMBL623935,1,BAO_0000218,,In vivo,,N,,Striatum,14608,Rattus norvegicus,50597,A,,1
,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 2 min,10116.0,Intermediate,,,11716,2046.0,CHEMBL623936,1,BAO_0000218,,In vivo,,N,,Thyroid gland,14608,Rattus norvegicus,50597,A,,1
,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 30 min,10116.0,Intermediate,,,11717,2046.0,CHEMBL623937,1,BAO_0000218,,In vivo,,N,,Thyroid gland,14608,Rattus norvegicus,50597,A,,1
,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 60 min,10116.0,Intermediate,,,11718,2046.0,CHEMBL623938,1,BAO_0000218,,In vivo,,N,,Thyroid gland,14608,Rattus norvegicus,50597,A,,1
,In vivo biodistribution in mice blood bearing intracerebral GL261 gliomas at the dose of 30 ug/day,10090.0,Intermediate,,,11719,,CHEMBL623939,1,BAO_0000218,,,,N,,,15383,Mus musculus,50594,A,,1
,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 10 ug/g,10090.0,Intermediate,,,11720,,CHEMBL623940,1,BAO_0000218,,,,N,,,15383,Mus musculus,50594,A,,1
,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 20 ug/g,10090.0,Intermediate,,,11721,,CHEMBL623941,1,BAO_0000218,,,,N,,,15383,Mus musculus,50594,A,,1
,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 30 ug/g,10090.0,Intermediate,,,11722,,CHEMBL627216,1,BAO_0000218,,,,N,,,15383,Mus musculus,50594,A,,1
,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 40 ug/g,10090.0,Intermediate,,,11723,,CHEMBL623942,1,BAO_0000218,,,,N,,,15383,Mus musculus,50594,A,,1
,In vivo biodistribution in mice brain bearing intracerebral GL261 gliomas at the dose of 30 ug/day,10090.0,Intermediate,,,11724,955.0,CHEMBL618793,1,BAO_0000218,,,,N,,Brain,15383,Mus musculus,50594,A,,1
,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 30 ug/g,10090.0,Intermediate,,,11725,955.0,CHEMBL618794,1,BAO_0000218,,,,N,,Brain,15383,Mus musculus,50594,A,,1
,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 40 ug/g,10090.0,Intermediate,,,11726,955.0,CHEMBL618795,1,BAO_0000218,,,,N,,Brain,15383,Mus musculus,50594,A,,1
,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 30 ug/g,10090.0,Intermediate,,,11727,,CHEMBL618796,1,BAO_0000218,,,,N,,,15383,Mus musculus,50594,A,,1
,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 40 ug/g,10090.0,Intermediate,,,11728,,CHEMBL618797,1,BAO_0000218,,,,N,,,15383,Mus musculus,50594,A,,1
,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,10090.0,Intermediate,,,11729,2113.0,CHEMBL618798,1,BAO_0000218,,,,N,,Kidney,15383,Mus musculus,50594,A,,1
,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 30 ug/day,10090.0,Intermediate,,,11730,2113.0,CHEMBL618799,1,BAO_0000218,,,,N,,Kidney,15383,Mus musculus,50594,A,,1
,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 10 ug/g,10090.0,Intermediate,,,11731,2113.0,CHEMBL618800,1,BAO_0000218,,,,N,,Kidney,15383,Mus musculus,50594,A,,1
,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 20 ug/g,10090.0,Intermediate,,,11732,2113.0,CHEMBL618801,1,BAO_0000218,,,,N,,Kidney,15383,Mus musculus,50594,A,,1
,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 30 ug/g,10090.0,Intermediate,,,11733,2113.0,CHEMBL618802,1,BAO_0000218,,,,N,,Kidney,15383,Mus musculus,50594,A,,1
,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 40 ug/g,10090.0,Intermediate,,,11734,2113.0,CHEMBL618803,1,BAO_0000218,,,,N,,Kidney,15383,Mus musculus,50594,A,,1
,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,10090.0,Intermediate,,,11735,2107.0,CHEMBL618804,1,BAO_0000218,,,,N,,Liver,15383,Mus musculus,50594,A,,1
,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 30 ug/day,10090.0,Intermediate,,,11736,2107.0,CHEMBL618805,1,BAO_0000218,,,,N,,Liver,15383,Mus musculus,50594,A,,1
,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 10 ug/g,10090.0,Intermediate,,,11737,2107.0,CHEMBL618806,1,BAO_0000218,,,,N,,Liver,15383,Mus musculus,50594,A,,1
,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 20 ug/g,10090.0,Intermediate,,,11738,2107.0,CHEMBL618807,1,BAO_0000218,,,,N,,Liver,15383,Mus musculus,50594,A,,1
,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 30 ug/g,10090.0,Intermediate,,,11739,2107.0,CHEMBL618808,1,BAO_0000218,,,,N,,Liver,15383,Mus musculus,50594,A,,1
,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 40 ug/g,10090.0,Intermediate,,,11740,2107.0,CHEMBL618809,1,BAO_0000218,,,,N,,Liver,15383,Mus musculus,50594,A,,1
,In vivo biodistribution in mice muscle bearing intracerebral GL261 gliomas at the dose of 30 ug/day,10090.0,Intermediate,,,11741,2385.0,CHEMBL618810,1,BAO_0000218,,,,N,,Muscle tissue,15383,Mus musculus,50594,A,,1
,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 10 ug/g,10090.0,Intermediate,,,11742,2385.0,CHEMBL618811,1,BAO_0000218,,,,N,,Muscle tissue,15383,Mus musculus,50594,A,,1
,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 20 ug/g,10090.0,Intermediate,,,11743,2385.0,CHEMBL875844,1,BAO_0000218,,,,N,,Muscle tissue,15383,Mus musculus,50594,A,,1
,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 30 ug/g,10090.0,Intermediate,,,11744,2385.0,CHEMBL618812,1,BAO_0000218,,,,N,,Muscle tissue,15383,Mus musculus,50594,A,,1
,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 40 ug/g,10090.0,Intermediate,,,11745,2385.0,CHEMBL618813,1,BAO_0000218,,,,N,,Muscle tissue,15383,Mus musculus,50594,A,,1
,In vivo biodistribution in mice skin bearing intracerebral GL261 gliomas at the dose of 30 ug/day,10090.0,Intermediate,,,11746,,CHEMBL618814,1,BAO_0000218,,,,N,,,15383,Mus musculus,50594,A,,1
,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 30 ug/g,10090.0,Intermediate,,,11747,,CHEMBL618815,1,BAO_0000218,,,,N,,,15383,Mus musculus,50594,A,,1
,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 40 ug/g,10090.0,Intermediate,,,11748,,CHEMBL618816,1,BAO_0000218,,,,N,,,15383,Mus musculus,50594,A,,1
,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 30 ug/g,10090.0,Intermediate,,,11749,,CHEMBL618817,1,BAO_0000218,,,,N,,,15383,Mus musculus,50594,A,,1
,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 40 ug/g,10090.0,Intermediate,,,11750,,CHEMBL620544,1,BAO_0000218,,,,N,,,15383,Mus musculus,50594,A,,1
,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intraperitoneal administration.,10116.0,Intermediate,,,11751,,CHEMBL626230,1,BAO_0000218,,In vivo,,N,,,15341,Rattus norvegicus,50597,A,,1
,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intravenous administration.,10116.0,Intermediate,,,11752,,CHEMBL626231,1,BAO_0000218,,In vivo,,N,,,15341,Rattus norvegicus,50597,A,,1
,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after peroral administration.,10116.0,Intermediate,,,11753,,CHEMBL626232,1,BAO_0000218,,In vivo,,N,,,15341,Rattus norvegicus,50597,A,,1
,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on dog.,9615.0,Intermediate,,,11754,1969.0,CHEMBL626233,1,BAO_0000218,,In vivo,,N,,Plasma,14906,Canis lupus familiaris,50588,A,,1
,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat,10116.0,Intermediate,,,11755,1969.0,CHEMBL626234,1,BAO_0000218,,In vivo,,N,,Plasma,14906,Rattus norvegicus,50597,A,,1
,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat.,10116.0,Intermediate,,,11756,1969.0,CHEMBL875341,1,BAO_0000218,,In vivo,,N,,Plasma,14906,Rattus norvegicus,50597,A,,1
,The maximum plasma concentration (100 mg/kg) administered orally in human,9606.0,Intermediate,,,11757,1969.0,CHEMBL626235,1,BAO_0000218,,In vivo,,N,,Plasma,14215,Homo sapiens,50587,A,,1
,The maximum plasma concentration (12.5 mg/kg) administered intravenously in marmoset,9481.0,Autocuration,,,11758,1969.0,CHEMBL626236,1,BAO_0000218,,In vivo,,U,,Plasma,14215,Callithrix,22224,A,,0
,The maximum plasma concentration (12.5 mg/kg) administered intravenously in monkey,314293.0,Autocuration,,,11759,1969.0,CHEMBL626237,1,BAO_0000218,,In vivo,,U,,Plasma,14215,Simiiformes,22224,A,,0
,The maximum plasma concentration (15 mg/kg) administered intravenously in dog,9615.0,Intermediate,,,11760,1969.0,CHEMBL626238,1,BAO_0000218,,In vivo,,N,,Plasma,14215,Canis lupus familiaris,50588,A,,1
,The maximum plasma concentration (200 mg/kg) administered orally in human,9606.0,Intermediate,,,11761,1969.0,CHEMBL622412,1,BAO_0000218,,In vivo,,N,,Plasma,14215,Homo sapiens,50587,A,,1
,The maximum plasma concentration (25 mg/kg) administered intravenously in rat,10116.0,Intermediate,,,11762,1969.0,CHEMBL623114,1,BAO_0000218,,In vivo,,N,,Plasma,14215,Rattus norvegicus,50597,A,,1
,The maximum plasma concentration (25 mg/kg) administered orally in marmoset,9481.0,Autocuration,,,11763,1969.0,CHEMBL623115,1,BAO_0000218,,In vivo,,U,,Plasma,14215,Callithrix,22224,A,,0
,The maximum plasma concentration (25 mg/kg) administered orally in monkey,314293.0,Autocuration,,,11764,1969.0,CHEMBL623116,1,BAO_0000218,,In vivo,,U,,Plasma,14215,Simiiformes,22224,A,,0
,The maximum plasma concentration (30 mg/kg) administered orally in dog,9615.0,Autocuration,,,11765,1969.0,CHEMBL623117,1,BAO_0000218,,In vivo,,U,,Plasma,14215,Canis lupus familiaris,22224,A,,0
,The maximum plasma concentration (400 mg/kg) administered orally in human,9606.0,Intermediate,,,11766,1969.0,CHEMBL623118,1,BAO_0000218,,In vivo,,N,,Plasma,14215,Homo sapiens,50587,A,,1
,The maximum plasma concentration (50 mg/kg) administered orally in fasted rat,10116.0,Intermediate,,,11767,1969.0,CHEMBL623119,1,BAO_0000218,,In vivo,,N,,Plasma,14215,Rattus norvegicus,50597,A,,1
,The maximum plasma concentration (50 mg/kg) administered orally in rat,10116.0,Intermediate,,,11768,1969.0,CHEMBL623120,1,BAO_0000218,,In vivo,,N,,Plasma,14215,Rattus norvegicus,50597,A,,1
,The maximum plasma concentration (800 mg/kg) administered orally in human,9606.0,Intermediate,,,11769,1969.0,CHEMBL623286,1,BAO_0000218,,In vivo,,N,,Plasma,14215,Homo sapiens,50587,A,,1
,The maximum plasma concentration was measured on rats,10116.0,Intermediate,,,11770,1969.0,CHEMBL623287,1,BAO_0000218,,In vivo,,N,,Plasma,14067,Rattus norvegicus,50597,A,,1
,The maximum plasma concentration was measured on rats after oral administration,10116.0,Intermediate,,,11771,1969.0,CHEMBL623288,1,BAO_0000218,,In vivo,,N,,Plasma,12350,Rattus norvegicus,50597,A,,1
,Plasma drug Cmax in rat (PO dose),10116.0,Intermediate,,,11772,1969.0,CHEMBL623289,1,BAO_0000218,,In vivo,,N,,Plasma,14813,Rattus norvegicus,50597,A,,1
,Time taken to reach maximum concentration after administration of 2 umol/kg dose intravenously,,Autocuration,,,11773,,CHEMBL623290,1,BAO_0000218,,In vivo,,U,,,12536,,22224,A,,0
,maximum Plasma concentration in Dog was determined after Peroral administration,9615.0,Intermediate,,,11774,1969.0,CHEMBL623291,1,BAO_0000218,,In vivo,,N,,Plasma,14169,Canis lupus familiaris,50588,A,,1
,maximum Plasma concentration in Rats was determined after Peroral administration,10116.0,Intermediate,,,11775,1969.0,CHEMBL623292,1,BAO_0000218,,In vivo,,N,,Plasma,14169,Rattus norvegicus,50597,A,,1
,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,9615.0,Intermediate,,,11776,1969.0,CHEMBL623293,1,BAO_0000218,,In vivo,,N,,Plasma,15604,Canis lupus familiaris,50588,A,,1
,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,314293.0,Autocuration,,,11777,1969.0,CHEMBL623294,1,BAO_0000218,,In vivo,,U,,Plasma,15604,Simiiformes,22224,A,,0
,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,10116.0,Intermediate,,,11778,1969.0,CHEMBL623295,1,BAO_0000218,,In vivo,,N,,Plasma,15604,Rattus norvegicus,50597,A,,1
,maximum concentration was measured when administered through oral route in mice,10090.0,Intermediate,,,11779,,CHEMBL623296,1,BAO_0000218,,In vivo,,N,,,14387,Mus musculus,50594,A,,1
,Compound was evaluated for Cmax/Tmax when administered through oral route in mouse; Value is 0.93/1,10090.0,Intermediate,,,11780,,CHEMBL875349,1,BAO_0000218,,,,N,,,15115,Mus musculus,50594,A,,1
,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.34/1,314293.0,Autocuration,,,11781,,CHEMBL623297,1,BAO_0000019,,,,U,,,15115,Simiiformes,22224,A,,0
,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.81/1.6,314293.0,Autocuration,,,11782,,CHEMBL623298,1,BAO_0000019,,,,U,,,15115,Simiiformes,22224,A,,0
,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 1.1/1.3,314293.0,Autocuration,,,11783,,CHEMBL623299,1,BAO_0000019,,,,U,,,15115,Simiiformes,22224,A,,0
,Pharmacokinetic parameter was evaluated in rats,10116.0,Intermediate,,,11784,,CHEMBL623300,1,BAO_0000218,,,,N,,,16359,Rattus norvegicus,50597,A,,1
,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,10090.0,Intermediate,,,11785,,CHEMBL623301,1,BAO_0000218,,,,N,,,12829,Mus musculus,50594,A,,1
,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle,10090.0,Intermediate,,,11786,,CHEMBL623302,1,BAO_0000218,,,,N,,,12829,Mus musculus,50594,A,,1
,Plasma concentration at time-0 was measured in mice at 120 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,10090.0,Intermediate,,,11787,,CHEMBL623303,1,BAO_0000218,,,,N,,,12829,Mus musculus,50594,A,,1
,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle,10090.0,Intermediate,,,11788,,CHEMBL623304,1,BAO_0000218,,,,N,,,12829,Mus musculus,50594,A,,1
,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle,10090.0,Intermediate,,,11789,,CHEMBL623305,1,BAO_0000218,,,,N,,,12829,Mus musculus,50594,A,,1
,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats(Cerebral Cortex) after 30 min.,10116.0,Intermediate,,,11790,1969.0,CHEMBL623306,1,BAO_0000218,,,,N,,Plasma,15137,Rattus norvegicus,50597,A,,1
,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats(Cerebral Cortex) after 30 min.,10116.0,Intermediate,,,11791,1969.0,CHEMBL623307,1,BAO_0000218,,,,N,,Plasma,15137,Rattus norvegicus,50597,A,,1
,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats(Cerebral Cortex) after 30 min.,10116.0,Intermediate,,,11792,1969.0,CHEMBL623308,1,BAO_0000218,,,,N,,Plasma,15137,Rattus norvegicus,50597,A,,1
,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats(Cerebral Cortex) after 30 min.,10090.0,Intermediate,,,11793,1969.0,CHEMBL623309,1,BAO_0000218,,,,N,,Plasma,15137,Mus musculus,50594,A,,1
,Plasma Concentration after 120 min of oral administration to mice,10090.0,Intermediate,,,11794,,CHEMBL623310,1,BAO_0000218,,,,N,,,13509,Mus musculus,50594,A,,1
,Plasma Concentration after 30 min of oral administration to mice,10090.0,Intermediate,,,11795,,CHEMBL623311,1,BAO_0000218,,,,N,,,13509,Mus musculus,50594,A,,1
,Plasma Concentration after 60 min of oral administration to mice,9541.0,Intermediate,,,11796,,CHEMBL623312,1,BAO_0000218,,,,N,,,13509,Macaca fascicularis,100710,A,,1
,Plasma Concentration after 60 min of oral administration to mice; Not determined,10090.0,Intermediate,,,11797,,CHEMBL875350,1,BAO_0000218,,,,N,,,13509,Mus musculus,50594,A,,1
,Plasma Concentration after 90 min of oral administration to mice,10090.0,Intermediate,,,11798,,CHEMBL628635,1,BAO_0000218,,,,N,,,13509,Mus musculus,50594,A,,1
,Plasma concentration level in rat after 1 hour of oral administration at 50 mg/kg,10116.0,Intermediate,,,11799,,CHEMBL628636,1,BAO_0000218,,,,N,,,12064,Rattus norvegicus,50597,A,,1
,Plasma concentration level in rat after 15 hours of oral administration at 50 mg/kg,10116.0,Intermediate,,,11800,,CHEMBL628637,1,BAO_0000218,,,,N,,,12064,Rattus norvegicus,50597,A,,1
,Plasma concentration level in rat after 4 hours of oral administration at 50 mg/kg,10116.0,Intermediate,,,11801,,CHEMBL628058,1,BAO_0000218,,,,N,,,12064,Rattus norvegicus,50597,A,,1
,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 0-1 hr time,10116.0,Intermediate,,,11802,,CHEMBL628059,1,BAO_0000218,,,,N,,,10677,Rattus norvegicus,50597,A,,1
,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 1-2 hr time,10116.0,Intermediate,,,11803,,CHEMBL628060,1,BAO_0000218,,,,N,,,10677,Rattus norvegicus,50597,A,,1
,Distribution in the lung after 15 min of intravenous administration,,Autocuration,,,11804,,CHEMBL628061,1,BAO_0000019,,,,U,,,8926,,22224,A,,0
,Distribution in the lung after 30 min of intravenous administration,,Autocuration,,,11805,,CHEMBL628062,1,BAO_0000019,,,,U,,,8926,,22224,A,,0
,Distribution in the lung after 5 min of intravenous administration,,Autocuration,,,11806,,CHEMBL628063,1,BAO_0000019,,,,U,,,8926,,22224,A,,0
,Distribution in the lung after 60 min of intravenous administration,,Autocuration,,,11807,,CHEMBL628064,1,BAO_0000019,,,,U,,,8926,,22224,A,,0
,Distribution in the lung after 90 min of intravenous administration,,Autocuration,,,11808,,CHEMBL628065,1,BAO_0000019,,,,U,,,8926,,22224,A,,0
,Distribution in the muscle after 120 min of intravenous administration,,Autocuration,,,11809,2385.0,CHEMBL628066,1,BAO_0000019,,,,U,,Muscle tissue,8926,,22224,A,,0
,Distribution in the muscle after 15 min of intravenous administration,,Autocuration,,,11810,2385.0,CHEMBL628067,1,BAO_0000019,,,,U,,Muscle tissue,8926,,22224,A,,0
,Distribution in the muscle after 30 min of intravenous administration,10090.0,Intermediate,,,11811,2385.0,CHEMBL874646,1,BAO_0000218,,,,N,,Muscle tissue,8926,Mus musculus,50594,A,,1
,Distribution in the muscle after 5 min of intravenous administration,,Autocuration,,,11812,2385.0,CHEMBL628068,1,BAO_0000019,,,,U,,Muscle tissue,8926,,22224,A,,0
,Distribution in the muscle after 60 min of intravenous administration,,Autocuration,,,11813,2385.0,CHEMBL628069,1,BAO_0000019,,,,U,,Muscle tissue,8926,,22224,A,,0
,Distribution in the muscle after 90 min of intravenous administration,,Autocuration,,,11814,2385.0,CHEMBL628070,1,BAO_0000019,,,,U,,Muscle tissue,8926,,22224,A,,0
,Distribution in the spleen after 120 min of intravenous administration,,Autocuration,,,11815,2106.0,CHEMBL628071,1,BAO_0000019,,,,U,,Spleen,8926,,22224,A,,0
,Distribution in the spleen after 15 min of intravenous administration,,Autocuration,,,11816,2106.0,CHEMBL628072,1,BAO_0000019,,,,U,,Spleen,8926,,22224,A,,0
,Distribution in the spleen after 30 min of intravenous administration,,Autocuration,,,11817,2106.0,CHEMBL628073,1,BAO_0000019,,,,U,,Spleen,8926,,22224,A,,0
,Distribution in the spleen after 5 min of intravenous administration,,Autocuration,,,11818,2106.0,CHEMBL628074,1,BAO_0000019,,,,U,,Spleen,8926,,22224,A,,0
,Distribution in the spleen after 60 min of intravenous administration,,Autocuration,,,11819,2106.0,CHEMBL628075,1,BAO_0000019,,,,U,,Spleen,8926,,22224,A,,0
,Distribution in the spleen after 90 min of intravenous administration,,Autocuration,,,11820,2106.0,CHEMBL628076,1,BAO_0000019,,,,U,,Spleen,8926,,22224,A,,0
,Evaluated for distribution at 0.5 hr after intravenous administration in adrenal cortex of female Sprague Dawley rats,10116.0,Intermediate,,,11821,1235.0,CHEMBL628077,1,BAO_0000218,,,,N,,Adrenal cortex,7570,Rattus norvegicus,50597,A,,1
,Evaluated for distribution at 0.5 hr after intravenous administration in blood of female Sprague Dawley rats,10116.0,Intermediate,,,11822,178.0,CHEMBL628078,1,BAO_0000218,,,,N,,Blood,7570,Rattus norvegicus,50597,A,,1
,Evaluated for distribution at 0.5 hr after intravenous administration in liver of female Sprague Dawley rats,10116.0,Intermediate,,,11823,2107.0,CHEMBL628079,1,BAO_0000218,,,,N,,Liver,7570,Rattus norvegicus,50597,A,,1
,Evaluated for distribution at 0.5 hr after intravenous administration in ovary of female Sprague Dawley rats,10116.0,Intermediate,,,11824,992.0,CHEMBL628080,1,BAO_0000218,,,,N,,Female gonad,7570,Rattus norvegicus,50597,A,,1
,Evaluated for distribution at 0.5 hr after intravenous administration in thyroid of female Sprague Dawley rats,10116.0,Intermediate,,,11825,2046.0,CHEMBL628081,1,BAO_0000218,,,,N,,Thyroid gland,7570,Rattus norvegicus,50597,A,,1
,Evaluated for distribution at 24 hours after intravenous administration in adrenal cortex of female Sprague Dawley rats,10116.0,Intermediate,,,11826,1235.0,CHEMBL628082,1,BAO_0000218,,,,N,,Adrenal cortex,7570,Rattus norvegicus,50597,A,,1
,Evaluated for distribution at 24 hours after intravenous administration in blood of female Sprague Dawley rats,10116.0,Intermediate,,,11827,178.0,CHEMBL874647,1,BAO_0000218,,,,N,,Blood,7570,Rattus norvegicus,50597,A,,1
,Evaluated for distribution at 24 hours after intravenous administration in liver of female Sprague Dawley rats,10116.0,Intermediate,,,11828,2107.0,CHEMBL626406,1,BAO_0000218,,,,N,,Liver,7570,Rattus norvegicus,50597,A,,1
,Evaluated for distribution at 24 hours after intravenous administration in ovary of female Sprague Dawley rats,10116.0,Intermediate,,,11829,992.0,CHEMBL626407,1,BAO_0000218,,,,N,,Female gonad,7570,Rattus norvegicus,50597,A,,1
,Evaluated for distribution at 24 hours after intravenous administration in thyroid of female Sprague Dawley rats,10116.0,Intermediate,,,11830,2046.0,CHEMBL626408,1,BAO_0000218,,,,N,,Thyroid gland,7570,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.07-0.09",10116.0,Intermediate,,,11831,178.0,CHEMBL626409,1,BAO_0000218,,,,N,,Blood,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.10-0.13",10116.0,Intermediate,,,11832,178.0,CHEMBL626410,1,BAO_0000218,,,,N,,Blood,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.18-0.24",10116.0,Intermediate,,,11833,178.0,CHEMBL626411,1,BAO_0000218,,,,N,,Blood,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.19-0.24",10116.0,Intermediate,,,11834,178.0,CHEMBL626412,1,BAO_0000218,,,,N,,Blood,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.22-0.32",10116.0,Intermediate,,,11835,178.0,CHEMBL626413,1,BAO_0000218,,,,N,,Blood,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.25-0.32",10116.0,Intermediate,,,11836,178.0,CHEMBL626414,1,BAO_0000218,,,,N,,Blood,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.10-0.14",10116.0,Intermediate,,,11837,178.0,CHEMBL626415,1,BAO_0000218,,,,N,,Blood,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.25-0.34",10116.0,Intermediate,,,11838,178.0,CHEMBL626416,1,BAO_0000218,,,,N,,Blood,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.27-0.33",10116.0,Intermediate,,,11839,178.0,CHEMBL627062,1,BAO_0000218,,,,N,,Blood,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.32-0.46",10116.0,Intermediate,,,11840,178.0,CHEMBL627063,1,BAO_0000218,,,,N,,Blood,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.40-0.45",10116.0,Intermediate,,,11841,178.0,CHEMBL627064,1,BAO_0000218,,,,N,,Blood,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.44-0.52",10116.0,Intermediate,,,11842,178.0,CHEMBL627227,1,BAO_0000218,,,,N,,Blood,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.08-0.09",10116.0,Intermediate,,,11843,178.0,CHEMBL627228,1,BAO_0000218,,,,N,,Blood,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.12-0.14",10116.0,Intermediate,,,11844,178.0,CHEMBL627229,1,BAO_0000218,,,,N,,Blood,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.13-0.15",10116.0,Intermediate,,,11845,178.0,CHEMBL625792,1,BAO_0000218,,,,N,,Blood,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.20",10116.0,Intermediate,,,11846,178.0,CHEMBL625793,1,BAO_0000218,,,,N,,Blood,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.23",10116.0,Intermediate,,,11847,178.0,CHEMBL625794,1,BAO_0000218,,,,N,,Blood,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.16-0.21",10116.0,Intermediate,,,11848,178.0,CHEMBL625795,1,BAO_0000218,,,,N,,Blood,8608,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter AUC for the compound after intravenous administration into BALB/c Mice in plasma samples.,10090.0,Intermediate,,,11849,,CHEMBL625796,1,BAO_0000218,,,,N,,,13792,Mus musculus,50594,A,,1
,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 375 mg/kg,9615.0,Intermediate,,,11850,,CHEMBL625797,1,BAO_0000218,,,,N,,,13376,Canis lupus familiaris,50588,A,,1
,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 500 mg/kg,9615.0,Intermediate,,,11851,,CHEMBL625798,1,BAO_0000218,,,,N,,,13376,Canis lupus familiaris,50588,A,,1
,Pharmacokinetic parameter AUC evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,Autocuration,,,11852,,CHEMBL875613,1,BAO_0000218,,,,U,,,14380,,22224,A,,0
,Pharmacokinetic parameter AUC was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,Autocuration,,,11853,,CHEMBL625799,1,BAO_0000218,,,,U,,,14380,,22224,A,,0
,Pharmacokinetic parameter AUC was evaluated in 10% PEG suspension at a dose of 20 mg/kg orally,,Autocuration,,,11854,,CHEMBL625800,1,BAO_0000218,,,,U,,,14380,,22224,A,,0
,Pharmacokinetic parameter AUC was evaluated in 100% PEG solution at a dose of 20 mg/kg orally,,Autocuration,,,11855,,CHEMBL625801,1,BAO_0000218,,,,U,,,14380,,22224,A,,0
,Pharmacokinetic parameter AUC was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,,Autocuration,,,11856,,CHEMBL625802,1,BAO_0000218,,,,U,,,14380,,22224,A,,0
,Pharmacokinetic parameter AUC was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,Autocuration,,,11857,,CHEMBL625803,1,BAO_0000218,,,,U,,,14380,,22224,A,,0
,Pharmacokinetic parameter AUC was evaluated in Hp-beta-CD solution,,Autocuration,,,11858,,CHEMBL625804,1,BAO_0000019,,,,U,,,14380,,22224,A,,0
,Pharmacokinetic parameter AUC was evaluated in saline solution at a dose of 20 mg/kg orally,,Autocuration,,,11859,,CHEMBL622530,1,BAO_0000218,,,,U,,,14380,,22224,A,,0
,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h); not detected,10090.0,Intermediate,,,11860,,CHEMBL622531,1,BAO_0000218,,,,N,,,13701,Mus musculus,50594,A,,1
,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),10090.0,Intermediate,,,11861,,CHEMBL622532,1,BAO_0000218,,,,N,,,13701,Mus musculus,50594,A,,1
,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),10090.0,Intermediate,,,11862,,CHEMBL623176,1,BAO_0000218,,,,N,,,13701,Mus musculus,50594,A,,1
,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),10090.0,Intermediate,,,11863,,CHEMBL623177,1,BAO_0000218,,,,N,,,13701,Mus musculus,50594,A,,1
,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),10090.0,Intermediate,,,11864,,CHEMBL623178,1,BAO_0000218,,,,N,,,13701,Mus musculus,50594,A,,1
,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration using FMAddA as substrate in mice brain; AUC 0-r (mM.h); not detected,10090.0,Intermediate,,,11865,,CHEMBL623179,1,BAO_0000218,,,,N,,,13701,Mus musculus,50594,A,,1
,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),10090.0,Intermediate,,,11866,,CHEMBL623180,1,BAO_0000218,,,,N,,,13701,Mus musculus,50594,A,,1
,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),10090.0,Intermediate,,,11867,,CHEMBL623181,1,BAO_0000218,,,,N,,,13701,Mus musculus,50594,A,,1
,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),10090.0,Intermediate,,,11868,,CHEMBL624131,1,BAO_0000218,,,,N,,,13701,Mus musculus,50594,A,,1
,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration using 2`-F-ara-ddI as substrate in mice serum; AUC (mM.h),10090.0,Intermediate,,,11869,,CHEMBL624132,1,BAO_0000218,,,,N,,,13701,Mus musculus,50594,A,,1
,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),10090.0,Intermediate,,,11870,,CHEMBL624133,1,BAO_0000218,,,,N,,,13701,Mus musculus,50594,A,,1
,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h).,10090.0,Intermediate,,,11871,,CHEMBL624846,1,BAO_0000218,,,,N,,,13701,Mus musculus,50594,A,,1
,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),10090.0,Intermediate,,,11872,,CHEMBL624847,1,BAO_0000218,,,,N,,,13701,Mus musculus,50594,A,,1
,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),10090.0,Intermediate,,,11873,,CHEMBL624848,1,BAO_0000218,,,,N,,,13701,Mus musculus,50594,A,,1
,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),10090.0,Intermediate,,,11874,,CHEMBL625012,1,BAO_0000218,,,,N,,,13701,Mus musculus,50594,A,,1
,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),10090.0,Intermediate,,,11875,,CHEMBL625013,1,BAO_0000218,,,,N,,,13701,Mus musculus,50594,A,,1
,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain; AUC 0-r (mM.h); not detected,10090.0,Intermediate,,,11876,,CHEMBL625014,1,BAO_0000218,,,,N,,,13701,Mus musculus,50594,A,,1
,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC (mM.h),10090.0,Intermediate,,,11877,,CHEMBL625015,1,BAO_0000218,,,,N,,,13701,Mus musculus,50594,A,,1
,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),10090.0,Intermediate,,,11878,,CHEMBL625016,1,BAO_0000218,,,,N,,,13701,Mus musculus,50594,A,,1
,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral in mice brain; AUC (mM.h); not detected,10090.0,Intermediate,,,11879,,CHEMBL625017,1,BAO_0000218,,,,N,,,13701,Mus musculus,50594,A,,1
,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),10090.0,Intermediate,,,11880,,CHEMBL625018,1,BAO_0000218,,,,N,,,13701,Mus musculus,50594,A,,1
,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration mice serum.; AUC 0-r (mM.h),10090.0,Intermediate,,,11881,,CHEMBL625019,1,BAO_0000218,,,,N,,,13701,Mus musculus,50594,A,,1
,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain.; AUC 0-r (mM.h),10090.0,Intermediate,,,11882,,CHEMBL625020,1,BAO_0000218,,,,N,,,13701,Mus musculus,50594,A,,1
,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum.,10090.0,Intermediate,,,11883,,CHEMBL625021,1,BAO_0000218,,,,N,,,13701,Mus musculus,50594,A,,1
,Pharmacokinetic parameter [area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,10116.0,Intermediate,,,11884,,CHEMBL625022,1,BAO_0000218,,,,N,,,14393,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter area under the curve (0-24 hr) for the compound was evaluated in nude mice after oral administration. ,10090.0,Intermediate,,,11885,,CHEMBL625023,1,BAO_0000218,,,,N,,,14731,Mus musculus,50594,A,,1
,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration,9541.0,Intermediate,,,11886,,CHEMBL625024,1,BAO_0000218,,,,N,,,14731,Macaca fascicularis,100710,A,,1
,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,9541.0,Intermediate,,,11887,,CHEMBL627626,1,BAO_0000218,,,,N,,,14731,Macaca fascicularis,100710,A,,1
,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,,Autocuration,,,11888,955.0,CHEMBL627627,1,BAO_0000218,,,,U,,Brain,13758,,22224,A,,0
,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in serum,,Autocuration,,,11889,1977.0,CHEMBL627628,1,BAO_0000218,,,,U,,Serum,13758,,22224,A,,0
,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,,Autocuration,,,11890,955.0,CHEMBL627629,1,BAO_0000218,,,,U,,Brain,13758,,22224,A,,0
,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in serum,,Autocuration,,,11891,1977.0,CHEMBL627630,1,BAO_0000218,,,,U,,Serum,13758,,22224,A,,0
,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/Kg orally; range (0.19-0.35),,Autocuration,,,11892,,CHEMBL627631,1,BAO_0000019,,,,U,,,16359,,22224,A,,0
,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/kg intravenously; range (2.1-2.3),,Autocuration,,,11893,,CHEMBL629515,1,BAO_0000218,,,,U,,,16359,,22224,A,,0
,In vivo biodistribution in mice spleen bearing intracerebral GL261 gliomas at the dose of 30 ug/day,10090.0,Intermediate,,,11894,2106.0,CHEMBL629516,1,BAO_0000218,,,,N,,Spleen,15383,Mus musculus,50594,A,,1
,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 30 ug/g,10090.0,Intermediate,,,11895,2106.0,CHEMBL629517,1,BAO_0000218,,,,N,,Spleen,15383,Mus musculus,50594,A,,1
,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 40 ug/g,10090.0,Intermediate,,,11896,2106.0,CHEMBL629518,1,BAO_0000218,,,,N,,Spleen,15383,Mus musculus,50594,A,,1
,In vivo biodistribution in mice tumor bearing intracerebral GL261 gliomas at the dose of 30 ug/day,10090.0,Intermediate,,,11897,,CHEMBL877499,1,BAO_0000218,,,,N,,,15383,Mus musculus,50594,A,,1
,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 20 ug/g,10090.0,Intermediate,,,11898,,CHEMBL629519,1,BAO_0000218,,,,N,,,15383,Mus musculus,50594,A,,1
,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 30 ug/g,10090.0,Intermediate,,,11899,,CHEMBL629520,1,BAO_0000218,,,,N,,,15383,Mus musculus,50594,A,,1
,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 40 ug/g,10090.0,Intermediate,,,11900,,CHEMBL629521,1,BAO_0000218,,,,N,,,15383,Mus musculus,50594,A,,1
,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Blood (B),10090.0,Intermediate,,,11901,,CHEMBL629522,1,BAO_0000218,,,,N,,,14439,Mus musculus,50594,A,,1
,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Lung (L),10090.0,Intermediate,,,11902,,CHEMBL629523,1,BAO_0000218,,,,N,,,14439,Mus musculus,50594,A,,1
,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and Muscle (M),10090.0,Intermediate,,,11903,,CHEMBL629524,1,BAO_0000218,,,,N,,,14439,Mus musculus,50594,A,,1
,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and blood (B),10090.0,Intermediate,,,11904,,CHEMBL629525,1,BAO_0000218,,,,N,,,14439,Mus musculus,50594,A,,1
,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Blood (B),10090.0,Intermediate,,,11905,,CHEMBL629526,1,BAO_0000218,,,,N,,,14439,Mus musculus,50594,A,,1
,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Lung (L),10090.0,Intermediate,,,11906,,CHEMBL629527,1,BAO_0000218,,,,N,,,14439,Mus musculus,50594,A,,1
,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and Muscle (M),10090.0,Intermediate,,,11907,,CHEMBL629528,1,BAO_0000218,,,,N,,,14439,Mus musculus,50594,A,,1
,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and blood (B),10090.0,Intermediate,,,11908,,CHEMBL629529,1,BAO_0000218,,,,N,,,14439,Mus musculus,50594,A,,1
,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Blood (B),10090.0,Intermediate,,,11909,,CHEMBL629530,1,BAO_0000218,,,,N,,,14439,Mus musculus,50594,A,,1
,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Lung (L),10090.0,Intermediate,,,11910,,CHEMBL629531,1,BAO_0000218,,,,N,,,14439,Mus musculus,50594,A,,1
,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and Muscle (M),10090.0,Intermediate,,,11911,,CHEMBL628656,1,BAO_0000218,,,,N,,,14439,Mus musculus,50594,A,,1
,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and blood (B),10090.0,Intermediate,,,11912,,CHEMBL628657,1,BAO_0000218,,,,N,,,14439,Mus musculus,50594,A,,1
,"Biodistribution in abdominal Dawley rat after 30min, expressed as percent injected dose/g",10116.0,Intermediate,,,11913,,CHEMBL628658,1,BAO_0000218,,In vivo,,N,,,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in abdominal of mature female Dawley rat after 10min, expressed as percent injected dose/g",10116.0,Intermediate,,,11914,,CHEMBL628659,1,BAO_0000218,,In vivo,,N,,,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in abdominal of mature female Dawley rat after 15min, expressed as percent injected dose/g",10116.0,Intermediate,,,11915,,CHEMBL877500,1,BAO_0000218,,In vivo,,N,,,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in abdominal of mature female Dawley rat after 1h, expressed as percent injected dose/g",10116.0,Intermediate,,,11916,,CHEMBL628660,1,BAO_0000218,,In vivo,,N,,,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in abdominal of mature female Dawley rat after 3 h, expressed as percent injected dose/g",10116.0,Intermediate,,,11917,,CHEMBL628661,1,BAO_0000218,,In vivo,,N,,,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in abdominal of mature female Dawley rat after 30min, expressed as percent injected dose/g",10116.0,Intermediate,,,11918,,CHEMBL628662,1,BAO_0000218,,In vivo,,N,,,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in abdominal of mature female Dawley rat after 45min, expressed as percent injected dose/g",10116.0,Intermediate,,,11919,,CHEMBL628663,1,BAO_0000218,,In vivo,,N,,,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in abdominal of mature female Dawley rat after 5min, expressed as percent injected dose/g",10116.0,Intermediate,,,11920,,CHEMBL628664,1,BAO_0000218,,In vivo,,N,,,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in blood of mature female Dawley rat after 10min, expressed as percent injected dose/g",10116.0,Intermediate,,,11921,178.0,CHEMBL628665,1,BAO_0000218,,In vivo,,N,,Blood,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in blood of mature female Dawley rat after 15min, expressed as percent injected dose/g",10116.0,Intermediate,,,11922,178.0,CHEMBL628666,1,BAO_0000218,,In vivo,,N,,Blood,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in blood of mature female Dawley rat after 1h, expressed as percent injected dose/g",10116.0,Intermediate,,,11923,178.0,CHEMBL628667,1,BAO_0000218,,In vivo,,N,,Blood,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in blood of mature female Dawley rat after 3 h, expressed as percent injected dose/g",10116.0,Intermediate,,,11924,178.0,CHEMBL628668,1,BAO_0000218,,In vivo,,N,,Blood,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in blood of mature female Dawley rat after 30min, expressed as percent injected dose/g",10116.0,Intermediate,,,11925,178.0,CHEMBL628669,1,BAO_0000218,,In vivo,,N,,Blood,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in blood of mature female Dawley rat after 45min, expressed as percent injected dose/g",10116.0,Intermediate,,,11926,178.0,CHEMBL628670,1,BAO_0000218,,In vivo,,N,,Blood,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in blood of mature female Dawley rat after 5min, expressed as percent injected dose/g",10116.0,Intermediate,,,11927,178.0,CHEMBL628671,1,BAO_0000218,,In vivo,,N,,Blood,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in bone of mature female Dawley rat after 10min, expressed as percent injected dose/g",10116.0,Intermediate,,,11928,10000001.0,CHEMBL628672,1,BAO_0000218,,In vivo,,N,,Bone,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in bone of mature female Dawley rat after 1h, expressed as percent injected dose/g",10116.0,Intermediate,,,11929,10000001.0,CHEMBL630300,1,BAO_0000218,,In vivo,,N,,Bone,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in bone of mature female Dawley rat after 3 h, expressed as percent injected dose/g",10116.0,Intermediate,,,11930,10000001.0,CHEMBL629787,1,BAO_0000218,,In vivo,,N,,Bone,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in bone of mature female Dawley rat after 30min, expressed as percent injected dose/g",10116.0,Intermediate,,,11931,10000001.0,CHEMBL629788,1,BAO_0000218,,In vivo,,N,,Bone,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in brain of mature female Dawley rat after 10min, expressed as percent injected dose/g",10116.0,Intermediate,,,11932,955.0,CHEMBL629789,1,BAO_0000218,,In vivo,,N,,Brain,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in brain of mature female Dawley rat after 15min, expressed as percent injected dose/g",10116.0,Intermediate,,,11933,955.0,CHEMBL629790,1,BAO_0000218,,In vivo,,N,,Brain,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in brain of mature female Dawley rat after 1h, expressed as percent injected dose/g",10116.0,Intermediate,,,11934,955.0,CHEMBL629791,1,BAO_0000218,,In vivo,,N,,Brain,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in brain of mature female Dawley rat after 3 h, expressed as percent injected dose/g",10116.0,Intermediate,,,11935,955.0,CHEMBL629792,1,BAO_0000218,,In vivo,,N,,Brain,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",10116.0,Intermediate,,,11936,955.0,CHEMBL629793,1,BAO_0000218,,In vivo,,N,,Brain,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in brain of mature female Dawley rat after 45min, expressed as percent injected dose/g",10116.0,Intermediate,,,11937,955.0,CHEMBL629794,1,BAO_0000218,,In vivo,,N,,Brain,13751,Rattus norvegicus,50597,A,,1
,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 2-3 hr time,10116.0,Intermediate,,,11938,,CHEMBL874459,1,BAO_0000218,,,,N,,,10677,Rattus norvegicus,50597,A,,1
,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 3-4 hr time,10116.0,Intermediate,,,11939,,CHEMBL629795,1,BAO_0000218,,,,N,,,10677,Rattus norvegicus,50597,A,,1
,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 4-5 hr time,10116.0,Intermediate,,,11940,,CHEMBL629796,1,BAO_0000218,,,,N,,,10677,Rattus norvegicus,50597,A,,1
,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 5-6 hr time,10116.0,Intermediate,,,11941,,CHEMBL629797,1,BAO_0000218,,,,N,,,10677,Rattus norvegicus,50597,A,,1
,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 6-24 h time,10116.0,Intermediate,,,11942,,CHEMBL629798,1,BAO_0000218,,,,N,,,10677,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,11943,2369.0,CHEMBL629799,1,BAO_0000218,,In vivo,,N,,Adrenal gland,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,11944,2369.0,CHEMBL629800,1,BAO_0000218,,In vivo,,N,,Adrenal gland,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the adrenals of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,11945,2369.0,CHEMBL629801,1,BAO_0000218,,In vivo,,N,,Adrenal gland,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour,10116.0,Intermediate,,,11946,2369.0,CHEMBL629802,1,BAO_0000218,,In vivo,,N,,Adrenal gland,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,11947,2369.0,CHEMBL629803,1,BAO_0000218,,In vivo,,N,,Adrenal gland,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the blood of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,11948,178.0,CHEMBL629804,1,BAO_0000218,,In vivo,,N,,Blood,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the blood of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,11949,178.0,CHEMBL629805,1,BAO_0000218,,In vivo,,N,,Blood,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the blood of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,11950,178.0,CHEMBL629806,1,BAO_0000218,,In vivo,,N,,Blood,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the blood of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,11951,178.0,CHEMBL629807,1,BAO_0000218,,In vivo,,N,,Blood,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the blood of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,11952,178.0,CHEMBL629808,1,BAO_0000218,,In vivo,,N,,Blood,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the brain of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,11953,955.0,CHEMBL629809,1,BAO_0000218,,In vivo,,N,,Brain,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the brain of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,11954,955.0,CHEMBL629810,1,BAO_0000218,,In vivo,,N,,Brain,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the brain of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,11955,955.0,CHEMBL629811,1,BAO_0000218,,In vivo,,N,,Brain,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the brain of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,11956,955.0,CHEMBL629812,1,BAO_0000218,,In vivo,,N,,Brain,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the brain of immature Fischer female rats at 5 hou; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,11957,955.0,CHEMBL629813,1,BAO_0000218,,In vivo,,N,,Brain,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the brain of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,11958,955.0,CHEMBL874460,1,BAO_0000218,,In vivo,,N,,Brain,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the fat of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,11959,,CHEMBL629814,1,BAO_0000218,,In vivo,,N,,,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the fat of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,11960,,CHEMBL629815,1,BAO_0000218,,In vivo,,N,,,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the fat of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,11961,,CHEMBL629816,1,BAO_0000218,,In vivo,,N,,,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the fat of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,11962,,CHEMBL629817,1,BAO_0000218,,In vivo,,N,,,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,11963,2113.0,CHEMBL626643,1,BAO_0000218,,In vivo,,N,,Kidney,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,11964,2113.0,CHEMBL626644,1,BAO_0000218,,In vivo,,N,,Kidney,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the kidneys of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,11965,2113.0,CHEMBL626806,1,BAO_0000218,,In vivo,,N,,Kidney,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the kidneys of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,11966,2113.0,CHEMBL626807,1,BAO_0000218,,In vivo,,N,,Kidney,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the liver of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,11967,2107.0,CHEMBL627261,1,BAO_0000218,,In vivo,,N,,Liver,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the liver of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,11968,2107.0,CHEMBL627262,1,BAO_0000218,,In vivo,,N,,Liver,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the liver of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,11969,2107.0,CHEMBL627263,1,BAO_0000218,,In vivo,,N,,Liver,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the liver of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,11970,2107.0,CHEMBL627264,1,BAO_0000218,,In vivo,,N,,Liver,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the lungs of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,11971,2048.0,CHEMBL627265,1,BAO_0000218,,In vivo,,N,,Lung,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the lungs of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,11972,2048.0,CHEMBL627266,1,BAO_0000218,,In vivo,,N,,Lung,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the lungs of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,11973,2048.0,CHEMBL627267,1,BAO_0000218,,In vivo,,N,,Lung,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the lungs of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,11974,2048.0,CHEMBL627268,1,BAO_0000218,,In vivo,,N,,Lung,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the muscle of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,11975,2385.0,CHEMBL627269,1,BAO_0000218,,In vivo,,N,,Muscle tissue,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the muscle of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,11976,2385.0,CHEMBL627270,1,BAO_0000218,,In vivo,,N,,Muscle tissue,10911,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 0.95-1.44",10116.0,Intermediate,,,11977,,CHEMBL627271,1,BAO_0000218,,,,N,,,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 1.39-2.43",10116.0,Intermediate,,,11978,,CHEMBL627946,1,BAO_0000218,,,,N,,,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.47-2.96",10116.0,Intermediate,,,11979,,CHEMBL875472,1,BAO_0000218,,,,N,,,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-3.69",10116.0,Intermediate,,,11980,,CHEMBL627947,1,BAO_0000218,,,,N,,,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-4.31",10116.0,Intermediate,,,11981,,CHEMBL627948,1,BAO_0000218,,,,N,,,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 3.17-4.70",10116.0,Intermediate,,,11982,,CHEMBL628113,1,BAO_0000218,,,,N,,,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration.; dose/g, range 2.20-2.97",10116.0,Intermediate,,,11983,,CHEMBL628114,1,BAO_0000218,,,,N,,,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 0.90-1.46",10116.0,Intermediate,,,11984,,CHEMBL628115,1,BAO_0000218,,,,N,,,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.72-3.52",10116.0,Intermediate,,,11985,,CHEMBL628116,1,BAO_0000218,,,,N,,,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.78-3.62",10116.0,Intermediate,,,11986,,CHEMBL628117,1,BAO_0000218,,,,N,,,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.82-3.86",10116.0,Intermediate,,,11987,,CHEMBL628118,1,BAO_0000218,,,,N,,,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 3.80-5.74",10116.0,Intermediate,,,11988,,CHEMBL628119,1,BAO_0000218,,,,N,,,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.05-1.57",10116.0,Intermediate,,,11989,,CHEMBL628120,1,BAO_0000218,,,,N,,,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.93-3.58",10116.0,Intermediate,,,11990,,CHEMBL628121,1,BAO_0000218,,,,N,,,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 2.88-4.32",10116.0,Intermediate,,,11991,,CHEMBL628122,1,BAO_0000218,,,,N,,,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3-3.70",10116.0,Intermediate,,,11992,,CHEMBL627297,1,BAO_0000218,,,,N,,,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.21-3.92",10116.0,Intermediate,,,11993,,CHEMBL627298,1,BAO_0000218,,,,N,,,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.51-5.44",10116.0,Intermediate,,,11994,,CHEMBL627299,1,BAO_0000218,,,,N,,,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 0.24-0.31",10116.0,Intermediate,,,11995,,CHEMBL627300,1,BAO_0000218,,,,N,,,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 10.5-14.4",10116.0,Intermediate,,,11996,,CHEMBL627301,1,BAO_0000218,,,,N,,,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.28-7.41",10116.0,Intermediate,,,11997,,CHEMBL627302,1,BAO_0000218,,,,N,,,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.47-10.2",10116.0,Intermediate,,,11998,,CHEMBL627303,1,BAO_0000218,,,,N,,,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 7.21-7.95",10116.0,Intermediate,,,11999,,CHEMBL627304,1,BAO_0000218,,,,N,,,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 8.28-10.72",10116.0,Intermediate,,,12000,,CHEMBL627305,1,BAO_0000218,,,,N,,,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 1.04-2.56",10116.0,Intermediate,,,12001,,CHEMBL627306,1,BAO_0000218,,,,N,,,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 10.7-16.9",10116.0,Intermediate,,,12002,,CHEMBL623982,1,BAO_0000218,,,,N,,,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 11.7-14.6",10116.0,Intermediate,,,12003,,CHEMBL623983,1,BAO_0000218,,,,N,,,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 14.4-20.1",10116.0,Intermediate,,,12004,,CHEMBL623984,1,BAO_0000218,,,,N,,,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 4.78-9.72",10116.0,Intermediate,,,12005,,CHEMBL623985,1,BAO_0000218,,,,N,,,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 9.87-11.9",10116.0,Intermediate,,,12006,,CHEMBL623986,1,BAO_0000218,,,,N,,,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 0.17-0.25",10116.0,Intermediate,,,12007,,CHEMBL623987,1,BAO_0000218,,,,N,,,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 3.33-4.68",10116.0,Intermediate,,,12008,,CHEMBL623988,1,BAO_0000218,,,,N,,,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.59-8.81",10116.0,Intermediate,,,12009,,CHEMBL623989,1,BAO_0000218,,,,N,,,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.62-5.60",10116.0,Intermediate,,,12010,,CHEMBL622215,1,BAO_0000218,,,,N,,,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.02-6.57",10116.0,Intermediate,,,12011,,CHEMBL622216,1,BAO_0000218,,,,N,,,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.67-8.41",10116.0,Intermediate,,,12012,,CHEMBL877481,1,BAO_0000218,,,,N,,,8608,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter was evaluated which is represented as AUC when administered orally a dose of 5 mg/kg; range (4.2-8.8),,Autocuration,,,12013,,CHEMBL622217,1,BAO_0000218,,,,U,,,16359,,22224,A,,0
,Pharmacokinetic parameters was measured at 55 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),10090.0,Intermediate,,,12014,,CHEMBL622218,1,BAO_0000218,,,,N,,,13701,Mus musculus,50594,A,,1
,Pharmacokinetic profile AUC was evaluated in rats,10116.0,Intermediate,,,12015,,CHEMBL622219,1,BAO_0000218,,,,N,,,14554,Rattus norvegicus,50597,A,,1
,Pharmacokinetic property (Area under curve),,Autocuration,,,12016,,CHEMBL622220,1,BAO_0000019,,,,U,,,6241,,22224,A,,0
,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg).",9615.0,Intermediate,,,12017,,CHEMBL622221,1,BAO_0000218,,,,N,,,11537,Canis lupus familiaris,50588,A,,1
,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg).",10090.0,Intermediate,,,12018,,CHEMBL622222,1,BAO_0000218,,,,N,,,11537,Mus musculus,50594,A,,1
,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to dog (25 mg/kg).",9615.0,Intermediate,,,12019,,CHEMBL622223,1,BAO_0000218,,,,N,,,11537,Canis lupus familiaris,50588,A,,1
,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to mice (50 mg/kg).",10090.0,Intermediate,,,12020,,CHEMBL622224,1,BAO_0000218,,,,N,,,11537,Mus musculus,50594,A,,1
,Plasma concentration (AUC) was determined,,Autocuration,,,12021,,CHEMBL622225,1,BAO_0000019,,,,U,,,13118,,22224,A,,0
,Plasma concentration (AUC) was determined; Not detectable,,Autocuration,,,12022,,CHEMBL622226,1,BAO_0000019,,,,U,,,13118,,22224,A,,0
,Prolongation of time to collapse in guinea pig treated with aerosolized histamine was measured in vivo as area under curve (AUC),10141.0,Intermediate,,,12023,,CHEMBL624154,1,BAO_0000218,,,,N,,,9562,Cavia porcellus,50512,A,,1
,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg,10116.0,Intermediate,,,12024,,CHEMBL624155,1,BAO_0000218,,,,N,,,10363,Rattus norvegicus,50597,A,,1
,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,10116.0,Intermediate,,,12025,,CHEMBL624156,1,BAO_0000218,,,,N,,,10363,Rattus norvegicus,50597,A,,1
,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 60 mg/kg,10116.0,Intermediate,,,12026,,CHEMBL624157,1,BAO_0000218,,,,N,,,10363,Rattus norvegicus,50597,A,,1
,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 7.5 mg/kg,10116.0,Intermediate,,,12027,,CHEMBL624158,1,BAO_0000218,,,,N,,,10363,Rattus norvegicus,50597,A,,1
,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 1,10116.0,Intermediate,,,12028,,CHEMBL624159,1,BAO_0000218,,,,N,,,12504,Rattus norvegicus,50597,A,,1
,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 2,10116.0,Intermediate,,,12029,,CHEMBL624160,1,BAO_0000218,,,,N,,,12504,Rattus norvegicus,50597,A,,1
,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 3,10116.0,Intermediate,,,12030,,CHEMBL624161,1,BAO_0000218,,,,N,,,12504,Rattus norvegicus,50597,A,,1
,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 4,10116.0,Intermediate,,,12031,,CHEMBL624162,1,BAO_0000218,,,,N,,,12504,Rattus norvegicus,50597,A,,1
,Tested for pharmacokinetic parameter in fasted Beagle dogs (Area Under Curve value) iv administration.,9615.0,Intermediate,,,12032,,CHEMBL624163,1,BAO_0000218,,,,N,,,13317,Canis lupus familiaris,50588,A,,1
,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",10116.0,Intermediate,,,12033,,CHEMBL624164,1,BAO_0000218,,,,N,,,15078,Rattus norvegicus,50597,A,,1
,The AUC(0-infinity) values in female wistar rats.,10116.0,Intermediate,,,12034,,CHEMBL624165,1,BAO_0000218,,,,N,,,14941,Rattus norvegicus,50597,A,,1
,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",10116.0,Intermediate,,,12035,,CHEMBL624166,1,BAO_0000218,,,,N,,,15078,Rattus norvegicus,50597,A,,1
,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose in mice",10116.0,Intermediate,,,12036,,CHEMBL624167,1,BAO_0000218,,,,N,,,15078,Rattus norvegicus,50597,A,,1
,The AUC(0-t)values in female wistar rats.,10116.0,Intermediate,,,12037,,CHEMBL624168,1,BAO_0000218,,,,N,,,14941,Rattus norvegicus,50597,A,,1
,The Area under the concentration time curve of compound was measured on rats,10116.0,Intermediate,,,12038,,CHEMBL624169,1,BAO_0000218,,,,N,,,14067,Rattus norvegicus,50597,A,,1
,The area under curve (100 mg/kg) administered orally in humans,9606.0,Intermediate,,,12039,,CHEMBL624170,1,BAO_0000218,,,,N,,,14215,Homo sapiens,50587,A,,1
,The area under curve (12.5 mg/kg) administered intravenously in marmoset,9481.0,Autocuration,,,12040,,CHEMBL624171,1,BAO_0000218,,,,U,,,14215,Callithrix,22224,A,,0
,The area under curve (12.5 mg/kg) administered intravenously in monkey,314293.0,Autocuration,,,12041,,CHEMBL624172,1,BAO_0000218,,,,U,,,14215,Simiiformes,22224,A,,0
,The area under curve (15 mg/kg) administered intravenously in dog,9615.0,Intermediate,,,12042,,CHEMBL624173,1,BAO_0000218,,,,N,,,14215,Canis lupus familiaris,50588,A,,1
,The area under curve (200 mg/kg) administered orally in humans,9606.0,Intermediate,,,12043,,CHEMBL877488,1,BAO_0000218,,,,N,,,14215,Homo sapiens,50587,A,,1
,The area under curve (25 mg/kg) administered intravenously in rat,10116.0,Intermediate,,,12044,,CHEMBL624174,1,BAO_0000218,,,,N,,,14215,Rattus norvegicus,50597,A,,1
,The area under curve (25 mg/kg) administered orally in marmoset,9481.0,Autocuration,,,12045,,CHEMBL624175,1,BAO_0000218,,,,U,,,14215,Callithrix,22224,A,,0
,The area under curve (25 mg/kg) administered orally in monkey,314293.0,Autocuration,,,12046,,CHEMBL624176,1,BAO_0000218,,,,U,,,14215,Simiiformes,22224,A,,0
,The area under curve (30 mg/kg) administered orally in dog,9615.0,Intermediate,,,12047,,CHEMBL624177,1,BAO_0000218,,,,N,,,14215,Canis lupus familiaris,50588,A,,1
,The area under curve (400 mg/kg) administered orally in humans,9606.0,Intermediate,,,12048,,CHEMBL624178,1,BAO_0000218,,,,N,,,14215,Homo sapiens,50587,A,,1
,The area under curve (50 mg/kg) administered orally in fasted rat,10116.0,Intermediate,,,12049,,CHEMBL624179,1,BAO_0000218,,,,N,,,14215,Rattus norvegicus,50597,A,,1
,The area under curve (50 mg/kg) administered orally in rat,10116.0,Intermediate,,,12050,,CHEMBL627689,1,BAO_0000218,,,,N,,,14215,Rattus norvegicus,50597,A,,1
,The area under curve (800 mg/kg) administered orally in humans,9606.0,Intermediate,,,12051,,CHEMBL627690,1,BAO_0000218,,,,N,,,14215,Homo sapiens,50587,A,,1
,The compound was evaluated for area under the curve,,Autocuration,,,12052,,CHEMBL627691,1,BAO_0000019,,,,U,,,11324,,22224,A,,0
,The compound was evaluated for area under the curve in marmosets,9481.0,Autocuration,,,12053,,CHEMBL627692,1,BAO_0000019,,,,U,,,11324,Callithrix,22224,A,,0
,The compound was evaluated for area under the curve in marmosets,9481.0,Autocuration,,,12054,,CHEMBL627693,1,BAO_0000019,,,,U,,,11324,Callithrix,22224,A,,0
,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,10116.0,Intermediate,,,12055,,CHEMBL627694,1,BAO_0000218,,,,N,,,13875,Rattus norvegicus,50597,A,,1
,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po) in conscious spontaneously hypertensive rat,10116.0,Intermediate,,,12056,,CHEMBL627695,1,BAO_0000218,,,,N,,,13875,Rattus norvegicus,50597,A,,1
,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po),,Autocuration,,,12057,,CHEMBL627696,1,BAO_0000218,,,,U,,,13875,,22224,A,,0
,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,10116.0,Intermediate,,,12058,,CHEMBL627697,1,BAO_0000218,,,,N,,,13875,Rattus norvegicus,50597,A,,1
,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,10116.0,Intermediate,,,12059,,CHEMBL627698,1,BAO_0000218,,,,N,,,13875,Rattus norvegicus,50597,A,,1
,The compound was tested for the area of the change in MABP versus time curve at dose 5 mg/kg (po) in conscious spontaneously hypertensive rat,10116.0,Intermediate,,,12060,,CHEMBL627699,1,BAO_0000218,,,,N,,,13875,Rattus norvegicus,50597,A,,1
,Total absorption was estimated by area under curve (AUC) after intravenous administration in rat,10116.0,Intermediate,,,12061,,CHEMBL627700,1,BAO_0000218,,,,N,,,13807,Rattus norvegicus,50597,A,,1
,Total drug exposure is determined after oral dosing in rats.,10116.0,Intermediate,,,12062,,CHEMBL627701,1,BAO_0000218,,,,N,,,14127,Rattus norvegicus,50597,A,,1
,Total drug exposure (5 mg/kg) when administered intravenously,,Autocuration,,,12063,,CHEMBL627702,1,BAO_0000218,,,,U,,,15116,,22224,A,,0
,Total drug exposure (5 mg/kg) when administered orally,,Autocuration,,,12064,,CHEMBL627703,1,BAO_0000218,,,,U,,,15116,,22224,A,,0
,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,314293.0,Autocuration,,,12065,,CHEMBL626873,1,BAO_0000218,,,,U,,,15604,Simiiformes,22224,A,,0
,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,10116.0,Intermediate,,,12066,,CHEMBL629583,1,BAO_0000218,,,,N,,,15604,Rattus norvegicus,50597,A,,1
,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,9615.0,Intermediate,,,12067,,CHEMBL629584,1,BAO_0000218,,,,N,,,15604,Canis lupus familiaris,50588,A,,1
,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,9615.0,Intermediate,,,12068,,CHEMBL629585,1,BAO_0000218,,,,N,,,15604,Canis lupus familiaris,50588,A,,1
,"Biodistribution in brain of mature female Dawley rat after 5min, expressed as percent injected dose/g",10116.0,Intermediate,,,12069,955.0,CHEMBL629586,1,BAO_0000218,,In vivo,,N,,Brain,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",10116.0,Intermediate,,,12070,955.0,CHEMBL629587,1,BAO_0000218,,In vivo,,N,,Brain,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in fat of mature female Dawley rat after 10min, expressed as percent injected dose/g",10116.0,Intermediate,,,12071,,CHEMBL629588,1,BAO_0000218,,In vivo,,N,,,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in fat of mature female Dawley rat after 15min, expressed as percent injected dose/g",10116.0,Intermediate,,,12072,,CHEMBL629589,1,BAO_0000218,,In vivo,,N,,,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in fat of mature female Dawley rat after 1h, expressed as percent injected dose/g",10116.0,Intermediate,,,12073,,CHEMBL629590,1,BAO_0000218,,In vivo,,N,,,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in fat of mature female Dawley rat after 3 h, expressed as percent injected dose/g",10116.0,Intermediate,,,12074,,CHEMBL629591,1,BAO_0000218,,In vivo,,N,,,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in fat of mature female Dawley rat after 30min, expressed as percent injected dose/g",10116.0,Intermediate,,,12075,,CHEMBL629592,1,BAO_0000218,,In vivo,,N,,,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in fat of mature female Dawley rat after 45min, expressed as percent injected dose/g",10116.0,Intermediate,,,12076,,CHEMBL629593,1,BAO_0000218,,In vivo,,N,,,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in fat of mature female Dawley rat after 5min, expressed as percent injected dose/g",10116.0,Intermediate,,,12077,,CHEMBL629594,1,BAO_0000218,,In vivo,,N,,,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in heart of mature female Dawley rat after 10min, expressed as percent injected dose/g",10116.0,Intermediate,,,12078,948.0,CHEMBL629595,1,BAO_0000218,,In vivo,,N,,Heart,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in heart of mature female Dawley rat after 15min, expressed as percent injected dose/g",10116.0,Intermediate,,,12079,948.0,CHEMBL630290,1,BAO_0000218,,In vivo,,N,,Heart,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in heart of mature female Dawley rat after 1h, expressed as percent injected dose/g",10116.0,Intermediate,,,12080,948.0,CHEMBL627137,1,BAO_0000218,,In vivo,,N,,Heart,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in heart of mature female Dawley rat after 3 h, expressed as percent injected dose/g",10116.0,Intermediate,,,12081,948.0,CHEMBL627138,1,BAO_0000218,,In vivo,,N,,Heart,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in heart of mature female Dawley rat after 30min, expressed as percent injected dose/g",10116.0,Intermediate,,,12082,948.0,CHEMBL627139,1,BAO_0000218,,In vivo,,N,,Heart,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in heart of mature female Dawley rat after 45min, expressed as percent injected dose/g",10116.0,Intermediate,,,12083,948.0,CHEMBL627140,1,BAO_0000218,,In vivo,,N,,Heart,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in heart of mature female Dawley rat after 5min, expressed as percent injected dose/g",10116.0,Intermediate,,,12084,948.0,CHEMBL627141,1,BAO_0000218,,In vivo,,N,,Heart,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in kidney of mature female Dawley rat after 10min, expressed as percent injected dose/g",10116.0,Intermediate,,,12085,2113.0,CHEMBL627142,1,BAO_0000218,,In vivo,,N,,Kidney,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in kidney of mature female Dawley rat after 15min, expressed as percent injected dose/g",10116.0,Intermediate,,,12086,2113.0,CHEMBL627143,1,BAO_0000218,,In vivo,,N,,Kidney,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in kidney of mature female Dawley rat after 1h, expressed as percent injected dose/g",10116.0,Intermediate,,,12087,2113.0,CHEMBL874449,1,BAO_0000218,,In vivo,,N,,Kidney,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in kidney of mature female Dawley rat after 3 h, expressed as percent injected dose/g",10116.0,Intermediate,,,12088,2113.0,CHEMBL627144,1,BAO_0000218,,In vivo,,N,,Kidney,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in kidney of mature female Dawley rat after 30min, expressed as percent injected dose/g",10116.0,Intermediate,,,12089,2113.0,CHEMBL627145,1,BAO_0000218,,In vivo,,N,,Kidney,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in kidney of mature female Dawley rat after 45min, expressed as percent injected dose/g",10116.0,Intermediate,,,12090,2113.0,CHEMBL627146,1,BAO_0000218,,In vivo,,N,,Kidney,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in kidney of mature female Dawley rat after 5min, expressed as percent injected dose/g",10116.0,Intermediate,,,12091,2113.0,CHEMBL627147,1,BAO_0000218,,In vivo,,N,,Kidney,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in liver of mature female Dawley rat after 10min, expressed as percent injected dose/g",10116.0,Intermediate,,,12092,2107.0,CHEMBL627148,1,BAO_0000218,,In vivo,,N,,Liver,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in lung of mature female Dawley rat after 10min, expressed as percent injected dose/g",10116.0,Intermediate,,,12093,2048.0,CHEMBL627149,1,BAO_0000218,,In vivo,,N,,Lung,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in lung of mature female Dawley rat after 15min, expressed as percent injected dose/g",10116.0,Intermediate,,,12094,2048.0,CHEMBL632160,1,BAO_0000218,,In vivo,,N,,Lung,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in lung of mature female Dawley rat after 1h, expressed as percent injected dose/g",10116.0,Intermediate,,,12095,2048.0,CHEMBL632161,1,BAO_0000218,,In vivo,,N,,Lung,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in lung of mature female Dawley rat after 3 h, expressed as percent injected dose/g",10116.0,Intermediate,,,12096,2048.0,CHEMBL632162,1,BAO_0000218,,In vivo,,N,,Lung,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in lung of mature female Dawley rat after 30min, expressed as percent injected dose/g",10116.0,Intermediate,,,12097,2048.0,CHEMBL632163,1,BAO_0000218,,In vivo,,N,,Lung,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in lung of mature female Dawley rat after 45min, expressed as percent injected dose/g",10116.0,Intermediate,,,12098,2048.0,CHEMBL874469,1,BAO_0000218,,In vivo,,N,,Lung,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in lung of mature female Dawley rat after 5min, expressed as percent injected dose/g",10116.0,Intermediate,,,12099,2048.0,CHEMBL627182,1,BAO_0000218,,In vivo,,N,,Lung,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in muscle of mature female Dawley rat after 10min, expressed as percent injected dose/g",10116.0,Intermediate,,,12100,2385.0,CHEMBL627183,1,BAO_0000218,,In vivo,,N,,Muscle tissue,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in muscle of mature female Dawley rat after 15min, expressed as percent injected dose/g",10116.0,Intermediate,,,12101,2385.0,CHEMBL627184,1,BAO_0000218,,In vivo,,N,,Muscle tissue,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in muscle of mature female Dawley rat after 1h, expressed as percent injected dose/g",10116.0,Intermediate,,,12102,2385.0,CHEMBL627185,1,BAO_0000218,,In vivo,,N,,Muscle tissue,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in muscle of mature female Dawley rat after 3 h, expressed as percent injected dose/g",10116.0,Intermediate,,,12103,2385.0,CHEMBL627186,1,BAO_0000218,,In vivo,,N,,Muscle tissue,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in muscle of mature female Dawley rat after 30min, expressed as percent injected dose/g",10116.0,Intermediate,,,12104,2385.0,CHEMBL627187,1,BAO_0000218,,In vivo,,N,,Muscle tissue,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in muscle of mature female Dawley rat after 45min, expressed as percent injected dose/g",10116.0,Intermediate,,,12105,2385.0,CHEMBL627188,1,BAO_0000218,,In vivo,,N,,Muscle tissue,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution in muscle of mature female Dawley rat after 5min, expressed as percent injected dose/g",10116.0,Intermediate,,,12106,2385.0,CHEMBL627189,1,BAO_0000218,,In vivo,,N,,Muscle tissue,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution inl ilver of mature female Dawley rat after 30min, expressed as percent injected dose/g",10116.0,Intermediate,,,12107,,CHEMBL627190,1,BAO_0000218,,In vivo,,N,,,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution inl iver of mature female Dawley rat after 15min, expressed as percent injected dose/g",10116.0,Intermediate,,,12108,2107.0,CHEMBL627191,1,BAO_0000218,,In vivo,,N,,Liver,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution inl iver of mature female Dawley rat after 3 h, expressed as percent injected dose/g",10116.0,Intermediate,,,12109,2107.0,CHEMBL627192,1,BAO_0000218,,In vivo,,N,,Liver,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution inl iver of mature female Dawley rat after 5min, expressed as percent injected dose/g",10116.0,Intermediate,,,12110,2107.0,CHEMBL627193,1,BAO_0000218,,In vivo,,N,,Liver,13751,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the muscle of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,12111,2385.0,CHEMBL874590,1,BAO_0000218,,In vivo,,N,,Muscle tissue,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the muscle of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,12112,2385.0,CHEMBL627194,1,BAO_0000218,,In vivo,,N,,Muscle tissue,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the muscle of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,12113,2385.0,CHEMBL627195,1,BAO_0000218,,In vivo,,N,,Muscle tissue,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,12114,992.0,CHEMBL627196,1,BAO_0000218,,In vivo,,N,,Female gonad,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,12115,992.0,CHEMBL627197,1,BAO_0000218,,In vivo,,N,,Female gonad,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the ovaries of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,12116,992.0,CHEMBL627198,1,BAO_0000218,,In vivo,,N,,Female gonad,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour,10116.0,Intermediate,,,12117,992.0,CHEMBL627199,1,BAO_0000218,,In vivo,,N,,Female gonad,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,12118,992.0,CHEMBL627200,1,BAO_0000218,,In vivo,,N,,Female gonad,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the plasma of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,12119,1969.0,CHEMBL627201,1,BAO_0000218,,In vivo,,N,,Plasma,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the plasma of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,12120,1969.0,CHEMBL627202,1,BAO_0000218,,In vivo,,N,,Plasma,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the plasma of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,12121,1969.0,CHEMBL627203,1,BAO_0000218,,In vivo,,N,,Plasma,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the plasma of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,12122,1969.0,CHEMBL627204,1,BAO_0000218,,In vivo,,N,,Plasma,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the spleen of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,12123,2106.0,CHEMBL627205,1,BAO_0000218,,In vivo,,N,,Spleen,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the spleen of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,12124,2106.0,CHEMBL627206,1,BAO_0000218,,In vivo,,N,,Spleen,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the spleen of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,12125,2106.0,CHEMBL627207,1,BAO_0000218,,In vivo,,N,,Spleen,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the spleen of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,12126,2106.0,CHEMBL627208,1,BAO_0000218,,In vivo,,N,,Spleen,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,12127,2046.0,CHEMBL627209,1,BAO_0000218,,In vivo,,N,,Thyroid gland,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,12128,2046.0,CHEMBL627210,1,BAO_0000218,,In vivo,,N,,Thyroid gland,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the thyroid of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,12129,2046.0,CHEMBL627211,1,BAO_0000218,,In vivo,,N,,Thyroid gland,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the thyroid of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,12130,2046.0,CHEMBL627212,1,BAO_0000218,,In vivo,,N,,Thyroid gland,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the uterus of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,12131,995.0,CHEMBL627213,1,BAO_0000218,,In vivo,,N,,Uterus,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the uterus of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,12132,995.0,CHEMBL626599,1,BAO_0000218,,In vivo,,N,,Uterus,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the uterus of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,12133,995.0,CHEMBL626600,1,BAO_0000218,,In vivo,,N,,Uterus,10911,Rattus norvegicus,50597,A,,1
,Biodistribution studied in the uterus of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,10116.0,Intermediate,,,12134,995.0,CHEMBL626601,1,BAO_0000218,,In vivo,,N,,Uterus,10911,Rattus norvegicus,50597,A,,1
,C(f=2) is the concentration at which the half life (t1/2) in the time course of inhibition of BChE by DFP increased by twofold in the presence of compound,,Autocuration,,,12135,,CHEMBL627484,1,BAO_0000019,,,,U,,,8081,,22224,A,,0
,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg),9541.0,Intermediate,,,12136,1969.0,CHEMBL627485,1,BAO_0000218,,,,N,,Plasma,17248,Macaca fascicularis,100710,A,,1
,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not applicable,9541.0,Intermediate,,,12137,1969.0,CHEMBL628147,1,BAO_0000218,,,,N,,Plasma,17248,Macaca fascicularis,100710,A,,1
,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not determined,9541.0,Intermediate,,,12138,1969.0,CHEMBL628148,1,BAO_0000218,,,,N,,Plasma,17248,Macaca fascicularis,100710,A,,1
,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg),9615.0,Intermediate,,,12139,1969.0,CHEMBL628149,1,BAO_0000218,,,,N,,Plasma,17248,Canis lupus familiaris,50588,A,,1
,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 1,9615.0,Intermediate,,,12140,1969.0,CHEMBL628150,1,BAO_0000218,,,,N,,Plasma,17248,Canis lupus familiaris,50588,A,,1
,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 2,9615.0,Intermediate,,,12141,1969.0,CHEMBL628318,1,BAO_0000218,,,,N,,Plasma,17248,Canis lupus familiaris,50588,A,,1
,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg); Not applicable,9615.0,Intermediate,,,12142,1969.0,CHEMBL628319,1,BAO_0000218,,,,N,,Plasma,17248,Canis lupus familiaris,50588,A,,1
,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",9615.0,Intermediate,,,12143,,CHEMBL875609,1,BAO_0000218,,,,N,,,15592,Canis lupus familiaris,50588,A,,1
,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10,,Autocuration,,,12144,,CHEMBL628320,1,BAO_0000019,,,,U,,,7040,,22224,A,,0
,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10.5,,Autocuration,,,12145,,CHEMBL628321,1,BAO_0000019,,,,U,,,7040,,22224,A,,0
,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 6.8,,Autocuration,,,12146,,CHEMBL628322,1,BAO_0000019,,,,U,,,7040,,22224,A,,0
,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.2,,Autocuration,,,12147,,CHEMBL628323,1,BAO_0000019,,,,U,,,7040,,22224,A,,0
,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.6,,Autocuration,,,12148,,CHEMBL628324,1,BAO_0000019,,,,U,,,7040,,22224,A,,0
,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 8.2,,Autocuration,,,12149,,CHEMBL628325,1,BAO_0000019,,,,U,,,7040,,22224,A,,0
,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 9.6,,Autocuration,,,12150,,CHEMBL628326,1,BAO_0000019,,,,U,,,7040,,22224,A,,0
,"Concentration of compound in adrenal medulla of dog 2, after administering intravenously",9615.0,Intermediate,,,12151,1236.0,CHEMBL628327,1,BAO_0000218,,,,N,,Adrenal medulla,9614,Canis lupus familiaris,50588,A,,1
,"Concentration of compound in adrenal medulla of dog1, after administering intravenously",9615.0,Intermediate,,,12152,1236.0,CHEMBL628328,1,BAO_0000218,,,,N,,Adrenal medulla,9614,Canis lupus familiaris,50588,A,,1
,"Concentration of compound in blood of dog 1, after administering intravenously",9615.0,Intermediate,,,12153,178.0,CHEMBL628329,1,BAO_0000218,,,,N,,Blood,9614,Canis lupus familiaris,50588,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration.; dose/g, range 0.23-0.29",10116.0,Intermediate,,,12154,2107.0,CHEMBL628330,1,BAO_0000218,,,,N,,Liver,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.22-0.30",10116.0,Intermediate,,,12155,2107.0,CHEMBL628331,1,BAO_0000218,,,,N,,Liver,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.55-0.71",10116.0,Intermediate,,,12156,2107.0,CHEMBL628332,1,BAO_0000218,,,,N,,Liver,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.57-0.72",10116.0,Intermediate,,,12157,2107.0,CHEMBL628333,1,BAO_0000218,,,,N,,Liver,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 1.51-2.23",10116.0,Intermediate,,,12158,2107.0,CHEMBL628334,1,BAO_0000218,,,,N,,Liver,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 2.30-3.12",10116.0,Intermediate,,,12159,2107.0,CHEMBL628335,1,BAO_0000218,,,,N,,Liver,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 0.93-1.20",10116.0,Intermediate,,,12160,2107.0,CHEMBL628336,1,BAO_0000218,,,,N,,Liver,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.04-2.56",10116.0,Intermediate,,,12161,2107.0,CHEMBL628337,1,BAO_0000218,,,,N,,Liver,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.06-1.70",10116.0,Intermediate,,,12162,2107.0,CHEMBL628338,1,BAO_0000218,,,,N,,Liver,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.26-2.45",10116.0,Intermediate,,,12163,2107.0,CHEMBL875610,1,BAO_0000218,,,,N,,Liver,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 3.12-4.56",10116.0,Intermediate,,,12164,2107.0,CHEMBL628339,1,BAO_0000218,,,,N,,Liver,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 4.12-6.30",10116.0,Intermediate,,,12165,2107.0,CHEMBL628340,1,BAO_0000218,,,,N,,Liver,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.14-0.19",10116.0,Intermediate,,,12166,2107.0,CHEMBL628341,1,BAO_0000218,,,,N,,Liver,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.15-0.19",10116.0,Intermediate,,,12167,2107.0,CHEMBL622214,1,BAO_0000218,,,,N,,Liver,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.24-0.30",10116.0,Intermediate,,,12168,2107.0,CHEMBL623167,1,BAO_0000218,,,,N,,Liver,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.44-0.54",10116.0,Intermediate,,,12169,2107.0,CHEMBL623168,1,BAO_0000218,,,,N,,Liver,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.73-1.19",10116.0,Intermediate,,,12170,2107.0,CHEMBL623169,1,BAO_0000218,,,,N,,Liver,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 1.08-2.31",10116.0,Intermediate,,,12171,2107.0,CHEMBL623170,1,BAO_0000218,,,,N,,Liver,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration.; dose/g, range 0.34-0.47",10116.0,Intermediate,,,12172,2048.0,CHEMBL627224,1,BAO_0000218,,,,N,,Lung,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.83-1.21",10116.0,Intermediate,,,12173,2048.0,CHEMBL875634,1,BAO_0000218,,,,N,,Lung,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.91-1.74",10116.0,Intermediate,,,12174,2048.0,CHEMBL627225,1,BAO_0000218,,,,N,,Lung,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.99-1.23",10116.0,Intermediate,,,12175,2048.0,CHEMBL627226,1,BAO_0000218,,,,N,,Lung,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.07-1.30",10116.0,Intermediate,,,12176,2048.0,CHEMBL626083,1,BAO_0000218,,,,N,,Lung,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.12-1.39",10116.0,Intermediate,,,12177,2048.0,CHEMBL626084,1,BAO_0000218,,,,N,,Lung,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.51-0.66",10116.0,Intermediate,,,12178,2048.0,CHEMBL626085,1,BAO_0000218,,,,N,,Lung,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.95-1.49",10116.0,Intermediate,,,12179,2048.0,CHEMBL626086,1,BAO_0000218,,,,N,,Lung,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.96-1.35",10116.0,Intermediate,,,12180,2048.0,CHEMBL626087,1,BAO_0000218,,,,N,,Lung,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.18-1.44",10116.0,Intermediate,,,12181,2048.0,CHEMBL626088,1,BAO_0000218,,,,N,,Lung,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.20-1.52",10116.0,Intermediate,,,12182,2048.0,CHEMBL626089,1,BAO_0000218,,,,N,,Lung,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.41-2.17",10116.0,Intermediate,,,12183,2048.0,CHEMBL626090,1,BAO_0000218,,,,N,,Lung,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.28-0.33",10116.0,Intermediate,,,12184,2048.0,CHEMBL626091,1,BAO_0000218,,,,N,,Lung,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.81-1.13",10116.0,Intermediate,,,12185,2048.0,CHEMBL626092,1,BAO_0000218,,,,N,,Lung,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.83-2.11",10116.0,Intermediate,,,12186,2048.0,CHEMBL626093,1,BAO_0000218,,,,N,,Lung,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.94-1.36",10116.0,Intermediate,,,12187,2048.0,CHEMBL626094,1,BAO_0000218,,,,N,,Lung,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.97-1.54",10116.0,Intermediate,,,12188,2048.0,CHEMBL626095,1,BAO_0000218,,,,N,,Lung,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 1.07-1.26",10116.0,Intermediate,,,12189,2048.0,CHEMBL626096,1,BAO_0000218,,,,N,,Lung,8608,Rattus norvegicus,50597,A,,1
,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,314293.0,Autocuration,,,12190,,CHEMBL626097,1,BAO_0000218,,,,U,,,15604,Simiiformes,22224,A,,0
,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,10116.0,Intermediate,,,12191,,CHEMBL626098,1,BAO_0000218,,,,N,,,15604,Rattus norvegicus,50597,A,,1
,compound was evaluated for area under the plasma concentration vs. time curve at different dose 27.5 mg/kg DMP323 equiv,,Autocuration,,,12192,1969.0,CHEMBL626099,1,BAO_0000218,,,,U,,Plasma,1806,,22224,A,,0
,compound was evaluated for area under the plasma concentration vs. time curve at different dose 7.7 mg/kg DMP323 equiv,,Autocuration,,,12193,1969.0,CHEMBL626100,1,BAO_0000218,,,,U,,Plasma,1806,,22224,A,,0
,AUC 0-inf in dog,9615.0,Intermediate,,,12194,1969.0,CHEMBL626101,1,BAO_0000218,,,,N,,Plasma,17237,Canis lupus familiaris,50588,A,,1
,AUC 0-inf in guinea pig,10141.0,Intermediate,,,12195,1969.0,CHEMBL626102,1,BAO_0000218,,,,N,,Plasma,17237,Cavia porcellus,50512,A,,1
,AUC 0-t in dog,9615.0,Intermediate,,,12196,1969.0,CHEMBL626103,1,BAO_0000218,,,,N,,Plasma,17237,Canis lupus familiaris,50588,A,,1
,AUC 0-t in guinea pig,10141.0,Intermediate,,,12197,1969.0,CHEMBL628391,1,BAO_0000218,,,,N,,Plasma,17237,Cavia porcellus,50512,A,,1
,The compound was tested for brain to plasma partition in rat,10116.0,Intermediate,,,12198,,CHEMBL628392,1,BAO_0000218,,,,N,,,15194,Rattus norvegicus,50597,A,,1
,The compound was tested for brain to plasma partition in rat.,10116.0,Intermediate,,,12199,,CHEMBL628393,1,BAO_0000218,,,,N,,,15194,Rattus norvegicus,50597,A,,1
,Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure,,Autocuration,,,12200,178.0,CHEMBL628394,1,BAO_0000019,,,,U,,Blood,8787,,22224,A,,0
,Area under concentration-time curve of compound was determined in dog at 5 mg/kg intravenously admn.,9615.0,Intermediate,,,12201,,CHEMBL628395,1,BAO_0000218,,,,N,,,17025,Canis lupus familiaris,50588,A,,1
,Area under concentration-time curve of compound was determined in monkey at 5 mg/kg intravenously admn.,314293.0,Autocuration,,,12202,,CHEMBL628396,1,BAO_0000218,,,,U,,,17025,Simiiformes,22224,A,,0
,Area under concentration-time curve of compound was determined in rabbit at 5 mg/kg intravenously admn.,9986.0,Intermediate,,,12203,,CHEMBL628397,1,BAO_0000218,,,,N,,,17025,Oryctolagus cuniculus,50592,A,,1
,Area under concentration-time curve of compound was determined in rat at 5 mg/kg intravenously admn.,10116.0,Intermediate,,,12204,,CHEMBL628398,1,BAO_0000218,,,,N,,,17025,Rattus norvegicus,50597,A,,1
,Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey,9544.0,Intermediate,,,12205,,CHEMBL628399,1,BAO_0000218,,,,N,,,4236,Macaca mulatta,50797,A,,1
,The Plasma area under the compound concentration -time curve was measured in dogs after oral administration of 1 mg/kg dose,9615.0,Intermediate,,,12206,,CHEMBL628400,1,BAO_0000218,,,,N,,,15343,Canis lupus familiaris,50588,A,,1
,The Plasma area under the compound concentration -time curve was measured in rats after oral administration of 1 mg/kg dose,10116.0,Intermediate,,,12207,,CHEMBL874907,1,BAO_0000218,,,,N,,,15343,Rattus norvegicus,50597,A,,1
,Area under curve of the compound was determined,,Autocuration,,,12208,,CHEMBL628401,1,BAO_0000019,,,,U,,,17720,,22224,A,,0
,AUC in monkeys at a dose of 1 mg/kg,314293.0,Autocuration,,,12209,1969.0,CHEMBL628402,1,BAO_0000218,,,,U,,Plasma,17788,Simiiformes,22224,A,,0
,AUC in rats at a dose of 1 mg/kg,10116.0,Intermediate,,,12210,1969.0,CHEMBL628403,1,BAO_0000218,,,,N,,Plasma,17788,Rattus norvegicus,50597,A,,1
,Compound was evaluated for the overall absorbance loss at pH of 2,,Autocuration,,,12211,,CHEMBL628404,1,BAO_0000019,,,,U,,,8778,,22224,A,,0
,Compound was evaluated for the overall absorbance loss at pH of 4,,Autocuration,,,12212,,CHEMBL628405,1,BAO_0000019,,,,U,,,8778,,22224,A,,0
,Compound was evaluated for the overall absorbance loss at pH of 7,,Autocuration,,,12213,,CHEMBL628406,1,BAO_0000019,,,,U,,,8778,,22224,A,,0
,Compound was evaluated for its absorption in the rats,10116.0,Intermediate,,,12214,,CHEMBL628407,1,BAO_0000218,,,,N,,,2249,Rattus norvegicus,50597,A,,1
,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,10116.0,Intermediate,,,12215,1088.0,CHEMBL628408,1,BAO_0000218,,,,N,,Urine,8881,Rattus norvegicus,50597,A,,1
,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight.,10116.0,Intermediate,,,12216,1088.0,CHEMBL629171,1,BAO_0000218,,,,N,,Urine,8881,Rattus norvegicus,50597,A,,1
,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,10116.0,Intermediate,,,12217,1088.0,CHEMBL629172,1,BAO_0000218,,,,N,,Urine,8881,Rattus norvegicus,50597,A,,1
,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of per moiety tranexamic acid,10116.0,Intermediate,,,12218,1088.0,CHEMBL629173,1,BAO_0000218,,,,N,,Urine,8881,Rattus norvegicus,50597,A,,1
,In vitro percent permeability into rat ileum,10116.0,Intermediate,,,12219,,CHEMBL629174,1,BAO_0000218,,,,N,,,15286,Rattus norvegicus,50597,A,,1
,In vitro percent permeability into rat ileum; Range is 10-17,10116.0,Intermediate,,,12220,,CHEMBL629175,1,BAO_0000218,,,,N,,,15286,Rattus norvegicus,50597,A,,1
,In vitro percent permeability into rat ileum; Range is 10-18,10116.0,Intermediate,,,12221,,CHEMBL629176,1,BAO_0000218,,,,N,,,15286,Rattus norvegicus,50597,A,,1
,In vitro percent permeability into rat ileum; Range is 10-19,10116.0,Intermediate,,,12222,,CHEMBL629177,1,BAO_0000218,,,,N,,,15286,Rattus norvegicus,50597,A,,1
,In vitro percent permeability into rat ileum; Range is 12-15,10116.0,Intermediate,,,12223,,CHEMBL629178,1,BAO_0000218,,,,N,,,15286,Rattus norvegicus,50597,A,,1
,In vitro percent permeability into rat ileum; Range is 13-19,10116.0,Intermediate,,,12224,,CHEMBL631869,1,BAO_0000218,,,,N,,,15286,Rattus norvegicus,50597,A,,1
,In vitro percent permeability into rat ileum; Range is 14-17,10116.0,Intermediate,,,12225,,CHEMBL631870,1,BAO_0000218,,,,N,,,15286,Rattus norvegicus,50597,A,,1
,In vitro percent permeability into rat ileum; Range is 15-18,10116.0,Intermediate,,,12226,,CHEMBL631871,1,BAO_0000218,,,,N,,,15286,Rattus norvegicus,50597,A,,1
,In vitro percent permeability into rat ileum; Range is 2-5,10116.0,Intermediate,,,12227,,CHEMBL631872,1,BAO_0000218,,,,N,,,15286,Rattus norvegicus,50597,A,,1
,In vitro percent permeability into rat ileum; Range is 23-42,,Autocuration,,,12228,2116.0,CHEMBL875775,1,BAO_0000221,,,,U,,Ileum,15286,,22224,A,,0
,In vitro percent permeability into rat ileum; Range is 28-36,10116.0,Intermediate,,,12229,,CHEMBL631873,1,BAO_0000218,,,,N,,,15286,Rattus norvegicus,50597,A,,1
,In vitro percent permeability into rat ileum; Range is 29-35,10116.0,Intermediate,,,12230,,CHEMBL631874,1,BAO_0000218,,,,N,,,15286,Rattus norvegicus,50597,A,,1
,In vitro percent permeability into rat ileum; Range is 46-66,10116.0,Intermediate,,,12231,,CHEMBL631875,1,BAO_0000218,,,,N,,,15286,Rattus norvegicus,50597,A,,1
,In vitro percent permeability into rat ileum; Range is 50-68,10116.0,Intermediate,,,12232,,CHEMBL631876,1,BAO_0000218,,,,N,,,15286,Rattus norvegicus,50597,A,,1
,In vitro percent permeability into rat ileum; Range is 78-81,10116.0,Intermediate,,,12233,,CHEMBL631877,1,BAO_0000218,,,,N,,,15286,Rattus norvegicus,50597,A,,1
,In vitro percent permeability into rat ileum; insol indicates not soluble in aqueous buffer,10116.0,Intermediate,,,12234,,CHEMBL631878,1,BAO_0000218,,,,N,,,15286,Rattus norvegicus,50597,A,,1
,In vitro percent permeability into rat ileum; nd indicates not detected,10116.0,Intermediate,,,12235,,CHEMBL631879,1,BAO_0000218,,,,N,,,15286,Rattus norvegicus,50597,A,,1
,In vitro percent permeability into rat ileum; nt indicates not detected,10116.0,Intermediate,,,12236,,CHEMBL631880,1,BAO_0000218,,,,N,,,15286,Rattus norvegicus,50597,A,,1
,In vitro percent permeability into rat ileum; nt indicates not tested,10116.0,Intermediate,,,12237,,CHEMBL631881,1,BAO_0000218,,,,N,,,15286,Rattus norvegicus,50597,A,,1
,Compound was tested for oral absorption in bile-duct cannulated rats,10116.0,Intermediate,,,12238,,CHEMBL631882,1,BAO_0000218,,,,N,,,13770,Rattus norvegicus,50597,A,,1
,Compound was tested for oral absorption in bile-duct cannulated rats.,10116.0,Intermediate,,,12239,,CHEMBL630749,1,BAO_0000218,,,,N,,,13770,Rattus norvegicus,50597,A,,1
,Oral absorption using Caco-2 cell monolayers.,9606.0,Intermediate,,,12240,,CHEMBL630750,1,BAO_0000218,,,,N,,,5202,Homo sapiens,50587,A,,1
,Percent of the drug absorbed after administration to humans was determined,9606.0,Intermediate,,,12241,,CHEMBL630253,1,BAO_0000218,,,,N,,,14920,Homo sapiens,50587,A,,1
,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 120 minutes.,10116.0,Intermediate,,,12242,1969.0,CHEMBL630254,1,BAO_0000218,,,,N,,Plasma,14103,Rattus norvegicus,50597,A,,1
,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 15 minutes.,10116.0,Intermediate,,,12243,1969.0,CHEMBL630255,1,BAO_0000218,,,,N,,Plasma,14103,Rattus norvegicus,50597,A,,1
,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 180 minutes.,10116.0,Intermediate,,,12244,1969.0,CHEMBL630256,1,BAO_0000218,,,,N,,Plasma,14103,Rattus norvegicus,50597,A,,1
,"Biodistribution inl liver of mature female Dawley rat after 1h, expressed as percent injected dose/g",10116.0,Intermediate,,,12245,2107.0,CHEMBL875781,1,BAO_0000218,,In vivo,,N,,Liver,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution inl liver of mature female Dawley rat after 30min, expressed as percent injected dose/g",10116.0,Intermediate,,,12246,2107.0,CHEMBL630257,1,BAO_0000218,,In vivo,,N,,Liver,13751,Rattus norvegicus,50597,A,,1
,"Biodistribution inl liver of mature female Dawley rat after 45min, expressed as percent injected dose/g",10116.0,Intermediate,,,12247,2107.0,CHEMBL630258,1,BAO_0000218,,In vivo,,N,,Liver,13751,Rattus norvegicus,50597,A,,1
,"Distribution of radioactivity in rat blood after 2 minutes of iv administration at the dose of 10.05-0.07 gram of tissue, expressed as percent injected dose per gram of tissue",10116.0,Intermediate,,,12248,,CHEMBL630259,1,BAO_0000218,,,,N,,,15807,Rattus norvegicus,50597,A,,1
,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 1.89-3.73 g of tissue, expressed as percent injected dose per gram of tissue",10116.0,Intermediate,,,12249,2435.0,CHEMBL630260,1,BAO_0000218,,,,N,,Striatum,15807,Rattus norvegicus,50597,A,,1
,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 3.44-4.80 g of tissue, expressed as percent injected dose per gram of tissue",10116.0,Intermediate,,,12250,2435.0,CHEMBL630261,1,BAO_0000218,,,,N,,Striatum,15807,Rattus norvegicus,50597,A,,1
,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat and 5-alpha-DHT was reported,10116.0,Intermediate,,,12251,,CHEMBL630262,1,BAO_0000218,,,,N,,,14950,Rattus norvegicus,50597,A,,1
,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 1 hour time,10116.0,Intermediate,,,12252,,CHEMBL630263,1,BAO_0000218,,,,N,,,14950,Rattus norvegicus,50597,A,,1
,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 2 hours time,10116.0,Intermediate,,,12253,,CHEMBL630264,1,BAO_0000218,,,,N,,,14950,Rattus norvegicus,50597,A,,1
,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 0.5 hours time,10116.0,Intermediate,,,12254,,CHEMBL630265,1,BAO_0000218,,,,N,,,14950,Rattus norvegicus,50597,A,,1
,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 4 hours time,10116.0,Intermediate,,,12255,,CHEMBL630266,1,BAO_0000218,,,,N,,,14950,Rattus norvegicus,50597,A,,1
,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 0.5 hours time,10116.0,Intermediate,,,12256,2113.0,CHEMBL630267,1,BAO_0000218,,,,N,,Kidney,14950,Rattus norvegicus,50597,A,,1
,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 4 hours time,10116.0,Intermediate,,,12257,2113.0,CHEMBL630268,1,BAO_0000218,,,,N,,Kidney,14950,Rattus norvegicus,50597,A,,1
,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 1 hour time,10116.0,Intermediate,,,12258,,CHEMBL630269,1,BAO_0000218,,,,N,,,14950,Rattus norvegicus,50597,A,,1
,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 2 hours time,10116.0,Intermediate,,,12259,,CHEMBL630270,1,BAO_0000218,,,,N,,,14950,Rattus norvegicus,50597,A,,1
,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 1 hour time,10116.0,Intermediate,,,12260,2048.0,CHEMBL630141,1,BAO_0000218,,,,N,,Lung,14950,Rattus norvegicus,50597,A,,1
,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 2 hours time,10116.0,Intermediate,,,12261,2048.0,CHEMBL630142,1,BAO_0000218,,,,N,,Lung,14950,Rattus norvegicus,50597,A,,1
,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 0.5 hours time,10116.0,Intermediate,,,12262,2385.0,CHEMBL630143,1,BAO_0000218,,,,N,,Muscle tissue,14950,Rattus norvegicus,50597,A,,1
,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 4 hours time,10116.0,Intermediate,,,12263,2385.0,CHEMBL630144,1,BAO_0000218,,,,N,,Muscle tissue,14950,Rattus norvegicus,50597,A,,1
,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 0.5 hours time,10116.0,Intermediate,,,12264,2367.0,CHEMBL630145,1,BAO_0000218,,,,N,,Prostate gland,14950,Rattus norvegicus,50597,A,,1
,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 4 hours time,10116.0,Intermediate,,,12265,2367.0,CHEMBL630146,1,BAO_0000218,,,,N,,Prostate gland,14950,Rattus norvegicus,50597,A,,1
,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood,10116.0,Intermediate,,,12266,,CHEMBL630147,1,BAO_0000218,,,,N,,,14950,Rattus norvegicus,50597,A,,1
,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 1 hours time,10116.0,Intermediate,,,12267,,CHEMBL630148,1,BAO_0000218,,,,N,,,14950,Rattus norvegicus,50597,A,,1
,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 2 hours time,10116.0,Intermediate,,,12268,,CHEMBL630149,1,BAO_0000218,,,,N,,,14950,Rattus norvegicus,50597,A,,1
,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 1 hour time,10116.0,Intermediate,,,12269,2106.0,CHEMBL630150,1,BAO_0000218,,,,N,,Spleen,14950,Rattus norvegicus,50597,A,,1
,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 2 hours time,10116.0,Intermediate,,,12270,2106.0,CHEMBL630151,1,BAO_0000218,,,,N,,Spleen,14950,Rattus norvegicus,50597,A,,1
,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 0.5 hours time,10116.0,Intermediate,,,12271,2046.0,CHEMBL632031,1,BAO_0000218,,,,N,,Thyroid gland,14950,Rattus norvegicus,50597,A,,1
,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 4 hours time,10116.0,Intermediate,,,12272,2046.0,CHEMBL632032,1,BAO_0000218,,,,N,,Thyroid gland,14950,Rattus norvegicus,50597,A,,1
,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat fat at 1 hour time,10116.0,Intermediate,,,12273,,CHEMBL632033,1,BAO_0000218,,,,N,,,14950,Rattus norvegicus,50597,A,,1
,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat kidney at 1 hour time,10116.0,Intermediate,,,12274,,CHEMBL632034,1,BAO_0000218,,,,N,,,14950,Rattus norvegicus,50597,A,,1
,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat muscle at 1 hour time,10116.0,Intermediate,,,12275,2385.0,CHEMBL632035,1,BAO_0000218,,,,N,,Muscle tissue,14950,Rattus norvegicus,50597,A,,1
,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat prostrateat 1 hour time,10116.0,Intermediate,,,12276,,CHEMBL632036,1,BAO_0000218,,,,N,,,14950,Rattus norvegicus,50597,A,,1
,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat thyroid at 1 hour time,10116.0,Intermediate,,,12277,2046.0,CHEMBL632037,1,BAO_0000218,,,,N,,Thyroid gland,14950,Rattus norvegicus,50597,A,,1
,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,10116.0,Intermediate,,,12278,178.0,CHEMBL632038,1,BAO_0000218,,,,N,,Blood,8631,Rattus norvegicus,50597,A,,1
,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,10116.0,Intermediate,,,12279,178.0,CHEMBL632039,1,BAO_0000218,,,,N,,Blood,8631,Rattus norvegicus,50597,A,,1
,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,10116.0,Intermediate,,,12280,178.0,CHEMBL632040,1,BAO_0000218,,,,N,,Blood,8631,Rattus norvegicus,50597,A,,1
,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,10116.0,Intermediate,,,12281,178.0,CHEMBL632041,1,BAO_0000218,,,,N,,Blood,8631,Rattus norvegicus,50597,A,,1
,"Concentration of compound in blood of dog 2, after administering intravenously",9615.0,Intermediate,,,12282,178.0,CHEMBL632042,1,BAO_0000218,,,,N,,Blood,9614,Canis lupus familiaris,50588,A,,1
,"Concentration of compound in left ventricle of dog 1, after administering intravenously",9615.0,Intermediate,,,12283,,CHEMBL632043,1,BAO_0000218,,,,N,,,9614,Canis lupus familiaris,50588,A,,1
,"Concentration of compound in left ventricle of dog 2, after administering intravenously",9615.0,Intermediate,,,12284,,CHEMBL632044,1,BAO_0000218,,,,N,,,9614,Canis lupus familiaris,50588,A,,1
,"Concentration of compound in liver of dog 1, after administering intravenously",9615.0,Intermediate,,,12285,2107.0,CHEMBL632045,1,BAO_0000218,,,,N,,Liver,9614,Canis lupus familiaris,50588,A,,1
,"Concentration of compound in liver of dog 2, after administering intravenously",9615.0,Intermediate,,,12286,2107.0,CHEMBL632046,1,BAO_0000218,,,,N,,Liver,9614,Canis lupus familiaris,50588,A,,1
,"Concentration of compound in lung of dog 1, after administering intravenously",9615.0,Intermediate,,,12287,2048.0,CHEMBL632047,1,BAO_0000218,,,,N,,Lung,9614,Canis lupus familiaris,50588,A,,1
,"Concentration of compound in lung of dog 2, after administering intravenously",9615.0,Intermediate,,,12288,2048.0,CHEMBL632048,1,BAO_0000218,,,,N,,Lung,9614,Canis lupus familiaris,50588,A,,1
,"Concentration of compound in muscle of dog 1, after administering intravenously",9615.0,Intermediate,,,12289,2385.0,CHEMBL632049,1,BAO_0000218,,,,N,,Muscle tissue,9614,Canis lupus familiaris,50588,A,,1
,"Concentration of compound in muscle of dog 2, after administering intravenously",9615.0,Intermediate,,,12290,2385.0,CHEMBL876418,1,BAO_0000218,,,,N,,Muscle tissue,9614,Canis lupus familiaris,50588,A,,1
,"Concentration of compound in spleen of dog 1,after administering intravenously",9615.0,Intermediate,,,12291,2106.0,CHEMBL632050,1,BAO_0000218,,,,N,,Spleen,9614,Canis lupus familiaris,50588,A,,1
,"Concentration of compound in spleen of dog 2, after administering intravenously",9615.0,Intermediate,,,12292,2106.0,CHEMBL632051,1,BAO_0000218,,,,N,,Spleen,9614,Canis lupus familiaris,50588,A,,1
,Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).,,Autocuration,,,12293,,CHEMBL632052,1,BAO_0000218,,,,U,,,10353,,22224,F,,0
,Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).,,Autocuration,,,12294,,CHEMBL632053,1,BAO_0000218,,,,U,,,10353,,22224,F,,0
,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,Autocuration,,,12295,,CHEMBL632054,1,BAO_0000218,,,,U,,,10353,,22224,A,,0
,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,Autocuration,,,12296,,CHEMBL632055,1,BAO_0000218,,,,U,,,10353,,22224,F,,0
,Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).,,Autocuration,,,12297,,CHEMBL631181,1,BAO_0000218,,,,U,,,10353,,22224,F,,0
,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous after 1.5 hr,,Autocuration,,,12298,,CHEMBL631182,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,Autocuration,,,12299,,CHEMBL631183,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,Autocuration,,,12300,,CHEMBL631184,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,Autocuration,,,12301,,CHEMBL629774,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,Autocuration,,,12302,,CHEMBL629775,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,Autocuration,,,12303,,CHEMBL876549,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,Autocuration,,,12304,,CHEMBL628172,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,Autocuration,,,12305,,CHEMBL628173,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous after 1.5 hr,,Autocuration,,,12306,,CHEMBL628174,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 4.0 hr,,Autocuration,,,12307,,CHEMBL628175,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,Autocuration,,,12308,,CHEMBL628176,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,Autocuration,,,12309,,CHEMBL628177,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,Autocuration,,,12310,,CHEMBL628178,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,Autocuration,,,12311,,CHEMBL628179,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg i intravenous dosage after 1.0 hr; insufficient gastric juice produced,,Autocuration,,,12312,,CHEMBL628180,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 2.5 hr,,Autocuration,,,12313,,CHEMBL628181,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,Autocuration,,,12314,,CHEMBL628182,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,Autocuration,,,12315,,CHEMBL628183,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr; ND means not determined,,Autocuration,,,12316,,CHEMBL628184,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,Autocuration,,,12317,,CHEMBL628185,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,Autocuration,,,12318,,CHEMBL875617,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,Autocuration,,,12319,,CHEMBL628186,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,Autocuration,,,12320,,CHEMBL628187,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,Autocuration,,,12321,,CHEMBL628188,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,Autocuration,,,12322,,CHEMBL628189,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr; ND means not determined,,Autocuration,,,12323,,CHEMBL628190,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,Autocuration,,,12324,,CHEMBL628191,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr; ND means not determined,,Autocuration,,,12325,,CHEMBL626513,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 19-24",10116.0,Intermediate,,,12326,2046.0,CHEMBL626514,1,BAO_0000218,,,,N,,Thyroid gland,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 26-40",10116.0,Intermediate,,,12327,2046.0,CHEMBL626515,1,BAO_0000218,,,,N,,Thyroid gland,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 29-44",10116.0,Intermediate,,,12328,2046.0,CHEMBL626516,1,BAO_0000218,,,,N,,Thyroid gland,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 32-42",10116.0,Intermediate,,,12329,2046.0,CHEMBL626517,1,BAO_0000218,,,,N,,Thyroid gland,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 33-60",10116.0,Intermediate,,,12330,2046.0,CHEMBL626518,1,BAO_0000218,,,,N,,Thyroid gland,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 4-7",10116.0,Intermediate,,,12331,2046.0,CHEMBL626519,1,BAO_0000218,,,,N,,Thyroid gland,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 13-18",10116.0,Intermediate,,,12332,2046.0,CHEMBL626520,1,BAO_0000218,,,,N,,Thyroid gland,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 16-32",10116.0,Intermediate,,,12333,2046.0,CHEMBL626521,1,BAO_0000218,,,,N,,Thyroid gland,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 22-25",10116.0,Intermediate,,,12334,2046.0,CHEMBL626522,1,BAO_0000218,,,,N,,Thyroid gland,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 26-49",10116.0,Intermediate,,,12335,2046.0,CHEMBL626523,1,BAO_0000218,,,,N,,Thyroid gland,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 29-36",10116.0,Intermediate,,,12336,2046.0,CHEMBL626524,1,BAO_0000218,,,,N,,Thyroid gland,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 5-8",10116.0,Intermediate,,,12337,2046.0,CHEMBL626688,1,BAO_0000218,,,,N,,Thyroid gland,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 26-42",10116.0,Intermediate,,,12338,2046.0,CHEMBL626689,1,BAO_0000218,,,,N,,Thyroid gland,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 30-53",10116.0,Intermediate,,,12339,2046.0,CHEMBL626690,1,BAO_0000218,,,,N,,Thyroid gland,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 32-43",10116.0,Intermediate,,,12340,2046.0,CHEMBL626691,1,BAO_0000218,,,,N,,Thyroid gland,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 35-53",10116.0,Intermediate,,,12341,2046.0,CHEMBL627319,1,BAO_0000218,,,,N,,Thyroid gland,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 5-12",10116.0,Intermediate,,,12342,2046.0,CHEMBL624052,1,BAO_0000218,,,,N,,Thyroid gland,8608,Rattus norvegicus,50597,A,,1
,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 55-102",10116.0,Intermediate,,,12343,2046.0,CHEMBL624053,1,BAO_0000218,,,,N,,Thyroid gland,8608,Rattus norvegicus,50597,A,,1
,In vivo distribution of the drug in plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,10116.0,Intermediate,,,12344,,CHEMBL624054,1,BAO_0000218,,,,N,,,8085,Rattus norvegicus,50597,A,,1
,In vivo distribution of the drug in plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,10116.0,Intermediate,,,12345,,CHEMBL624055,1,BAO_0000218,,,,N,,,8085,Rattus norvegicus,50597,A,,1
,In vivo distribution of the drug in plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,10116.0,Intermediate,,,12346,,CHEMBL624056,1,BAO_0000218,,,,N,,,8085,Rattus norvegicus,50597,A,,1
,In vivo distribution of the drug in uterus was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,10116.0,Intermediate,,,12347,995.0,CHEMBL624057,1,BAO_0000218,,,,N,,Uterus,8085,Rattus norvegicus,50597,A,,1
,In vivo distribution of the drug in uterus was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,10116.0,Intermediate,,,12348,995.0,CHEMBL622281,1,BAO_0000218,,,,N,,Uterus,8085,Rattus norvegicus,50597,A,,1
,In vivo distribution of the drug in uterus was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,10116.0,Intermediate,,,12349,995.0,CHEMBL622282,1,BAO_0000218,,,,N,,Uterus,8085,Rattus norvegicus,50597,A,,1
,In vivo distribution of the drug in uterus/plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,10116.0,Intermediate,,,12350,995.0,CHEMBL622283,1,BAO_0000218,,,,N,,Uterus,8085,Rattus norvegicus,50597,A,,1
,In vivo distribution of the drug in uterus/plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,10116.0,Intermediate,,,12351,995.0,CHEMBL622284,1,BAO_0000218,,,,N,,Uterus,8085,Rattus norvegicus,50597,A,,1
,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,10116.0,Intermediate,,,12352,995.0,CHEMBL622285,1,BAO_0000218,,,,N,,Uterus,8085,Rattus norvegicus,50597,A,,1
,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,10116.0,Intermediate,,,12353,995.0,CHEMBL622286,1,BAO_0000218,,,,N,,Uterus,8085,Rattus norvegicus,50597,A,,1
,Distribution coefficient (D %) between octanol and buffer of pH 7.4,,Autocuration,,,12354,,CHEMBL622287,1,BAO_0000100,,,,U,,,7657,,22224,P,,0
,Partition coefficient (logD7.4),10090.0,Intermediate,,,12355,,CHEMBL622288,1,BAO_0000218,,,,N,,,8935,Mus musculus,50594,A,,1
,"Percentage of radioactivity in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",10090.0,Intermediate,,,12356,,CHEMBL622289,1,BAO_0000218,,,,N,,,13792,Mus musculus,50594,A,,1
,"Percentage of radioactivity in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",10090.0,Intermediate,,,12357,955.0,CHEMBL622290,1,BAO_0000218,,,,N,,Brain,13792,Mus musculus,50594,A,,1
,Percentage of radioactivity in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,10090.0,Intermediate,,,12358,,CHEMBL622291,1,BAO_0000218,,,,N,,,13792,Mus musculus,50594,A,,1
,Percentage of radioactivity in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,10090.0,Intermediate,,,12359,955.0,CHEMBL622292,1,BAO_0000218,,,,N,,Brain,13792,Mus musculus,50594,A,,1
,"Percentage of total protein recovered in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",10090.0,Intermediate,,,12360,,CHEMBL622293,1,BAO_0000218,,,,N,,,13792,Mus musculus,50594,A,,1
,"Percentage of total protein recovered in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",10090.0,Intermediate,,,12361,955.0,CHEMBL622294,1,BAO_0000218,,,,N,,Brain,13792,Mus musculus,50594,A,,1
,Percentage of total protein recovered in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,10090.0,Intermediate,,,12362,,CHEMBL622295,1,BAO_0000218,,,,N,,,13792,Mus musculus,50594,A,,1
,Percentage of total protein recovered in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,10116.0,Intermediate,,,12363,955.0,CHEMBL622296,1,BAO_0000218,,,,N,,Brain,13792,Rattus norvegicus,50597,A,,1
,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 2 minutes.,10116.0,Intermediate,,,12364,1969.0,CHEMBL874409,1,BAO_0000218,,,,N,,Plasma,14103,Rattus norvegicus,50597,A,,1
,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 240 minutes.,10116.0,Intermediate,,,12365,1969.0,CHEMBL622297,1,BAO_0000218,,,,N,,Plasma,14103,Rattus norvegicus,50597,A,,1
,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 30 minutes.,10116.0,Intermediate,,,12366,1969.0,CHEMBL622298,1,BAO_0000218,,,,N,,Plasma,14103,Rattus norvegicus,50597,A,,1
,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 45 minutes.,10116.0,Intermediate,,,12367,1969.0,CHEMBL622299,1,BAO_0000218,,,,N,,Plasma,14103,Rattus norvegicus,50597,A,,1
,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 5 minutes.,10116.0,Intermediate,,,12368,1969.0,CHEMBL622300,1,BAO_0000218,,,,N,,Plasma,14103,Rattus norvegicus,50597,A,,1
,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 60 minutes.,10116.0,Intermediate,,,12369,1969.0,CHEMBL622301,1,BAO_0000218,,,,N,,Plasma,14103,Rattus norvegicus,50597,A,,1
,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 90 minutes.,10116.0,Intermediate,,,12370,1969.0,CHEMBL622302,1,BAO_0000218,,,,N,,Plasma,14103,Rattus norvegicus,50597,A,,1
,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 120 minutes.,10116.0,Intermediate,,,12371,1969.0,CHEMBL622303,1,BAO_0000218,,,,N,,Plasma,14103,Rattus norvegicus,50597,A,,1
,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes.,10116.0,Intermediate,,,12372,1969.0,CHEMBL622304,1,BAO_0000218,,,,N,,Plasma,14103,Rattus norvegicus,50597,A,,1
,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes;nd=not determined,10116.0,Intermediate,,,12373,1969.0,CHEMBL622305,1,BAO_0000218,,,,N,,Plasma,14103,Rattus norvegicus,50597,A,,1
,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 180 minutes.,10116.0,Intermediate,,,12374,1969.0,CHEMBL622306,1,BAO_0000218,,,,N,,Plasma,14103,Rattus norvegicus,50597,A,,1
,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 2 minutes;nd=not determined,10116.0,Intermediate,,,12375,1969.0,CHEMBL626864,1,BAO_0000218,,,,N,,Plasma,14103,Rattus norvegicus,50597,A,,1
,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes.,10116.0,Intermediate,,,12376,1969.0,CHEMBL626865,1,BAO_0000218,,,,N,,Plasma,14103,Rattus norvegicus,50597,A,,1
,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes;nd=not determined,10116.0,Intermediate,,,12377,1969.0,CHEMBL626866,1,BAO_0000218,,,,N,,Plasma,14103,Rattus norvegicus,50597,A,,1
,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 30 minutes.,10116.0,Intermediate,,,12378,1969.0,CHEMBL626867,1,BAO_0000218,,,,N,,Plasma,14103,Rattus norvegicus,50597,A,,1
,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes.,10116.0,Intermediate,,,12379,1969.0,CHEMBL626868,1,BAO_0000218,,,,N,,Plasma,14103,Rattus norvegicus,50597,A,,1
,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes;nd=not determined,10116.0,Intermediate,,,12380,1969.0,CHEMBL626869,1,BAO_0000218,,,,N,,Plasma,14103,Rattus norvegicus,50597,A,,1
,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes.,10116.0,Intermediate,,,12381,1969.0,CHEMBL626870,1,BAO_0000218,,,,N,,Plasma,14103,Rattus norvegicus,50597,A,,1
,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes;nd=not determined,10116.0,Intermediate,,,12382,1969.0,CHEMBL626871,1,BAO_0000218,,,,N,,Plasma,14103,Rattus norvegicus,50597,A,,1
,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 60 minutes.,10116.0,Intermediate,,,12383,1969.0,CHEMBL626872,1,BAO_0000218,,,,N,,Plasma,14103,Rattus norvegicus,50597,A,,1
,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes.,10116.0,Intermediate,,,12384,1969.0,CHEMBL632185,1,BAO_0000218,,,,N,,Plasma,14103,Rattus norvegicus,50597,A,,1
,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes;nd=not determined,10116.0,Intermediate,,,12385,1969.0,CHEMBL632186,1,BAO_0000218,,,,N,,Plasma,14103,Rattus norvegicus,50597,A,,1
,Amount of acetic acid produced by the compound,,Autocuration,,,12386,,CHEMBL629310,1,BAO_0000019,,,,U,,,12904,,22224,A,,0
,Apparent first-order rate of solvolysis for the bipinnatin-A(A4) was determined,,Autocuration,,,12387,,CHEMBL629311,1,BAO_0000019,,,,U,,,12904,,22224,A,,0
,Log of (Cbrain/Cblood) in rats,10116.0,Intermediate,,,12388,,CHEMBL629312,1,BAO_0000218,,,,N,,,9663,Rattus norvegicus,50597,A,,1
,Compound in absence of MPM cell homogenate at pH 3 to isolate compound 4 (ng),,Autocuration,,,12389,,CHEMBL629313,1,BAO_0000221,,,,U,,,7652,,22224,A,,0
,Compound in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,Autocuration,,,12390,,CHEMBL629314,1,BAO_0000221,,,,U,,,7652,,22224,A,,0
,Compound in absence of MPM cell homogenate at pH 7 to isolate compound 4 (ng),,Autocuration,,,12391,,CHEMBL629315,1,BAO_0000221,,,,U,,,7652,,22224,A,,0
,Compound in presence of MPM cells and in absence of inactivator at pH 8 to isolate compound 4 (ng),,Autocuration,,,12392,,CHEMBL629316,1,BAO_0000219,,,,U,,,7652,,22224,B,,0
,Compound treated in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,Autocuration,,,12393,,CHEMBL629317,1,BAO_0000221,,,,U,,,7652,,22224,A,,0
,Compound treated with MPM cell homogenate at pH 3 to isolate compound 4 (ng),,Autocuration,,,12394,,CHEMBL629318,1,BAO_0000019,,,,U,,,7652,,22224,A,,0
,Compound treated with MPM cell homogenate at pH 3.5 to isolate compound 4 (ng),,Autocuration,,,12395,,CHEMBL877497,1,BAO_0000019,,,,U,,,7652,,22224,A,,0
,Compound treated with MPM cell homogenate at pH 4 to isolate compound 4 (ng),,Autocuration,,,12396,,CHEMBL629319,1,BAO_0000019,,,,U,,,7652,,22224,A,,0
,Compound treated with MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,Autocuration,,,12397,,CHEMBL629320,1,BAO_0000019,,,,U,,,7652,,22224,A,,0
,Compound treated with MPM cell homogenate at pH 5 to isolate compound 4 (ng),,Autocuration,,,12398,,CHEMBL629496,1,BAO_0000019,,,,U,,,7652,,22224,A,,0
,Compound treated with MPM cell homogenate at pH 5.5 to isolate compound 4 (ng),,Autocuration,,,12399,,CHEMBL629497,1,BAO_0000019,,,,U,,,7652,,22224,A,,0
,Compound treated with MPM cell homogenate at pH 6 to isolate compound 4 (ng),,Autocuration,,,12400,,CHEMBL629498,1,BAO_0000019,,,,U,,,7652,,22224,A,,0
,Compound treated with MPM cell homogenate at pH 6.5 to isolate compound 4 (ng),,Autocuration,,,12401,,CHEMBL629499,1,BAO_0000019,,,,U,,,7652,,22224,A,,0
,Compound treated with MPM cell homogenate at pH 7 to isolate compound 4 (ng),,Autocuration,,,12402,,CHEMBL629500,1,BAO_0000019,,,,U,,,7652,,22224,A,,0
,Compound treated with MPM cell homogenate at pH 7.5 to isolate compound 4 (ng),,Autocuration,,,12403,,CHEMBL629501,1,BAO_0000019,,,,U,,,7652,,22224,A,,0
,Compound treated with MPM cell homogenate at pH 8 to isolate compound 4 (ng),,Autocuration,,,12404,,CHEMBL629502,1,BAO_0000019,,,,U,,,7652,,22224,A,,0
,Compound was evaluated for its urinary recovery after oral administration (100 mg) to Beagle dogs,,Autocuration,,,12405,,CHEMBL629503,1,BAO_0000218,,In vivo,,U,,,8267,,22224,F,,0
,Compound was evaluated for its urinary recovery after oral administration (200 mg) to Beagle dogs,9615.0,Intermediate,,,12406,,CHEMBL629504,1,BAO_0000218,,,,N,,,8267,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for the rate of degradation by Carboxypeptidase A.,,Autocuration,,,12407,,CHEMBL629505,1,BAO_0000019,,,,U,,,14479,,22224,A,,0
,Compound was evaluated for total body clearance,,Autocuration,,,12408,,CHEMBL629506,1,BAO_0000019,,,,U,,,17515,,22224,A,,0
,Compound was evaluated for volume of distribution at steady state,,Autocuration,,,12409,,CHEMBL629507,1,BAO_0000019,,,,U,,,17515,,22224,A,,0
,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.,,Autocuration,,,12410,,CHEMBL877498,1,BAO_0000019,,,,U,,,8142,,22224,A,,0
,Percentage of the diamine which is monoprotonated at pH 7.4,,Autocuration,,,12411,,CHEMBL629508,1,BAO_0000019,,,,U,,,14849,,22224,A,,0
,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells,,Autocuration,,,12412,,CHEMBL629509,1,BAO_0000019,,,,U,,,7653,,22224,A,,0
,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,10116.0,Intermediate,,,12413,178.0,CHEMBL629510,1,BAO_0000218,,,,N,,Blood,8631,Rattus norvegicus,50597,A,,1
,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,10116.0,Intermediate,,,12414,178.0,CHEMBL629511,1,BAO_0000218,,,,N,,Blood,8631,Rattus norvegicus,50597,A,,1
,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,10116.0,Intermediate,,,12415,178.0,CHEMBL629512,1,BAO_0000218,,,,N,,Blood,8631,Rattus norvegicus,50597,A,,1
,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,10116.0,Intermediate,,,12416,178.0,CHEMBL629513,1,BAO_0000218,,,,N,,Blood,8631,Rattus norvegicus,50597,A,,1
,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,10116.0,Intermediate,,,12417,178.0,CHEMBL629514,1,BAO_0000218,,,,N,,Blood,8631,Rattus norvegicus,50597,A,,1
,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,10116.0,Intermediate,,,12418,178.0,CHEMBL628447,1,BAO_0000218,,,,N,,Blood,8631,Rattus norvegicus,50597,A,,1
,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,10116.0,Intermediate,,,12419,178.0,CHEMBL628448,1,BAO_0000218,,,,N,,Blood,8631,Rattus norvegicus,50597,A,,1
,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,10116.0,Intermediate,,,12420,178.0,CHEMBL628449,1,BAO_0000218,,,,N,,Blood,8631,Rattus norvegicus,50597,A,,1
,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,10116.0,Intermediate,,,12421,178.0,CHEMBL631119,1,BAO_0000218,,,,N,,Blood,8631,Rattus norvegicus,50597,A,,1
,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,10116.0,Intermediate,,,12422,178.0,CHEMBL631120,1,BAO_0000218,,,,N,,Blood,8631,Rattus norvegicus,50597,A,,1
,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,10116.0,Intermediate,,,12423,178.0,CHEMBL631121,1,BAO_0000218,,,,N,,Blood,8631,Rattus norvegicus,50597,A,,1
,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 min,10116.0,Intermediate,,,12424,178.0,CHEMBL874458,1,BAO_0000218,,,,N,,Blood,8631,Rattus norvegicus,50597,A,,1
,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,10116.0,Intermediate,,,12425,178.0,CHEMBL631122,1,BAO_0000218,,,,N,,Blood,8631,Rattus norvegicus,50597,A,,1
,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,10116.0,Intermediate,,,12426,178.0,CHEMBL631123,1,BAO_0000218,,,,N,,Blood,8631,Rattus norvegicus,50597,A,,1
,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,10116.0,Intermediate,,,12427,178.0,CHEMBL631124,1,BAO_0000218,,,,N,,Blood,8631,Rattus norvegicus,50597,A,,1
,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,10116.0,Intermediate,,,12428,178.0,CHEMBL631125,1,BAO_0000218,,,,N,,Blood,8631,Rattus norvegicus,50597,A,,1
,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,10116.0,Intermediate,,,12429,178.0,CHEMBL631290,1,BAO_0000218,,,,N,,Blood,8631,Rattus norvegicus,50597,A,,1
,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,10116.0,Intermediate,,,12430,178.0,CHEMBL631291,1,BAO_0000218,,,,N,,Blood,8631,Rattus norvegicus,50597,A,,1
,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,10116.0,Intermediate,,,12431,178.0,CHEMBL631292,1,BAO_0000218,,,,N,,Blood,8631,Rattus norvegicus,50597,A,,1
,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,10116.0,Intermediate,,,12432,178.0,CHEMBL631293,1,BAO_0000218,,,,N,,Blood,8631,Rattus norvegicus,50597,A,,1
,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,10116.0,Intermediate,,,12433,178.0,CHEMBL631294,1,BAO_0000218,,,,N,,Blood,8631,Rattus norvegicus,50597,A,,1
,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,10116.0,Intermediate,,,12434,178.0,CHEMBL631295,1,BAO_0000218,,,,N,,Blood,8631,Rattus norvegicus,50597,A,,1
,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,10116.0,Intermediate,,,12435,178.0,CHEMBL631296,1,BAO_0000218,,,,N,,Blood,8631,Rattus norvegicus,50597,A,,1
,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,10116.0,Intermediate,,,12436,178.0,CHEMBL631297,1,BAO_0000218,,,,N,,Blood,8631,Rattus norvegicus,50597,A,,1
,Maximum biodistribution (Bmax) was determined.,,Autocuration,,,12437,,CHEMBL631298,1,BAO_0000218,,,,U,,,10263,,22224,A,,0
,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 1.5625 (mg/kg) intravenous dose in 6 mice,10090.0,Intermediate,,,12438,,CHEMBL631299,1,BAO_0000218,,,,N,,,12364,Mus musculus,50594,A,,1
,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 10 (mg/kg) intravenous dose in 6 mice,10090.0,Intermediate,,,12439,,CHEMBL631300,1,BAO_0000218,,,,N,,,12364,Mus musculus,50594,A,,1
,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 3.125 (mg/kg) intravenous dose in 6 mice,10090.0,Intermediate,,,12440,,CHEMBL631301,1,BAO_0000218,,,,N,,,12364,Mus musculus,50594,A,,1
,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 6.25 (mg/kg) intravenous dose in 6 mice,10090.0,Intermediate,,,12441,,CHEMBL630291,1,BAO_0000218,,,,N,,,12364,Mus musculus,50594,A,,1
,Brain concentration after 0.25 hr at a dose of 10 mg/kg when administered intraperitoneally,,Autocuration,,,12442,,CHEMBL630292,1,BAO_0000218,,,,U,,,14793,,22224,A,,0
,Brain concentration after 0.25 h at a dose of 10 mg/kg when administered intravenously,,Autocuration,,,12443,,CHEMBL630293,1,BAO_0000218,,,,U,,,14793,,22224,A,,0
,Brain concentration after 0.5 h at a dose of 100 mg/kg when administered perorally,,Autocuration,,,12444,,CHEMBL630294,1,BAO_0000218,,,,U,,,14793,,22224,A,,0
,Brain concentration after 0.5 h at a dose of 10 mg/kg when administered intraperitoneally,,Autocuration,,,12445,,CHEMBL630295,1,BAO_0000218,,,,U,,,14793,,22224,A,,0
,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered intravenously,,Autocuration,,,12446,,CHEMBL630296,1,BAO_0000218,,,,U,,,14793,,22224,A,,0
,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered perorally,,Autocuration,,,12447,,CHEMBL626782,1,BAO_0000218,,,,U,,,14793,,22224,A,,0
,Brain concentration after 1 hr at a dose of 100 mg/kg when administered perorally,,Autocuration,,,12448,,CHEMBL626783,1,BAO_0000218,,,,U,,,14793,,22224,A,,0
,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intraperitoneally,,Autocuration,,,12449,,CHEMBL626784,1,BAO_0000218,,,,U,,,14793,,22224,A,,0
,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intravenously,,Autocuration,,,12450,,CHEMBL626785,1,BAO_0000218,,,,U,,,14793,,22224,A,,0
,Brain concentration after 1 hr at a dose of 10 mg/kg when administered perorally,,Autocuration,,,12451,,CHEMBL626786,1,BAO_0000218,,,,U,,,14793,,22224,A,,0
,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,Autocuration,,,12452,,CHEMBL626787,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,Autocuration,,,12453,,CHEMBL626788,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,Autocuration,,,12454,,CHEMBL625927,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,10116.0,Intermediate,,,12455,178.0,CHEMBL625928,1,BAO_0000218,,,,N,,Blood,8374,Rattus norvegicus,50597,A,,1
,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,10116.0,Intermediate,,,12456,178.0,CHEMBL625929,1,BAO_0000218,,,,N,,Blood,8374,Rattus norvegicus,50597,A,,1
,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected.,10116.0,Intermediate,,,12457,178.0,CHEMBL625930,1,BAO_0000218,,,,N,,Blood,8374,Rattus norvegicus,50597,A,,1
,"Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound, Compound was found to be in trace amount.",10116.0,Intermediate,,,12458,178.0,CHEMBL625931,1,BAO_0000218,,,,N,,Blood,8374,Rattus norvegicus,50597,A,,1
,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected.,10116.0,Intermediate,,,12459,178.0,CHEMBL627230,1,BAO_0000218,,,,N,,Blood,8374,Rattus norvegicus,50597,A,,1
,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,10116.0,Intermediate,,,12460,178.0,CHEMBL627231,1,BAO_0000218,,,,N,,Blood,8374,Rattus norvegicus,50597,A,,1
,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,10116.0,Intermediate,,,12461,178.0,CHEMBL627232,1,BAO_0000218,,,,N,,Blood,8374,Rattus norvegicus,50597,A,,1
,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected.,10116.0,Intermediate,,,12462,178.0,CHEMBL627233,1,BAO_0000218,,,,N,,Blood,8374,Rattus norvegicus,50597,A,,1
,Concentration 5a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,10116.0,Intermediate,,,12463,178.0,CHEMBL875470,1,BAO_0000218,,,,N,,Blood,8374,Rattus norvegicus,50597,A,,1
,Concentration 5a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,10116.0,Intermediate,,,12464,178.0,CHEMBL627234,1,BAO_0000218,,,,N,,Blood,8374,Rattus norvegicus,50597,A,,1
,Concentration 5b detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,10116.0,Intermediate,,,12465,178.0,CHEMBL627235,1,BAO_0000218,,,,N,,Blood,8374,Rattus norvegicus,50597,A,,1
,Concentration 5b detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,10116.0,Intermediate,,,12466,178.0,CHEMBL627236,1,BAO_0000218,,,,N,,Blood,8374,Rattus norvegicus,50597,A,,1
,Concentration 5c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,10116.0,Intermediate,,,12467,178.0,CHEMBL627237,1,BAO_0000218,,,,N,,Blood,8374,Rattus norvegicus,50597,A,,1
,Concentration 5c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,10116.0,Intermediate,,,12468,178.0,CHEMBL627238,1,BAO_0000218,,,,N,,Blood,8374,Rattus norvegicus,50597,A,,1
,Concentration 5d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,10116.0,Intermediate,,,12469,178.0,CHEMBL627239,1,BAO_0000218,,,,N,,Blood,8374,Rattus norvegicus,50597,A,,1
,Concentration 5d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,10116.0,Intermediate,,,12470,178.0,CHEMBL627240,1,BAO_0000218,,,,N,,Blood,8374,Rattus norvegicus,50597,A,,1
,Concentration 5e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,10116.0,Intermediate,,,12471,178.0,CHEMBL627241,1,BAO_0000218,,,,N,,Blood,8374,Rattus norvegicus,50597,A,,1
,Concentration 5e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,10116.0,Intermediate,,,12472,178.0,CHEMBL627242,1,BAO_0000218,,,,N,,Blood,8374,Rattus norvegicus,50597,A,,1
,Concentration 5f detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected,10116.0,Intermediate,,,12473,178.0,CHEMBL627243,1,BAO_0000218,,,,N,,Blood,8374,Rattus norvegicus,50597,A,,1
,Concentration 5f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,10116.0,Intermediate,,,12474,178.0,CHEMBL627244,1,BAO_0000218,,,,N,,Blood,8374,Rattus norvegicus,50597,A,,1
,Concentration 6a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,10116.0,Intermediate,,,12475,178.0,CHEMBL627245,1,BAO_0000218,,,,N,,Blood,8374,Rattus norvegicus,50597,A,,1
,Concentration 6a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,10116.0,Intermediate,,,12476,178.0,CHEMBL627246,1,BAO_0000218,,,,N,,Blood,8374,Rattus norvegicus,50597,A,,1
,Concentration 6c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,10116.0,Intermediate,,,12477,178.0,CHEMBL627247,1,BAO_0000218,,,,N,,Blood,8374,Rattus norvegicus,50597,A,,1
,Concentration 6c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,10116.0,Intermediate,,,12478,178.0,CHEMBL627248,1,BAO_0000218,,,,N,,Blood,8374,Rattus norvegicus,50597,A,,1
,Concentration 6d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,10116.0,Intermediate,,,12479,178.0,CHEMBL627249,1,BAO_0000218,,,,N,,Blood,8374,Rattus norvegicus,50597,A,,1
,Concentration 6d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,10116.0,Intermediate,,,12480,178.0,CHEMBL625569,1,BAO_0000218,,,,N,,Blood,8374,Rattus norvegicus,50597,A,,1
,Concentration 6e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,10116.0,Intermediate,,,12481,178.0,CHEMBL625570,1,BAO_0000218,,,,N,,Blood,8374,Rattus norvegicus,50597,A,,1
,Concentration 6e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,10116.0,Intermediate,,,12482,178.0,CHEMBL625571,1,BAO_0000218,,,,N,,Blood,8374,Rattus norvegicus,50597,A,,1
,Concentration 6f detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,10116.0,Intermediate,,,12483,178.0,CHEMBL625572,1,BAO_0000218,,,,N,,Blood,8374,Rattus norvegicus,50597,A,,1
,Concentration 6f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,10116.0,Intermediate,,,12484,178.0,CHEMBL625573,1,BAO_0000218,,,,N,,Blood,8374,Rattus norvegicus,50597,A,,1
,Concentration detected in blood of rat 1 hr after an oral dose of 200 mg/kg,10116.0,Intermediate,,,12485,178.0,CHEMBL625574,1,BAO_0000218,,,,N,,Blood,8374,Rattus norvegicus,50597,A,,1
,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,10116.0,Intermediate,,,12486,178.0,CHEMBL626245,1,BAO_0000218,,,,N,,Blood,8374,Rattus norvegicus,50597,A,,1
,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,10116.0,Intermediate,,,12487,178.0,CHEMBL626246,1,BAO_0000218,,,,N,,Blood,8374,Rattus norvegicus,50597,A,,1
,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,Autocuration,,,12488,,CHEMBL626247,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,Autocuration,,,12489,,CHEMBL626248,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,Autocuration,,,12490,,CHEMBL626249,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,Autocuration,,,12491,,CHEMBL626420,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,Autocuration,,,12492,,CHEMBL626421,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,Autocuration,,,12493,,CHEMBL626422,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,Autocuration,,,12494,,CHEMBL626423,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,Autocuration,,,12495,,CHEMBL626424,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Volume of distribution in Beagles dog at a dose of 1 mg/kg given intravenously,9615.0,Intermediate,,,12496,,CHEMBL626425,1,BAO_0000218,,,,N,,,12023,Canis lupus familiaris,50588,A,,1
,Volume of distribution in CD rat at a dose of 5 mg/kg given intravenously,10116.0,Intermediate,,,12497,,CHEMBL875476,1,BAO_0000218,,,,N,,,12023,Rattus norvegicus,50597,A,,1
,Volume of distribution in Cynomolgus monkey at a dose of 5 mg/kg given intravenously,9541.0,Intermediate,,,12498,,CHEMBL626426,1,BAO_0000218,,,,N,,,12023,Macaca fascicularis,100710,A,,1
,Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol,,Autocuration,,,12499,,CHEMBL626427,1,BAO_0000100,,,,U,,,10580,,22224,P,,0
,Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol,,Autocuration,,,12500,,CHEMBL626428,1,BAO_0000100,,,,U,,,10580,,22224,P,,0
,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in bile by subcutaneous dose of 150 umol/kg,,Autocuration,,,12501,,CHEMBL626429,1,BAO_0000019,,,,U,,,16032,,22224,A,,0
,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in urine by subcutaneous dose of 150 umol/kg,,Autocuration,,,12502,1088.0,CHEMBL625025,1,BAO_0000019,,,,U,,Urine,16032,,22224,A,,0
,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,10116.0,Intermediate,,,12503,178.0,CHEMBL625026,1,BAO_0000218,,,,N,,Blood,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,10116.0,Intermediate,,,12504,178.0,CHEMBL625027,1,BAO_0000218,,,,N,,Blood,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,10116.0,Intermediate,,,12505,178.0,CHEMBL874410,1,BAO_0000218,,,,N,,Blood,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,10116.0,Intermediate,,,12506,178.0,CHEMBL625028,1,BAO_0000218,,,,N,,Blood,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,10116.0,Intermediate,,,12507,178.0,CHEMBL625029,1,BAO_0000218,,,,N,,Blood,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,10116.0,Intermediate,,,12508,178.0,CHEMBL625030,1,BAO_0000218,,,,N,,Blood,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,10116.0,Intermediate,,,12509,178.0,CHEMBL625031,1,BAO_0000218,,,,N,,Blood,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,10116.0,Intermediate,,,12510,178.0,CHEMBL625032,1,BAO_0000218,,,,N,,Blood,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,10116.0,Intermediate,,,12511,178.0,CHEMBL625033,1,BAO_0000218,,,,N,,Blood,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,10116.0,Intermediate,,,12512,178.0,CHEMBL625034,1,BAO_0000218,,,,N,,Blood,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,10116.0,Intermediate,,,12513,948.0,CHEMBL624872,1,BAO_0000218,,,,N,,Heart,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,10116.0,Intermediate,,,12514,948.0,CHEMBL624873,1,BAO_0000218,,,,N,,Heart,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,10116.0,Intermediate,,,12515,948.0,CHEMBL624874,1,BAO_0000218,,,,N,,Heart,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,10116.0,Intermediate,,,12516,948.0,CHEMBL624875,1,BAO_0000218,,,,N,,Heart,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,10116.0,Intermediate,,,12517,948.0,CHEMBL624876,1,BAO_0000218,,,,N,,Heart,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,10116.0,Intermediate,,,12518,948.0,CHEMBL624877,1,BAO_0000218,,,,N,,Heart,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,10116.0,Intermediate,,,12519,948.0,CHEMBL624878,1,BAO_0000218,,,,N,,Heart,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,10116.0,Intermediate,,,12520,948.0,CHEMBL624879,1,BAO_0000218,,,,N,,Heart,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,10116.0,Intermediate,,,12521,948.0,CHEMBL624880,1,BAO_0000218,,,,N,,Heart,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 10 min (radiolabeled with [125I]-,10116.0,Intermediate,,,12522,948.0,CHEMBL624881,1,BAO_0000218,,,,N,,Heart,8594,Rattus norvegicus,50597,A,,1
,"Concentration was measured in heart tissue of unfasted Fischer 344 rats, administered intravenous, after 5 minute (radiolabeled with [125I]-",10116.0,Intermediate,,,12523,948.0,CHEMBL624882,1,BAO_0000218,,,,N,,Heart,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,10116.0,Intermediate,,,12524,2113.0,CHEMBL624883,1,BAO_0000218,,,,N,,Kidney,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,10116.0,Intermediate,,,12525,2113.0,CHEMBL624884,1,BAO_0000218,,,,N,,Kidney,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,10116.0,Intermediate,,,12526,2113.0,CHEMBL624885,1,BAO_0000218,,,,N,,Kidney,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,10116.0,Intermediate,,,12527,2113.0,CHEMBL624886,1,BAO_0000218,,,,N,,Kidney,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,10116.0,Intermediate,,,12528,2113.0,CHEMBL624887,1,BAO_0000218,,,,N,,Kidney,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,10116.0,Intermediate,,,12529,2113.0,CHEMBL624888,1,BAO_0000218,,,,N,,Kidney,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,10116.0,Intermediate,,,12530,2113.0,CHEMBL624889,1,BAO_0000218,,,,N,,Kidney,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,10116.0,Intermediate,,,12531,2113.0,CHEMBL624890,1,BAO_0000218,,,,N,,Kidney,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,10116.0,Intermediate,,,12532,2113.0,CHEMBL621964,1,BAO_0000218,,,,N,,Kidney,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,10116.0,Intermediate,,,12533,2113.0,CHEMBL621965,1,BAO_0000218,,,,N,,Kidney,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,10116.0,Intermediate,,,12534,2107.0,CHEMBL621966,1,BAO_0000218,,,,N,,Liver,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,10116.0,Intermediate,,,12535,2107.0,CHEMBL621967,1,BAO_0000218,,,,N,,Liver,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,10116.0,Intermediate,,,12536,2107.0,CHEMBL622164,1,BAO_0000218,,,,N,,Liver,8594,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (nucleic acids),,Autocuration,,,12537,,CHEMBL623097,1,BAO_0000019,,,,U,,,7653,,22224,A,,0
,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (protein),,Autocuration,,,12538,,CHEMBL623098,1,BAO_0000019,,,,U,,,7653,,22224,A,,0
,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid soluble,,Autocuration,,,12539,,CHEMBL623099,1,BAO_0000019,,,,U,,,7653,,22224,A,,0
,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; total uptake,,Autocuration,,,12540,,CHEMBL623100,1,BAO_0000019,,,,U,,,7653,,22224,A,,0
,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated Number of new tumors observed",10116.0,Intermediate,,,12541,,CHEMBL628673,1,BAO_0000218,,,,N,,,9104,Rattus norvegicus,50597,A,,1
,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated complete percent remission indicates tumor not palpable.",10116.0,Intermediate,,,12542,,CHEMBL628674,1,BAO_0000218,,,,N,,,9104,Rattus norvegicus,50597,A,,1
,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated number of tumors at the beginning of the test.",10116.0,Intermediate,,,12543,,CHEMBL628675,1,BAO_0000218,,,,N,,,9104,Rattus norvegicus,50597,A,,1
,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated of percent static tumors indicates size of tumor 51-150% of the initial size",10116.0,Intermediate,,,12544,,CHEMBL627644,1,BAO_0000218,,,,N,,,9104,Rattus norvegicus,50597,A,,1
,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated partial percent remission indicates reduction of initial tumor size <=50%.",10116.0,Intermediate,,,12545,,CHEMBL627645,1,BAO_0000218,,,,N,,,9104,Rattus norvegicus,50597,A,,1
,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent progress in tumor size indicates >150% of the initial size",10116.0,Intermediate,,,12546,,CHEMBL627646,1,BAO_0000218,,,,N,,,9104,Rattus norvegicus,50597,A,,1
,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent static tumors indicates size of tumor 51-150% of the initial size",10116.0,Intermediate,,,12547,,CHEMBL627647,1,BAO_0000218,,,,N,,,9104,Rattus norvegicus,50597,A,,1
,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent tumor area measured as the average on the 28th day of therapy.",10116.0,Intermediate,,,12548,,CHEMBL627648,1,BAO_0000218,,,,N,,,9104,Rattus norvegicus,50597,A,,1
,Free level in rat plasma,10116.0,Intermediate,,,12549,,CHEMBL627649,1,BAO_0000218,,,,N,,,12902,Rattus norvegicus,50597,A,,1
,Level reaching in blood plasma of rat or human was determined,,Autocuration,,,12550,,CHEMBL628313,1,BAO_0000019,,,,U,,,6614,,22224,A,,0
,Log (Cbrain/Cblood) in rats,10116.0,Intermediate,,,12551,,CHEMBL628314,1,BAO_0000218,,,,N,,,9663,Rattus norvegicus,50597,A,,1
,Mean percentage of compound transport through P-glycoprotein; expressed as p-glycoprotein affinity,,Autocuration,,,12552,,CHEMBL628315,1,BAO_0000019,,,,U,,,17658,,22224,A,,0
,Mean percentage of compound transport through membrane; expressed as membrane transport,,Autocuration,,,12553,,CHEMBL628316,1,BAO_0000019,,,,U,,,17658,,22224,A,,0
,Metabolic breakdown to the o-sulfate of p-chloroaniline (2-amino-5-chlorophenyl sulfate) by giving 100 mg/kg oral doses of the compound,,Autocuration,,,12554,,CHEMBL628317,1,BAO_0000218,,,,U,,,14314,,22224,A,,0
,Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5,,Autocuration,,,12555,,CHEMBL628473,1,BAO_0000019,,,,U,,,7385,,22224,A,,0
,"Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5, ND=Not determined",,Autocuration,,,12556,,CHEMBL628474,1,BAO_0000019,,,,U,,,7385,,22224,A,,0
,Michaelis-Menten constant was measured in the inactivation of trypsin; Km x 10 e5,,Autocuration,,,12557,,CHEMBL628475,1,BAO_0000019,,,,U,,,7385,,22224,A,,0
,Net water uptake by a carrier mediated transport (%cm) mechanism,,Autocuration,,,12558,,CHEMBL628476,1,BAO_0000019,,,,U,,,1329,,22224,A,,0
,Peak concentration was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,314293.0,Autocuration,,,12559,,CHEMBL628477,1,BAO_0000218,,,,U,,,12187,Simiiformes,22224,A,,0
,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,9669.0,Intermediate,,,12560,,CHEMBL628478,1,BAO_0000218,,,,N,,,12187,Mustela putorius furo,50506,A,,1
,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",9669.0,Intermediate,,,12561,,CHEMBL628479,1,BAO_0000218,,,,N,,,12187,Mustela putorius furo,50506,A,,1
,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,314293.0,Autocuration,,,12562,,CHEMBL628480,1,BAO_0000218,,,,U,,,12187,Simiiformes,22224,A,,0
,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey, determined by renin inhibition assay",314293.0,Autocuration,,,12563,,CHEMBL628481,1,BAO_0000218,,,,U,,,12187,Simiiformes,22224,A,,0
,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,10116.0,Intermediate,,,12564,,CHEMBL628482,1,BAO_0000218,,,,N,,,12187,Rattus norvegicus,50597,A,,1
,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",10116.0,Intermediate,,,12565,,CHEMBL628483,1,BAO_0000218,,,,N,,,12187,Rattus norvegicus,50597,A,,1
,"Peak plasma concentration at a dose of 10 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",10116.0,Intermediate,,,12566,1969.0,CHEMBL628484,1,BAO_0000218,,,,N,,Plasma,9278,Rattus norvegicus,50597,A,,1
,"Peak plasma concentration at a dose of 100 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",10116.0,Intermediate,,,12567,1969.0,CHEMBL628485,1,BAO_0000218,,,,N,,Plasma,9278,Rattus norvegicus,50597,A,,1
,"Peak plasma concentration at a dose of 20 mg/kg, oral route in monkey (Macaca fascicularis) suspended in carboxymethyl cellulose (CMC);Range is between (5.5-6)",9541.0,Intermediate,,,12568,1969.0,CHEMBL628486,1,BAO_0000218,,,,N,,Plasma,9278,Macaca fascicularis,100710,A,,1
,"Peak plasma concentration at a dose of 200 mg/kg, oral route in human",9606.0,Intermediate,,,12569,1969.0,CHEMBL628487,1,BAO_0000218,,,,N,,Plasma,9278,Homo sapiens,50587,A,,1
,"Peak plasma concentration at a dose of 25 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",10116.0,Intermediate,,,12570,1969.0,CHEMBL628488,1,BAO_0000218,,,,N,,Plasma,9278,Rattus norvegicus,50597,A,,1
,"Peak plasma concentration at a dose of 25 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",10116.0,Intermediate,,,12571,1969.0,CHEMBL628489,1,BAO_0000218,,,,N,,Plasma,9278,Rattus norvegicus,50597,A,,1
,"Peak plasma concentration at a dose of 50 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",10116.0,Intermediate,,,12572,1969.0,CHEMBL628490,1,BAO_0000218,,,,N,,Plasma,9278,Rattus norvegicus,50597,A,,1
,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,9541.0,Intermediate,,,12573,,CHEMBL628491,1,BAO_0000218,,,,N,,,12186,Macaca fascicularis,100710,A,,1
,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,9541.0,Intermediate,,,12574,,CHEMBL877507,1,BAO_0000218,,,,N,,,12186,Macaca fascicularis,100710,A,,1
,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,Autocuration,,,12575,,CHEMBL628492,1,BAO_0000218,,,,U,,,12186,,22224,A,,0
,% metabolized in monkey S-9 after 2 hours (10 ug/mL),314293.0,Autocuration,,,12576,,CHEMBL628493,1,BAO_0000019,,,,U,,,12041,Simiiformes,22224,A,,0
,% metabolized in monkey S-9 after 2 hours (1 ug/ml),314293.0,Autocuration,,,12577,,CHEMBL628494,1,BAO_0000019,,,,U,,,12041,Simiiformes,22224,A,,0
,% metabolized in monkey S-9 after 2 hours (10 ug/ml),314293.0,Autocuration,,,12578,,CHEMBL628495,1,BAO_0000019,,,,U,,,12041,Simiiformes,22224,A,,0
,Permeability in Caco-2 assay at 10E-6,9606.0,Intermediate,,,12579,,CHEMBL628496,1,BAO_0000218,,,,N,,,6737,Homo sapiens,50587,A,,1
,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,,Autocuration,,,12580,955.0,CHEMBL628497,1,BAO_0000218,,,,U,,Brain,13758,,22224,A,,0
,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,,Autocuration,,,12581,955.0,CHEMBL628498,1,BAO_0000218,,,,U,,Brain,13758,,22224,A,,0
,Plasma protein binding was determined,,Autocuration,,,12582,,CHEMBL628499,1,BAO_0000019,,,,U,,,5676,,22224,A,,0
,Brain concentration after 2 hr at a dose of 100 mg/kg when administered perorally,,Autocuration,,,12583,,CHEMBL627656,1,BAO_0000218,,,,U,,,14793,,22224,A,,0
,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intraperitoneally,,Autocuration,,,12584,,CHEMBL627657,1,BAO_0000218,,,,U,,,14793,,22224,A,,0
,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intravenously,,Autocuration,,,12585,,CHEMBL626808,1,BAO_0000218,,,,U,,,14793,,22224,A,,0
,Brain concentration after 2 hr at a dose of 10 mg/kg when administered perorally,,Autocuration,,,12586,,CHEMBL626809,1,BAO_0000218,,,,U,,,14793,,22224,A,,0
,Brain concentration after 4 hr at a dose of 100 mg/kg when administered perorally,,Autocuration,,,12587,,CHEMBL626810,1,BAO_0000218,,,,U,,,14793,,22224,A,,0
,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intraperitoneally,,Autocuration,,,12588,,CHEMBL626811,1,BAO_0000218,,,,U,,,14793,,22224,A,,0
,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intravenously,,Autocuration,,,12589,,CHEMBL874465,1,BAO_0000218,,,,U,,,14793,,22224,A,,0
,Brain concentration after 4 hr at a dose of 10 mg/kg when administered perorally,,Autocuration,,,12590,,CHEMBL626812,1,BAO_0000218,,,,U,,,14793,,22224,A,,0
,Brain concentration after 6 hr at a dose of 100 mg/kg when administered perorally,,Autocuration,,,12591,,CHEMBL626813,1,BAO_0000218,,,,U,,,14793,,22224,A,,0
,Brain concentration after 6 hr at a dose of 10 mg/kg when administered perorally,,Autocuration,,,12592,,CHEMBL626814,1,BAO_0000218,,,,U,,,14793,,22224,A,,0
,Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.,,Autocuration,,,12593,,CHEMBL626815,1,BAO_0000019,,,,U,,,14000,,22224,A,,0
,Partition coefficient (logP),,Autocuration,,,12594,,CHEMBL628566,1,BAO_0000019,,,,U,,,5948,,22224,A,,0
,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,Autocuration,,,12595,,CHEMBL628567,1,BAO_0000100,,,,U,,,13824,,22229,P,,0
,Calculated partition coefficient (clogP),,Autocuration,,,12596,,CHEMBL628568,1,BAO_0000100,,,,U,,,10778,,22229,P,,0
,C max in dog,9615.0,Intermediate,,,12597,,CHEMBL628569,1,BAO_0000218,,In vivo,,N,,,17237,Canis lupus familiaris,50588,A,,1
,C max in guinea pig,10141.0,Intermediate,,,12598,,CHEMBL628570,1,BAO_0000218,,In vivo,,N,,,17237,Cavia porcellus,50512,A,,1
,C max value was evaluated,,Autocuration,,,12599,,CHEMBL628571,1,BAO_0000218,,In vivo,,U,,,2809,,22224,A,,0
,Cmax value after oral dose of 0.1 mg//kg,,Autocuration,,,12600,,CHEMBL628572,1,BAO_0000218,,In vivo,,U,,,11954,,22224,A,,0
,Cmax value after oral dose of 0.3 mg/kg,,Autocuration,,,12601,,CHEMBL628573,1,BAO_0000218,,In vivo,,U,,,11954,,22224,A,,0
,Cmax value after oral dose of 1 mg/kg,,Autocuration,,,12602,,CHEMBL628574,1,BAO_0000218,,In vivo,,U,,,11954,,22224,A,,0
,Cmax value after oral dose of 10 mg/kg,,Autocuration,,,12603,,CHEMBL628575,1,BAO_0000218,,In vivo,,U,,,11954,,22224,A,,0
,Cmax value after oral dose of 23.4 mg/kg,,Autocuration,,,12604,,CHEMBL628576,1,BAO_0000218,,In vivo,,U,,,11954,,22224,A,,0
,Cmax value after oral dose of 3 mg/kg,,Autocuration,,,12605,,CHEMBL628577,1,BAO_0000218,,In vivo,,U,,,11954,,22224,A,,0
,Cmax value after oral dose of 3.87 mg/kg,,Autocuration,,,12606,,CHEMBL628578,1,BAO_0000218,,In vivo,,U,,,11954,,22224,A,,0
,Cmax value in female Beagle dogs,9615.0,Intermediate,,,12607,,CHEMBL874466,1,BAO_0000218,,In vivo,,N,,,12768,Canis lupus familiaris,50588,A,,1
,Cmax value in male rats,10116.0,Intermediate,,,12608,,CHEMBL628579,1,BAO_0000218,,In vivo,,N,,,12768,Rattus norvegicus,50597,A,,1
,Cmax value in rat plasma when administered 20 mg/kg perorally,10116.0,Intermediate,,,12609,1969.0,CHEMBL628580,1,BAO_0000218,,In vivo,,N,,Plasma,12780,Rattus norvegicus,50597,A,,1
,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,9615.0,Intermediate,,,12610,1969.0,CHEMBL628581,1,BAO_0000218,,In vivo,,N,,Plasma,15592,Canis lupus familiaris,50588,A,,1
,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,9615.0,Intermediate,,,12611,1969.0,CHEMBL628582,1,BAO_0000218,,In vivo,,N,,Plasma,15592,Canis lupus familiaris,50588,A,,1
,Peak concentration of compound at Time = 0 was determined in dog at 5 mg/kg intravenously admn.,9615.0,Intermediate,,,12612,,CHEMBL628583,1,BAO_0000218,,,,N,,,17025,Canis lupus familiaris,50588,A,,1
,Peak concentration of compound at Time = 0 was determined in monkey at 5 mg/kg intravenously admn.,314293.0,Autocuration,,,12613,,CHEMBL625782,1,BAO_0000218,,,,U,,,17025,Simiiformes,22224,A,,0
,Peak concentration of compound at Time = 0 was determined in rabbit at 5 mg/kg intravenously admn.,9986.0,Intermediate,,,12614,,CHEMBL625783,1,BAO_0000218,,,,N,,,17025,Oryctolagus cuniculus,50592,A,,1
,Peak concentration of compound at Time = 0 was determined in rat at 5 mg/kg intravenously admn.,10116.0,Intermediate,,,12615,,CHEMBL625784,1,BAO_0000218,,,,N,,,17025,Rattus norvegicus,50597,A,,1
,Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey,9544.0,Intermediate,,,12616,1969.0,CHEMBL625785,1,BAO_0000218,,,,N,,Plasma,4236,Macaca mulatta,50797,A,,1
,C5min (nM) value was determined in rats after intravenous dose of 5 mg/kg,10116.0,Intermediate,,,12617,,CHEMBL625786,1,BAO_0000218,,,,N,,,15791,Rattus norvegicus,50597,A,,1
,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate,,Autocuration,,,12618,,CHEMBL874467,1,BAO_0000019,,,,U,,,11149,,22224,A,,0
,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",9615.0,Intermediate,,,12619,,CHEMBL625787,1,BAO_0000218,,,,N,,,15592,Canis lupus familiaris,50588,A,,1
,cytotoxicity against HIV protease enzyme.,12721.0,Intermediate,,,12620,,CHEMBL625964,1,BAO_0000218,,,,N,,,15778,Human immunodeficiency virus,50677,A,,1
,Apparent clearance in mice after intravenous administration of 105.1 mg/kg of dose,10090.0,Intermediate,,,12621,,CHEMBL625965,1,BAO_0000218,,,,N,,,12745,Mus musculus,50594,A,,1
,Apparent clearance in mice after oral administration of 100 mg/kg of dose,10090.0,Intermediate,,,12622,,CHEMBL625966,1,BAO_0000218,,,,N,,,12745,Mus musculus,50594,A,,1
,The plasma clearance in dog.,9615.0,Intermediate,,,12623,1969.0,CHEMBL625967,1,BAO_0000218,,In vivo,,N,,Plasma,13941,Canis lupus familiaris,50588,A,,1
,The plasma clearance in rat.,10116.0,Intermediate,,,12624,1969.0,CHEMBL625968,1,BAO_0000218,,In vivo,,N,,Plasma,13941,Rattus norvegicus,50597,A,,1
,Clearance from plasma in male Sprague-Dawley rats,10116.0,Intermediate,,,12625,1969.0,CHEMBL625969,1,BAO_0000218,,In vivo,,N,,Plasma,16449,Rattus norvegicus,50597,A,,1
,Clearance from plasma in male cynomolgus monkeys,9541.0,Intermediate,,,12626,1969.0,CHEMBL625970,1,BAO_0000218,,In vivo,,N,,Plasma,16449,Macaca fascicularis,100710,A,,1
,"Clearance of compound (5 mg/kg, intravenously), in dog plasma",9615.0,Intermediate,,,12627,1969.0,CHEMBL625971,1,BAO_0000218,,In vivo,,N,,Plasma,14224,Canis lupus familiaris,50588,A,,1
,Clearance of compound in dog plasma,9615.0,Intermediate,,,12628,1969.0,CHEMBL625972,1,BAO_0000218,,In vivo,,N,,Plasma,14224,Canis lupus familiaris,50588,A,,1
,Clearance of compound in human plasma,9606.0,Intermediate,,,12629,1969.0,CHEMBL625973,1,BAO_0000218,,In vivo,,N,,Plasma,14224,Homo sapiens,50587,A,,1
,Clearance of compound when administered intravenously as a mixture (five-in-one dose) to a single dog.,9615.0,Intermediate,,,12630,,CHEMBL625974,1,BAO_0000218,,In vivo,,N,,,14317,Canis lupus familiaris,50588,A,,1
,Clearance of compound when administered intravenously as an individual dose to a single dog.,9615.0,Intermediate,,,12631,,CHEMBL625975,1,BAO_0000218,,In vivo,,N,,,14317,Canis lupus familiaris,50588,A,,1
,"Clearance (10 mg/kg, intravenously) in dog plasma",9615.0,Intermediate,,,12632,1969.0,CHEMBL625976,1,BAO_0000218,,In vivo,,N,,Plasma,14224,Canis lupus familiaris,50588,A,,1
,Clearance value in dog,9615.0,Intermediate,,,12633,,CHEMBL625977,1,BAO_0000218,,In vivo,,N,,,17237,Canis lupus familiaris,50588,A,,1
,Clearance value in guinea pig,10141.0,Intermediate,,,12634,,CHEMBL625978,1,BAO_0000218,,In vivo,,N,,,17237,Cavia porcellus,50512,A,,1
,Clearance values in rats after iv administration.,10116.0,Intermediate,,,12635,,CHEMBL874468,1,BAO_0000218,,In vivo,,N,,,14187,Rattus norvegicus,50597,A,,1
,Compound was tested for plasma clearance on administered orally as aqueous solutions at 1 mpk and by iv at 0.2 mpk,,Autocuration,,,12636,1969.0,CHEMBL625421,1,BAO_0000218,,In vivo,,U,,Plasma,4806,,22224,A,,0
,In vivo clearance (5 mg/kg) was determined in rabbits,9986.0,Intermediate,,,12637,,CHEMBL625422,1,BAO_0000218,,In vivo,,N,,,15025,Oryctolagus cuniculus,50592,A,,1
,Plasma Clearance rate was determined for the compound in rats,10116.0,Intermediate,,,12638,,CHEMBL625423,1,BAO_0000218,,In vivo,,N,,,13197,Rattus norvegicus,50597,A,,1
,Plasma Clearance rate was determined for the compound in squirrel monkeys,9520.0,Autocuration,,,12639,,CHEMBL625424,1,BAO_0000218,,In vivo,,U,,,13197,Saimiri,22224,A,,0
,Plasma clearance in rat,10116.0,Intermediate,,,12640,,CHEMBL625425,1,BAO_0000218,,In vivo,,N,,,13960,Rattus norvegicus,50597,A,,1
,Plasma clearance of the compound,,Autocuration,,,12641,,CHEMBL625426,1,BAO_0000218,,In vivo,,U,,,17820,,22224,A,,0
,Plasma clearance in guinea pigs at 2 mg/kg after iv administration,10141.0,Intermediate,,,12642,,CHEMBL625427,1,BAO_0000218,,In vivo,,N,,,14706,Cavia porcellus,50512,A,,1
,Plasma clearance in guinea pigs at 3 mg/kg after iv administration,10141.0,Intermediate,,,12643,,CHEMBL625428,1,BAO_0000218,,In vivo,,N,,,14706,Cavia porcellus,50512,A,,1
,Plasma clearance was determined,,Autocuration,,,12644,,CHEMBL625429,1,BAO_0000218,,In vivo,,U,,,6504,,22224,A,,0
,Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.,9615.0,Intermediate,,,12645,,CHEMBL625430,1,BAO_0000218,,In vivo,,N,,,14925,Canis lupus familiaris,50588,A,,1
,Plasma clearance rate was determined for the compound in rats,10116.0,Intermediate,,,12646,,CHEMBL625431,1,BAO_0000218,,In vivo,,N,,,13197,Rattus norvegicus,50597,A,,1
,Plasma clearance rate was determined for the compound in squirrel monkeys,9520.0,Autocuration,,,12647,,CHEMBL627307,1,BAO_0000218,,In vivo,,U,,,13197,Saimiri,22224,A,,0
,Slow clearance (CL) was determined,,Autocuration,,,12648,,CHEMBL627308,1,BAO_0000218,,In vivo,,U,,,3437,,22224,A,,0
,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,Autocuration,,,12649,,CHEMBL627309,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr; insufficient gastric juice produced,,Autocuration,,,12650,,CHEMBL627310,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,Autocuration,,,12651,,CHEMBL627311,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,Autocuration,,,12652,,CHEMBL627312,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,Autocuration,,,12653,,CHEMBL627313,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,Autocuration,,,12654,,CHEMBL627314,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,Autocuration,,,12655,,CHEMBL627315,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,Autocuration,,,12656,,CHEMBL627316,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,Autocuration,,,12657,,CHEMBL627317,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,Autocuration,,,12658,,CHEMBL627318,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,Autocuration,,,12659,,CHEMBL627999,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,Autocuration,,,12660,,CHEMBL628000,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,Autocuration,,,12661,,CHEMBL628001,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,Autocuration,,,12662,,CHEMBL628002,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,Autocuration,,,12663,,CHEMBL625610,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,Autocuration,,,12664,,CHEMBL625611,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,Autocuration,,,12665,,CHEMBL625612,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,Autocuration,,,12666,,CHEMBL625613,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,Autocuration,,,12667,,CHEMBL875479,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,Autocuration,,,12668,,CHEMBL625614,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,Autocuration,,,12669,,CHEMBL625615,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,Autocuration,,,12670,,CHEMBL626302,1,BAO_0000218,,,,U,,,9196,,22224,A,,0
,Cumulative concentration 6b and compound 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,10116.0,Intermediate,,,12671,178.0,CHEMBL626303,1,BAO_0000218,,,,N,,Blood,8374,Rattus norvegicus,50597,A,,1
,Cumulative concentration 6b and compound 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,10116.0,Intermediate,,,12672,178.0,CHEMBL627420,1,BAO_0000218,,,,N,,Blood,8374,Rattus norvegicus,50597,A,,1
,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 1 hour relative to initial concentration of 1 uM,10116.0,Intermediate,,,12673,,CHEMBL627421,1,BAO_0000218,,,,N,,,13477,Rattus norvegicus,50597,A,,1
,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 24 hour relative to initial concentration of 1 uM,10116.0,Intermediate,,,12674,,CHEMBL625695,1,BAO_0000218,,,,N,,,13477,Rattus norvegicus,50597,A,,1
,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 4 hour relative to initial concentration of 1 uM,10116.0,Intermediate,,,12675,,CHEMBL625696,1,BAO_0000218,,,,N,,,13477,Rattus norvegicus,50597,A,,1
,Distribution of compound in mice brain was measured after 1 hr,10090.0,Intermediate,,,12676,955.0,CHEMBL875606,1,BAO_0000218,,,,N,,Brain,10009,Mus musculus,50594,A,,1
,Distribution of compound in mice brain was measured after 24 hr r,10090.0,Intermediate,,,12677,955.0,CHEMBL625697,1,BAO_0000218,,,,N,,Brain,10009,Mus musculus,50594,A,,1
,Distribution of compound in mice brain was measured after 2 hr,10090.0,Intermediate,,,12678,955.0,CHEMBL625698,1,BAO_0000218,,,,N,,Brain,10009,Mus musculus,50594,A,,1
,Distribution of compound in mice brain was measured after 3 hr,10090.0,Intermediate,,,12679,955.0,CHEMBL625699,1,BAO_0000218,,,,N,,Brain,10009,Mus musculus,50594,A,,1
,Distribution of compound in mice brain was measured after 6 hr,10090.0,Intermediate,,,12680,955.0,CHEMBL625700,1,BAO_0000218,,,,N,,Brain,10009,Mus musculus,50594,A,,1
,Distribution of compound in mice liver was measured after 1 hr,10090.0,Intermediate,,,12681,,CHEMBL625701,1,BAO_0000218,,,,N,,,10009,Mus musculus,50594,A,,1
,Distribution of compound in mice liver was measured after 24 hr; b=Undetected,10090.0,Intermediate,,,12682,,CHEMBL625702,1,BAO_0000218,,,,N,,,10009,Mus musculus,50594,A,,1
,Distribution of compound in mice liver was measured after 2 hr,10090.0,Intermediate,,,12683,,CHEMBL625703,1,BAO_0000218,,,,N,,,10009,Mus musculus,50594,A,,1
,Distribution of compound in mice liver was measured after 3 hr,10090.0,Intermediate,,,12684,,CHEMBL625704,1,BAO_0000218,,,,N,,,10009,Mus musculus,50594,A,,1
,Distribution of compound in mice liver was measured after 6 hr,10090.0,Intermediate,,,12685,,CHEMBL625705,1,BAO_0000218,,,,N,,,10009,Mus musculus,50594,A,,1
,Distribution in dog adrenal medulla 30 min after administration.,9615.0,Intermediate,,,12686,1236.0,CHEMBL625706,1,BAO_0000218,,,,N,,Adrenal medulla,8170,Canis lupus familiaris,50588,A,,1
,Distribution in dog adrenal medulla 72 hours after administration.,9615.0,Intermediate,,,12687,1236.0,CHEMBL625707,1,BAO_0000218,,,,N,,Adrenal medulla,8170,Canis lupus familiaris,50588,A,,1
,Distribution in female dog Ovary 24 hours after administration.,9615.0,Intermediate,,,12688,,CHEMBL625708,1,BAO_0000218,,,,N,,,8170,Canis lupus familiaris,50588,A,,1
,Distribution in female dog Ovary 72 hours after administration.,9615.0,Intermediate,,,12689,,CHEMBL625709,1,BAO_0000218,,,,N,,,8170,Canis lupus familiaris,50588,A,,1
,Distribution in female dog adipose 24 hours after administration.,9615.0,Intermediate,,,12690,,CHEMBL624180,1,BAO_0000218,,,,N,,,8170,Canis lupus familiaris,50588,A,,1
,Distribution in female dog adipose 72 hours after administration.,9615.0,Intermediate,,,12691,,CHEMBL624181,1,BAO_0000218,,,,N,,,8170,Canis lupus familiaris,50588,A,,1
,Distribution in female dog adrenal cortex 72 hours after administration.,9615.0,Intermediate,,,12692,1235.0,CHEMBL624182,1,BAO_0000218,,,,N,,Adrenal cortex,8170,Canis lupus familiaris,50588,A,,1
,Distribution in female dog adrenal cortex 72 hours after administration.,9615.0,Intermediate,,,12693,1235.0,CHEMBL624183,1,BAO_0000218,,,,N,,Adrenal cortex,8170,Canis lupus familiaris,50588,A,,1
,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,10116.0,Intermediate,,,12694,2107.0,CHEMBL624184,1,BAO_0000218,,,,N,,Liver,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,10116.0,Intermediate,,,12695,2107.0,CHEMBL877489,1,BAO_0000218,,,,N,,Liver,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,10116.0,Intermediate,,,12696,2107.0,CHEMBL624185,1,BAO_0000218,,,,N,,Liver,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,10116.0,Intermediate,,,12697,2107.0,CHEMBL624186,1,BAO_0000218,,,,N,,Liver,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,10116.0,Intermediate,,,12698,2107.0,CHEMBL624187,1,BAO_0000218,,,,N,,Liver,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,10116.0,Intermediate,,,12699,2107.0,CHEMBL624188,1,BAO_0000218,,,,N,,Liver,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,10116.0,Intermediate,,,12700,2048.0,CHEMBL624189,1,BAO_0000218,,,,N,,Lung,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,10116.0,Intermediate,,,12701,2048.0,CHEMBL624190,1,BAO_0000218,,,,N,,Lung,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,10116.0,Intermediate,,,12702,2048.0,CHEMBL624191,1,BAO_0000218,,,,N,,Lung,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,10116.0,Intermediate,,,12703,2048.0,CHEMBL624192,1,BAO_0000218,,,,N,,Lung,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,10116.0,Intermediate,,,12704,2048.0,CHEMBL624193,1,BAO_0000218,,,,N,,Lung,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,10116.0,Intermediate,,,12705,2048.0,CHEMBL624194,1,BAO_0000218,,,,N,,Lung,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,10116.0,Intermediate,,,12706,2048.0,CHEMBL624891,1,BAO_0000218,,,,N,,Lung,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,10116.0,Intermediate,,,12707,2048.0,CHEMBL624892,1,BAO_0000218,,,,N,,Lung,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,10116.0,Intermediate,,,12708,2048.0,CHEMBL624893,1,BAO_0000218,,,,N,,Lung,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,10116.0,Intermediate,,,12709,2048.0,CHEMBL627632,1,BAO_0000218,,,,N,,Lung,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,10116.0,Intermediate,,,12710,,CHEMBL627633,1,BAO_0000218,,,,N,,,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,10116.0,Intermediate,,,12711,,CHEMBL627634,1,BAO_0000218,,,,N,,,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,10116.0,Intermediate,,,12712,,CHEMBL627635,1,BAO_0000218,,,,N,,,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,10116.0,Intermediate,,,12713,,CHEMBL627636,1,BAO_0000218,,,,N,,,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,10116.0,Intermediate,,,12714,,CHEMBL626816,1,BAO_0000218,,,,N,,,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,10116.0,Intermediate,,,12715,,CHEMBL626817,1,BAO_0000218,,,,N,,,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,10116.0,Intermediate,,,12716,,CHEMBL626818,1,BAO_0000218,,,,N,,,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,10116.0,Intermediate,,,12717,,CHEMBL626819,1,BAO_0000218,,,,N,,,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,10116.0,Intermediate,,,12718,,CHEMBL626820,1,BAO_0000218,,,,N,,,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,10116.0,Intermediate,,,12719,,CHEMBL626821,1,BAO_0000218,,,,N,,,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,10116.0,Intermediate,,,12720,2046.0,CHEMBL626822,1,BAO_0000218,,,,N,,Thyroid gland,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,10116.0,Intermediate,,,12721,2046.0,CHEMBL626823,1,BAO_0000218,,,,N,,Thyroid gland,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,10116.0,Intermediate,,,12722,2046.0,CHEMBL626824,1,BAO_0000218,,,,N,,Thyroid gland,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,10116.0,Intermediate,,,12723,2046.0,CHEMBL626825,1,BAO_0000218,,,,N,,Thyroid gland,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,10116.0,Intermediate,,,12724,2046.0,CHEMBL626826,1,BAO_0000218,,,,N,,Thyroid gland,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,10116.0,Intermediate,,,12725,2046.0,CHEMBL626827,1,BAO_0000218,,,,N,,Thyroid gland,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,10116.0,Intermediate,,,12726,2046.0,CHEMBL626828,1,BAO_0000218,,,,N,,Thyroid gland,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,10116.0,Intermediate,,,12727,2046.0,CHEMBL626829,1,BAO_0000218,,,,N,,Thyroid gland,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,10116.0,Intermediate,,,12728,2046.0,CHEMBL626830,1,BAO_0000218,,,,N,,Thyroid gland,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,10116.0,Intermediate,,,12729,,CHEMBL627150,1,BAO_0000218,,,,N,,,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,10116.0,Intermediate,,,12730,,CHEMBL627151,1,BAO_0000218,,,,N,,,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,10116.0,Intermediate,,,12731,,CHEMBL627152,1,BAO_0000218,,,,N,,,8594,Rattus norvegicus,50597,A,,1
,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,10116.0,Intermediate,,,12732,,CHEMBL627153,1,BAO_0000218,,,,N,,,8594,Rattus norvegicus,50597,A,,1
,Rate of acetate production by the compound was determined,,Autocuration,,,12733,,CHEMBL627154,1,BAO_0000019,,,,U,,,12904,,22224,A,,0
,Rate of acetate production by the compound was determined; Not determined,,Autocuration,,,12734,,CHEMBL627155,1,BAO_0000019,,,,U,,,12904,,22224,A,,0
,Rate of hydrolysis of nitrocefin by compound was evaluated in water,,Autocuration,,,12735,,CHEMBL627156,1,BAO_0000019,,,,U,,,3730,,22224,A,,0
,Reductive elimination of leaving group was determined at pH 7.4; expressed as loss of parent,,Autocuration,,,12736,,CHEMBL627157,1,BAO_0000019,,,,U,,,3627,,22224,A,,0
,Relative concentration of compound (70 mg/Kg) in brain compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,9986.0,Intermediate,,,12737,,CHEMBL627158,1,BAO_0000218,,,,N,,,13799,Oryctolagus cuniculus,50592,A,,1
,Relative concentration of compound (70 mg/Kg) in lung compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,9986.0,Intermediate,,,12738,1969.0,CHEMBL627159,1,BAO_0000218,,,,N,,Plasma,13799,Oryctolagus cuniculus,50592,A,,1
,Relative concentration of compound in brain compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,10090.0,Intermediate,,,12739,,CHEMBL627160,1,BAO_0000218,,,,N,,,13799,Mus musculus,50594,A,,1
,Relative concentration of compound in brain compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,10116.0,Intermediate,,,12740,,CHEMBL628540,1,BAO_0000218,,,,N,,,13799,Rattus norvegicus,50597,A,,1
,Relative concentration of compound in lung compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,10116.0,Intermediate,,,12741,1969.0,CHEMBL628541,1,BAO_0000218,,,,N,,Plasma,13799,Rattus norvegicus,50597,A,,1
,Relative concentration of compound in lung compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,10116.0,Intermediate,,,12742,1969.0,CHEMBL628542,1,BAO_0000218,,,,N,,Plasma,13799,Rattus norvegicus,50597,A,,1
,Solubility after at a pH 1.2,,Autocuration,,,12743,,CHEMBL628543,1,BAO_0000100,,,,U,,,6629,,22229,P,,0
,Solubility after at pH 1.2,,Autocuration,,,12744,,CHEMBL628544,1,BAO_0000100,,,,U,,,6629,,22229,P,,0
,Solubility after injection of water,,Autocuration,,,12745,,CHEMBL628545,1,BAO_0000100,,,,U,,,6629,,22229,P,,0
,Statistical significance of IC 50 values; Expressed as R value,,Autocuration,,,12746,,CHEMBL628546,1,BAO_0000019,,,,U,,,14000,,22224,A,,0
,Systemic availability with respect to methyldopa was determined,,Autocuration,,,12747,,CHEMBL874455,1,BAO_0000019,,,,U,,,8267,,22224,A,,0
,Tissue distribution of the in rat brain relative to plasma concentration of 1 ug/kg; relative concentration,10116.0,Intermediate,,,12748,,CHEMBL628547,1,BAO_0000218,,,,N,,,13799,Rattus norvegicus,50597,A,,1
,Tissue distribution of the in rat lung relative to plasma concentration of 1 ug/kg; relative concentration,10116.0,Intermediate,,,12749,1969.0,CHEMBL628548,1,BAO_0000218,,,,N,,Plasma,13799,Rattus norvegicus,50597,A,,1
,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated",9986.0,Intermediate,,,12750,1988.0,CHEMBL628549,1,BAO_0000218,,,,N,,Feces,7132,Oryctolagus cuniculus,50592,A,,1
,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 liver, and radioactivity content in feces was estimated",9986.0,Intermediate,,,12751,1988.0,CHEMBL628550,1,BAO_0000218,,,,N,,Feces,7132,Oryctolagus cuniculus,50592,A,,1
,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit3, and radioactivity content in feces was estimated at total hours",9986.0,Intermediate,,,12752,1988.0,CHEMBL628551,1,BAO_0000218,,,,N,,Feces,7132,Oryctolagus cuniculus,50592,A,,1
,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit1, and radioactivity content in urine was estimated at 0-2 hr",9986.0,Intermediate,,,12753,1088.0,CHEMBL628552,1,BAO_0000218,,,,N,,Urine,7132,Oryctolagus cuniculus,50592,A,,1
,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-24 hr",9986.0,Intermediate,,,12754,1088.0,CHEMBL628553,1,BAO_0000218,,,,N,,Urine,7132,Oryctolagus cuniculus,50592,A,,1
,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-48 hr",9986.0,Intermediate,,,12755,1088.0,CHEMBL628554,1,BAO_0000218,,,,N,,Urine,7132,Oryctolagus cuniculus,50592,A,,1
,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 24-48 h",9986.0,Intermediate,,,12756,1088.0,CHEMBL628555,1,BAO_0000218,,,,N,,Urine,7132,Oryctolagus cuniculus,50592,A,,1
,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 48-72 h",9986.0,Intermediate,,,12757,1088.0,CHEMBL628556,1,BAO_0000218,,,,N,,Urine,7132,Oryctolagus cuniculus,50592,A,,1
,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit kidney, and radioactivity content in feces was estimated",9986.0,Intermediate,,,12758,2113.0,CHEMBL628557,1,BAO_0000218,,,,N,,Kidney,7132,Oryctolagus cuniculus,50592,A,,1
,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated",9986.0,Intermediate,,,12759,1988.0,CHEMBL628558,1,BAO_0000218,,,,N,,Feces,7132,Oryctolagus cuniculus,50592,A,,1
,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated at",9986.0,Intermediate,,,12760,1988.0,CHEMBL628559,1,BAO_0000218,,,,N,,Feces,7132,Oryctolagus cuniculus,50592,A,,1
,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit1plasma, and radioactivity content in feces was estimated",9986.0,Intermediate,,,12761,1988.0,CHEMBL628560,1,BAO_0000218,,,,N,,Feces,7132,Oryctolagus cuniculus,50592,A,,1
,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at total hours",9986.0,Intermediate,,,12762,1088.0,CHEMBL874456,1,BAO_0000218,,,,N,,Urine,7132,Oryctolagus cuniculus,50592,A,,1
,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at 0-48 hr",9986.0,Intermediate,,,12763,1988.0,CHEMBL628561,1,BAO_0000218,,,,N,,Feces,7132,Oryctolagus cuniculus,50592,A,,1
,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at total hours",9986.0,Intermediate,,,12764,1988.0,CHEMBL628562,1,BAO_0000218,,,,N,,Feces,7132,Oryctolagus cuniculus,50592,A,,1
,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit2, and radioactivity content in urine was estimated at 0-4 hr",9986.0,Intermediate,,,12765,1088.0,CHEMBL628563,1,BAO_0000218,,,,N,,Urine,7132,Oryctolagus cuniculus,50592,A,,1
,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at",9986.0,Intermediate,,,12766,1088.0,CHEMBL628564,1,BAO_0000218,,,,N,,Urine,7132,Oryctolagus cuniculus,50592,A,,1
,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 24-48 h",9986.0,Intermediate,,,12767,1088.0,CHEMBL628565,1,BAO_0000218,,,,N,,Urine,7132,Oryctolagus cuniculus,50592,A,,1
,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 48-72 h",9986.0,Intermediate,,,12768,1088.0,CHEMBL631248,1,BAO_0000218,,,,N,,Urine,7132,Oryctolagus cuniculus,50592,A,,1
,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at total hours",9986.0,Intermediate,,,12769,1088.0,CHEMBL631249,1,BAO_0000218,,,,N,,Urine,7132,Oryctolagus cuniculus,50592,A,,1
,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 kidney, and radioactivity content in feces was estimated",9986.0,Intermediate,,,12770,2113.0,CHEMBL627214,1,BAO_0000218,,,,N,,Kidney,7132,Oryctolagus cuniculus,50592,A,,1
,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 liver, and radioactivity content in feces was estimated",9986.0,Intermediate,,,12771,1988.0,CHEMBL874591,1,BAO_0000218,,,,N,,Feces,7132,Oryctolagus cuniculus,50592,A,,1
,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 lung, and radioactivity content in feces was estimated",9986.0,Intermediate,,,12772,1988.0,CHEMBL627215,1,BAO_0000218,,,,N,,Feces,7132,Oryctolagus cuniculus,50592,A,,1
,200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 plasma and radioactivity content in feces was estimated,9986.0,Intermediate,,,12773,1988.0,CHEMBL625471,1,BAO_0000218,,,,N,,Feces,7132,Oryctolagus cuniculus,50592,A,,1
,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 1,9986.0,Intermediate,,,12774,,CHEMBL625472,1,BAO_0000218,,,,N,,,7132,Oryctolagus cuniculus,50592,A,,1
,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 3 by Gas-liquid chromatographic analysis,9986.0,Intermediate,,,12775,,CHEMBL625473,1,BAO_0000218,,,,N,,,7132,Oryctolagus cuniculus,50592,A,,1
,Tested for pharmacokinetic parameter in fasted Beagle dogs (Clearance value of the compound) iv administration.,9615.0,Intermediate,,,12776,,CHEMBL625474,1,BAO_0000218,,In vivo,,N,,,13317,Canis lupus familiaris,50588,A,,1
,The clearance was measured in dog at dose 5 mg/kg after intravenous administration.,9615.0,Intermediate,,,12777,,CHEMBL625475,1,BAO_0000218,,In vivo,,N,,,15341,Canis lupus familiaris,50588,A,,1
,The clearance was measured in rat at dose 12 mg/kg after intravenous administration.,10116.0,Intermediate,,,12778,,CHEMBL625476,1,BAO_0000218,,In vivo,,N,,,15341,Rattus norvegicus,50597,A,,1
,The clearance was measured in rat at dose 1 mg/kg after intravenous administration.,10116.0,Intermediate,,,12779,,CHEMBL625477,1,BAO_0000218,,In vivo,,N,,,15341,Rattus norvegicus,50597,A,,1
,The clearance was measured in rat at dose 30 mg/kg after intravenous administration.,10116.0,Intermediate,,,12780,,CHEMBL625478,1,BAO_0000218,,In vivo,,N,,,15341,Rattus norvegicus,50597,A,,1
,The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose,10116.0,Intermediate,,,12781,,CHEMBL625479,1,BAO_0000218,,In vitro,,N,,esophageal tunica muscularis mucosae,12801,Rattus norvegicus,50597,A,,1
,The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose,10116.0,Intermediate,,,12782,,CHEMBL625480,1,BAO_0000218,,In vitro,,N,,esophageal tunica muscularis mucosae,12801,Rattus norvegicus,50597,A,,1
,The compound was tested for systemic plasma clearance(CL) in rats and is expressed in mL/min/kg.,10116.0,Intermediate,,,12783,1969.0,CHEMBL625481,1,BAO_0000218,,In vivo,,N,,Plasma,14856,Rattus norvegicus,50597,A,,1
,Total body clearance at an intravenous dose of 5.2 mg/kg in rat,10116.0,Intermediate,,,12784,,CHEMBL625482,1,BAO_0000218,,In vivo,,N,,,14062,Rattus norvegicus,50597,A,,1
,Total body clearance at an intravenous dose of 5.5 mg/kg in rat,10116.0,Intermediate,,,12785,,CHEMBL625483,1,BAO_0000218,,In vivo,,N,,,14062,Rattus norvegicus,50597,A,,1
,Total body clearance at an intravenous dose of 6.3 mg/kg in rat,10116.0,Intermediate,,,12786,,CHEMBL625484,1,BAO_0000218,,In vivo,,N,,,14062,Rattus norvegicus,50597,A,,1
,Total body clearance at an intravenous dose of 6.5 mg/kg in rat,10116.0,Intermediate,,,12787,,CHEMBL625485,1,BAO_0000218,,In vivo,,N,,,14062,Rattus norvegicus,50597,A,,1
,Total plasma clearance value was obtained after intravenous administration of 1.8 mg/kg of drug in male Beagle dogs,9615.0,Intermediate,,,12788,1969.0,CHEMBL625486,1,BAO_0000218,,In vivo,,N,,Plasma,14346,Canis lupus familiaris,50588,A,,1
,Total plasma clearance value was obtained after intravenous administration of 2.5 mg/kg of drug in male Dawley rats,10116.0,Intermediate,,,12789,1969.0,CHEMBL625487,1,BAO_0000218,,In vivo,,N,,Plasma,14346,Rattus norvegicus,50597,A,,1
,Total plasma clearance value was obtained after intravenous administration of 2.6 mg/kg of drug in male Dawley rats,10116.0,Intermediate,,,12790,1969.0,CHEMBL625488,1,BAO_0000218,,In vivo,,N,,Plasma,14346,Rattus norvegicus,50597,A,,1
,Total plasma clearance value was obtained after intravenous administration of 2.7 mg/kg of drug in male Dawley rats,10116.0,Intermediate,,,12791,1969.0,CHEMBL625489,1,BAO_0000218,,In vivo,,N,,Plasma,14346,Rattus norvegicus,50597,A,,1
,Total plasma clearance value was obtained after intravenous administration of 2.8 mg/kg of drug in male Dawley rats,10116.0,Intermediate,,,12792,1969.0,CHEMBL625490,1,BAO_0000218,,In vivo,,N,,Plasma,14346,Rattus norvegicus,50597,A,,1
,Total plasma clearance value was obtained after intravenous administration of 4.9 mg/kg of drug in male Beagle dogs,9615.0,Intermediate,,,12793,1969.0,CHEMBL625491,1,BAO_0000218,,In vivo,,N,,Plasma,14346,Canis lupus familiaris,50588,A,,1
,Total plasma clearance value was obtained after intravenous administration of 5.1 mg/kg of drug in male Dawley rats,10116.0,Intermediate,,,12794,1969.0,CHEMBL625492,1,BAO_0000218,,In vivo,,N,,Plasma,14346,Rattus norvegicus,50597,A,,1
,plasma clearance in human,9606.0,Intermediate,,,12795,1969.0,CHEMBL625493,1,BAO_0000218,,In vivo,,N,,Plasma,15711,Homo sapiens,50587,A,,1
,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,10116.0,Intermediate,,,12796,,CHEMBL625494,1,BAO_0000218,,In vivo,,N,,,14886,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,10116.0,Intermediate,,,12797,,CHEMBL625495,1,BAO_0000218,,In vivo,,N,,,14886,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter (CL/F) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,10116.0,Intermediate,,,12798,,CHEMBL625496,1,BAO_0000218,,In vivo,,N,,,14886,Rattus norvegicus,50597,A,,1
,1-Octanol/water partition coefficient measured at 7.4,,Autocuration,,,12799,,CHEMBL625497,1,BAO_0000100,,,,U,,,4115,,22229,P,,0
,Calculated partition coefficient (clogP),,Autocuration,,,12800,,CHEMBL625498,1,BAO_0000100,,,,U,,,13733,,22229,P,,0
,Partition coefficient (logP),,Autocuration,,,12801,,CHEMBL625499,1,BAO_0000019,,,,U,,,12102,,22224,A,,0
,Calculated partition coefficient (clogP),,Autocuration,,,12802,,CHEMBL625500,1,BAO_0000100,,,,U,,,12676,,22229,P,,0
,Calculated partition coefficient (clogP),,Autocuration,,,12803,,CHEMBL625501,1,BAO_0000100,,,,U,,,13733,,22229,P,,0
,Calculated partition coefficient (clogP),,Autocuration,,,12804,,CHEMBL625502,1,BAO_0000100,,,,U,,,13740,,22229,P,,0
,Calculated partition coefficient (clogP) (relative to BAY K 8644),,Autocuration,,,12805,,CHEMBL625503,1,BAO_0000100,,,,U,,,12766,,22229,P,,0
,Calculated partition coefficient (clogP),,Autocuration,,,12806,,CHEMBL625504,1,BAO_0000100,,,,U,,,2764,,22229,P,,0
,Calculated partition coefficient (clogP),,Autocuration,,,12807,,CHEMBL625505,1,BAO_0000100,,,,U,,,12355,,22229,P,,0
,Calculated partition coefficient of the compound,,Autocuration,,,12808,,CHEMBL625506,1,BAO_0000100,,,,U,,,11314,,22229,P,,0
,Partition coefficient (logP),,Autocuration,,,12809,,CHEMBL625507,1,BAO_0000019,,,,U,,,12706,,22224,A,,0
,Calculated partition coefficient (clogP),,Autocuration,,,12810,,CHEMBL625508,1,BAO_0000100,,,,U,,,12645,,22229,P,,0
,Calculated partition coefficient (clogP),,Autocuration,,,12811,,CHEMBL625509,1,BAO_0000100,,,,U,,,13668,,22229,P,,0
,Calculated partition coefficient (clogP),,Autocuration,,,12812,,CHEMBL625510,1,BAO_0000100,,,,U,,,12819,,22229,P,,0
,Calculated partition coefficient (clogP),,Autocuration,,,12813,,CHEMBL883125,1,BAO_0000100,,,,U,,,13668,,22229,P,,0
,Calculated partition coefficient (clogP),,Autocuration,,,12814,,CHEMBL625511,1,BAO_0000100,,,,U,,,13017,,22229,P,,0
,Partition coefficient of the compound,,Autocuration,,,12815,,CHEMBL874650,1,BAO_0000019,,,,U,,,2448,,22224,A,,0
,Partition coefficient of the compound,,Autocuration,,,12816,,CHEMBL625512,1,BAO_0000019,,,,U,,,11526,,22224,A,,0
,Partition coefficient of compound was determined,,Autocuration,,,12817,,CHEMBL625513,1,BAO_0000019,,,,U,,,12426,,22224,A,,0
,Partition coefficient was determined,,Autocuration,,,12818,,CHEMBL625514,1,BAO_0000019,,,,U,,,2448,,22224,A,,0
,Calculated partition coefficient (clogP),,Autocuration,,,12819,,CHEMBL625515,1,BAO_0000100,,,,U,,,12001,,22229,P,,0
,partition coefficient of compound was determined,,Autocuration,,,12820,,CHEMBL625516,1,BAO_0000100,,,,U,,,12426,,22229,P,,0
,The total body administered intravenously in dog,9615.0,Intermediate,,,12821,,CHEMBL625517,1,BAO_0000218,,In vivo,,N,,,13204,Canis lupus familiaris,50588,A,,1
,The total body administered intravenously in rats,10116.0,Intermediate,,,12822,,CHEMBL625518,1,BAO_0000218,,In vivo,,N,,,13204,Rattus norvegicus,50597,A,,1
,Time taken for the administration to female NIH mice weighing 25-30 g.,10090.0,Intermediate,,,12823,,CHEMBL625519,1,BAO_0000218,,,,N,,,13889,Mus musculus,50594,A,,1
,Time taken for the administration,,Autocuration,,,12824,,CHEMBL625520,1,BAO_0000019,,,,U,,,13889,,22224,A,,0
,Total clearance of compound was determined in dog at 5 mg/kg intravenously admn.,9615.0,Intermediate,,,12825,,CHEMBL874651,1,BAO_0000218,,In vivo,,N,,,17025,Canis lupus familiaris,50588,A,,1
,Total clearance of compound was determined in monkey at 5 mg/kg intravenously admn.,314293.0,Autocuration,,,12826,,CHEMBL625521,1,BAO_0000218,,In vivo,,U,,,17025,Simiiformes,22224,A,,0
,Total clearance of compound was determined in rabbit at 5 mg/kg intravenously admn.,9986.0,Intermediate,,,12827,,CHEMBL623171,1,BAO_0000218,,In vivo,,N,,,17025,Oryctolagus cuniculus,50592,A,,1
,Total clearance of compound was determined in rat at 5 mg/kg intravenously admn.,10116.0,Intermediate,,,12828,,CHEMBL623853,1,BAO_0000218,,In vivo,,N,,,17025,Rattus norvegicus,50597,A,,1
,Plasma clearance for the compound was determined.,,Autocuration,,,12829,,CHEMBL623854,1,BAO_0000019,,,,U,,,15067,,22224,A,,0
,CLog P value of the compound,,Autocuration,,,12830,,CHEMBL874405,1,BAO_0000100,,,,U,,,3091,,22224,P,,0
,Calculated partition coefficient (clogP),,Autocuration,,,12831,,CHEMBL623855,1,BAO_0000100,,,,U,,,15592,,22229,P,,0
,Calculated partition coefficient (clogP),,Autocuration,,,12832,,CHEMBL623856,1,BAO_0000100,,,,U,,,14738,,22229,P,,0
,ClogP value of the compound; nd ='no data',,Autocuration,,,12833,,CHEMBL623857,1,BAO_0000100,,,,U,,,14738,,22224,P,,0
,ClogP value of the compound; nd ='not determined',,Autocuration,,,12834,,CHEMBL623858,1,BAO_0000100,,,,U,,,14738,,22224,P,,0
,CLog P was determined,,Autocuration,,,12835,,CHEMBL623859,1,BAO_0000100,,,,U,,,6076,,22224,P,,0
,Calculated partition coefficient (clogP),,Autocuration,,,12836,,CHEMBL839829,1,BAO_0000100,,,,U,,,17840,,22229,P,,0
,CLogP was calculated,,Autocuration,,,12837,,CHEMBL623860,1,BAO_0000019,,,,U,,,13589,,22224,A,,0
,CLogP value was determined,,Autocuration,,,12838,,CHEMBL623861,1,BAO_0000019,,,,U,,,17655,,22224,A,,0
,CLogP value was evaluated using http://esc.syrres.com/interkow/kowdemo.htm.,,Autocuration,,,12839,,CHEMBL623862,1,BAO_0000019,,,,U,,,5867,,22224,A,,0
,Calculated partition coefficient (clogP),,Autocuration,,,12840,,CHEMBL874406,1,BAO_0000100,,,,U,,,5867,,22229,P,,0
,Calculated partition coefficient (clogP),,Autocuration,,,12841,,CHEMBL623863,1,BAO_0000100,,,,U,,,10783,,22229,P,,0
,Calculated partition coefficient (clogP),,Autocuration,,,12842,,CHEMBL624021,1,BAO_0000100,,,,U,,,14849,,22229,P,,0
,Distribution in female dog adrenal medulla 24 hours after administration.,9615.0,Intermediate,,,12843,1236.0,CHEMBL624022,1,BAO_0000218,,,,N,,Adrenal medulla,8170,Canis lupus familiaris,50588,A,,1
,Distribution in female dog adrenal medulla 72 hours after administration.,9615.0,Intermediate,,,12844,1236.0,CHEMBL624023,1,BAO_0000218,,,,N,,Adrenal medulla,8170,Canis lupus familiaris,50588,A,,1
,Distribution in female dog bile 24 hours after administration.,9615.0,Intermediate,,,12845,,CHEMBL624024,1,BAO_0000218,,,,N,,,8170,Canis lupus familiaris,50588,A,,1
,Distribution in female dog bile 72 hr after administration.,9615.0,Intermediate,,,12846,,CHEMBL624025,1,BAO_0000218,,,,N,,,8170,Canis lupus familiaris,50588,A,,1
,Distribution in female dog blood 24 hours after administration.,9615.0,Intermediate,,,12847,,CHEMBL624026,1,BAO_0000218,,,,N,,,8170,Canis lupus familiaris,50588,A,,1
,Distribution in female dog blood 72 hours after administration.,9615.0,Intermediate,,,12848,,CHEMBL624027,1,BAO_0000218,,,,N,,,8170,Canis lupus familiaris,50588,A,,1
,Distribution in female dog heart 24 hours after administration.,9615.0,Intermediate,,,12849,,CHEMBL624028,1,BAO_0000218,,,,N,,,8170,Canis lupus familiaris,50588,A,,1
,Distribution in female dog heart 72 hours after administration.,9615.0,Intermediate,,,12850,,CHEMBL624029,1,BAO_0000218,,,,N,,,8170,Canis lupus familiaris,50588,A,,1
,Distribution in female dog kidney 24 hours after administration.,9615.0,Intermediate,,,12851,,CHEMBL624030,1,BAO_0000218,,,,N,,,8170,Canis lupus familiaris,50588,A,,1
,Distribution in female dog kidney 72 hours after administration.,9615.0,Intermediate,,,12852,,CHEMBL624031,1,BAO_0000218,,,,N,,,8170,Canis lupus familiaris,50588,A,,1
,Distribution in female dog large intestine 24 hours after administration.,9615.0,Intermediate,,,12853,160.0,CHEMBL624032,1,BAO_0000218,,,,N,,Intestine,8170,Canis lupus familiaris,50588,A,,1
,Distribution in female dog large intestine 72 hours after administration.,9615.0,Intermediate,,,12854,160.0,CHEMBL874407,1,BAO_0000218,,,,N,,Intestine,8170,Canis lupus familiaris,50588,A,,1
,Distribution in female dog liver 24 hours after administration.,9615.0,Intermediate,,,12855,,CHEMBL624033,1,BAO_0000218,,,,N,,,8170,Canis lupus familiaris,50588,A,,1
,Distribution in female dog liver 72 hours after administration.,9615.0,Intermediate,,,12856,,CHEMBL624034,1,BAO_0000218,,,,N,,,8170,Canis lupus familiaris,50588,A,,1
,Distribution in female dog lung 24 hours after administration.,9615.0,Intermediate,,,12857,,CHEMBL624035,1,BAO_0000218,,,,N,,,8170,Canis lupus familiaris,50588,A,,1
,Distribution in female dog lung 72 hours after administration.,9615.0,Intermediate,,,12858,,CHEMBL624036,1,BAO_0000218,,,,N,,,8170,Canis lupus familiaris,50588,A,,1
,Distribution in female dog muscle 24 hours after administration.,9615.0,Intermediate,,,12859,2385.0,CHEMBL624037,1,BAO_0000218,,,,N,,Muscle tissue,8170,Canis lupus familiaris,50588,A,,1
,Distribution in female dog muscle 72 hours after administration.,9615.0,Intermediate,,,12860,2385.0,CHEMBL624038,1,BAO_0000218,,,,N,,Muscle tissue,8170,Canis lupus familiaris,50588,A,,1
,Distribution in female dog pancreas 24 hours after administration.,9615.0,Intermediate,,,12861,,CHEMBL624039,1,BAO_0000218,,,,N,,,8170,Canis lupus familiaris,50588,A,,1
,Distribution in female dog pancreas 72 hours after administration.,9615.0,Intermediate,,,12862,,CHEMBL624040,1,BAO_0000218,,,,N,,,8170,Canis lupus familiaris,50588,A,,1
,Distribution in female dog small intestine 24 hours after administration.,9615.0,Intermediate,,,12863,160.0,CHEMBL624041,1,BAO_0000218,,,,N,,Intestine,8170,Canis lupus familiaris,50588,A,,1
,Distribution in female dog small intestine 72 hours after administration.,9615.0,Intermediate,,,12864,160.0,CHEMBL624042,1,BAO_0000218,,,,N,,Intestine,8170,Canis lupus familiaris,50588,A,,1
,Distribution in female dog spleen 24 hours after administration.,9615.0,Intermediate,,,12865,2106.0,CHEMBL624043,1,BAO_0000218,,,,N,,Spleen,8170,Canis lupus familiaris,50588,A,,1
,Distribution in female dog spleen 72 hours after administration.,9615.0,Intermediate,,,12866,2106.0,CHEMBL624044,1,BAO_0000218,,,,N,,Spleen,8170,Canis lupus familiaris,50588,A,,1
,Distribution in female dog stomach 24 hours after administration.,9615.0,Intermediate,,,12867,945.0,CHEMBL624045,1,BAO_0000218,,,,N,,Stomach,8170,Canis lupus familiaris,50588,A,,1
,Distribution in female dog stomach 72 hours after administration.,9615.0,Intermediate,,,12868,945.0,CHEMBL624046,1,BAO_0000218,,,,N,,Stomach,8170,Canis lupus familiaris,50588,A,,1
,Distribution in female dog thyroid 24 hours after administration.,9615.0,Intermediate,,,12869,2046.0,CHEMBL624047,1,BAO_0000218,,,,N,,Thyroid gland,8170,Canis lupus familiaris,50588,A,,1
,Distribution in female dog thyroid 72 hours after administration.,9615.0,Intermediate,,,12870,2046.0,CHEMBL624048,1,BAO_0000218,,,,N,,Thyroid gland,8170,Canis lupus familiaris,50588,A,,1
,Distribution in female dog urine 24 hours after administration.,9615.0,Intermediate,,,12871,1088.0,CHEMBL874408,1,BAO_0000218,,,,N,,Urine,8170,Canis lupus familiaris,50588,A,,1
,Distribution in female dog urine 72 hr after administration.,9615.0,Intermediate,,,12872,1088.0,CHEMBL624049,1,BAO_0000218,,,,N,,Urine,8170,Canis lupus familiaris,50588,A,,1
,Mean plasma concentration measured 1 h following an oral dose of 30 mg/kg,,Autocuration,,,12873,1969.0,CHEMBL624050,1,BAO_0000218,,,,U,,Plasma,14283,,22224,A,,0
,Plasma concentration at 7 hr after intravenous dosing,,Autocuration,,,12874,,CHEMBL624051,1,BAO_0000019,,,,U,,,5623,,22224,A,,0
,Plasma concentration of 3 mg/kg iv after 0.25 hr in rats,10116.0,Intermediate,,,12875,,CHEMBL623278,1,BAO_0000218,,,,N,,,13477,Rattus norvegicus,50597,A,,1
,Plasma concentration of 3 mg/kg iv after 0.5 hr in rats,10116.0,Intermediate,,,12876,,CHEMBL623279,1,BAO_0000218,,,,N,,,13477,Rattus norvegicus,50597,A,,1
,Plasma concentration of 3 mg/kg iv after 1 hr in rats,10116.0,Intermediate,,,12877,,CHEMBL623280,1,BAO_0000218,,,,N,,,13477,Rattus norvegicus,50597,A,,1
,Plasma concentration of 3 mg/kg iv after 2 hr in rats,10116.0,Intermediate,,,12878,,CHEMBL623963,1,BAO_0000218,,,,N,,,13477,Rattus norvegicus,50597,A,,1
,Plasma concentration of 3 mg/kg iv after 4 hr in rats,10116.0,Intermediate,,,12879,,CHEMBL623964,1,BAO_0000218,,,,N,,,13477,Rattus norvegicus,50597,A,,1
,Plasma concentration of 3 mg/kg iv after 6 hr in rats,10116.0,Intermediate,,,12880,,CHEMBL623965,1,BAO_0000218,,,,N,,,13477,Rattus norvegicus,50597,A,,1
,Plasma concentration of 3 mg/kg po after 0.083 hr in rats,10116.0,Intermediate,,,12881,,CHEMBL623966,1,BAO_0000218,,,,N,,,13477,Rattus norvegicus,50597,A,,1
,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.083 h,10116.0,Intermediate,,,12882,,CHEMBL874415,1,BAO_0000218,,,,N,,,13477,Rattus norvegicus,50597,A,,1
,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.25 hr,10116.0,Intermediate,,,12883,,CHEMBL623967,1,BAO_0000218,,,,N,,,13477,Rattus norvegicus,50597,A,,1
,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.5 hr,10116.0,Intermediate,,,12884,,CHEMBL623968,1,BAO_0000218,,,,N,,,13477,Rattus norvegicus,50597,A,,1
,Plasma concentration after 3 mg/kg peroral dosing in rat at 1 hr,10116.0,Intermediate,,,12885,,CHEMBL623969,1,BAO_0000218,,,,N,,,13477,Rattus norvegicus,50597,A,,1
,Plasma concentration after 3 mg/kg peroral dosing in rat at 2 hr,10116.0,Intermediate,,,12886,,CHEMBL628409,1,BAO_0000218,,,,N,,,13477,Rattus norvegicus,50597,A,,1
,Plasma concentration after 3 mg/kg peroral dosing in rat at 4 hr,10116.0,Intermediate,,,12887,,CHEMBL628410,1,BAO_0000218,,,,N,,,13477,Rattus norvegicus,50597,A,,1
,Plasma concentration after 3 mg/kg peroral dosing in rat at 6 hr,10116.0,Intermediate,,,12888,,CHEMBL628411,1,BAO_0000218,,,,N,,,13477,Rattus norvegicus,50597,A,,1
,Plasma concentration after 3 mg/kg peroral dosing in rat at 8 hr,10116.0,Intermediate,,,12889,,CHEMBL628412,1,BAO_0000218,,,,N,,,13477,Rattus norvegicus,50597,A,,1
,Tested for the highest concentration at which toxicity was not observed or the concentration which provided the highest number of net grain counts,,Autocuration,,,12890,,CHEMBL628413,1,BAO_0000019,,,,U,,,12553,,22224,A,,0
,The concentration in plasmat; Not determined,,Autocuration,,,12891,1969.0,CHEMBL628414,1,BAO_0000019,,,,U,,Plasma,14548,,22224,A,,0
,Tissue level at 10 mg/kg/po in wistar rats in blood,10116.0,Intermediate,,,12892,,CHEMBL628415,1,BAO_0000218,,,,N,,,14393,Rattus norvegicus,50597,A,,1
,Tissue level at 10 mg/kg/po in wistar rats in brown fat,10116.0,Intermediate,,,12893,,CHEMBL628416,1,BAO_0000218,,,,N,,,14393,Rattus norvegicus,50597,A,,1
,Tissue level at 10 mg/kg/po in wistar rats in heart,10116.0,Intermediate,,,12894,,CHEMBL628417,1,BAO_0000218,,,,N,,,14393,Rattus norvegicus,50597,A,,1
,Tissue level at 10 mg/kg/po in wistar rats in liver,10116.0,Intermediate,,,12895,2107.0,CHEMBL874908,1,BAO_0000218,,,,N,,Liver,14393,Rattus norvegicus,50597,A,,1
,Tissue level at 10 mg/kg/po in wistar rats in plasma,10116.0,Intermediate,,,12896,,CHEMBL628418,1,BAO_0000218,,,,N,,,14393,Rattus norvegicus,50597,A,,1
,Tissue level at 10 mg/kg/po in wistar rats in skeletal muscle,10116.0,Intermediate,,,12897,2385.0,CHEMBL628419,1,BAO_0000218,,,,N,,Muscle tissue,14393,Rattus norvegicus,50597,A,,1
,Tissue level at 10 mg/kg/po in wistar rats in subcutaneous fat,10116.0,Intermediate,,,12898,,CHEMBL628420,1,BAO_0000218,,,,N,,,14393,Rattus norvegicus,50597,A,,1
,Water solubility at 37 degree C.,,Autocuration,,,12899,,CHEMBL628421,1,BAO_0000019,,,,U,,,1629,,22224,A,,0
,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,Autocuration,,,12900,,CHEMBL626726,1,BAO_0000100,,,,U,,,8194,,22229,P,,0
,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,Autocuration,,,12901,,CHEMBL626727,1,BAO_0000100,,,,U,,,8194,,22229,P,,0
,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,10116.0,Intermediate,,,12902,178.0,CHEMBL626728,1,BAO_0000218,,,,N,,Blood,8594,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,10116.0,Intermediate,,,12903,178.0,CHEMBL626729,1,BAO_0000218,,,,N,,Blood,8594,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,10116.0,Intermediate,,,12904,178.0,CHEMBL626730,1,BAO_0000218,,,,N,,Blood,8594,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,10116.0,Intermediate,,,12905,178.0,CHEMBL626731,1,BAO_0000218,,,,N,,Blood,8594,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,10116.0,Intermediate,,,12906,178.0,CHEMBL626732,1,BAO_0000218,,,,N,,Blood,8594,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,10116.0,Intermediate,,,12907,948.0,CHEMBL626733,1,BAO_0000218,,,,N,,Heart,8594,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,10116.0,Intermediate,,,12908,948.0,CHEMBL626734,1,BAO_0000218,,,,N,,Heart,8594,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,10116.0,Intermediate,,,12909,948.0,CHEMBL626735,1,BAO_0000218,,,,N,,Heart,8594,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,10116.0,Intermediate,,,12910,948.0,CHEMBL874909,1,BAO_0000218,,,,N,,Heart,8594,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,10116.0,Intermediate,,,12911,948.0,CHEMBL626736,1,BAO_0000218,,,,N,,Heart,8594,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,10116.0,Intermediate,,,12912,2113.0,CHEMBL626737,1,BAO_0000218,,,,N,,Kidney,8594,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,10116.0,Intermediate,,,12913,2113.0,CHEMBL630999,1,BAO_0000218,,,,N,,Kidney,8594,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,10116.0,Intermediate,,,12914,2113.0,CHEMBL631000,1,BAO_0000218,,,,N,,Kidney,8594,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,10116.0,Intermediate,,,12915,2113.0,CHEMBL631001,1,BAO_0000218,,,,N,,Kidney,8594,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,10116.0,Intermediate,,,12916,2113.0,CHEMBL631002,1,BAO_0000218,,,,N,,Kidney,8594,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,10116.0,Intermediate,,,12917,2107.0,CHEMBL631003,1,BAO_0000218,,,,N,,Liver,8594,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,10116.0,Intermediate,,,12918,2107.0,CHEMBL631004,1,BAO_0000218,,,,N,,Liver,8594,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,10116.0,Intermediate,,,12919,2107.0,CHEMBL631005,1,BAO_0000218,,,,N,,Liver,8594,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,10116.0,Intermediate,,,12920,2107.0,CHEMBL631006,1,BAO_0000218,,,,N,,Liver,8594,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,10116.0,Intermediate,,,12921,2107.0,CHEMBL631007,1,BAO_0000218,,,,N,,Liver,8594,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,10116.0,Intermediate,,,12922,2048.0,CHEMBL631008,1,BAO_0000218,,,,N,,Lung,8594,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,10116.0,Intermediate,,,12923,2048.0,CHEMBL631009,1,BAO_0000218,,,,N,,Lung,8594,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,10116.0,Intermediate,,,12924,2048.0,CHEMBL631010,1,BAO_0000218,,,,N,,Lung,8594,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,10116.0,Intermediate,,,12925,2048.0,CHEMBL631011,1,BAO_0000218,,,,N,,Lung,8594,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,10116.0,Intermediate,,,12926,2048.0,CHEMBL631012,1,BAO_0000218,,,,N,,Lung,8594,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,10116.0,Intermediate,,,12927,2046.0,CHEMBL630271,1,BAO_0000218,,,,N,,Thyroid gland,8594,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,10116.0,Intermediate,,,12928,2046.0,CHEMBL630272,1,BAO_0000218,,,,N,,Thyroid gland,8594,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,10116.0,Intermediate,,,12929,2046.0,CHEMBL630273,1,BAO_0000218,,,,N,,Thyroid gland,8594,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,10116.0,Intermediate,,,12930,2046.0,CHEMBL630274,1,BAO_0000218,,,,N,,Thyroid gland,8594,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,10116.0,Intermediate,,,12931,2046.0,CHEMBL630275,1,BAO_0000218,,,,N,,Thyroid gland,8594,Rattus norvegicus,50597,A,,1
,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 15 minutes (radiolabeled with [125I]-,10116.0,Intermediate,,,12932,,CHEMBL875782,1,BAO_0000218,,,,N,,,8594,Rattus norvegicus,50597,A,,1
,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 2 minutes (radiolabeled with [125I]-,10116.0,Intermediate,,,12933,,CHEMBL630276,1,BAO_0000218,,,,N,,,8594,Rattus norvegicus,50597,A,,1
,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 30 minutes (radiolabeled with [125I]-,10116.0,Intermediate,,,12934,,CHEMBL630277,1,BAO_0000218,,,,N,,,8594,Rattus norvegicus,50597,A,,1
,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 5 minutes (radiolabeled with [125I]-,10116.0,Intermediate,,,12935,,CHEMBL630278,1,BAO_0000218,,,,N,,,8594,Rattus norvegicus,50597,A,,1
,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 60 minutes (radiolabeled with [125I]-,10116.0,Intermediate,,,12936,,CHEMBL630279,1,BAO_0000218,,,,N,,,8594,Rattus norvegicus,50597,A,,1
,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg,,Autocuration,,,12937,,CHEMBL630280,1,BAO_0000019,,,,U,,,8151,,22224,A,,0
,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,Autocuration,,,12938,,CHEMBL630281,1,BAO_0000019,,,,U,,,8151,,22224,A,,0
,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 4 by Gas-liquid chromatographic analysis,9986.0,Intermediate,,,12939,,CHEMBL630282,1,BAO_0000218,,,,N,,,7132,Oryctolagus cuniculus,50592,A,,1
,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 2,9986.0,Intermediate,,,12940,,CHEMBL630283,1,BAO_0000218,,,,N,,,7132,Oryctolagus cuniculus,50592,A,,1
,Alkylating activity (0.1 mM) was determined at pH 7.4; expressed as OD (540n m)/mM of drug),,Autocuration,,,12941,,CHEMBL630284,1,BAO_0000019,,,,U,,,5797,,22224,A,,0
,Alkylating activity was determined,,Autocuration,,,12942,,CHEMBL630285,1,BAO_0000019,,,,U,,,7849,,22224,A,,0
,Amount of metabolites in the microsomal medium after 90 min incubation of BTCP (500 uM),,Autocuration,,Microsomes,12943,,CHEMBL630286,1,BAO_0000251,,,,U,,,14220,,22224,A,,0
,"Formation of metabolite by rabbit liver microsomal preparation in absence of NADPH, at 2 hours",9986.0,Intermediate,,,12944,,CHEMBL630069,1,BAO_0000218,,,,N,,,8650,Oryctolagus cuniculus,50592,A,,1
,"Formation of metabolite by rabbit liver microsomal preparation in presence of Co-O2 (90:10),at 2 hour",9986.0,Intermediate,,,12945,,CHEMBL630070,1,BAO_0000218,,,,N,,,8650,Oryctolagus cuniculus,50592,A,,1
,"Formation of metabolite by rabbit liver microsomal preparation in presence of N2,at 2 hour",9986.0,Intermediate,,,12946,,CHEMBL630071,1,BAO_0000218,,,,N,,,8650,Oryctolagus cuniculus,50592,A,,1
,"Formation of metabolite by rabbit liver microsomal preparation in presence of NADPH, at 2 hours",9986.0,Intermediate,,,12947,,CHEMBL630072,1,BAO_0000218,,,,N,,,8650,Oryctolagus cuniculus,50592,A,,1
,"Formation of metabolite by rabbit liver microsomal preparation in presence of SKF525A,at 2 hour",9986.0,Intermediate,,,12948,,CHEMBL875110,1,BAO_0000218,,,,N,,,8650,Oryctolagus cuniculus,50592,A,,1
,Compound was tested for antidiuretic activity in rats,10116.0,Intermediate,,,12949,,CHEMBL630073,1,BAO_0000218,,,,N,,,7116,Rattus norvegicus,50597,A,,1
,Compound was tested for inactivation kinetic values,,Autocuration,,,12950,,CHEMBL630074,1,BAO_0000019,,,,U,,,14131,,22224,A,,0
,Compound was evaluated for the average apparent volume of distribution when administered through intravenous route,,Autocuration,,,12951,,CHEMBL630075,1,BAO_0000218,,In vivo,,U,,,7415,,22224,A,,0
,Dissociation rate calculated from the first-order equation using the t1/2 value,,Autocuration,,,12952,,CHEMBL630076,1,BAO_0000019,,,,U,,,13178,,22224,A,,0
,Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water,,Autocuration,,,12953,,CHEMBL630077,1,BAO_0000100,,,,U,,,8815,,22229,P,,0
,Aqueous solubility was measured,,Autocuration,,,12954,,CHEMBL630078,1,BAO_0000100,,,,U,,,1450,,22229,P,,0
,Aqueous solubility was measured at a pH 4,,Autocuration,,,12955,,CHEMBL630079,1,BAO_0000100,,,,U,,,1450,,22229,P,,0
,Aqueous solubility (pH 7),,Autocuration,,,12956,,CHEMBL630080,1,BAO_0000100,,,,U,,,1450,,22229,P,,0
,Aqueous solubility was measured at a pH 9,,Autocuration,,,12957,,CHEMBL630081,1,BAO_0000100,,,,U,,,1450,,22229,P,,0
,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents",,Autocuration,,,12958,,CHEMBL630082,1,BAO_0000019,,,,U,,,12711,,22224,A,,0
,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,Autocuration,,,12959,,CHEMBL630083,1,BAO_0000019,,,,U,,,12711,,22224,A,,0
,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,Autocuration,,,12960,,CHEMBL630084,1,BAO_0000019,,,,U,,,12711,,22224,A,,0
,Aqueous solubility of the compound,,Autocuration,,,12961,,CHEMBL629198,1,BAO_0000100,,,,U,,,15032,,22229,P,,0
,Aqueous solubility at 37 degree Celsius at pH 7.38,,Autocuration,,,12962,,CHEMBL629199,1,BAO_0000100,,,,U,,,9964,,22229,P,,0
,Aqueous solubility in pH 7.4 phosphate buffer,,Autocuration,,,12963,,CHEMBL629200,1,BAO_0000100,,,,U,,,14962,,22229,P,,0
,Mean arterial pressure response following 10 mg/kg intraduodenal administration to salt depleted dog,9615.0,Intermediate,,,12964,,CHEMBL629201,1,BAO_0000218,,,,N,,,12487,Canis lupus familiaris,50588,A,,1
,Mean arterial pressure response following 1 mg/kg intravenous administration to salt depleted dog,9615.0,Intermediate,,,12965,,CHEMBL629202,1,BAO_0000218,,,,N,,,12487,Canis lupus familiaris,50588,A,,1
,Percentage of aspirin formed during hydrolysis in 10% human plasma at pH 7.4 at 37 degrees celsius,9606.0,Intermediate,,,12966,,CHEMBL875111,1,BAO_0000218,,,,N,,,10026,Homo sapiens,50587,A,,1
,Percentage of aspirin formed during hydrolysis in undiluted human plasma at pH 7.4 at 37 degrees celsius,9606.0,Intermediate,,,12967,,CHEMBL629203,1,BAO_0000218,,,,N,,,10026,Homo sapiens,50587,A,,1
,The percentage of aspirin formed during hydrolysis in 100% human plasma at pH 7.4 at 37 degrees celsius,9606.0,Intermediate,,,12968,,CHEMBL629204,1,BAO_0000218,,,,N,,,10026,Homo sapiens,50587,A,,1
,The percentage of aspirin formed during hydrolysis in 20% human plasma at pH 7.4 at 37 degrees celsius,9606.0,Intermediate,,,12969,,CHEMBL629205,1,BAO_0000218,,,,N,,,10026,Homo sapiens,50587,A,,1
,The percentage of aspirin formed during hydrolysis in 60% human plasma at pH 7.4 at 37 degrees celsius,9606.0,Intermediate,,,12970,,CHEMBL629206,1,BAO_0000218,,,,N,,,10026,Homo sapiens,50587,A,,1
,The percentage of aspirin formed during hydrolysis in 80% human plasma at pH 7.4 at 37 degrees celsius,,Autocuration,,,12971,,CHEMBL631185,1,BAO_0000019,,,,U,,,10026,,22224,A,,0
,Compound was evaluated for the average bile flow rat in rats,10116.0,Intermediate,,,12972,,CHEMBL631186,1,BAO_0000218,,,,N,,,7415,Rattus norvegicus,50597,A,,1
,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 15 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",9986.0,Intermediate,,,12973,,CHEMBL631187,1,BAO_0000218,,,,N,,,17025,Oryctolagus cuniculus,50592,A,,1
,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 25 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",9986.0,Intermediate,,,12974,,CHEMBL631188,1,BAO_0000218,,,,N,,,17025,Oryctolagus cuniculus,50592,A,,1
,Average half life period was determined,,Autocuration,,,12975,,CHEMBL876419,1,BAO_0000019,,,,U,,,10184,,22224,A,,0
,Average half life period was determined,,Autocuration,,,12976,,CHEMBL631189,1,BAO_0000019,,,,U,,,10184,,22224,A,,0
,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,10298.0,Intermediate,,,12977,,CHEMBL631190,1,BAO_0000218,,,,N,,,8613,Human herpesvirus 1,50602,A,,1
,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,10298.0,Intermediate,,,12978,,CHEMBL631191,1,BAO_0000218,,,,N,,,8613,Human herpesvirus 1,50602,A,,1
,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day.,10298.0,Intermediate,,,12979,,CHEMBL631192,1,BAO_0000218,,,,N,,,8613,Human herpesvirus 1,50602,A,,1
,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day.,10298.0,Intermediate,,,12980,,CHEMBL632400,1,BAO_0000218,,,,N,,,8613,Human herpesvirus 1,50602,A,,1
,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,10298.0,Intermediate,,,12981,,CHEMBL630564,1,BAO_0000218,,,,N,,,8613,Human herpesvirus 1,50602,A,,1
,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,10298.0,Intermediate,,,12982,,CHEMBL630565,1,BAO_0000218,,,,N,,,8613,Human herpesvirus 1,50602,A,,1
,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day.,10298.0,Intermediate,,,12983,,CHEMBL630566,1,BAO_0000218,,,,N,,,8613,Human herpesvirus 1,50602,A,,1
,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day.,10298.0,Intermediate,,,12984,,CHEMBL631229,1,BAO_0000218,,,,N,,,8613,Human herpesvirus 1,50602,A,,1
,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day.,10298.0,Intermediate,,,12985,,CHEMBL631230,1,BAO_0000218,,,,N,,,8613,Human herpesvirus 1,50602,A,,1
,Calculated partition coefficient (clogP),,Autocuration,,,12986,,CHEMBL876428,1,BAO_0000100,,,,U,,,6030,,22229,P,,0
,Calculated partition coefficient (clogP),,Autocuration,,,12987,,CHEMBL631231,1,BAO_0000100,,,,U,,,6147,,22229,P,,0
,Calculated partition coefficient (clogP) (MacLogP),,Autocuration,,,12988,,CHEMBL631232,1,BAO_0000100,,,,U,,,14556,,22229,P,,0
,Hydrophilicity was determined,,Autocuration,,,12989,,CHEMBL631233,1,BAO_0000019,,,,U,,,768,,22224,A,,0
,Calculated partition coefficient (clogP),,Autocuration,,,12990,,CHEMBL631234,1,BAO_0000100,,,,U,,,14452,,22229,P,,0
,Increased absorption was determined,,Autocuration,,,12991,,CHEMBL883126,1,BAO_0000019,,,,U,,,5237,,22224,A,,0
,Lipophilicity value was evaluated,,Autocuration,,,12992,,CHEMBL631235,1,BAO_0000100,,,,U,,,14378,,22224,P,,0
,Log P value of the compound.,,Autocuration,,,12993,,CHEMBL631236,1,BAO_0000100,,,,U,,,14418,,22224,P,,0
,Partition coefficient of compound was determined,,Autocuration,,,12994,,CHEMBL631237,1,BAO_0000019,,,,U,,,5249,,22224,A,,0
,Calculated partition coefficient (clogP),,Autocuration,,,12995,,CHEMBL631238,1,BAO_0000100,,,,U,,,14621,,22229,P,,0
,Calculated partition coefficient (clogP),,Autocuration,,,12996,,CHEMBL876429,1,BAO_0000100,,,,U,,,12542,,22229,P,,0
,Partition coefficient was measured by medchem software; Not calculated,,Autocuration,,,12997,,CHEMBL631414,1,BAO_0000019,,,,U,,,12542,,22224,A,,0
,Partition coefficient was measured by octanol-water using standard shake-flask method,,Autocuration,,,12998,,CHEMBL631415,1,BAO_0000100,,,,U,,,12542,,22224,P,,0
,Calculated partition coefficient (clogP),,Autocuration,,,12999,,CHEMBL631416,1,BAO_0000100,,,,U,,,15462,,22229,P,,0
,Partition coefficient (logP),,Autocuration,,,13000,,CHEMBL631417,1,BAO_0000019,,,,U,,,14884,,22224,A,,0
,Calculated partition coefficient (clogP),,Autocuration,,,13001,,CHEMBL631418,1,BAO_0000100,,,,U,,,16526,,22229,P,,0
,The Octanol/Water partition coefficient CLogP,,Autocuration,,,13002,,CHEMBL631419,1,BAO_0000100,,,,U,,,13693,,22229,P,,0
,The pharmacokinetic parameter C Log p was reported,,Autocuration,,,13003,,CHEMBL631420,1,BAO_0000019,,,,U,,,13693,,22224,A,,0
,Calculated partition coefficient (clogP),,Autocuration,,,13004,,CHEMBL631421,1,BAO_0000100,,,,U,,,13779,,22229,P,,0
,Calculated partition coefficient (clogP),,Autocuration,,,13005,,CHEMBL631422,1,BAO_0000100,,,,U,,,14772,,22229,P,,0
,Calculated partition coefficient (clogP),,Autocuration,,,13006,,CHEMBL631423,1,BAO_0000100,,,,U,,,14393,,22229,P,,0
,Clearance rate in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,10116.0,Intermediate,,,13007,1969.0,CHEMBL876430,1,BAO_0000218,,In vivo,,N,,Plasma,14793,Rattus norvegicus,50597,A,,1
,Clearance rate in rat plasma when administered intravenously at a dose of 10 mg/kg,10116.0,Intermediate,,,13008,1969.0,CHEMBL631424,1,BAO_0000218,,In vivo,,N,,Plasma,14793,Rattus norvegicus,50597,A,,1
,Compound was administered intravenously in dog to evaluate plasma clearance values,9615.0,Intermediate,,,13009,1969.0,CHEMBL631425,1,BAO_0000218,,In vivo,,N,,Plasma,13744,Canis lupus familiaris,50588,A,,1
,Compound was administered intravenously in monkey to evaluate plasma clearance values,314293.0,Autocuration,,,13010,1969.0,CHEMBL631426,1,BAO_0000218,,In vivo,,U,,Plasma,13744,Simiiformes,22224,A,,0
,Compound was administered intravenously in mouse to evaluate plasma clearance values,10090.0,Intermediate,,,13011,1969.0,CHEMBL631427,1,BAO_0000218,,In vivo,,N,,Plasma,13744,Mus musculus,50594,A,,1
,Compound was evaluated in vivo for plasma clearance in dog after intravenous dose at 2 mg/Kg,9615.0,Intermediate,,,13012,1969.0,CHEMBL631428,1,BAO_0000218,,In vivo,,N,,Plasma,13207,Canis lupus familiaris,50588,A,,1
,Intrinsic clearance in Rhesus liver microsome,9544.0,Intermediate,,Microsomes,13013,2107.0,CHEMBL631429,1,BAO_0000218,,In vitro,,N,,Liver,5669,Macaca mulatta,50797,A,,1
,Intrinsic clearance in dog liver microsome,9615.0,Intermediate,,Microsomes,13014,2107.0,CHEMBL631430,1,BAO_0000218,,In vitro,,N,,Liver,5669,Canis lupus familiaris,50588,A,,1
,Intrinsic clearance in rat liver microsome,10116.0,Intermediate,,Microsomes,13015,2107.0,CHEMBL631431,1,BAO_0000218,,In vitro,,N,,Liver,5669,Rattus norvegicus,50597,A,,1
,Low plasma clearance was calculated in rhesus monkey,9544.0,Intermediate,,,13016,1969.0,CHEMBL631432,1,BAO_0000218,,In vivo,,N,,Plasma,4853,Macaca mulatta,50797,A,,1
,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,9615.0,Intermediate,,,13017,,CHEMBL631433,1,BAO_0000218,,In vivo,,N,,,16452,Canis lupus familiaris,50588,A,,1
,Plasma clearance after intravenous dose of 0.3 mg/kg,,Autocuration,,,13018,,CHEMBL631434,1,BAO_0000218,,In vivo,,U,,,11954,,22224,A,,0
,Plasma clearance after intravenous dose of 1 mg/kg,,Autocuration,,,13019,,CHEMBL631435,1,BAO_0000218,,In vivo,,U,,,11954,,22224,A,,0
,Plasma clearance after intravenous dose of 3 mg/kg,,Autocuration,,,13020,,CHEMBL631436,1,BAO_0000218,,In vivo,,U,,,11954,,22224,A,,0
,Plasma clearance after intravenous dose of 3.87 mg/kg,,Autocuration,,,13021,,CHEMBL631437,1,BAO_0000218,,In vivo,,U,,,11954,,22224,A,,0
,Plasma clearance after peroral administration at 10 mpk in Rat,10116.0,Intermediate,,,13022,,CHEMBL631438,1,BAO_0000218,,In vivo,,N,,,5669,Rattus norvegicus,50597,A,,1
,Plasma clearance after peroral administration at 10 mpk in Rhesus,9544.0,Intermediate,,,13023,,CHEMBL876431,1,BAO_0000218,,In vivo,,N,,,5669,Macaca mulatta,50797,A,,1
,Plasma clearance after peroral administration at 10 mpk in dog,9615.0,Intermediate,,,13024,,CHEMBL631439,1,BAO_0000218,,In vivo,,N,,,5669,Canis lupus familiaris,50588,A,,1
,Totla clearance of compound reported after 5 mg/kg i.v. dose in rat,10116.0,Intermediate,,,13025,,CHEMBL631440,1,BAO_0000218,,In vivo,,N,,,13662,Rattus norvegicus,50597,A,,1
,Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC),,Autocuration,,,13026,,CHEMBL631441,1,BAO_0000019,,,,U,,,8272,,22224,A,,0
,Critical Micellar concentration was determined,,Autocuration,,,13027,,CHEMBL631442,1,BAO_0000019,,,,U,,,13410,,22224,A,,0
,Critical Micellar concentration of the compound. was determined,,Autocuration,,,13028,,CHEMBL626525,1,BAO_0000019,,,,U,,,13410,,22224,A,,0
,Critical micelle concentration determined from the plots of the fluorescence intensity as a function of compound concentration,,Autocuration,,,13029,,CHEMBL627168,1,BAO_0000019,,,,U,,,12628,,22224,A,,0
,Critical micellar concentration was measured in water by the dye solubilization method,,Autocuration,,,13030,,CHEMBL875618,1,BAO_0000019,,,,U,,,9675,,22224,A,,0
,Hydrolysis turn over determined from the plots of the fluorescence assay quantified by HPLC,,Autocuration,,,13031,,CHEMBL626612,1,BAO_0000019,,,,U,,,12628,,22224,B,,0
,CMR value (relative to BAY K 8644),,Autocuration,,,13032,,CHEMBL626613,1,BAO_0000019,,,,U,,,12766,,22224,A,,0
,Carbamoylating activity was determined,,Autocuration,,,13033,,CHEMBL626614,1,BAO_0000019,,,,U,,,7849,,22224,A,,0
,Hypotension peak is percentage change from predose baseline pressure observed after intraduodenal dose of 10 mg/kg in monkey,314293.0,Autocuration,,,13034,,CHEMBL626615,1,BAO_0000218,,,,U,,,12187,Simiiformes,22224,A,,0
,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.,,Autocuration,,,13035,,CHEMBL626616,1,BAO_0000019,,,,U,,,2040,,22224,A,,0
,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.,,Autocuration,,,13036,,CHEMBL626617,1,BAO_0000019,,,,U,,,2040,,22224,A,,0
,Clearance from dog plasma after intravenous injection of 1 mg/kg of compound,9615.0,Intermediate,,,13037,1969.0,CHEMBL626618,1,BAO_0000218,,In vivo,,N,,Plasma,14180,Canis lupus familiaris,50588,A,,1
,Clearance from rat plasma after intravenous injection of 1 mg/kg of compound,10116.0,Intermediate,,,13038,1969.0,CHEMBL626619,1,BAO_0000218,,In vivo,,N,,Plasma,14180,Rattus norvegicus,50597,A,,1
,"Clearance rate at 0.46 mg/kg, iv, in dogs",9615.0,Intermediate,,,13039,,CHEMBL626620,1,BAO_0000218,,In vivo,,N,,,14474,Canis lupus familiaris,50588,A,,1
,"Clearance rate at 5.5 mg/kg, iv, in rat",10116.0,Intermediate,,,13040,,CHEMBL626621,1,BAO_0000218,,In vivo,,N,,,14474,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,9541.0,Intermediate,,,13041,,CHEMBL626622,1,BAO_0000218,,In vivo,,N,,,14548,Macaca fascicularis,100710,A,,1
,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,9541.0,Intermediate,,,13042,,CHEMBL626623,1,BAO_0000218,,In vivo,,N,,,14548,Macaca fascicularis,100710,A,,1
,Pharmacokinetic parameter Cl calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,9615.0,Intermediate,,,13043,,CHEMBL626624,1,BAO_0000218,,In vivo,,N,,,14548,Canis lupus familiaris,50588,A,,1
,Pharmacokinetic parameter Cl calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,10116.0,Intermediate,,,13044,,CHEMBL626625,1,BAO_0000218,,In vivo,,N,,,14548,Rattus norvegicus,50597,A,,1
,Clearance rate constant using isolated perfused rat liver (IPRL) assay,10116.0,Intermediate,,,13045,2107.0,CHEMBL626626,1,BAO_0000218,,Ex vivo,,N,,Liver,6125,Rattus norvegicus,50597,A,,1
,Tested for the total clearance of the compound,,Autocuration,,,13046,,CHEMBL626627,1,BAO_0000218,,In vivo,,U,,,6874,,22224,A,,0
,The clearance was measured in dogs after intravenous administration of 1 mg/kg dose,9615.0,Intermediate,,,13047,,CHEMBL626628,1,BAO_0000218,,In vivo,,N,,,15343,Canis lupus familiaris,50588,A,,1
,Total body clearance was determined,,Autocuration,,,13048,,CHEMBL626629,1,BAO_0000218,,In vivo,,U,,,6236,,22224,A,,0
,Mean Chlorine excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,10116.0,Intermediate,,,13049,,CHEMBL626630,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,10116.0,Intermediate,,,13050,,CHEMBL626631,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,Autocuration,,,13051,,CHEMBL626632,1,BAO_0000100,,,,U,,,8194,,22229,P,,0
,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,Autocuration,,,13052,,CHEMBL626633,1,BAO_0000100,,,,U,,,8194,,22229,P,,0
,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 8.0 hr,,Autocuration,,,13053,,CHEMBL626634,1,BAO_0000100,,,,U,,,8194,,22229,P,,0
,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,Autocuration,,,13054,,CHEMBL626635,1,BAO_0000100,,,,U,,,8194,,22229,P,,0
,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,Autocuration,,,13055,,CHEMBL626636,1,BAO_0000100,,,,U,,,8194,,22229,P,,0
,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,Autocuration,,,13056,,CHEMBL626637,1,BAO_0000100,,,,U,,,8194,,22229,P,,0
,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 10.9 uM/Kg/day),4754.0,Intermediate,,,13057,,CHEMBL626638,1,BAO_0000218,,,,N,,,13273,Pneumocystis carinii,50339,A,,1
,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.3 uM/Kg/day,4754.0,Intermediate,,,13058,,CHEMBL626639,1,BAO_0000218,,,,N,,,13273,Pneumocystis carinii,50339,A,,1
,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 23.3 uM/Kg/day,4754.0,Intermediate,,,13059,,CHEMBL626640,1,BAO_0000218,,,,N,,,13273,Pneumocystis carinii,50339,A,,1
,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 4.8 uM/Kg/day,4754.0,Intermediate,,,13060,,CHEMBL626641,1,BAO_0000218,,,,N,,,13273,Pneumocystis carinii,50339,A,,1
,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 9.2 uM/Kg/day,4754.0,Intermediate,,,13061,,CHEMBL627272,1,BAO_0000218,,,,N,,,13273,Pneumocystis carinii,50339,A,,1
,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted uM/Kg/day,4754.0,Intermediate,,,13062,,CHEMBL627273,1,BAO_0000218,,,,N,,,13273,Pneumocystis carinii,50339,A,,1
,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.027 (uM/kg/day),4754.0,Intermediate,,,13063,,CHEMBL627441,1,BAO_0000218,,,,N,,,13273,Pneumocystis carinii,50339,A,,1
,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.27 (uM/kg/day),4754.0,Intermediate,,,13064,,CHEMBL628355,1,BAO_0000218,,,,N,,,13273,Pneumocystis carinii,50339,A,,1
,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 13.3 (uM/kg/day),4754.0,Intermediate,,,13065,,CHEMBL628356,1,BAO_0000218,,,,N,,,13273,Pneumocystis carinii,50339,A,,1
,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.7 (uM/kg/day),4754.0,Intermediate,,,13066,,CHEMBL628357,1,BAO_0000218,,,,N,,,13273,Pneumocystis carinii,50339,A,,1
,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 22.1 (uM/kg/day),4754.0,Intermediate,,,13067,,CHEMBL628358,1,BAO_0000218,,,,N,,,13273,Pneumocystis carinii,50339,A,,1
,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 66.3 (uM/kg/day),4754.0,Intermediate,,,13068,,CHEMBL622307,1,BAO_0000218,,,,N,,,13273,Pneumocystis carinii,50339,A,,1
,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0,,Autocuration,,,13069,,CHEMBL622527,1,BAO_0000019,,,,U,,,13118,,22224,A,,0
,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0; Not detectable,,Autocuration,,,13070,,CHEMBL622528,1,BAO_0000019,,,,U,,,13118,,22224,A,,0
,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4,,Autocuration,,,13071,,CHEMBL622529,1,BAO_0000019,,,,U,,,13118,,22224,A,,0
,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4; Not detectable,,Autocuration,,,13072,,CHEMBL622992,1,BAO_0000019,,,,U,,,13118,,22224,A,,0
,Conversion rate by hydrolysis of compound in plasma after 6 hr. ,,Autocuration,,,13073,,CHEMBL622993,1,BAO_0000019,,,,U,,,13118,,22224,A,,0
,Conversion rate by hydrolysis of compound in plasma after 6 h; Not detectable,,Autocuration,,,13074,,CHEMBL622994,1,BAO_0000019,,,,U,,,13118,,22224,A,,0
,"In vitro rate constant, correlation coefficient for the conversion to progesterone in rat liver homogenate",10116.0,Intermediate,,,13075,,CHEMBL622995,1,BAO_0000218,,,,N,,,10633,Rattus norvegicus,50597,A,,1
,"In vitro rate constant, correlation coefficient for the conversion to progesterone in whole rat blood.",10116.0,Intermediate,,,13076,,CHEMBL622996,1,BAO_0000218,,,,N,,,10633,Rattus norvegicus,50597,A,,1
,"In vitro rate constant, correlation coefficient for the disappearance in rat liver homogenate",10116.0,Intermediate,,,13077,,CHEMBL622997,1,BAO_0000218,,,,N,,,10633,Rattus norvegicus,50597,A,,1
,"In vitro rate constant, correlation coefficient for the disappearance in rat brain homogenate",10116.0,Intermediate,,,13078,,CHEMBL622998,1,BAO_0000218,,,,N,,,10633,Rattus norvegicus,50597,A,,1
,Cp max following ip administration at 1 mg/kg,,Autocuration,,,13079,,CHEMBL622999,1,BAO_0000218,,,,U,,,5767,,22224,A,,0
,Maximum concentration in plasma was reported at 0.5 hour,,Autocuration,,,13080,1969.0,CHEMBL623000,1,BAO_0000218,,In vivo,,U,,Plasma,3302,,22224,A,,0
,Maximum concentration in plasma was reported at 2 hour,,Autocuration,,,13081,1969.0,CHEMBL623001,1,BAO_0000218,,In vivo,,U,,Plasma,3302,,22224,A,,0
,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK3 murine fibrosarcoma cells,10090.0,Intermediate,,,13082,,CHEMBL623002,1,BAO_0000218,,,,N,,,12467,Mus musculus,50594,A,,1
,Aqueous solubility in 25 mM N-glycyl-glycine and 10 mM MgSO4 (pH 7.8),,Autocuration,,,13083,,CHEMBL623003,1,BAO_0000100,,,,U,,,11778,,22229,P,,0
,Steady state concentration was evaluated,,Autocuration,,,13084,,CHEMBL623004,1,BAO_0000019,,,,U,,,4321,,22224,A,,0
,Partition coefficient (logP),,Autocuration,,,13085,,CHEMBL623005,1,BAO_0000019,,,,U,,,14884,,22224,A,,0
,Partition coefficient (logD7.4),,Autocuration,,,13086,,CHEMBL623006,1,BAO_0000019,,,,U,,,15234,,22224,A,,0
,Biodistribution of {18]Fluoro-CGP 12388 (60 minutes post injection) in liver of male wistar rats,10116.0,Intermediate,,,13087,2107.0,CHEMBL623007,1,BAO_0000218,,In vivo,,N,,Liver,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in bone of male wistar rats,10116.0,Intermediate,,,13088,10000001.0,CHEMBL623008,1,BAO_0000218,,In vivo,,N,,Bone,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cerebellum of male wistar rats,10116.0,Intermediate,,,13089,2037.0,CHEMBL876654,1,BAO_0000218,,In vivo,,N,,Cerebellum,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cortex of male wistar rats,10116.0,Intermediate,,,13090,,CHEMBL623009,1,BAO_0000218,,In vivo,,N,,,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in fat of male wistar rats,10116.0,Intermediate,,,13091,,CHEMBL623010,1,BAO_0000218,,In vivo,,N,,,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in heart of male wistar rats,10116.0,Intermediate,,,13092,948.0,CHEMBL623011,1,BAO_0000218,,In vivo,,N,,Heart,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in intestine of male wistar rats,10116.0,Intermediate,,,13093,160.0,CHEMBL623012,1,BAO_0000218,,In vivo,,N,,Intestine,14198,Rattus norvegicus,50597,A,,1
,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,,Autocuration,,,13094,,CHEMBL623013,1,BAO_0000019,,,,U,,,8151,,22224,A,,0
,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,Autocuration,,,13095,,CHEMBL623014,1,BAO_0000019,,,,U,,,8151,,22224,A,,0
,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 10 mg/Kg,,Autocuration,,,13096,1088.0,CHEMBL623015,1,BAO_0000019,,,,U,,Urine,8151,,22224,A,,0
,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,Autocuration,,,13097,1088.0,CHEMBL623016,1,BAO_0000019,,,,U,,Urine,8151,,22224,A,,0
,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 25 mg/Kg,,Autocuration,,,13098,1088.0,CHEMBL624858,1,BAO_0000019,,,,U,,Urine,8151,,22224,A,,0
,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg.,10116.0,Intermediate,,,13099,,CHEMBL624859,1,BAO_0000218,,,,N,,,8151,Rattus norvegicus,50597,A,,1
,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,10116.0,Intermediate,,,13100,,CHEMBL624860,1,BAO_0000218,,,,N,,,8151,Rattus norvegicus,50597,A,,1
,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,10116.0,Intermediate,,,13101,,CHEMBL624861,1,BAO_0000218,,,,N,,,8151,Rattus norvegicus,50597,A,,1
,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,10116.0,Intermediate,,,13102,,CHEMBL624862,1,BAO_0000218,,,,N,,,8151,Rattus norvegicus,50597,A,,1
,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg.,10116.0,Intermediate,,,13103,,CHEMBL624863,1,BAO_0000218,,,,N,,,8151,Rattus norvegicus,50597,A,,1
,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,10116.0,Intermediate,,,13104,,CHEMBL876655,1,BAO_0000218,,,,N,,,8151,Rattus norvegicus,50597,A,,1
,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,9615.0,Intermediate,,,13105,,CHEMBL624864,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,9615.0,Intermediate,,,13106,,CHEMBL624865,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,9615.0,Intermediate,,,13107,,CHEMBL624866,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Salidiuretic activity in dog following i.v. dosing at 5 mg/kg,9615.0,Expert,,,13108,,CHEMBL624867,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,F,,1
,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,9615.0,Intermediate,,,13109,,CHEMBL624868,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600- 799,9615.0,Intermediate,,,13110,,CHEMBL628450,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,9615.0,Intermediate,,,13111,,CHEMBL628451,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,9615.0,Intermediate,,,13112,,CHEMBL628452,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,9615.0,Intermediate,,,13113,,CHEMBL628453,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; act above 5 mg/kg,9615.0,Intermediate,,,13114,,CHEMBL628454,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,9615.0,Intermediate,,,13115,,CHEMBL628455,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,9615.0,Intermediate,,,13116,,CHEMBL628456,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,9615.0,Intermediate,,,13117,,CHEMBL628457,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-299,9615.0,Intermediate,,,13118,,CHEMBL877505,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 250-399,9615.0,Intermediate,,,13119,,CHEMBL628458,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,9615.0,Intermediate,,,13120,,CHEMBL628459,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,9615.0,Intermediate,,,13121,,CHEMBL628460,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,9615.0,Intermediate,,,13122,,CHEMBL628461,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 16.5 mg/kg",,Autocuration,,,13123,,CHEMBL628462,1,BAO_0000218,,,,U,,,6996,,22224,B,,0
,Compound administered orally at a dose of 1 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,9615.0,Intermediate,,,13124,,CHEMBL628463,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 50 mg/kg",10116.0,Expert,,,13125,,CHEMBL625666,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,F,,1
,Compound administered orally at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,Autocuration,,,13126,,CHEMBL625667,1,BAO_0000218,,,,U,,,6996,,22224,B,,0
,Compound administered orally at a dose of 81 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,10116.0,Expert,,,13127,,CHEMBL625668,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Compound administered orally was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,10116.0,Intermediate,,,13128,,CHEMBL625669,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry,,Autocuration,,,13129,,CHEMBL625670,1,BAO_0000019,,,,U,,,7114,,22224,A,,0
,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry in rat,10116.0,Intermediate,,,13130,,CHEMBL625671,1,BAO_0000218,,,,N,,,7114,Rattus norvegicus,50597,A,,1
,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day.,10298.0,Intermediate,,,13131,,CHEMBL625672,1,BAO_0000218,,,,N,,,8613,Human herpesvirus 1,50602,A,,1
,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously,10298.0,Intermediate,,,13132,,CHEMBL625673,1,BAO_0000218,,,,N,,,8613,Human herpesvirus 1,50602,A,,1
,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously.,10298.0,Intermediate,,,13133,,CHEMBL625674,1,BAO_0000218,,,,N,,,8613,Human herpesvirus 1,50602,A,,1
,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously,10298.0,Intermediate,,,13134,,CHEMBL625675,1,BAO_0000218,,,,N,,,8613,Human herpesvirus 1,50602,A,,1
,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,10298.0,Intermediate,,,13135,,CHEMBL627637,1,BAO_0000218,,,,N,,,8613,Human herpesvirus 1,50602,A,,1
,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered orally.,10298.0,Intermediate,,,13136,,CHEMBL627638,1,BAO_0000218,,,,N,,,8613,Human herpesvirus 1,50602,A,,1
,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously,10298.0,Intermediate,,,13137,,CHEMBL627639,1,BAO_0000218,,,,N,,,8613,Human herpesvirus 1,50602,A,,1
,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously.,10298.0,Intermediate,,,13138,,CHEMBL627640,1,BAO_0000218,,,,N,,,8613,Human herpesvirus 1,50602,A,,1
,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered orally.,10298.0,Intermediate,,,13139,,CHEMBL627641,1,BAO_0000218,,,,N,,,8613,Human herpesvirus 1,50602,A,,1
,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,10298.0,Intermediate,,,13140,,CHEMBL627642,1,BAO_0000218,,,,N,,,8613,Human herpesvirus 1,50602,A,,1
,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,10298.0,Intermediate,,,13141,,CHEMBL877506,1,BAO_0000218,,,,N,,,8613,Human herpesvirus 1,50602,A,,1
,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,10090.0,Intermediate,,,13142,,CHEMBL627275,1,BAO_0000218,,,,N,,,8613,Mus musculus,50594,A,,1
,"Average area under curve value dosed at 0.3 mg/kg, iv in ferrets.",9669.0,Intermediate,,,13143,,CHEMBL627643,1,BAO_0000218,,,,N,,,11219,Mustela putorius furo,50506,A,,1
,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",9669.0,Intermediate,,,13144,,CHEMBL631246,1,BAO_0000218,,,,N,,,11219,Mustela putorius furo,50506,A,,1
,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",9669.0,Intermediate,,,13145,,CHEMBL631247,1,BAO_0000218,,,,N,,,11219,Mustela putorius furo,50506,A,,1
,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,9669.0,Intermediate,,,13146,,CHEMBL629532,1,BAO_0000218,,,,N,,,11219,Mustela putorius furo,50506,A,,1
,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from arterial blood).,9669.0,Intermediate,,,13147,,CHEMBL629533,1,BAO_0000218,,,,N,,,11219,Mustela putorius furo,50506,A,,1
,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,9669.0,Intermediate,,,13148,,CHEMBL629534,1,BAO_0000218,,,,N,,,11219,Mustela putorius furo,50506,A,,1
,Average peak plasma drug concentration after iv dose of 0.3 mg/kg in ferrets.,9669.0,Intermediate,,,13149,,CHEMBL629535,1,BAO_0000218,,,,N,,,11219,Mustela putorius furo,50506,A,,1
,Pharmacokinetic parameter :drug bound to plasma was reported,,Autocuration,,,13150,,CHEMBL625932,1,BAO_0000019,,,,U,,,14837,,22224,A,,0
,compound was evaluated for drug bound in plasma,,Autocuration,,,13151,,CHEMBL625933,1,BAO_0000019,,,,U,,,14837,,22224,A,,0
,The Brain concentration compared to plasma concentration in rats after oral administration of 1 mg/kg dose,10116.0,Intermediate,,,13152,,CHEMBL625934,1,BAO_0000218,,,,N,,,15343,Rattus norvegicus,50597,A,,1
,Bioavailability,9347.0,Autocuration,,,13153,,CHEMBL625935,1,BAO_0000218,,,,U,,,13761,Eutheria,22224,A,,0
,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported,10116.0,Intermediate,,,13154,,CHEMBL625936,1,BAO_0000218,,,,N,,,14810,Rattus norvegicus,50597,A,,1
,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported; Not tested,10116.0,Intermediate,,,13155,,CHEMBL625937,1,BAO_0000218,,,,N,,,14810,Rattus norvegicus,50597,A,,1
,Oral bioavailability in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,9615.0,Intermediate,,,13156,,CHEMBL625938,1,BAO_0000218,,,,N,,,13249,Canis lupus familiaris,50588,A,,1
,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-1 hr after the treatment.,10116.0,Intermediate,,,13157,1970.0,CHEMBL625939,1,BAO_0000218,,,,N,,Bile,9267,Rattus norvegicus,50597,A,,1
,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-2 hr after the treatment.,10116.0,Intermediate,,,13158,1970.0,CHEMBL625940,1,BAO_0000218,,,,N,,Bile,9267,Rattus norvegicus,50597,A,,1
,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-3 hr after the treatment.,10116.0,Intermediate,,,13159,1970.0,CHEMBL874464,1,BAO_0000218,,,,N,,Bile,9267,Rattus norvegicus,50597,A,,1
,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-4 hr after the treatment.,10116.0,Intermediate,,,13160,1970.0,CHEMBL625941,1,BAO_0000218,,,,N,,Bile,9267,Rattus norvegicus,50597,A,,1
,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-5 hr after the treatment.,10116.0,Intermediate,,,13161,1970.0,CHEMBL625942,1,BAO_0000218,,,,N,,Bile,9267,Rattus norvegicus,50597,A,,1
,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-6 hr after the treatment.,10116.0,Intermediate,,,13162,1970.0,CHEMBL625943,1,BAO_0000218,,,,N,,Bile,9267,Rattus norvegicus,50597,A,,1
,In vitro protein binding in human serum at 5 ug/ml,9606.0,Intermediate,,,13163,1977.0,CHEMBL625944,1,BAO_0000218,,,,N,,Serum,15549,Homo sapiens,50587,A,,1
,Serum protein binding ability was measured,,Autocuration,,,13164,,CHEMBL625945,1,BAO_0000019,,,,U,,,10929,,22224,A,,0
,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),,Autocuration,,,13165,,CHEMBL625946,1,BAO_0000019,,,,U,,,15444,,22224,A,,0
,Oral bioavailability in dog,9615.0,Autocuration,,,13166,,CHEMBL625947,1,BAO_0000218,,In vivo,,U,,,12860,Canis lupus familiaris,22224,A,,0
,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,10116.0,Intermediate,,,13167,,CHEMBL625948,1,BAO_0000218,,In vivo,,N,,,12170,Rattus norvegicus,50597,A,,1
,Absolute oral bioavailability at an iv dose of 14 mg/kg,,Autocuration,,,13168,,CHEMBL625949,1,BAO_0000218,,In vivo,,U,,,15173,,22224,A,,0
,Absolute oral bioavailability at an iv dose of 15.2 mg/kg,,Autocuration,,,13169,,CHEMBL625950,1,BAO_0000218,,In vivo,,U,,,15173,,22224,A,,0
,Oral bioavailability (dose 15 mg/kg i.v.),9347.0,Autocuration,,,13170,,CHEMBL625951,1,BAO_0000218,,In vivo,,U,,,15173,Eutheria,22224,A,,0
,Absolute oral bioavailability at an peroral dose of 15 mg/kg orally.,,Autocuration,,,13171,,CHEMBL625952,1,BAO_0000218,,In vivo,,U,,,15173,,22224,A,,0
,Absolute oral bioavailability at an peroral dose of 30 mg/kg orally,,Autocuration,,,13172,,CHEMBL625953,1,BAO_0000218,,In vivo,,U,,,15173,,22224,A,,0
,Absolute oral bioavailability at an peroral dose of 30.2 mg/kg orally.,,Autocuration,,,13173,,CHEMBL625954,1,BAO_0000218,,In vivo,,U,,,15173,,22224,A,,0
,Absolute oral bioavailability at an peroral dose of 30.3 mg/kg orally.,,Autocuration,,,13174,,CHEMBL882959,1,BAO_0000218,,In vivo,,U,,,15173,,22224,A,,0
,Apparent bioavailability in dogs at 15 mg/kg in an iv vs po dosing regimen,9615.0,Intermediate,,,13175,,CHEMBL625955,1,BAO_0000218,,In vivo,,N,,,11767,Canis lupus familiaris,50588,A,,1
,Bioavailability in ferret,9669.0,Autocuration,,,13176,,CHEMBL625956,1,BAO_0000218,,In vivo,,U,,,11219,Mustela putorius furo,22224,A,,0
,Bioavailability after intraduodenal administration at a dose 10 mg/kg in cynomolgus monkeys using renin inhibition assay,9541.0,Intermediate,,,13177,,CHEMBL625957,1,BAO_0000218,,In vivo,,N,,,12186,Macaca fascicularis,100710,A,,1
,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,10116.0,Intermediate,,,13178,,CHEMBL625958,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,10116.0,Intermediate,,,13179,,CHEMBL625959,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,10116.0,Intermediate,,,13180,,CHEMBL626642,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,10116.0,Intermediate,,,13181,,CHEMBL631330,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,10116.0,Intermediate,,,13182,,CHEMBL631331,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,10116.0,Intermediate,,,13183,,CHEMBL631332,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,10116.0,Intermediate,,,13184,,CHEMBL631333,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,10116.0,Intermediate,,,13185,,CHEMBL632018,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,10116.0,Intermediate,,,13186,,CHEMBL632019,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,10116.0,Intermediate,,,13187,,CHEMBL632020,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,10116.0,Intermediate,,,13188,,CHEMBL632021,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,10116.0,Intermediate,,,13189,,CHEMBL632022,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,10116.0,Intermediate,,,13190,,CHEMBL632023,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,10116.0,Intermediate,,,13191,,CHEMBL632024,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,10116.0,Intermediate,,,13192,,CHEMBL874472,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,10116.0,Intermediate,,,13193,,CHEMBL632025,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,10116.0,Intermediate,,,13194,,CHEMBL632026,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,10116.0,Intermediate,,,13195,,CHEMBL632027,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,10116.0,Intermediate,,,13196,,CHEMBL632028,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,10116.0,Intermediate,,,13197,,CHEMBL626430,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,10116.0,Intermediate,,,13198,,CHEMBL626431,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,10116.0,Intermediate,,,13199,,CHEMBL626432,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,10116.0,Intermediate,,,13200,,CHEMBL626433,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,10116.0,Intermediate,,,13201,,CHEMBL626434,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,10116.0,Intermediate,,,13202,,CHEMBL627280,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,10116.0,Intermediate,,,13203,,CHEMBL627281,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,10116.0,Intermediate,,,13204,,CHEMBL627282,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Total body clearance was measured at given dose,,Autocuration,,,13205,,CHEMBL627283,1,BAO_0000019,,,,U,,,7199,,22224,A,,0
,Total body clearance was measured at given dose.,,Autocuration,,,13206,,CHEMBL627284,1,BAO_0000218,,,,U,,,7199,,22224,A,,0
,Metabolic clearance from the body in rat,10116.0,Intermediate,,,13207,,CHEMBL627285,1,BAO_0000218,,,,N,,,7095,Rattus norvegicus,50597,A,,1
,Renal clearance from the body,,Autocuration,,,13208,,CHEMBL627286,1,BAO_0000218,,In vivo,,U,,,7095,,22224,A,,0
,Renal clearance from the body in rat,10116.0,Intermediate,,,13209,,CHEMBL875477,1,BAO_0000218,,In vivo,,N,,,7095,Rattus norvegicus,50597,A,,1
,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat,10116.0,Intermediate,,,13210,,CHEMBL627287,1,BAO_0000218,,In vivo,,N,,,12528,Rattus norvegicus,50597,A,,1
,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog,9615.0,Intermediate,,,13211,,CHEMBL627288,1,BAO_0000218,,In vivo,,N,,,12528,Canis lupus familiaris,50588,A,,1
,Total clearance from the body in rat,10116.0,Intermediate,,,13212,,CHEMBL627289,1,BAO_0000218,,,,N,,,7095,Rattus norvegicus,50597,A,,1
,Clearance into cortex from rat plasma or PBS,10116.0,Intermediate,,,13213,1969.0,CHEMBL627290,1,BAO_0000218,,In vivo,,N,,Plasma,14223,Rattus norvegicus,50597,A,,1
,Clearance at an iv dose of 15 mg/Kg and po dose of 120 mg/Kg,,Autocuration,,,13214,,CHEMBL627291,1,BAO_0000218,,In vivo,,U,,,13569,,22224,A,,0
,Clearance at an iv dose of 15 mg/Kg and po dose of 240 mg/Kg,,Autocuration,,,13215,,CHEMBL627292,1,BAO_0000218,,In vivo,,U,,,13569,,22224,A,,0
,Clearance at an iv dose of 15 mg/Kg and po dose of 29.1 mg/Kg,,Autocuration,,,13216,,CHEMBL627293,1,BAO_0000218,,In vivo,,U,,,13569,,22224,A,,0
,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,,Autocuration,,,13217,,CHEMBL627294,1,BAO_0000218,,In vivo,,U,,,13569,,22224,A,,0
,Clearance at an iv dose of 15 mg/Kg and po dose of 60 mg/Kg,,Autocuration,,,13218,,CHEMBL875478,1,BAO_0000218,,In vivo,,U,,,13569,,22224,A,,0
,Clearance was determined,,Autocuration,,,13219,,CHEMBL627295,1,BAO_0000218,,In vivo,,U,,,13979,,22224,A,,0
,Clearance was measured in mouse after administration of compound 20 mg/kg intravenously,10090.0,Intermediate,,,13220,,CHEMBL627296,1,BAO_0000218,,In vivo,,N,,,14315,Mus musculus,50594,A,,1
,Clearance was measured in rabbit after administration of compound 20 mg/kg intravenously,9986.0,Intermediate,,,13221,,CHEMBL626119,1,BAO_0000218,,In vivo,,N,,,14315,Oryctolagus cuniculus,50592,A,,1
,Clearance was measured in rat after administration of compound 20 mg/kg intravenously,10116.0,Intermediate,,,13222,,CHEMBL626120,1,BAO_0000218,,In vivo,,N,,,14315,Rattus norvegicus,50597,A,,1
,Clearance in rat after iv dose (100 ug/kg),10116.0,Intermediate,,,13223,,CHEMBL626121,1,BAO_0000218,,In vivo,,N,,,12174,Rattus norvegicus,50597,A,,1
,Clearance in guinea pig,10141.0,Autocuration,,,13224,,CHEMBL626122,1,BAO_0000218,,In vivo,,U,,,12797,Cavia porcellus,22224,A,,0
,Compound was evaluated for clearance in rat,10116.0,Intermediate,,,13225,,CHEMBL626123,1,BAO_0000218,,In vivo,,N,,,12797,Rattus norvegicus,50597,A,,1
,Compound was evaluated for the clearance in dog,9615.0,Intermediate,,,13226,,CHEMBL623456,1,BAO_0000218,,In vivo,,N,,,12797,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for the clearance in rat,10116.0,Intermediate,,,13227,,CHEMBL623457,1,BAO_0000218,,In vivo,,N,,,12797,Rattus norvegicus,50597,A,,1
,Compound was tested in vivo for clearance after iv administration in the rat,10116.0,Intermediate,,,13228,,CHEMBL623458,1,BAO_0000218,,In vivo,,N,,,11500,Rattus norvegicus,50597,A,,1
,IV clearance determined at an iv dose of 14 mg/kg,,Autocuration,,,13229,,CHEMBL623459,1,BAO_0000218,,In vivo,,U,,,15173,,22224,A,,0
,IV clearance determined at an iv dose of 15.2 mg/kg,,Autocuration,,,13230,,CHEMBL875484,1,BAO_0000218,,In vivo,,U,,,15173,,22224,A,,0
,IV clearance determined at an iv dose of 15 mg/kg,,Autocuration,,,13231,,CHEMBL623460,1,BAO_0000218,,In vivo,,U,,,15173,,22224,A,,0
,IV clearance determined at an peroral dose of 30 mg/kg.,,Autocuration,,,13232,,CHEMBL623461,1,BAO_0000218,,In vivo,,U,,,15173,,22224,A,,0
,IV clearance determined at an peroral dose of 30.2 mg/kg.,,Autocuration,,,13233,,CHEMBL623462,1,BAO_0000218,,In vivo,,U,,,15173,,22224,A,,0
,IV clearance determined at an peroral dose of 30.3 mg/kg.,,Autocuration,,,13234,,CHEMBL627386,1,BAO_0000218,,In vivo,,U,,,15173,,22224,A,,0
,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in kidney of male wistar rats,10116.0,Intermediate,,,13235,2113.0,CHEMBL627387,1,BAO_0000218,,In vivo,,N,,Kidney,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in liver of male wistar rats,10116.0,Intermediate,,,13236,2107.0,CHEMBL627388,1,BAO_0000218,,In vivo,,N,,Liver,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in lung of male wistar rats,10116.0,Intermediate,,,13237,2048.0,CHEMBL627389,1,BAO_0000218,,In vivo,,N,,Lung,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in muscle of male wistar rats,10116.0,Intermediate,,,13238,2385.0,CHEMBL627390,1,BAO_0000218,,In vivo,,N,,Muscle tissue,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in plasma of male wistar rats,10116.0,Intermediate,,,13239,1969.0,CHEMBL627391,1,BAO_0000218,,In vivo,,N,,Plasma,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in red blood cells of male wistar rats,10116.0,Intermediate,,,13240,,CHEMBL627392,1,BAO_0000218,,In vivo,,N,,,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in spleen of male wistar rats,10116.0,Intermediate,,,13241,2106.0,CHEMBL627393,1,BAO_0000218,,In vivo,,N,,Spleen,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in trachea of male wistar rats,10116.0,Intermediate,,,13242,3126.0,CHEMBL627394,1,BAO_0000218,,In vivo,,N,,Trachea,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in bone of male wistar rats,10116.0,Intermediate,,,13243,10000001.0,CHEMBL627395,1,BAO_0000218,,In vivo,,N,,Bone,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cerebellum of male wistar rats,10116.0,Intermediate,,,13244,2037.0,CHEMBL875485,1,BAO_0000218,,In vivo,,N,,Cerebellum,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cortex of male wistar rats,10116.0,Intermediate,,,13245,,CHEMBL627396,1,BAO_0000218,,In vivo,,N,,,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in fat of male wistar rats,10116.0,Intermediate,,,13246,,CHEMBL627397,1,BAO_0000218,,In vivo,,N,,,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in heart of male wistar rats,10116.0,Intermediate,,,13247,948.0,CHEMBL627398,1,BAO_0000218,,In vivo,,N,,Heart,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in intestine bone of male wistar rats,10116.0,Intermediate,,,13248,10000001.0,CHEMBL627399,1,BAO_0000218,,In vivo,,N,,Bone,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in kidney of male wistar rats,10116.0,Intermediate,,,13249,2113.0,CHEMBL627400,1,BAO_0000218,,In vivo,,N,,Kidney,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in liver of male wistar rats,10116.0,Intermediate,,,13250,2107.0,CHEMBL627401,1,BAO_0000218,,In vivo,,N,,Liver,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in lung of male wistar rats,10116.0,Intermediate,,,13251,2048.0,CHEMBL627402,1,BAO_0000218,,In vivo,,N,,Lung,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in muscle of male wistar rats,10116.0,Intermediate,,,13252,2385.0,CHEMBL627403,1,BAO_0000218,,In vivo,,N,,Muscle tissue,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in plasma of male wistar rats,10116.0,Intermediate,,,13253,1969.0,CHEMBL627404,1,BAO_0000218,,In vivo,,N,,Plasma,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in red blood cells of male wistar rats,10116.0,Intermediate,,,13254,,CHEMBL623101,1,BAO_0000218,,In vivo,,N,,,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in spleen of male wistar rats,10116.0,Intermediate,,,13255,2106.0,CHEMBL877480,1,BAO_0000218,,In vivo,,N,,Spleen,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in trachea of male wistar rats,10116.0,Intermediate,,,13256,3126.0,CHEMBL623102,1,BAO_0000218,,In vivo,,N,,Trachea,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in bone of male wistar rats,10116.0,Intermediate,,,13257,10000001.0,CHEMBL623103,1,BAO_0000218,,In vivo,,N,,Bone,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cerebellum of male wistar rats,10116.0,Intermediate,,,13258,2037.0,CHEMBL623104,1,BAO_0000218,,In vivo,,N,,Cerebellum,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cortex of male wistar rats,10116.0,Intermediate,,,13259,,CHEMBL623105,1,BAO_0000218,,In vivo,,N,,,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in fat of male wistar rats,10116.0,Intermediate,,,13260,,CHEMBL623106,1,BAO_0000218,,In vivo,,N,,,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in heart of male wistar rats,10116.0,Intermediate,,,13261,948.0,CHEMBL623107,1,BAO_0000218,,In vivo,,N,,Heart,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in intestine of male wistar rats,10116.0,Intermediate,,,13262,160.0,CHEMBL623108,1,BAO_0000218,,In vivo,,N,,Intestine,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in kidney of male wistar rats,10116.0,Intermediate,,,13263,2113.0,CHEMBL623109,1,BAO_0000218,,In vivo,,N,,Kidney,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in liver of male wistar rats,10116.0,Intermediate,,,13264,2107.0,CHEMBL623110,1,BAO_0000218,,In vivo,,N,,Liver,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in lung of male wistar rats,10116.0,Intermediate,,,13265,2048.0,CHEMBL623111,1,BAO_0000218,,In vivo,,N,,Lung,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in muscle of male wistar rats,10116.0,Intermediate,,,13266,2385.0,CHEMBL625060,1,BAO_0000218,,In vivo,,N,,Muscle tissue,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in plasma of male wistar rats,10116.0,Intermediate,,,13267,1969.0,CHEMBL625061,1,BAO_0000218,,In vivo,,N,,Plasma,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in red blood cells of male wistar rats,10116.0,Intermediate,,,13268,,CHEMBL625062,1,BAO_0000218,,In vivo,,N,,,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in spleen of male wistar rats,10116.0,Intermediate,,,13269,2106.0,CHEMBL625063,1,BAO_0000218,,In vivo,,N,,Spleen,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in trachea of male wistar rats,10116.0,Intermediate,,,13270,3126.0,CHEMBL625064,1,BAO_0000218,,In vivo,,N,,Trachea,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in bone of male wistar rats,10116.0,Intermediate,,,13271,10000001.0,CHEMBL625065,1,BAO_0000218,,In vivo,,N,,Bone,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cerebellum of male wistar rats,10116.0,Intermediate,,,13272,2037.0,CHEMBL625066,1,BAO_0000218,,In vivo,,N,,Cerebellum,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cortex of male wistar rats,10116.0,Intermediate,,,13273,,CHEMBL625067,1,BAO_0000218,,In vivo,,N,,,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in fat of male wistar rats,10116.0,Intermediate,,,13274,,CHEMBL625068,1,BAO_0000218,,In vivo,,N,,,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in heart of male wistar rats,10116.0,Intermediate,,,13275,948.0,CHEMBL622159,1,BAO_0000218,,In vivo,,N,,Heart,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in intestine of male wistar rats,10116.0,Intermediate,,,13276,160.0,CHEMBL622160,1,BAO_0000218,,In vivo,,N,,Intestine,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in kidney of male wistar rats,10116.0,Intermediate,,,13277,2113.0,CHEMBL622161,1,BAO_0000218,,In vivo,,N,,Kidney,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in lung of male wistar rats,10116.0,Intermediate,,,13278,2048.0,CHEMBL622162,1,BAO_0000218,,In vivo,,N,,Lung,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in muscle of male wistar rats,10116.0,Intermediate,,,13279,2385.0,CHEMBL622163,1,BAO_0000218,,In vivo,,N,,Muscle tissue,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in plasma of male wistar rats,10116.0,Intermediate,,,13280,1969.0,CHEMBL622313,1,BAO_0000218,,In vivo,,N,,Plasma,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in red blood cells of male wistar rats,10116.0,Intermediate,,,13281,,CHEMBL622314,1,BAO_0000218,,In vivo,,N,,,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in spleen of male wistar rats,10116.0,Intermediate,,,13282,2106.0,CHEMBL622315,1,BAO_0000218,,In vivo,,N,,Spleen,14198,Rattus norvegicus,50597,A,,1
,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in trachea of male wistar rats,10116.0,Intermediate,,,13283,3126.0,CHEMBL622316,1,BAO_0000218,,In vivo,,N,,Trachea,14198,Rattus norvegicus,50597,A,,1
,Normal diffusion coefficient in water for Escherichia coli,562.0,Intermediate,,,13284,,CHEMBL877486,1,BAO_0000218,,,,N,,,15599,Escherichia coli,50212,A,,1
,Average max percent decrease in RVR (renal vascular resistance) was determined,,Autocuration,,,13285,,CHEMBL622317,1,BAO_0000019,,,,U,,,8204,,22224,A,,0
,Average max percent decrease in RVR (renal vascular resistance) was determined.,,Autocuration,,,13286,,CHEMBL622318,1,BAO_0000019,,,,U,,,8204,,22224,A,,0
,In vitro stability to pepsin promoting hydrolysis after 1 hr incubation time,,Autocuration,,,13287,,CHEMBL622319,1,BAO_0000019,,,,U,,,6154,,22224,A,,0
,In vitro stability to pepsin promoting hydrolysis after 2 hr incubation time,,Autocuration,,,13288,,CHEMBL622320,1,BAO_0000019,,,,U,,,6154,,22224,A,,0
,In vitro stability to pepsin promoting hydrolysis after 64h incubation time,,Autocuration,,,13289,,CHEMBL622321,1,BAO_0000019,,,,U,,,6154,,22224,A,,0
,In vitro stability to pepsin promoting hydrolysis after 84 hr incubation time,,Autocuration,,,13290,,CHEMBL622322,1,BAO_0000019,,,,U,,,6154,,22224,A,,0
,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry,,Autocuration,,,13291,,CHEMBL622323,1,BAO_0000019,,,,U,,,7114,,22224,A,,0
,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry in rat,10116.0,Intermediate,,,13292,,CHEMBL622324,1,BAO_0000218,,,,N,,,7114,Rattus norvegicus,50597,A,,1
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",9615.0,Intermediate,,,13293,1088.0,CHEMBL622325,1,BAO_0000218,,,,N,,Urine,8133,Canis lupus familiaris,50588,A,,1
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",9615.0,Intermediate,,,13294,1088.0,CHEMBL622326,1,BAO_0000218,,,,N,,Urine,8133,Canis lupus familiaris,50588,A,,1
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 10.0 mg/kg, po",9615.0,Intermediate,,,13295,1088.0,CHEMBL877487,1,BAO_0000218,,,,N,,Urine,8133,Canis lupus familiaris,50588,A,,1
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",9615.0,Intermediate,,,13296,1088.0,CHEMBL622327,1,BAO_0000218,,,,N,,Urine,8133,Canis lupus familiaris,50588,A,,1
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3.0 mg/kg, po",9615.0,Intermediate,,,13297,1088.0,CHEMBL622328,1,BAO_0000218,,,,N,,Urine,8133,Canis lupus familiaris,50588,A,,1
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",9615.0,Intermediate,,,13298,1088.0,CHEMBL622329,1,BAO_0000218,,,,N,,Urine,8133,Canis lupus familiaris,50588,A,,1
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",9615.0,Intermediate,,,13299,1088.0,CHEMBL622330,1,BAO_0000218,,,,N,,Urine,8133,Canis lupus familiaris,50588,A,,1
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 0.3mg/kg, po",9615.0,Intermediate,,,13300,1088.0,CHEMBL622331,1,BAO_0000218,,,,N,,Urine,8133,Canis lupus familiaris,50588,A,,1
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",9615.0,Intermediate,,,13301,1088.0,CHEMBL622332,1,BAO_0000218,,,,N,,Urine,8133,Canis lupus familiaris,50588,A,,1
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3 mg/kg, po",9615.0,Intermediate,,,13302,1088.0,CHEMBL622333,1,BAO_0000218,,,,N,,Urine,8133,Canis lupus familiaris,50588,A,,1
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",314293.0,Autocuration,,,13303,1088.0,CHEMBL627658,1,BAO_0000218,,,,U,,Urine,8133,Simiiformes,22224,A,,0
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 10mg/kg, po",314293.0,Autocuration,,,13304,1088.0,CHEMBL630428,1,BAO_0000218,,,,U,,Urine,8133,Simiiformes,22224,A,,0
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",314293.0,Autocuration,,,13305,1088.0,CHEMBL630429,1,BAO_0000218,,,,U,,Urine,8133,Simiiformes,22224,A,,0
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 30 mg/kg, po",314293.0,Autocuration,,,13306,1088.0,CHEMBL630430,1,BAO_0000218,,,,U,,Urine,8133,Simiiformes,22224,A,,0
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 3 mg/kg, po",314293.0,Autocuration,,,13307,1088.0,CHEMBL630431,1,BAO_0000218,,,,U,,Urine,8133,Simiiformes,22224,A,,0
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",10116.0,Intermediate,,,13308,1088.0,CHEMBL630432,1,BAO_0000218,,,,N,,Urine,8133,Rattus norvegicus,50597,A,,1
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",10116.0,Intermediate,,,13309,1088.0,CHEMBL630433,1,BAO_0000218,,,,N,,Urine,8133,Rattus norvegicus,50597,A,,1
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",10116.0,Intermediate,,,13310,1088.0,CHEMBL630434,1,BAO_0000218,,,,N,,Urine,8133,Rattus norvegicus,50597,A,,1
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",10116.0,Intermediate,,,13311,1088.0,CHEMBL629372,1,BAO_0000218,,,,N,,Urine,8133,Rattus norvegicus,50597,A,,1
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 100.0mg/kg, po",10116.0,Intermediate,,,13312,1088.0,CHEMBL629553,1,BAO_0000218,,,,N,,Urine,8133,Rattus norvegicus,50597,A,,1
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",10116.0,Intermediate,,,13313,1088.0,CHEMBL629554,1,BAO_0000218,,,,N,,Urine,8133,Rattus norvegicus,50597,A,,1
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",10116.0,Intermediate,,,13314,1088.0,CHEMBL874447,1,BAO_0000218,,,,N,,Urine,8133,Rattus norvegicus,50597,A,,1
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",10116.0,Intermediate,,,13315,1088.0,CHEMBL629555,1,BAO_0000218,,,,N,,Urine,8133,Rattus norvegicus,50597,A,,1
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",10116.0,Intermediate,,,13316,1088.0,CHEMBL629556,1,BAO_0000218,,,,N,,Urine,8133,Rattus norvegicus,50597,A,,1
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded rats at 30.0 mg/kg, po",10116.0,Intermediate,,,13317,1088.0,CHEMBL629557,1,BAO_0000218,,,,N,,Urine,8133,Rattus norvegicus,50597,A,,1
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",10116.0,Intermediate,,,13318,1088.0,CHEMBL629558,1,BAO_0000218,,,,N,,Urine,8133,Rattus norvegicus,50597,A,,1
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",10116.0,Intermediate,,,13319,1088.0,CHEMBL629559,1,BAO_0000218,,,,N,,Urine,8133,Rattus norvegicus,50597,A,,1
,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",10116.0,Intermediate,,,13320,1088.0,CHEMBL629560,1,BAO_0000218,,,,N,,Urine,8133,Rattus norvegicus,50597,A,,1
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",9615.0,Intermediate,,,13321,1088.0,CHEMBL629561,1,BAO_0000218,,,,N,,Urine,8133,Canis lupus familiaris,50588,A,,1
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",9615.0,Intermediate,,,13322,1088.0,CHEMBL629562,1,BAO_0000218,,,,N,,Urine,8133,Canis lupus familiaris,50588,A,,1
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.3mg/kg, po",9615.0,Intermediate,,,13323,1088.0,CHEMBL629563,1,BAO_0000218,,,,N,,Urine,8133,Canis lupus familiaris,50588,A,,1
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",9615.0,Intermediate,,,13324,1088.0,CHEMBL629564,1,BAO_0000218,,,,N,,Urine,8133,Canis lupus familiaris,50588,A,,1
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10.0mg/kg, po",9615.0,Intermediate,,,13325,1088.0,CHEMBL629565,1,BAO_0000218,,,,N,,Urine,8133,Canis lupus familiaris,50588,A,,1
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",9615.0,Intermediate,,,13326,1088.0,CHEMBL629566,1,BAO_0000218,,,,N,,Urine,8133,Canis lupus familiaris,50588,A,,1
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1 mg/kg, po",9615.0,Intermediate,,,13327,1088.0,CHEMBL629567,1,BAO_0000218,,,,N,,Urine,8133,Canis lupus familiaris,50588,A,,1
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",9615.0,Intermediate,,,13328,1088.0,CHEMBL629568,1,BAO_0000218,,,,N,,Urine,8133,Canis lupus familiaris,50588,A,,1
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 30mg/kg, po",9615.0,Intermediate,,,13329,1088.0,CHEMBL629569,1,BAO_0000218,,,,N,,Urine,8133,Canis lupus familiaris,50588,A,,1
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",9615.0,Intermediate,,,13330,1088.0,CHEMBL629570,1,BAO_0000218,,,,N,,Urine,8133,Canis lupus familiaris,50588,A,,1
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",314293.0,Autocuration,,,13331,1088.0,CHEMBL629571,1,BAO_0000218,,,,U,,Urine,8133,Simiiformes,22224,A,,0
,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,10116.0,Autocuration,,,13332,,CHEMBL629572,1,BAO_0000218,,In vivo,,U,,,12170,Rattus norvegicus,22224,A,,0
,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,10116.0,Autocuration,,,13333,,CHEMBL629573,1,BAO_0000218,,In vivo,,U,,,12170,Rattus norvegicus,22224,A,,0
,Bioavailability (dose 20 mg/kg),9347.0,Autocuration,,,13334,,CHEMBL629574,1,BAO_0000218,,In vivo,,U,,,4985,Eutheria,22224,A,,0
,Bioavailability in dog,9615.0,Autocuration,,,13335,,CHEMBL629575,1,BAO_0000218,,In vivo,,U,,,15145,Canis lupus familiaris,22224,A,,0
,Bioavailability in rat (Sprague-Dawley) (male),10116.0,Autocuration,,,13336,,CHEMBL874448,1,BAO_0000218,,In vivo,,U,,,14080,Rattus norvegicus,22224,A,,0
,Bioavailability in monkey (dose 10 mg/kg i.d.),9443.0,Autocuration,,,13337,,CHEMBL629576,1,BAO_0000218,,In vivo,,U,,,11219,Primates,22224,A,,0
,Bioavailability in rat,10116.0,Autocuration,,,13338,,CHEMBL629577,1,BAO_0000218,,In vivo,,U,,,15145,Rattus norvegicus,22224,A,,0
,Bioavailability in rat,10116.0,Autocuration,,,13339,,CHEMBL629578,1,BAO_0000218,,In vivo,,U,,,15145,Rattus norvegicus,22224,A,,0
,Bioavailability in dog (dose 3.0 mg/kg p.o.),9615.0,Autocuration,,,13340,,CHEMBL629579,1,BAO_0000218,,In vivo,,U,,,1202,Canis lupus familiaris,22224,A,,0
,Bioavailability in dog (dose of 1.0 mg/kg i.v.) 0.5 hr,9615.0,Autocuration,,,13341,,CHEMBL882958,1,BAO_0000218,,In vivo,,U,,,1202,Canis lupus familiaris,22224,A,,0
,Bioavailability was calculated after peroral dose of 10 mg/Kg in chimp,9598.0,Intermediate,,,13342,,CHEMBL629580,1,BAO_0000218,,In vivo,,N,,,1202,Pan troglodytes,50505,A,,1
,Bioavailability,9347.0,Autocuration,,,13343,,CHEMBL629581,1,BAO_0000218,,In vivo,,U,,,4026,Eutheria,22224,A,,0
,Bioavailability in squirrel monkey,9520.0,Autocuration,,,13344,,CHEMBL629582,1,BAO_0000218,,In vivo,,U,,,1492,Saimiri,22224,A,,0
,Bioavailability was evaluated in dog,9615.0,Intermediate,,,13345,,CHEMBL628522,1,BAO_0000218,,In vivo,,N,,,12793,Canis lupus familiaris,50588,A,,1
,Bioavailability was evaluated in hamster,10026.0,Intermediate,,,13346,,CHEMBL625432,1,BAO_0000218,,In vivo,,N,,,12793,Cricetinae,100712,A,,1
,Bioavailability in rat,10116.0,Autocuration,,,13347,,CHEMBL625433,1,BAO_0000218,,In vivo,,U,,,12793,Rattus norvegicus,22224,A,,0
,Bioavailability was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,10116.0,Intermediate,,,13348,1969.0,CHEMBL625434,1,BAO_0000218,,In vivo,,N,,Plasma,14793,Rattus norvegicus,50597,A,,1
,Bioavailability was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg; <Tr>,10116.0,Intermediate,,,13349,1969.0,CHEMBL625435,1,BAO_0000218,,In vivo,,N,,Plasma,14793,Rattus norvegicus,50597,A,,1
,Bioavailability in rat (dose 10 mg/kg p.o.),10116.0,Autocuration,,,13350,,CHEMBL625436,1,BAO_0000218,,In vivo,,U,,,14793,Rattus norvegicus,22224,A,,0
,Bioavailability was measured in cynomolgus monkeys.,9541.0,Intermediate,,,13351,,CHEMBL874588,1,BAO_0000218,,In vivo,,N,,,14731,Macaca fascicularis,100710,A,,1
,Bioavailability was measured in nude mice.,10090.0,Intermediate,,,13352,,CHEMBL625437,1,BAO_0000218,,In vivo,,N,,,14731,Mus musculus,50594,A,,1
,Bioavailability in ferret (dose 10 mg/kg i.d.),9669.0,Autocuration,,,13353,,CHEMBL625438,1,BAO_0000218,,In vivo,,U,,,12187,Mustela putorius furo,22224,A,,0
,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose),314293.0,Autocuration,,,13354,,CHEMBL625439,1,BAO_0000218,,In vivo,,U,,,12187,Simiiformes,22224,A,,0
,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose), determined by renin inhibition assay",314293.0,Autocuration,,,13355,,CHEMBL625440,1,BAO_0000218,,In vivo,,U,,,12187,Simiiformes,22224,A,,0
,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 1 mg/kg intravenous dose),314293.0,Autocuration,,,13356,,CHEMBL625441,1,BAO_0000218,,In vivo,,U,,,12187,Simiiformes,22224,A,,0
,Bioavailability in rat (dose 10 mg/kg i.d.),10116.0,Autocuration,,,13357,,CHEMBL625442,1,BAO_0000218,,In vivo,,U,,,12187,Rattus norvegicus,22224,A,,0
,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",10116.0,Intermediate,,,13358,,CHEMBL625443,1,BAO_0000218,,In vivo,,N,,,12187,Rattus norvegicus,50597,A,,1
,Bioavailability was determined; extremely poor,,Autocuration,,,13359,,CHEMBL625444,1,BAO_0000218,,In vivo,,U,,,17431,,22224,A,,0
,% bioavailability in mice after oral administration of prodrug,10090.0,Intermediate,,,13360,,CHEMBL625445,1,BAO_0000218,,In vivo,,N,,,13318,Mus musculus,50594,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose 10/30 range (low/high); -21/-5,9615.0,Intermediate,,,13361,,CHEMBL625446,1,BAO_0000218,,In vivo,,N,,,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -2/6,9615.0,Intermediate,,,13362,,CHEMBL882960,1,BAO_0000218,,In vivo,,N,,,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -4/-14,9615.0,Intermediate,,,13363,,CHEMBL625447,1,BAO_0000218,,In vivo,,N,,,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -5/-12,9615.0,Intermediate,,,13364,,CHEMBL625448,1,BAO_0000218,,In vivo,,N,,,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3/10 range (low/high); -1/-7/-11,9615.0,Intermediate,,,13365,,CHEMBL625449,1,BAO_0000218,,In vivo,,N,,,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high),9615.0,Intermediate,,,13366,,CHEMBL874589,1,BAO_0000218,,In vivo,,N,,,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -1/-9,9615.0,Intermediate,,,13367,,CHEMBL625450,1,BAO_0000218,,In vivo,,N,,,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -11/-28,9615.0,Intermediate,,,13368,,CHEMBL625451,1,BAO_0000218,,In vivo,,N,,,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/-29,9615.0,Intermediate,,,13369,,CHEMBL626584,1,BAO_0000218,,In vivo,,N,,,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/30,9615.0,Intermediate,,,13370,,CHEMBL626585,1,BAO_0000218,,In vivo,,N,,,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-18,9615.0,Intermediate,,,13371,,CHEMBL626586,1,BAO_0000218,,In vivo,,N,,,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-35,9615.0,Intermediate,,,13372,,CHEMBL626587,1,BAO_0000218,,In vivo,,N,,,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -19/-50,9615.0,Intermediate,,,13373,,CHEMBL626588,1,BAO_0000218,,In vivo,,N,,,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -21/-29,9615.0,Intermediate,,,13374,,CHEMBL626589,1,BAO_0000218,,In vivo,,N,,,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -24/-56,9615.0,Intermediate,,,13375,,CHEMBL626590,1,BAO_0000218,,In vivo,,N,,,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -25/-33,9615.0,Intermediate,,,13376,,CHEMBL626591,1,BAO_0000218,,In vivo,,N,,,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -3/-13,9615.0,Intermediate,,,13377,,CHEMBL627181,1,BAO_0000218,,In vivo,,N,,,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -5/-47,9615.0,Intermediate,,,13378,,CHEMBL628083,1,BAO_0000218,,In vivo,,N,,,9025,Canis lupus familiaris,50588,A,,1
,IV clearance determined at an peroral dose of 15 mg/kg.,,Autocuration,,,13379,,CHEMBL628084,1,BAO_0000218,,In vivo,,U,,,15173,,22224,A,,0
,Mouse oral clearance was measured against Hymenolepiasis nana.,102285.0,Expert,,,13380,,CHEMBL628085,1,BAO_0000218,,In vivo,,N,,,7732,Hymenolepis nana,50064,F,,1
,Mouse oral clearance was measured against Nematospiroides dubius,6339.0,Expert,,,13381,,CHEMBL628086,1,BAO_0000218,,In vivo,,N,,,7732,Heligmosomoides polygyrus,50545,F,,1
,Mouse oral clearance was measured against N. dubius; NT is Not Tested,,Autocuration,,,13382,,CHEMBL628087,1,BAO_0000218,,In vivo,,U,,,7732,,22224,F,,0
,Mouse oral clearance was measured against N. nana; NT is Not Tested,10090.0,Intermediate,,,13383,,CHEMBL628088,1,BAO_0000218,,In vivo,,N,,,7732,Mus musculus,50594,A,,1
,Mouse oral clearance was measured against N. nana; NT is Not Tested,,Autocuration,,,13384,,CHEMBL628089,1,BAO_0000218,,In vivo,,U,,,7732,,22224,B,,0
,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation,,Autocuration,,,13385,,CHEMBL628090,1,BAO_0000218,,In vivo,,U,,,8328,,22224,A,,0
,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation,,Autocuration,,,13386,,CHEMBL628091,1,BAO_0000218,,In vivo,,U,,,8328,,22224,A,,0
,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation,,Autocuration,,,13387,,CHEMBL628092,1,BAO_0000218,,In vivo,,U,,,8328,,22224,A,,0
,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 9 J/cm e2 ultraviolet-A radiation,,Autocuration,,,13388,,CHEMBL628093,1,BAO_0000218,,In vivo,,U,,,8328,,22224,A,,0
,Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation,,Autocuration,,,13389,,CHEMBL875607,1,BAO_0000218,,In vivo,,U,,,8328,,22224,A,,0
,Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation,,Autocuration,,,13390,,CHEMBL625710,1,BAO_0000218,,In vivo,,U,,,8328,,22224,A,,0
,Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation,,Autocuration,,,13391,,CHEMBL625711,1,BAO_0000218,,In vivo,,U,,,8328,,22224,A,,0
,Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation,,Autocuration,,,13392,,CHEMBL625712,1,BAO_0000218,,In vivo,,U,,,8328,,22224,A,,0
,Percentage of clearance of psoriatic lesions by the compound at dose of 9 J/cm e2 ultraviolet-A radiation,,Autocuration,,,13393,,CHEMBL625713,1,BAO_0000218,,In vivo,,U,,,8328,,22224,A,,0
,Pharmacokinetic parameter clearance was determined in fed Beagle dogs after iv administration of 1.5 mg/kg,9615.0,Intermediate,,,13394,,CHEMBL625714,1,BAO_0000218,,In vivo,,N,,,13376,Canis lupus familiaris,50588,A,,1
,Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey,9544.0,Intermediate,,,13395,,CHEMBL625715,1,BAO_0000218,,In vivo,,N,,,13477,Macaca mulatta,50797,A,,1
,Plasma clearance after intravenous administration dosing (30 mg/kg) in rat,10116.0,Intermediate,,,13396,,CHEMBL625716,1,BAO_0000218,,In vivo,,N,,,13477,Rattus norvegicus,50597,A,,1
,Plasma clearance after intravenous administration iv dosing of 3 mg/kg in rat,10116.0,Intermediate,,,13397,,CHEMBL625717,1,BAO_0000218,,In vivo,,N,,,13477,Rattus norvegicus,50597,A,,1
,Plasma clearance was determined for the compound in rats,10116.0,Intermediate,,,13398,,CHEMBL625718,1,BAO_0000218,,In vivo,,N,,,13313,Rattus norvegicus,50597,A,,1
,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 1,10116.0,Intermediate,,,13399,,CHEMBL625719,1,BAO_0000218,,In vivo,,N,,,12504,Rattus norvegicus,50597,A,,1
,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 2,10116.0,Intermediate,,,13400,,CHEMBL625720,1,BAO_0000218,,In vivo,,N,,,12504,Rattus norvegicus,50597,A,,1
,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 3,10116.0,Intermediate,,,13401,,CHEMBL625721,1,BAO_0000218,,In vivo,,N,,,12504,Rattus norvegicus,50597,A,,1
,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 4,10116.0,Intermediate,,,13402,,CHEMBL625722,1,BAO_0000218,,In vivo,,N,,,12504,Rattus norvegicus,50597,A,,1
,The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat.,10116.0,Intermediate,,,13403,,CHEMBL625723,1,BAO_0000218,,In vivo,,N,,,13129,Rattus norvegicus,50597,A,,1
,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.0125 concentration of diet.,6339.0,Intermediate,,,13404,,CHEMBL625724,1,BAO_0000218,,In vivo,,N,,,7732,Heligmosomoides polygyrus,50545,A,,1
,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.025 concentration of diet.,6339.0,Intermediate,,,13405,,CHEMBL625725,1,BAO_0000218,,In vivo,,N,,,7732,Heligmosomoides polygyrus,50545,A,,1
,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.05 concentration of diet.,6339.0,Intermediate,,,13406,,CHEMBL625726,1,BAO_0000218,,In vivo,,N,,,7732,Heligmosomoides polygyrus,50545,A,,1
,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.1 concentration of diet.,6339.0,Intermediate,,,13407,,CHEMBL875608,1,BAO_0000218,,In vivo,,N,,,7732,Heligmosomoides polygyrus,50545,A,,1
,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.2 concentration of diet.,6339.0,Intermediate,,,13408,,CHEMBL625727,1,BAO_0000218,,In vivo,,N,,,7732,Heligmosomoides polygyrus,50545,A,,1
,Urinary clearance was determined in rat at 100 mg/kg os dosage;ND is defined as no-data.,10116.0,Autocuration,,,13409,1088.0,CHEMBL625728,1,BAO_0000218,,In vivo,,U,,Urine,9278,Rattus norvegicus,22224,A,,0
,Total clearance was determined in rat at 10 mg/kg intraperitoneal dosage,10116.0,Autocuration,,,13410,,CHEMBL625729,1,BAO_0000218,,In vivo,,U,,,9278,Rattus norvegicus,22224,A,,0
,Total clearance was determined in rat at 25 mg/kg os dosage;ND is defined as no-data.,10116.0,Autocuration,,,13411,,CHEMBL625730,1,BAO_0000218,,In vivo,,U,,,9278,Rattus norvegicus,22224,A,,0
,Urinary clearance was determined in rat at 10 mg/kg intraperitoneal dosage,10116.0,Autocuration,,,13412,1088.0,CHEMBL625731,1,BAO_0000218,,In vivo,,U,,Urine,9278,Rattus norvegicus,22224,A,,0
,Urinary clearance was determined in rat at 25 mg/kg os dosage,10116.0,Autocuration,,,13413,1088.0,CHEMBL626417,1,BAO_0000218,,In vivo,,U,,Urine,9278,Rattus norvegicus,22224,A,,0
,Urinary clearance was determined at 100 mg/kg oral dosage in human,9606.0,Intermediate,,,13414,1088.0,CHEMBL626418,1,BAO_0000218,,In vivo,,N,,Urine,9278,Homo sapiens,50587,A,,1
,Urinary clearance was determined at 20 mg/kg oral dosage in dog(beagle);ND is defined as no-data.,9615.0,Intermediate,,,13415,1088.0,CHEMBL626419,1,BAO_0000218,,In vivo,,N,,Urine,9278,Canis lupus familiaris,50588,A,,1
,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,9615.0,Intermediate,,,13416,1969.0,CHEMBL626592,1,BAO_0000218,,In vivo,,N,,Plasma,5932,Canis lupus familiaris,50588,A,,1
,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,10116.0,Intermediate,,,13417,1969.0,CHEMBL626593,1,BAO_0000218,,In vivo,,N,,Plasma,5932,Rattus norvegicus,50597,A,,1
,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,10116.0,Intermediate,,,13418,,CHEMBL626594,1,BAO_0000218,,In vivo,,N,,,5182,Rattus norvegicus,50597,A,,1
,Clearance rate in dogs,9615.0,Intermediate,,,13419,,CHEMBL625035,1,BAO_0000218,,In vivo,,N,,,10499,Canis lupus familiaris,50588,A,,1
,Compound was measured for intrinsic clearance,,Autocuration,,,13420,,CHEMBL625036,1,BAO_0000019,,In vitro,,U,,,6051,,22224,A,,0
,Calculated partition coefficient (clogP),,Autocuration,,,13421,,CHEMBL625037,1,BAO_0000100,,,,U,,,17508,,22229,P,,0
,Calculated partition coefficient (clogP),,Autocuration,,,13422,,CHEMBL625038,1,BAO_0000100,,,,U,,,6228,,22229,P,,0
,Calculated partition coefficient (clogP),,Autocuration,,,13423,,CHEMBL625039,1,BAO_0000100,,,,U,,,6231,,22229,P,,0
,Calculated partition coefficient (clogP),,Autocuration,,,13424,,CHEMBL625040,1,BAO_0000100,,,,U,,,17740,,22229,P,,0
,Calculated partition coefficient (clogP),,Autocuration,,,13425,,CHEMBL625041,1,BAO_0000100,,,,U,,,6495,,22229,P,,0
,Calculated partition coefficient (clogP),,Autocuration,,,13426,,CHEMBL625042,1,BAO_0000100,,,,U,,,2171,,22229,P,,0
,Partition coefficient of the compound,,Autocuration,,,13427,,CHEMBL874411,1,BAO_0000019,,,,U,,,3255,,22224,A,,0
,Permeability,,Autocuration,,,13428,,CHEMBL625043,1,BAO_0000019,,,,U,,,6821,,22224,A,,0
,Calculated partition coefficient (clogP),,Autocuration,,,13429,,CHEMBL625044,1,BAO_0000100,,,,U,,,2685,,22229,P,,0
,Partition coefficient (logD),,Autocuration,,,13430,,CHEMBL625045,1,BAO_0000019,,,,U,,,17584,,22224,A,,0
,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,Autocuration,,,13431,,CHEMBL625046,1,BAO_0000100,,,,U,,,13824,,22229,P,,0
,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,Autocuration,,,13432,,CHEMBL625047,1,BAO_0000100,,,,U,,,13824,,22229,P,,0
,Calculated partition coefficient (clogP),,Autocuration,,,13433,,CHEMBL625048,1,BAO_0000100,,,,U,,,16479,,22229,P,,0
,Calculated partition coefficient (clogP),,Autocuration,,,13434,,CHEMBL625049,1,BAO_0000100,,,,U,,,11997,,22229,P,,0
,Calculated logarithm of partition coefficient (P) was determined,,Autocuration,,,13435,,CHEMBL625050,1,BAO_0000100,,,,U,,,2988,,22229,P,,0
,Calculated partition coefficient (clogP),,Autocuration,,,13436,,CHEMBL625051,1,BAO_0000100,,,,U,,,931,,22229,P,,0
,Calculated partition coefficient (clogP),,Autocuration,,,13437,,CHEMBL874412,1,BAO_0000100,,,,U,,,4381,,22229,P,,0
,Calculated partition coefficient (clogP),,Autocuration,,,13438,,CHEMBL625052,1,BAO_0000100,,,,U,,,4397,,22229,P,,0
,Calculated partition coefficient (clogP),,Autocuration,,,13439,,CHEMBL625053,1,BAO_0000100,,,,U,,,5889,,22229,P,,0
,In vitro stability to pepsin promoting hydrolysis after 8 hr incubation time,,Autocuration,,,13440,,CHEMBL623250,1,BAO_0000019,,,,U,,,6154,,22224,A,,0
,In vitro stability to trypsin promoting hydrolysis after 1 hr incubation time,,Autocuration,,,13441,,CHEMBL623251,1,BAO_0000019,,,,U,,,6154,,22224,A,,0
,In vitro stability to trypsin promoting hydrolysis after 2 hr incubation time,,Autocuration,,,13442,,CHEMBL623252,1,BAO_0000019,,,,U,,,6154,,22224,A,,0
,In vitro stability to trypsin promoting hydrolysis after 64h incubation time,,Autocuration,,,13443,,CHEMBL623253,1,BAO_0000019,,,,U,,,6154,,22224,A,,0
,In vitro stability to trypsin promoting hydrolysis after 84 hr incubation time,,Autocuration,,,13444,,CHEMBL623254,1,BAO_0000019,,,,U,,,6154,,22224,A,,0
,In vitro stability to trypsin promoting hydrolysis after 8 hr incubation time,,Autocuration,,,13445,,CHEMBL623255,1,BAO_0000019,,,,U,,,6154,,22224,A,,0
,Percent degradation of compound at a pH of 1 over a 18 hr period,,Autocuration,,,13446,,CHEMBL626831,1,BAO_0000019,,,,U,,,6887,,22224,A,,0
,Percent degradation of compound at pH of 1 over an 18 hr period,,Autocuration,,,13447,,CHEMBL877494,1,BAO_0000019,,,,U,,,6887,,22224,A,,0
,Delta Logarithm of Partition Coefficient value was determined.,,Autocuration,,,13448,,CHEMBL626832,1,BAO_0000019,,,,U,,,14116,,22224,A,,0
,Delta logPoct-cyc,,Autocuration,,,13449,,CHEMBL626833,1,BAO_0000019,,,,U,,,11137,,22224,A,,0
,Lipophilicity estimated on reversed phase TLC,,Autocuration,,,13450,,CHEMBL626834,1,BAO_0000100,,,,U,,,7230,,22224,P,,0
,Delta Tm value ( Tmdrug-DNA )-TmDNA ) was obtained for the covalently cross-linked compound in the absence of formaldehyde using calf thymus DNA.,,Autocuration,,,13451,,CHEMBL626835,1,BAO_0000019,,,,U,,,15741,,22224,A,,0
,Delta logPoct-cyc,,Autocuration,,,13452,,CHEMBL626836,1,BAO_0000019,,,,U,,,9663,,22224,A,,0
,Change in logarithm of partition coefficient of the compound,,Autocuration,,,13453,,CHEMBL626837,1,BAO_0000100,,,,U,,,9663,,22229,P,,0
,Delta logD (pH 6.5),,Autocuration,,,13454,,CHEMBL626838,1,BAO_0000019,,,,U,,,13807,,22224,A,,0
,"Partition coefficient by standard shake-flask techniquesat 37 C, using octanol and cyclohexane",,Autocuration,,,13455,,CHEMBL626839,1,BAO_0000100,,,,U,,,13807,,22224,P,,0
,Oxygen pressure at which hemoglobin is 50% oxygenated; negative sign indicates that P50 of modified Hb is lower than that of unmodified Hb,,Autocuration,,,13456,,CHEMBL626840,1,BAO_0000019,,,,U,,,17425,,22224,A,,0
,Deoxyribose-damaging property as a measure of hydroxyl-radical formation (uM of malondialdehyde/mmol of deoxyribose released by 75 uM test compound),,Autocuration,,,13457,,CHEMBL626841,1,BAO_0000019,,,,U,,,12143,,22224,A,,0
,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in nine cells,,Autocuration,,,13458,,CHEMBL626842,1,BAO_0000219,,,,U,,,12608,,22224,A,,0
,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in six cells,,Autocuration,,,13459,,CHEMBL626843,1,BAO_0000219,,,,U,,,12608,,22224,A,,0
,Amount of deuterium retained was reported after normal workup in beta-naphthoflavone-treated male rats with the substrate rac 7-D,10116.0,Intermediate,,,13460,,CHEMBL626844,1,BAO_0000218,,,,N,,,8649,Rattus norvegicus,50597,A,,1
,Amount of deuterium retained was reported after normal workup in rats,10116.0,Intermediate,,,13461,,CHEMBL877495,1,BAO_0000218,,,,N,,,8649,Rattus norvegicus,50597,A,,1
,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats,10116.0,Intermediate,,,13462,,CHEMBL626845,1,BAO_0000218,,,,N,,,8649,Rattus norvegicus,50597,A,,1
,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats with rac 8-D,10116.0,Intermediate,,,13463,,CHEMBL626846,1,BAO_0000218,,,,N,,,8649,Rattus norvegicus,50597,A,,1
,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,10116.0,Intermediate,,,13464,,CHEMBL626847,1,BAO_0000218,,,,N,,,8649,Rattus norvegicus,50597,A,,1
,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,10116.0,Intermediate,,,13465,,CHEMBL628677,1,BAO_0000218,,,,N,,,8649,Rattus norvegicus,50597,A,,1
,Compound incubated with microsomal preparations from phenobarbital treated male rats with the substrate rac 8-D and the amount of deuterium retained was reported after normal workup,10116.0,Intermediate,,,13466,,CHEMBL628678,1,BAO_0000218,,,,N,,,8649,Rattus norvegicus,50597,A,,1
,Compound was subjected to electrochemical oxidation,,Autocuration,,,13467,,CHEMBL628679,1,BAO_0000019,,,,U,,,9659,,22224,A,,0
,Compound was subjected to photochemical oxidation,,Autocuration,,,13468,,CHEMBL628680,1,BAO_0000019,,,,U,,,9659,,22224,A,,0
,Oxidation of compound by Chloroperoxidase in presence of ethylperoxide,,Autocuration,,,13469,,CHEMBL628681,1,BAO_0000019,,,,U,,,9659,,22224,A,,0
,Oxidation of compound by horseradish peroxidase in presence of hydroperoxide,,Autocuration,,,13470,,CHEMBL628682,1,BAO_0000019,,,,U,,,9659,,22224,A,,0
,Oxidation of compound by methemoglobin in presence of hydroperoxide,,Autocuration,,,13471,,CHEMBL628683,1,BAO_0000019,,,,U,,,9659,,22224,A,,0
,Percent diffusion through fuzzy rat skin after 48 h of incubation,10116.0,Intermediate,,,13472,,CHEMBL628684,1,BAO_0000218,,,,N,,,9607,Rattus norvegicus,50597,A,,1
,Dissociation constant (pKa),,Autocuration,,,13473,,CHEMBL877501,1,BAO_0000100,,,,U,,,7057,,22229,P,,0
,Dissociation constant value of the compound; ND means not determined.,,Autocuration,,,13474,,CHEMBL628685,1,BAO_0000100,,,,U,,,7057,,22224,P,,0
,% distribution of the radioiron in blood of rat followed by intravenous injection of chelating agent,10116.0,Intermediate,,,13475,178.0,CHEMBL628686,1,BAO_0000218,,,,N,,Blood,7911,Rattus norvegicus,50597,A,,1
,% distribution of the radioiron in blood of rats followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,10116.0,Intermediate,,,13476,178.0,CHEMBL628687,1,BAO_0000218,,,,N,,Blood,7911,Rattus norvegicus,50597,A,,1
,% distribution of the radioiron in rat kidney followed by intravenous injection of chelating agent,10116.0,Intermediate,,,13477,,CHEMBL628688,1,BAO_0000218,,,,N,,,7911,Rattus norvegicus,50597,A,,1
,% distribution of the radioiron in rat kidney followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,10116.0,Intermediate,,,13478,,CHEMBL628689,1,BAO_0000218,,,,N,,,7911,Rattus norvegicus,50597,A,,1
,% distribution of the radioiron in rat liver followed by intravenous injection of chelating agent,10116.0,Intermediate,,,13479,2107.0,CHEMBL628690,1,BAO_0000218,,,,N,,Liver,7911,Rattus norvegicus,50597,A,,1
,% distribution of the radioiron in rat liver followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,10116.0,Intermediate,,,13480,2107.0,CHEMBL629363,1,BAO_0000218,,,,N,,Liver,7911,Rattus norvegicus,50597,A,,1
,% distribution of the radioiron in rat spleen followed by intravenous injection of chelating agent,10116.0,Intermediate,,,13481,2106.0,CHEMBL629364,1,BAO_0000218,,,,N,,Spleen,7911,Rattus norvegicus,50597,A,,1
,% distribution of the radioiron in rat spleen followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,10116.0,Intermediate,,,13482,2106.0,CHEMBL629365,1,BAO_0000218,,,,N,,Spleen,7911,Rattus norvegicus,50597,A,,1
,% excretion of ferritin determined in faces of rat followed by intravenous injection of chelating agent,10116.0,Intermediate,,,13483,,CHEMBL629366,1,BAO_0000218,,,,N,,,7911,Rattus norvegicus,50597,A,,1
,% excretion of ferritin determined in urine of rat followed by intravenous injection of chelating agent,10116.0,Intermediate,,,13484,1088.0,CHEMBL629367,1,BAO_0000218,,,,N,,Urine,7911,Rattus norvegicus,50597,A,,1
,% excretion of radioiron determined in feces of rat followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,10116.0,Intermediate,,,13485,1988.0,CHEMBL629368,1,BAO_0000218,,,,N,,Feces,7911,Rattus norvegicus,50597,A,,1
,% excretion of radioiron determined in urine of rat followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,10116.0,Intermediate,,,13486,1088.0,CHEMBL877502,1,BAO_0000218,,,,N,,Urine,7911,Rattus norvegicus,50597,A,,1
,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cerebellum,10090.0,Intermediate,,,13487,2037.0,CHEMBL629369,1,BAO_0000218,,,,N,,Cerebellum,13792,Mus musculus,50594,A,,1
,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cortex,10090.0,Intermediate,,,13488,955.0,CHEMBL629370,1,BAO_0000218,,,,N,,Brain,13792,Mus musculus,50594,A,,1
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded monkey at 10 mg/kg, po",314293.0,Autocuration,,,13489,1088.0,CHEMBL629371,1,BAO_0000218,,,,U,,Urine,8133,Simiiformes,22224,A,,0
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",314293.0,Autocuration,,,13490,1088.0,CHEMBL626276,1,BAO_0000218,,,,U,,Urine,8133,Simiiformes,22224,A,,0
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",314293.0,Autocuration,,,13491,1088.0,CHEMBL626277,1,BAO_0000218,,,,U,,Urine,8133,Simiiformes,22224,A,,0
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",314293.0,Autocuration,,,13492,1088.0,CHEMBL631250,1,BAO_0000218,,,,U,,Urine,8133,Simiiformes,22224,A,,0
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",10116.0,Intermediate,,,13493,1088.0,CHEMBL631251,1,BAO_0000218,,,,N,,Urine,8133,Rattus norvegicus,50597,A,,1
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",10116.0,Intermediate,,,13494,1088.0,CHEMBL631252,1,BAO_0000218,,,,N,,Urine,8133,Rattus norvegicus,50597,A,,1
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 1.0 mg/kg, po",10116.0,Intermediate,,,13495,1088.0,CHEMBL631253,1,BAO_0000218,,,,N,,Urine,8133,Rattus norvegicus,50597,A,,1
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",10116.0,Intermediate,,,13496,1088.0,CHEMBL631254,1,BAO_0000218,,,,N,,Urine,8133,Rattus norvegicus,50597,A,,1
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",10116.0,Intermediate,,,13497,1088.0,CHEMBL631255,1,BAO_0000218,,,,N,,Urine,8133,Rattus norvegicus,50597,A,,1
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",10116.0,Intermediate,,,13498,1088.0,CHEMBL631256,1,BAO_0000218,,,,N,,Urine,8133,Rattus norvegicus,50597,A,,1
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",10116.0,Intermediate,,,13499,1088.0,CHEMBL631257,1,BAO_0000218,,,,N,,Urine,8133,Rattus norvegicus,50597,A,,1
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 207.6 mg/kg, po",10116.0,Intermediate,,,13500,1088.0,CHEMBL628009,1,BAO_0000218,,,,N,,Urine,8133,Rattus norvegicus,50597,A,,1
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",10116.0,Intermediate,,,13501,1088.0,CHEMBL628010,1,BAO_0000218,,,,N,,Urine,8133,Rattus norvegicus,50597,A,,1
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",10116.0,Intermediate,,,13502,1088.0,CHEMBL628011,1,BAO_0000218,,,,N,,Urine,8133,Rattus norvegicus,50597,A,,1
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 6.9 mg/kg, po",10116.0,Intermediate,,,13503,1088.0,CHEMBL628012,1,BAO_0000218,,,,N,,Urine,8133,Rattus norvegicus,50597,A,,1
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",10116.0,Intermediate,,,13504,1088.0,CHEMBL628013,1,BAO_0000218,,,,N,,Urine,8133,Rattus norvegicus,50597,A,,1
,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",10116.0,Intermediate,,,13505,1088.0,CHEMBL628014,1,BAO_0000218,,,,N,,Urine,8133,Rattus norvegicus,50597,A,,1
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.03 mg/kg, po",9615.0,Intermediate,,,13506,1088.0,CHEMBL628015,1,BAO_0000218,,,,N,,Urine,8133,Canis lupus familiaris,50588,A,,1
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",9615.0,Intermediate,,,13507,1088.0,CHEMBL628016,1,BAO_0000218,,,,N,,Urine,8133,Canis lupus familiaris,50588,A,,1
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.3 mg/kg, po",9615.0,Intermediate,,,13508,1088.0,CHEMBL874461,1,BAO_0000218,,,,N,,Urine,8133,Canis lupus familiaris,50588,A,,1
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",9615.0,Intermediate,,,13509,1088.0,CHEMBL628017,1,BAO_0000218,,,,N,,Urine,8133,Canis lupus familiaris,50588,A,,1
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 10.0mg/kg, po",9615.0,Intermediate,,,13510,1088.0,CHEMBL628018,1,BAO_0000218,,,,N,,Urine,8133,Canis lupus familiaris,50588,A,,1
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",9615.0,Intermediate,,,13511,1088.0,CHEMBL628019,1,BAO_0000218,,,,N,,Urine,8133,Canis lupus familiaris,50588,A,,1
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",9615.0,Intermediate,,,13512,1088.0,CHEMBL628020,1,BAO_0000218,,,,N,,Urine,8133,Canis lupus familiaris,50588,A,,1
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",9615.0,Intermediate,,,13513,1088.0,CHEMBL628021,1,BAO_0000218,,,,N,,Urine,8133,Canis lupus familiaris,50588,A,,1
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",9615.0,Intermediate,,,13514,1088.0,CHEMBL628022,1,BAO_0000218,,,,N,,Urine,8133,Canis lupus familiaris,50588,A,,1
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",9615.0,Intermediate,,,13515,1088.0,CHEMBL628023,1,BAO_0000218,,,,N,,Urine,8133,Canis lupus familiaris,50588,A,,1
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",314293.0,Autocuration,,,13516,1088.0,CHEMBL628024,1,BAO_0000218,,,,U,,Urine,8133,Simiiformes,22224,A,,0
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 10mg/kg, po",314293.0,Autocuration,,,13517,1088.0,CHEMBL628025,1,BAO_0000218,,,,U,,Urine,8133,Simiiformes,22224,A,,0
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",314293.0,Autocuration,,,13518,1088.0,CHEMBL628026,1,BAO_0000218,,,,U,,Urine,8133,Simiiformes,22224,A,,0
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",314293.0,Autocuration,,,13519,1088.0,CHEMBL628027,1,BAO_0000218,,,,U,,Urine,8133,Simiiformes,22224,A,,0
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",314293.0,Autocuration,,,13520,1088.0,CHEMBL628028,1,BAO_0000218,,,,U,,Urine,8133,Simiiformes,22224,A,,0
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",10116.0,Intermediate,,,13521,1088.0,CHEMBL628029,1,BAO_0000218,,,,N,,Urine,8133,Rattus norvegicus,50597,A,,1
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 0.3 mg/kg, po",10116.0,Intermediate,,,13522,1088.0,CHEMBL628030,1,BAO_0000218,,,,N,,Urine,8133,Rattus norvegicus,50597,A,,1
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",10116.0,Intermediate,,,13523,1088.0,CHEMBL628031,1,BAO_0000218,,,,N,,Urine,8133,Rattus norvegicus,50597,A,,1
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 10.0 mg/kg, po",10116.0,Intermediate,,,13524,1088.0,CHEMBL628032,1,BAO_0000218,,,,N,,Urine,8133,Rattus norvegicus,50597,A,,1
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",10116.0,Intermediate,,,13525,1088.0,CHEMBL628033,1,BAO_0000218,,,,N,,Urine,8133,Rattus norvegicus,50597,A,,1
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 2.08 mg/kg, po",10116.0,Intermediate,,,13526,1088.0,CHEMBL628034,1,BAO_0000218,,,,N,,Urine,8133,Rattus norvegicus,50597,A,,1
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",10116.0,Intermediate,,,13527,1088.0,CHEMBL628035,1,BAO_0000218,,,,N,,Urine,8133,Rattus norvegicus,50597,A,,1
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 3.0 mg/kg, po",10116.0,Intermediate,,,13528,1088.0,CHEMBL628036,1,BAO_0000218,,,,N,,Urine,8133,Rattus norvegicus,50597,A,,1
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",10116.0,Intermediate,,,13529,1088.0,CHEMBL874462,1,BAO_0000218,,,,N,,Urine,8133,Rattus norvegicus,50597,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -8/-38,9615.0,Intermediate,,,13530,,CHEMBL628037,1,BAO_0000218,,In vivo,,N,,,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 13/-25,9615.0,Intermediate,,,13531,,CHEMBL628123,1,BAO_0000218,,In vivo,,N,,,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 27/-15,9615.0,Intermediate,,,13532,,CHEMBL628124,1,BAO_0000218,,In vivo,,N,,,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -2/-19,9615.0,Intermediate,,,13533,,CHEMBL628125,1,BAO_0000218,,In vivo,,N,,,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/60 range (low/high); -3/-4,9615.0,Intermediate,,,13534,,CHEMBL628126,1,BAO_0000218,,In vivo,,N,,,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3 range (low/high),9615.0,Intermediate,,,13535,,CHEMBL628127,1,BAO_0000218,,In vivo,,N,,,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); -9/24,9615.0,Intermediate,,,13536,,CHEMBL628128,1,BAO_0000218,,In vivo,,N,,,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); 3/-1,9615.0,Intermediate,,,13537,,CHEMBL628129,1,BAO_0000218,,In vivo,,N,,,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/030 range (low/high); 12/23,9615.0,Intermediate,,,13538,,CHEMBL628130,1,BAO_0000218,,In vivo,,N,,,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 1/3,9615.0,Intermediate,,,13539,,CHEMBL628131,1,BAO_0000218,,In vivo,,N,,,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 6/16,9615.0,Intermediate,,,13540,,CHEMBL628132,1,BAO_0000218,,In vivo,,N,,,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 7/14,9615.0,Intermediate,,,13541,,CHEMBL628133,1,BAO_0000218,,In vivo,,N,,,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3/10 range (low/high); 4/4/23,9615.0,Intermediate,,,13542,,CHEMBL628134,1,BAO_0000218,,In vivo,,N,,,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 10/14,9615.0,Intermediate,,,13543,,CHEMBL628135,1,BAO_0000218,,In vivo,,N,,,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/15,9615.0,Intermediate,,,13544,,CHEMBL628136,1,BAO_0000218,,In vivo,,N,,,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/44,9615.0,Intermediate,,,13545,,CHEMBL628137,1,BAO_0000218,,In vivo,,N,,,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 14/28,9615.0,Intermediate,,,13546,,CHEMBL628138,1,BAO_0000218,,In vivo,,N,,,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 15-28,9615.0,Intermediate,,,13547,,CHEMBL628139,1,BAO_0000218,,In vivo,,N,,,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 2/3,9615.0,Intermediate,,,13548,,CHEMBL628140,1,BAO_0000218,,In vivo,,N,,,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 26/32,9615.0,Intermediate,,,13549,,CHEMBL628141,1,BAO_0000218,,In vivo,,N,,,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/1,9615.0,Intermediate,,,13550,,CHEMBL628142,1,BAO_0000218,,In vivo,,N,,,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/12,9615.0,Intermediate,,,13551,,CHEMBL628143,1,BAO_0000218,,In vivo,,N,,,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 6/7,9615.0,Intermediate,,,13552,,CHEMBL628144,1,BAO_0000218,,In vivo,,N,,,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 7/6,9615.0,Intermediate,,,13553,,CHEMBL628145,1,BAO_0000218,,In vivo,,N,,,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/12,9615.0,Intermediate,,,13554,,CHEMBL628146,1,BAO_0000218,,In vivo,,N,,,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/27,9615.0,Intermediate,,,13555,,CHEMBL625355,1,BAO_0000218,,In vivo,,N,,,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/14,9615.0,Intermediate,,,13556,,CHEMBL625356,1,BAO_0000218,,In vivo,,N,,,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/16,9615.0,Intermediate,,,13557,,CHEMBL625357,1,BAO_0000218,,In vivo,,N,,,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/60 range (low/high); 12/23,9615.0,Intermediate,,,13558,,CHEMBL625527,1,BAO_0000218,,In vivo,,N,,,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3 range (low/high),9615.0,Intermediate,,,13559,,CHEMBL875473,1,BAO_0000218,,In vivo,,N,,,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 10/22,9615.0,Intermediate,,,13560,,CHEMBL625528,1,BAO_0000218,,In vivo,,N,,,9025,Canis lupus familiaris,50588,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 4/12,10116.0,Intermediate,,,13561,,CHEMBL626304,1,BAO_0000218,,In vivo,,N,,,9025,Rattus norvegicus,50597,A,,1
,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a 10/30 dose range; 11/-11,9615.0,Intermediate,,,13562,1637.0,CHEMBL624138,1,BAO_0000218,,In vivo,,N,,Artery,9025,Canis lupus familiaris,50588,A,,1
,Calculated partition coefficient (clogP),,Autocuration,,,13563,,CHEMBL624139,1,BAO_0000100,,,,U,,,6448,,22229,P,,0
,Calculated partition coefficient (clogP),,Autocuration,,,13564,,CHEMBL624140,1,BAO_0000100,,,,U,,,17221,,22229,P,,0
,Calculated partition coefficient (clogP),,Autocuration,,,13565,,CHEMBL624141,1,BAO_0000100,,,,U,,,6545,,22229,P,,0
,Calculated partition coefficient (clogP),,Autocuration,,,13566,,CHEMBL624142,1,BAO_0000100,,,,U,,,577,,22229,P,,0
,Calculated partition coefficient (clogP),,Autocuration,,,13567,,CHEMBL624143,1,BAO_0000100,,,,U,,,6285,,22229,P,,0
,Calculated partition coefficient (clogP),,Autocuration,,,13568,,CHEMBL624144,1,BAO_0000100,,,,U,,,6500,,22229,P,,0
,Calculated partition coefficient (clogP),,Autocuration,,,13569,,CHEMBL624145,1,BAO_0000100,,,,U,,,6716,,22229,P,,0
,Calculated partition coefficient (clogP),,Autocuration,,,13570,,CHEMBL624146,1,BAO_0000100,,,,U,,,13658,,22229,P,,0
,Calculated partition coefficient (clogP),,Autocuration,,,13571,,CHEMBL624147,1,BAO_0000100,,,,U,,,6549,,22229,P,,0
,Calculated partition coefficient (clogP) (MacLogP),,Autocuration,,,13572,,CHEMBL883123,1,BAO_0000100,,,,U,,,14685,,22229,P,,0
,Partition coefficient (logP),,Autocuration,,,13573,,CHEMBL624148,1,BAO_0000019,,,,U,,,6893,,22224,A,,0
,Kinetic parameter was determined,,Autocuration,,,13574,,CHEMBL874416,1,BAO_0000019,,,,U,,,3687,,22224,A,,0
,Calculated partition coefficient (clogP),,Autocuration,,,13575,,CHEMBL624149,1,BAO_0000100,,,,U,,,4207,,22229,P,,0
,Calculated partition coefficient (clogP),,Autocuration,,,13576,,CHEMBL624150,1,BAO_0000100,,,,U,,,4626,,22229,P,,0
,Lipophilicity was determined,,Autocuration,,,13577,,CHEMBL624151,1,BAO_0000100,,,,U,,,1021,,22224,P,,0
,Lipophilicity was determined,,Autocuration,,,13578,,CHEMBL624152,1,BAO_0000100,,,,U,,,3777,,22224,P,,0
,Lipophilicity was determined,,Autocuration,,,13579,,CHEMBL622139,1,BAO_0000100,,,,U,,,17533,,22224,P,,0
,Calculated partition coefficient (clogP),,Autocuration,,,13580,,CHEMBL622140,1,BAO_0000100,,,,U,,,6524,,22229,P,,0
,Lipophilicity was determined,,Autocuration,,,13581,,CHEMBL622141,1,BAO_0000100,,,,U,,,17533,,22224,P,,0
,Lipophilicity in octanol-water,,Autocuration,,,13582,,CHEMBL622142,1,BAO_0000100,,,,U,,,6480,,22224,P,,0
,Calculated partition coefficient (clogP),,Autocuration,,,13583,,CHEMBL622143,1,BAO_0000100,,,,U,,,17606,,22229,P,,0
,Octanol-water partition coefficient was determined,,Autocuration,,,13584,,CHEMBL622144,1,BAO_0000100,,,,U,,,6863,,22229,P,,0
,Partition coefficient (logP),,Autocuration,,,13585,,CHEMBL877473,1,BAO_0000019,,,,U,,,1356,,22224,A,,0
,Calculated partition coefficient (clogP),,Autocuration,,,13586,,CHEMBL622145,1,BAO_0000100,,,,U,,,3326,,22229,P,,0
,Partition coefficient was determined; ND means not determined,,Autocuration,,,13587,,CHEMBL622146,1,BAO_0000019,,,,U,,,1356,,22224,A,,0
,Calculated partition coefficient (clogP),,Autocuration,,,13588,,CHEMBL622147,1,BAO_0000100,,,,U,,,12984,,22229,P,,0
,Partition coefficient of the compound,,Autocuration,,,13589,,CHEMBL622148,1,BAO_0000019,,,,U,,,17363,,22224,A,,0
,Permeability was determined,,Autocuration,,,13590,,CHEMBL883124,1,BAO_0000019,,,,U,,,6827,,22224,A,,0
,The compound was evaluated for the partition coefficient,,Autocuration,,,13591,,CHEMBL622149,1,BAO_0000100,,,,U,,,261,,22229,P,,0
,Partition coefficient (logP),,Autocuration,,,13592,,CHEMBL622150,1,BAO_0000019,,,,U,,,2685,,22224,A,,0
,The lipophilicity was reported,,Autocuration,,,13593,,CHEMBL622151,1,BAO_0000100,,,,U,,,414,,22224,P,,0
,logarithm of the octanol-water partition coefficient for the compound,,Autocuration,,,13594,,CHEMBL622152,1,BAO_0000100,,,,U,,,15769,,22229,P,,0
,Clogp value was determined,,Autocuration,,,13595,,CHEMBL622153,1,BAO_0000019,,,,U,,,17248,,22224,A,,0
,Clp at a dose of 1.5 mg/kg,,Autocuration,,,13596,,CHEMBL877474,1,BAO_0000218,,In vivo,,U,,,16935,,22224,A,,0
,Clp at a dose of 2.0 mg/kg,,Autocuration,,,13597,,CHEMBL622154,1,BAO_0000218,,In vivo,,U,,,16935,,22224,A,,0
,"Clp, plasma clearance at a dose of 10 mg/kg",,Autocuration,,,13598,1969.0,CHEMBL622155,1,BAO_0000218,,In vivo,,U,,Plasma,14832,,22224,A,,0
,"Clp, plasma clearance at a dose of 50 mg/kg",,Autocuration,,,13599,1969.0,CHEMBL622156,1,BAO_0000218,,In vivo,,U,,Plasma,14832,,22224,A,,0
,Compound was tested for plasma clearance in rat,10116.0,Intermediate,,,13600,1969.0,CHEMBL622157,1,BAO_0000218,,In vivo,,N,,Plasma,2399,Rattus norvegicus,50597,A,,1
,Compound was tested for plasma clearance in rat; Not determined,10116.0,Intermediate,,,13601,1969.0,CHEMBL622158,1,BAO_0000218,,In vivo,,N,,Plasma,2399,Rattus norvegicus,50597,A,,1
,Plasma clearance (pharmacokinetic parameter) in rat (in vivo) at a dose of 10 mg/kg,10116.0,Intermediate,,,13602,,CHEMBL622807,1,BAO_0000218,,In vivo,,N,,,6227,Rattus norvegicus,50597,A,,1
,Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg,9544.0,Intermediate,,,13603,,CHEMBL622808,1,BAO_0000218,,In vivo,,N,,,6227,Macaca mulatta,50797,A,,1
,Plasma clearance by iv administration at a dose 0.003 ug/mL,,Autocuration,,,13604,,CHEMBL622809,1,BAO_0000218,,In vivo,,U,,,5623,,22224,A,,0
,Plasma clearance determined,,Autocuration,,,13605,,CHEMBL622810,1,BAO_0000218,,In vivo,,U,,,4854,,22224,A,,0
,Plasma clearance after iv administration at 3 mg/kg in hamster,10026.0,Intermediate,,,13606,,CHEMBL876653,1,BAO_0000218,,In vivo,,N,,,4493,Cricetinae,100712,A,,1
,Plasma clearance after iv administration at 4 mg/kg in hamster,10026.0,Intermediate,,,13607,,CHEMBL622811,1,BAO_0000218,,In vivo,,N,,,4493,Cricetinae,100712,A,,1
,Rate of clearance in rat was determined,10116.0,Intermediate,,,13608,,CHEMBL622986,1,BAO_0000218,,In vivo,,N,,,14956,Rattus norvegicus,50597,A,,1
,Total plasma clearance Clp was determined for the compound after iv dose of 5.06 mg/kg in rats,10116.0,Intermediate,,,13609,1969.0,CHEMBL622987,1,BAO_0000218,,In vivo,,N,,Plasma,15372,Rattus norvegicus,50597,A,,1
,Total plasma clearance after iv dose of 5.10 mg/kg in rats,10116.0,Intermediate,,,13610,1969.0,CHEMBL622988,1,BAO_0000218,,In vivo,,N,,Plasma,15372,Rattus norvegicus,50597,A,,1
,Total plasma clearance was determined for the compound after iv dose of 4.74 mg/kg in rats,10116.0,Intermediate,,,13611,1969.0,CHEMBL622989,1,BAO_0000218,,In vivo,,N,,Plasma,15372,Rattus norvegicus,50597,A,,1
,Total plasma clearance was determined for the compound after iv dose of 4.97 mg/kg in rats,10116.0,Intermediate,,,13612,1969.0,CHEMBL622990,1,BAO_0000218,,In vivo,,N,,Plasma,15372,Rattus norvegicus,50597,A,,1
,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,314293.0,Autocuration,,,13613,1969.0,CHEMBL622991,1,BAO_0000218,,In vivo,,U,,Plasma,15604,Simiiformes,22224,A,,0
,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,10116.0,Intermediate,,,13614,1969.0,CHEMBL622227,1,BAO_0000218,,In vivo,,N,,Plasma,15604,Rattus norvegicus,50597,A,,1
,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,9615.0,Intermediate,,,13615,1969.0,CHEMBL622228,1,BAO_0000218,,In vivo,,N,,Plasma,15604,Canis lupus familiaris,50588,A,,1
,Clpl value in rat,10116.0,Intermediate,,,13616,,CHEMBL622229,1,BAO_0000218,,In vivo,,N,,,14964,Rattus norvegicus,50597,A,,1
,Cmax (ng /mL) value after oral administration of 10 mg/kg in guinea pig.,10141.0,Intermediate,,,13617,,CHEMBL622230,1,BAO_0000218,,In vivo,,N,,,15240,Cavia porcellus,50512,A,,1
,Cmax after an oral dose of 10 uM/Kg in male Sprague-Dawley rats,10116.0,Intermediate,,,13618,,CHEMBL622231,1,BAO_0000218,,In vivo,,N,,,16449,Rattus norvegicus,50597,A,,1
,Cmax after an oral dose of 10 uM/Kg in male cynomolgus monkeys,9541.0,Intermediate,,,13619,,CHEMBL622232,1,BAO_0000218,,In vivo,,N,,,16449,Macaca fascicularis,100710,A,,1
,Cmax in minutes at a iv dose of 1.0(pmol/g/h).,,Autocuration,,,13620,,CHEMBL622233,1,BAO_0000218,,In vivo,,U,,,12902,,22224,A,,0
,Cmax in minutes at a iv dose of 2.0(pmol/g/h).,,Autocuration,,,13621,,CHEMBL622234,1,BAO_0000218,,In vivo,,U,,,12902,,22224,A,,0
,Cmax in minutes at a iv dose of 4.0(pmol/g/h).,,Autocuration,,,13622,,CHEMBL622235,1,BAO_0000218,,In vivo,,U,,,12902,,22224,A,,0
,Cmax in minutes at a iv dose of 5.0(pmol/g/h).,,Autocuration,,,13623,,CHEMBL622236,1,BAO_0000218,,In vivo,,U,,,12902,,22224,A,,0
,Cmax in minutes at a iv dose of 54.0(pmol/g/h).,,Autocuration,,,13624,,CHEMBL622237,1,BAO_0000218,,In vivo,,U,,,12902,,22224,A,,0
,Cmax in minutes at a po dose of 10.0(pmol/g/h).,,Autocuration,,,13625,,CHEMBL877482,1,BAO_0000218,,In vivo,,U,,,12902,,22224,A,,0
,Cmax in minutes at a po dose of 20.0(pmol/g/h).,,Autocuration,,,13626,,CHEMBL622238,1,BAO_0000218,,In vivo,,U,,,12902,,22224,A,,0
,Cmax in minutes at a po dose of 40.0(pmol/g/h).,,Autocuration,,,13627,,CHEMBL622239,1,BAO_0000218,,In vivo,,U,,,12902,,22224,A,,0
,Cmax was calculated as maximum concentration reached in the blood,,Autocuration,,,13628,178.0,CHEMBL622240,1,BAO_0000218,,In vivo,,U,,Blood,11149,,22224,A,,0
,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate,,Autocuration,,,13629,178.0,CHEMBL622241,1,BAO_0000218,,In vivo,,U,,Blood,11149,,22224,A,,0
,Cmax was determine after peroral administration at 10 mpk in Rat,10116.0,Intermediate,,,13630,,CHEMBL631013,1,BAO_0000218,,In vivo,,N,,,5669,Rattus norvegicus,50597,A,,1
,Cmax was determine after peroral administration at 10 mpk in Rhesus,9544.0,Intermediate,,,13631,,CHEMBL631014,1,BAO_0000218,,In vivo,,N,,,5669,Macaca mulatta,50797,A,,1
,Cmax was determine after peroral administration at 10 mpk in dog,9615.0,Intermediate,,,13632,,CHEMBL631015,1,BAO_0000218,,In vivo,,N,,,5669,Canis lupus familiaris,50588,A,,1
,Cmax was determine after peroral administration at 160 mpk in Rat,10116.0,Intermediate,,,13633,,CHEMBL631016,1,BAO_0000218,,In vivo,,N,,,5669,Rattus norvegicus,50597,A,,1
,Cmax was determine after peroral administration at 20 mpk in Rat,10116.0,Intermediate,,,13634,,CHEMBL631017,1,BAO_0000218,,In vivo,,N,,,5669,Rattus norvegicus,50597,A,,1
,Cmax was determine after peroral administration at 50 mpk in Rat,10116.0,Intermediate,,,13635,,CHEMBL631018,1,BAO_0000218,,In vivo,,N,,,5669,Rattus norvegicus,50597,A,,1
,Cmax was determined,,Autocuration,,,13636,,CHEMBL631019,1,BAO_0000218,,In vivo,,U,,,4236,,22224,A,,0
,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hippocampus,10090.0,Intermediate,,,13637,955.0,CHEMBL875761,1,BAO_0000218,,,,N,,Brain,13792,Mus musculus,50594,A,,1
,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hypothalamus,10090.0,Intermediate,,,13638,955.0,CHEMBL631020,1,BAO_0000218,,,,N,,Brain,13792,Mus musculus,50594,A,,1
,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into pons and medulla,10090.0,Intermediate,,,13639,955.0,CHEMBL631669,1,BAO_0000218,,,,N,,Brain,13792,Mus musculus,50594,A,,1
,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into rest of the brain,10090.0,Intermediate,,,13640,955.0,CHEMBL631670,1,BAO_0000218,,,,N,,Brain,13792,Mus musculus,50594,A,,1
,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into striatum,10090.0,Intermediate,,,13641,2435.0,CHEMBL631671,1,BAO_0000218,,,,N,,Striatum,13792,Mus musculus,50594,A,,1
,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.31-0.4,10116.0,Intermediate,,,13642,178.0,CHEMBL631672,1,BAO_0000218,,,,N,,Blood,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.97-1.12,10116.0,Intermediate,,,13643,178.0,CHEMBL631673,1,BAO_0000218,,,,N,,Blood,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.35-0.37,10116.0,Intermediate,,,13644,178.0,CHEMBL631856,1,BAO_0000218,,,,N,,Blood,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.72-1.03,10116.0,Intermediate,,,13645,178.0,CHEMBL631857,1,BAO_0000218,,,,N,,Blood,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.95-1.06,10116.0,Intermediate,,,13646,178.0,CHEMBL631858,1,BAO_0000218,,,,N,,Blood,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.35-0.4,10116.0,Intermediate,,,13647,178.0,CHEMBL631859,1,BAO_0000218,,,,N,,Blood,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.73-0.85,10116.0,Intermediate,,,13648,178.0,CHEMBL631860,1,BAO_0000218,,,,N,,Blood,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.65-0.83,10116.0,Intermediate,,,13649,178.0,CHEMBL631861,1,BAO_0000218,,,,N,,Blood,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.69-0.84,10116.0,Intermediate,,,13650,178.0,CHEMBL631862,1,BAO_0000218,,,,N,,Blood,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.46,10116.0,Intermediate,,,13651,178.0,CHEMBL631863,1,BAO_0000218,,,,N,,Blood,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.38-1.5,10116.0,Intermediate,,,13652,178.0,CHEMBL631864,1,BAO_0000218,,,,N,,Blood,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.34-0.48,10116.0,Intermediate,,,13653,178.0,CHEMBL631865,1,BAO_0000218,,,,N,,Blood,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.58-1.17,10116.0,Intermediate,,,13654,178.0,CHEMBL631866,1,BAO_0000218,,,,N,,Blood,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.0-1.24,10116.0,Intermediate,,,13655,178.0,CHEMBL629360,1,BAO_0000218,,,,N,,Blood,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.28-0.37,10116.0,Intermediate,,,13656,178.0,CHEMBL629361,1,BAO_0000218,,,,N,,Blood,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.54-0.63,10116.0,Intermediate,,,13657,178.0,CHEMBL629362,1,BAO_0000218,,,,N,,Blood,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.25-0.32,10116.0,Intermediate,,,13658,178.0,CHEMBL630740,1,BAO_0000218,,,,N,,Blood,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.58,10116.0,Intermediate,,,13659,178.0,CHEMBL630741,1,BAO_0000218,,,,N,,Blood,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.77,10116.0,Intermediate,,,13660,178.0,CHEMBL630742,1,BAO_0000218,,,,N,,Blood,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.20-0.25,10116.0,Intermediate,,,13661,,CHEMBL630743,1,BAO_0000218,,,,N,,,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.25,10116.0,Intermediate,,,13662,,CHEMBL630744,1,BAO_0000218,,,,N,,,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.03,10116.0,Intermediate,,,13663,,CHEMBL630745,1,BAO_0000218,,,,N,,,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.06,10116.0,Intermediate,,,13664,,CHEMBL630746,1,BAO_0000218,,,,N,,,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.34-0.5,10116.0,Intermediate,,,13665,,CHEMBL630747,1,BAO_0000218,,,,N,,,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.17-0.20,10116.0,Intermediate,,,13666,,CHEMBL630748,1,BAO_0000218,,,,N,,,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.81-1.26,10116.0,Intermediate,,,13667,,CHEMBL632056,1,BAO_0000218,,,,N,,,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.03-0.06,10116.0,Intermediate,,,13668,,CHEMBL632057,1,BAO_0000218,,,,N,,,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.18-0.36,10116.0,Intermediate,,,13669,,CHEMBL632058,1,BAO_0000218,,,,N,,,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.37,10116.0,Intermediate,,,13670,,CHEMBL632059,1,BAO_0000218,,,,N,,,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.97-2.17,10116.0,Intermediate,,,13671,,CHEMBL632060,1,BAO_0000218,,,,N,,,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.02-0.03,10116.0,Intermediate,,,13672,,CHEMBL632061,1,BAO_0000218,,,,N,,,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.05-0.07,10116.0,Intermediate,,,13673,,CHEMBL629207,1,BAO_0000218,,,,N,,,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.35-0.72,10116.0,Intermediate,,,13674,,CHEMBL629208,1,BAO_0000218,,,,N,,,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.15-0.19,10116.0,Intermediate,,,13675,,CHEMBL629209,1,BAO_0000218,,,,N,,,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.76-1.42,10116.0,Intermediate,,,13676,,CHEMBL629210,1,BAO_0000218,,,,N,,,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.02-0.03,10116.0,Intermediate,,,13677,,CHEMBL629211,1,BAO_0000218,,,,N,,,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.03-0.06,10116.0,Intermediate,,,13678,,CHEMBL629212,1,BAO_0000218,,,,N,,,8418,Rattus norvegicus,50597,A,,1
,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.05-0.06,10116.0,Intermediate,,,13679,,CHEMBL629213,1,BAO_0000218,,,,N,,,8418,Rattus norvegicus,50597,A,,1
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",10116.0,Intermediate,,,13680,1088.0,CHEMBL629214,1,BAO_0000218,,,,N,,Urine,8133,Rattus norvegicus,50597,A,,1
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 69.2 mg/kg, po",10116.0,Intermediate,,,13681,1088.0,CHEMBL629215,1,BAO_0000218,,,,N,,Urine,8133,Rattus norvegicus,50597,A,,1
,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 691.9 mg/kg, po",10116.0,Intermediate,,,13682,1088.0,CHEMBL635154,1,BAO_0000218,,,,N,,Urine,8133,Rattus norvegicus,50597,A,,1
,Oral diuretic activity measured by Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),10116.0,Intermediate,,,13683,,CHEMBL629216,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration,10116.0,Intermediate,,,13684,,CHEMBL629217,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),10116.0,Intermediate,,,13685,,CHEMBL629218,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration (0-5 hr),10116.0,Intermediate,,,13686,,CHEMBL629219,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),10116.0,Intermediate,,,13687,,CHEMBL629220,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),10116.0,Intermediate,,,13688,,CHEMBL629221,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),10116.0,Intermediate,,,13689,,CHEMBL631127,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration,10116.0,Intermediate,,,13690,,CHEMBL631128,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),10116.0,Intermediate,,,13691,,CHEMBL631129,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration (0-5 hr),10116.0,Intermediate,,,13692,,CHEMBL631130,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),10116.0,Intermediate,,,13693,,CHEMBL631131,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),10116.0,Intermediate,,,13694,,CHEMBL631132,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),10116.0,Intermediate,,,13695,,CHEMBL631133,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration,10116.0,Intermediate,,,13696,,CHEMBL631134,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),10116.0,Intermediate,,,13697,,CHEMBL875120,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration (0-5 hr),10116.0,Intermediate,,,13698,,CHEMBL631135,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),10116.0,Intermediate,,,13699,,CHEMBL631136,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),10116.0,Intermediate,,,13700,,CHEMBL631137,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),10116.0,Intermediate,,,13701,,CHEMBL631138,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration,10116.0,Intermediate,,,13702,,CHEMBL631139,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),10116.0,Intermediate,,,13703,,CHEMBL631140,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration (0-5 hr),10116.0,Intermediate,,,13704,,CHEMBL631141,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),10116.0,Intermediate,,,13705,,CHEMBL631142,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),10116.0,Intermediate,,,13706,,CHEMBL631143,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),10116.0,Intermediate,,,13707,,CHEMBL631144,1,BAO_0000218,,,,N,,,6996,Rattus norvegicus,50597,A,,1
,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.312 mg/kg after ip administration,9615.0,Intermediate,,,13708,,CHEMBL631145,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),9615.0,Intermediate,,,13709,,CHEMBL631146,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.625 mg/kg after ip administration,9615.0,Intermediate,,,13710,,CHEMBL631147,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),9615.0,Intermediate,,,13711,,CHEMBL631148,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),9615.0,Intermediate,,,13712,,CHEMBL631149,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration (0-6 hr),9615.0,Intermediate,,,13713,,CHEMBL631150,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),9615.0,Intermediate,,,13714,,CHEMBL631151,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),9615.0,Intermediate,,,13715,,CHEMBL631152,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),9615.0,Intermediate,,,13716,,CHEMBL631443,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration (0-6 hr),9615.0,Intermediate,,,13717,,CHEMBL631444,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),9615.0,Intermediate,,,13718,,CHEMBL631445,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),9615.0,Intermediate,,,13719,,CHEMBL631446,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg g after ip administration (0-6 hr),9615.0,Intermediate,,,13720,,CHEMBL631447,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),9615.0,Intermediate,,,13721,,CHEMBL631448,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration,9615.0,Intermediate,,,13722,,CHEMBL631449,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration (0-6 hr),9615.0,Intermediate,,,13723,,CHEMBL631450,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),9615.0,Intermediate,,,13724,,CHEMBL629724,1,BAO_0000218,,,,N,,,6996,Canis lupus familiaris,50588,A,,1
,"Biodistribution in mice skin, after 24 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",10090.0,Intermediate,,,13725,14.0,CHEMBL629725,1,BAO_0000218,,In vivo,,N,,Zone of skin,9716,Mus musculus,50594,A,,1
,"Biodistribution in mice skin, after 48 hr of intravenous administration of 1-2 ug ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",10090.0,Intermediate,,,13726,14.0,CHEMBL629726,1,BAO_0000218,,In vivo,,N,,Zone of skin,9716,Mus musculus,50594,A,,1
,"Biodistribution in mice spleen, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",10090.0,Intermediate,,,13727,2106.0,CHEMBL629727,1,BAO_0000218,,In vivo,,N,,Spleen,9716,Mus musculus,50594,A,,1
,"Biodistribution in mice spleen, after 1 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",10090.0,Intermediate,,,13728,2106.0,CHEMBL630404,1,BAO_0000218,,In vivo,,N,,Spleen,9716,Mus musculus,50594,A,,1
,"Biodistribution in mice spleen, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",10090.0,Intermediate,,,13729,2106.0,CHEMBL630405,1,BAO_0000218,,In vivo,,N,,Spleen,9716,Mus musculus,50594,A,,1
,"Biodistribution in mice spleen, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",10090.0,Intermediate,,,13730,2106.0,CHEMBL630406,1,BAO_0000218,,In vivo,,N,,Spleen,9716,Mus musculus,50594,A,,1
,"Biodistribution in mice stomach, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",10090.0,Intermediate,,,13731,945.0,CHEMBL630407,1,BAO_0000218,,In vivo,,N,,Stomach,9716,Mus musculus,50594,A,,1
,"Biodistribution in mice stomach, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",10090.0,Intermediate,,,13732,945.0,CHEMBL630573,1,BAO_0000218,,In vivo,,N,,Stomach,9716,Mus musculus,50594,A,,1
,"Biodistribution in mice stomach, after 24 hr of intravenous administration of 1-2 ug of ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",10090.0,Intermediate,,,13733,945.0,CHEMBL630574,1,BAO_0000218,,In vivo,,N,,Stomach,9716,Mus musculus,50594,A,,1
,"Biodistribution in mice stomach, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",10090.0,Intermediate,,,13734,945.0,CHEMBL630575,1,BAO_0000218,,In vivo,,N,,Stomach,9716,Mus musculus,50594,A,,1
,"Biodistribution in mice tail, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",10090.0,Intermediate,,,13735,,CHEMBL630576,1,BAO_0000218,,In vivo,,N,,,9716,Mus musculus,50594,A,,1
,"Biodistribution in mice tail, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",10090.0,Intermediate,,,13736,,CHEMBL630577,1,BAO_0000218,,In vivo,,N,,,9716,Mus musculus,50594,A,,1
,"Biodistribution in mice tail, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",10090.0,Intermediate,,,13737,,CHEMBL630578,1,BAO_0000218,,In vivo,,N,,,9716,Mus musculus,50594,A,,1
,"Biodistribution in mice tail, after 48 hr of intravenous administration of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",10090.0,Intermediate,,,13738,,CHEMBL630579,1,BAO_0000218,,In vivo,,N,,,9716,Mus musculus,50594,A,,1
,Percent of injected 238-Plutonium(IV) in mice kidney at 24 hr (orally administered),10090.0,Intermediate,,,13739,2113.0,CHEMBL630580,1,BAO_0000218,,,,N,,Kidney,12192,Mus musculus,50594,A,,1
,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 h,10090.0,Intermediate,,,13740,2113.0,CHEMBL630581,1,BAO_0000218,,,,N,,Kidney,12192,Mus musculus,50594,A,,1
,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 hr (orally administered),10090.0,Intermediate,,,13741,2113.0,CHEMBL630582,1,BAO_0000218,,,,N,,Kidney,12192,Mus musculus,50594,A,,1
,Percent of injected 238-Plutonium(IV) in mice liver at 24 h,10090.0,Intermediate,,,13742,,CHEMBL630583,1,BAO_0000218,,,,N,,,12192,Mus musculus,50594,A,,1
,Percent of injected 238-Plutonium(IV) in mice liver at 24 hr (orally administered),10090.0,Intermediate,,,13743,,CHEMBL630584,1,BAO_0000218,,,,N,,,12192,Mus musculus,50594,A,,1
,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 h,10090.0,Intermediate,,,13744,,CHEMBL630585,1,BAO_0000218,,,,N,,,12192,Mus musculus,50594,A,,1
,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 hr (orally administered),10090.0,Intermediate,,,13745,,CHEMBL630586,1,BAO_0000218,,,,N,,,12192,Mus musculus,50594,A,,1
,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 h,10090.0,Intermediate,,,13746,,CHEMBL630587,1,BAO_0000218,,,,N,,,12192,Mus musculus,50594,A,,1
,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 hr (orally administered),10090.0,Intermediate,,,13747,,CHEMBL630588,1,BAO_0000218,,,,N,,,12192,Mus musculus,50594,A,,1
,Percent of injected 238-Plutonium(IV) in mice whole body at 24 h,10090.0,Intermediate,,,13748,,CHEMBL630589,1,BAO_0000218,,,,N,,,12192,Mus musculus,50594,A,,1
,Percent of injected 238-Plutonium(IV) in mice whole body at 24 hr (orally administered),10090.0,Intermediate,,,13749,,CHEMBL630590,1,BAO_0000218,,,,N,,,12192,Mus musculus,50594,A,,1
,Removal of 238-Plutonium(IV) in feces at 24 h,,Autocuration,,,13750,1988.0,CHEMBL630591,1,BAO_0000019,,,,U,,Feces,12192,,22224,A,,0
,Removal of 238-Plutonium(IV) in feces at 24 hr (orally administered),,Autocuration,,,13751,1988.0,CHEMBL630592,1,BAO_0000019,,,,U,,Feces,12192,,22224,A,,0
,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 h,,Autocuration,,,13752,,CHEMBL630593,1,BAO_0000019,,,,U,,,12192,,22224,A,,0
,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 hr (orally administered),,Autocuration,,,13753,,CHEMBL630594,1,BAO_0000019,,,,U,,,12192,,22224,A,,0
,Removal of 238-Plutonium(IV) in urine 0-4 h (orally administered),,Autocuration,,,13754,1088.0,CHEMBL630595,1,BAO_0000019,,,,U,,Urine,12192,,22224,A,,0
,Removal of 238-Plutonium(IV) in urine 4-24 hr (orally administered),,Autocuration,,,13755,1088.0,CHEMBL630596,1,BAO_0000019,,,,U,,Urine,12192,,22224,A,,0
,Removal of 238-Plutonium(IV) in urine after 0-24 h,,Autocuration,,,13756,1088.0,CHEMBL630597,1,BAO_0000019,,,,U,,Urine,12192,,22224,A,,0
,Removal of 238-Plutonium(IV) in urine after 0-24 hr (orally administered),,Autocuration,,,13757,1088.0,CHEMBL630598,1,BAO_0000019,,,,U,,Urine,12192,,22224,A,,0
,Removal of 238-Plutonium(IV) in urine after 0-4 h,,Autocuration,,,13758,1088.0,CHEMBL630599,1,BAO_0000019,,,,U,,Urine,12192,,22224,A,,0
,Removal of 238-Plutonium(IV) in urine after 0-4 hr (orally administered),,Autocuration,,,13759,1088.0,CHEMBL630600,1,BAO_0000019,,,,U,,Urine,12192,,22224,A,,0
,Removal of 238-Plutonium(IV) in urine after 4-24 h,,Autocuration,,,13760,1088.0,CHEMBL630601,1,BAO_0000019,,,,U,,Urine,12192,,22224,A,,0
,Removal of 238-Plutonium(IV) in urine after 4-24 hr (orally administered),,Autocuration,,,13761,1088.0,CHEMBL630602,1,BAO_0000019,,,,U,,Urine,12192,,22224,A,,0
,Removal of 238-Plutonium(IV) in urine at 0-4 hr (orally administered),,Autocuration,,,13762,1088.0,CHEMBL630603,1,BAO_0000019,,,,U,,Urine,12192,,22224,A,,0
,Removal of 238-Plutonium(IV) in urine at 4-24 hr (orally administered),,Autocuration,,,13763,1088.0,CHEMBL630604,1,BAO_0000019,,,,U,,Urine,12192,,22224,A,,0
,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,13764,178.0,CHEMBL624869,1,BAO_0000218,,In vivo,,N,,Blood,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,13765,178.0,CHEMBL624870,1,BAO_0000218,,In vivo,,N,,Blood,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),10116.0,Intermediate,,,13766,178.0,CHEMBL623189,1,BAO_0000218,,In vivo,,N,,Blood,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,13767,178.0,CHEMBL623190,1,BAO_0000218,,In vivo,,N,,Blood,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,13768,178.0,CHEMBL623191,1,BAO_0000218,,In vivo,,N,,Blood,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,13769,,CHEMBL623192,1,BAO_0000218,,In vivo,,N,,,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,13770,,CHEMBL623193,1,BAO_0000218,,In vivo,,N,,,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),10116.0,Intermediate,,,13771,,CHEMBL623194,1,BAO_0000218,,In vivo,,N,,,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,13772,,CHEMBL623195,1,BAO_0000218,,In vivo,,N,,,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,13773,,CHEMBL623196,1,BAO_0000218,,In vivo,,N,,,12017,Rattus norvegicus,50597,A,,1
,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 15 microCi of the drug and 15 micro g of estradiol,10116.0,Intermediate,,,13774,,CHEMBL623197,1,BAO_0000218,,,,N,,,11836,Rattus norvegicus,50597,A,,1
,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,10116.0,Intermediate,,,13775,,CHEMBL623198,1,BAO_0000218,,,,N,,,11836,Rattus norvegicus,50597,A,,1
,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,10116.0,Intermediate,,,13776,,CHEMBL623199,1,BAO_0000218,,,,N,,,11836,Rattus norvegicus,50597,A,,1
,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 100 microCi of drug in 10%ethanol saline,10116.0,Intermediate,,,13777,2385.0,CHEMBL623200,1,BAO_0000218,,,,N,,Muscle tissue,11836,Rattus norvegicus,50597,A,,1
,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 120 microCi of drug in 10%ethanol saline,10116.0,Intermediate,,,13778,2385.0,CHEMBL623201,1,BAO_0000218,,,,N,,Muscle tissue,11836,Rattus norvegicus,50597,A,,1
,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 15 microCi of drug in 10%ethanol saline,10116.0,Intermediate,,,13779,2385.0,CHEMBL623202,1,BAO_0000218,,,,N,,Muscle tissue,11836,Rattus norvegicus,50597,A,,1
,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 50 microCi of drug in 10%ethanol saline,10116.0,Intermediate,,,13780,2385.0,CHEMBL623203,1,BAO_0000218,,,,N,,Muscle tissue,11836,Rattus norvegicus,50597,A,,1
,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of drug in 10%ethanol saline,10116.0,Intermediate,,,13781,2385.0,CHEMBL623204,1,BAO_0000218,,,,N,,Muscle tissue,11836,Rattus norvegicus,50597,A,,1
,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of the drug and 15 ug of estradiol,10116.0,Intermediate,,,13782,2385.0,CHEMBL623205,1,BAO_0000218,,,,N,,Muscle tissue,11836,Rattus norvegicus,50597,A,,1
,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,10116.0,Intermediate,,,13783,2385.0,CHEMBL623206,1,BAO_0000218,,,,N,,Muscle tissue,11836,Rattus norvegicus,50597,A,,1
,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of the drug and 15 micro g of estradiol,10116.0,Intermediate,,,13784,2385.0,CHEMBL623207,1,BAO_0000218,,,,N,,Muscle tissue,11836,Rattus norvegicus,50597,A,,1
,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 15 microCi of the drug and 15 ug of estradiol,10116.0,Intermediate,,,13785,2385.0,CHEMBL623208,1,BAO_0000218,,,,N,,Muscle tissue,11836,Rattus norvegicus,50597,A,,1
,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,10116.0,Intermediate,,,13786,2385.0,CHEMBL623209,1,BAO_0000218,,,,N,,Muscle tissue,11836,Rattus norvegicus,50597,A,,1
,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,10116.0,Intermediate,,,13787,2385.0,CHEMBL623210,1,BAO_0000218,,,,N,,Muscle tissue,11836,Rattus norvegicus,50597,A,,1
,Tested in vivo for the biodistribution in rat fat at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,10116.0,Intermediate,,,13788,,CHEMBL623211,1,BAO_0000218,,,,N,,,11836,Rattus norvegicus,50597,A,,1
,Tested in vivo for the biodistribution in rat uterus at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,10116.0,Intermediate,,,13789,995.0,CHEMBL623212,1,BAO_0000218,,,,N,,Uterus,11836,Rattus norvegicus,50597,A,,1
,Tested in vitro for intrinsic activity relative to quinpirole,,Autocuration,,,13790,,CHEMBL623213,1,BAO_0000019,,,,U,,,12640,,22224,A,,0
,"Relative ion enhancement, determined in pulsed ultrafiltration",,Autocuration,,,13791,,CHEMBL623214,1,BAO_0000019,,,,U,,,14218,,22224,A,,0
,% ionization at the pH 7.4 at 37 degree Centigrade,,Autocuration,,,13792,,CHEMBL623215,1,BAO_0000019,,,,U,,,11296,,22224,A,,0
,Percentage ionization was measured,,Autocuration,,,13793,,CHEMBL623216,1,BAO_0000019,,,,U,,,10929,,22224,A,,0
,Association constant of binding of compound with calf thymus DNA was determined by using equilibrium dialysis.,9913.0,Intermediate,,,13794,,CHEMBL623217,1,BAO_0000218,,,,N,,,13841,Bos taurus,50591,A,,1
,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 Pseudo-first-order rate constant,,Autocuration,,,13795,,CHEMBL623218,1,BAO_0000019,,,,U,,,10431,,22224,A,,0
,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer Pseudo-first-order rate constant,,Autocuration,,,13796,,CHEMBL623913,1,BAO_0000019,,,,U,,,10431,,22224,A,,0
,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer pseudo-first-order rate constant 0.1 mM EDTA,,Autocuration,,,13797,,CHEMBL623914,1,BAO_0000019,,,,U,,,10431,,22224,A,,0
,Compound was evaluated for the partition coefficient in octanol/water,,Autocuration,,,13798,,CHEMBL623915,1,BAO_0000100,,,,U,,,8826,,22229,P,,0
,Compound was evaluated for the partition coefficient in octanol/water (1-octanol / 10 mM phosphate buffer at pH 7.4),,Autocuration,,,13799,,CHEMBL624080,1,BAO_0000100,,,,U,,,8826,,22229,P,,0
,Equilibrium constant measured by the pulse radiolysis at pH 7,,Autocuration,,,13800,,CHEMBL624081,1,BAO_0000019,,,,U,,,9884,,22224,A,,0
,In vitro hydrolytic rate constant determined in human blood,9606.0,Intermediate,,,13801,,CHEMBL624082,1,BAO_0000218,,,,N,,,9827,Homo sapiens,50587,A,,1
,In vitro oxidation of compound to its pyridinium salt (3) in presence of human plasma,9606.0,Intermediate,,,13802,,CHEMBL625054,1,BAO_0000218,,,,N,,,10009,Homo sapiens,50587,A,,1
,In vitro oxidation of compound to its pyridinium salt (3) in presence of hydrogen peroxide,,Autocuration,,,13803,,CHEMBL877485,1,BAO_0000019,,,,U,,,10009,,22224,A,,0
,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse brain homogenate,10090.0,Intermediate,,,13804,,CHEMBL625055,1,BAO_0000218,,,,N,,,10009,Mus musculus,50594,A,,1
,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse liver homogenate,10090.0,Intermediate,,,13805,,CHEMBL625056,1,BAO_0000218,,,,N,,,10009,Mus musculus,50594,A,,1
,In vitro oxidation of compound in presence of human plasma,9606.0,Intermediate,,,13806,,CHEMBL625057,1,BAO_0000218,,,,N,,,10009,Homo sapiens,50587,A,,1
,In vitro oxidation of compound in presence of hydrogen peroxide,,Autocuration,,,13807,,CHEMBL625058,1,BAO_0000019,,,,U,,,10009,,22224,A,,0
,In vitro oxidation of compound in presence of mouse brain homogenate,10090.0,Intermediate,,,13808,,CHEMBL625059,1,BAO_0000218,,,,N,,,10009,Mus musculus,50594,A,,1
,In vitro oxidation of compound in presence of mouse liver homogenate,10090.0,Intermediate,,,13809,,CHEMBL629536,1,BAO_0000218,,,,N,,,10009,Mus musculus,50594,A,,1
,Mean potassium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,10116.0,Intermediate,,,13810,,CHEMBL629537,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,10116.0,Intermediate,,,13811,,CHEMBL629538,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,10116.0,Intermediate,,,13812,,CHEMBL629539,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,10116.0,Intermediate,,,13813,,CHEMBL874445,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,10116.0,Intermediate,,,13814,,CHEMBL629540,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,10116.0,Intermediate,,,13815,,CHEMBL629541,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,10116.0,Intermediate,,,13816,,CHEMBL629542,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,10116.0,Intermediate,,,13817,,CHEMBL630243,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,10116.0,Intermediate,,,13818,,CHEMBL630244,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,10116.0,Intermediate,,,13819,,CHEMBL630245,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,10116.0,Intermediate,,,13820,,CHEMBL630246,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,10116.0,Intermediate,,,13821,,CHEMBL630247,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,10116.0,Intermediate,,,13822,,CHEMBL630248,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Biodistribution in rat blood at 240 minutes after dose administration.,10116.0,Intermediate,,,13823,178.0,CHEMBL630249,1,BAO_0000218,,In vivo,,N,,Blood,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat blood at 30 minutes after dose administration.,10116.0,Intermediate,,,13824,178.0,CHEMBL630250,1,BAO_0000218,,In vivo,,N,,Blood,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat blood at 360 minutes after dose administration.,10116.0,Intermediate,,,13825,178.0,CHEMBL630251,1,BAO_0000218,,In vivo,,N,,Blood,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat blood at 3 hr after dose administration.,10116.0,Intermediate,,,13826,178.0,CHEMBL630252,1,BAO_0000218,,In vivo,,N,,Blood,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat blood at 60 minutes after dose administration.,10116.0,Intermediate,,,13827,178.0,CHEMBL630408,1,BAO_0000218,,In vivo,,N,,Blood,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat cerebellum at 120 minutes after dose administration.,10116.0,Intermediate,,,13828,2037.0,CHEMBL630409,1,BAO_0000218,,In vivo,,N,,Cerebellum,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat cerebellum at 1440 minutes after dose administration.,10116.0,Intermediate,,,13829,2037.0,CHEMBL874446,1,BAO_0000218,,In vivo,,N,,Cerebellum,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat cerebellum at 15 minutes after dose administration.,10116.0,Intermediate,,,13830,2037.0,CHEMBL630410,1,BAO_0000218,,In vivo,,N,,Cerebellum,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat cerebellum at 240 minutes after dose administration.,10116.0,Intermediate,,,13831,2037.0,CHEMBL630411,1,BAO_0000218,,In vivo,,N,,Cerebellum,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat cerebellum at 30 minutes after dose administration.,10116.0,Intermediate,,,13832,2037.0,CHEMBL630412,1,BAO_0000218,,In vivo,,N,,Cerebellum,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat cerebellum at 360 minutes after dose administration.,10116.0,Intermediate,,,13833,2037.0,CHEMBL630413,1,BAO_0000218,,In vivo,,N,,Cerebellum,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat cerebellum at 3 hr after dose administration.,10116.0,Intermediate,,,13834,2037.0,CHEMBL630414,1,BAO_0000218,,In vivo,,N,,Cerebellum,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat cerebellum at 60 minutes after dose administration.,10116.0,Intermediate,,,13835,2037.0,CHEMBL630415,1,BAO_0000218,,In vivo,,N,,Cerebellum,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat cortex at 120 minutes after dose administration.,10116.0,Intermediate,,,13836,,CHEMBL630416,1,BAO_0000218,,In vivo,,N,,,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat cortex at 1440 minutes after dose administration.,10116.0,Intermediate,,,13837,,CHEMBL630417,1,BAO_0000218,,In vivo,,N,,,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat cortex at 15 minutes after dose administration.,10116.0,Intermediate,,,13838,,CHEMBL630418,1,BAO_0000218,,In vivo,,N,,,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat cortex at 240 minutes after dose administration.,10116.0,Intermediate,,,13839,,CHEMBL630419,1,BAO_0000218,,In vivo,,N,,,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat cortex at 30 minutes after dose administration.,10116.0,Intermediate,,,13840,,CHEMBL630420,1,BAO_0000218,,In vivo,,N,,,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat cortex at 360 minutes after dose administration.,10116.0,Intermediate,,,13841,,CHEMBL630421,1,BAO_0000218,,In vivo,,N,,,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat cortex at 3 hr after dose administration.,10116.0,Intermediate,,,13842,,CHEMBL630422,1,BAO_0000218,,In vivo,,N,,,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat cortex at 60 minutes after dose administration.,10116.0,Intermediate,,,13843,,CHEMBL630423,1,BAO_0000218,,In vivo,,N,,,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat heart at 120 minutes after dose administration.,10116.0,Intermediate,,,13844,948.0,CHEMBL630424,1,BAO_0000218,,In vivo,,N,,Heart,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat heart at 15 minutes after dose administration.,10116.0,Intermediate,,,13845,948.0,CHEMBL630425,1,BAO_0000218,,In vivo,,N,,Heart,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat heart at 240 minutes after dose administration.,10116.0,Intermediate,,,13846,948.0,CHEMBL629462,1,BAO_0000218,,In vivo,,N,,Heart,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat heart at 30 minutes after dose administration.,10116.0,Intermediate,,,13847,948.0,CHEMBL630426,1,BAO_0000218,,In vivo,,N,,Heart,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat heart at 360 minutes after dose administration.,10116.0,Intermediate,,,13848,948.0,CHEMBL630427,1,BAO_0000218,,In vivo,,N,,Heart,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat heart at 3 hr after dose administration.,10116.0,Intermediate,,,13849,948.0,CHEMBL625877,1,BAO_0000218,,In vivo,,N,,Heart,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat heart at 60 minutes after dose administration.,10116.0,Intermediate,,,13850,948.0,CHEMBL625878,1,BAO_0000218,,In vivo,,N,,Heart,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat hippocampus at 1440 minutes after dose administration.,10116.0,Intermediate,,,13851,10000000.0,CHEMBL625879,1,BAO_0000218,,In vivo,,N,,Hippocampus,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat hippocampus at 240 minutes after dose administration.,10116.0,Intermediate,,,13852,10000000.0,CHEMBL625880,1,BAO_0000218,,In vivo,,N,,Hippocampus,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat hippocampus at 30 minutes after dose administration.,10116.0,Intermediate,,,13853,10000000.0,CHEMBL625881,1,BAO_0000218,,In vivo,,N,,Hippocampus,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat hippocampus at 360 minutes after dose administration.,10116.0,Intermediate,,,13854,10000000.0,CHEMBL625882,1,BAO_0000218,,In vivo,,N,,Hippocampus,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat hippocampus at 15 minutes after dose administration.,10116.0,Intermediate,,,13855,10000000.0,CHEMBL625883,1,BAO_0000218,,In vivo,,N,,Hippocampus,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat kidney at 120 minutes after dose administration.,10116.0,Intermediate,,,13856,2113.0,CHEMBL625884,1,BAO_0000218,,In vivo,,N,,Kidney,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat kidney at 1440 minutes after dose administration.,10116.0,Intermediate,,,13857,2113.0,CHEMBL625885,1,BAO_0000218,,In vivo,,N,,Kidney,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat kidney at 15 minutes after dose administration.,10116.0,Intermediate,,,13858,2113.0,CHEMBL628649,1,BAO_0000218,,In vivo,,N,,Kidney,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat kidney at 240 minutes after dose administration.,10116.0,Intermediate,,,13859,2113.0,CHEMBL628650,1,BAO_0000218,,In vivo,,N,,Kidney,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat kidney at 30 minutes after dose administration.,10116.0,Intermediate,,,13860,2113.0,CHEMBL628651,1,BAO_0000218,,In vivo,,N,,Kidney,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat kidney at 360 minutes after dose administration.,10116.0,Intermediate,,,13861,2113.0,CHEMBL628652,1,BAO_0000218,,In vivo,,N,,Kidney,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat kidney at 60 minutes after dose administration.,10116.0,Intermediate,,,13862,2113.0,CHEMBL628653,1,BAO_0000218,,In vivo,,N,,Kidney,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat liver at 120 minutes after dose administration.,10116.0,Intermediate,,,13863,2107.0,CHEMBL628654,1,BAO_0000218,,In vivo,,N,,Liver,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat liver at 1440 minutes after dose administration.,10116.0,Intermediate,,,13864,2107.0,CHEMBL628655,1,BAO_0000218,,In vivo,,N,,Liver,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat liver at 15 minutes after dose administration.,10116.0,Intermediate,,,13865,2107.0,CHEMBL625238,1,BAO_0000218,,In vivo,,N,,Liver,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat liver at 240 minutes after dose administration.,10116.0,Intermediate,,,13866,2107.0,CHEMBL625239,1,BAO_0000218,,In vivo,,N,,Liver,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat liver at 30 minutes after dose administration.,10116.0,Intermediate,,,13867,2107.0,CHEMBL625240,1,BAO_0000218,,In vivo,,N,,Liver,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat liver at 360 minutes after dose administration.,10116.0,Intermediate,,,13868,2107.0,CHEMBL625241,1,BAO_0000218,,In vivo,,N,,Liver,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat liver at 60 minutes after dose administration.,10116.0,Intermediate,,,13869,2107.0,CHEMBL625242,1,BAO_0000218,,In vivo,,N,,Liver,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat lung at 120 minutes after dose administration.,10116.0,Intermediate,,,13870,2048.0,CHEMBL874587,1,BAO_0000218,,In vivo,,N,,Lung,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat lung at 1440 minutes after dose administration.,10116.0,Intermediate,,,13871,2048.0,CHEMBL625405,1,BAO_0000218,,In vivo,,N,,Lung,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat lung at 15 minutes after dose administration.,10116.0,Intermediate,,,13872,2048.0,CHEMBL625406,1,BAO_0000218,,In vivo,,N,,Lung,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat lung at 240 minutes after dose administration.,10116.0,Intermediate,,,13873,2048.0,CHEMBL625407,1,BAO_0000218,,In vivo,,N,,Lung,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat lung at 30 minutes after dose administration.,10116.0,Intermediate,,,13874,2048.0,CHEMBL625408,1,BAO_0000218,,In vivo,,N,,Lung,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat lung at 360 minutes after dose administration.,10116.0,Intermediate,,,13875,2048.0,CHEMBL625409,1,BAO_0000218,,In vivo,,N,,Lung,13100,Rattus norvegicus,50597,A,,1
,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer,10116.0,Intermediate,,,13876,1515.0,CHEMBL625410,1,BAO_0000218,,,,N,,Thoracic aorta,12361,Rattus norvegicus,50597,A,,1
,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine,10116.0,Intermediate,,,13877,1515.0,CHEMBL625411,1,BAO_0000218,,,,N,,Thoracic aorta,12361,Rattus norvegicus,50597,A,,1
,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil,10116.0,Intermediate,,,13878,1515.0,CHEMBL625412,1,BAO_0000218,,,,N,,Thoracic aorta,12361,Rattus norvegicus,50597,A,,1
,Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR,10116.0,Intermediate,,,13879,1515.0,CHEMBL625413,1,BAO_0000218,,,,N,,Thoracic aorta,12361,Rattus norvegicus,50597,A,,1
,Percent of maximal contractile response to compound in rat thoracic aorta strips v,10116.0,Intermediate,,,13880,1515.0,CHEMBL625414,1,BAO_0000218,,,,N,,Thoracic aorta,12361,Rattus norvegicus,50597,A,,1
,Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips,10116.0,Intermediate,,,13881,1515.0,CHEMBL625415,1,BAO_0000218,,,,N,,Thoracic aorta,12361,Rattus norvegicus,50597,A,,1
,Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips,10116.0,Intermediate,,,13882,1515.0,CHEMBL625416,1,BAO_0000218,,,,N,,Thoracic aorta,12361,Rattus norvegicus,50597,A,,1
,% of the total radioactive dose of compound present in the 0-24 hour urine after a single 5 mg/kg dose administered intravenously in rats,10116.0,Intermediate,,,13883,1088.0,CHEMBL625417,1,BAO_0000218,,,,N,,Urine,12712,Rattus norvegicus,50597,A,,1
,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through feces,10116.0,Intermediate,,,13884,1988.0,CHEMBL625418,1,BAO_0000218,,,,N,,Feces,7415,Rattus norvegicus,50597,A,,1
,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through urine,10116.0,Intermediate,,,13885,1088.0,CHEMBL625419,1,BAO_0000218,,,,N,,Urine,7415,Rattus norvegicus,50597,A,,1
,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 1 mg/kg,10116.0,Intermediate,,,13886,,CHEMBL625420,1,BAO_0000218,,,,N,,,7415,Rattus norvegicus,50597,A,,1
,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 10 mg/kg,10116.0,Intermediate,,,13887,,CHEMBL626996,1,BAO_0000218,,,,N,,,7415,Rattus norvegicus,50597,A,,1
,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through feces",10116.0,Intermediate,,,13888,1988.0,CHEMBL626997,1,BAO_0000218,,,,N,,Feces,7415,Rattus norvegicus,50597,A,,1
,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through urine",10116.0,Intermediate,,,13889,1088.0,CHEMBL626998,1,BAO_0000218,,,,N,,Urine,7415,Rattus norvegicus,50597,A,,1
,"Compound was evaluated for the in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour biliary excretion",10116.0,Intermediate,,,13890,,CHEMBL626999,1,BAO_0000218,,,,N,,,7415,Rattus norvegicus,50597,A,,1
,faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h,10090.0,Intermediate,,,13891,,CHEMBL627000,1,BAO_0000218,,,,N,,,8050,Mus musculus,50594,A,,1
,fecal levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-30h,10090.0,Intermediate,,,13892,,CHEMBL627001,1,BAO_0000218,,,,N,,,8050,Mus musculus,50594,A,,1
,fecal levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-30h,10090.0,Intermediate,,,13893,,CHEMBL627002,1,BAO_0000218,,,,N,,,8050,Mus musculus,50594,A,,1
,fecal levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-30h,10090.0,Intermediate,,,13894,,CHEMBL627003,1,BAO_0000218,,,,N,,,8050,Mus musculus,50594,A,,1
,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-24 hr,10090.0,Intermediate,,,13895,1088.0,CHEMBL627004,1,BAO_0000218,,,,N,,Urine,8050,Mus musculus,50594,A,,1
,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-6 hr,10090.0,Intermediate,,,13896,1088.0,CHEMBL627005,1,BAO_0000218,,,,N,,Urine,8050,Mus musculus,50594,A,,1
,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 24-30 hr,10090.0,Intermediate,,,13897,1088.0,CHEMBL874594,1,BAO_0000218,,,,N,,Urine,8050,Mus musculus,50594,A,,1
,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-24 hr,10090.0,Intermediate,,,13898,1088.0,CHEMBL627006,1,BAO_0000218,,,,N,,Urine,8050,Mus musculus,50594,A,,1
,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-6 hr,10090.0,Intermediate,,,13899,1088.0,CHEMBL627007,1,BAO_0000218,,,,N,,Urine,8050,Mus musculus,50594,A,,1
,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 24-30 hr,10090.0,Intermediate,,,13900,1088.0,CHEMBL627884,1,BAO_0000218,,,,N,,Urine,8050,Mus musculus,50594,A,,1
,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-24 hr,10090.0,Intermediate,,,13901,1088.0,CHEMBL627885,1,BAO_0000218,,,,N,,Urine,8050,Mus musculus,50594,A,,1
,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-6 hr,10090.0,Intermediate,,,13902,1088.0,CHEMBL627886,1,BAO_0000218,,,,N,,Urine,8050,Mus musculus,50594,A,,1
,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 24-30 hr,10090.0,Intermediate,,,13903,1088.0,CHEMBL627887,1,BAO_0000218,,,,N,,Urine,8050,Mus musculus,50594,A,,1
,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr,10090.0,Intermediate,,,13904,1088.0,CHEMBL627888,1,BAO_0000218,,,,N,,Urine,8050,Mus musculus,50594,A,,1
,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr,10090.0,Intermediate,,,13905,1088.0,CHEMBL628057,1,BAO_0000218,,,,N,,Urine,8050,Mus musculus,50594,A,,1
,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr,10090.0,Intermediate,,,13906,1088.0,CHEMBL627405,1,BAO_0000218,,,,N,,Urine,8050,Mus musculus,50594,A,,1
,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,9615.0,Intermediate,,,13907,1088.0,CHEMBL627406,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,9615.0,Intermediate,,,13908,1088.0,CHEMBL627407,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,9615.0,Intermediate,,,13909,1088.0,CHEMBL627408,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,9615.0,Intermediate,,,13910,1088.0,CHEMBL627409,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,9615.0,Intermediate,,,13911,1088.0,CHEMBL875486,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,9615.0,Intermediate,,,13912,1088.0,CHEMBL627410,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,9615.0,Intermediate,,,13913,1088.0,CHEMBL627411,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,9615.0,Intermediate,,,13914,1088.0,CHEMBL627412,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,9615.0,Intermediate,,,13915,1088.0,CHEMBL627413,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,9615.0,Intermediate,,,13916,1088.0,CHEMBL627414,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 10.1 uM/Kg of drug,9615.0,Intermediate,,,13917,1088.0,CHEMBL627415,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 102 uM/Kg of drug,9615.0,Intermediate,,,13918,1088.0,CHEMBL627416,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.40 uM/Kg of drug,9615.0,Intermediate,,,13919,1088.0,CHEMBL627417,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.76 uM/Kg of drug,9615.0,Intermediate,,,13920,1088.0,CHEMBL627418,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 34.1 uM/Kg of drug,9615.0,Intermediate,,,13921,1088.0,CHEMBL627419,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 50.8 uM/Kg of drug,9615.0,Intermediate,,,13922,1088.0,CHEMBL627320,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 68.1 uM/Kg of drug,9615.0,Intermediate,,,13923,1088.0,CHEMBL627321,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,13924,2113.0,CHEMBL627322,1,BAO_0000218,,In vivo,,N,,Kidney,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,13925,2113.0,CHEMBL627323,1,BAO_0000218,,In vivo,,N,,Kidney,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),10116.0,Intermediate,,,13926,2113.0,CHEMBL627491,1,BAO_0000218,,In vivo,,N,,Kidney,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,13927,2113.0,CHEMBL627492,1,BAO_0000218,,In vivo,,N,,Kidney,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,13928,2113.0,CHEMBL627493,1,BAO_0000218,,In vivo,,N,,Kidney,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,13929,2107.0,CHEMBL627494,1,BAO_0000218,,In vivo,,N,,Liver,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,13930,2107.0,CHEMBL627495,1,BAO_0000218,,In vivo,,N,,Liver,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),10116.0,Intermediate,,,13931,2107.0,CHEMBL627496,1,BAO_0000218,,In vivo,,N,,Liver,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,13932,2107.0,CHEMBL627497,1,BAO_0000218,,In vivo,,N,,Liver,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,13933,2107.0,CHEMBL627498,1,BAO_0000218,,In vivo,,N,,Liver,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,13934,2048.0,CHEMBL627499,1,BAO_0000218,,In vivo,,N,,Lung,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,13935,2048.0,CHEMBL627500,1,BAO_0000218,,In vivo,,N,,Lung,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),10116.0,Intermediate,,,13936,2048.0,CHEMBL627501,1,BAO_0000218,,In vivo,,N,,Lung,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,13937,2048.0,CHEMBL625616,1,BAO_0000218,,In vivo,,N,,Lung,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,13938,2048.0,CHEMBL625617,1,BAO_0000218,,In vivo,,N,,Lung,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,13939,2385.0,CHEMBL625618,1,BAO_0000218,,In vivo,,N,,Muscle tissue,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,13940,2385.0,CHEMBL625619,1,BAO_0000218,,In vivo,,N,,Muscle tissue,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),10116.0,Intermediate,,,13941,2385.0,CHEMBL625620,1,BAO_0000218,,In vivo,,N,,Muscle tissue,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,13942,2385.0,CHEMBL625621,1,BAO_0000218,,In vivo,,N,,Muscle tissue,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,13943,2385.0,CHEMBL625622,1,BAO_0000218,,In vivo,,N,,Muscle tissue,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,13944,2106.0,CHEMBL625788,1,BAO_0000218,,In vivo,,N,,Spleen,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,13945,2106.0,CHEMBL625789,1,BAO_0000218,,In vivo,,N,,Spleen,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),10116.0,Intermediate,,,13946,2106.0,CHEMBL625790,1,BAO_0000218,,In vivo,,N,,Spleen,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,13947,2106.0,CHEMBL625791,1,BAO_0000218,,In vivo,,N,,Spleen,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,13948,2106.0,CHEMBL622334,1,BAO_0000218,,In vivo,,N,,Spleen,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,13949,2046.0,CHEMBL622335,1,BAO_0000218,,In vivo,,N,,Thyroid gland,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,13950,2046.0,CHEMBL622336,1,BAO_0000218,,In vivo,,N,,Thyroid gland,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),10116.0,Intermediate,,,13951,2046.0,CHEMBL622337,1,BAO_0000218,,In vivo,,N,,Thyroid gland,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in thyroid of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,13952,2046.0,CHEMBL622338,1,BAO_0000218,,In vivo,,N,,Thyroid gland,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in thyroid of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,13953,2046.0,CHEMBL622339,1,BAO_0000218,,In vivo,,N,,Thyroid gland,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in uterus / blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,13954,,CHEMBL624153,1,BAO_0000218,,In vivo,,N,,,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,13955,,CHEMBL628430,1,BAO_0000218,,In vivo,,N,,,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),10116.0,Intermediate,,,13956,,CHEMBL628431,1,BAO_0000218,,In vivo,,N,,,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in uterus / blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,13957,,CHEMBL628432,1,BAO_0000218,,In vivo,,N,,,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in uterus / blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,13958,,CHEMBL628433,1,BAO_0000218,,In vivo,,N,,,12017,Rattus norvegicus,50597,A,,1
,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",10116.0,Intermediate,,,13959,2106.0,CHEMBL628434,1,BAO_0000218,,In vivo,,N,,Spleen,12017,Rattus norvegicus,50597,A,,1
,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",10116.0,Intermediate,,,13960,2106.0,CHEMBL626789,1,BAO_0000218,,In vivo,,N,,Spleen,12017,Rattus norvegicus,50597,A,,1
,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)",10116.0,Intermediate,,,13961,2106.0,CHEMBL626790,1,BAO_0000218,,In vivo,,N,,Spleen,12017,Rattus norvegicus,50597,A,,1
,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",10116.0,Intermediate,,,13962,2106.0,CHEMBL626791,1,BAO_0000218,,In vivo,,N,,Spleen,12017,Rattus norvegicus,50597,A,,1
,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",10116.0,Intermediate,,,13963,2106.0,CHEMBL626792,1,BAO_0000218,,In vivo,,N,,Spleen,12017,Rattus norvegicus,50597,A,,1
,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",10116.0,Intermediate,,,13964,2106.0,CHEMBL626793,1,BAO_0000218,,In vivo,,N,,Spleen,12017,Rattus norvegicus,50597,A,,1
,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,10116.0,Intermediate,,,13965,,CHEMBL627436,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,10116.0,Intermediate,,,13966,,CHEMBL627437,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,10116.0,Intermediate,,,13967,,CHEMBL627438,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,10116.0,Intermediate,,,13968,,CHEMBL627439,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,10116.0,Intermediate,,,13969,,CHEMBL627440,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,10116.0,Intermediate,,,13970,,CHEMBL627602,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,10116.0,Intermediate,,,13971,,CHEMBL627603,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,10116.0,Intermediate,,,13972,,CHEMBL627604,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,10116.0,Intermediate,,,13973,,CHEMBL627605,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,10116.0,Intermediate,,,13974,,CHEMBL627606,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,10116.0,Intermediate,,,13975,,CHEMBL627607,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,10116.0,Intermediate,,,13976,,CHEMBL627608,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,10116.0,Intermediate,,,13977,,CHEMBL627609,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,10116.0,Intermediate,,,13978,,CHEMBL627610,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,10116.0,Intermediate,,,13979,,CHEMBL627611,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,10116.0,Intermediate,,,13980,,CHEMBL627612,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Octanol:water partition coefficient is evaluated,,Autocuration,,,13981,,CHEMBL627613,1,BAO_0000100,,,,U,,,8362,,22229,P,,0
,Partition coefficient in 1-octanol/water system,,Autocuration,,,13982,,CHEMBL627614,1,BAO_0000100,,,,U,,,8257,,22224,P,,0
,Partition coefficient in 1-octanol/water system measured using radio active compounds,,Autocuration,,,13983,,CHEMBL627615,1,BAO_0000100,,,,U,,,8257,,22224,P,,0
,Partition coefficient in octanol/water system was determined,,Autocuration,,,13984,,CHEMBL627616,1,BAO_0000100,,,,U,,,9468,,22224,P,,0
,Partition coefficient in octanol/water system was determined using [14C]-labeled compounds.,,Autocuration,,,13985,,CHEMBL627617,1,BAO_0000100,,,,U,,,9468,,22224,P,,0
,Pseudo-first-order rate constant at pH 10 and 35 degrees Centigrade,,Autocuration,,,13986,,CHEMBL627618,1,BAO_0000019,,,,U,,,10568,,22224,A,,0
,"Pseudo-first-order rate constant at pH 10, micro=0.5, 35 degrees Centigrade",,Autocuration,,,13987,,CHEMBL627619,1,BAO_0000019,,,,U,,,10568,,22224,A,,0
,Pseudo-first-order rate constant of the compound,,Autocuration,,,13988,,CHEMBL627620,1,BAO_0000019,,,,U,,,15359,,22224,A,,0
,Pseudo-first-order rate constant with 1-min time point,,Autocuration,,,13989,,CHEMBL627621,1,BAO_0000019,,,,U,,,15359,,22224,A,,0
,Pseudo-first-order rate constant without 1-min time point,,Autocuration,,,13990,,CHEMBL627622,1,BAO_0000019,,,,U,,,15359,,22224,A,,0
,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 0.5 mM EDTA,,Autocuration,,,13991,,CHEMBL627623,1,BAO_0000019,,,,U,,,10431,,22224,A,,0
,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 50 mM EDTA,,Autocuration,,,13992,,CHEMBL627624,1,BAO_0000019,,,,U,,,10431,,22224,A,,0
,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 70 mM EDTA,,Autocuration,,,13993,,CHEMBL627625,1,BAO_0000019,,,,U,,,10431,,22224,A,,0
,Rate constants determined using 31P NMR Kinetics experiments at 37 degrees Centigrade,,Autocuration,,,13994,,CHEMBL628523,1,BAO_0000019,,,,U,,,15704,,22224,A,,0
,The alkaline hydrolysis second order rate constant(K OH) of the compound,,Autocuration,,,13995,,CHEMBL628524,1,BAO_0000019,,,,U,,,15287,,22224,A,,0
,The efflux rate constant of the compound,,Autocuration,,,13996,,CHEMBL628525,1,BAO_0000019,,,,U,,,7516,,22224,A,,0
,The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,Autocuration,,,13997,,CHEMBL625732,1,BAO_0000019,,,,U,,,12973,,22224,A,,0
,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,Autocuration,,,13998,,CHEMBL625733,1,BAO_0000019,,,,U,,,12973,,22224,A,,0
,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,Autocuration,,,13999,,CHEMBL625734,1,BAO_0000019,,,,U,,,12973,,22224,F,,0
,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine; ND= not determined,,Autocuration,,,14000,,CHEMBL625913,1,BAO_0000019,,,,U,,,12973,,22224,A,,0
,Association constant was evaluated towards synthetic peptidoglycan analogue Ac2-Lys-D-Ala-D-Ala,,Autocuration,,,14001,,CHEMBL625914,1,BAO_0000019,,,,U,,,8696,,22224,A,,0
,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of electroneutral DMPC in PBSbuffer at pH 7.4 and 37 C,,Autocuration,,,14002,,CHEMBL625915,1,BAO_0000019,,,,U,,,15052,,22224,A,,0
,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of negatively charged DMPG in PBS buffer at pH 7.4 and 37 C,,Autocuration,,,14003,,CHEMBL625916,1,BAO_0000019,,,,U,,,15052,,22224,A,,0
,Evaluated for the mustard reactivity by determining rate constant for hydrolysis of mustard in aqueous acetone (K H),,Autocuration,,,14004,,CHEMBL625917,1,BAO_0000019,,,,U,,,10503,,22224,A,,0
,"Effective biomolecular rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,Autocuration,,,14005,,CHEMBL625918,1,BAO_0000019,,,,U,,,8354,,22224,A,,0
,"Effective biomolecular rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,Autocuration,,,14006,,CHEMBL625919,1,BAO_0000019,,,,U,,,8354,,22224,A,,0
,"Effective biomolecular rate constant at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,Autocuration,,,14007,,CHEMBL625920,1,BAO_0000019,,,,U,,,8354,,22224,A,,0
,"Effective biomolecular rate constant at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,Autocuration,,,14008,,CHEMBL874453,1,BAO_0000019,,,,U,,,8354,,22224,A,,0
,"Effective biomolecular rate constant in the conditions of 25degreeC,pH 7.6",,Autocuration,,,14009,,CHEMBL625921,1,BAO_0000019,,,,U,,,8354,,22224,A,,0
,Evaluated for the mustard reactivity by determining rate constant for alkylation of 4-(4-nitrobenzyl)pyridine using NBP alkylation assay,,Autocuration,,,14010,,CHEMBL625922,1,BAO_0000019,,,,U,,,10503,,22224,A,,0
,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,Autocuration,,,14011,,CHEMBL625923,1,BAO_0000019,,,,U,,,8354,,22224,A,,0
,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,Autocuration,,,14012,,CHEMBL625924,1,BAO_0000019,,,,U,,,8354,,22224,A,,0
,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,Autocuration,,,14013,,CHEMBL625925,1,BAO_0000019,,,,U,,,8354,,22224,A,,0
,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,Autocuration,,,14014,,CHEMBL625926,1,BAO_0000019,,,,U,,,8354,,22224,A,,0
,Biodistribution in rat lung at 60 minutes after dose administration.,10116.0,Intermediate,,,14015,2048.0,CHEMBL627704,1,BAO_0000218,,In vivo,,N,,Lung,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat pons/medulla at 120 minutes after dose administration.,10116.0,Intermediate,,,14016,,CHEMBL627705,1,BAO_0000218,,In vivo,,N,,,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat pons/medulla at 15 minutes after dose administration.,10116.0,Intermediate,,,14017,,CHEMBL627706,1,BAO_0000218,,In vivo,,N,,,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat pons/medulla at 240 minutes after dose administration.,10116.0,Intermediate,,,14018,,CHEMBL627707,1,BAO_0000218,,In vivo,,N,,,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat pons/medulla at 30 minutes after dose administration.,10116.0,Intermediate,,,14019,,CHEMBL627708,1,BAO_0000218,,In vivo,,N,,,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat pons/medulla at 360 minutes after dose administration.,10116.0,Intermediate,,,14020,,CHEMBL628361,1,BAO_0000218,,In vivo,,N,,,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat pons/medulla at 60 minutes after dose administration.,10116.0,Intermediate,,,14021,,CHEMBL628362,1,BAO_0000218,,In vivo,,N,,,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat striatum at 120 minutes after dose administration.,10116.0,Intermediate,,,14022,2435.0,CHEMBL628363,1,BAO_0000218,,In vivo,,N,,Striatum,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat striatum at 1440 minutes after dose administration.,10116.0,Intermediate,,,14023,2435.0,CHEMBL628364,1,BAO_0000218,,In vivo,,N,,Striatum,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat striatum at 15 minutes after dose administration.,10116.0,Intermediate,,,14024,2435.0,CHEMBL628365,1,BAO_0000218,,In vivo,,N,,Striatum,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat striatum at 240 minutes after dose administration.,10116.0,Intermediate,,,14025,2435.0,CHEMBL874454,1,BAO_0000218,,In vivo,,N,,Striatum,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat striatum at 30 minutes after dose administration.,10116.0,Intermediate,,,14026,2435.0,CHEMBL628531,1,BAO_0000218,,In vivo,,N,,Striatum,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat striatum at 360 minutes after dose administration.,10116.0,Intermediate,,,14027,2435.0,CHEMBL628532,1,BAO_0000218,,In vivo,,N,,Striatum,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat striatum at 3 hr after dose administration.,10116.0,Intermediate,,,14028,2435.0,CHEMBL628533,1,BAO_0000218,,In vivo,,N,,Striatum,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat striatum at 60 minutes after dose administration.,10116.0,Intermediate,,,14029,2435.0,CHEMBL628534,1,BAO_0000218,,In vivo,,N,,Striatum,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat thyroid at 120 minutes after dose administration.,10116.0,Intermediate,,,14030,2046.0,CHEMBL628535,1,BAO_0000218,,In vivo,,N,,Thyroid gland,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat thyroid at 1440 minutes after dose administration.,10116.0,Intermediate,,,14031,2046.0,CHEMBL628536,1,BAO_0000218,,In vivo,,N,,Thyroid gland,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat thyroid at 15 minutes after dose administration.,10116.0,Intermediate,,,14032,2046.0,CHEMBL628537,1,BAO_0000218,,In vivo,,N,,Thyroid gland,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat thyroid at 240 minutes after dose administration.,10116.0,Intermediate,,,14033,2046.0,CHEMBL628538,1,BAO_0000218,,In vivo,,N,,Thyroid gland,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat thyroid at 30 minutes after dose administration.,10116.0,Intermediate,,,14034,2046.0,CHEMBL628539,1,BAO_0000218,,In vivo,,N,,Thyroid gland,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat thyroid at 360 minutes after dose administration.,10116.0,Intermediate,,,14035,2046.0,CHEMBL630297,1,BAO_0000218,,In vivo,,N,,Thyroid gland,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rat thyroid at 60 minutes after dose administration.,10116.0,Intermediate,,,14036,2046.0,CHEMBL630298,1,BAO_0000218,,In vivo,,N,,Thyroid gland,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rest of brain of rat 120 minutes after dose administration.,10116.0,Intermediate,,,14037,955.0,CHEMBL630299,1,BAO_0000218,,In vivo,,N,,Brain,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rest of brain of rat at 1440 minutes after dose administration.,10116.0,Intermediate,,,14038,955.0,CHEMBL628094,1,BAO_0000218,,In vivo,,N,,Brain,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rest of brain of rat at 15 minutes after dose administration.,10116.0,Intermediate,,,14039,955.0,CHEMBL628095,1,BAO_0000218,,In vivo,,N,,Brain,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rest of brain of rat at 240 minutes after dose administration.,10116.0,Intermediate,,,14040,955.0,CHEMBL874648,1,BAO_0000218,,In vivo,,N,,Brain,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rest of brain of rat at 30 minutes after dose administration.,10116.0,Intermediate,,,14041,955.0,CHEMBL628096,1,BAO_0000218,,In vivo,,N,,Brain,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rest of brain of rat at 360 minutes after dose administration.,10116.0,Intermediate,,,14042,955.0,CHEMBL628097,1,BAO_0000218,,In vivo,,N,,Brain,13100,Rattus norvegicus,50597,A,,1
,Biodistribution in rest of brain of rat at 60 minutes after dose administration.,10116.0,Intermediate,,,14043,955.0,CHEMBL628098,1,BAO_0000218,,In vivo,,N,,Brain,13100,Rattus norvegicus,50597,A,,1
,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (10:1)",,Autocuration,,,14044,,CHEMBL628099,1,BAO_0000019,,,,U,,,13331,,22224,A,,0
,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,Autocuration,,,14045,,CHEMBL628100,1,BAO_0000019,,,,U,,,13331,,22224,A,,0
,Mean rate constant for the hydrolysis of compound in buffers at pH 7.4 at 37 degrees Centigrade in incubation mixture - d(A)-d(T) (10:!),,Autocuration,,,14046,,CHEMBL628101,1,BAO_0000019,,,,U,,,13331,,22224,A,,0
,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - 5'-GMP/5'-CMP (1:1)",,Autocuration,,,14047,,CHEMBL628102,1,BAO_0000019,,,,U,,,13331,,22224,A,,0
,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (1:1)",,Autocuration,,,14048,,CHEMBL628103,1,BAO_0000019,,,,U,,,13331,,22224,A,,0
,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,Autocuration,,,14049,,CHEMBL628104,1,BAO_0000019,,,,U,,,13331,,22224,A,,0
,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (1:1)",,Autocuration,,,14050,,CHEMBL628105,1,BAO_0000019,,,,U,,,13331,,22224,A,,0
,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(T) (10:1)",,Autocuration,,,14051,,CHEMBL628106,1,BAO_0000019,,,,U,,,13331,,22224,A,,0
,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,10116.0,Intermediate,,,14052,1088.0,CHEMBL628107,1,BAO_0000218,,,,N,,Urine,10086,Rattus norvegicus,50597,A,,1
,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,,Autocuration,,,14053,1088.0,CHEMBL628108,1,BAO_0000218,,,,U,,Urine,10086,,22224,F,,0
,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,10116.0,Intermediate,,,14054,1088.0,CHEMBL628109,1,BAO_0000218,,,,N,,Urine,10086,Rattus norvegicus,50597,A,,1
,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,,Autocuration,,,14055,1088.0,CHEMBL625299,1,BAO_0000218,,,,U,,Urine,10086,,22224,F,,0
,Mean urine volume excretion in conscious rats at a dose of 10 mg/kg given orally,10116.0,Intermediate,,,14056,1088.0,CHEMBL625300,1,BAO_0000218,,,,N,,Urine,10086,Rattus norvegicus,50597,A,,1
,Mean urine volume excretion in conscious rats at a dose of 100 mg/kg given orally,10116.0,Intermediate,,,14057,1088.0,CHEMBL625301,1,BAO_0000218,,,,N,,Urine,10086,Rattus norvegicus,50597,A,,1
,Mean urine volume excretion in conscious rats at a dose of 3.0 mg/kg given orally,10116.0,Intermediate,,,14058,1088.0,CHEMBL625302,1,BAO_0000218,,,,N,,Urine,10086,Rattus norvegicus,50597,A,,1
,Mean urine volume excretion in conscious rats at a dose of 30 mg/kg given orally,10116.0,Intermediate,,,14059,1088.0,CHEMBL874649,1,BAO_0000218,,,,N,,Urine,10086,Rattus norvegicus,50597,A,,1
,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes,10116.0,Intermediate,,,14060,,CHEMBL625303,1,BAO_0000218,,,,N,,,13248,Rattus norvegicus,50597,A,,1
,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes; NA= Not tested,10116.0,Intermediate,,,14061,,CHEMBL625463,1,BAO_0000218,,,,N,,,13248,Rattus norvegicus,50597,A,,1
,In vitro metabolism in human liver microsomes,9606.0,Intermediate,,,14062,2107.0,CHEMBL625464,1,BAO_0000218,,,,N,,Liver,14527,Homo sapiens,50587,A,,1
,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated.,9606.0,Intermediate,,,14063,,CHEMBL625465,1,BAO_0000218,,,,N,,,3008,Homo sapiens,50587,A,,1
,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.06 uM/Kg of drug,9615.0,Intermediate,,,14064,1088.0,CHEMBL625466,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.6 uM/Kg of drug,9615.0,Intermediate,,,14065,1088.0,CHEMBL625467,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,Total electrolytic excretion of chlorine in urine of rats after intravenous administration of 7.94 uM/Kg of drug,10116.0,Intermediate,,,14066,1088.0,CHEMBL625468,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 0 uM/Kg of drug,10116.0,Intermediate,,,14067,1088.0,CHEMBL625469,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.01 uM/Kg of drug,10116.0,Intermediate,,,14068,1088.0,CHEMBL625470,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.13 uM/Kg of drug,10116.0,Intermediate,,,14069,1088.0,CHEMBL632418,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 10.1 uM/Kg of drug,10116.0,Intermediate,,,14070,1088.0,CHEMBL627250,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 102 uM/Kg of drug,10116.0,Intermediate,,,14071,1088.0,CHEMBL627251,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 105 uM/Kg of drug,10116.0,Intermediate,,,14072,1088.0,CHEMBL627252,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 11.3 uM/Kg of drug,10116.0,Intermediate,,,14073,1088.0,CHEMBL627253,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 113 uM/Kg of drug,10116.0,Intermediate,,,14074,1088.0,CHEMBL627254,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 19.5 uM/Kg of drug,10116.0,Intermediate,,,14075,1088.0,CHEMBL875471,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 195 uM/Kg of drug,10116.0,Intermediate,,,14076,1088.0,CHEMBL627255,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 21.7 uM/Kg of drug,10116.0,Intermediate,,,14077,1088.0,CHEMBL627256,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 217 uM/Kg of drug,10116.0,Intermediate,,,14078,1088.0,CHEMBL627257,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 23.9 uM/Kg of drug,10116.0,Intermediate,,,14079,1088.0,CHEMBL627258,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 239 uM/Kg of drug,10116.0,Intermediate,,,14080,1088.0,CHEMBL627259,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 24.9 uM/Kg of drug,10116.0,Intermediate,,,14081,1088.0,CHEMBL627260,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 249 uM/Kg of drug,10116.0,Intermediate,,,14082,1088.0,CHEMBL623256,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 25.9 uM/Kg of drug,10116.0,Intermediate,,,14083,1088.0,CHEMBL874413,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 259 uM/Kg of drug,10116.0,Intermediate,,,14084,1088.0,CHEMBL623257,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 26.5 uM/Kg of drug,10116.0,Intermediate,,,14085,1088.0,CHEMBL623258,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 265 uM/Kg of drug,10116.0,Intermediate,,,14086,1088.0,CHEMBL623259,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27 uM/Kg of drug,10116.0,Intermediate,,,14087,1088.0,CHEMBL623260,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27.9 uM/Kg of drug,10116.0,Intermediate,,,14088,1088.0,CHEMBL623261,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 270 uM/Kg of drug,10116.0,Intermediate,,,14089,1088.0,CHEMBL623262,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 279 uM/Kg of drug,10116.0,Intermediate,,,14090,1088.0,CHEMBL623263,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.2 uM/Kg of drug,10116.0,Intermediate,,,14091,1088.0,CHEMBL623264,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.22 uM/Kg of drug,10116.0,Intermediate,,,14092,1088.0,CHEMBL623265,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.9 uM/Kg of drug,10116.0,Intermediate,,,14093,1088.0,CHEMBL623266,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 282 uM/Kg of drug,10116.0,Intermediate,,,14094,1088.0,CHEMBL623267,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 289 uM/Kg of drug,10116.0,Intermediate,,,14095,1088.0,CHEMBL623268,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.40 uM/Kg of drug,10116.0,Intermediate,,,14096,1088.0,CHEMBL623269,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.76 uM/Kg of drug,10116.0,Intermediate,,,14097,1088.0,CHEMBL623270,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 30.2 uM/Kg of drug,10116.0,Intermediate,,,14098,1088.0,CHEMBL623271,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 302 uM/Kg of drug,10116.0,Intermediate,,,14099,1088.0,CHEMBL623272,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 31.6 uM/Kg of drug,10116.0,Intermediate,,,14100,1088.0,CHEMBL623273,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 316 uM/Kg of drug,10116.0,Intermediate,,,14101,1088.0,CHEMBL623274,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 32.4 uM/Kg of drug,10116.0,Intermediate,,,14102,1088.0,CHEMBL874414,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 324 uM/Kg of drug,10116.0,Intermediate,,,14103,1088.0,CHEMBL623275,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.0 uM/Kg of drug,10116.0,Intermediate,,,14104,1088.0,CHEMBL629150,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.1 uM/Kg of drug,10116.0,Intermediate,,,14105,1088.0,CHEMBL623276,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.8 uM/Kg of drug,10116.0,Intermediate,,,14106,1088.0,CHEMBL623277,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 341 uM/Kg of drug,10116.0,Intermediate,,,14107,1088.0,CHEMBL623112,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 348 uM/Kg of drug,10116.0,Intermediate,,,14108,1088.0,CHEMBL623113,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 37.6 uM/Kg of drug,10116.0,Intermediate,,,14109,1088.0,CHEMBL623800,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 58.4 uM/Kg of drug,10116.0,Intermediate,,,14110,1088.0,CHEMBL623801,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",10116.0,Intermediate,,,14111,2106.0,CHEMBL623802,1,BAO_0000218,,In vivo,,N,,Spleen,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in uterus of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14112,995.0,CHEMBL623803,1,BAO_0000218,,In vivo,,N,,Uterus,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in uterus of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14113,995.0,CHEMBL623970,1,BAO_0000218,,In vivo,,N,,Uterus,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in uterus of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14114,995.0,CHEMBL623971,1,BAO_0000218,,In vivo,,N,,Uterus,12017,Rattus norvegicus,50597,A,,1
,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 10 min post injection (Average of three to five animals),10116.0,Intermediate,,,14115,178.0,CHEMBL623972,1,BAO_0000218,,In vivo,,N,,Blood,14045,Rattus norvegicus,50597,A,,1
,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 30 min post injection (Average of three to five animals),10116.0,Intermediate,,,14116,178.0,CHEMBL623973,1,BAO_0000218,,In vivo,,N,,Blood,14045,Rattus norvegicus,50597,A,,1
,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 5 min post injection (Average of three to five animals),10116.0,Intermediate,,,14117,178.0,CHEMBL623974,1,BAO_0000218,,In vivo,,N,,Blood,14045,Rattus norvegicus,50597,A,,1
,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 60 min post injection (Average of three to five animals),10116.0,Intermediate,,,14118,178.0,CHEMBL623975,1,BAO_0000218,,In vivo,,N,,Blood,14045,Rattus norvegicus,50597,A,,1
,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 10 min post injection (Average of three to five animals),10116.0,Intermediate,,,14119,955.0,CHEMBL623976,1,BAO_0000218,,In vivo,,N,,Brain,14045,Rattus norvegicus,50597,A,,1
,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 30 min post injection (Average of three to five animals),10116.0,Intermediate,,,14120,955.0,CHEMBL623977,1,BAO_0000218,,In vivo,,N,,Brain,14045,Rattus norvegicus,50597,A,,1
,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 5 min post injection (Average of three to five animals),10116.0,Intermediate,,,14121,955.0,CHEMBL623978,1,BAO_0000218,,In vivo,,N,,Brain,14045,Rattus norvegicus,50597,A,,1
,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 60 min post injection (Average of three to five animals),10116.0,Intermediate,,,14122,955.0,CHEMBL623979,1,BAO_0000218,,In vivo,,N,,Brain,14045,Rattus norvegicus,50597,A,,1
,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 10 min post injection (Average of three to five animals),10116.0,Intermediate,,,14123,,CHEMBL623980,1,BAO_0000218,,In vivo,,N,,,14045,Rattus norvegicus,50597,A,,1
,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 30 min post injection (Average of three to five animals),10116.0,Intermediate,,,14124,,CHEMBL623981,1,BAO_0000218,,In vivo,,N,,,14045,Rattus norvegicus,50597,A,,1
,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 5 min post injection (Average of three to five animals),10116.0,Intermediate,,,14125,,CHEMBL626278,1,BAO_0000218,,In vivo,,N,,,14045,Rattus norvegicus,50597,A,,1
,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 60 min post injection (Average of three to five animals),10116.0,Intermediate,,,14126,,CHEMBL626279,1,BAO_0000218,,In vivo,,N,,,14045,Rattus norvegicus,50597,A,,1
,Biodistribution in mice bladder plus excreted urine was determined,10090.0,Intermediate,,,14127,,CHEMBL626280,1,BAO_0000218,,In vivo,,N,,,14045,Mus musculus,50594,A,,1
,"Percentage biodistribution in mouse blood, 10 minutes post injection",10090.0,Intermediate,,,14128,,CHEMBL626281,1,BAO_0000218,,,,N,,,14045,Mus musculus,50594,A,,1
,"Percentage biodistribution in mouse blood, 30 minutes post injection",10090.0,Intermediate,,,14129,,CHEMBL626282,1,BAO_0000218,,,,N,,,14045,Mus musculus,50594,A,,1
,"Percentage biodistribution in mouse blood, 5 minutes post injection",10090.0,Intermediate,,,14130,,CHEMBL626283,1,BAO_0000218,,,,N,,,14045,Mus musculus,50594,A,,1
,"Percentage biodistribution in mouse blood, 60 minutes post injection",10090.0,Intermediate,,,14131,,CHEMBL626284,1,BAO_0000218,,,,N,,,14045,Mus musculus,50594,A,,1
,"Percentage biodistribution in mouse brain, 10 minutes post injection",10090.0,Intermediate,,,14132,955.0,CHEMBL626285,1,BAO_0000218,,,,N,,Brain,14045,Mus musculus,50594,A,,1
,"Percentage biodistribution in mouse brain, 30 minutes post injection",10090.0,Intermediate,,,14133,955.0,CHEMBL626286,1,BAO_0000218,,,,N,,Brain,14045,Mus musculus,50594,A,,1
,"Percentage biodistribution in mouse brain, 5 minutes post injection",10090.0,Intermediate,,,14134,955.0,CHEMBL626287,1,BAO_0000218,,,,N,,Brain,14045,Mus musculus,50594,A,,1
,"Percentage biodistribution in mouse brain, 60 minutes post injection",10090.0,Intermediate,,,14135,955.0,CHEMBL626288,1,BAO_0000218,,,,N,,Brain,14045,Mus musculus,50594,A,,1
,"Percentage biodistribution in mouse heart, 10 minutes post injection",10090.0,Intermediate,,,14136,,CHEMBL626289,1,BAO_0000218,,,,N,,,14045,Mus musculus,50594,A,,1
,"Percentage biodistribution in mouse heart, 30 minutes post injection",10090.0,Intermediate,,,14137,,CHEMBL626290,1,BAO_0000218,,,,N,,,14045,Mus musculus,50594,A,,1
,"Percentage biodistribution in mouse heart, 5 minutes post injection",10090.0,Intermediate,,,14138,,CHEMBL626291,1,BAO_0000218,,,,N,,,14045,Mus musculus,50594,A,,1
,"Percentage biodistribution in mouse heart, 60 minutes post injection",10090.0,Intermediate,,,14139,,CHEMBL839888,1,BAO_0000218,,,,N,,,14045,Mus musculus,50594,A,,1
,"Percentage biodistribution in mouse intestine, 10 minutes post injection",10090.0,Intermediate,,,14140,160.0,CHEMBL626292,1,BAO_0000218,,,,N,,Intestine,14045,Mus musculus,50594,A,,1
,"Percentage biodistribution in mouse intestine, 30 minutes post injection",10090.0,Intermediate,,,14141,160.0,CHEMBL626293,1,BAO_0000218,,,,N,,Intestine,14045,Mus musculus,50594,A,,1
,"Percentage biodistribution in mouse intestine, 5 minutes post injection",10090.0,Intermediate,,,14142,160.0,CHEMBL626294,1,BAO_0000218,,,,N,,Intestine,14045,Mus musculus,50594,A,,1
,"Percentage biodistribution in mouse intestine, 60 minutes post injection",10090.0,Intermediate,,,14143,160.0,CHEMBL626295,1,BAO_0000218,,,,N,,Intestine,14045,Mus musculus,50594,A,,1
,"Percentage biodistribution in mouse liver, 10 minutes post injection",10090.0,Intermediate,,,14144,2107.0,CHEMBL627659,1,BAO_0000218,,,,N,,Liver,14045,Mus musculus,50594,A,,1
,"Percentage biodistribution in mouse liver, 30 minutes of post injection",10090.0,Intermediate,,,14145,2107.0,CHEMBL627660,1,BAO_0000218,,,,N,,Liver,14045,Mus musculus,50594,A,,1
,"Percentage biodistribution in mouse liver, 5 minutes post injection",10090.0,Intermediate,,,14146,2107.0,CHEMBL627661,1,BAO_0000218,,,,N,,Liver,14045,Mus musculus,50594,A,,1
,Biodistribution in mice liver at 60 minutes of post injection,10090.0,Intermediate,,,14147,2107.0,CHEMBL627662,1,BAO_0000218,,In vivo,,N,,Liver,14045,Mus musculus,50594,A,,1
,Biodistribution in mice lungs at 10 min of post injection,10090.0,Intermediate,,,14148,2048.0,CHEMBL627663,1,BAO_0000218,,In vivo,,N,,Lung,14045,Mus musculus,50594,A,,1
,"Percentage biodistribution in mouse lung, 30 minutes post injection",10090.0,Intermediate,,,14149,,CHEMBL627664,1,BAO_0000218,,,,N,,,14045,Mus musculus,50594,A,,1
,"Percentage biodistribution in mousee lung, 5 minutes post injection",10090.0,Intermediate,,,14150,,CHEMBL627665,1,BAO_0000218,,,,N,,,14045,Mus musculus,50594,A,,1
,Biodistribution in mice lungs at 60 min of post injection,10090.0,Intermediate,,,14151,2048.0,CHEMBL627666,1,BAO_0000218,,In vivo,,N,,Lung,14045,Mus musculus,50594,A,,1
,Percentage biodistribution in mouse spleen,10090.0,Intermediate,,,14152,2106.0,CHEMBL627667,1,BAO_0000218,,,,N,,Spleen,14045,Mus musculus,50594,A,,1
,Percentage biodistribution in mouse stomach,10090.0,Intermediate,,,14153,945.0,CHEMBL627668,1,BAO_0000218,,,,N,,Stomach,14045,Mus musculus,50594,A,,1
,Mean biodistribution and elimination data in urine was reported 24 h after administering compound intravenously in tumor-bearing female BALB-C mice.,10090.0,Intermediate,,,14154,1088.0,CHEMBL627669,1,BAO_0000218,,,,N,,Urine,11745,Mus musculus,50594,A,,1
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bladder,,Autocuration,,,14155,1255.0,CHEMBL627670,1,BAO_0000218,,In vivo,,U,,Urinary bladder,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in blood,,Autocuration,,,14156,178.0,CHEMBL627671,1,BAO_0000218,,In vivo,,U,,Blood,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bone,,Autocuration,,,14157,1474.0,CHEMBL627672,1,BAO_0000218,,In vivo,,U,,Bone element,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in fat,,Autocuration,,,14158,,CHEMBL627673,1,BAO_0000218,,In vivo,,U,,,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in kidney,,Autocuration,,,14159,2113.0,CHEMBL627674,1,BAO_0000218,,In vivo,,U,,Kidney,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in liver,,Autocuration,,,14160,2107.0,CHEMBL627675,1,BAO_0000218,,In vivo,,U,,Liver,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in lung,,Autocuration,,,14161,2048.0,CHEMBL627676,1,BAO_0000218,,In vivo,,U,,Lung,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in muscle,,Autocuration,,,14162,2385.0,CHEMBL627677,1,BAO_0000218,,In vivo,,U,,Muscle tissue,13257,,22224,A,,0
,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator in the conditions of 25degreeC,pH 7.6",,Autocuration,,,14163,,CHEMBL627678,1,BAO_0000019,,,,U,,,8354,,22224,A,,0
,Affinity for protein binding expressed as association constant in fresh rat serum,10116.0,Intermediate,,,14164,1977.0,CHEMBL627679,1,BAO_0000218,,,,N,,Serum,7095,Rattus norvegicus,50597,A,,1
,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,Autocuration,,,14165,,CHEMBL627680,1,BAO_0000019,,,,U,,,12185,,22224,A,,0
,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,Autocuration,,,14166,,CHEMBL627681,1,BAO_0000019,,,,U,,,12185,,22224,A,,0
,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,Autocuration,,,14167,,CHEMBL627682,1,BAO_0000019,,,,U,,,12185,,22224,A,,0
,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,Autocuration,,,14168,,CHEMBL627683,1,BAO_0000019,,,,U,,,12185,,22224,A,,0
,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4,,Autocuration,,,14169,,CHEMBL627684,1,BAO_0000019,,,,U,,,12686,,22224,A,,0
,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,Autocuration,,,14170,,CHEMBL874441,1,BAO_0000019,,,,U,,,12686,,22224,A,,0
,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; No cyclization detected over 4 h,,Autocuration,,,14171,,CHEMBL627685,1,BAO_0000019,,,,U,,,12686,,22224,A,,0
,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,Autocuration,,,14172,,CHEMBL627686,1,BAO_0000019,,,,U,,,12686,,22224,A,,0
,Apparent rate constant Koff for inactivation of dTMP synthase.,,Autocuration,,,14173,,CHEMBL627687,1,BAO_0000019,,,,U,,,8057,,22224,A,,0
,The irreversible inhibitor activity by second order rate equation.,,Autocuration,,,14174,,CHEMBL627688,1,BAO_0000019,,,,U,,,15778,,22224,A,,0
,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 1 mg/kg concentration,10116.0,Intermediate,,,14175,,CHEMBL628038,1,BAO_0000218,,,,N,,,12375,Rattus norvegicus,50597,A,,1
,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 5 mg/kg concentration,10116.0,Intermediate,,,14176,,CHEMBL628039,1,BAO_0000218,,,,N,,,12375,Rattus norvegicus,50597,A,,1
,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at vehicle concentration,10116.0,Intermediate,,,14177,,CHEMBL628040,1,BAO_0000218,,,,N,,,12375,Rattus norvegicus,50597,A,,1
,Dissociation rate calculated from the first-order equation using t1/2 value,,Autocuration,,,14178,,CHEMBL628041,1,BAO_0000019,,,,U,,,13588,,22224,A,,0
,The compound was tested for Binding constant against DNA,,Autocuration,,,14179,,CHEMBL630226,1,BAO_0000019,,,,U,,,15039,,22224,A,,0
,First order rate constant for cyclization of the compound,,Autocuration,,,14180,,CHEMBL628042,1,BAO_0000019,,,,U,,,9500,,22224,A,,0
,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,Autocuration,,,14181,,CHEMBL625232,1,BAO_0000019,,,,U,,,10014,,22224,A,,0
,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,Autocuration,,,14182,,CHEMBL625233,1,BAO_0000019,,,,U,,,10014,,22224,A,,0
,Hydrolysis rate constant was determined,,Autocuration,,,14183,,CHEMBL625979,1,BAO_0000019,,,,U,,,568,,22224,A,,0
,Observed first order rate constant,,Autocuration,,,14184,,CHEMBL625980,1,BAO_0000019,,,,U,,,10026,,22224,A,,0
,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,Autocuration,,,14185,,CHEMBL625981,1,BAO_0000019,,,,U,,,10281,,22224,A,,0
,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,Autocuration,,,14186,,CHEMBL625982,1,BAO_0000019,,,,U,,,10281,,22224,A,,0
,Second-order rate constant for attack on PNPA at 25 degree Centigrade,,Autocuration,,,14187,,CHEMBL625983,1,BAO_0000019,,,,U,,,9680,,22224,A,,0
,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,,,14188,,CHEMBL625984,1,BAO_0000019,,,,U,,,13028,,22224,A,,0
,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,,,14189,,CHEMBL625985,1,BAO_0000019,,,,U,,,13028,,22224,A,,0
,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,,,14190,,CHEMBL625986,1,BAO_0000019,,,,U,,,13028,,22224,A,,0
,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,,,14191,,CHEMBL625987,1,BAO_0000019,,,,U,,,13028,,22224,A,,0
,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,,,14192,,CHEMBL625988,1,BAO_0000019,,,,U,,,13028,,22224,A,,0
,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,,,14193,,CHEMBL625989,1,BAO_0000019,,,,U,,,13028,,22224,A,,0
,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,,,14194,,CHEMBL625990,1,BAO_0000019,,,,U,,,13028,,22224,A,,0
,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,,,14195,,CHEMBL625991,1,BAO_0000019,,,,U,,,13028,,22224,A,,0
,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,,,14196,,CHEMBL625992,1,BAO_0000019,,,,U,,,13028,,22224,A,,0
,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,,,14197,,CHEMBL625993,1,BAO_0000019,,,,U,,,13028,,22224,A,,0
,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,,,14198,,CHEMBL631973,1,BAO_0000019,,,,U,,,13028,,22224,A,,0
,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,,,14199,,CHEMBL632143,1,BAO_0000019,,,,U,,,13028,,22224,A,,0
,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,,,14200,,CHEMBL632144,1,BAO_0000019,,,,U,,,13028,,22224,A,,0
,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,,,14201,,CHEMBL632145,1,BAO_0000019,,,,U,,,13028,,22224,A,,0
,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,,,14202,,CHEMBL632146,1,BAO_0000019,,,,U,,,13028,,22224,A,,0
,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,,,14203,,CHEMBL632147,1,BAO_0000019,,,,U,,,13028,,22224,A,,0
,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,,,14204,,CHEMBL632148,1,BAO_0000019,,,,U,,,13028,,22224,A,,0
,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,,,14205,,CHEMBL632149,1,BAO_0000019,,,,U,,,13028,,22224,A,,0
,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,,,14206,,CHEMBL632150,1,BAO_0000019,,,,U,,,13028,,22224,A,,0
,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,,,14207,,CHEMBL632151,1,BAO_0000019,,,,U,,,13028,,22224,A,,0
,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated; not detected,9606.0,Intermediate,,,14208,,CHEMBL632152,1,BAO_0000218,,,,N,,,3008,Homo sapiens,50587,A,,1
,Metabolism after 30 min of incubation with human liver microsomes in the absence of cofactor NADH (2.0 mM) at a concentration of 25 uM,9606.0,Intermediate,,,14209,,CHEMBL632153,1,BAO_0000218,,,,N,,,4509,Homo sapiens,50587,A,,1
,Metabolism after 30 min of incubation with human liver microsomes in the presence of cofactor NADH (2.0 mM) at a concentration of 25 uM,9606.0,Intermediate,,,14210,,CHEMBL632154,1,BAO_0000218,,,,N,,,4509,Homo sapiens,50587,A,,1
,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Tested mice 10,10298.0,Intermediate,,,14211,,CHEMBL632155,1,BAO_0000218,,,,N,,,8613,Human herpesvirus 1,50602,A,,1
,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Total mice tested 10,10298.0,Intermediate,,,14212,,CHEMBL632156,1,BAO_0000218,,,,N,,,8613,Human herpesvirus 1,50602,A,,1
,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day; Tested mice 10,10298.0,Intermediate,,,14213,,CHEMBL632157,1,BAO_0000218,,,,N,,,8613,Human herpesvirus 1,50602,A,,1
,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Tested mice 10,10298.0,Intermediate,,,14214,,CHEMBL632158,1,BAO_0000218,,,,N,,,8613,Human herpesvirus 1,50602,A,,1
,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Total mice tested 10,10298.0,Intermediate,,,14215,,CHEMBL632159,1,BAO_0000218,,,,N,,,8613,Human herpesvirus 1,50602,A,,1
,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 0.8 mg/kg per day; Tested mice 10,10298.0,Intermediate,,,14216,,CHEMBL626305,1,BAO_0000218,,,,N,,,8613,Human herpesvirus 1,50602,A,,1
,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 3.1 mg/kg per day; Total mice tested 10,10298.0,Intermediate,,,14217,,CHEMBL626306,1,BAO_0000218,,,,N,,,8613,Human herpesvirus 1,50602,A,,1
,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day; Tested mice 10,10298.0,Intermediate,,,14218,,CHEMBL626307,1,BAO_0000218,,,,N,,,8613,Human herpesvirus 1,50602,A,,1
,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day; Tested mice 10,10298.0,Intermediate,,,14219,,CHEMBL626308,1,BAO_0000218,,,,N,,,8613,Human herpesvirus 1,50602,A,,1
,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day; Tested mice 10,10298.0,Intermediate,,,14220,,CHEMBL626479,1,BAO_0000218,,,,N,,,8613,Human herpesvirus 1,50602,A,,1
,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day; Tested mice 10,10298.0,Intermediate,,,14221,,CHEMBL626480,1,BAO_0000218,,,,N,,,8613,Human herpesvirus 1,50602,A,,1
,Calculated partition coefficient (clogP) (MlogP),,Autocuration,,,14222,,CHEMBL626481,1,BAO_0000100,,,,U,,,6021,,22229,P,,0
,Equipotent potent ratio relative to carbachol (nicotinic activity),,Autocuration,,,14223,,CHEMBL626482,1,BAO_0000019,,,,U,,,9348,,22224,A,,0
,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 ); NA denotes not available",9615.0,Intermediate,,,14224,,CHEMBL626483,1,BAO_0000218,,,,N,,,15592,Canis lupus familiaris,50588,A,,1
,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 );NA denotes not available",9615.0,Intermediate,,,14225,,CHEMBL626484,1,BAO_0000218,,,,N,,,15592,Canis lupus familiaris,50588,A,,1
,Solubility at pH 7.4 in micro g/mL;NA denotes available,,Autocuration,,,14226,,CHEMBL626485,1,BAO_0000100,,,,U,,,15592,,22229,P,,0
,Solubility at pH 7.4 in micro g/mL;NA denotes not available,,Autocuration,,,14227,,CHEMBL626486,1,BAO_0000100,,,,U,,,15592,,22229,P,,0
,Solubility at pH 7.4 in ug/mL;NA denotes not available,,Autocuration,,,14228,,CHEMBL626487,1,BAO_0000100,,,,U,,,15592,,22229,P,,0
,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,9615.0,Intermediate,,,14229,1969.0,CHEMBL626488,1,BAO_0000218,,In vivo,,N,,Plasma,15592,Canis lupus familiaris,50588,A,,1
,Affinity for protein binding expressed as association constant in fresh rat serum; ND is Not Determined.,10116.0,Intermediate,,,14230,1977.0,CHEMBL626489,1,BAO_0000218,,,,N,,Serum,7095,Rattus norvegicus,50597,A,,1
,Area under the MAP curve measured over 5 min; ND means Not determined,,Autocuration,,,14231,,CHEMBL626490,1,BAO_0000019,,,,U,,,16618,,22224,A,,0
,Lipophilicity expressed as the negative logarithm of the equilibrium constant; ND denotes no data.,,Autocuration,,,14232,,CHEMBL626491,1,BAO_0000100,,,,U,,,16835,,22224,P,,0
,The apparent partition coefficient(D) in cyclohexane-0.05 M phosphate buffer (pH 7.4) at 21 degree celsius; not determined,,Autocuration,,,14233,,CHEMBL626492,1,BAO_0000100,,,,U,,,15284,,22229,P,,0
,Half-life was measured in the presence of NADPH at 20 uM; No inhibition,,Autocuration,,,14234,,CHEMBL626493,1,BAO_0000019,,,,U,,,15750,,22224,A,,0
,Half life after oral administration to Sprague-Dawley rats; NT is Not tested,10116.0,Intermediate,,,14235,,CHEMBL626494,1,BAO_0000218,,In vivo,,N,,,16618,Rattus norvegicus,50597,A,,1
,Half life after oral tested,,Autocuration,,,14236,,CHEMBL626495,1,BAO_0000218,,In vivo,,U,,,16618,,22224,A,,0
,Half life was determined in plasma of rat; NT indicates not tested,10116.0,Intermediate,,,14237,1969.0,CHEMBL626496,1,BAO_0000218,,,,N,,Plasma,15812,Rattus norvegicus,50597,A,,1
,Oral bioavailability after oral administration to Sprague-Dawley rats; NT is Not tested,10116.0,Intermediate,,,14238,,CHEMBL626497,1,BAO_0000218,,In vivo,,N,,,16618,Rattus norvegicus,50597,A,,1
,Oral bioavailability after oral tested,,Autocuration,,,14239,,CHEMBL626498,1,BAO_0000218,,In vivo,,U,,,16618,,22224,A,,0
,The bioavailability in rats at 15.9 uM/Kg after intravenous administration; NT=Not tested (F),10116.0,Intermediate,,,14240,,CHEMBL626499,1,BAO_0000218,,,,N,,,13098,Rattus norvegicus,50597,A,,1
,The compound was tested for volume of distribution in rat at 15.9 uM/Kg after peroral administration; NT=Not tested (Vd L/Kg),10116.0,Intermediate,,,14241,,CHEMBL626500,1,BAO_0000218,,,,N,,,13098,Rattus norvegicus,50597,A,,1
,half life was determined in plasma of rat; NT indicates not tested,10116.0,Intermediate,,,14242,1969.0,CHEMBL626501,1,BAO_0000218,,,,N,,Plasma,15812,Rattus norvegicus,50597,A,,1
,half life was determined in plasma of rat; NT means not tested,10116.0,Intermediate,,,14243,1969.0,CHEMBL626502,1,BAO_0000218,,,,N,,Plasma,15812,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats (Control/Drug treatment value); Value 0.41/2.32,10116.0,Intermediate,,,14244,,CHEMBL626503,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats (Control/Drug treatment value); inactive,10116.0,Intermediate,,,14245,,CHEMBL626504,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats (Control/Drug treatment value); value 0.17/0.43,10116.0,Intermediate,,,14246,,CHEMBL626505,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats (Control/Drug treatment value); value 0.2/0.38,10116.0,Intermediate,,,14247,,CHEMBL626506,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats (Control/Drug treatment value); value 0.26/0.23,10116.0,Intermediate,,,14248,,CHEMBL626507,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats (Control/Drug treatment value); value 0.28/0.26,10116.0,Intermediate,,,14249,,CHEMBL626508,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats (Control/Drug treatment value); value 0.31/0.35,10116.0,Intermediate,,,14250,,CHEMBL626509,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats (Control/Drug treatment value); value 0.35/2.88,10116.0,Intermediate,,,14251,,CHEMBL875480,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.29,10116.0,Intermediate,,,14252,,CHEMBL626510,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.47,10116.0,Intermediate,,,14253,,CHEMBL626511,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.49,10116.0,Intermediate,,,14254,,CHEMBL626512,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats (Control/Drug treatment value); value 0.38/0.23,10116.0,Intermediate,,,14255,,CHEMBL628208,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats (Control/Drug treatment value); value 0.39/0.22,10116.0,Intermediate,,,14256,,CHEMBL628209,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/0.48,10116.0,Intermediate,,,14257,,CHEMBL628210,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/1.49,10116.0,Intermediate,,,14258,,CHEMBL628211,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/2.06,10116.0,Intermediate,,,14259,,CHEMBL628212,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats (Control/Drug treatment value); value 0.42/0.65,10116.0,Intermediate,,,14260,,CHEMBL628213,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 65.2 uM/Kg of drug,10116.0,Intermediate,,,14261,1088.0,CHEMBL628214,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.6 uM/Kg of drug,10116.0,Intermediate,,,14262,1088.0,CHEMBL628215,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.8 uM/Kg of drug,10116.0,Intermediate,,,14263,1088.0,CHEMBL628216,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 74.8 uM/Kg of drug,10116.0,Intermediate,,,14264,1088.0,CHEMBL626595,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 77.5 uM/Kg of drug,10116.0,Intermediate,,,14265,1088.0,CHEMBL626596,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 79.4 uM/Kg of drug,10116.0,Intermediate,,,14266,1088.0,CHEMBL626597,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 80.9 uM/Kg of drug,10116.0,Intermediate,,,14267,1088.0,CHEMBL626598,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 83.8 uM/Kg of drug,10116.0,Intermediate,,,14268,1088.0,CHEMBL622242,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.5 uM/Kg of drug,10116.0,Intermediate,,,14269,1088.0,CHEMBL622243,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.7 uM/Kg of drug,10116.0,Intermediate,,,14270,1088.0,CHEMBL622244,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.7 uM/Kg of drug,10116.0,Intermediate,,,14271,1088.0,CHEMBL622245,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.9 uM/Kg of drug,10116.0,Intermediate,,,14272,1088.0,CHEMBL622246,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 9.06 uM/Kg of drug,10116.0,Intermediate,,,14273,1088.0,CHEMBL622247,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 90.6 uM/Kg of drug,10116.0,Intermediate,,,14274,1088.0,CHEMBL622248,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 94.9 uM/Kg of drug,10116.0,Intermediate,,,14275,1088.0,CHEMBL877483,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 97.1 uM/Kg of drug,10116.0,Intermediate,,,14276,1088.0,CHEMBL622249,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,9615.0,Intermediate,,,14277,1088.0,CHEMBL622250,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,9615.0,Intermediate,,,14278,1088.0,CHEMBL622251,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,9615.0,Intermediate,,,14279,1088.0,CHEMBL622252,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,9615.0,Intermediate,,,14280,1088.0,CHEMBL622253,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,9615.0,Intermediate,,,14281,1088.0,CHEMBL622254,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,9615.0,Intermediate,,,14282,1088.0,CHEMBL622255,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,9615.0,Intermediate,,,14283,1088.0,CHEMBL622256,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,9615.0,Intermediate,,,14284,1088.0,CHEMBL622257,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,9615.0,Intermediate,,,14285,1088.0,CHEMBL622258,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,9615.0,Intermediate,,,14286,1088.0,CHEMBL622259,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,9615.0,Intermediate,,,14287,1088.0,CHEMBL622927,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,9615.0,Intermediate,,,14288,1088.0,CHEMBL622928,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,9615.0,Intermediate,,,14289,1088.0,CHEMBL622929,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.06 uM/Kg of drug,9615.0,Intermediate,,,14290,1088.0,CHEMBL623182,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,9615.0,Intermediate,,,14291,1088.0,CHEMBL623183,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 0 uM/Kg of drug,10116.0,Intermediate,,,14292,1088.0,CHEMBL623184,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.01 uM/Kg of drug,10116.0,Intermediate,,,14293,1088.0,CHEMBL623185,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.13 uM/Kg of drug,10116.0,Intermediate,,,14294,1088.0,CHEMBL877484,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 10.1 uM/Kg of drug,10116.0,Intermediate,,,14295,1088.0,CHEMBL627274,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 102 uM/Kg of drug,10116.0,Intermediate,,,14296,1088.0,CHEMBL623186,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 105 uM/Kg of drug,10116.0,Intermediate,,,14297,1088.0,CHEMBL623187,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 11.3 uM/Kg of drug,10116.0,Intermediate,,,14298,1088.0,CHEMBL623188,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 113 uM/Kg of drug,10116.0,Intermediate,,,14299,1088.0,CHEMBL628055,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 19.5 uM/Kg of drug,10116.0,Intermediate,,,14300,1088.0,CHEMBL628056,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 195 uM/Kg of drug,10116.0,Intermediate,,,14301,1088.0,CHEMBL628200,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 21.7 uM/Kg of drug,10116.0,Intermediate,,,14302,1088.0,CHEMBL628201,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 217 uM/Kg of drug,10116.0,Intermediate,,,14303,1088.0,CHEMBL628202,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 23.9 uM/Kg of drug,10116.0,Intermediate,,,14304,1088.0,CHEMBL628203,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 239 uM/Kg of drug,10116.0,Intermediate,,,14305,1088.0,CHEMBL628204,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 24.9 uM/Kg of drug,10116.0,Intermediate,,,14306,1088.0,CHEMBL628205,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 249 uM/Kg of drug,10116.0,Intermediate,,,14307,1088.0,CHEMBL628206,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d),,Autocuration,,,14308,2367.0,CHEMBL628207,1,BAO_0000218,,In vivo,,U,,Prostate gland,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/biood,,Autocuration,,,14309,2367.0,CHEMBL627220,1,BAO_0000218,,In vivo,,U,,Prostate gland,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/muscle,,Autocuration,,,14310,2385.0,CHEMBL627221,1,BAO_0000218,,In vivo,,U,,Muscle tissue,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v),,Autocuration,,,14311,2367.0,CHEMBL627222,1,BAO_0000218,,In vivo,,U,,Prostate gland,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/blood,,Autocuration,,,14312,,CHEMBL627223,1,BAO_0000218,,In vivo,,U,,,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/muscle,,Autocuration,,,14313,2385.0,CHEMBL632062,1,BAO_0000218,,In vivo,,U,,Muscle tissue,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in spleen,,Autocuration,,,14314,2106.0,CHEMBL632063,1,BAO_0000218,,In vivo,,U,,Spleen,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bladder,,Autocuration,,,14315,1255.0,CHEMBL632064,1,BAO_0000218,,In vivo,,U,,Urinary bladder,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in blood,,Autocuration,,,14316,178.0,CHEMBL632065,1,BAO_0000218,,In vivo,,U,,Blood,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bone,,Autocuration,,,14317,1474.0,CHEMBL632066,1,BAO_0000218,,In vivo,,U,,Bone element,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in fat,,Autocuration,,,14318,,CHEMBL632067,1,BAO_0000218,,In vivo,,U,,,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in kidney,,Autocuration,,,14319,2113.0,CHEMBL629188,1,BAO_0000218,,In vivo,,U,,Kidney,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in liver,,Autocuration,,,14320,2107.0,CHEMBL629189,1,BAO_0000218,,In vivo,,U,,Liver,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in lung,,Autocuration,,,14321,2048.0,CHEMBL629190,1,BAO_0000218,,In vivo,,U,,Lung,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in muscle,,Autocuration,,,14322,2385.0,CHEMBL629191,1,BAO_0000218,,In vivo,,U,,Muscle tissue,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d),,Autocuration,,,14323,2367.0,CHEMBL629192,1,BAO_0000218,,In vivo,,U,,Prostate gland,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)/muscle,,Autocuration,,,14324,2385.0,CHEMBL629193,1,BAO_0000218,,In vivo,,U,,Muscle tissue,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v),,Autocuration,,,14325,2367.0,CHEMBL629194,1,BAO_0000218,,In vivo,,U,,Prostate gland,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/blood,,Autocuration,,,14326,,CHEMBL629195,1,BAO_0000218,,In vivo,,U,,,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/muscle,,Autocuration,,,14327,2385.0,CHEMBL629373,1,BAO_0000218,,In vivo,,U,,Muscle tissue,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in spleen,,Autocuration,,,14328,2106.0,CHEMBL629374,1,BAO_0000218,,In vivo,,U,,Spleen,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked)i n prostate (d)/biood,,Autocuration,,,14329,2367.0,CHEMBL629375,1,BAO_0000218,,In vivo,,U,,Prostate gland,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bladder,,Autocuration,,,14330,1255.0,CHEMBL629376,1,BAO_0000218,,In vivo,,U,,Urinary bladder,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in blood,,Autocuration,,,14331,178.0,CHEMBL629377,1,BAO_0000218,,In vivo,,U,,Blood,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bone,,Autocuration,,,14332,1474.0,CHEMBL629378,1,BAO_0000218,,In vivo,,U,,Bone element,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in fat,,Autocuration,,,14333,,CHEMBL629379,1,BAO_0000218,,In vivo,,U,,,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in kidney,,Autocuration,,,14334,2113.0,CHEMBL629151,1,BAO_0000218,,In vivo,,U,,Kidney,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in liver,,Autocuration,,,14335,2107.0,CHEMBL629152,1,BAO_0000218,,In vivo,,U,,Liver,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in lung,,Autocuration,,,14336,2048.0,CHEMBL629153,1,BAO_0000218,,In vivo,,U,,Lung,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in muscle,,Autocuration,,,14337,2385.0,CHEMBL629154,1,BAO_0000218,,In vivo,,U,,Muscle tissue,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d),,Autocuration,,,14338,2367.0,CHEMBL629155,1,BAO_0000218,,In vivo,,U,,Prostate gland,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/biood,,Autocuration,,,14339,2367.0,CHEMBL629156,1,BAO_0000218,,In vivo,,U,,Prostate gland,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/muscle,,Autocuration,,,14340,2385.0,CHEMBL629157,1,BAO_0000218,,In vivo,,U,,Muscle tissue,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v),,Autocuration,,,14341,2367.0,CHEMBL629158,1,BAO_0000218,,In vivo,,U,,Prostate gland,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/blood,,Autocuration,,,14342,,CHEMBL629159,1,BAO_0000218,,In vivo,,U,,,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/muscle,,Autocuration,,,14343,2385.0,CHEMBL629160,1,BAO_0000218,,In vivo,,U,,Muscle tissue,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in spleen,,Autocuration,,,14344,2106.0,CHEMBL629161,1,BAO_0000218,,In vivo,,U,,Spleen,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bladder,,Autocuration,,,14345,1255.0,CHEMBL629162,1,BAO_0000218,,In vivo,,U,,Urinary bladder,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in blood,,Autocuration,,,14346,178.0,CHEMBL629163,1,BAO_0000218,,In vivo,,U,,Blood,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bone,,Autocuration,,,14347,1474.0,CHEMBL629164,1,BAO_0000218,,In vivo,,U,,Bone element,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in fat,,Autocuration,,,14348,,CHEMBL629165,1,BAO_0000218,,In vivo,,U,,,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in liver,,Autocuration,,,14349,2107.0,CHEMBL629166,1,BAO_0000218,,In vivo,,U,,Liver,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in lung,,Autocuration,,,14350,2048.0,CHEMBL629167,1,BAO_0000218,,In vivo,,U,,Lung,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in muscle,,Autocuration,,,14351,2385.0,CHEMBL629168,1,BAO_0000218,,In vivo,,U,,Muscle tissue,13257,,22224,A,,0
,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM,,Autocuration,,,14352,,CHEMBL629169,1,BAO_0000019,,,,U,,,2193,,22224,A,,0
,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM; no inhibition is observed at this concentration,,Autocuration,,,14353,,CHEMBL629170,1,BAO_0000019,,,,U,,,2193,,22224,A,,0
,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM,,Autocuration,,,14354,,CHEMBL631153,1,BAO_0000019,,,,U,,,2193,,22224,A,,0
,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM; too active and complete inhibition is observed,,Autocuration,,,14355,,CHEMBL875121,1,BAO_0000019,,,,U,,,2193,,22224,A,,0
,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM,,Autocuration,,,14356,,CHEMBL631154,1,BAO_0000019,,,,U,,,2193,,22224,A,,0
,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM; too active and complete inhibition is observed,,Autocuration,,,14357,,CHEMBL631155,1,BAO_0000019,,,,U,,,2193,,22224,A,,0
,Hydrolysis rate constant was determined,,Autocuration,,,14358,,CHEMBL631156,1,BAO_0000019,,,,U,,,568,,22224,A,,0
,"K2, The intrinsic biomolecular reactivation rate constant on VX at 25 degree Centigrade",,Autocuration,,,14359,,CHEMBL631157,1,BAO_0000019,,,,U,,,9680,,22224,A,,0
,"K2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,Autocuration,,,14360,,CHEMBL631158,1,BAO_0000019,,,,U,,,9680,,22224,A,,0
,"K2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,Autocuration,,,14361,,CHEMBL631159,1,BAO_0000019,,,,U,,,9680,,22224,A,,0
,Observed second order rate constant,,Autocuration,,,14362,,CHEMBL631160,1,BAO_0000019,,,,U,,,10026,,22224,A,,0
,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,Autocuration,,,14363,,CHEMBL631161,1,BAO_0000019,,,,U,,,10281,,22224,A,,0
,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,Autocuration,,,14364,,CHEMBL631162,1,BAO_0000019,,,,U,,,10014,,22224,A,,0
,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,Autocuration,,,14365,,CHEMBL630313,1,BAO_0000019,,,,U,,,10014,,22224,A,,0
,"k2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,Autocuration,,,14366,,CHEMBL630314,1,BAO_0000019,,,,U,,,9680,,22224,A,,0
,"k2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,Autocuration,,,14367,,CHEMBL630315,1,BAO_0000019,,,,U,,,9680,,22224,A,,0
,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,,,14368,,CHEMBL630316,1,BAO_0000019,,,,U,,,13028,,22224,A,,0
,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,,,14369,,CHEMBL630986,1,BAO_0000019,,,,U,,,13028,,22224,A,,0
,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,,,14370,,CHEMBL630987,1,BAO_0000019,,,,U,,,13028,,22224,A,,0
,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0(or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,,,14371,,CHEMBL630988,1,BAO_0000019,,,,U,,,13028,,22224,A,,0
,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,,,14372,,CHEMBL630989,1,BAO_0000019,,,,U,,,13028,,22224,A,,0
,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,,,14373,,CHEMBL630990,1,BAO_0000019,,,,U,,,13028,,22224,A,,0
,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,,,14374,,CHEMBL630991,1,BAO_0000019,,,,U,,,13028,,22224,A,,0
,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,,,14375,,CHEMBL630992,1,BAO_0000019,,,,U,,,13028,,22224,A,,0
,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,,,14376,,CHEMBL630993,1,BAO_0000019,,,,U,,,13028,,22224,A,,0
,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,Autocuration,,,14377,,CHEMBL630994,1,BAO_0000019,,,,U,,,13028,,22224,A,,0
,Rate constants of compound was determined at muscarinic receptor in the rat cerebral cortex,10116.0,Intermediate,,,14378,,CHEMBL630995,1,BAO_0000218,,,,N,,,10014,Rattus norvegicus,50597,A,,1
,Association constant for compound at 31 degree C was determined,,Autocuration,,,14379,,CHEMBL629252,1,BAO_0000019,,,,U,,,9962,,22224,A,,0
,Calculated antagonist equilibrium dissociation constant of the compound,,Autocuration,,,14380,,CHEMBL629253,1,BAO_0000019,,,,U,,,12029,,22224,A,,0
,Calculated antagonist equilibrium dissociation constant of the compound; No statistically significant antagonism observed,,Autocuration,,,14381,,CHEMBL629944,1,BAO_0000019,,,,U,,,12029,,22224,A,,0
,Dissociation constants vs LTE4 on guinea pig trachea,10141.0,Intermediate,,,14382,3126.0,CHEMBL629945,1,BAO_0000218,,,,N,,Trachea,10583,Cavia porcellus,50512,A,,1
,"Tested for hydrolysis in presence of boric acid by UV spectrophotometry, dissociation constant was evaluated at the pH < 8",,Autocuration,,,14383,,CHEMBL629946,1,BAO_0000019,,,,U,,,568,,22224,A,,0
,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 8.5",,Autocuration,,,14384,,CHEMBL629947,1,BAO_0000019,,,,U,,,568,,22224,A,,0
,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 9.5",,Autocuration,,,14385,,CHEMBL629948,1,BAO_0000019,,,,U,,,568,,22224,A,,0
,"Tested for hydrolysis in presence of phenylboronic acid, rate constant was evaluated at the pH 9.5",,Autocuration,,,14386,,CHEMBL856024,1,BAO_0000019,,,,U,,,568,,22224,A,,0
,Affinity constant KD value was derived from TMP,,Autocuration,,,14387,,CHEMBL629949,1,BAO_0000019,,,,U,,,7493,,22224,A,,0
,Apparent dissociation (binding) rate constant was evaluated,,Autocuration,,,14388,,CHEMBL629950,1,BAO_0000019,,,,U,,,8371,,22224,A,,0
,Dissociation constant (KD) of the compound,,Autocuration,,,14389,,CHEMBL630127,1,BAO_0000100,,,,U,,,13114,,22224,P,,0
,Dissociation constant determined by heteronuclear 1H/15N correlation NMR spectroscopy,,Autocuration,,,14390,,CHEMBL630128,1,BAO_0000100,,,,U,,,15515,,22224,P,,0
,Dissociation constant from ESR titration experiments,,Autocuration,,,14391,,CHEMBL630129,1,BAO_0000100,,,,U,,,522,,22224,P,,0
,Dissociation constant was evaluated which is similar to Ki (inhibitory constant),,Autocuration,,,14392,,CHEMBL630130,1,BAO_0000019,,,,U,,,13888,,22224,,,0
,Dissociation constant was evaluated.,,Autocuration,,,14393,,CHEMBL875234,1,BAO_0000100,,,,U,,,2616,,22224,P,,0
,Dissociation constant was reported,,Autocuration,,,14394,,CHEMBL630131,1,BAO_0000100,,,,U,,,3798,,22224,P,,0
,Dissociation constant was determined in rat pituitary cells.,10116.0,Intermediate,,,14395,,CHEMBL630132,1,BAO_0000218,,,,N,,,8731,Rattus norvegicus,50597,A,,1
,Equilibrium dissociation constant of CA complex for enantiomer 1 of compound,,Autocuration,,,14396,,CHEMBL630133,1,BAO_0000019,,,,U,,,11892,,22224,A,,0
,Equilibrium dissociation constant of CA complex for enantiomer 2 of compound,,Autocuration,,,14397,,CHEMBL630134,1,BAO_0000019,,,,U,,,11892,,22224,A,,0
,Equilibrium dissociation constant of the compound,,Autocuration,,,14398,,CHEMBL630135,1,BAO_0000019,,,,U,,,2582,,22224,A,,0
,Equilibrium dissociation constant was determined,,Autocuration,,,14399,,CHEMBL630136,1,BAO_0000019,,,,U,,,11892,,22224,A,,0
,Kinetic constant KD was evaluated,,Autocuration,,,14400,,CHEMBL630137,1,BAO_0000019,,,,U,,,13396,,22224,A,,0
,Tested for dissociation constant of the compound; Value ranges from 0.1-0.3,,Autocuration,,,14401,,CHEMBL630138,1,BAO_0000019,,,,U,,,603,,22224,A,,0
,Equilibrium association constant interacting with unilamellar vesicles of electroneutral in PBS buffer at pH 7.4,,Autocuration,,,14402,,CHEMBL630139,1,BAO_0000019,,,,U,,,15673,,22224,A,,0
,Rate constant for hydrolysis in aqueous acetone.,,Autocuration,,,14403,,CHEMBL630140,1,BAO_0000019,,,,U,,,10368,,22224,A,,0
,Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,,Autocuration,,,14404,,CHEMBL875235,1,BAO_0000019,,,,U,,,14228,,22224,A,,0
,Mean sodium excretion in rats (Control/Drug treatment value); value 0.43/2.86,10116.0,Intermediate,,,14405,,CHEMBL876439,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats (Control/Drug treatment value); value 0.44/2.68,10116.0,Intermediate,,,14406,,CHEMBL630605,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats (Control/Drug treatment value); value 0.45/1.55,10116.0,Intermediate,,,14407,,CHEMBL630606,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats (Control/Drug treatment value); value 0.48/0.95,10116.0,Intermediate,,,14408,,CHEMBL630607,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats (Control/Drug treatment value); value 0.5/1.79,10116.0,Intermediate,,,14409,,CHEMBL630608,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats (Control/Drug treatment value); value 0.51/0.66,10116.0,Intermediate,,,14410,,CHEMBL630609,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats (Control/Drug treatment value); value 0.52/2.02,10116.0,Intermediate,,,14411,,CHEMBL630610,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats (Control/Drug treatment value); value 0.61//0.37,10116.0,Intermediate,,,14412,,CHEMBL630611,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats (Control/Drug treatment value); value 0.71/0.36,10116.0,Intermediate,,,14413,,CHEMBL629552,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,10116.0,Intermediate,,,14414,,CHEMBL629733,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,10116.0,Intermediate,,,14415,,CHEMBL629734,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,10116.0,Intermediate,,,14416,,CHEMBL629735,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,10116.0,Intermediate,,,14417,,CHEMBL629736,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,10116.0,Intermediate,,,14418,,CHEMBL629737,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,10116.0,Intermediate,,,14419,,CHEMBL629738,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,10116.0,Intermediate,,,14420,,CHEMBL629739,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,10116.0,Intermediate,,,14421,,CHEMBL629740,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,10116.0,Intermediate,,,14422,,CHEMBL629741,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,10116.0,Intermediate,,,14423,,CHEMBL629742,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,10116.0,Intermediate,,,14424,,CHEMBL629743,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,10116.0,Intermediate,,,14425,,CHEMBL629744,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,10116.0,Intermediate,,,14426,,CHEMBL629745,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,10116.0,Intermediate,,,14427,,CHEMBL629746,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,10116.0,Intermediate,,,14428,,CHEMBL629747,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,10116.0,Intermediate,,,14429,,CHEMBL629748,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,10116.0,Intermediate,,,14430,,CHEMBL629749,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,10116.0,Intermediate,,,14431,,CHEMBL629750,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,10116.0,Intermediate,,,14432,,CHEMBL629751,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,10116.0,Intermediate,,,14433,,CHEMBL629752,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,10116.0,Intermediate,,,14434,,CHEMBL629753,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,10116.0,Intermediate,,,14435,,CHEMBL629754,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,10116.0,Intermediate,,,14436,,CHEMBL629755,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,10116.0,Intermediate,,,14437,,CHEMBL629756,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,10116.0,Intermediate,,,14438,,CHEMBL629757,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,10116.0,Intermediate,,,14439,,CHEMBL629758,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,10116.0,Intermediate,,,14440,,CHEMBL629759,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,10116.0,Intermediate,,,14441,,CHEMBL629760,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,10116.0,Intermediate,,,14442,,CHEMBL876443,1,BAO_0000218,,,,N,,,11510,Rattus norvegicus,50597,A,,1
,Na+ excretion mequiv /kg in 6 conscious female dogs administered perorally during 0-6 hr,9615.0,Intermediate,,,14443,,CHEMBL629761,1,BAO_0000218,,,,N,,,8310,Canis lupus familiaris,50588,A,,1
,Na+ excretion mequiv /kg in conscious female dogs administered perorally during 0-6 hr,9615.0,Intermediate,,,14444,,CHEMBL629762,1,BAO_0000218,,,,N,,,8310,Canis lupus familiaris,50588,A,,1
,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,10090.0,Intermediate,,,14445,,CHEMBL629763,1,BAO_0000218,,,,N,,,8310,Mus musculus,50594,A,,1
,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,10090.0,Intermediate,,,14446,,CHEMBL629764,1,BAO_0000218,,,,N,,,8310,Mus musculus,50594,A,,1
,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,10090.0,Intermediate,,,14447,,CHEMBL629765,1,BAO_0000218,,,,N,,,8310,Mus musculus,50594,A,,1
,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 50 ml/kg perorally,10090.0,Intermediate,,,14448,,CHEMBL629766,1,BAO_0000218,,,,N,,,8310,Mus musculus,50594,A,,1
,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,10090.0,Intermediate,,,14449,,CHEMBL629767,1,BAO_0000218,,,,N,,,8310,Mus musculus,50594,A,,1
,Na+ excretion mequiv/kg in 4 conscious female dogs administered perorally during 0-6 hr,9615.0,Intermediate,,,14450,,CHEMBL629768,1,BAO_0000218,,,,N,,,8310,Canis lupus familiaris,50588,A,,1
,Na+ excretion mequiv/kg in 4 saline-loaded mice administered at a dose 50 ml/kg perorally,10090.0,Intermediate,,,14451,,CHEMBL629769,1,BAO_0000218,,,,N,,,8310,Mus musculus,50594,A,,1
,Na+ excretion mequiv/kg in 6 conscious female dogs administered perorally during 0-6 hr,9615.0,Intermediate,,,14452,,CHEMBL629770,1,BAO_0000218,,,,N,,,8310,Canis lupus familiaris,50588,A,,1
,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 0.3 ml/kg perorally,9615.0,Intermediate,,,14453,,CHEMBL629771,1,BAO_0000218,,,,N,,,8310,Canis lupus familiaris,50588,A,,1
,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,10090.0,Intermediate,,,14454,,CHEMBL629772,1,BAO_0000218,,,,N,,,8310,Mus musculus,50594,A,,1
,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,10090.0,Intermediate,,,14455,,CHEMBL629773,1,BAO_0000218,,,,N,,,8310,Mus musculus,50594,A,,1
,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 2 ml/kg perorally,10090.0,Intermediate,,,14456,,CHEMBL625455,1,BAO_0000218,,,,N,,,8310,Mus musculus,50594,A,,1
,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 250 ml/kg perorally,10090.0,Intermediate,,,14457,,CHEMBL625456,1,BAO_0000218,,,,N,,,8310,Mus musculus,50594,A,,1
,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 3 ml/kg perorally,10090.0,Intermediate,,,14458,,CHEMBL625457,1,BAO_0000218,,,,N,,,8310,Mus musculus,50594,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 25.9 uM/Kg of drug,10116.0,Intermediate,,,14459,1088.0,CHEMBL625458,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 259 uM/Kg of drug,10116.0,Intermediate,,,14460,1088.0,CHEMBL625459,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 26.5 uM/Kg of drug,10116.0,Intermediate,,,14461,1088.0,CHEMBL875483,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 265 uM/Kg of drug,10116.0,Intermediate,,,14462,1088.0,CHEMBL634779,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27 uM/Kg of drug,10116.0,Intermediate,,,14463,1088.0,CHEMBL625460,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27.9 uM/Kg of drug,10116.0,Intermediate,,,14464,1088.0,CHEMBL626117,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 270 uM/Kg of drug,10116.0,Intermediate,,,14465,1088.0,CHEMBL626118,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 279 uM/Kg of drug,10116.0,Intermediate,,,14466,1088.0,CHEMBL628342,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.2 uM/Kg of drug,10116.0,Intermediate,,,14467,1088.0,CHEMBL628343,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.22 uM/Kg of drug,10116.0,Intermediate,,,14468,1088.0,CHEMBL628344,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.9 uM/Kg of drug,10116.0,Intermediate,,,14469,1088.0,CHEMBL628345,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 282 uM/Kg of drug,10116.0,Intermediate,,,14470,1088.0,CHEMBL628346,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 289 uM/Kg of drug,10116.0,Intermediate,,,14471,1088.0,CHEMBL628347,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.40 uM/Kg of drug,10116.0,Intermediate,,,14472,1088.0,CHEMBL628348,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.76 uM/Kg of drug,10116.0,Intermediate,,,14473,1088.0,CHEMBL628349,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 30.2 uM/Kg of drug,10116.0,Intermediate,,,14474,1088.0,CHEMBL875611,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 302 uM/Kg of drug,10116.0,Intermediate,,,14475,1088.0,CHEMBL628350,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 31.6 uM/Kg of drug,10116.0,Intermediate,,,14476,1088.0,CHEMBL628351,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 316 uM/Kg of drug,10116.0,Intermediate,,,14477,1088.0,CHEMBL628352,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 32.4 uM/Kg of drug,10116.0,Intermediate,,,14478,1088.0,CHEMBL628353,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 324 uM/Kg of drug,10116.0,Intermediate,,,14479,1088.0,CHEMBL628354,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.0 uM/Kg of drug,10116.0,Intermediate,,,14480,1088.0,CHEMBL626667,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.1 uM/Kg of drug,10116.0,Intermediate,,,14481,1088.0,CHEMBL626668,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.8 uM/Kg of drug,10116.0,Intermediate,,,14482,1088.0,CHEMBL626669,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 341 uM/Kg of drug,10116.0,Intermediate,,,14483,1088.0,CHEMBL626670,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 348 uM/Kg of drug,10116.0,Intermediate,,,14484,1088.0,CHEMBL626671,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 37.6 uM/Kg of drug,10116.0,Intermediate,,,14485,1088.0,CHEMBL626672,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 50.8 uM/Kg of drug,10116.0,Intermediate,,,14486,1088.0,CHEMBL626673,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 58.4 uM/Kg of drug,10116.0,Intermediate,,,14487,1088.0,CHEMBL626674,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 65.2 uM/Kg of drug,10116.0,Intermediate,,,14488,1088.0,CHEMBL626675,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 68.1 uM/Kg of drug,10116.0,Intermediate,,,14489,1088.0,CHEMBL626676,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 7.94 uM/Kg of drug,10116.0,Intermediate,,,14490,1088.0,CHEMBL626677,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.6 uM/Kg of drug,10116.0,Intermediate,,,14491,1088.0,CHEMBL626678,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.8 uM/Kg of drug,10116.0,Intermediate,,,14492,1088.0,CHEMBL626679,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 74.8 uM/Kg of drug,10116.0,Intermediate,,,14493,1088.0,CHEMBL875612,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 77.5 uM/Kg of drug,10116.0,Intermediate,,,14494,1088.0,CHEMBL626680,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 79.4 uM/Kg of drug,10116.0,Intermediate,,,14495,1088.0,CHEMBL626681,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 80.9 uM/Kg of drug,10116.0,Intermediate,,,14496,1088.0,CHEMBL626682,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 83.8 uM/Kg of drug,10116.0,Intermediate,,,14497,1088.0,CHEMBL626683,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.5 uM/Kg of drug,10116.0,Intermediate,,,14498,1088.0,CHEMBL626684,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.7 uM/Kg of drug,10116.0,Intermediate,,,14499,1088.0,CHEMBL626685,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.7 uM/Kg of drug,10116.0,Intermediate,,,14500,1088.0,CHEMBL626686,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.9 uM/Kg of drug,10116.0,Intermediate,,,14501,1088.0,CHEMBL626687,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 9.06 uM/Kg of drug,10116.0,Intermediate,,,14502,1088.0,CHEMBL624978,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 90.6 uM/Kg of drug,10116.0,Intermediate,,,14503,1088.0,CHEMBL624979,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 94.9 uM/Kg of drug,10116.0,Intermediate,,,14504,1088.0,CHEMBL624980,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of potassium in urine of rats after peroral administration of 97.1 uM/Kg of drug,10116.0,Intermediate,,,14505,1088.0,CHEMBL624981,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,9615.0,Intermediate,,,14506,1088.0,CHEMBL624982,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d),,Autocuration,,,14507,2367.0,CHEMBL627564,1,BAO_0000218,,In vivo,,U,,Prostate gland,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v),,Autocuration,,,14508,2367.0,CHEMBL627565,1,BAO_0000218,,In vivo,,U,,Prostate gland,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/blood,,Autocuration,,,14509,,CHEMBL627566,1,BAO_0000218,,In vivo,,U,,,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/muscle,,Autocuration,,,14510,2385.0,CHEMBL627567,1,BAO_0000218,,In vivo,,U,,Muscle tissue,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in spleen,,Autocuration,,,14511,2106.0,CHEMBL627568,1,BAO_0000218,,In vivo,,U,,Spleen,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hr in kidney,,Autocuration,,,14512,2113.0,CHEMBL627569,1,BAO_0000218,,In vivo,,U,,Kidney,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bladder,,Autocuration,,,14513,1255.0,CHEMBL627570,1,BAO_0000218,,In vivo,,U,,Urinary bladder,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in blood,,Autocuration,,,14514,178.0,CHEMBL627571,1,BAO_0000218,,In vivo,,U,,Blood,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bone,,Autocuration,,,14515,1474.0,CHEMBL627572,1,BAO_0000218,,In vivo,,U,,Bone element,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in fat,,Autocuration,,,14516,,CHEMBL627573,1,BAO_0000218,,In vivo,,U,,,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in kidney,,Autocuration,,,14517,2113.0,CHEMBL627574,1,BAO_0000218,,In vivo,,U,,Kidney,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in liver,,Autocuration,,,14518,2107.0,CHEMBL627575,1,BAO_0000218,,In vivo,,U,,Liver,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in lung,,Autocuration,,,14519,2048.0,CHEMBL627576,1,BAO_0000218,,In vivo,,U,,Lung,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in muscle,,Autocuration,,,14520,2385.0,CHEMBL627577,1,BAO_0000218,,In vivo,,U,,Muscle tissue,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d),,Autocuration,,,14521,2367.0,CHEMBL627578,1,BAO_0000218,,In vivo,,U,,Prostate gland,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/biood,,Autocuration,,,14522,2367.0,CHEMBL627579,1,BAO_0000218,,In vivo,,U,,Prostate gland,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/muscle,,Autocuration,,,14523,2385.0,CHEMBL627580,1,BAO_0000218,,In vivo,,U,,Muscle tissue,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v),,Autocuration,,,14524,2367.0,CHEMBL627581,1,BAO_0000218,,In vivo,,U,,Prostate gland,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/blood,,Autocuration,,,14525,,CHEMBL627582,1,BAO_0000218,,In vivo,,U,,,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/muscle,,Autocuration,,,14526,2385.0,CHEMBL627583,1,BAO_0000218,,In vivo,,U,,Muscle tissue,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in spleen,,Autocuration,,,14527,2106.0,CHEMBL627584,1,BAO_0000218,,In vivo,,U,,Spleen,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/biood,,Autocuration,,,14528,2367.0,CHEMBL627585,1,BAO_0000218,,In vivo,,U,,Prostate gland,13257,,22224,A,,0
,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/muscle,,Autocuration,,,14529,2385.0,CHEMBL627586,1,BAO_0000218,,In vivo,,U,,Muscle tissue,13257,,22224,A,,0
,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 200 nmol of WAY 100635,10116.0,Intermediate,,,14530,,CHEMBL627587,1,BAO_0000218,,In vivo,,N,,,15413,Rattus norvegicus,50597,A,,1
,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,10116.0,Intermediate,,,14531,,CHEMBL627588,1,BAO_0000218,,In vivo,,N,,,15413,Rattus norvegicus,50597,A,,1
,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 200 nmol of WAY 100635,10116.0,Intermediate,,,14532,,CHEMBL628250,1,BAO_0000218,,In vivo,,N,,,15413,Rattus norvegicus,50597,A,,1
,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,10116.0,Intermediate,,,14533,,CHEMBL628251,1,BAO_0000218,,In vivo,,N,,,15413,Rattus norvegicus,50597,A,,1
,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 200 nmol of WAY 100635,10116.0,Intermediate,,,14534,10000000.0,CHEMBL628252,1,BAO_0000218,,In vivo,,N,,Hippocampus,15413,Rattus norvegicus,50597,A,,1
,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,10116.0,Intermediate,,,14535,10000000.0,CHEMBL628253,1,BAO_0000218,,In vivo,,N,,Hippocampus,15413,Rattus norvegicus,50597,A,,1
,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 200 nmol of WAY 100635,10116.0,Intermediate,,,14536,1898.0,CHEMBL628254,1,BAO_0000218,,In vivo,,N,,Hypothalamus,15413,Rattus norvegicus,50597,A,,1
,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,10116.0,Intermediate,,,14537,1898.0,CHEMBL877493,1,BAO_0000218,,In vivo,,N,,Hypothalamus,15413,Rattus norvegicus,50597,A,,1
,Biodistribution of the Radiolabeled FCWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,10116.0,Intermediate,,,14538,,CHEMBL628255,1,BAO_0000218,,In vivo,,N,,,15413,Rattus norvegicus,50597,A,,1
,Biodistribution of the Radiolabeled FCWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,10116.0,Intermediate,,,14539,,CHEMBL628256,1,BAO_0000218,,In vivo,,N,,,15413,Rattus norvegicus,50597,A,,1
,Biodistribution of the Radiolabeled FCWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,10116.0,Intermediate,,,14540,10000000.0,CHEMBL628257,1,BAO_0000218,,In vivo,,N,,Hippocampus,15413,Rattus norvegicus,50597,A,,1
,Biodistribution of the Radiolabeled FCWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,10116.0,Intermediate,,,14541,1898.0,CHEMBL628258,1,BAO_0000218,,In vivo,,N,,Hypothalamus,15413,Rattus norvegicus,50597,A,,1
,Biodistribution of the Radiolabeled MeFBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,10116.0,Intermediate,,,14542,,CHEMBL628259,1,BAO_0000218,,In vivo,,N,,,15413,Rattus norvegicus,50597,A,,1
,Biodistribution of the Radiolabeled MeFBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,10116.0,Intermediate,,,14543,,CHEMBL628429,1,BAO_0000218,,In vivo,,N,,,15413,Rattus norvegicus,50597,A,,1
,Biodistribution of the Radiolabeled MeFBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,10116.0,Intermediate,,,14544,10000000.0,CHEMBL626862,1,BAO_0000218,,In vivo,,N,,Hippocampus,15413,Rattus norvegicus,50597,A,,1
,Biodistribution of the Radiolabeled MeFBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635; Not determined,10116.0,Intermediate,,,14545,1898.0,CHEMBL626863,1,BAO_0000218,,In vivo,,N,,Hypothalamus,15413,Rattus norvegicus,50597,A,,1
,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum,10116.0,Intermediate,,,14546,2037.0,CHEMBL625886,1,BAO_0000218,,In vivo,,N,,Cerebellum,15413,Rattus norvegicus,50597,A,,1
,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum co-injected with 50 nM of WAY 100635.,10116.0,Intermediate,,,14547,2037.0,CHEMBL625887,1,BAO_0000218,,In vivo,,N,,Cerebellum,15413,Rattus norvegicus,50597,A,,1
,Biodistribution of the [11C]-radiolabeled compound in rat cortex,10116.0,Intermediate,,,14548,,CHEMBL625888,1,BAO_0000218,,In vivo,,N,,,15413,Rattus norvegicus,50597,A,,1
,Biodistribution of the [11C]-radiolabeled compound in rat cortex co-injected with 50 nM of WAY 100635.,10116.0,Intermediate,,,14549,,CHEMBL625889,1,BAO_0000218,,In vivo,,N,,,15413,Rattus norvegicus,50597,A,,1
,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus,10116.0,Intermediate,,,14550,10000000.0,CHEMBL625890,1,BAO_0000218,,In vivo,,N,,Hippocampus,15413,Rattus norvegicus,50597,A,,1
,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus co-injected with 50 nM of WAY 100635.,10116.0,Intermediate,,,14551,10000000.0,CHEMBL625891,1,BAO_0000218,,In vivo,,N,,Hippocampus,15413,Rattus norvegicus,50597,A,,1
,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus,10116.0,Intermediate,,,14552,1898.0,CHEMBL625892,1,BAO_0000218,,In vivo,,N,,Hypothalamus,15413,Rattus norvegicus,50597,A,,1
,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus co-injected with 50 nM of WAY 100635.,10116.0,Intermediate,,,14553,1898.0,CHEMBL625893,1,BAO_0000218,,In vivo,,N,,Hypothalamus,15413,Rattus norvegicus,50597,A,,1
,Biodistribution of the [18F]-radiolabeled compound in rat cerebellum,10116.0,Intermediate,,,14554,2037.0,CHEMBL625894,1,BAO_0000218,,In vivo,,N,,Cerebellum,15413,Rattus norvegicus,50597,A,,1
,Biodistribution of the [18F]-radiolabeled compound in rat cortex,10116.0,Intermediate,,,14555,,CHEMBL625895,1,BAO_0000218,,In vivo,,N,,,15413,Rattus norvegicus,50597,A,,1
,Reaction rate parameter value for phosphate with transfer with respect to ATP,,Autocuration,,,14556,,CHEMBL625896,1,BAO_0000019,,,,U,,,12404,,22224,A,,0
,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 8.5(Apparent inhibition constant)",,Autocuration,,,14557,,CHEMBL625897,1,BAO_0000019,,,,U,,,568,,22224,A,,0
,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,Autocuration,,,14558,,CHEMBL625898,1,BAO_0000019,,,,U,,,568,,22224,A,,0
,"Tested for hydrolysis in presence of phenylboronic acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,Autocuration,,,14559,,CHEMBL625899,1,BAO_0000019,,,,U,,,568,,22224,A,,0
,Reaction rate parameter value for phosphate with transfer with respect to ATP,,Autocuration,,,14560,,CHEMBL626124,1,BAO_0000019,,,,U,,,12404,,22224,A,,0
,Ability to inhibit Escherichia coli adenylate kinase II activity expressed as half maximal velocity,562.0,Intermediate,,,14561,,CHEMBL628500,1,BAO_0000218,,,,N,,,7624,Escherichia coli,50212,A,,1
,"Ability to inhibit rat adenylate kinase II, activity expressed as half-maximal velocity",10116.0,Intermediate,,,14562,,CHEMBL857856,1,BAO_0000218,,,,N,,,7624,Rattus norvegicus,50597,A,,1
,"Ability to inhibit rat adenylate kinase III, activity expressed as half-maximal velocity",10116.0,Intermediate,,,14563,,CHEMBL628501,1,BAO_0000218,,,,N,,,7624,Rattus norvegicus,50597,A,,1
,"Compound was evaluated for the Michaelis-Menten constant, Km in a generic protein phosphatase stopped assay system",,Autocuration,,,14564,,CHEMBL628502,1,BAO_0000019,,,,U,,,4643,,22224,A,,0
,Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.,,Autocuration,,,14565,,CHEMBL628503,1,BAO_0000019,,,,U,,,11532,,22224,A,,0
,Kinetic parameter KM at pH 7.4 and 37 degree Centigrade,,Autocuration,,,14566,,CHEMBL628504,1,BAO_0000019,,,,U,,,11018,,22224,A,,0
,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,Autocuration,,,14567,,CHEMBL628505,1,BAO_0000019,,,,U,,,2276,,22224,A,,0
,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as KM",,Autocuration,,,14568,,CHEMBL874452,1,BAO_0000019,,,,U,,,2276,,22224,A,,0
,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as KM; Not determined",,Autocuration,,,14569,,CHEMBL628506,1,BAO_0000019,,,,U,,,2276,,22224,A,,0
,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,Autocuration,,,14570,,CHEMBL628507,1,BAO_0000019,,,,U,,,2276,,22224,A,,0
,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as KM",,Autocuration,,,14571,,CHEMBL628508,1,BAO_0000019,,,,U,,,2276,,22224,A,,0
,Michaelis constant (KM) was evaluated,,Autocuration,,,14572,,CHEMBL628509,1,BAO_0000019,,,,U,,,8949,,22224,A,,0
,Reaction rate parameter value for phosphate with transfer with respect to ATP,,Autocuration,,,14573,,CHEMBL628510,1,BAO_0000019,,,,U,,,12404,,22224,A,,0
,Substrate concentration for half maximal velocity was reported for rat hexokinase I,,Autocuration,,,14574,,CHEMBL628511,1,BAO_0000019,,,,U,,,7625,,22224,B,,0
,Substrate concentration for half maximal velocity was reported for rat hexokinase II,,Autocuration,,,14575,,CHEMBL628512,1,BAO_0000019,,,,U,,,7625,,22224,B,,0
,Substrate concentration for half maximal velocity was reported for rat hexokinase III,,Autocuration,,,14576,,CHEMBL628513,1,BAO_0000019,,,,U,,,7625,,22224,B,,0
,Substrate concentration for half maximal velocity was reported for yeast hexokinase,,Autocuration,,,14577,,CHEMBL628514,1,BAO_0000019,,,,U,,,7625,,22224,B,,0
,Pseudo-first-order rate constant for alkylation of NBP in 50% aqueous acetone at 66 degrees celsius with 50 uM and 25 uM of NBP.,,Autocuration,,,14578,,CHEMBL628515,1,BAO_0000019,,,,U,,,12908,,22224,A,,0
,Rate constant for alkylation of 4-(4-nitrobenzyl)pyridine,,Autocuration,,,14579,,CHEMBL628516,1,BAO_0000019,,,,U,,,10368,,22224,A,,0
,Bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,Autocuration,,,14580,,CHEMBL628517,1,BAO_0000019,,,,U,,,13108,,22224,A,,0
,its bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,Autocuration,,,14581,,CHEMBL628518,1,BAO_0000019,,,,U,,,13108,,22224,A,,0
,Acid dissociation constant evaluated towards Hematin mu-oxo dimer,,Autocuration,,,14582,,CHEMBL628519,1,BAO_0000019,,,,U,,,15217,,22224,A,,0
,Acid dissociation constant evaluated towards Hematin mu-oxo dimer; Not available,,Autocuration,,,14583,,CHEMBL628520,1,BAO_0000019,,,,U,,,15217,,22224,A,,0
,Binding constant was determined,,Autocuration,,,14584,,CHEMBL628521,1,BAO_0000019,,,,U,,,10933,,22224,A,,0
,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree Centigrade,,Autocuration,,,14585,,CHEMBL630443,1,BAO_0000019,,,,U,,,2363,,22224,A,,0
,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree centigrade; Not determined,,Autocuration,,,14586,,CHEMBL630444,1,BAO_0000019,,,,U,,,2363,,22224,A,,0
,Rate constant with triethylamine at 30 degree C in 0.1 M potassium chloride was expressed as Kamine,,Autocuration,,,14587,,CHEMBL857732,1,BAO_0000019,,,,U,,,2276,,22224,A,,0
,Octanol-water apparent distribution coefficient measured in TRIS buffer at a pH 7.4.,,Autocuration,,,14588,,CHEMBL630445,1,BAO_0000100,,,,U,,,14915,,22224,P,,0
,Catalytic rate constant of the compound,,Autocuration,,,14589,,CHEMBL630446,1,BAO_0000019,,,,U,,,8847,,22224,A,,0
,inactivation rate constant calculated from experimental IC50 value for dipeptidyl peptidase IV inhibition,,Autocuration,,,14590,,CHEMBL630447,1,BAO_0000019,,,,U,,,15357,,22224,B,,0
,Catalytic constant expressed as Kinetic behavior of enzyme (PicK/6-His),,Autocuration,,,14591,,CHEMBL630448,1,BAO_0000019,,,,U,,,2869,,22224,A,,0
,Catalytic rate constant against phospholipase A2 was determined,,Autocuration,,,14592,,CHEMBL630449,1,BAO_0000019,,,,U,,,3484,,22224,A,,0
,"Compound was evaluated for catalytic constant, Kcat",,Autocuration,,,14593,,CHEMBL630450,1,BAO_0000019,,,,U,,,1373,,22224,A,,0
,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined,,Autocuration,,,14594,,CHEMBL630451,1,BAO_0000019,,,,U,,,8142,,22224,A,,0
,Kcat calculated from 0.693/T1/2,,Autocuration,,,14595,,CHEMBL630452,1,BAO_0000019,,,,U,,,14131,,22224,A,,0
,Kcat was determined,,Autocuration,,,14596,,CHEMBL630453,1,BAO_0000019,,,,U,,,17269,,22224,A,,0
,Kcat against class A PCI beta-lactamase catalyzed lactone hydrolysis,,Autocuration,,,14597,,CHEMBL630454,1,BAO_0000019,,,,U,,,3485,,22224,A,,0
,Kcat against class A TEM beta-lactamase catalyzed lactone hydrolysis,,Autocuration,,,14598,,CHEMBL630455,1,BAO_0000019,,,,U,,,3485,,22224,A,,0
,Kcat against class C P99 beta-lactamase catalyzed lactone hydrolysis,,Autocuration,,,14599,,CHEMBL631487,1,BAO_0000019,,,,U,,,3485,,22224,A,,0
,Kcat value was determined,,Autocuration,,,14600,,CHEMBL631488,1,BAO_0000019,,,,U,,,5962,,22224,A,,0
,Kinetic constant for the hydrolysis by the catalyst CPA was evaluated,,Autocuration,,,14601,,CHEMBL876440,1,BAO_0000019,,,,U,,,3133,,22224,A,,0
,Kinetic constant for the hydrolysis by the catalyst McAbIIF9D8 was evaluated,,Autocuration,,,14602,,CHEMBL631489,1,BAO_0000019,,,,U,,,3133,,22224,A,,0
,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,Autocuration,,,14603,,CHEMBL857742,1,BAO_0000019,,,,U,,,2276,,22224,A,,0
,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat",,Autocuration,,,14604,,CHEMBL631490,1,BAO_0000019,,,,U,,,2276,,22224,A,,0
,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat; Not determined",,Autocuration,,,14605,,CHEMBL631491,1,BAO_0000019,,,,U,,,2276,,22224,A,,0
,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,Autocuration,,,14606,,CHEMBL631492,1,BAO_0000019,,,,U,,,2276,,22224,A,,0
,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat",,Autocuration,,,14607,,CHEMBL631493,1,BAO_0000019,,,,U,,,2276,,22224,A,,0
,Kinetic parameter for rate of conversion to PABA was determined,,Autocuration,,,14608,,CHEMBL631494,1,BAO_0000019,,,,U,,,4892,,22224,A,,0
,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,Autocuration,,,14609,,CHEMBL631495,1,BAO_0000019,,,,U,,,3133,,22224,A,,0
,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",10116.0,Intermediate,,,14610,1988.0,CHEMBL631496,1,BAO_0000218,,,,N,,Feces,11488,Rattus norvegicus,50597,A,,1
,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",10116.0,Intermediate,,,14611,1088.0,CHEMBL631497,1,BAO_0000218,,,,N,,Urine,11488,Rattus norvegicus,50597,A,,1
,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",10116.0,Intermediate,,,14612,1088.0,CHEMBL631498,1,BAO_0000218,,,,N,,Urine,11488,Rattus norvegicus,50597,A,,1
,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",10116.0,Intermediate,,,14613,1088.0,CHEMBL629776,1,BAO_0000218,,,,N,,Urine,11488,Rattus norvegicus,50597,A,,1
,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",10116.0,Intermediate,,,14614,1088.0,CHEMBL629777,1,BAO_0000218,,,,N,,Urine,11488,Rattus norvegicus,50597,A,,1
,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",10116.0,Intermediate,,,14615,1088.0,CHEMBL629778,1,BAO_0000218,,,,N,,Urine,11488,Rattus norvegicus,50597,A,,1
,Cumulative dose excreted after intraduodenal administration at 0-0.5 hours in rats,10116.0,Intermediate,,,14616,,CHEMBL630456,1,BAO_0000218,,,,N,,,11488,Rattus norvegicus,50597,A,,1
,Cumulative dose excreted after intraduodenal administration at 0.5-1.0 hours in rats,10116.0,Intermediate,,,14617,,CHEMBL630457,1,BAO_0000218,,,,N,,,11488,Rattus norvegicus,50597,A,,1
,Cumulative dose excreted after intraduodenal administration at 1.0-1.5 hours in rats,10116.0,Intermediate,,,14618,,CHEMBL630458,1,BAO_0000218,,,,N,,,11488,Rattus norvegicus,50597,A,,1
,Cumulative dose excreted after intraduodenal administration at 1.5-2.0 hours in rats,10116.0,Intermediate,,,14619,,CHEMBL630459,1,BAO_0000218,,,,N,,,11488,Rattus norvegicus,50597,A,,1
,Cumulative dose excreted after intraduodenal administration at 2-3 hours in rats,10116.0,Intermediate,,,14620,,CHEMBL630460,1,BAO_0000218,,,,N,,,11488,Rattus norvegicus,50597,A,,1
,Cumulative dose excreted after intraduodenal administration at 3-4 hours in rats,10116.0,Intermediate,,,14621,,CHEMBL876550,1,BAO_0000218,,,,N,,,11488,Rattus norvegicus,50597,A,,1
,Cumulative dose excreted after intraduodenal administration at 4-6 hours in rats,10116.0,Intermediate,,,14622,,CHEMBL630461,1,BAO_0000218,,,,N,,,11488,Rattus norvegicus,50597,A,,1
,Cumulative dose excreted after intraduodenal administration at 6-8 hours in rats,10116.0,Intermediate,,,14623,,CHEMBL630462,1,BAO_0000218,,,,N,,,11488,Rattus norvegicus,50597,A,,1
,Cumulative dose excreted after intraduodenal administration at 8-24 hours in rats,10116.0,Intermediate,,,14624,,CHEMBL630463,1,BAO_0000218,,,,N,,,11488,Rattus norvegicus,50597,A,,1
,Cumulative dose excreted after intravenous administration at 0-0.5 hours in rats,10116.0,Intermediate,,,14625,,CHEMBL630464,1,BAO_0000218,,,,N,,,11488,Rattus norvegicus,50597,A,,1
,Cumulative dose excreted after intravenous administration at 0.5-1 hours in rats,10116.0,Intermediate,,,14626,,CHEMBL630465,1,BAO_0000218,,,,N,,,11488,Rattus norvegicus,50597,A,,1
,Cumulative dose excreted after intravenous administration at 1.0-1.5 hours in rats,10116.0,Intermediate,,,14627,,CHEMBL630466,1,BAO_0000218,,,,N,,,11488,Rattus norvegicus,50597,A,,1
,Cumulative dose excreted after intravenous administration at 1.5-2 hours in rats,10116.0,Intermediate,,,14628,,CHEMBL630467,1,BAO_0000218,,,,N,,,11488,Rattus norvegicus,50597,A,,1
,Cumulative dose excreted after intravenous administration at 2-3 hours in rats,10116.0,Intermediate,,,14629,,CHEMBL630633,1,BAO_0000218,,,,N,,,11488,Rattus norvegicus,50597,A,,1
,Cumulative dose excreted after intravenous administration at 3-4 hours in rats,10116.0,Intermediate,,,14630,,CHEMBL630634,1,BAO_0000218,,,,N,,,11488,Rattus norvegicus,50597,A,,1
,Cumulative dose excreted after intravenous administration at 4-6 hours in rats,10116.0,Intermediate,,,14631,,CHEMBL630635,1,BAO_0000218,,,,N,,,11488,Rattus norvegicus,50597,A,,1
,Cumulative dose excreted after intravenous administration at 6-8 hours in rats,10116.0,Intermediate,,,14632,,CHEMBL630636,1,BAO_0000218,,,,N,,,11488,Rattus norvegicus,50597,A,,1
,Cumulative dose excreted after intravenous administration at 8-24 hours in rats,10116.0,Intermediate,,,14633,,CHEMBL630637,1,BAO_0000218,,,,N,,,11488,Rattus norvegicus,50597,A,,1
,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",9986.0,Intermediate,,,14634,1988.0,CHEMBL630638,1,BAO_0000218,,,,N,,Feces,7132,Oryctolagus cuniculus,50592,A,,1
,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",9986.0,Intermediate,,,14635,1988.0,CHEMBL630639,1,BAO_0000218,,,,N,,Feces,7132,Oryctolagus cuniculus,50592,A,,1
,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",9986.0,Intermediate,,,14636,1988.0,CHEMBL630640,1,BAO_0000218,,,,N,,Feces,7132,Oryctolagus cuniculus,50592,A,,1
,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",9986.0,Intermediate,,,14637,1988.0,CHEMBL876551,1,BAO_0000218,,,,N,,Feces,7132,Oryctolagus cuniculus,50592,A,,1
,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated (total)",9986.0,Intermediate,,,14638,1088.0,CHEMBL630641,1,BAO_0000218,,,,N,,Urine,7132,Oryctolagus cuniculus,50592,A,,1
,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",9986.0,Intermediate,,,14639,1088.0,CHEMBL630642,1,BAO_0000218,,,,N,,Urine,7132,Oryctolagus cuniculus,50592,A,,1
,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",9986.0,Intermediate,,,14640,1088.0,CHEMBL630643,1,BAO_0000218,,,,N,,Urine,7132,Oryctolagus cuniculus,50592,A,,1
,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",9986.0,Intermediate,,,14641,1088.0,CHEMBL630644,1,BAO_0000218,,,,N,,Urine,7132,Oryctolagus cuniculus,50592,A,,1
,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",9986.0,Intermediate,,,14642,1088.0,CHEMBL630645,1,BAO_0000218,,,,N,,Urine,7132,Oryctolagus cuniculus,50592,A,,1
,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",9986.0,Intermediate,,,14643,1988.0,CHEMBL625599,1,BAO_0000218,,,,N,,Feces,7132,Oryctolagus cuniculus,50592,A,,1
,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",9986.0,Intermediate,,,14644,1988.0,CHEMBL625600,1,BAO_0000218,,,,N,,Feces,7132,Oryctolagus cuniculus,50592,A,,1
,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",9986.0,Intermediate,,,14645,1988.0,CHEMBL625601,1,BAO_0000218,,,,N,,Feces,7132,Oryctolagus cuniculus,50592,A,,1
,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",9986.0,Intermediate,,,14646,1988.0,CHEMBL625602,1,BAO_0000218,,,,N,,Feces,7132,Oryctolagus cuniculus,50592,A,,1
,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated (total)",9986.0,Intermediate,,,14647,1088.0,CHEMBL627470,1,BAO_0000218,,,,N,,Urine,7132,Oryctolagus cuniculus,50592,A,,1
,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",9986.0,Intermediate,,,14648,1088.0,CHEMBL627471,1,BAO_0000218,,,,N,,Urine,7132,Oryctolagus cuniculus,50592,A,,1
,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",9986.0,Intermediate,,,14649,1088.0,CHEMBL627472,1,BAO_0000218,,,,N,,Urine,7132,Oryctolagus cuniculus,50592,A,,1
,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",9986.0,Intermediate,,,14650,1088.0,CHEMBL627473,1,BAO_0000218,,,,N,,Urine,7132,Oryctolagus cuniculus,50592,A,,1
,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",9986.0,Intermediate,,,14651,1088.0,CHEMBL627474,1,BAO_0000218,,,,N,,Urine,7132,Oryctolagus cuniculus,50592,A,,1
,Biodistribution in rat blood post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,10116.0,Intermediate,,,14652,178.0,CHEMBL627475,1,BAO_0000218,,In vivo,,N,,Blood,13925,Rattus norvegicus,50597,A,,1
,Biodistribution in rat blood post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,10116.0,Intermediate,,,14653,178.0,CHEMBL627476,1,BAO_0000218,,In vivo,,N,,Blood,13925,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,9615.0,Intermediate,,,14654,1088.0,CHEMBL627477,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,9615.0,Intermediate,,,14655,1088.0,CHEMBL627478,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,9615.0,Intermediate,,,14656,1088.0,CHEMBL627479,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,9615.0,Intermediate,,,14657,1088.0,CHEMBL627480,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,9615.0,Intermediate,,,14658,1088.0,CHEMBL627481,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,9615.0,Intermediate,,,14659,1088.0,CHEMBL627482,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,9615.0,Intermediate,,,14660,1088.0,CHEMBL627483,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,9615.0,Intermediate,,,14661,1088.0,CHEMBL875636,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,9615.0,Intermediate,,,14662,1088.0,CHEMBL625764,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,9615.0,Intermediate,,,14663,1088.0,CHEMBL625765,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 102 uM/Kg of drug,9615.0,Intermediate,,,14664,1088.0,CHEMBL625766,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,9615.0,Intermediate,,,14665,1088.0,CHEMBL625767,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,9615.0,Intermediate,,,14666,1088.0,CHEMBL625768,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 34.1 uM/Kg of drug,9615.0,Intermediate,,,14667,1088.0,CHEMBL625769,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 50.8 uM/Kg of drug,9615.0,Intermediate,,,14668,1088.0,CHEMBL625770,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 68.1 uM/Kg of drug,9615.0,Intermediate,,,14669,1088.0,CHEMBL625771,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.060 uM/Kg of drug,9615.0,Intermediate,,,14670,1088.0,CHEMBL625772,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,9615.0,Intermediate,,,14671,1088.0,CHEMBL625773,1,BAO_0000218,,,,N,,Urine,12582,Canis lupus familiaris,50588,A,,1
,Total electrolytic excretion of sodium in urine of rats after intravenous administration of 7.94 uM/Kg of drug,10116.0,Intermediate,,,14672,1088.0,CHEMBL625774,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 0 uM/Kg of drug,10116.0,Intermediate,,,14673,1088.0,CHEMBL625775,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.01 uM/Kg of drug,10116.0,Intermediate,,,14674,1088.0,CHEMBL625776,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.13 uM/Kg of drug,10116.0,Intermediate,,,14675,1088.0,CHEMBL625777,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 10.1 uM/Kg of drug,10116.0,Intermediate,,,14676,1088.0,CHEMBL625778,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 102 uM/Kg of drug,10116.0,Intermediate,,,14677,1088.0,CHEMBL625779,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 105 uM/Kg of drug,10116.0,Intermediate,,,14678,1088.0,CHEMBL625780,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 11.3 uM/Kg of drug,10116.0,Intermediate,,,14679,1088.0,CHEMBL625781,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 113 uM/Kg of drug,10116.0,Intermediate,,,14680,1088.0,CHEMBL875637,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 19.5 uM/Kg of drug,10116.0,Intermediate,,,14681,1088.0,CHEMBL626473,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 195 uM/Kg of drug,10116.0,Intermediate,,,14682,1088.0,CHEMBL626474,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 21.7 uM/Kg of drug,10116.0,Intermediate,,,14683,1088.0,CHEMBL626475,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 217 uM/Kg of drug,10116.0,Intermediate,,,14684,1088.0,CHEMBL626476,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 23.9 uM/Kg of drug,10116.0,Intermediate,,,14685,1088.0,CHEMBL634397,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 239 uM/Kg of drug,10116.0,Intermediate,,,14686,1088.0,CHEMBL626477,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 24.9 uM/Kg of drug,10116.0,Intermediate,,,14687,1088.0,CHEMBL631069,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 249 uM/Kg of drug,10116.0,Intermediate,,,14688,1088.0,CHEMBL631070,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 25.9 uM/Kg of drug,10116.0,Intermediate,,,14689,1088.0,CHEMBL631071,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 259 uM/Kg of drug,10116.0,Intermediate,,,14690,1088.0,CHEMBL631072,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 26.5 uM/Kg of drug,10116.0,Intermediate,,,14691,1088.0,CHEMBL631073,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 265 uM/Kg of drug,10116.0,Intermediate,,,14692,1088.0,CHEMBL631074,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27 uM/Kg of drug,10116.0,Intermediate,,,14693,1088.0,CHEMBL631075,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27.9 uM/Kg of drug,10116.0,Intermediate,,,14694,1088.0,CHEMBL631725,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 270 uM/Kg of drug,10116.0,Intermediate,,,14695,1088.0,CHEMBL631726,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 279 uM/Kg of drug,10116.0,Intermediate,,,14696,1088.0,CHEMBL631727,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.2 uM/Kg of drug,10116.0,Intermediate,,,14697,1088.0,CHEMBL631728,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.9 uM/Kg of drug,10116.0,Intermediate,,,14698,1088.0,CHEMBL631729,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 282 uM/Kg of drug,10116.0,Intermediate,,,14699,1088.0,CHEMBL631730,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 289 uM/Kg of drug,10116.0,Intermediate,,,14700,1088.0,CHEMBL631731,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.40 uM/Kg of drug,10116.0,Intermediate,,,14701,1088.0,CHEMBL631910,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Biodistribution of the [18F]-radiolabeled compound in rat hippocampus,10116.0,Intermediate,,,14702,10000000.0,CHEMBL631911,1,BAO_0000218,,In vivo,,N,,Hippocampus,15413,Rattus norvegicus,50597,A,,1
,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus,10116.0,Intermediate,,,14703,1898.0,CHEMBL631912,1,BAO_0000218,,In vivo,,N,,Hypothalamus,15413,Rattus norvegicus,50597,A,,1
,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus; Not determined,10116.0,Intermediate,,,14704,1898.0,CHEMBL631913,1,BAO_0000218,,In vivo,,N,,Hypothalamus,15413,Rattus norvegicus,50597,A,,1
,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14705,178.0,CHEMBL631914,1,BAO_0000218,,In vivo,,N,,Blood,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14706,178.0,CHEMBL631915,1,BAO_0000218,,In vivo,,N,,Blood,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),10116.0,Intermediate,,,14707,178.0,CHEMBL875778,1,BAO_0000218,,In vivo,,N,,Blood,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14708,178.0,CHEMBL631916,1,BAO_0000218,,In vivo,,N,,Blood,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14709,178.0,CHEMBL631917,1,BAO_0000218,,In vivo,,N,,Blood,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in blood of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14710,178.0,CHEMBL631918,1,BAO_0000218,,In vivo,,N,,Blood,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14711,178.0,CHEMBL631919,1,BAO_0000218,,In vivo,,N,,Blood,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),10116.0,Intermediate,,,14712,178.0,CHEMBL631920,1,BAO_0000218,,In vivo,,N,,Blood,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in blood of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14713,178.0,CHEMBL631921,1,BAO_0000218,,In vivo,,N,,Blood,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in blood of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14714,178.0,CHEMBL631922,1,BAO_0000218,,In vivo,,N,,Blood,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in blood of immature femalee rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),10116.0,Intermediate,,,14715,178.0,CHEMBL631923,1,BAO_0000218,,In vivo,,N,,Blood,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14716,,CHEMBL631924,1,BAO_0000218,,In vivo,,N,,,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14717,,CHEMBL630234,1,BAO_0000218,,In vivo,,N,,,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),10116.0,Intermediate,,,14718,,CHEMBL630235,1,BAO_0000218,,In vivo,,N,,,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14719,,CHEMBL630236,1,BAO_0000218,,In vivo,,N,,,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14720,,CHEMBL630237,1,BAO_0000218,,In vivo,,N,,,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in fat of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14721,,CHEMBL630238,1,BAO_0000218,,In vivo,,N,,,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14722,,CHEMBL630239,1,BAO_0000218,,In vivo,,N,,,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),10116.0,Intermediate,,,14723,,CHEMBL630303,1,BAO_0000218,,In vivo,,N,,,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in fat of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14724,,CHEMBL630304,1,BAO_0000218,,In vivo,,N,,,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in fat of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14725,,CHEMBL630305,1,BAO_0000218,,In vivo,,N,,,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14726,2113.0,CHEMBL630306,1,BAO_0000218,,In vivo,,N,,Kidney,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14727,2113.0,CHEMBL630307,1,BAO_0000218,,In vivo,,N,,Kidney,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),10116.0,Intermediate,,,14728,2113.0,CHEMBL630308,1,BAO_0000218,,In vivo,,N,,Kidney,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14729,2113.0,CHEMBL630309,1,BAO_0000218,,In vivo,,N,,Kidney,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14730,2113.0,CHEMBL629309,1,BAO_0000218,,In vivo,,N,,Kidney,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14731,2113.0,CHEMBL629993,1,BAO_0000218,,In vivo,,N,,Kidney,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14732,2113.0,CHEMBL629994,1,BAO_0000218,,In vivo,,N,,Kidney,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),10116.0,Intermediate,,,14733,2113.0,CHEMBL629995,1,BAO_0000218,,In vivo,,N,,Kidney,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in kidney of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14734,2113.0,CHEMBL631993,1,BAO_0000218,,In vivo,,N,,Kidney,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in kidney of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14735,2113.0,CHEMBL631994,1,BAO_0000218,,In vivo,,N,,Kidney,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14736,2113.0,CHEMBL631995,1,BAO_0000218,,In vivo,,N,,Kidney,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in liver of Iimmature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),10116.0,Intermediate,,,14737,2107.0,CHEMBL631996,1,BAO_0000218,,In vivo,,N,,Liver,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in liver of Iimmature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14738,2107.0,CHEMBL631997,1,BAO_0000218,,In vivo,,N,,Liver,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14739,2107.0,CHEMBL631998,1,BAO_0000218,,In vivo,,N,,Liver,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14740,2107.0,CHEMBL631999,1,BAO_0000218,,In vivo,,N,,Liver,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),10116.0,Intermediate,,,14741,2107.0,CHEMBL632000,1,BAO_0000218,,In vivo,,N,,Liver,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14742,2107.0,CHEMBL632001,1,BAO_0000218,,In vivo,,N,,Liver,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14743,2107.0,CHEMBL874424,1,BAO_0000218,,In vivo,,N,,Liver,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in liver of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14744,2107.0,CHEMBL632002,1,BAO_0000218,,In vivo,,N,,Liver,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14745,2107.0,CHEMBL632003,1,BAO_0000218,,In vivo,,N,,Liver,12017,Rattus norvegicus,50597,A,,1
,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,Autocuration,,,14746,,CHEMBL632004,1,BAO_0000019,,,,U,,,3133,,22224,A,,0
,Compound was tested for amidase rate in the presence of N62C fully characterised enzyme,,Autocuration,,,14747,,CHEMBL632005,1,BAO_0000019,,,,U,,,2742,,22224,A,,0
,Compound was tested for amidase rate in the presence of N62C screen enzyme,,Autocuration,,,14748,,CHEMBL632006,1,BAO_0000019,,,,U,,,2742,,22224,A,,0
,Compound was tested for amidase rate in the presence of S166C fully characterised enzyme,,Autocuration,,,14749,,CHEMBL632007,1,BAO_0000019,,,,U,,,2742,,22224,A,,0
,Compound was tested for amidase rate in the presence of S166C screen enzyme,,Autocuration,,,14750,,CHEMBL632008,1,BAO_0000019,,,,U,,,2742,,22224,A,,0
,Compound was tested for esterase rate in the presence of N62C fully characterised enzyme,,Autocuration,,,14751,,CHEMBL632009,1,BAO_0000019,,,,U,,,2742,,22224,A,,0
,Compound was tested for esterase rate in the presence of N62C screen enzyme,,Autocuration,,,14752,,CHEMBL632010,1,BAO_0000019,,,,U,,,2742,,22224,A,,0
,Compound was tested for esterase rate in the presence of S166C fully characterised enzyme,,Autocuration,,,14753,,CHEMBL857750,1,BAO_0000019,,,,U,,,2742,,22224,A,,0
,Compound was tested for esterase rate in the presence of S166C screen enzyme,,Autocuration,,,14754,,CHEMBL632011,1,BAO_0000019,,,,U,,,2742,,22224,A,,0
,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,Autocuration,,,14755,,CHEMBL632012,1,BAO_0000019,,,,U,,,2276,,22224,A,,0
,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,Autocuration,,,14756,,CHEMBL632013,1,BAO_0000019,,,,U,,,2276,,22224,A,,0
,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat/KM",,Autocuration,,,14757,,CHEMBL632014,1,BAO_0000019,,,,U,,,2276,,22224,A,,0
,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,Autocuration,,,14758,,CHEMBL629622,1,BAO_0000019,,,,U,,,2276,,22224,A,,0
,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,Autocuration,,,14759,,CHEMBL629623,1,BAO_0000019,,,,U,,,2276,,22224,A,,0
,"Rate constant at 30 degree C in phosphate buffer pH 7.1, 0.5 % acetonitrile was expressed as Kcat/KM",,Autocuration,,,14760,,CHEMBL629624,1,BAO_0000019,,,,U,,,2276,,22224,A,,0
,Ratio of Kcat to that of Km was determined,,Autocuration,,,14761,,CHEMBL629625,1,BAO_0000019,,,,U,,,17269,,22224,A,,0
,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,Autocuration,,,14762,,CHEMBL629626,1,BAO_0000019,,,,U,,,2276,,22224,A,,0
,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,Autocuration,,,14763,,CHEMBL629627,1,BAO_0000019,,,,U,,,2276,,22224,A,,0
,"Compound was evaluated for constant, Kd",,Autocuration,,,14764,,CHEMBL629628,1,BAO_0000019,,,,U,,,15917,,22224,A,,0
,Deacylation rate constant(Kd fast) was determined by proflavin displacement assay,,Autocuration,,,14765,,CHEMBL629629,1,BAO_0000019,,,,U,,,10933,,22224,A,,0
,Deacylation rate constant(Kd slow) was determined by proflavin displacement assay,,Autocuration,,,14766,,CHEMBL629630,1,BAO_0000019,,,,U,,,10933,,22224,A,,0
,Dissociation Constant of compound determined,,Autocuration,,,14767,,CHEMBL856030,1,BAO_0000019,,,,U,,,14293,,22224,A,,0
,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined,,Autocuration,,,14768,,CHEMBL629631,1,BAO_0000019,,,,U,,,6698,,22224,B,,0
,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined; No data,,Autocuration,,,14769,,CHEMBL629632,1,BAO_0000019,,,,U,,,6698,,22224,B,,0
,Dissociation constant of compound with Fructose was determined,,Autocuration,,,14770,,CHEMBL629633,1,BAO_0000100,,,,U,,,4318,,22224,P,,0
,Dissociation constant of compound with Fructose was determined; Not determined,,Autocuration,,,14771,,CHEMBL629634,1,BAO_0000100,,,,U,,,4318,,22224,P,,0
,Dissociation constant of compound with Lactulose was determined,,Autocuration,,,14772,,CHEMBL629635,1,BAO_0000100,,,,U,,,4318,,22224,P,,0
,Dissociation constant of compound with Lactulose was determined; Not determined,,Autocuration,,,14773,,CHEMBL629636,1,BAO_0000100,,,,U,,,4318,,22224,P,,0
,Dissociation constant of the Compound,,Autocuration,,,14774,,CHEMBL629637,1,BAO_0000100,,,,U,,,14959,,22224,P,,0
,Dissociation constant by non-linear regression analysis,,Autocuration,,,14775,,CHEMBL629638,1,BAO_0000100,,,,U,,,5913,,22224,P,,0
,Dissociation constant was determined,,Autocuration,,,14776,,CHEMBL629639,1,BAO_0000100,,,,U,,,14218,,22224,P,,0
,Dissociation constant of the compound; value ranges from 0.81-1.2 nM,,Autocuration,,,14777,,CHEMBL629640,1,BAO_0000100,,,,U,,,10689,,22224,P,,0
,Dissociation constant was determined,,Autocuration,,,14778,,CHEMBL629641,1,BAO_0000100,,,,U,,,13925,,22224,P,,0
,Dissociation constant was determined,,Autocuration,,,14779,,CHEMBL631344,1,BAO_0000100,,,,U,,,16359,,22224,P,,0
,Equilibrium dissociation constant based on membrane concentration in rat smooth muscle,10116.0,Intermediate,,,14780,2385.0,CHEMBL631345,1,BAO_0000218,,,,N,,Muscle tissue,10944,Rattus norvegicus,50597,A,,1
,The dissociation constant determined by fluorescence displacement assay,,Autocuration,,,14781,,CHEMBL631346,1,BAO_0000019,,,,U,,,11080,,22224,A,,0
,kd value surface plasmon resonance (SPR) method,,Autocuration,,,14782,,CHEMBL631524,1,BAO_0000019,,,,U,,,17805,,22224,A,,0
,Equilibrium dissociation constant based on aqueous concentration in rat smooth muscle,10116.0,Intermediate,,,14783,2385.0,CHEMBL631525,1,BAO_0000218,,,,N,,Muscle tissue,10944,Rattus norvegicus,50597,A,,1
,First dissociation constant of the binding of compound to V30M TTR,,Autocuration,,,14784,,CHEMBL631526,1,BAO_0000019,,,,U,,,16645,,22224,F,,0
,Second dissociation constant of the binding of compound to V30M TTR,,Autocuration,,,14785,,CHEMBL631527,1,BAO_0000019,,,,U,,,16645,,22224,F,,0
,"Compound was evaluated for equilibrium constant, Ke",,Autocuration,,,14786,,CHEMBL631528,1,BAO_0000019,,,,U,,,7793,,22224,A,,0
,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus,,Autocuration,,,14787,1898.0,CHEMBL631529,1,BAO_0000019,,,,U,,Hypothalamus,12199,,22224,A,,0
,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus; inactive,,Autocuration,,,14788,1898.0,CHEMBL631530,1,BAO_0000019,,,,U,,Hypothalamus,12199,,22224,A,,0
,Keff is the effective biomolecular rate constant on VX for reactivation at pH 7.8 at 25 degree Centigrade,,Autocuration,,,14789,,CHEMBL631531,1,BAO_0000019,,,,U,,,9680,,22224,A,,0
,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,,Autocuration,,,14790,,CHEMBL631532,1,BAO_0000019,,,,U,,,9680,,22224,A,,0
,Keff is the effective biomolecular rate constant on sarin for reactivation at pH 7.8 at 25 degree Centigrade,,Autocuration,,,14791,,CHEMBL631533,1,BAO_0000019,,,,U,,,9680,,22224,A,,0
,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,10090.0,Intermediate,,,14792,,CHEMBL876552,1,BAO_0000218,,,,N,,,13758,Mus musculus,50594,A,,1
,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,10090.0,Intermediate,,,14793,,CHEMBL631534,1,BAO_0000218,,,,N,,,13758,Mus musculus,50594,A,,1
,In vitro biotransformation of compound in mice brain homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,10090.0,Intermediate,,,14794,,CHEMBL631535,1,BAO_0000218,,,,N,,,13758,Mus musculus,50594,A,,1
,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,10090.0,Intermediate,,,14795,,CHEMBL631536,1,BAO_0000218,,,,N,,,13758,Mus musculus,50594,A,,1
,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-hypoxanthine(ara-H) analyte,10090.0,Intermediate,,,14796,,CHEMBL631537,1,BAO_0000218,,,,N,,,13758,Mus musculus,50594,A,,1
,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,10090.0,Intermediate,,,14797,,CHEMBL631538,1,BAO_0000218,,,,N,,,13758,Mus musculus,50594,A,,1
,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-H) analyte,10090.0,Intermediate,,,14798,,CHEMBL631539,1,BAO_0000218,,,,N,,,13758,Mus musculus,50594,A,,1
,In vitro biotransformation of compound in mice serum 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,10090.0,Intermediate,,,14799,,CHEMBL631540,1,BAO_0000218,,,,N,,,13758,Mus musculus,50594,A,,1
,Pharmacokinetic Parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,10116.0,Intermediate,,,14800,,CHEMBL625637,1,BAO_0000218,,,,N,,,14393,Rattus norvegicus,50597,A,,1
,Pharmacokinetic parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,10116.0,Intermediate,,,14801,,CHEMBL625638,1,BAO_0000218,,,,N,,,14393,Rattus norvegicus,50597,A,,1
,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",10116.0,Intermediate,,,14802,,CHEMBL625639,1,BAO_0000218,,,,N,,,15078,Rattus norvegicus,50597,A,,1
,Biodistribution in rat brain post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,10116.0,Intermediate,,,14803,955.0,CHEMBL625640,1,BAO_0000218,,In vivo,,N,,Brain,13925,Rattus norvegicus,50597,A,,1
,Biodistribution in rat brain post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,10116.0,Intermediate,,,14804,955.0,CHEMBL625641,1,BAO_0000218,,In vivo,,N,,Brain,13925,Rattus norvegicus,50597,A,,1
,Biodistribution in rat heart post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,10116.0,Intermediate,,,14805,948.0,CHEMBL625642,1,BAO_0000218,,In vivo,,N,,Heart,13925,Rattus norvegicus,50597,A,,1
,Biodistribution in rat heart post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,10116.0,Intermediate,,,14806,948.0,CHEMBL625643,1,BAO_0000218,,In vivo,,N,,Heart,13925,Rattus norvegicus,50597,A,,1
,Biodistribution in rat kidney post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,10116.0,Intermediate,,,14807,2113.0,CHEMBL625644,1,BAO_0000218,,In vivo,,N,,Kidney,13925,Rattus norvegicus,50597,A,,1
,Biodistribution in rat kidney post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,10116.0,Intermediate,,,14808,2113.0,CHEMBL625645,1,BAO_0000218,,In vivo,,N,,Kidney,13925,Rattus norvegicus,50597,A,,1
,Biodistribution in rat liver post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,10116.0,Intermediate,,,14809,2107.0,CHEMBL625646,1,BAO_0000218,,In vivo,,N,,Liver,13925,Rattus norvegicus,50597,A,,1
,Biodistribution in rat liver post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,10116.0,Intermediate,,,14810,2107.0,CHEMBL625647,1,BAO_0000218,,In vivo,,N,,Liver,13925,Rattus norvegicus,50597,A,,1
,Biodistribution in rat lung post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,10116.0,Intermediate,,,14811,2048.0,CHEMBL625648,1,BAO_0000218,,In vivo,,N,,Lung,13925,Rattus norvegicus,50597,A,,1
,Biodistribution in rat lung post intravenous injection for 60 min of [99mTc]-TRODAT ligand expressed as percent dose per organ,10116.0,Intermediate,,,14812,2048.0,CHEMBL625649,1,BAO_0000218,,In vivo,,N,,Lung,13925,Rattus norvegicus,50597,A,,1
,Biodistribution in rat muscle post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,10116.0,Intermediate,,,14813,2385.0,CHEMBL625650,1,BAO_0000218,,In vivo,,N,,Muscle tissue,13925,Rattus norvegicus,50597,A,,1
,Biodistribution in rat muscle post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,10116.0,Intermediate,,,14814,2385.0,CHEMBL625651,1,BAO_0000218,,In vivo,,N,,Muscle tissue,13925,Rattus norvegicus,50597,A,,1
,Biodistribution in rat skin post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,10116.0,Intermediate,,,14815,14.0,CHEMBL625652,1,BAO_0000218,,In vivo,,N,,Zone of skin,13925,Rattus norvegicus,50597,A,,1
,Biodistribution in rat skin post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,10116.0,Intermediate,,,14816,14.0,CHEMBL625653,1,BAO_0000218,,In vivo,,N,,Zone of skin,13925,Rattus norvegicus,50597,A,,1
,Biodistribution in rat spleen post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,10116.0,Intermediate,,,14817,2106.0,CHEMBL625654,1,BAO_0000218,,In vivo,,N,,Spleen,13925,Rattus norvegicus,50597,A,,1
,Biodistribution in rat spleen post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,10116.0,Intermediate,,,14818,2106.0,CHEMBL625655,1,BAO_0000218,,In vivo,,N,,Spleen,13925,Rattus norvegicus,50597,A,,1
,Biodistribution of Compound in rat blood after 15 minutes of administration,10116.0,Intermediate,,,14819,178.0,CHEMBL625656,1,BAO_0000218,,In vivo,,N,,Blood,9712,Rattus norvegicus,50597,A,,1
,Biodistribution of Compound in rat blood after 2 minutes of administration,10116.0,Intermediate,,,14820,178.0,CHEMBL625657,1,BAO_0000218,,In vivo,,N,,Blood,9712,Rattus norvegicus,50597,A,,1
,Biodistribution of Compound in rat brain after 15 minutes of administration,10116.0,Intermediate,,,14821,955.0,CHEMBL625658,1,BAO_0000218,,In vivo,,N,,Brain,9712,Rattus norvegicus,50597,A,,1
,Biodistribution of Compound in rat brain after 2 minutes of administration,10116.0,Intermediate,,,14822,955.0,CHEMBL625659,1,BAO_0000218,,In vivo,,N,,Brain,9712,Rattus norvegicus,50597,A,,1
,Biodistribution of Compound in rat heart after 15 minutes of administration,10116.0,Intermediate,,,14823,948.0,CHEMBL625660,1,BAO_0000218,,In vivo,,N,,Heart,9712,Rattus norvegicus,50597,A,,1
,Biodistribution of Compound in rat heart after 2 minutes of administration,10116.0,Intermediate,,,14824,948.0,CHEMBL625661,1,BAO_0000218,,In vivo,,N,,Heart,9712,Rattus norvegicus,50597,A,,1
,Biodistribution of Compound in rat liver after 15 minutes of administration,10116.0,Intermediate,,,14825,2107.0,CHEMBL625662,1,BAO_0000218,,In vivo,,N,,Liver,9712,Rattus norvegicus,50597,A,,1
,Biodistribution of Compound in rat liver after 2 minutes of administration,10116.0,Intermediate,,,14826,2107.0,CHEMBL625663,1,BAO_0000218,,In vivo,,N,,Liver,9712,Rattus norvegicus,50597,A,,1
,Biodistribution of Compound in rat lung after 15 minutes of administration,10116.0,Intermediate,,,14827,2048.0,CHEMBL875621,1,BAO_0000218,,In vivo,,N,,Lung,9712,Rattus norvegicus,50597,A,,1
,Biodistribution of Compound in rat lung after 2 minutes of administration,10116.0,Intermediate,,,14828,2048.0,CHEMBL628382,1,BAO_0000218,,In vivo,,N,,Lung,9712,Rattus norvegicus,50597,A,,1
,Biodistribution of Compound in rat muscle after 15 minutes of administration,10116.0,Intermediate,,,14829,2385.0,CHEMBL628383,1,BAO_0000218,,In vivo,,N,,Muscle tissue,9712,Rattus norvegicus,50597,A,,1
,Biodistribution of Compound in rat muscle after 2 minutes of administration,10116.0,Intermediate,,,14830,2385.0,CHEMBL628384,1,BAO_0000218,,In vivo,,N,,Muscle tissue,9712,Rattus norvegicus,50597,A,,1
,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 2 mins,10116.0,Intermediate,,,14831,,CHEMBL628385,1,BAO_0000218,,,,N,,,13925,Rattus norvegicus,50597,A,,1
,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 30 mins,10116.0,Intermediate,,,14832,,CHEMBL875753,1,BAO_0000218,,,,N,,,13925,Rattus norvegicus,50597,A,,1
,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 60 mins,10116.0,Intermediate,,,14833,,CHEMBL628386,1,BAO_0000218,,,,N,,,13925,Rattus norvegicus,50597,A,,1
,Organ distribution in rat blood 2 minutes after intravenous injection,10116.0,Intermediate,,,14834,,CHEMBL628387,1,BAO_0000218,,,,N,,,6941,Rattus norvegicus,50597,A,,1
,Organ distribution in rat blood 2 hr after intravenous injection,10116.0,Intermediate,,,14835,,CHEMBL628388,1,BAO_0000218,,,,N,,,6941,Rattus norvegicus,50597,A,,1
,Organ distribution in rat blood 30 minutes after intravenous injection,10116.0,Intermediate,,,14836,,CHEMBL628389,1,BAO_0000218,,,,N,,,6941,Rattus norvegicus,50597,A,,1
,Organ distribution in rat blood 30 min after intravenous injection,10116.0,Intermediate,,,14837,,CHEMBL632756,1,BAO_0000218,,,,N,,,6941,Rattus norvegicus,50597,A,,1
,Organ distribution in rat brain 2 minutes after intravenous injection,10116.0,Intermediate,,,14838,,CHEMBL628390,1,BAO_0000218,,,,N,,,6941,Rattus norvegicus,50597,A,,1
,Organ distribution in rat brain 2 hr after intravenous injection,10116.0,Intermediate,,,14839,,CHEMBL631811,1,BAO_0000218,,,,N,,,6941,Rattus norvegicus,50597,A,,1
,Organ distribution in rat brain 30 minutes after intravenous injection,10116.0,Intermediate,,,14840,,CHEMBL631812,1,BAO_0000218,,,,N,,,6941,Rattus norvegicus,50597,A,,1
,Organ distribution in rat heart 2 minutes after intravenous injection,10116.0,Intermediate,,,14841,,CHEMBL631813,1,BAO_0000218,,,,N,,,6941,Rattus norvegicus,50597,A,,1
,Organ distribution in rat heart 2 hr after intravenous injection,10116.0,Intermediate,,,14842,,CHEMBL631814,1,BAO_0000218,,,,N,,,6941,Rattus norvegicus,50597,A,,1
,Organ distribution in rat heart 30 minutes after intravenous injection,10116.0,Intermediate,,,14843,,CHEMBL631815,1,BAO_0000218,,,,N,,,6941,Rattus norvegicus,50597,A,,1
,Organ distribution in rat kidney 2 minutes after intravenous injection,10116.0,Intermediate,,,14844,,CHEMBL631816,1,BAO_0000218,,,,N,,,6941,Rattus norvegicus,50597,A,,1
,Organ distribution in rat kidney 2 hr after intravenous injection,10116.0,Intermediate,,,14845,,CHEMBL875758,1,BAO_0000218,,,,N,,,6941,Rattus norvegicus,50597,A,,1
,Organ distribution in rat kidney 30 minutes after intravenous injection,10116.0,Intermediate,,,14846,,CHEMBL631817,1,BAO_0000218,,,,N,,,6941,Rattus norvegicus,50597,A,,1
,Organ distribution in rat liver 2 minutes after intravenous injection,10116.0,Intermediate,,,14847,2107.0,CHEMBL631818,1,BAO_0000218,,,,N,,Liver,6941,Rattus norvegicus,50597,A,,1
,Organ distribution in rat liver 2 hr after intravenous injection,10116.0,Intermediate,,,14848,2107.0,CHEMBL631819,1,BAO_0000218,,,,N,,Liver,6941,Rattus norvegicus,50597,A,,1
,Organ distribution in rat liver 30 minutes after intravenous injection,10116.0,Intermediate,,,14849,2107.0,CHEMBL631820,1,BAO_0000218,,,,N,,Liver,6941,Rattus norvegicus,50597,A,,1
,Organ distribution in rat lung 2 minutes after intravenous injection,10116.0,Intermediate,,,14850,,CHEMBL631821,1,BAO_0000218,,,,N,,,6941,Rattus norvegicus,50597,A,,1
,Organ distribution in rat lung 2 hr after intravenous injection,10116.0,Intermediate,,,14851,,CHEMBL631822,1,BAO_0000218,,,,N,,,6941,Rattus norvegicus,50597,A,,1
,Organ distribution in rat lung 30 minutes after intravenous injection,10116.0,Intermediate,,,14852,,CHEMBL631823,1,BAO_0000218,,,,N,,,6941,Rattus norvegicus,50597,A,,1
,Organ distribution in rat muscle 2 minutes after intravenous injection,10116.0,Intermediate,,,14853,2385.0,CHEMBL631824,1,BAO_0000218,,,,N,,Muscle tissue,6941,Rattus norvegicus,50597,A,,1
,Organ distribution in rat muscle 2 hr after intravenous injection,10116.0,Intermediate,,,14854,2385.0,CHEMBL631825,1,BAO_0000218,,,,N,,Muscle tissue,6941,Rattus norvegicus,50597,A,,1
,Organ distribution in rat muscle 30 minutes after intravenous injection,10116.0,Intermediate,,,14855,2385.0,CHEMBL631826,1,BAO_0000218,,,,N,,Muscle tissue,6941,Rattus norvegicus,50597,A,,1
,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Blood (B),10090.0,Intermediate,,,14856,,CHEMBL631827,1,BAO_0000218,,In vivo,,N,,,14439,Mus musculus,50594,A,,1
,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Heart (H),10090.0,Intermediate,,,14857,,CHEMBL631828,1,BAO_0000218,,In vivo,,N,,,14439,Mus musculus,50594,A,,1
,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Lung (L),10090.0,Intermediate,,,14858,,CHEMBL631829,1,BAO_0000218,,In vivo,,N,,,14439,Mus musculus,50594,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.76 uM/Kg of drug,10116.0,Intermediate,,,14859,1088.0,CHEMBL875759,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 30.20 uM/Kg of drug,10116.0,Intermediate,,,14860,1088.0,CHEMBL631830,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 302 uM/Kg of drug,10116.0,Intermediate,,,14861,1088.0,CHEMBL631831,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 31.6 uM/Kg of drug,10116.0,Intermediate,,,14862,1088.0,CHEMBL631832,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 316 uM/Kg of drug,10116.0,Intermediate,,,14863,1088.0,CHEMBL631833,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 32.4 uM/Kg of drug,10116.0,Intermediate,,,14864,1088.0,CHEMBL631834,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 324 uM/Kg of drug,10116.0,Intermediate,,,14865,1088.0,CHEMBL631835,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.0 uM/Kg of drug,10116.0,Intermediate,,,14866,1088.0,CHEMBL631836,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.1 uM/Kg of drug,10116.0,Intermediate,,,14867,1088.0,CHEMBL631837,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.8 uM/Kg of drug,10116.0,Intermediate,,,14868,1088.0,CHEMBL631838,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 341 uM/Kg of drug,10116.0,Intermediate,,,14869,1088.0,CHEMBL631839,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 348 uM/Kg of drug,10116.0,Intermediate,,,14870,1088.0,CHEMBL631840,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 37.6 uM/Kg of drug,10116.0,Intermediate,,,14871,1088.0,CHEMBL631841,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 58.4 uM/Kg of drug,10116.0,Intermediate,,,14872,1088.0,CHEMBL631842,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 65.2 uM/Kg of drug,10116.0,Intermediate,,,14873,1088.0,CHEMBL631843,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.6 uM/Kg of drug,10116.0,Intermediate,,,14874,1088.0,CHEMBL631844,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.8 uM/Kg of drug,10116.0,Intermediate,,,14875,1088.0,CHEMBL631845,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 74.8 uM/Kg of drug,10116.0,Intermediate,,,14876,1088.0,CHEMBL631846,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 77.5 uM/Kg of drug,10116.0,Intermediate,,,14877,1088.0,CHEMBL875760,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 79.4 uM/Kg of drug,10116.0,Intermediate,,,14878,1088.0,CHEMBL632199,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 80.9 uM/Kg of drug,10116.0,Intermediate,,,14879,1088.0,CHEMBL631847,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 83.8 uM/Kg of drug,10116.0,Intermediate,,,14880,1088.0,CHEMBL631848,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.5 uM/Kg of drug,10116.0,Intermediate,,,14881,1088.0,CHEMBL628707,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.7 uM/Kg of drug,10116.0,Intermediate,,,14882,1088.0,CHEMBL628708,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.7 uM/Kg of drug,10116.0,Intermediate,,,14883,1088.0,CHEMBL628709,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.9 uM/Kg of drug,10116.0,Intermediate,,,14884,1088.0,CHEMBL628710,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 9.06 uM/Kg of drug,10116.0,Intermediate,,,14885,1088.0,CHEMBL628711,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 90.6 uM/Kg of drug,10116.0,Intermediate,,,14886,1088.0,CHEMBL628712,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 94.9 uM/Kg of drug,10116.0,Intermediate,,,14887,1088.0,CHEMBL628713,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,Total electrolytic excretion of sodium in urine of rats after peroral administration of 97.1 uM/Kg of drug,10116.0,Intermediate,,,14888,1088.0,CHEMBL628714,1,BAO_0000218,,,,N,,Urine,12582,Rattus norvegicus,50597,A,,1
,"excretion rate in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour Rate of biliary excretion; 0.06-0.15%/h",10116.0,Intermediate,,,14889,,CHEMBL628715,1,BAO_0000218,,,,N,,,7415,Rattus norvegicus,50597,A,,1
,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 3.75-120 uM,,Autocuration,,,14890,,CHEMBL629179,1,BAO_0000019,,,,U,,,7313,,22224,A,,0
,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 30 uM,,Autocuration,,,14891,,CHEMBL629180,1,BAO_0000019,,,,U,,,7313,,22224,A,,0
,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 7.5-120 uM,,Autocuration,,,14892,,CHEMBL875108,1,BAO_0000019,,,,U,,,7313,,22224,A,,0
,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,,Autocuration,,,14893,1235.0,CHEMBL629181,1,BAO_0000019,,,,U,,Adrenal cortex,7570,,22224,A,,0
,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,,Autocuration,,,14894,1235.0,CHEMBL629182,1,BAO_0000019,,,,U,,Adrenal cortex,7570,,22224,A,,0
,Percent lipid extracted at 0.5 hr from liver plasma using CHCl3/CH3OH.,,Autocuration,,,14895,,CHEMBL629183,1,BAO_0000019,,,,U,,,7570,,22224,A,,0
,Percent lipid extracted at 0.5 hr from liver using CHCl3/CH3OH.,,Autocuration,,,14896,,CHEMBL629184,1,BAO_0000019,,,,U,,,7570,,22224,A,,0
,Percent lipid extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,,Autocuration,,,14897,1235.0,CHEMBL629185,1,BAO_0000019,,,,U,,Adrenal cortex,7570,,22224,A,,0
,Percent lipid extracted at 24 hours from adrenal cortex liver using CHCl3/CH3OH.,,Autocuration,,,14898,1235.0,CHEMBL629186,1,BAO_0000019,,,,U,,Adrenal cortex,7570,,22224,A,,0
,Percent lipid extracted at 24 hours from liverliver using CHCl3/CH3OH.,,Autocuration,,,14899,,CHEMBL629187,1,BAO_0000019,,,,U,,,7570,,22224,A,,0
,Percent lipid extracted at 24 hours from plasma using CHCl3/CH3OH.,,Autocuration,,,14900,,CHEMBL629887,1,BAO_0000019,,,,U,,,7570,,22224,A,,0
,Percent lipid extracted at 24 hours from plasmaliver using CHCl3/CH3OH.,,Autocuration,,,14901,,CHEMBL629888,1,BAO_0000019,,,,U,,,7570,,22224,A,,0
,Percent lipid extracted at 24 hr from liver using CHCl3/CH3OH.,,Autocuration,,,14902,,CHEMBL629889,1,BAO_0000019,,,,U,,,7570,,22224,A,,0
,Percent parent compound extracted at 0.5 hr from adrenal cortex using CHCl3/CH3OH.,,Autocuration,,,14903,1235.0,CHEMBL629890,1,BAO_0000019,,,,U,,Adrenal cortex,7570,,22224,A,,0
,Percent parent compound extracted at 0.5 hr from liver using CHCl3/CH3OH.,,Autocuration,,,14904,,CHEMBL629891,1,BAO_0000019,,,,U,,,7570,,22224,A,,0
,Percent parent compound extracted at 0.5 hr from plasma using CHCl3/CH3OH.,,Autocuration,,,14905,,CHEMBL629892,1,BAO_0000019,,,,U,,,7570,,22224,A,,0
,Percent parent compound extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,,Autocuration,,,14906,1235.0,CHEMBL629893,1,BAO_0000019,,,,U,,Adrenal cortex,7570,,22224,A,,0
,Percent parent compound extracted at 24 hours from liver using CHCl3/CH3OH.,,Autocuration,,,14907,,CHEMBL629894,1,BAO_0000019,,,,U,,,7570,,22224,A,,0
,Percent parent compound extracted at 24 hours from plasma using CHCl3/CH3OH.,,Autocuration,,,14908,,CHEMBL629895,1,BAO_0000019,,,,U,,,7570,,22224,A,,0
,"+Ratio of intravenous to oral integrated area under the concentration vs time curve, for compound in dog plasma",9615.0,Autocuration,,,14909,,CHEMBL875109,1,BAO_0000218,,In vivo,,U,,,14122,Canis lupus familiaris,22224,A,,0
,Absolute bioavailability in male cynomolgus monkeys,9541.0,Autocuration,,,14910,,CHEMBL629896,1,BAO_0000218,,In vivo,,U,,,16449,Macaca fascicularis,22224,A,,0
,Absolute bioavailability in maleSprague-Dawley rats,10116.0,Autocuration,,,14911,,CHEMBL629897,1,BAO_0000218,,In vivo,,U,,,16449,Rattus norvegicus,22224,A,,0
,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),10116.0,Intermediate,,,14912,2107.0,CHEMBL629898,1,BAO_0000218,,In vivo,,N,,Liver,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in liver of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14913,2107.0,CHEMBL630057,1,BAO_0000218,,In vivo,,N,,Liver,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in liver of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14914,2107.0,CHEMBL630058,1,BAO_0000218,,In vivo,,N,,Liver,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14915,2048.0,CHEMBL630059,1,BAO_0000218,,In vivo,,N,,Lung,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14916,2048.0,CHEMBL630060,1,BAO_0000218,,In vivo,,N,,Lung,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),10116.0,Intermediate,,,14917,2048.0,CHEMBL630061,1,BAO_0000218,,In vivo,,N,,Lung,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14918,2048.0,CHEMBL630062,1,BAO_0000218,,In vivo,,N,,Lung,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14919,2048.0,CHEMBL630063,1,BAO_0000218,,In vivo,,N,,Lung,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in lungs of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14920,2048.0,CHEMBL630064,1,BAO_0000218,,In vivo,,N,,Lung,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14921,2048.0,CHEMBL630065,1,BAO_0000218,,In vivo,,N,,Lung,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),10116.0,Intermediate,,,14922,2048.0,CHEMBL630066,1,BAO_0000218,,In vivo,,N,,Lung,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in lungs of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14923,2048.0,CHEMBL630067,1,BAO_0000218,,In vivo,,N,,Lung,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14924,2048.0,CHEMBL630068,1,BAO_0000218,,In vivo,,N,,Lung,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14925,2385.0,CHEMBL631113,1,BAO_0000218,,In vivo,,N,,Muscle tissue,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14926,2385.0,CHEMBL631114,1,BAO_0000218,,In vivo,,N,,Muscle tissue,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),10116.0,Intermediate,,,14927,2385.0,CHEMBL631115,1,BAO_0000218,,In vivo,,N,,Muscle tissue,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14928,2385.0,CHEMBL631116,1,BAO_0000218,,In vivo,,N,,Muscle tissue,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14929,2385.0,CHEMBL630528,1,BAO_0000218,,In vivo,,N,,Muscle tissue,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in muscle of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14930,2385.0,CHEMBL630529,1,BAO_0000218,,In vivo,,N,,Muscle tissue,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14931,2385.0,CHEMBL630530,1,BAO_0000218,,In vivo,,N,,Muscle tissue,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),10116.0,Intermediate,,,14932,2385.0,CHEMBL630531,1,BAO_0000218,,In vivo,,N,,Muscle tissue,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in muscle of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14933,2385.0,CHEMBL630532,1,BAO_0000218,,In vivo,,N,,Muscle tissue,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in muscle of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14934,2385.0,CHEMBL630533,1,BAO_0000218,,In vivo,,N,,Muscle tissue,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in normal mice blood after 120 hr,10090.0,Intermediate,,,14935,178.0,CHEMBL630534,1,BAO_0000218,,In vivo,,N,,Blood,15045,Mus musculus,50594,A,,1
,Biodistribution in normal mice blood after 24 hr,10090.0,Intermediate,,,14936,178.0,CHEMBL630535,1,BAO_0000218,,In vivo,,N,,Blood,15045,Mus musculus,50594,A,,1
,Biodistribution in normal mice blood after 4 hr,10090.0,Intermediate,,,14937,178.0,CHEMBL630536,1,BAO_0000218,,In vivo,,N,,Blood,15045,Mus musculus,50594,A,,1
,Biodistribution in normal mice bone after 120 hr,10090.0,Intermediate,,,14938,10000001.0,CHEMBL630537,1,BAO_0000218,,In vivo,,N,,Bone,15045,Mus musculus,50594,A,,1
,Biodistribution in normal mice bone after 24 hr,10090.0,Intermediate,,,14939,10000001.0,CHEMBL630538,1,BAO_0000218,,In vivo,,N,,Bone,15045,Mus musculus,50594,A,,1
,Biodistribution in normal mice bone after 4 hr,10090.0,Intermediate,,,14940,10000001.0,CHEMBL630539,1,BAO_0000218,,In vivo,,N,,Bone,15045,Mus musculus,50594,A,,1
,Biodistribution in normal mice heart after 120 hr,10090.0,Intermediate,,,14941,948.0,CHEMBL630540,1,BAO_0000218,,In vivo,,N,,Heart,15045,Mus musculus,50594,A,,1
,Biodistribution in normal mice heart after 24 hr,10090.0,Intermediate,,,14942,948.0,CHEMBL630541,1,BAO_0000218,,In vivo,,N,,Heart,15045,Mus musculus,50594,A,,1
,Biodistribution in normal mice heart after 4 hr,10090.0,Intermediate,,,14943,948.0,CHEMBL630542,1,BAO_0000218,,In vivo,,N,,Heart,15045,Mus musculus,50594,A,,1
,Biodistribution in normal mice kidney after 120 hr,10090.0,Intermediate,,,14944,2113.0,CHEMBL630543,1,BAO_0000218,,In vivo,,N,,Kidney,15045,Mus musculus,50594,A,,1
,Biodistribution in normal mice kidney after 24 hr,10090.0,Intermediate,,,14945,2113.0,CHEMBL630544,1,BAO_0000218,,In vivo,,N,,Kidney,15045,Mus musculus,50594,A,,1
,Biodistribution in normal mice kidney after 4 hr,10090.0,Intermediate,,,14946,2113.0,CHEMBL630545,1,BAO_0000218,,In vivo,,N,,Kidney,15045,Mus musculus,50594,A,,1
,Biodistribution in normal mice liver after 120 hr,10090.0,Intermediate,,,14947,2107.0,CHEMBL630546,1,BAO_0000218,,In vivo,,N,,Liver,15045,Mus musculus,50594,A,,1
,Biodistribution in normal mice liver after 24 hr,10090.0,Intermediate,,,14948,2107.0,CHEMBL630547,1,BAO_0000218,,In vivo,,N,,Liver,15045,Mus musculus,50594,A,,1
,Biodistribution in normal mice liver after 4 hr,10090.0,Intermediate,,,14949,2107.0,CHEMBL630548,1,BAO_0000218,,In vivo,,N,,Liver,15045,Mus musculus,50594,A,,1
,Biodistribution in normal mice spleen after 120 hr,10090.0,Intermediate,,,14950,2106.0,CHEMBL630549,1,BAO_0000218,,In vivo,,N,,Spleen,15045,Mus musculus,50594,A,,1
,Biodistribution in normal mice spleen after 24 hr,10090.0,Intermediate,,,14951,2106.0,CHEMBL630550,1,BAO_0000218,,In vivo,,N,,Spleen,15045,Mus musculus,50594,A,,1
,Biodistribution in normal mice spleen after 4 hr,10090.0,Intermediate,,,14952,2106.0,CHEMBL876426,1,BAO_0000218,,In vivo,,N,,Spleen,15045,Mus musculus,50594,A,,1
,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14953,2106.0,CHEMBL630551,1,BAO_0000218,,In vivo,,N,,Spleen,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14954,2106.0,CHEMBL630552,1,BAO_0000218,,In vivo,,N,,Spleen,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),10116.0,Intermediate,,,14955,2106.0,CHEMBL630553,1,BAO_0000218,,In vivo,,N,,Spleen,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14956,2106.0,CHEMBL630554,1,BAO_0000218,,In vivo,,N,,Spleen,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14957,2106.0,CHEMBL630555,1,BAO_0000218,,In vivo,,N,,Spleen,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in spleen of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14958,2106.0,CHEMBL630556,1,BAO_0000218,,In vivo,,N,,Spleen,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14959,2106.0,CHEMBL630557,1,BAO_0000218,,In vivo,,N,,Spleen,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),10116.0,Intermediate,,,14960,2106.0,CHEMBL630558,1,BAO_0000218,,In vivo,,N,,Spleen,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in spleen of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14961,2106.0,CHEMBL630559,1,BAO_0000218,,In vivo,,N,,Spleen,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in spleen of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14962,2106.0,CHEMBL630560,1,BAO_0000218,,In vivo,,N,,Spleen,12017,Rattus norvegicus,50597,A,,1
,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,10116.0,Intermediate,,,14963,2046.0,CHEMBL876427,1,BAO_0000218,,In vivo,,N,,Thyroid gland,12017,Rattus norvegicus,50597,A,,1
,The Kel values in female wistar rats.,10116.0,Intermediate,,,14964,,CHEMBL630561,1,BAO_0000218,,,,N,,,14941,Rattus norvegicus,50597,A,,1
,The equilibrium constant pair at a pH of 7.0 and temperature of 25 degree Centigrade,,Autocuration,,,14965,,CHEMBL630562,1,BAO_0000019,,,,U,,,4646,,22224,A,,0
,Hydrolysis rate constant of the compound,,Autocuration,,,14966,,CHEMBL630563,1,BAO_0000019,,,,U,,,8847,,22224,A,,0
,Headecane/water partition coefficient expressed as the equilibrium ratio of the molar concentration in n-hexadecane to that in the buffer,,Autocuration,,,14967,,CHEMBL629673,1,BAO_0000100,,,,U,,,11778,,22229,P,,0
,"Hydrolysis in acetone/water (50:50) at a pH of 8.0, T=66 degree Centigrade",,Autocuration,,,14968,,CHEMBL629674,1,BAO_0000019,,,,U,,,2363,,22224,A,,0
,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree Centigrade",,Autocuration,,,14969,,CHEMBL629675,1,BAO_0000019,,,,U,,,2363,,22224,A,,0
,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; No data",,Autocuration,,,14970,,CHEMBL629676,1,BAO_0000019,,,,U,,,2363,,22224,A,,0
,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; Not determined",,Autocuration,,,14971,,CHEMBL629677,1,BAO_0000019,,,,U,,,2363,,22224,A,,0
,Apparent inactivation rate constant was evaluated,,Autocuration,,,14972,,CHEMBL629678,1,BAO_0000019,,,,U,,,8371,,22224,A,,0
,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 25 degree Centigrade.,,Autocuration,,,14973,,CHEMBL629679,1,BAO_0000019,,,,U,,,14883,,22224,A,,0
,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 37 degree Centigrade,,Autocuration,,,14974,,CHEMBL629680,1,BAO_0000019,,,,U,,,14883,,22224,A,,0
,Compound was evaluated for the Ki value for peptide alcohol for competitive inhibition in the presence of Mn2+ ions at pH 7.5,,Autocuration,,,14975,,CHEMBL629681,1,BAO_0000019,,,,U,,,4643,,22224,A,,0
,Compound was tested for the inhibition of antibody-catalyzed hydrolysis.,,Autocuration,,,14976,,CHEMBL629682,1,BAO_0000019,,,,U,,,3519,,22224,A,,0
,DBH (dopamine beta-hydroxylase) activity expressed as Ki value determined by degree to which compound inhibited conversion of tyramine to octopamine,,Autocuration,,,14977,,CHEMBL629683,1,BAO_0000019,,,,U,,,10600,,22224,A,,0
,Dissociation constant against constrictor response to the compound blocked competitively by phentolamine for alpha-mediated events,,Autocuration,,,14978,,CHEMBL629684,1,BAO_0000019,,,,U,,,8501,,22224,F,,0
,Dissociation constant was determined,,Autocuration,,,14979,,CHEMBL629685,1,BAO_0000100,,,,U,,,8505,,22224,P,,0
,Dissociation constant was determined,,Autocuration,,,14980,,CHEMBL629686,1,BAO_0000100,,,,U,,,9778,,22224,P,,0
,Dissociation constant at pH 7.4,,Autocuration,,,14981,,CHEMBL872932,1,BAO_0000100,,,,U,,,9778,,22224,P,,0
,Dissociation constant in presence of 1 mM dithiothreitol,,Autocuration,,,14982,,CHEMBL629687,1,BAO_0000100,,,,U,,,9778,,22224,P,,0
,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,Autocuration,,,14983,,CHEMBL872931,1,BAO_0000019,,,,U,,,13007,,22224,A,,0
,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,Autocuration,,,14984,,CHEMBL628151,1,BAO_0000019,,,,U,,,13007,,22224,A,,0
,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,Autocuration,,,14985,,CHEMBL628152,1,BAO_0000019,,,,U,,,13007,,22224,A,,0
,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,Autocuration,,,14986,,CHEMBL628153,1,BAO_0000019,,,,U,,,13007,,22224,A,,0
,Kinetic constant for aromatization of androstenedione,,Autocuration,,,14987,,CHEMBL628154,1,BAO_0000019,,,,U,,,11482,,22224,A,,0
,Kinetic constant for aromatization of testosterone,,Autocuration,,,14988,,CHEMBL628155,1,BAO_0000019,,,,U,,,11482,,22224,A,,0
,Kinetic parameter for hydrolysis of 1 by Antibody 2D10 after addition of compound 12,,Autocuration,,,14989,,CHEMBL628156,1,BAO_0000019,,,,U,,,2303,,22224,A,,0
,Local inhibition constant was determined,,Autocuration,,,14990,,CHEMBL628157,1,BAO_0000019,,,,U,,,11964,,22224,A,,0
,Rate of inactivation of sterol methyl transferase from Saccharomyces cerevisiae using mechanism based inhibitor,4932.0,Intermediate,,,14991,,CHEMBL857533,1,BAO_0000218,,,,N,,,3140,Saccharomyces cerevisiae,50347,A,,1
,Dissociation constant value of the compound,,Autocuration,,,14992,,CHEMBL628158,1,BAO_0000100,,,,U,,,10650,,22224,P,,0
,In vitro permeability through cornea without epithelium,,Autocuration,,,14993,964.0,CHEMBL628159,1,BAO_0000019,,,,U,,Cornea,4667,,22224,A,,0
,In vitro permeability through intact cornea,,Autocuration,,,14994,964.0,CHEMBL875616,1,BAO_0000019,,,,U,,Cornea,4667,,22224,A,,0
,Evaluated for first order rate constant (Kin) for transcorneal penetration in anesthetized rabbits,9986.0,Intermediate,,,14995,964.0,CHEMBL628160,1,BAO_0000218,,,,N,,Cornea,9199,Oryctolagus cuniculus,50592,A,,1
,Rate of enzyme inactivation for the compound was determined,,Autocuration,,,14996,,CHEMBL628161,1,BAO_0000019,,,,U,,,11966,,22224,A,,0
,In vitro permeability through cornea without epithelium,,Autocuration,,,14997,964.0,CHEMBL628162,1,BAO_0000019,,,,U,,Cornea,4667,,22224,A,,0
,In vitro permeability through intact cornea,,Autocuration,,,14998,964.0,CHEMBL628163,1,BAO_0000019,,,,U,,Cornea,4667,,22224,A,,0
,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,Autocuration,,,14999,,CHEMBL628164,1,BAO_0000019,,,,U,,,8354,,22224,A,,0
,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,Autocuration,,,15000,,CHEMBL628165,1,BAO_0000019,,,,U,,,8354,,22224,A,,0
,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,Autocuration,,,15001,,CHEMBL628166,1,BAO_0000019,,,,U,,,8354,,22224,A,,0
,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,Autocuration,,,15002,,CHEMBL628167,1,BAO_0000019,,,,U,,,8354,,22224,A,,0
,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.050 mM [HOX] in the conditions of 25degreeC,pH 7.6",,Autocuration,,,15003,,CHEMBL628168,1,BAO_0000019,,,,U,,,8354,,22224,A,,0
,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,Autocuration,,,15004,,CHEMBL628169,1,BAO_0000019,,,,U,,,8354,,22224,A,,0
,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,Autocuration,,,15005,,CHEMBL628170,1,BAO_0000019,,,,U,,,8354,,22224,A,,0
,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0800 mM [HOX] in the conditions of 25degreeC,pH 7.6",,Autocuration,,,15006,,CHEMBL628171,1,BAO_0000019,,,,U,,,8354,,22224,A,,0
,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.100 mM [HOX] in the conditions of 25degreeC,pH 7.6",,Autocuration,,,15007,,CHEMBL627434,1,BAO_0000019,,,,U,,,8354,,22224,A,,0
,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.200 mM [HOX] in the conditions of 25degreeC,pH 7.6",,Autocuration,,,15008,,CHEMBL627435,1,BAO_0000019,,,,U,,,8354,,22224,A,,0
,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,Autocuration,,,15009,,CHEMBL628110,1,BAO_0000019,,,,U,,,8354,,22224,A,,0
,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,Autocuration,,,15010,,CHEMBL628111,1,BAO_0000019,,,,U,,,8354,,22224,A,,0
,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,Autocuration,,,15011,,CHEMBL628112,1,BAO_0000019,,,,U,,,8354,,22224,A,,0
,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,Autocuration,,,15012,,CHEMBL628260,1,BAO_0000019,,,,U,,,8354,,22224,A,,0
,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,Autocuration,,,15013,,CHEMBL628261,1,BAO_0000019,,,,U,,,8354,,22224,A,,0
,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Muscle (M),10090.0,Intermediate,,,15014,,CHEMBL628262,1,BAO_0000218,,In vivo,,N,,,14439,Mus musculus,50594,A,,1
,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Tumor (T) cells,9606.0,Intermediate,,,15015,,CHEMBL628263,1,BAO_0000218,,In vivo,,N,,,14439,Homo sapiens,50587,A,,1
,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Blood (B),10090.0,Intermediate,,,15016,,CHEMBL628264,1,BAO_0000218,,In vivo,,N,,,14439,Mus musculus,50594,A,,1
,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Heart (H),10090.0,Intermediate,,,15017,,CHEMBL628265,1,BAO_0000218,,In vivo,,N,,,14439,Mus musculus,50594,A,,1
,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Lung (L),10090.0,Intermediate,,,15018,,CHEMBL628266,1,BAO_0000218,,In vivo,,N,,,14439,Mus musculus,50594,A,,1
,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Muscle (M),10090.0,Intermediate,,,15019,,CHEMBL628267,1,BAO_0000218,,In vivo,,N,,,14439,Mus musculus,50594,A,,1
,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Tumor (T) cells,10090.0,Intermediate,,,15020,,CHEMBL628268,1,BAO_0000218,,In vivo,,N,,,14439,Mus musculus,50594,A,,1
,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Blood (B),10090.0,Intermediate,,,15021,,CHEMBL628269,1,BAO_0000218,,In vivo,,N,,,14439,Mus musculus,50594,A,,1
,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Heart (H),10090.0,Intermediate,,,15022,,CHEMBL628270,1,BAO_0000218,,In vivo,,N,,,14439,Mus musculus,50594,A,,1
,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Lung (L),10090.0,Intermediate,,,15023,,CHEMBL628271,1,BAO_0000218,,In vivo,,N,,,14439,Mus musculus,50594,A,,1
,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Muscle (M),10090.0,Intermediate,,,15024,,CHEMBL628272,1,BAO_0000218,,In vivo,,N,,,14439,Mus musculus,50594,A,,1
